Citrus Sinensis ID: 010429
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | 2.2.26 [Sep-21-2011] | |||||||
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | yes | no | 0.978 | 0.813 | 0.868 | 0.0 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.949 | 0.782 | 0.818 | 0.0 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 0.949 | 0.772 | 0.826 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.984 | 0.804 | 0.802 | 0.0 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.947 | 0.805 | 0.715 | 0.0 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.925 | 0.741 | 0.552 | 1e-144 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.982 | 0.818 | 0.556 | 1e-143 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.925 | 0.744 | 0.527 | 1e-138 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.964 | 0.812 | 0.546 | 1e-138 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.990 | 0.800 | 0.528 | 1e-136 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 837 bits (2162), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/500 (86%), Positives = 462/500 (92%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSEN 69
F IL DL+LRV+ NAEGDAL+ALK +LADPN VLQSWDATLV PCTWFHVTCNS+N
Sbjct: 9 CFFWLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDN 68
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
SVTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+G +PE+LGNLT LVSLDLYLNNL
Sbjct: 69 SVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNL 128
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+GPIP+TLG+L KLRFLRLNNNSL GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSL
Sbjct: 129 SGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSL 188
Query: 190 FTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAY 249
FTPISFAN +L P SPPPP+ PTPP + N TGAIAGGVAAGAALLFA PAIALA+
Sbjct: 189 FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAW 248
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 309
WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL
Sbjct: 249 WRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL 308
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M N
Sbjct: 309 ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 368
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429
GSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEF
Sbjct: 369 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 428
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG
Sbjct: 429 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 488
Query: 490 QRAFDLARLANDDDVMLLDW 509
QRAFDLARLANDDDVMLLDW
Sbjct: 489 QRAFDLARLANDDDVMLLDW 508
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 778 bits (2008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/490 (81%), Positives = 436/490 (88%), Gaps = 5/490 (1%)
Query: 23 RVASNAEGDALNALKTNLA--DP-NNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNA 79
RVA NAEGDAL LK +L+ DP NNVLQSWDATLV PCTWFHVTCN EN VTRVDLGNA
Sbjct: 26 RVAGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNA 85
Query: 80 NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139
LSG+LV +LGQL NLQYLELYSNNI+G++PEELG+L LVSLDLY N+++GPIP++LGK
Sbjct: 86 KLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGK 145
Query: 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQ 199
L KLRFLRLNNNSL GEIP +LT+V LQVLD+SNN+L+GDIP NGSFSLFTPISFANN
Sbjct: 146 LGKLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANNS 204
Query: 200 LNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHF 259
L + P PP PTP SG T AIAGGVAAGAALLFA PAIA A+W +RKP+DHF
Sbjct: 205 LTDLPEPPPTSTSPTP-PPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHF 263
Query: 260 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKR 319
FDVPAEEDPEVHLGQLKRF+LREL VATDNFSN+N+LGRGGFGKVYKGRL DG+LVAVKR
Sbjct: 264 FDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKR 323
Query: 320 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 379
LKEERT+GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER
Sbjct: 324 LKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 383
Query: 380 GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439
+ P L+W RK IALG+ARGLAYLHDHCD KIIHRDVKAANILLDEEFEAVVGDFGLA
Sbjct: 384 PEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLA 443
Query: 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499
KLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ+AFDLARLA
Sbjct: 444 KLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLA 503
Query: 500 NDDDVMLLDW 509
NDDD+MLLDW
Sbjct: 504 NDDDIMLLDW 513
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 771 bits (1991), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/497 (82%), Positives = 442/497 (88%), Gaps = 12/497 (2%)
Query: 25 ASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQ 84
+SN EGDAL++L+ NL DPNNVLQSWD TLVNPCTWFHVTCN+ENSV RVDLGNA+LSGQ
Sbjct: 28 SSNMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSGQ 87
Query: 85 LVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLR 144
LV QLGQL NLQYLELYSNNI+G VP +LGNLTNLVSLDLYLN+ GPIP +LGKL KLR
Sbjct: 88 LVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLR 147
Query: 145 FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN-QLNNP 203
FLRLNNNSL G IP SLTN+ +LQVLDLSNN+L+G +P NGSFSLFTPISFANN L P
Sbjct: 148 FLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGP 207
Query: 204 PPS-----------PPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRK 252
S PPP + P G SATGAIAGGVAAGAALLFAAPA+A A+WR+
Sbjct: 208 VTSRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRR 267
Query: 253 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDG 312
RKP++ FFDVPAEEDPEVHLGQLKRFSLRELQVATD+FSN+NILGRGGFGKVYKGRL DG
Sbjct: 268 RKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADG 327
Query: 313 SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSV
Sbjct: 328 TLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 387
Query: 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432
ASCLRER SQ PL WS+R+QIALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAV
Sbjct: 388 ASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAV 447
Query: 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 492
VGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRA
Sbjct: 448 VGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRA 507
Query: 493 FDLARLANDDDVMLLDW 509
FDLARLANDDDVMLLDW
Sbjct: 508 FDLARLANDDDVMLLDW 524
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 768 bits (1983), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/516 (80%), Positives = 442/516 (85%), Gaps = 13/516 (2%)
Query: 7 VVWAFLVSILFFDLLLRVAS-NAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTC 65
VV+ L IL + L +AS N EGDAL+ L+ L DPNNVLQSWD TLVNPCTWFHVTC
Sbjct: 6 VVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTC 65
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
N+ENSV RVDLGNA LSG LV +LG L NLQYLELYSNNI+G +P LGNLTNLVSLDLY
Sbjct: 66 NNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLY 125
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
LN+ +GPIP +LGKLSKLRFLRLNNNSL G IP SLTN+ +LQVLDLSNN+L+G +P NG
Sbjct: 126 LNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNG 185
Query: 186 SFSLFTPISFANN-QLNNPPPSPPPPLQPTPP-----------GASSGNSATGAIAGGVA 233
SFSLFTPISFANN L P S P P P SG TGAIAGGVA
Sbjct: 186 SFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVA 245
Query: 234 AGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNR 293
AGAALLFAAPAIA A+WR+RKP D FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSN+
Sbjct: 246 AGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNK 305
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
NILGRGGFGKVYKGRL DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGF
Sbjct: 306 NILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 365
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
CMTPTERLLVYP+M NGSVASCLRER SQPPL+W RK+IALG+ARGL+YLHDHCDPKI
Sbjct: 366 CMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKI 425
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK
Sbjct: 426 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 485
Query: 474 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509
TDVFGYG+MLLELITGQRAFDLARLANDDDVMLLDW
Sbjct: 486 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDW 521
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/503 (71%), Positives = 411/503 (81%), Gaps = 19/503 (3%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLAD---PNNVLQSWDATLVNPCTWFHVTCN 66
F+ ILF D + RV + DAL AL+++L+ NN+LQSW+AT V PC+WFHVTCN
Sbjct: 8 GFIWLILFLDFVSRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCN 67
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
+ENSVTR+DLG+ANLSG+LV QL QL NLQYLEL++NNI+G++PEELG+L LVSLDL+
Sbjct: 68 TENSVTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFA 127
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
NN++GPIP++LGKL KLRFLRL NNSL GEIPRSLT + L VLD+SNN+L+GDIP NGS
Sbjct: 128 NNISGPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTAL-PLDVLDISNNRLSGDIPVNGS 186
Query: 187 FSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIA 246
FS FT +SFANN+L + S + + AI GVAAGAALLFA
Sbjct: 187 FSQFTSMSFANNKLR----------PRPASPSPSPSGTSAAIVVGVAAGAALLFALAWWL 236
Query: 247 LAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYK 306
+RK + HF DVPAEEDPEV+LGQ KRFSLREL VAT+ FS RN+LG+G FG +YK
Sbjct: 237 -----RRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYK 291
Query: 307 GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366
GRL D +LVAVKRL EERT+GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+
Sbjct: 292 GRLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 351
Query: 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 426
M NGSVASCLRER + P L+W RK IALG+ARGLAYLHDHCD KIIH DVKAANILLD
Sbjct: 352 MANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLD 411
Query: 427 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
EEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL
Sbjct: 412 EEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 471
Query: 487 ITGQRAFDLARLANDDDVMLLDW 509
ITGQ+AFDLARLANDDD+MLLDW
Sbjct: 472 ITGQKAFDLARLANDDDIMLLDW 494
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 511 bits (1316), Expect = e-144, Method: Compositional matrix adjust.
Identities = 275/498 (55%), Positives = 348/498 (69%), Gaps = 25/498 (5%)
Query: 27 NAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLV 86
N E AL +K +L DP+ VL +WD V+PC+W VTC+SEN V + + NLSG L
Sbjct: 39 NFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSENFVIGLGTPSQNLSGTLS 98
Query: 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146
+ LTNL+ + L +NNI GK+P E+G LT L +LDL N +G IP ++G L L++L
Sbjct: 99 PSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYL 158
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
RLNNNSL G P SL+N+ L LDLS N L+G +P F+ T S N L P +
Sbjct: 159 RLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP---RFAAKT-FSIVGNPLICPTGT 214
Query: 207 PP----PPLQP---------TPPGASSGNSATGAIAGGVAAG-AALLFAAPAIALAYWRK 252
P L P P A + AIA G + G +L+F A + L +WR+
Sbjct: 215 EPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFL-WWRQ 273
Query: 253 RKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 311
R ++ FFDV EV LG L+RF RELQ+AT+NFS++N+LG+GG+G VYKG L D
Sbjct: 274 RHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGD 333
Query: 312 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371
++VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYP+M NGS
Sbjct: 334 STVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGS 393
Query: 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431
VAS R +++P L+WS+RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLD+ EA
Sbjct: 394 VAS----RMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEA 449
Query: 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491
VVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLEL+TGQR
Sbjct: 450 VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQR 509
Query: 492 AFDLARLANDDDVMLLDW 509
AF+ + AN VM LDW
Sbjct: 510 AFEFGKAANQKGVM-LDW 526
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 507 bits (1306), Expect = e-143, Method: Compositional matrix adjust.
Identities = 285/512 (55%), Positives = 348/512 (67%), Gaps = 10/512 (1%)
Query: 1 MGKLERVVWAFLVSILFFDLLLR-VASNAEGDALNALKTNLADPNNVLQSWDATLVNPCT 59
M L+++ AF ++LFF L V+ +A+GDAL AL+ +L N L W+ VNPCT
Sbjct: 3 MFSLQKMAMAF--TLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCT 60
Query: 60 WFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL 119
W V C+ +N VT + L + N SG L S++G L NL+ L L N I+G++PE+ GNLT+L
Sbjct: 61 WSQVICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSL 120
Query: 120 VSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
SLDL N L G IP+T+G L KL+FL L+ N L G IP SLT + +L L L +N L+G
Sbjct: 121 TSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSG 180
Query: 180 DIPTNGSFSLFT--PISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAA 237
IP SLF +F +N LN P P + S TG IAG VA
Sbjct: 181 QIPQ----SLFEIPKYNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTV 236
Query: 238 LLFAAPAIALAYWR-KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNIL 296
+LF R K D F DV E D + GQLKRF+ RELQ+ATDNFS +N+L
Sbjct: 237 VLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVL 296
Query: 297 GRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356
G+GGFGKVYKG L D + VAVKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC T
Sbjct: 297 GQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 356
Query: 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 416
TERLLVYPFM N S+A LRE P L+W RK+IALGAARG YLH+HC+PKIIHR
Sbjct: 357 QTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHR 416
Query: 417 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV 476
DVKAAN+LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDV
Sbjct: 417 DVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDV 476
Query: 477 FGYGVMLLELITGQRAFDLARLANDDDVMLLD 508
FGYG+MLLEL+TGQRA D +RL +DDV+LLD
Sbjct: 477 FGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 508
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1268), Expect = e-138, Method: Compositional matrix adjust.
Identities = 262/497 (52%), Positives = 337/497 (67%), Gaps = 24/497 (4%)
Query: 27 NAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLV 86
N E AL +K++L DP+ VL +WD T V+PC+W +TC S+ V R++ + NLSG L
Sbjct: 40 NFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITC-SDGFVIRLEAPSQNLSGTLS 98
Query: 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146
S +G LTNLQ + L +N I+G +P E+G L L +LDL NN G IP TL L++L
Sbjct: 99 SSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYL 158
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
R+NNNSL G IP SL N+ L LDLS N L+G +P SL + N P +
Sbjct: 159 RVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPR----SLAKTFNVMGNSQICPTGT 214
Query: 207 P-------PPPLQPTPPGASSGNSATG------AIAGGVAAGAALLFAAPAIALAYWRKR 253
P P+ T + + +S G A+ GV+ L L +WR+R
Sbjct: 215 EKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRRR 274
Query: 254 KPEDH-FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDG 312
+ FFD+ + E+ LG L+RF+ +ELQ AT NFS++N++G+GGFG VYKG L DG
Sbjct: 275 HNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDG 334
Query: 313 SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
S++AVKRLK+ GGE+QFQTE+EMIS+AVHRNLLRL GFC T +ERLLVYP+M NGSV
Sbjct: 335 SIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSV 394
Query: 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432
AS R +++P L+W RK+IALGA RGL YLH+ CDPKIIHRDVKAANILLD+ FEAV
Sbjct: 395 AS----RLKAKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAV 450
Query: 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 492
VGDFGLAKL+D++++HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG RA
Sbjct: 451 VGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRA 510
Query: 493 FDLARLANDDDVMLLDW 509
+ + AN +LDW
Sbjct: 511 LEFGKAANQRGA-ILDW 526
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1264), Expect = e-138, Method: Compositional matrix adjust.
Identities = 275/503 (54%), Positives = 341/503 (67%), Gaps = 10/503 (1%)
Query: 11 FLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENS 70
+ +++F L V+ +A+GDAL AL+++L L W+ V+PCTW V C+ +
Sbjct: 5 IITALVFSSLWSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPCTWSQVICDDKKH 64
Query: 71 VTRVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
VT V L N S G L S +G LT L+ L L N I G +PE +GNL++L SLDL N+L
Sbjct: 65 VTSVTLSYMNFSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSLDLEDNHL 124
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
IP+TLG L L+FL L+ N+L G IP SLT ++ L + L +N L+G+IP SL
Sbjct: 125 TDRIPSTLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQ----SL 180
Query: 190 FT--PISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIAL 247
F +F N L+ P P + + P S + TG IAG V +G A++
Sbjct: 181 FKIPKYNFTANNLSCGGTFPQPCVTESSPSGDSSSRKTGIIAG-VVSGIAVILLGFFFFF 239
Query: 248 AYWRKRK--PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVY 305
K K D F DV E D + GQL+RF+ RELQ+ATD FS +N+LG+GGFGKVY
Sbjct: 240 FCKDKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVY 299
Query: 306 KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365
KG L+DG+ VAVKRL + GG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYP
Sbjct: 300 KGLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYP 359
Query: 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425
FM N SVA CLRE P L+W RKQIALGAARGL YLH+HC+PKIIHRDVKAAN+LL
Sbjct: 360 FMQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGLEYLHEHCNPKIIHRDVKAANVLL 419
Query: 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 485
DE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPE +STGKSSEKTDVFGYG+MLLE
Sbjct: 420 DEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLE 479
Query: 486 LITGQRAFDLARLANDDDVMLLD 508
L+TGQRA D +RL +DDV+LLD
Sbjct: 480 LVTGQRAIDFSRLEEEDDVLLLD 502
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1249), Expect = e-136, Method: Compositional matrix adjust.
Identities = 276/522 (52%), Positives = 357/522 (68%), Gaps = 16/522 (3%)
Query: 1 MGKLERVVW--AFLVSILFFDL----LLRVASNAEGDALNALKTNLADPNNVLQSWDATL 54
M + VVW FLV + FFD+ L N E AL A+K L DP VL++WD
Sbjct: 1 MEGVRFVVWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNS 60
Query: 55 VNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG 114
V+PC+W V+C ++ V+ +DL + +LSG L ++G LT LQ + L +N I+G +PE +G
Sbjct: 61 VDPCSWRMVSC-TDGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIG 119
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
L L SLDL N+ G IP +LG+L L +LRLNNNSL+G P SL+ + L ++D+S
Sbjct: 120 RLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISY 179
Query: 175 NKLTGDIPTNGSFSLFTPISFA----NNQLNNPPPSPPPPLQPTPPGASSGNSATG---A 227
N L+G +P S F I A ++N P P P SG G A
Sbjct: 180 NNLSGSLP-KVSARTFKVIGNALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVA 238
Query: 228 IAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVAT 287
+A + AA + +WR R+ + FFDV + DPEV LG LKR++ +EL+ AT
Sbjct: 239 LAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSAT 298
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
++F+++NILGRGG+G VYKG L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNL
Sbjct: 299 NHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNL 358
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
LRLRGFC + ER+LVYP+M NGSVAS L++ + +P L+WS RK+IA+G ARGL YLH+
Sbjct: 359 LRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHE 418
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
CDPKIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLST
Sbjct: 419 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 478
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509
G+SSEKTDVFG+G++LLELITGQ+A D R A+ VM LDW
Sbjct: 479 GQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVM-LDW 519
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | ||||||
| 359485981 | 610 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.976 | 0.818 | 0.894 | 0.0 | |
| 356510695 | 621 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.996 | 0.819 | 0.805 | 0.0 | |
| 18418211 | 615 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.978 | 0.813 | 0.868 | 0.0 | |
| 333952414 | 620 | somatic embryogenesis receptor-like kina | 0.986 | 0.812 | 0.881 | 0.0 | |
| 14573459 | 615 | somatic embryogenesis receptor-like kina | 0.978 | 0.813 | 0.868 | 0.0 | |
| 297798596 | 612 | bri1-associated receptor kinase [Arabido | 0.976 | 0.815 | 0.868 | 0.0 | |
| 356558614 | 616 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.990 | 0.821 | 0.868 | 0.0 | |
| 356558616 | 620 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.990 | 0.816 | 0.868 | 0.0 | |
| 397880702 | 632 | leucine-rich repeat receptor-like kinase | 0.984 | 0.795 | 0.829 | 0.0 | |
| 327422167 | 620 | somatic embryogenesis receptor-like kina | 0.984 | 0.811 | 0.876 | 0.0 |
| >gi|359485981|ref|XP_002262698.2| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like [Vitis vinifera] gi|296081547|emb|CBI20070.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2195), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/500 (89%), Positives = 471/500 (94%), Gaps = 1/500 (0%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSEN 69
F+ I+ F LRV+ N+EGDALNALK+NLADPNNVLQSWDATLVNPCTWFHVTCNS+N
Sbjct: 9 VFVSLIIVFSAFLRVSGNSEGDALNALKSNLADPNNVLQSWDATLVNPCTWFHVTCNSDN 68
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK+PEELGNLTNLVSLDLY+N L
Sbjct: 69 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKIPEELGNLTNLVSLDLYMNKL 128
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+GPIPTTL KL+KLRFLRLNNN+L G IPRSLT V +LQVLDLSNN+LTGDIP +GSFSL
Sbjct: 129 SGPIPTTLAKLAKLRFLRLNNNTLTGTIPRSLTTVMTLQVLDLSNNQLTGDIPVDGSFSL 188
Query: 190 FTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAY 249
FTPISF NN+LN P SPPPP+ PT ASSGNSATGAIAGGVAAGAALLFAAPAI LA+
Sbjct: 189 FTPISFNNNRLNPLPVSPPPPISPTLT-ASSGNSATGAIAGGVAAGAALLFAAPAIVLAW 247
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 309
WR+RKP++HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN++ILGRGGFGKVYKGRL
Sbjct: 248 WRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKHILGRGGFGKVYKGRL 307
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN
Sbjct: 308 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 367
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429
GSVASCLRER Q PLNW +RKQIALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEF
Sbjct: 368 GSVASCLRERADGQSPLNWPIRKQIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 427
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG
Sbjct: 428 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 487
Query: 490 QRAFDLARLANDDDVMLLDW 509
QRAFDLARLANDDDVMLLDW
Sbjct: 488 QRAFDLARLANDDDVMLLDW 507
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510695|ref|XP_003524071.1| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 841 bits (2173), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/514 (80%), Positives = 446/514 (86%), Gaps = 5/514 (0%)
Query: 1 MGKLERVV-----WAFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLV 55
M +ERV+ W L +IL DLLL+V+ N EGDAL ALK +++DPNNVLQSWD+TLV
Sbjct: 1 MANMERVISDFMSWFPLWAILVLDLLLKVSGNTEGDALTALKNSVSDPNNVLQSWDSTLV 60
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN 115
+PCTWFHVTCN+ENSVTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+GK+P+ELG+
Sbjct: 61 DPCTWFHVTCNNENSVTRVDLGNANLSGQLVPQLGQLPNLQYLELYSNNITGKIPDELGS 120
Query: 116 LTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175
L NLVSLDLY NN+ GPI L L KLRFLRLNNNSL G+IP LT V+SLQVLDLSNN
Sbjct: 121 LRNLVSLDLYSNNITGPISDNLANLKKLRFLRLNNNSLSGKIPVRLTTVDSLQVLDLSNN 180
Query: 176 KLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAG 235
LTGDIP NGSFS FTPISF NN N PPP + P + +GN A IAGGVA G
Sbjct: 181 NLTGDIPINGSFSSFTPISFRNNPSLNNTLVPPPAVTPPQSSSGNGNRAIVIIAGGVAVG 240
Query: 236 AALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNI 295
AALLFAAP I L YW++RKP D FFDV AEEDPEVHLGQLKRFSLRELQVATD F+N+NI
Sbjct: 241 AALLFAAPVIVLVYWKRRKPRDFFFDVAAEEDPEVHLGQLKRFSLRELQVATDTFNNKNI 300
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+GGFGKVYKGRLT+G LVAVKRLKEERTQGGE+QFQTEVEMISMAVHRNLLRLRGFCM
Sbjct: 301 LGKGGFGKVYKGRLTNGDLVAVKRLKEERTQGGEMQFQTEVEMISMAVHRNLLRLRGFCM 360
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
TPTERLLVYPFM NGSVASCLR+R +SQPPL W RK IALGAARGLAYLHDHCDPKIIH
Sbjct: 361 TPTERLLVYPFMSNGSVASCLRDRPESQPPLEWPKRKNIALGAARGLAYLHDHCDPKIIH 420
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 475
RDVKAANILLD++FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD
Sbjct: 421 RDVKAANILLDDDFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 480
Query: 476 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509
VFGYGVMLLELITGQRAFDLARLANDDDVMLLDW
Sbjct: 481 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 514
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18418211|ref|NP_567920.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] gi|29427920|sp|Q94F62.2|BAK1_ARATH RecName: Full=BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1; Short=AtBAK1; Short=BRI1-associated receptor kinase 1; AltName: Full=Protein ELONGATED; AltName: Full=Somatic embryogenesis receptor kinase 3; Short=AtSERK3; AltName: Full=Somatic embryogenesis receptor-like kinase 3; Flags: Precursor gi|224589645|gb|ACN59355.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332660823|gb|AEE86223.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2162), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/500 (86%), Positives = 462/500 (92%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSEN 69
F IL DL+LRV+ NAEGDAL+ALK +LADPN VLQSWDATLV PCTWFHVTCNS+N
Sbjct: 9 CFFWLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDN 68
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
SVTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+G +PE+LGNLT LVSLDLYLNNL
Sbjct: 69 SVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNL 128
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+GPIP+TLG+L KLRFLRLNNNSL GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSL
Sbjct: 129 SGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSL 188
Query: 190 FTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAY 249
FTPISFAN +L P SPPPP+ PTPP + N TGAIAGGVAAGAALLFA PAIALA+
Sbjct: 189 FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAW 248
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 309
WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL
Sbjct: 249 WRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL 308
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M N
Sbjct: 309 ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 368
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429
GSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEF
Sbjct: 369 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 428
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG
Sbjct: 429 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 488
Query: 490 QRAFDLARLANDDDVMLLDW 509
QRAFDLARLANDDDVMLLDW
Sbjct: 489 QRAFDLARLANDDDVMLLDW 508
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|333952414|gb|AEG25668.1| somatic embryogenesis receptor-like kinase 3 protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2162), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/505 (88%), Positives = 467/505 (92%), Gaps = 1/505 (0%)
Query: 5 ERVVWAFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVT 64
+R++ L I FDL RVA NAEGDALNALKTN+ DPNNVLQSWD TLVNPCTWFHVT
Sbjct: 7 QRLISFCLWLIFVFDLAFRVAGNAEGDALNALKTNMVDPNNVLQSWDPTLVNPCTWFHVT 66
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
CNSENSVTRVDLGNANL+GQLV QLG L NLQYLELYSNNISG +P+ELGNLT LVSLDL
Sbjct: 67 CNSENSVTRVDLGNANLTGQLVPQLGSLPNLQYLELYSNNISGTIPDELGNLTELVSLDL 126
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
YLN L G IPTTLG+L KLRFLRLNNNSL G IPRSLT +++LQVLDLSNN L GD+P N
Sbjct: 127 YLNKLTGDIPTTLGQLKKLRFLRLNNNSLAGTIPRSLTTIDTLQVLDLSNNGLVGDVPVN 186
Query: 185 GSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPA 244
GSFSLFTPISFANN+LNNPPP+PPPP+ PTPP A SG S+TGAIAGGVAAGAALLFAAPA
Sbjct: 187 GSFSLFTPISFANNKLNNPPPAPPPPIPPTPP-AQSGISSTGAIAGGVAAGAALLFAAPA 245
Query: 245 IALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKV 304
I LA WRKRK DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN+NILGRGGFGKV
Sbjct: 246 IVLALWRKRKAPDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKNILGRGGFGKV 305
Query: 305 YKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364
YKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY
Sbjct: 306 YKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 365
Query: 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
PFMVNGSVASCLRER +SQP L+W++RK+IALGAARGLAYLHDHCDPKIIHRDVKAANIL
Sbjct: 366 PFMVNGSVASCLRERSESQPALDWAIRKRIALGAARGLAYLHDHCDPKIIHRDVKAANIL 425
Query: 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 484
LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL
Sbjct: 426 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 485
Query: 485 ELITGQRAFDLARLANDDDVMLLDW 509
ELITGQRAFDLARLANDDDVMLLDW
Sbjct: 486 ELITGQRAFDLARLANDDDVMLLDW 510
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14573459|gb|AAK68074.1|AF384970_1 somatic embryogenesis receptor-like kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2161), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/500 (86%), Positives = 462/500 (92%)
Query: 10 AFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSEN 69
F IL DL+LRV+ NAEGDAL+ALK +LADPN VLQSWDATLV PCTWFHVTCNS+N
Sbjct: 9 CFFGLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDN 68
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
SVTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+G +PE+LGNLT LVSLDLYLNNL
Sbjct: 69 SVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNL 128
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+GPIP+TLG+L KLRFLRLNNNSL GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSL
Sbjct: 129 SGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSL 188
Query: 190 FTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAY 249
FTPISFAN +L P SPPPP+ PTPP + N TGAIAGGVAAGAALLFA PAIALA+
Sbjct: 189 FTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAW 248
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 309
WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL
Sbjct: 249 WRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL 308
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M N
Sbjct: 309 ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 368
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429
GSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEF
Sbjct: 369 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 428
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG
Sbjct: 429 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 488
Query: 490 QRAFDLARLANDDDVMLLDW 509
QRAFDLARLANDDDVMLLDW
Sbjct: 489 QRAFDLARLANDDDVMLLDW 508
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798596|ref|XP_002867182.1| bri1-associated receptor kinase [Arabidopsis lyrata subsp. lyrata] gi|297313018|gb|EFH43441.1| bri1-associated receptor kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/501 (86%), Positives = 462/501 (92%), Gaps = 2/501 (0%)
Query: 11 FLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENS 70
F IL DL+LRV+ NAEGDAL+ALK +LADPN VLQSWDATLV PCTWFHVTCNS+NS
Sbjct: 5 FFWLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDNS 64
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
VTRVDLGNANLSGQLV QLGQL NLQYLELYSNNI+G +PE+LGNLT LVSLDLYLNNL+
Sbjct: 65 VTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNLS 124
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF 190
GPIP+TLG+L KLRFLRLNNNSL GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSLF
Sbjct: 125 GPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNGLTGDIPVNGSFSLF 184
Query: 191 TP--ISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALA 248
TP ISFAN +L P SPPPP+ PTPP + N TGAIAGGVAAGAALLFA PAIALA
Sbjct: 185 TPGLISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALA 244
Query: 249 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 308
+WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSNRNILGRGGFGKVYKGR
Sbjct: 245 WWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNRNILGRGGFGKVYKGR 304
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
L DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 305 LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 364
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
NGSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 365 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 424
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT
Sbjct: 425 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 484
Query: 489 GQRAFDLARLANDDDVMLLDW 509
GQRAFDLARLANDDDVMLLDW
Sbjct: 485 GQRAFDLARLANDDDVMLLDW 505
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558614|ref|XP_003547599.1| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2149), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/511 (86%), Positives = 470/511 (91%), Gaps = 5/511 (0%)
Query: 4 LERVVWAFLVSILFF-----DLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPC 58
+ERV +F+ S F+ DL+L+ + N EGDALNALK+NL DPNNVLQSWDATLVNPC
Sbjct: 1 MERVTSSFMGSFFFWAILVLDLVLKASGNQEGDALNALKSNLQDPNNVLQSWDATLVNPC 60
Query: 59 TWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
TWFHVTCNS+NSVTRVDLGNA+LSGQLVSQLGQLTNLQYLELYSN I+GK+P+ELGNLTN
Sbjct: 61 TWFHVTCNSDNSVTRVDLGNADLSGQLVSQLGQLTNLQYLELYSNKITGKIPDELGNLTN 120
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
LVSLDLYLN LNGPIPTTLGKL+KLRFLRLNNNSL G IP SLTNV+SLQVLDLSNN L
Sbjct: 121 LVSLDLYLNTLNGPIPTTLGKLAKLRFLRLNNNSLTGGIPISLTNVSSLQVLDLSNNHLK 180
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAAL 238
G+IP NGSFSLFTPIS+ NN P P P+ PTPP ASSGNS TGAIAGGVAAGAAL
Sbjct: 181 GEIPVNGSFSLFTPISYQNNLGLIQPKYTPSPVSPTPPPASSGNSNTGAIAGGVAAGAAL 240
Query: 239 LFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGR 298
LFAAPAIALAYWR+RKP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN++ILGR
Sbjct: 241 LFAAPAIALAYWRRRKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKHILGR 300
Query: 299 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358
GGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT
Sbjct: 301 GGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 360
Query: 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418
ERLLVYP+M NGSVASCLRER +SQPPL W RK+IALG+ARGLAYLHDHCDPKIIHRDV
Sbjct: 361 ERLLVYPYMANGSVASCLRERQESQPPLGWPERKRIALGSARGLAYLHDHCDPKIIHRDV 420
Query: 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 478
KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG
Sbjct: 421 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 480
Query: 479 YGVMLLELITGQRAFDLARLANDDDVMLLDW 509
YGVMLLELITGQRAFDLARLANDDDVMLLDW
Sbjct: 481 YGVMLLELITGQRAFDLARLANDDDVMLLDW 511
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558616|ref|XP_003547600.1| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2148), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/511 (86%), Positives = 470/511 (91%), Gaps = 5/511 (0%)
Query: 4 LERVVWAFLVSILFF-----DLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPC 58
+ERV +F+ S F+ DL+L+ + N EGDALNALK+NL DPNNVLQSWDATLVNPC
Sbjct: 5 MERVTSSFMGSFFFWAILVLDLVLKASGNQEGDALNALKSNLQDPNNVLQSWDATLVNPC 64
Query: 59 TWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
TWFHVTCNS+NSVTRVDLGNA+LSGQLVSQLGQLTNLQYLELYSN I+GK+P+ELGNLTN
Sbjct: 65 TWFHVTCNSDNSVTRVDLGNADLSGQLVSQLGQLTNLQYLELYSNKITGKIPDELGNLTN 124
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
LVSLDLYLN LNGPIPTTLGKL+KLRFLRLNNNSL G IP SLTNV+SLQVLDLSNN L
Sbjct: 125 LVSLDLYLNTLNGPIPTTLGKLAKLRFLRLNNNSLTGGIPISLTNVSSLQVLDLSNNHLK 184
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAAL 238
G+IP NGSFSLFTPIS+ NN P P P+ PTPP ASSGNS TGAIAGGVAAGAAL
Sbjct: 185 GEIPVNGSFSLFTPISYQNNLGLIQPKYTPSPVSPTPPPASSGNSNTGAIAGGVAAGAAL 244
Query: 239 LFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGR 298
LFAAPAIALAYWR+RKP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN++ILGR
Sbjct: 245 LFAAPAIALAYWRRRKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKHILGR 304
Query: 299 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358
GGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT
Sbjct: 305 GGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 364
Query: 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418
ERLLVYP+M NGSVASCLRER +SQPPL W RK+IALG+ARGLAYLHDHCDPKIIHRDV
Sbjct: 365 ERLLVYPYMANGSVASCLRERQESQPPLGWPERKRIALGSARGLAYLHDHCDPKIIHRDV 424
Query: 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 478
KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG
Sbjct: 425 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 484
Query: 479 YGVMLLELITGQRAFDLARLANDDDVMLLDW 509
YGVMLLELITGQRAFDLARLANDDDVMLLDW
Sbjct: 485 YGVMLLELITGQRAFDLARLANDDDVMLLDW 515
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397880702|gb|AFO67895.1| leucine-rich repeat receptor-like kinase (mitochondrion) [Brassica rapa subsp. campestris] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/523 (82%), Positives = 464/523 (88%), Gaps = 20/523 (3%)
Query: 3 KLERVVWAFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFH 62
K+ R W LV FDL+LR + NAEGDAL+ALK +L+DPN VLQSWDATLV PCTWFH
Sbjct: 7 KIARFFWLVLV----FDLVLRTSGNAEGDALSALKNSLSDPNKVLQSWDATLVTPCTWFH 62
Query: 63 VTCNSENSVTRV----------------DLGNANLSGQLVSQLGQLTNLQYLELYSNNIS 106
VTCNSENSVTRV DLGNANLSGQLV+QLGQL NLQYLELYSNNI+
Sbjct: 63 VTCNSENSVTRVMVLLFASVTKSLSLLSDLGNANLSGQLVTQLGQLPNLQYLELYSNNIT 122
Query: 107 GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166
G +PE+LGNLT LVSLDLYLNNL+GPIP++LG+L KLRFLRLNNNSL GEIPRSLT V S
Sbjct: 123 GPIPEQLGNLTELVSLDLYLNNLSGPIPSSLGRLQKLRFLRLNNNSLSGEIPRSLTAVLS 182
Query: 167 LQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATG 226
LQVLDLSN +LTGDIP NGSFSLFTPISFAN L P SPPPP+ PTPP + N TG
Sbjct: 183 LQVLDLSNTRLTGDIPVNGSFSLFTPISFANTNLTPLPASPPPPISPTPPSPAGSNRITG 242
Query: 227 AIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 286
AIAGGVAAGAALLFA PAIALA WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA
Sbjct: 243 AIAGGVAAGAALLFAVPAIALALWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 302
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+DNFSNRNILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRN
Sbjct: 303 SDNFSNRNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 362
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
LLRLRGFCMTPTERLLVYP+M NGSVASCLR+R +SQPPL+W R++IALG+ARGLAYLH
Sbjct: 363 LLRLRGFCMTPTERLLVYPYMANGSVASCLRDRPESQPPLDWPKRQRIALGSARGLAYLH 422
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
DHCDPKIIHRDVKAANILLDE+FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS
Sbjct: 423 DHCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 482
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509
TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW
Sbjct: 483 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 525
|
Source: Brassica rapa subsp. campestris Species: Brassica rapa Genus: Brassica Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|327422167|gb|AEA76434.1| somatic embryogenesis receptor-like kinase 2 protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2134), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/504 (87%), Positives = 464/504 (92%), Gaps = 1/504 (0%)
Query: 6 RVVWAFLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTC 65
R++ L I DL RVA NAEGDALNALKTN+ADPNNVLQSWD TLVNPCTWFHVTC
Sbjct: 8 RLISFCLWLIFVLDLAFRVAGNAEGDALNALKTNMADPNNVLQSWDPTLVNPCTWFHVTC 67
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
NSENSVTRVDLGNANL+GQLV QLG L NLQYLELYSNNISG +P+ELGNLT LVSLDLY
Sbjct: 68 NSENSVTRVDLGNANLTGQLVPQLGSLPNLQYLELYSNNISGMIPDELGNLTELVSLDLY 127
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
LN L G IPTTLG+L KLRFLRLNNNSL+G IP SLT +++LQVLDLSNN L GD+P NG
Sbjct: 128 LNKLTGDIPTTLGQLKKLRFLRLNNNSLVGTIPLSLTTIDTLQVLDLSNNGLIGDVPVNG 187
Query: 186 SFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAI 245
SFSLFTPISFANN+LNNPPP+PPPP+ PTPP A SG S+TGAIAGGVAAGAALLFAAPAI
Sbjct: 188 SFSLFTPISFANNKLNNPPPAPPPPIPPTPP-AQSGISSTGAIAGGVAAGAALLFAAPAI 246
Query: 246 ALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVY 305
LA WRKRK DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN+NILGRGGFGKVY
Sbjct: 247 VLALWRKRKAPDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKNILGRGGFGKVY 306
Query: 306 KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365
KGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP
Sbjct: 307 KGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 366
Query: 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425
FMVNGSVASCLRER + QP L+W++RK+IALGAARGLAYLHDHCDPKIIHRDVKAANILL
Sbjct: 367 FMVNGSVASCLRERSEFQPALDWAIRKRIALGAARGLAYLHDHCDPKIIHRDVKAANILL 426
Query: 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 485
DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV GYGVMLLE
Sbjct: 427 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVSGYGVMLLE 486
Query: 486 LITGQRAFDLARLANDDDVMLLDW 509
LITGQRAFDLARLANDDDVMLLDW
Sbjct: 487 LITGQRAFDLARLANDDDVMLLDW 510
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | ||||||
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.510 | 0.415 | 0.915 | 2.2e-198 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.510 | 0.417 | 0.919 | 6.7e-197 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.988 | 0.814 | 0.724 | 6.5e-193 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.945 | 0.803 | 0.673 | 6.9e-173 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.508 | 0.411 | 0.685 | 6.2e-129 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.500 | 0.401 | 0.683 | 5.5e-128 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.493 | 0.411 | 0.706 | 1.9e-127 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.475 | 0.395 | 0.681 | 3.8e-114 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.972 | 0.766 | 0.467 | 3.2e-113 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.972 | 0.783 | 0.460 | 1.4e-112 |
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1262 (449.3 bits), Expect = 2.2e-198, Sum P(2) = 2.2e-198
Identities = 239/261 (91%), Positives = 253/261 (96%)
Query: 249 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 308
+WR+RKP++ FFDVPAEEDPEVHLGQLKRFSLRELQVATD+FSN+NILGRGGFGKVYKGR
Sbjct: 264 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
L DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
NGSVASCLRER SQ PL WS+R+QIALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
FEAVVGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 503
Query: 489 GQRAFDLARLANDDDVMLLDW 509
GQRAFDLARLANDDDVMLLDW
Sbjct: 504 GQRAFDLARLANDDDVMLLDW 524
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1262 (449.3 bits), Expect = 6.7e-197, Sum P(2) = 6.7e-197
Identities = 240/261 (91%), Positives = 251/261 (96%)
Query: 249 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 308
+WR+RKP D FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSN+NILGRGGFGKVYKGR
Sbjct: 261 WWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGR 320
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
L DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 321 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 380
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
NGSVASCLRER SQPPL+W RK+IALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 381 NGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 440
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 441 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 500
Query: 489 GQRAFDLARLANDDDVMLLDW 509
GQRAFDLARLANDDDVMLLDW
Sbjct: 501 GQRAFDLARLANDDDVMLLDW 521
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1869 (663.0 bits), Expect = 6.5e-193, P = 6.5e-193
Identities = 370/511 (72%), Positives = 406/511 (79%)
Query: 3 KLE-RVVWAFLVSILFFDLLLRVASNAEGDALNALKTNLA--DP-NNVLQSWDATLVNPC 58
K+E R + FL +L F+ LRVA NAEGDAL LK +L+ DP NNVLQSWDATLV PC
Sbjct: 5 KMEQRSLLCFLYLLLLFNFTLRVAGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPC 64
Query: 59 TWFHVTCNSENSVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTN 118
TWFHVTCN EN VTRVDLGNA NLQYLELYSNNI+G++PEELG+L
Sbjct: 65 TWFHVTCNPENKVTRVDLGNAKLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVE 124
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
LVSLDLY N+++GPIP++LGKL KLRFLRLNNNSL GEIP +LT+V LQVLD+SNN+L+
Sbjct: 125 LVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLS 183
Query: 179 GDIPTNGSFSLFTPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXXXXXXXXXX 238
GDIP NGSFSLFTPISFA SG
Sbjct: 184 GDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPTPP-PPSGGQMTAAIAGGVAAGAAL 242
Query: 239 XXXXXXXXXXYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGR 298
+W +RKP+DHFFDVPAEEDPEVHLGQLKRF+LREL VATDNFSN+N+LGR
Sbjct: 243 LFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGR 302
Query: 299 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358
GGFGKVYKGRL DG+LVAVKRLKEERT+GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT
Sbjct: 303 GGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 362
Query: 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418
ERLLVYP+M NGSVASCLRER + P L+W RK IALG+ARGLAYLHDHCD KIIHRDV
Sbjct: 363 ERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDV 422
Query: 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 478
KAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG
Sbjct: 423 KAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 482
Query: 479 YGVMLLELITGQRAFDLARLANDDDVMLLDW 509
YGVMLLELITGQ+AFDLARLANDDD+MLLDW
Sbjct: 483 YGVMLLELITGQKAFDLARLANDDDIMLLDW 513
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1680 (596.4 bits), Expect = 6.9e-173, P = 6.9e-173
Identities = 338/502 (67%), Positives = 386/502 (76%)
Query: 11 FLVSILFFDLLLRVASNAEGDALNALKTNLAD---PNNVLQSWDATLVNPCTWFHVTCNS 67
F+ ILF D + RV + DAL AL+++L+ NN+LQSW+AT V PC+WFHVTCN+
Sbjct: 9 FIWLILFLDFVSRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCNT 68
Query: 68 ENSVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
ENSVTR+DLG+AN NLQYLEL++NNI+G++PEELG+L LVSLDL+ N
Sbjct: 69 ENSVTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFAN 128
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
N++GPIP++LGKL KLRFLRL NNSL GEIPRSLT + L VLD+SNN+L+GDIP NGSF
Sbjct: 129 NISGPIPSSLGKLGKLRFLRLYNNSLSGEIPRSLTAL-PLDVLDISNNRLSGDIPVNGSF 187
Query: 188 SLFTPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXXXXXXXXXXXXXXXXXXX 247
S FT +SFA + SG S
Sbjct: 188 SQFTSMSFANNKLRPRPASPSP--------SPSGTSAAIVVGVAAGAALLFALA------ 233
Query: 248 XYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
+W +RK + HF DVPAEEDPEV+LGQ KRFSLREL VAT+ FS RN+LG+G FG +YKG
Sbjct: 234 -WWLRRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKG 292
Query: 308 RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367
RL D +LVAVKRL EERT+GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 293 RLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 352
Query: 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427
NGSVASCLRER + P L+W RK IALG+ARGLAYLHDHCD KIIH DVKAANILLDE
Sbjct: 353 ANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDE 412
Query: 428 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487
EFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI
Sbjct: 413 EFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 472
Query: 488 TGQRAFDLARLANDDDVMLLDW 509
TGQ+AFDLARLANDDD+MLLDW
Sbjct: 473 TGQKAFDLARLANDDDIMLLDW 494
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 6.2e-129, Sum P(2) = 6.2e-129
Identities = 179/261 (68%), Positives = 221/261 (84%)
Query: 249 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 308
+WR R+ + FFDV + DPEV LG LKR++ +EL+ AT++F+++NILGRGG+G VYKG
Sbjct: 260 WWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGH 319
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNLLRLRGFC + ER+LVYP+M
Sbjct: 320 LNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMP 379
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
NGSVAS L++ + +P L+WS RK+IA+G ARGL YLH+ CDPKIIHRDVKAANILLDE+
Sbjct: 380 NGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDED 439
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELIT
Sbjct: 440 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 499
Query: 489 GQRAFDLARLANDDDVMLLDW 509
GQ+A D R A+ VML DW
Sbjct: 500 GQKALDFGRSAHQKGVML-DW 519
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 5.5e-128, Sum P(2) = 5.5e-128
Identities = 179/262 (68%), Positives = 220/262 (83%)
Query: 249 YWRKRKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
+WR+R ++ FFDV EV LG L+RF RELQ+AT+NFS++N+LG+GG+G VYKG
Sbjct: 270 WWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKG 329
Query: 308 RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367
L D ++VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYP+M
Sbjct: 330 ILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYM 389
Query: 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427
NGSVAS R +++P L+WS+RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLD+
Sbjct: 390 SNGSVAS----RMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445
Query: 428 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487
EAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLEL+
Sbjct: 446 YCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELV 505
Query: 488 TGQRAFDLARLANDDDVMLLDW 509
TGQRAF+ + AN VML DW
Sbjct: 506 TGQRAFEFGKAANQKGVML-DW 526
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 913 (326.5 bits), Expect = 1.9e-127, Sum P(2) = 1.9e-127
Identities = 178/252 (70%), Positives = 206/252 (81%)
Query: 257 DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVA 316
D F DV E D + GQLKRF+ RELQ+ATDNFS +N+LG+GGFGKVYKG L D + VA
Sbjct: 257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316
Query: 317 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL 376
VKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYPFM N S+A L
Sbjct: 317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376
Query: 377 RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436
RE P L+W RK+IALGAARG YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct: 377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 436
Query: 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496
GLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +
Sbjct: 437 GLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 496
Query: 497 RLANDDDVMLLD 508
RL +DDV+LLD
Sbjct: 497 RLEEEDDVLLLD 508
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 3.8e-114, Sum P(2) = 3.8e-114
Identities = 167/245 (68%), Positives = 197/245 (80%)
Query: 265 EEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER 324
++D E +G LKRFS RE+Q AT NFS +NILG+GGFG VYKG L +G++VAVKRLK+
Sbjct: 275 QQDYEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDP- 333
Query: 325 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 384
GE+QFQTEVEMI +AVHRNLLRL GFCMTP ER+LVYP+M NGSVA LR+ +P
Sbjct: 334 IYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKP 393
Query: 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444
L+W+ R IALGAARGL YLH+ C+PKIIHRDVKAANILLDE FEA+VGDFGLAKL+D
Sbjct: 394 SLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQ 453
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
+D+HVTTAVRGTIGHIAPEYLSTG+SSEKTDVFG+GV++LELITG + D
Sbjct: 454 RDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGN-GQVRKG 512
Query: 505 MLLDW 509
M+L W
Sbjct: 513 MILSW 517
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
Identities = 238/509 (46%), Positives = 322/509 (63%)
Query: 7 VVWAFLVSILFFDLLLRVAS-NAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTC 65
++++FL + F L L N E +AL +++ NL DP+ L +WD V+PC+W +TC
Sbjct: 15 LLYSFLF-LCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITC 73
Query: 66 NSENSVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
+ +N V + + + TNL+ + L +NNISGK+P ELG L L +LDL
Sbjct: 74 SPDNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLS 133
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-- 183
N +G IP ++ +LS L++LRLNNNSL G P SL+ + L LDLS N L+G +P
Sbjct: 134 NNRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFP 193
Query: 184 NGSFSLF-TPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXXXXXXXXXXXXXX 242
+F++ P+ +SSG
Sbjct: 194 ARTFNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILV 253
Query: 243 XXXXXXYW-RKRKPEDHFFDVPAEEDPEVH-LGQLKRFSLRELQVATDNFSNRNILGRGG 300
W RK++ ++ +++ + LG L+ F+ REL V TD FS++NILG GG
Sbjct: 254 LALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGG 313
Query: 301 FGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360
FG VY+G+L DG++VAVKRLK+ G+ QF+ E+EMIS+AVH+NLLRL G+C T ER
Sbjct: 314 FGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGER 373
Query: 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 420
LLVYP+M NGSVAS L+ S+P L+W++RK+IA+GAARGL YLH+ CDPKIIHRDVKA
Sbjct: 374 LLVYPYMPNGSVASKLK----SKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 429
Query: 421 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 480
ANILLDE FEAVVGDFGLAKL+++ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G
Sbjct: 430 ANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 489
Query: 481 VMLLELITGQRAFDLARLANDDDVMLLDW 509
++LLELITG RA + + + ML +W
Sbjct: 490 ILLLELITGLRALEFGKTVSQKGAML-EW 517
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1111 (396.2 bits), Expect = 1.4e-112, P = 1.4e-112
Identities = 234/508 (46%), Positives = 321/508 (63%)
Query: 8 VWAFLVSILFFDL--LLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTC 65
+++ L+ + FF L N E +AL +K L DP+ V ++WD V+PC+W ++C
Sbjct: 11 IFSVLLLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISC 70
Query: 66 NSENSVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
+S+N V + + + TNL+ + L +NNISGK+P E+ +L L +LDL
Sbjct: 71 SSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLS 130
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-- 183
N +G IP ++ +LS L++LRLNNNSL G P SL+ + L LDLS N L G +P
Sbjct: 131 NNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFP 190
Query: 184 NGSFSLF-TPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXXXXXXXXXXXXXX 242
+F++ P+ +SSG
Sbjct: 191 ARTFNVAGNPLICKNSLPEICSGSISASPLSVSLRSSSGRRTNILAVALGVSLGFAVSVI 250
Query: 243 XXXXXXYWRKRKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGF 301
++RK++ + +E+ + LG L+ F+ REL VATD FS+++ILG GGF
Sbjct: 251 LSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGF 310
Query: 302 GKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361
G VY+G+ DG++VAVKRLK+ G QF+TE+EMIS+AVHRNLLRL G+C + +ERL
Sbjct: 311 GNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERL 370
Query: 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421
LVYP+M NGSVAS L+ ++P L+W+ RK+IA+GAARGL YLH+ CDPKIIHRDVKAA
Sbjct: 371 LVYPYMSNGSVASRLK----AKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAA 426
Query: 422 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 481
NILLDE FEAVVGDFGLAKL++++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G+
Sbjct: 427 NILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 486
Query: 482 MLLELITGQRAFDLARLANDDDVMLLDW 509
+LLELITG RA + + + ML +W
Sbjct: 487 LLLELITGMRALEFGKSVSQKGAML-EW 513
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q94AG2 | SERK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8023 | 0.9843 | 0.8048 | no | no |
| Q8LPS5 | SERK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7157 | 0.9471 | 0.8053 | no | no |
| Q94F62 | BAK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.868 | 0.9784 | 0.8130 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.10 | 0.983 |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 511 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-45 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-20 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 9e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 68/199 (34%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 295 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FG+VYKG+L VAVK LKE+ ++ +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G C +V +M G + S LR+ +P L+ S AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
IHRD+ A N L+ E + DFGL++ + D + + I +APE L GK
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 470 SSEKTDVFGYGVMLLELIT 488
+ K+DV+ +GV+L E+ T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 295 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FG+VYKG L VAVK LKE+ ++ +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G C ++V +M G + LR+ L+ S AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK- 122
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
IHRD+ A N L+ E + DFGL++ + D + + I +APE L GK
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 470 SSEKTDVFGYGVMLLELIT 488
+ K+DV+ +GV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 69/194 (35%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG GGFG VY R G VA+K +K+E + + E+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
LV + GS+ L+E + L+ +I L GL YLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 415 HRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 472
HRD+K NILLD + + DFGL+KL+ + + T + GT ++APE L G SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 473 KTDVFGYGVMLLEL 486
K+D++ GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 4e-47
Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 352
LG G FG VYK + G +VAVK LK+ + + Q + E+ ++ H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
LV + G + L G PL+ K+IAL RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS 471
IIHRD+K NILLDE + DFGLAK + + +TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 472 EKTDVFGYGVMLLELITGQ 490
K DV+ GV+L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (406), Expect = 1e-45
Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 296 LGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FG+VYKG L VAVK LKE ++ +F E ++ H N++RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
G C +V +M G + LR+ G+ L Q+AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---APEYLST 467
+HRD+ A N L+ E + DFGL++ + D + G I APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKD 178
Query: 468 GKSSEKTDVFGYGVMLLELITG 489
GK + K+DV+ +GV+L E+ T
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+ LG G FGKVY R G LVA+K +K+++ + + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
RL + LV + G + L++RG+ +QI L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLHSK 116
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I+HRD+K NILLDE+ + DFGLA+ +D +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFD 494
+ D++ GV+L EL+TG+ F
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP 197
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 4e-45
Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FG+VYKG+L VAVK LKE+ ++ F E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP-----PLNWSVRKQIALGAARGLAY 404
L G C LV +M G + LR+ P L+ A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---A 461
L K +HRD+ A N L+ E+ + DFGL++ + D + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELIT 488
PE L G + K+DV+ +GV+L E+ T
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 9e-38
Identities = 121/447 (27%), Positives = 203/447 (45%), Gaps = 67/447 (14%)
Query: 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP 132
+DL SG + +LG L+ L L+L N +SG++P+EL + LVSLDL N L+G
Sbjct: 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP 192
IP + ++ L L L+ N L GEIP++L NV SL +++S+N L G +P+ G+F
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINA 598
Query: 193 ISFANNQL--NNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYW 250
+ A N S PP + S T + GA L+ A A +
Sbjct: 599 SAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTL------GAFLVLALVAFGFVFI 652
Query: 251 RKRKP-------------EDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILG 297
R R E FFD K ++ ++ + N++
Sbjct: 653 RGRNNLELKRVENEDGTWELQFFDSKV----------SKSITINDILSSL---KEENVIS 699
Query: 298 RGGFGKVYKGR-LTDGSLVAVKRLKE-------ERTQGGELQFQTEVEMISMAVHRNLLR 349
RG G YKG+ + +G VK + + E G+LQ H N+++
Sbjct: 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------------HPNIVK 747
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G C + L++ ++ +++ LR L+W R++IA+G A+ L +LH C
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRC 800
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
P ++ ++ I++D + E + L L+ ++ ++APE T
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKD 854
Query: 470 SSEKTDVFGYGVMLLELITGQRAFDLA 496
+EK+D++G+G++L+EL+TG+ D
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAE 881
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 294 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLR 351
+LGRG FG VY D G L+AVK ++ EL + E+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 352 GFCMTPTER-LLVY-PFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 406
G + L ++ ++ GS++S L++ G+ P+ +RK QI GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLH 118
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYL 465
+ I+HRD+K ANIL+D + + DFG AK + D + T +VRGT +APE +
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506
+ D++ G ++E+ TG+ + + L N +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
F +G+GGFG+VYK R G VA+K +K E + E E++++ H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARGLAYL 405
+ G + E +V F GS+ L+ Q L QIA +GL YL
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ---TLT---ESQIAYVCKELLKGLEYL 114
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEY 464
H + IIHRD+KAANILL + E + DFGL+ L D K + GT +APE
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEV 168
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQ 490
++ K D++ G+ +EL G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 295 ILGRGGFGKVYKGRLT-DGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+LG G FG VYKG +G VA+K L+EE + + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLH 406
L G C++ L+ M G + +R SQ LNW V QIA +G++YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIA----KGMSYLE 126
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 465
+ +++HRD+ A N+L+ + DFGLAKL+D + + I +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+ K+DV+ YGV + EL+T G + ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 353
+G+G FGKVY R +DG L +K + E + EV+++ H N+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPP------LNWSVRKQIALGAARGLAYLHD 407
+ +V + G ++ ++++ + P L+W V Q+ L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYLHS 121
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
KI+HRD+K NI L +GDFG++K++ T V GT +++PE L
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQ 176
Query: 468 GKS-SEKTDVFGYGVMLLELITGQRAFD 494
K + K+D++ G +L EL T + F+
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 66/224 (29%), Positives = 114/224 (50%), Gaps = 17/224 (7%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRN 346
N+ +++GRG FG VYKG L G VA+K++ E+ + L+ E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++ G T ++ + NGS+ +++ G L Q+ +GLAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH 116
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ +IHRD+KAANIL ++ + DFG+A ++ + +V GT +APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRA-FDLA------RLANDDD 503
+S +D++ G ++EL+TG +DL R+ DD
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH 216
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 63/198 (31%), Positives = 108/198 (54%), Gaps = 5/198 (2%)
Query: 11 FLVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENS 70
+ + F L + E + L + K+++ DP L +W+++ + C W +TCN+ +
Sbjct: 12 LIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSR 70
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT-NLVSLDLYLNNL 129
V +DL N+SG++ S + +L +Q + L +N +SG +P+++ + +L L+L NN
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
G IP G + L L L+NN L GEIP + + +SL+VLDL N L G IP + + +
Sbjct: 131 TGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT 188
Query: 189 LFTPISFANNQLNNPPPS 206
++ A+NQL P
Sbjct: 189 SLEFLTLASNQLVGQIPR 206
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G+G FG V G G VAVK LK++ F E +++ H NL++L G +
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
+V +M GS+ LR RG++ + + + AL G+ YL + +H
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 475
RD+ A N+L+ E+ A V DFGLAK V+ T APE L K S K+D
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSD 181
Query: 476 VFGYGVMLLELITGQRA 492
V+ +G++L E+ + R
Sbjct: 182 VWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
+ LG G FGKV R G VAVK L + F+ E+E++
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 343 VHRNLLRLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
H N+++ +G C P R L+ ++ +GS+ L+ + +N + +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICK 120
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IG 458
G+ YL + IHRD+ A NIL++ E + DFGLAK++ + G I
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
APE L T K S +DV+ +GV L EL T
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL--QFQTEVE-MISMAVHR 345
++ LG G FG+VY R D LVA+K L ++ + +F E++ + S+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++L F LV ++ GS+ L ++ + PL+ S I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 406 HDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHV-----TTAVRGTIGH 459
H IIHRD+K NILLD + + DFGLAKL+ + + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 460 IAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDL 495
+APE L S +S +D++ G+ L EL+TG F+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 290 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
F+ LG G FG+V++G + VA+K LK + + FQ EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGA--ARGLAYLH 406
L C ++ M GS+ + LR GQ P V I + A G+AYL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP-----VASLIDMACQVAEGMAYLE 121
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ IHRD+ A NIL+ E+ V DFGLA+L+ +D ++++ + APE S
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAAS 177
Query: 467 TGKSSEKTDVFGYGVMLLELIT-GQ 490
G S K+DV+ +G++L E+ T GQ
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQ 202
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 8e-27
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V +GRL VA+K LK + L F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L G +++ +M NGS+ LRE G+ + G A G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM 125
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPE 463
+HRD+ A NIL++ V DFGL++ ++ + TT +R T APE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQR 491
++ K + +DV+ +G+++ E+++ G+R
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGG---ELQ------FQTEVEMISMAVH 344
++G+G +G+VY +T G ++AVK+++ T G Q ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N+++ GF T + ++ GS+ SCLR G+ + L +Q+ GLAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----LEGLAY 123
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPE 463
LH I+HRD+KA N+L+D + + DFG++K D D +++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 464 YLSTGKS--SEKTDVFGYGVMLLELITGQR 491
+ + S K D++ G ++LE+ G+R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-26
Identities = 58/137 (42%), Positives = 83/137 (60%), Gaps = 1/137 (0%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
S+ +DL NL+G + S LG L NLQYL LY N +SG +P + +L L+SLDL N+L
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
+G IP + +L L L L +N+ G+IP +LT++ LQVL L +NK +G+IP N G +
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356
Query: 189 LFTPISFANNQLNNPPP 205
T + + N L P
Sbjct: 357 NLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 71/206 (34%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G FG VY G L D AVK L QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 350 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG--AARGLAYL 405
L G C+ P+E L+V P+M +G + + +R N +V+ I G A+G+ YL
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAP 462
K +HRD+ A N +LDE F V DFGLA+ + +Y H T + + +A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELIT 488
E L T K + K+DV+ +GV+L EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G+G FG VYKG L + VAVK + + +F E E++ H N+++L G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARGLAYLHDHCDPKI 413
+V + GS+ + LR++ V+K Q++L AA G+ YL
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLT-----VKKLLQMSLDAAAGMEYLESKN---C 114
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT----IGHIAPEYLSTGK 469
IHRD+ A N L+ E + DFG+++ ++ + T G I APE L+ G+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 470 SSEKTDVFGYGVMLLELITG 489
+ ++DV+ YG++L E +
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 51/107 (47%), Positives = 74/107 (69%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
L + L GQ+ +LGQ+ +L+++ L NN+SG++P E+G LT+L LDL NNL GPIP+
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
+LG L L++L L N L G IP S+ ++ L LDLS+N L+G+IP
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 51/107 (47%), Positives = 72/107 (67%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
LG NLSG++ ++G LT+L +L+L NN++G +P LGNL NL L LY N L+GPIP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
++ L KL L L++NSL GEIP + + +L++L L +N TG IP
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 8/204 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+ +LG+G G VYK R G + A+K++ + + Q E++ +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++ G E +V +M GS+A L++ G + V IA +GL YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLH 116
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
IIHRD+K +N+L++ + E + DFG++K+++ T V GT+ +++PE +
Sbjct: 117 T--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 467 TGKSSEKTDVFGYGVMLLELITGQ 490
S D++ G+ LLE G+
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 296 LGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ G D LVAVK LKE + F+ E E+++ H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG----------QSQPPLNWSVRKQIALGAA 399
G C ++V+ +M +G + LR G L S QIA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGT- 456
G+ YL +HRD+ N L+ + +GDFG++ +D + T V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTTDYYRVGGHT 184
Query: 457 ---IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
I + PE + K + ++DV+ +GV+L E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FG VY+G L DG AVK + + Q Q + E+ ++S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 351 RGFCMTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
G + L ++ +V GS+A L++ G P+ +QI LG L YLHD
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR- 121
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STG 468
+HRD+K ANIL+D + DFG+AK + + +G+ +APE + G
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQG 177
Query: 469 KSSEKTDVFGYGVMLLELITGQ 490
D++ G +LE+ TG+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 296 LGRGGFGKVYKG---RLTDGSL---VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG+G FG VY+G + G VA+K + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRER------GQSQPPLNWSVRKQIALGAARGLA 403
L G T L+V M G + S LR R P Q+A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTTAVRGTIG 458
YL K +HRD+ A N ++ E+ +GDFG+ + + DY K VR
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+APE L G + K+DV+ +GV+L E+ T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-23
Identities = 69/198 (34%), Positives = 102/198 (51%), Gaps = 10/198 (5%)
Query: 293 RNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL++L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
G C ++ FM G++ LRE + + +N V +A + + YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK--- 123
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKS 470
IHRD+ A N L+ E V DFGL++LM DT+ A + I APE L+ K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 471 SEKTDVFGYGVMLLELIT 488
S K+DV+ +GV+L E+ T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 9e-23
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKR--LKEERTQGGELQF---QTEVEMISMAVHRNLL 348
+LG+G +G VY G G L+AVK+ L E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+ G C+ + F+ GS++S L G P+ KQI G+AYLH++
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNN 121
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-----TAVRGTIGHIAPE 463
C ++HRD+K N++L + DFG A+ + + H T ++ GT +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQ 490
++ K+D++ G + E+ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 63/163 (38%), Positives = 89/163 (54%), Gaps = 3/163 (1%)
Query: 74 VDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
+DLG L G++ + L LT+L++L L SN + G++P ELG + +L + L NNL+G I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPI 193
P +G L+ L L L N+L G IP SL N+ +LQ L L NKL+G IP FSL I
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP-PSIFSLQKLI 287
Query: 194 S--FANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAA 234
S ++N L+ P LQ N+ TG I + +
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G +G VYK G +VA+K + + + E+ ++ +++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCD 410
T+ +V + GSV+ ++ ++ L ++IA +GL YLH +
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKT---LT---EEEIAAILYQTLKGLEYLHSN-- 118
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IG---HIAPEYLS 466
K IHRD+KA NILL+EE +A + DFG++ + T A R T IG +APE +
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEVIQ 172
Query: 467 TGKSSEKTDVFGYGVMLLELITG 489
+ K D++ G+ +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 60/219 (27%), Positives = 115/219 (52%), Gaps = 17/219 (7%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRL-TDG---SLVAVKRLKEERTQGGELQFQTEVEMI 339
++ + + + ++G G FG+V++G L G VA+K LK T+ F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL--G 397
H N++RL G +++ +M NG++ LR+ +S + + + G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRG 115
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRG 455
A G+ YL D +HRD+ A NIL++ E V DFGL++++ D + T+ T+ +
Sbjct: 116 IAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493
I APE ++ K + +DV+ +G+++ E+++ G+R +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 67/195 (34%), Positives = 105/195 (53%), Gaps = 14/195 (7%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+LG+G FG+V+KG L D + VAVK KE+ Q +++F +E ++ H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 355 MTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCD 410
T+R +Y M G S LR++ + L + AL AA G+AYL +C
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNC- 114
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
IHRD+ A N L+ E + DFG+++ D + + I APE L+ G+
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 471 SEKTDVFGYGVMLLE 485
S ++DV+ YG++L E
Sbjct: 172 SSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 23/224 (10%)
Query: 293 RNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRL 350
N +G G FGKVY L G L+AVK ++ + + + E++++ + H NL++
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 351 RGFCMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
G R VY FM G++ L L+ V + L GLAYLH
Sbjct: 65 YG---VEVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHS 117
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEY 464
H I+HRD+K ANI LD +GDFG A + T + V+ G ++APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 465 LSTGKSSEK---TDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
++ GK D++ G ++LE+ TG+R + + L N+ +M
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 6e-22
Identities = 70/198 (35%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
I+G G FG V +G T G VAVK +K + T F E +++ H+NL+RL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ +V M G++ + LR RG++ + + Q +L A G+ YL K++
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL--QFSLDVAEGMEYLESK---KLV 122
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+ A NIL+ E+ A V DFGLA++ + V+ T APE L K S K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 475 DVFGYGVMLLELITGQRA 492
DV+ YGV+L E+ + RA
Sbjct: 179 DVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 66/204 (32%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 296 LGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRL 350
LG G FG V +G + VAVK LK ++ F E M S+ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRL 61
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL----NWSVRKQIALGAARGLAYLH 406
G +T ++V GS+ LR+ + +++V QIA G+ YL
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIA----NGMRYLE 114
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT-IGHIAPEY 464
+ IHRD+ A NILL + + +GDFGL + L +D +V APE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 465 LSTGKSSEKTDVFGYGVMLLELIT 488
L T S +DV+ +GV L E+ T
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 9e-22
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 352
LG+G FGKV R D G L A+K LK+++ + TE ++S H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 353 FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIALGAARGLAYLHD 407
+ E+L LV + G + S L + G+ + + +I L L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGR----FSEERARFYAAEIVLA----LEYLHS 111
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
II+RD+K NILLD + + DFGLAK + T GT ++APE L
Sbjct: 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFD 494
+ D + GV+L E++TG+ F
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG+V++G + + VAVK LK + F E +++ H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
+V M GS+ L+ L + +A A G+AYL IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQ---NYIH 126
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 475
RD+ A N+L+ E V DFGLA+++ + I APE + S K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 476 VFGYGVMLLELIT 488
V+ +G++L E++T
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 352
LG G FG+V+ G + VA+K LK+ G + F E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHCD 410
+T ++ +M NGS+ L+ + +N K I + A A G+A++
Sbjct: 69 -VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN----KLIDMAAQIAEGMAFIERK-- 121
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
IHRD++AANIL+ E + DFGLA+L++ + + I APE ++ G
Sbjct: 122 -NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 471 SEKTDVFGYGVMLLELITGQR 491
+ K+DV+ +G++L E++T R
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 29/204 (14%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 352
LG G FG+V+ G + VAVK LK G + F E +++ H L++L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-----GTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 353 FCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLAYLHD 407
C +E +Y +M GS+ L+ + L + + + A A G+AYL
Sbjct: 69 VC---SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP----QLVDMAAQIAEGMAYLES 121
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEY 464
IHRD+ A NIL+ E + DFGLA+L+ +D TA G I APE
Sbjct: 122 R---NYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEY-TAREGAKFPIKWTAPEA 175
Query: 465 LSTGKSSEKTDVFGYGVMLLELIT 488
+ G+ + K+DV+ +G++L E++T
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 294 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 351
+G G +G+VYK R G LVA+K+++ E +G + E++++ H N++RL+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 352 GFCMTPTERL-----LVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAY 404
T + +V+ +M + + L ++ + KQ+ GL Y
Sbjct: 65 EIV---TSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK-CYMKQLL----EGLQY 115
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH + I+HRD+K +NIL++ + + DFGLA+ +++ T T+ + PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 465 L--STGKSSEKTDVFGYGVMLLELITGQRAF 493
L +T + + D++ G +L EL G+ F
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 296 LGRGGFGKVYKG--RLTDGSL--VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
LG G FG V KG + G VAVK LK+E G+ +F E +++ H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
G C +LV G + L++R + S K++A A G+AYL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK--- 114
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGK 469
+HRD+ A N+LL +A + DFG+++ + + TTA R + APE ++ GK
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 470 SSEKTDVFGYGVMLLELIT-GQR 491
S K+DV+ YGV L E + G +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 24/202 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V+ G+ VA+K ++E E F E +++ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA----RGLAYLHDHCDP 411
+V +M NG + + LRER + + L + YL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK-------LGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT---IGHIAPEYLST 467
IHRD+ A N L+ E+ V DFGLA+ ++D D + T+ +GT + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD--DQY--TSSQGTKFPVKWAPPEVFDY 175
Query: 468 GKSSEKTDVFGYGVMLLELITG 489
+ S K+DV+ +GV++ E+ +
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+G+G FG+V++ R ++VAVK LKEE + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRER------------------GQSQPPLNWSVR 391
L G C L++ +M G + LR R G + PL+ + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYKDTH 448
IA A G+AYL + K +HRD+ N L+ E + DFGL++ DY
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
A+ I + PE + + + ++DV+ YGV+L E+ +
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLR 349
LG+G FG V R L D G +VAVK+L+ + L+ F+ E+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69
Query: 350 LRGFCMTPTER--LLVYPFMVNGSVASCL---RERGQSQPPLNWSVRKQIALGAARGLAY 404
+G C + R LV ++ GS+ L RER + L ++ QI +G+ Y
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA--SQIC----KGMEY 123
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAP 462
L + +HRD+ NIL++ E +GDFGL K++ D + V I AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELIT 488
E L+ K S +DV+ +GV+L EL T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 66/229 (28%), Positives = 119/229 (51%), Gaps = 23/229 (10%)
Query: 295 ILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
++G G FG+V +GRL VA+K LK T+ F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIAL--GAARGLAYLHD 407
G +++ FM NG++ S LR+ GQ ++V + + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ------FTVIQLVGMLRGIAAGMKYLSE 124
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIG--HIAPE 463
+HRD+ A NIL++ V DFGL++ + D D T+++ G I APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWDF 511
++ K + +DV+ YG+++ E+++ G+R + ++N D + ++ D+
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMSNQDVINAIEQDY 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 9e-21
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 12/210 (5%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQT-EVEMISMAVHRN 346
+F N +G+G FG V+K R D + A+K++ + E + E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPPLN-WSVRKQIALGAARGLAY 404
++R + + +V + NG + L+ +RG+ P W QI LG LA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH KI+HRD+K+ N+ LD +GD G+AKL+ T V GT +++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPEL 172
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+EK+DV+ GV+L E TG+ FD
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G G FG V+ G + VA+K ++E E F E +++ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLR-ERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ LV+ FM +G ++ LR +RG+ SQ L + L G+AYL +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN---V 121
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
IHRD+ A N L+ E V DFG+ + + +T + + +PE S K S K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 474 TDVFGYGVMLLELIT 488
+DV+ +GV++ E+ +
Sbjct: 182 SDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKG----RLTDGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V D+ + LG G FG+VY+G R D VAVK L E ++ E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER--GQSQP-PLNWSVRKQI 394
++S H+N++RL G R ++ M G + S LRE +P L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTT 451
A A+G YL ++ IHRD+ A N LL + A + DFG+A+ + Y+ ++
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRK 177
Query: 452 AVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
R I + PE G + KTDV+ +GV+L E+
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 68/233 (29%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 32 ALNALKTNLADPNNVLQSWDATLVNPCT-----WFHVTCNSENSVTR-----VDLGNANL 81
AL LK++L P W+ +PC W C +++ + + L N L
Sbjct: 376 ALQTLKSSLGLPLRF--GWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGL 430
Query: 82 SGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS 141
G + + + +L +LQ + L N+I G +P LG++T+L LDL N+ NG IP +LG+L+
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 142 KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201
LR L LN NSL G +P +L G + + FT +
Sbjct: 491 SLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFNFT---------D 524
Query: 202 NPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRK 254
N P L+ P S G A IA GV+ L I W KR+
Sbjct: 525 NAGLCGIPGLRACGPHLSVG--AKIGIAFGVSVAFLFL----VICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 69/218 (31%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 294 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
N LG G FG+VY+G TD VAVK L++ T + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRK--QIALGAARGLA 403
+++L G C+ + ++ M G + S LR+ R + P ++++ I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTIG 458
YL IHRD+ A N L+ E+ +GDFGLA+ + YK + G +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLP 176
Query: 459 --HIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493
+APE L GK + ++DV+ +GV++ E++T GQ+ +
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 295 ILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNL 347
LG G FG+V K + S VAVK LK++ T+ +E+EM+ M H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP-------LNWSVRKQI------ 394
+ L G C +V + +G++ LR R +PP + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR---RPPGEYASPDDPRPPEETLTQKDLV 135
Query: 395 --ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTT 451
A ARG+ +L K IHRD+ A N+L+ E+ + DFGLA+ + + D + TT
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 352
LG+GGFG+V ++ G + A K+L ++R + GE E +++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGAARGLAYLHDHCD 410
T + LV M G + + G+ P ++ QI G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQR-- 114
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
+I++RD+K N+LLD+ + D GLA ++ K GT G++APE L
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 471 SEKTDVFGYGVMLLELITGQRAF 493
D F G L E+I G+ F
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-----FQTEVEMISMAVHRNLL 348
LG G F Y+ R + G+L+AVK++ R E + + E+ +++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
R+ G + L +M GSV+ L + G +V RGL+YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 409 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEY 464
+IIHRDVK AN+L+D + + + DFG A + K T + GTI +APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQ 490
L + DV+ G +++E+ T +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LKE ++ FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR---------ERGQSQP--PLNWSVRKQIALGA 398
G C L+V+ +M +G + LR G+ L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTI 457
A G+ YL +HRD+ N L+ + +GDFG+++ + D + V I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ PE + K + ++D++ +GV+L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 54/135 (40%), Positives = 80/135 (59%), Gaps = 2/135 (1%)
Query: 74 VDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
+DL N LSG++ + +G ++L+ L+L N + GK+P L NLT+L L L N L G I
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTP 192
P LG++ L+++ L N+L GEIP + + SL LDL N LTG IP++ G+
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY 264
Query: 193 ISFANNQLNNP-PPS 206
+ N+L+ P PPS
Sbjct: 265 LFLYQNKLSGPIPPS 279
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 295 ILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLR 349
ILG G FG V +G+L+ DGS VAVK +K + E++ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 350 LRGFCMTPTER------LLVYPFMVNGSVAS-CLRERGQSQP---PLNWSVRKQIALGAA 399
L G C + +++ PFM +G + S L R P PL ++ + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK--FMVDIA 123
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRG 455
G+ YL + IHRD+ A N +L E+ V DFGL+K + Y+ + +
Sbjct: 124 LGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KM 177
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 490
+ IA E L+ + K+DV+ +GV + E+ T GQ
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 296 LGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKVYKG LT + VA+K LKE + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 350 LRGFCMTPTERLLVYPFMVNG------------SVASCLRERGQSQPPLNWSVRKQIALG 397
L G C +++ ++ +G S + L+ S IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 456
A G+ YL H +HRD+ A N L+ E + DFGL++ + D + V +
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
+ + PE + GK + ++D++ +GV+L E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 48/227 (21%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F ++G+G FGKV + D + A+K + +++ + RN+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-------------CVEKGSVRNV 47
Query: 348 LRLRGFCMTPTERLLV----YPFMVNGSVASC----------------LRERGQSQPPLN 387
L ER ++ +PF+VN + LR + +
Sbjct: 48 LN---------ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS 98
Query: 388 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
K L YLH IIHRD+K NILLDE+ + DF +A
Sbjct: 99 EEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPD 153
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+TT+ GT G++APE L S D + GV E + G+R +
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLK--------EERTQGGELQFQTEVEMISMAVHR 345
++G G FG VY G + G L+AVK+++ ++R + E+ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++ G + + ++ GSVA+ L G + L + +QI +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-----AVRGTIGHI 460
H+ IIHRD+K ANIL+D + + DFG++K ++ T +++G++ +
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE + + K D++ G +++E++TG+ F
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+LG G FG VYKG + +G V A+K L E ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLH 406
L G C++PT + LV M +G + + E SQ LNW V+ A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL 465
+ +++HRD+ A N+L+ + DFGLA+L++ + + I +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
K + ++DV+ YGV + EL+T G + +D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 294 NILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLR 351
+G+G FG V K R +DG ++ K + T+ + Q +EV ++ H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 352 GFCMTPTERLLVYPFM---VNGSVAS----CLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+ + + L Y M G +A C +ER + W + Q+ L L
Sbjct: 66 DRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LYE 120
Query: 405 LH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
H ++HRD+K ANI LD +GDFGLAK++ + + T V GT +++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E L+ EK+D++ G ++ EL F
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 49/137 (35%), Positives = 71/137 (51%), Gaps = 14/137 (10%)
Query: 80 NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139
SG++ LG+ NL L+L +NN++G++PE L + NL L L+ N+L G IP +LG
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN--------------G 185
LR +RL +NS GE+P T + + LD+SNN L G I +
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 186 SFSLFTPISFANNQLNN 202
F P SF + +L N
Sbjct: 463 KFFGGLPDSFGSKRLEN 479
|
Length = 968 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 18/197 (9%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+GRG FG+V+ GRL D + VAVK +E + +F E ++ H N++RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKI 413
+V + G + LR G P L Q+ AA G+ YL HC
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKHC---- 115
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTG 468
IHRD+ A N L+ E+ + DFG+++ ++ A G + I APE L+ G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 469 KSSEKTDVFGYGVMLLE 485
+ S ++DV+ +G++L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 352
LG G FG+V+ G + + VAVK LK G + Q E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
++ +M GS+ L+ E G+ P QIA G+AY+
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIERK-- 122
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
IHRD++AAN+L+ E + DFGLA++++ + + I APE ++ G
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 471 SEKTDVFGYGVMLLELIT 488
+ K+DV+ +G++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+LG G FG VYKG + DG VA+K L+E + + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLH 406
L G C+T T +L V M G + +RE R SQ LNW V QIA +G++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV--QIA----KGMSYLE 126
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 465
+ +++HRD+ A N+L+ + DFGLA+L+D +T + I +A E +
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+ + ++DV+ YGV + EL+T G + +D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 289 NFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 346
+ ++GRG FG V+ R D LV +K++ E+ T+ L Q E +++ + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP----LNWSVRKQIALGAARGL 402
++ + ++V + G++A +++R S L++ V+ +AL
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------ 114
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
++H I+HRD+K NILLD+ V +GDFG++K++ K T V GT +I+
Sbjct: 115 HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYIS 169
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 498
PE ++K+D++ G +L EL + +RAF+ A L
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 295 ILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LGRG FG+V+ + +LV VK L++ + + + +F+ E++M H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 349 RLRGFCMTPTERLLVYPFMVNGS-----VASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
RL G C ++ + G A+ ++ PPL+ + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
+L + + +HRD+ A N L+ + E V L+K + + + + +APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT 488
+ S K+DV+ +GV++ E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 295 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
++G G FG+V GRL VA+K LK T+ F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIAL--GAARGLAYLHD 407
G ++V +M NGS+ + LR+ GQ ++V + + + G A G+ YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ------FTVIQLVGMLRGIASGMKYLSD 124
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYL 465
+HRD+ A NIL++ V DFGL++++ D + + T + I APE +
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQRAF 493
+ K + +DV+ YG+++ E+++ G+R +
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER----TQGGELQFQTEVEMISMAV 343
N+ +LG+G FG+VY D G +AVK++ + T+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 344 HRNLLRLRGFCMTPTERLLVY-PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
H +++ G C+ E L ++ +M GSV L+ G L +V ++ G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGV 117
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHI 460
YLH + I+HRD+K ANIL D +GDFG +K + + T +V GT +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT 488
+PE +S K DV+ G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
F +LG G FG VYKG + +G VA+K L+E + + E +++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARG 401
++ RL G C+T T +L + M G + +RE SQ LNW V QIA +G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIA----KG 121
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGH 459
+ YL + +++HRD+ A N+L+ + DFGLAKL+ D K+ H + I
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKW 177
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+A E + + ++DV+ YGV + EL+T G + +D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 47/109 (43%), Positives = 67/109 (61%)
Query: 74 VDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
+DL + +LSG++ + QL NL+ L L+SNN +GK+P L +L L L L+ N +G I
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
P LGK + L L L+ N+L GEIP L + +L L L +N L G+IP
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 22/222 (9%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVK-RLKEERTQGGELQFQTEVE-MISMAV--HRNLLR 349
+LG G FG V+KG + +G + + +K + + G FQ + M++M H ++R
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLH 406
L G C + +L V GS+ +R+ S P LNW V QIA +G+ YL
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV--QIA----KGMYYLE 126
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEY 464
+H ++HR++ A NILL + + DFG+A L+ Y D + + + I +A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKTPIKWMALES 182
Query: 465 LSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVM 505
+ G+ + ++DV+ YGV + E+++ G + R D++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D+ LG G G V K G ++AVK ++ E + + Q E++++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ G + + +M GS+ L+E Q + + +IA+ +GL YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEY 464
+ KIIHRDVK +NIL++ + + DFG++ + T V GT ++APE
Sbjct: 118 E--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPER 170
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQ 490
+ S K+D++ G+ L+EL TG+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 73/236 (30%), Positives = 102/236 (43%), Gaps = 44/236 (18%)
Query: 259 FFDVPAEEDPEVHLGQLKRFS-LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVA 316
F +DPE K F+ LRE+ G G FG VY R +VA
Sbjct: 8 FSK----DDPE------KLFTDLREI-------------GHGSFGAVYFARDVRTNEVVA 44
Query: 317 VKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373
+K++ Q E ++Q EV + H N + +G + LV + + GS +
Sbjct: 45 IKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSAS 102
Query: 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433
L + PL I GA +GLAYLH H IHRD+KA NILL E +
Sbjct: 103 DILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKL 156
Query: 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 486
DFG A L+ ++ V GT +APE + G+ K DV+ G+ +EL
Sbjct: 157 ADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 296 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV Y + G +VAVK LK E Q ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GLAYL 405
+G C + L+ ++ GS+ L P + Q+ L A + G+AYL
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--------PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIA 461
H IHRD+ A N+LLD + +GDFGLAK + + H VR + A
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVFWYA 178
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELIT 488
E L K S +DV+ +GV L EL+T
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 355 MTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ L +V +M GS+ LR RG+S L + +L + YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 474 TDVFGYGVMLLELITGQR 491
+DV+ +G++L E+ + R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 293 RNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
++G G VY L + VA+KR+ E+ Q + + EV+ +S H N+++
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
+ E LV P++ GS+ ++ + L+ ++ + +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSN--- 121
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST 467
IHRD+KA NILL E+ + DFG++ + T VR GT +APE +
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 468 GKS-SEKTDVFGYGVMLLELITG 489
K D++ +G+ +EL TG
Sbjct: 181 VHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-18
Identities = 45/103 (43%), Positives = 61/103 (59%)
Query: 80 NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139
N +G++ L L LQ L+L+SN SG++P+ LG NL LDL NNL G IP L
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L L L +NSL GEIP+SL SL+ + L +N +G++P
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKR--LKEERTQGGELQFQTEVEMISMAVHRN 346
F+ +G+G FG+VYK +VA+K L+E + ++Q E++ +S
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ--QEIQFLSQCRSPY 60
Query: 347 LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
+ + G +L ++ + GS L+ L+ + I GL YL
Sbjct: 61 ITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYL 114
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIA 461
H+ IHRD+KAANILL EE + + DFG L M ++T V GT +A
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMA 166
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITG 489
PE + EK D++ G+ +EL G
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK--RLKEERTQGGELQFQTEVEMI-SM 341
T F ++G G +GKVYK R G LVA+K + E+ E + + E ++
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59
Query: 342 AVHRNLLRLRG--FCMTPT----ERLLVYPFMVNGSV---ASCLRERGQSQPPLNWSVRK 392
+ H N+ G P + LV GSV LR++G+ +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK------EE 113
Query: 393 QIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
IA RGLAYLH++ K+IHRD+K NILL + E + DFG++ +D
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 450 TTAVRGTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQ 490
T + GT +APE ++ + + + DV+ G+ +EL G+
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 8e-18
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 296 LGRGGFGKVYKG---RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G FGKV G R + V VK L+ T +L F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR-----ERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
C+ LLV F G + + LR +Q V +++A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVASGLLWLHQ 118
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEY- 464
IH D+ N L + +GD+GLA L Y + + T + +APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 465 ------LSTGKSSEKTDVFGYGVMLLELIT 488
L ++K++++ GV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 10/209 (4%)
Query: 295 ILGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLR 351
+LG+G FG+ +Y+ R D SLV K + R E + E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
M L+ + G++ + + + + +A ++Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
I+HRD+K NI L + +GDFG++K++ + + T V GT +++PE K +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 472 EKTDVFGYGVMLLELITGQRAFDLARLAN 500
K+D++ G +L EL+T +R FD N
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 356 TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
E + +V +M GS+ L+ G+ L +A A G+AY+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 475 DVFGYGVMLLELITGQR 491
DV+ +G++L EL T R
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
+V +M NG + + LRE G+ P S ++ G+AYL + IH
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEYLSTGKSSE 472
RD+ A N L+D++ V DFGL++ + D T++V G+ + PE L K S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSV-GSKFPVRWSPPEVLLYSKFSS 180
Query: 473 KTDVFGYGVMLLELIT-GQRAFDL 495
K+DV+ +GV++ E+ + G+ ++
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 295 ILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV K + VAVK LKE + +E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP--------------------PLNW 388
+L G C LL+ + GS+ S LRE + P L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448
A +RG+ YL + K++HRD+ A N+L+ E + + DFGL++ + +D++
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 449 VTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V + R + +A E L + ++DV+ +GV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMIS-MAVHRNLLRL 350
I+G G F V + A+K L + + + + E E+++ + H +++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 351 RGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ E L V + NG + +R+ G L+ + A L YLH
Sbjct: 68 Y-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLHSK- 121
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------------YKDTHVT 450
IIHRD+K NILLD++ + DFG AK++D K+
Sbjct: 122 --GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ GT +++PE L+ + + +D++ G ++ +++TG+ F
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHR 345
FS+ +G G FG VY R + + +VA+K++ Q E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N ++ RG + LV + + GS + L + PL + GA +GLAYL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL 131
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY- 464
H H +IHRDVKA NILL E +GDFG A +M + V GT +APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 465 --LSTGKSSEKTDVFGYGVMLLEL 486
+ G+ K DV+ G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 31/217 (14%)
Query: 293 RNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLL 348
++++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRKQIALGA 398
L G C L + +G++ LR+ ++ P S ++ + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 399 --ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + V+ T
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 181
Query: 457 IGHI-----APEYLSTGKSSEKTDVFGYGVMLLELIT 488
+G + A E L+ + +DV+ YGV+L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G G +G VYK R G +VA+K++K ++G E++++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ LV+ FM + + +++R Q L S+ K +GLA+ H H I
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYLSTG 468
+HRD+K N+L++ E + DFGLA+ Y VT R APE L
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYR------APELLLGD 173
Query: 469 KS-SEKTDVFGYGVMLLELITGQRAF 493
K S D++ G + EL++ + F
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G +G VYK R + G LVA+K +K E E Q E+ M+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69
Query: 355 MTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCD 410
+ + +V + GS+ + RG PL+ QIA +GLAYLH+
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTRG----PLS---ELQIAYVCRETLKGLAYLHET-- 120
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH---IAPEYL- 465
IHRD+K ANILL E+ + + DFG++ + T T A R + IG +APE
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TA-TIAKRKSFIGTPYWMAPEVAA 174
Query: 466 --STGKSSEKTDVFGYGVMLLELITGQ 490
G K D++ G+ +EL Q
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-17
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 295 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 351
I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 352 GFCMT-----PTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYL 405
CMT P + + M G + L + G S+ + + + I GL ++
Sbjct: 60 -VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----GLEHM 113
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 466 STGKSSEKT-DVFGYGVMLLELITGQRAF 493
G + + + D F G ML +L+ G F
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 352
LG G FG+V+ + VAVK +K G + F E ++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHC 409
+T ++ FM GS+ L+ + G QP + K I A A G+A++
Sbjct: 69 -VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKLIDFSAQIAEGMAFIEQR- 121
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 470 SSEKTDVFGYGVMLLELITGQR 491
+ K+DV+ +G++L+E++T R
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 296 LGRGGFGKVYKGRLT-DGSL--VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 351
LG G FG V +G+L D S+ VAVK +K E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 352 GFCMTPTER------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLA 403
G C+ E +++ PFM +G + S L P + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAP 462
YL IHRD+ A N +L+E V DFGL+K + D + + + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493
E L+ + K+DV+ +GV + E+ T GQ +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 295 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 351
I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 352 GFCM-----TPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYL 405
CM TP + + M G + L + G S+ + + + I GL ++
Sbjct: 60 -VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL-----GLEHM 113
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 466 STGKSSEKT-DVFGYGVMLLELITGQRAF 493
G + + + D F G ML +L+ G F
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 296 LGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG+G FG VY+G D + VAVK + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR------ERGQSQPPLNWSVRKQIALGAARGLA 403
L G L+V M +G + S LR E +PP Q+A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIA 461
YL+ K +HRD+ A N ++ +F +GDFG+ + + Y+ + +G + +A
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELIT 488
PE L G + +D++ +GV+L E+ +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 22/221 (9%)
Query: 284 QVATDNFSNRNILGRGGFGKVY----KGRLTDG--SLVAVKRLKEERTQGGELQFQTEVE 337
+VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE--------RGQSQPPLNWS 389
++ +++RL G L++ M G + S LR Q+ P L
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
+ Q+A A G+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + Y+ +
Sbjct: 122 I--QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 175
Query: 450 TTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+G + ++PE L G + +DV+ +GV+L E+ T
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH---RNLLRL 350
++GRG +G VY+G+ + G +VA+K + + Q EV ++S N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
G + ++ + GSV + ++ ++ ++ +R+ + L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV-- 120
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
+IHRD+KAANIL+ + DFG+A L++ + +T V GT +APE ++ GK
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 471 SE-KTDVFGYGVMLLELITG 489
+ K D++ G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG+V+ G + VAVK LK T E F E +++ H L++L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPE-SFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 356 TPTERL-LVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
E + +V +M GS+ L++ R P L +A A G+AY+
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAAGMAYIERM--- 121
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
IHRD+++ANIL+ + + DFGLA+L++ + + I APE G+ +
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 472 EKTDVFGYGVMLLELITGQR 491
K+DV+ +G++L EL+T R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 296 LGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LK+ T FQ E E+++ H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALG 397
G C ++V+ +M +G + LR G Q++ L S IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 456
A G+ YL +HRD+ N L+ +GDFG+++ + D + V
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
I + PE + K + ++DV+ +GV+L E+ T
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + N +G G G+VYK G VA+K+++ + Q EL E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIIN-EILIMKDCKHP 75
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA---RGL 402
N++ + E +V +M GS+ + Q+ +N QIA +GL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEP---QIAYVCREVLQGL 129
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
YLH +IHRD+K+ NILL ++ + DFG A + + + + V GT +AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQ 490
E + K D++ G+M +E+ G+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 289 NFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 346
+F LG+G +G VYK RL+D A+K + +Q E+ +++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ + + + +V + G ++ + +R + + + +I + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ KI+HRD+K+ANILL +GD G++K++ K T + GT ++APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWK 174
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 501
S K+D++ G +L E+ T F+ AR D
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 295 ILGRGGFGKV----YKGRLTDGSLVAVKRLKE----ERTQGGELQFQTEV-EMISMAVHR 345
+LGRG FGKV YK G L A+K LK+ R + L + + E + H
Sbjct: 6 VLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI-ALGAARGLAY 404
L+ L T V + G + + S+P R A GL Y
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVVLGLQY 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPE 463
LH++ KI++RD+K N+LLD E + DFGL K M + D T+ GT +APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPE 171
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
L+ + D +G GV++ E++ G+ F
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L+ L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPE-AFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 356 TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
E + +V FM GS+ L+E L V +A A G+AY+ I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIERM---NYI 124
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD++AANIL+ + + DFGLA+L++ + + I APE G+ + K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 475 DVFGYGVMLLELITGQR 491
DV+ +G++L EL+T R
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LK+ + F E E+++ H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG-------QSQPP--LNWSVRKQIALGAAR 400
G C+ ++V+ +M +G + LR G + P L S IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH- 459
G+ YL +HRD+ N L+ E +GDFG++ +D + T R GH
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS-----RDVYSTDYYR-VGGHT 182
Query: 460 ------IAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ PE + K + ++DV+ GV+L E+ T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGF 353
LG G FGKVYK + G A K ++ E EL+ F E++++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 354 CMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
+ ++ F G++ S + ERG ++P + + V +Q+ L +LH H
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML----EALNFLHSH--- 122
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
K+IHRD+KA NILL + + + DFG+ AK T GT +APE ++
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETF 180
Query: 471 SE-----KTDVFGYGVMLLEL 486
+ K D++ G+ L+EL
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRN 346
F N +G G +G VY+ R T G +VA+K+++ + + G + E+ ++ H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 347 LLRLRGFCMTPTERLLVYPFMVNG----SVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
++ L+ + L F+V +AS L P + S K + L RGL
Sbjct: 68 IVELKEVV---VGKHLDSIFLVMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGL 121
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
YLH++ IIHRD+K +N+LL ++ + DFGLA+ +T V T+ + AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 463 EYL-STGKSSEKTDVFGYGVMLLELITGQ 490
E L + D++ G +L EL+ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 284 QVATDNFSNRNILGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTE 335
+V D LG G FG+V K + + VAVK LK + T+ +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 336 VEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER----------GQSQP 384
+EM+ M H+N++ L G C ++ + G++ LR R P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 385 PLNWSVRKQI--ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442
S + + A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 443 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ D + TT R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV R G VAVK LK E + E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+G C L+ F+ +GS+ L +++ +N + + A+ +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYLS 466
+ +HRD+ A N+L++ E + +GDFGL K ++ + T + + APE L
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 467 TGKSSEKTDVFGYGVMLLELIT 488
K +DV+ +GV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 28/216 (12%)
Query: 296 LGRGGFGKVYKGRLTDG--SLVAVKRL----------KEERTQGGELQFQTEVEMISMAV 343
LG G FG VYK R + +L+A+K + K ER + +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66
Query: 344 -HRNLLRLRGFCMTPTERLLVYPFMVNGS----VASCLRERGQSQPPLN-WSVRKQIALG 397
H N++R +RL + ++ G+ + L+E+ Q W++ Q+ L
Sbjct: 67 RHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
L YLH + +I+HRD+ NI+L E+ + + DFGLAK ++ +T+ V GTI
Sbjct: 126 ----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTI 177
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ PE + EK DV+ +G +L ++ T Q F
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + VAVK LK++ T +E+EM+ M H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP-LNWSV------RKQI----- 394
++ L G C ++ + G++ LR R +PP +++S +Q+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRAR---RPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 395 ---ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VT 450
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + D + T
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
T R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGF 353
+G G G V+K + G VA+K++ R +GG Q E++ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ +LV +M ++ LR+ + PL + K +G+AY+H + I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 472
+HRD+K AN+L+ + + DFGLA+L ++ + + T + APE L K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 473 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
D++ G + EL+ G F ++D+ L
Sbjct: 181 GVDLWAVGCIFAELLNGSPLF-----PGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRN 346
LG G FG+V K R VAVK LK+ T +E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QI 394
++ L G C ++ + G++ LR R P + + K
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 453
A ARG+ YL + IHRD+ A N+L+ E+ + DFGLA+ + D + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R + +APE L + ++DV+ +G+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQI 394
++ L G C ++ + G++ LR R + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 453
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R + +APE L + ++DV+ +GV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG- 352
+LG+G FGKV L L AVK LK++ + Q + ++ + +L L G
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKD------VILQDD-DVECTMTEKRVLALAGK 54
Query: 353 -------FCMTPT-ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
T +RL VNG L Q + + A GL +
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPE 463
LH+ II+RD+K N+LLD E + DFG+ K + T T+ GT +IAPE
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE 166
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 503
LS D + GV+L E++ GQ F+ +D+D
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE----GDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 296 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG FGK+YKG L LVA+K LK+ +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCL-------------RERGQSQPPLNWSVRKQIALG 397
G +++ ++ G + L E G + L+ IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 456
A G+ YL H +H+D+ A NIL+ E+ + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
I + PE + GK S +D++ +GV+L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMI 339
E + D R +LG+G +G VY R L+ +A+K + E ++ +Q E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALH 59
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER----GQSQPPLNWSVRKQIA 395
S HRN+++ G + + GS+++ LR + ++ + + KQI
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT-KQI- 117
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAV 453
GL YLHD+ +I+HRD+K N+L++ + VV DFG +K + + T
Sbjct: 118 ---LEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP-CTETF 169
Query: 454 RGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 493
GT+ ++APE + G D++ G ++E+ TG+ F
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 273 GQLKRFSLRELQVATDN---FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG 328
G LK + EL D F++ +G G FG VY R + +VA+K++ Q
Sbjct: 7 GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 329 ELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP 385
E ++Q EV+ + H N + +G + LV + + GS + L + P
Sbjct: 67 E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH---KKP 121
Query: 386 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445
L I GA +GLAYLH H +IHRD+KA NILL E + + DFG A +
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 446 DTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 486
++ V GT +APE + G+ K DV+ G+ +EL
Sbjct: 179 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 290 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
F+ +G+G FG+VYKG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
R G + T+ ++ ++ GS L+ PL + I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+ IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 469 KSSEKTDVFGYGVMLLELITGQ 490
K D++ G+ +EL G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 296 LGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+ +G +G+V+ K + T G + A+K +K+ Q E ++ ++ ++ +
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 354 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
++ LV ++ G +AS L G L+ V + L YLH +
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHSN--- 112
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAK-------LMDYKDTHVTTAVRGTIGHIAPEY 464
IIHRD+K NIL+D + DFGL+K + D + GT +IAPE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 465 LSTGKSSEKTDVFGYGVMLLELITG 489
+ S+ D + G +L E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 4e-15
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT----EVEMISMAVH 344
+ LG G +G VYK R G +VA+K+++ + + G + E+ ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKH 57
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N+++L T + LV+ + + + L +R PL+ ++ K I RGLAY
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAY 113
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
H H +I+HRD+K NIL++ + + DFGLA+ T V T+ + APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI 169
Query: 465 L------STGKSSEKTDVFGYGVMLLELITGQ 490
L ST D++ G + E+ITG+
Sbjct: 170 LLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 296 LGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRLR 351
+G G FG VY +VAVK++ Q E ++Q EV+ + H N + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
G + LV + + GS + L + PL I GA +GLAYLH H
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTG 468
+IHRD+KA NILL E + + DFG A ++ V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 469 KSSEKTDVFGYGVMLLEL 486
+ K DV+ G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V+ G+ VA+K + E E F E +++ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+V FM NG + + LR+R G+ + S+ + + G+ YL + I
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVC----EGMEYLERN---SFI 122
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 473
HRD+ A N L+ V DFG+ + + D + +++ + + PE + K S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 474 TDVFGYGVMLLELIT-GQRAFD 494
+DV+ +GV++ E+ T G+ F+
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHRNLLRLR 351
+LG+G FGKV RL G L AVK LK++ Q +++ TE ++S+A + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG---------- 401
C +RL VNG L + ++K AR
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG-------------DLMFHIQKSRRFDEARARFYAAEITSA 108
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L +LHD II+RD+K N+LLD E + DFG+ K + T+ GT +IA
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIA 164
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
PE L D + GV+L E++ G F+ N+DD+
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + +A ++ E +++ + E+E+++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 356 TPTERLLVYPFMVNGSVASCLRE--RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ ++ F G+V + + E RG ++P + R+ + L YLH KI
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSM---KI 131
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYL--ST 467
IHRD+KA N+LL + + + DFG++ K + +D+ + GT +APE + T
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 468 GKSSE---KTDVFGYGVMLLEL 486
K + K D++ G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 30/188 (15%)
Query: 294 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHR 345
+G G +G VYK R L G VA+K+++ ++ G E+ ++E H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61
Query: 346 NLLRLRGFCMTP-TER----LLVYPFMVNGSVASCLR---ERGQSQPPLNWSVRKQIALG 397
N++RL C P T+R LV+ V+ +A+ L + G + + +Q+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKD-LMRQLL-- 117
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
RG+ +LH H I+HRD+K NIL+ + + + DFGLA++ Y T+V T+
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTL 170
Query: 458 GHIAPEYL 465
+ APE L
Sbjct: 171 WYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 290 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+ G + T+ ++ ++ GS L E G PL+ + I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL-EPG----PLDETQIATILREILKGLDYLHSE 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLST 467
K IHRD+KAAN+LL E E + DFG+A + DT + GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 468 GKSSEKTDVFGYGVMLLELITGQ 490
K D++ G+ +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRG 352
++G G +G+VYKGR + G L A+K + + T+ E + + E+ M+ + HRN+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 353 FCMTPT------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ + + LV F GSV ++ + +W I RGLA+LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLH 138
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194
Query: 467 TGKSSEKT-----DVFGYGVMLLELITG 489
++ + T D++ G+ +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL----KEERTQGGELQFQTEVEMISMAV 343
N+ +LGRG FG+VY D G +AVK++ + T + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 344 HRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H +++ G P E+ L +M GS+ L+ G + +QI +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QG 118
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGH 459
++YLH + I+HRD+K ANIL D +GDFG +K + +V GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
++PE +S K DV+ ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---EVEMISMAV 343
+ + ++G G +G V K R G +VA+K+ KE E +T EV+++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H N++ L+ LV+ + V ++ L PP +VR I + +A
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEY-VERTLLELLEASPGGLPPD--AVRSYI-WQLLQAIA 114
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
Y H H IIHRD+K NIL+ E + DFG A+ + + T T + APE
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 464 YL----STGKSSEKTDVFGYGVMLLELITGQRAF 493
L + GK DV+ G ++ EL+ G+ F
Sbjct: 172 LLVGDTNYGKP---VDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 290 FSNRNILGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
F+ +G+G FG+V+KG D +VA+K + E + Q E+ ++S
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ + G + T+ ++ ++ GS LR + + ++ K+I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-TMLKEIL----KGLDYLH 118
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
K IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
Query: 467 TGKSSEKTDVFGYGVMLLELITGQ 490
K D++ G+ +EL G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G + VYKGR LTD +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
T LV+ ++ + + L + G S +N K RGL Y H K+
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 472
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 473 KTDVFGYGVMLLELITGQRAF 493
+ D++G G + E+ TG+ F
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRG 352
++G G +G+VYKGR + G L A+K + + T E + + E+ M+ + HRN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 353 FCMTPT------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ + LV F GSV ++ + W I RGL++LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH 128
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 184
Query: 467 TGKSSE-----KTDVFGYGVMLLELITG 489
++ + K+D++ G+ +E+ G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 345
+ + LG G G V K RL + ++ + +LQ Q E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSP 59
Query: 346 NLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
+++ G + + + + GS+ S ++ + + V +IA +GL+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAP 462
YLH KIIHRD+K +NILL + + + DFG++ +L++ T GT ++AP
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAP 172
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E + S +DV+ G+ LLE+ + F
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 295 ILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLR 349
+LG+G FG V + +L DGS VAVK LK + ++ +F E + H N+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 350 LRGFCM--TPTERL----LVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARG 401
L G + RL ++ PFM +G + + L + P ++ + + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHI 460
+ YL IHRD+ A N +L+E V DFGL+K + D + A + + +
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493
A E L+ + +DV+ +GV + E++T GQ +
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 295 ILGRGGFGKVYKGRLTD-GSLVAVKRLK---EERTQGGELQ-FQTEVEMISMAVHRNLLR 349
+LG+G FG+VY D G +AVK+++ E E+ + E++++ +H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 350 LRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
G P ER L M GS+ L+ G + +QI G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYL 465
+ I+HRD+K ANIL D +GDFG +K + T +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 466 STGKSSEKTDVFGYGVMLLELIT 488
S K D++ G ++E++T
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLK------EERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FG VY R G LVA+K++K EE E++ + + H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS-----LRKLNEHPNIV 61
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+L+ E V+ +M G++ +++R P + SV + I +GLA++H H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH 118
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL--S 466
HRD+K N+L+ + DFGLA+ + + + T V T + APE L S
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRS 173
Query: 467 TGKSSEKTDVFGYGVMLLELITGQ 490
T SS D++ G ++ EL T +
Sbjct: 174 TSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 289 NFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISM-A 342
NF +LG G +GKV+ G G L A+K LK+ Q + T E + A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 343 VHRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
V R L+ L T T+ L+ ++ G + + L +R VR IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIA-EIVL 116
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L +LH II+RD+K NILLD E V+ DFGL+K ++ + GTI ++
Sbjct: 117 ALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 461 APEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 493
APE + G + D + GV+ EL+TG F
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 59/221 (26%), Positives = 110/221 (49%), Gaps = 11/221 (4%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
NF LG G + VYKGR T G +VA+K + + +G E+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
+RL T + +LV+ +M + + + G + L+ + K +G+A+ H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
+ +++HRD+K N+L+++ E + DFGLA+ + V T+ + AP+ L
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 468 GKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
++ S D++ G ++ E+ITG+ F N++D +L
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLF---PGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 352
LG+GGFG+V ++ G + A K+L ++R + GE E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGAARGLAYLHDHCD 410
+ T LV M G + + G+ + + QI G LH H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI------LHLH-S 113
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
I++RD+K N+LLD++ + D GLA ++ KD T GT G++APE L
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 471 SEKTDVFGYGVMLLELITGQRAF 493
S D F G + E++ G+ F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS- 340
+N S LG G FGKV + +D + VAVK LK +E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN--WSVRKQIALGA 398
+ H N++ L G C L++ + G + + LR + +S L S Q+A
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA--- 151
Query: 399 ARGLAYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT 456
+G+A+L +C IHRD+ A N+LL + DFGLA+ +M+ + V R
Sbjct: 152 -KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ +APE + + ++DV+ YG++L E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 43/142 (30%), Positives = 79/142 (55%), Gaps = 15/142 (10%)
Query: 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANIL 424
FM GS+ ++ G P+ + +IA+ GL YL++ H +I+HRD+K +NIL
Sbjct: 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNIL 136
Query: 425 LDEEFEAVVGDFGLA-KLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 482
++ + + DFG++ +L++ DT V GT +++PE + GK + K+DV+ G+
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 483 LLELITGQRAFDLARLANDDDV 504
++EL G+ F + + +D
Sbjct: 192 IIELALGKFPFAFSNIDDDGQD 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 65/206 (31%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEM-ISMAVH-RNLLRLRG 352
LG+GGFG+V ++ G L A K+L ++R + + VE I VH R ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQP----PLNWSVRKQIALGAARGLAYLHDH 408
T T+ LV M G + + + P P QI G L +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQR 116
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEYLST 467
+II+RD+K N+LLD + + D GLA +L D + T GT G +APE L
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAF 493
+ D F GV L E+I + F
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----------ELQFQTEVEMISMAVH 344
LG G + VYK R G +VA+K++K + E++ E++ H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGA 398
N++ L + LV+ FM + ++++ S+ K L
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMT 111
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458
RGL YLH + I+HRD+K N+L+ + + DFGLA+ + +T V T
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 459 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
+ APE L + D++ G + EL+ + F L D D+
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF----LPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + ++A ++ + +++ + E+++++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415
++ F G+V + + E + PL + + L YLH++ KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 416 RDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
RD+KA NIL + + + DFG++ + + +D+ + GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 472 E-----KTDVFGYGVMLLEL 486
+ K DV+ G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
NF +LG+G FGKV R L A+K LK++ + T VE +A+
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 346 N---LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
L +L C +RL V ++ G + +++ G+ + P +I++G
Sbjct: 59 KPPFLTQLHS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG---- 113
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L +LH II+RD+K N++LD E + DFG+ K D T GT +IA
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIA 169
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE ++ + D + YGV+L E++ GQ FD
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 290 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 346
F +LG+GGFG+V ++ G + A K+L+++R + GE E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GLA 403
++ L T LV M G + + G++ + AA GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCGLE 116
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
LH +I++RD+K NILLD+ + D GLA + + GT+G++APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPE 171
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + + D + G +L E+I GQ F
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 289 NFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 345
+ +G G FGK+Y K + +D +K + + E + + EV +++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERG---QSQPPLNWSVRKQIALGAARG 401
N++ +V + G + + R+RG L+W V QI+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG---- 113
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L ++HD KI+HRD+K+ NI L + A +GDFG+A+ ++ T V GT ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYL 169
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+PE + KTD++ G +L EL T + F+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-----MDY 444
+ KQI GL YLH +IIHRDVK NI +++ + +GD G A+
Sbjct: 162 IEKQIL----EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487
+ GT+ APE L+ K + K D++ G++L E++
Sbjct: 215 -------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G + V+KGR LT+ +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
T LV+ ++ + + + + G N K RGLAY H K+
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN---VKIFLYQILRGLAYCHRR---KV 125
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 472
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 473 KTDVFGYGVMLLELITGQRAF 493
+ D++G G + E+ +G+ F
Sbjct: 185 QIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK----EERTQGGELQFQTEVEMISMAV 343
N+ +LG+G FG+VY D G +A K+++ T + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 344 HRNLLRLRGFCMTPTERLLV--YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H +++ G E+ L +M GSV L+ G L SV ++ G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEG 118
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGH 459
++YLH + I+HRD+K ANIL D +GDFG +K + T +V GT
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
++PE +S K DV+ G ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 48/144 (33%), Positives = 82/144 (56%), Gaps = 4/144 (2%)
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
++++ +DL + + L S L L NL+ L+L N++S +P+ L NL+NL +LDL
Sbjct: 136 GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
N ++ +P + LS L L L+NNS++ E+ SL+N+ +L L+LSNNKL +
Sbjct: 194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESI 251
Query: 185 GSFSLFTPISFANNQLNNPPPSPP 208
G+ S + +NNQ+++
Sbjct: 252 GNLSNLETLDLSNNQISSISSLGS 275
|
Length = 394 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLKEERTQGGELQFQTEVEM 338
L L TD + +G+G +GKVYK DGSL AVK L E++ + + +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72
Query: 339 ISMAVHRNLLRLRGFC-----MTPTERLLVYPFMVNGSVASCLR---ERGQSQPPLNWSV 390
S+ H N+++ G + + LV GSV ++ GQ L+ ++
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR---LDEAM 129
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450
I GA GL +LH++ +IIHRDVK NILL E + DFG++ +
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 451 TAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITG 489
T+V GT +APE ++ + + + DV+ G+ +EL G
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 296 LGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G FGKV G + G + V VK L+ + +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
C T LLV F G + LR R + + +++A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGK 469
IH D+ N LL + +GD+GL+ YK+ + T + + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHN-KYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 470 S-------SEKTDVFGYGVMLLEL 486
+++++V+ GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G + V+KGR LT +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
T LV+ ++ + + L G N K RGL+Y H KI
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHN---VKIFMFQLLRGLSYCHKR---KI 124
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 472
+HRD+K N+L++E+ E + DFGLA+ + V T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 473 KTDVFGYGVMLLELITGQRAF 493
D++G G +L E+ TG+ F
Sbjct: 184 PIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 63/250 (25%), Positives = 119/250 (47%), Gaps = 41/250 (16%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 331
GQ L +L+ + +G G G+VYK R G ++AVK+++ RT E
Sbjct: 7 GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKEEN 57
Query: 332 FQT--EVEMISMAVHR--NLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPL 386
+ +++++ + H +++ G+ +T ++ + M ++CL + + Q P+
Sbjct: 58 KRILMDLDVVLKS-HDCPYIVKCYGYFITDSDVFICMELM-----STCLDKLLKRIQGPI 111
Query: 387 NWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDY 444
+ ++ + + L YL + H +IHRDVK +NILLD + DFG++ +L+D
Sbjct: 112 PEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEK----TDVFGYGVMLLELITGQRAFD------ 494
K +A G ++APE + + K DV+ G+ L+EL TGQ +
Sbjct: 169 K-AKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225
Query: 495 --LARLANDD 502
L ++ ++
Sbjct: 226 EVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK--RLKEERTQGGELQFQTEVEMISMAVH 344
D F +G G +G+VYK R D G LVA+K RL E+ +G + E++++ H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNH 65
Query: 345 RNLLRLRGFCMTPTERL----------LVYPFM---VNGSVASCLRERGQSQPPLNWSVR 391
RN++ L+ + L LV+ +M + G + S L + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH---IKSFM 122
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
KQ+ GL Y H +HRD+K +NILL+ + + + DFGLA+L + +++ T
Sbjct: 123 KQL----LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 452 AVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T+ + PE L + DV+ G +L EL T + F
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F+ +LG+G FGKV R L A+K LK++ + Q + +M V + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD------VIIQDDDVECTM-VEKRV 53
Query: 348 LRLRG---------FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 397
L L G C +RL V ++ G + +++ G+ + P +IA+G
Sbjct: 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG 113
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
L +LH II+RD+K N++LD E + DFG+ K + T GT
Sbjct: 114 ----LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTP 165
Query: 458 GHIAPE---YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+IAPE Y GKS D + +GV+L E++ GQ FD
Sbjct: 166 DYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F+ +LG+G FGKV R L A+K LK++ + Q + +M V + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD------VVIQDDDVECTM-VEKRV 53
Query: 348 LRLRG---------FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 397
L L G C +RL V ++ G + +++ G+ + P +IA+G
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG 113
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
L +LH II+RD+K N++LD E + DFG+ K + D T GT
Sbjct: 114 ----LFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTP 165
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+IAPE ++ + D + +GV+L E++ GQ F+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 290 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 346
F +LG+GGFG+V ++ G + A KRL+++R + GE E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ L T LV M G + + G P ++ AA L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFE---EERALFYAAEILCGLE 116
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
D ++RD+K NILLD+ + D GLA + + GT+G++APE L+
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + D +G G ++ E+I GQ F
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 296 LGRGGFGKVY------------KGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 338
LG G FG+V+ K + + LVAVK L+ + + F EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER-------GQSQPPLNWSVR 391
+S N+ RL G C ++ +M NG + L++ + L++S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTH 448
+A A G+ YL +HRD+ N L+ + + + DFG+++ + DY
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR-- 187
Query: 449 VTTAVRGT----IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V+G I +A E + GK + K+DV+ +GV L E++T
Sbjct: 188 ----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 32/225 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG----ELQFQTEVEMISMA 342
D + +G G +GKVYK R G LVA+K+ + E + G L+ + ++M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 343 VHRNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395
++ ++RL + E LV+ ++ + PL K
Sbjct: 61 IY--IVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAK-----LMDYKDTHV 449
+G+A+ H H ++HRD+K N+L+D++ + + D GL + + Y V
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 450 TTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
T R APE L S D++ G + E+ Q F
Sbjct: 174 TLWYR------APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 295 ILGRGGFGKVYKGRLTDGS-LVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNL 347
+LG+G FGKV L + A+K LK++ + E M+ V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWEHPFL 58
Query: 348 LRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA--RGLA 403
L FC T+ L V ++ G + ++ G+ + + A GL
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR------FDEARARFYAAEIICGLQ 110
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
+LH II+RD+K N+LLD++ + DFG+ K + +T GT +IAPE
Sbjct: 111 FLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPE 166
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
L K +E D + +GV+L E++ GQ F
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 295 ILGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRL 350
++G+G FGKV R +DGS AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
T + V ++ G + L RER +P + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-----YAAEVASAIGYLHSL- 115
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 468
II+RD+K NILLD + V+ DFGL K ++ ++T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
D + G +L E++ G F
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 294 NILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLR 349
+++G G FG+V + + L A+K LKE ++ F E+E++ + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRK--QIALG 397
L G C + + G++ LR+ ++ P + ++ Q A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 456
A G+ YL + + IHRD+ A N+L+ E + + DFGL++ ++ +V T R
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ +A E L+ + K+DV+ +GV+L E+++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D++ LG G + VYKG+ +G LVA+K ++ + +G E ++ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ L T LV+ + V+ + + + P N K RGL+Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPEN---VKLFLFQLLRGLSYIH 120
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YL 465
I+HRD+K N+L+ + E + DFGLA+ +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLL 176
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + S D++G G + +E+I G AF
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 35/167 (20%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRL-- 350
LG G FG+VYK R + G +VA+K++ E+ G + E++++ H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLID 74
Query: 351 ------RGFCMTPTERLLVYPFMV--------NGSVASCLRERGQSQPPLNWSVRKQIAL 396
+V P+M N SV L S K L
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------------LTESQIKCYML 122
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443
G+ YLH++ I+HRD+KAANIL+D + + DFGLA+ D
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVH 344
T+ + + +G G FG V R G VA+K++ K T + E++++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L ++P E + ++ + L R PL + RGL Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKY 123
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
+H ++HRD+K +NIL++E + + DFGLA++ +D +T V T + APE
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV-STRYYRAPEI 176
Query: 465 LST-GKSSEKTDVFGYGVMLLELITGQRAF 493
+ T K + D++ G + E++ G+ F
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
N +G G G VYK G L A+K + Q E+E++ H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
E ++ FM GS L + V +QI G+AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADVARQIL----SGIAYLHRR---H 188
Query: 413 IIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I+HRD+K +N+L++ + DFG LA+ MD ++ V GTI +++PE ++T
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTD 243
Query: 469 KSSEK-----TDVFGYGVMLLELITGQRAFDLAR 497
+ D++ GV +LE G+ F + R
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 44/143 (30%), Positives = 73/143 (51%), Gaps = 3/143 (2%)
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
C+S N + ++ L + +L G++ LG +L+ + L N+ SG++P E L + LD+
Sbjct: 377 CSSGN-LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
NNL G I + + L+ L L N G +P S + L+ LDLS N+ +G +P
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRK 494
Query: 185 -GSFSLFTPISFANNQLNNPPPS 206
GS S + + N+L+ P
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 25/232 (10%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAV---HRNLLR 349
+G G +GKV+K R G VA+KR++ + +G L EV ++ H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 350 LRGFCM---TPTERLLVYPF-MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
L C T E L F V+ + + L + +P + K + RGL +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H H +++HRD+K NIL+ + + DFGLA++ ++ T+V T+ + APE L
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVL 181
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF----DLARLANDDDVMLL----DW 509
+ D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 345
D + N + G +G VY+ R G +VA+K+LK E+ +G + E+ ++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 346 NLLRLRGFCM--TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
N++ ++ + + +V ++ + + S + + P S K + L G+A
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVA 120
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIG 458
+LHD+ I+HRD+K +N+LL+ + DFGLA+ L Y VT R
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR---- 173
Query: 459 HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE L + S D++ G + EL+T + F
Sbjct: 174 --APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRG 352
+LG+G FGKV L G AVK LK++ + T VE +A+ N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 353 FCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--GLAYLHDH 408
+C T+ L V F+ G + ++++G+ + + + A GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR------FDLYRATFYAAEIVCGLQFLHSK 115
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
II+RD+K N++LD + + DFG+ K + D +T GT +IAPE L
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGL 171
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
K + D + +GV+L E++ GQ F
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 294 NILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLR 349
+++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRK--QIALG 397
L G C L + +G++ LR+ ++ P S ++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 456
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ ++ +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ +A E L+ + +DV+ YGV+L E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 296 LGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 352
+G G FGK + K + DG +K + + E + + EV ++S H N+++ +
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 353 FCMTPTERLLVYPFMVNGSVASCL-RERG---QSQPPLNWSVRKQIALGAARGLAYLHDH 408
+V + G + + +RG L+W V QI L L ++HD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV--QICLA----LKHVHDR 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
KI+HRD+K+ NI L ++ +GDFG+A++++ T + GT +++PE
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500
+ K+D++ G +L E+ T + AF+ + N
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 295 ILGRGGFGKVYKGRL--TDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHRNLLRL 350
+LG+G FGKV L TD + A+K LK++ Q ++ TE ++++A L
Sbjct: 2 VLGKGSFGKVMLAELKGTD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
C +RL VNG L + Q + + A L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGD---LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
+I+RD+K NILLD E + DFG+ K TT GT +IAPE L +
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEY 173
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
D + GV++ E++ GQ F+ N+DD+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 346
NF +G G +G VYK R G +VA+K+++ + T+G E+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAY 404
+++L T + LV+ F+ L++ + P + + K +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIGH 459
H H +++HRD+K N+L++ E + DFGLA+ + Y VT R
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR----- 167
Query: 460 IAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAF 493
APE L K S D++ G + E++T + F
Sbjct: 168 -APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 290 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 346
F + +LG+GGFG+V ++ G + A K+L+++R + GE E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL-GAARGLAYL 405
++ L T LV M G + + G N +Q A+ AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG------NPGFDEQRAIFYAAELCCGL 115
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---TIGHIAP 462
D +I++RD+K NILLD+ + D GLA + +T VRG T+G++AP
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAP 170
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E ++ K + D +G G ++ E+I GQ F
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH 344
D+F LG G FG+V R G A+K L + + E ++ H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIALGAAR 400
L+ L G + LV ++ G + S LR+ G+ P + + Q+ L
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVA--RFYAAQVVLA--- 113
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L YLH D I++RD+K N+LLD + + DFG AK + + T + GT ++
Sbjct: 114 -LEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYL 165
Query: 461 APEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
APE + + GK+ D + G+++ E++ G F DD+ + +
Sbjct: 166 APEIILSKGYGKAV---DWWALGILIYEMLAGYPPFF------DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-----VAVKRLKEERTQGGELQ---FQT 334
+ ++ D + ++L G FG+++ G L D V VK +K+ E+Q
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQ 57
Query: 335 EVEMISMAVHRNLLRLRGFCMTPTERLLV-YPFMVNGSVASCLRERGQSQPPLNWSVRKQ 393
E ++ H+N+L + C+ E V YP+M G++ L++ + ++ Q
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 394 ----IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYK- 445
+A+ A G++YLH +IH+D+ A N ++DEE + + D L++ MDY
Sbjct: 118 QLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 446 --DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
D + +A E L + S +DV+ +GV+L EL+T
Sbjct: 175 LGDNE-----NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 290 FSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHR 345
F + +LG+GGFG+V + R T G + A K+L+++R + GE E +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GL 402
++ L T LV M G + + G ++ AA GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVFYAAEITCGL 115
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
LH +I++RD+K NILLD+ + D GLA ++ + GT+G++AP
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAP 170
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E + + + D +G G ++ E+I G+ F
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 295 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
+G G FG VY+G VAVK K + +F E ++ H ++++L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 351 RGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
G ++ + P G + S L+ S L+ + + + LAYL
Sbjct: 73 IGVITENPVWIVMELAPL---GELRSYLQVNKYS---LDLASLILYSYQLSTALAYLESK 126
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+ +HRD+ A N+L+ +GDFGL++ ++ + + + + I +APE ++
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 469 KSSEKTDVFGYGVMLLE-LITGQRAFDLARLANDDDVMLLD 508
+ + +DV+ +GV + E L+ G + F + N+D + ++
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPF--QGVKNNDVIGRIE 222
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 8e-12
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 48/225 (21%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---------EVEMI 339
+ +G G +G V G VA+K++ F E++++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53
Query: 340 SMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 393
H N++ L + P +V M + L + +S PL +
Sbjct: 54 RHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQY 107
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH----- 448
RGL YLH +IHRD+K +NIL++ + + DFGLA+ +D +
Sbjct: 108 FLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 449 ---VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITG 489
VT R APE LS+ + ++ D++ G + EL+T
Sbjct: 165 EYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAV 343
NF +LG G +GKV+ R G L A+K LK+ Q + T E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 344 HRN---LLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGA 398
R L+ L T T+ L+ ++ G + + L RER + Q QI G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EVQIYSGE 113
Query: 399 -ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
L +LH II+RD+K NILLD V+ DFGL+K + + GTI
Sbjct: 114 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 458 GHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 493
++AP+ + G + D + GV++ EL+TG F
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 296 LGRGGFGKVYKG--RLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
LG G FG V KG ++ + VA+K LK E + + E E++ + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR--KQIALGAARGLAYLHDHCD 410
C E L++ M +G + + + ++ V Q+++G + YL
Sbjct: 63 VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEGK-- 114
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTG 468
+HRD+ A N+LL + A + DFGL+K + D++ +A + + APE ++
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 469 KSSEKTDVFGYGVMLLELIT-GQRAF 493
K S ++DV+ YG+ + E + GQ+ +
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 48/185 (25%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 314 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373
LVAVK L+ + T+ F E++++S + N++RL G C++ ++ +M NG +
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 374 SCLRER--------GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425
L +R + P ++ + +A+ A G+ YL +HRD+ N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVML 483
+ + DFG+++ + Y + R I +A E + GK + +DV+ +GV L
Sbjct: 163 GNHYTIKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 484 LELIT 488
E+ T
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 293 RNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
+ ILG G G VYK L ++AVK + + T + Q +E+E++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK---------- 55
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ----IALGAARGLAYLHD 407
C +P F V ++ C + + + IA+ +GL YL
Sbjct: 56 --CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS 113
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
KI+HRDVK +N+L++ + + DFG++ + ++ T V GT ++APE +S
Sbjct: 114 L---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISG 167
Query: 468 GKSSEKTDVFGYGVMLLELITGQ 490
+ +DV+ G+ +EL G+
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 39/93 (41%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHI 460
LAYLH IIHRDVK NI LDE AV+GDFG A KL + DT GT+
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+PE L+ KTD++ G++L E+
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 290 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRN 346
+ N ++G G +G V K + + G +VA+K+ E+ ++ + E+ M+ H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L+ L LV+ F+ + + L + + L+ S ++ RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTHVTTAVRGTIGHIA 461
H IIHRD+K NIL+ + + DFG A+ + Y D T R A
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR------A 168
Query: 462 PEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 493
PE L K D++ G ++ E++TG+ F
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 18/224 (8%)
Query: 295 ILGRGGFGKVYKGRL--TDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 350
++GRG + KV RL T+ + A+K +K+E E QTE + A + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTE-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN---WSVRKQIALGAARGLAYLHD 407
C RL VNG +R + P + +S +AL YLH+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE 114
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWDF 511
D + GV++ E++ G+ FD+ +++ D D+ F
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKE----ERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG GGFG+V ++ + A+K +K+ E Q + +E E++ H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ--QEHIFSEKEILEECNHPFIVKL 58
Query: 351 -RGFCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
R F ++ +Y + + G + + LR+RG + + YLH
Sbjct: 59 YRTF----KDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLH 110
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYL 465
+ II+RD+K N+LLD + DFG AK L + T T GT ++APE +
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEII 164
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
D + G++L EL+TG+ F +D+D M
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFG----EDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G + VYKGR LT LVA+K ++ E +G E ++ H N++ L
Sbjct: 13 LGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCD 410
T LV+ ++ + + + G N VR Q+ RGLAY H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN--VRLFLFQLL----RGLAYCHQR-- 122
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYL 465
+++HRD+K N+L+ E E + DFGLA+ Y + VT R P+ L
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVL 175
Query: 466 --STGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 501
ST S+ D++G G + E+ TG+ F + D
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 47/135 (34%), Positives = 75/135 (55%), Gaps = 5/135 (3%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+DL +LS L L L+NL L+L N IS +P E+ L+ L LDL N++
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII- 222
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
+ ++L L L L L+NN L ++P S+ N+++L+ LDLSNN+++ I + GS +
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLR 280
Query: 192 PISFANNQLNNPPPS 206
+ + N L+N P
Sbjct: 281 ELDLSGNSLSNALPL 295
|
Length = 394 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAV 343
NF +LG G +GKV+ R G L A+K L++ Q + T E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 344 HRN---LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
R L+ L T + L+ ++ G + + L +R N+S +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEI 114
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
LA H H I++RD+K NILLD E V+ DFGL+K ++ T + GTI ++
Sbjct: 115 ILALEHLH-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 461 APEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDL 495
APE + G + D + G+++ EL+TG F L
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 353
+G G +G VYK R L G L AVK +K E G + Q E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
++ + + + GS+ G PL+ + +GLAYLH
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLSTGK 469
+HRD+K ANILL + + + DFG+A + T A R GT +APE + K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 470 S---SEKTDVFGYGVMLLELITGQRA-FDL 495
+ ++ D++ G+ +EL Q FDL
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 40/96 (41%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIG 458
LA H H +IHRD+K+ANILL +GDFG +K+ Y T V GT
Sbjct: 154 LAVHHVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKM--YAATVSDDVGRTFCGTPY 210
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
++APE S+K D+F GV+L EL+T +R FD
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAV---HRNLLRL 350
+G G +G VYK R G VA+K ++ + + G L EV ++ H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDH 408
C T +V V LR PP L K + RGL +LH +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
C I+HRD+K NIL+ + + DFGLA++ + T V T+ + APE L
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQS 182
Query: 469 KSSEKTDVFGYGVMLLEL 486
+ D++ G + E+
Sbjct: 183 TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
N +G G G V + G VAVK++ + Q EL F EV ++ H N+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNI 78
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARGLAY 404
+ + + E +V F+ G++ + ++ QIA L + L++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSF 130
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH +IHRD+K+ +ILL + + DFG + K+ ++ GT +APE
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEV 186
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+S + D++ G+M++E++ G+ +
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLR- 351
++G+G +G+V R TDG +K+L E + + E +++S H N++ R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 352 ----GFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPP---LNWSVRKQIALGAARGLA 403
+ +V F G + L+E +G+ P + W V QIA+ L
Sbjct: 67 SWEGEDGLL----YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV--QIAMA----LQ 116
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
YLH+ I+HRD+K N+ L VGD G+A++++ + +T + GT +++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
S + K+DV+ G + E+ T + AF+
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G FGKV + DG AVK L+++ + + + + V ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQI-ALGAARGLAYLHD 407
L T + V ++ G + L RER +P R + A A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEIASALGYLHS 114
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLS 466
II+RD+K NILLD + V+ DFGL K +++ T T+ GT ++APE L
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLR 169
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
D + G +L E++ G F
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE--MISMA-VHRNLLRL 350
+LG+G FGKV+ L A+K LK++ + T VE ++S+A H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 351 RGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+C T+ L V ++ G + ++ + P +I G L +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK 115
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I++RD+K NILLD + + DFG+ K D T GT +IAPE L
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQ 171
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
K + D + +GV+L E++ GQ F
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
DNF +G G G V + + G LVAVK++ + Q EL F EV ++ H N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ + + E +V F+ G++ + + +N + L + L+ LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLH 133
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+IHRD+K+ +ILL + + DFG + K+ ++ GT +APE +S
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELIS 189
Query: 467 TGKSSEKTDVFGYGVMLLELITGQ 490
+ D++ G+M++E++ G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G +G V+K R + G +VA+K+ E+ ++ + E+ M+ H NL+ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHPNLVNLIE 67
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ LV+ + + + L E ++ + + K+I + + + H H
Sbjct: 68 VFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---N 120
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
IHRDVK NIL+ ++ + + DFG A+++ T V T + APE L G +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELL-VGDTQY 178
Query: 473 KT--DVFGYGVMLLELITGQ 490
DV+ G + EL+TGQ
Sbjct: 179 GPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 17/199 (8%)
Query: 312 GSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
G VA+K L+ + + +F+ E + + H N++ L P L V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---D 426
G LRE + L ++ L LA H+ I+HRD+K NI++
Sbjct: 63 GRT---LREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 427 EEFEAVVGDFGLAKLM-DYKDTHVTTAVR-----GTIGHIAPEYLSTGKSSEKTDVFGYG 480
A V DFG+ L+ +D V T R GT + APE L + +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 481 VMLLELITGQRAFDLARLA 499
++ LE +TGQR A +A
Sbjct: 177 LIFLECLTGQRVVQGASVA 195
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 53/223 (23%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEV------------------- 336
LG+G F K++KG ++ E GEL +TEV
Sbjct: 3 LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49
Query: 337 -EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNW--SVRKQ 393
M+S H++L+ G C+ E ++V ++ GS+ + L++ + ++W V KQ
Sbjct: 50 ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQ 108
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 453
+A L +L D + H +V A N+LL E + G+ KL D ++ V
Sbjct: 109 LAW----ALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITV 158
Query: 454 RGT------IGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITG 489
I + PE + ++ S D + +G L E+ +G
Sbjct: 159 LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 10/179 (5%)
Query: 312 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371
G VAVK++ + Q EL F EV ++ H N++ + + E +V F+ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431
+ + + +N + L R L+YLH+ +IHRD+K+ +ILL +
Sbjct: 106 LTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
+ DFG + K+ ++ GT +APE +S + D++ G+M++E+I G+
Sbjct: 158 KLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAV 343
NF +G+G F VYK L DG +VA+K+++ E E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAA 399
H N+++ + E +V G ++ ++ + + + W Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
L ++H +I+HRD+K AN+ + +GD GL + K T + V GT +
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
++PE + + K+D++ G +L E+ Q F
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRL-KEERTQGGELQFQTEV 336
+ +L++ ++F ++GRG FG+V R V A+K L K E + + F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 337 EMISMAVHRN---LLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWS-- 389
I MA H N +++L ++ L V +M G + + + P W+
Sbjct: 94 RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARF 146
Query: 390 --VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 446
+AL A + + IHRDVK N+LLD+ + DFG MD +
Sbjct: 147 YTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMD-ANG 196
Query: 447 -THVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 493
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNL 347
+G G +G VYK R G +VA+K+++ E G E+ E+ H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP--PLNWSVRKQIALGAARGLAYL 405
+RL + + LV+ F + L++ S P L+ + K +G+AY
Sbjct: 61 VRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIG 458
H H +++HRD+K N+L+D E + DFGLA+ + Y TH VT R
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYR---- 166
Query: 459 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
APE L + S D++ G + E++ + F
Sbjct: 167 --APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-10
Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 26 SNAEGDALNALKTNL-ADPNNVLQSWDATLVNPCTWFHVTCN 66
N + DAL A K++L DP+ L SW+ + +PC+W VTC+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 12/221 (5%)
Query: 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV-HRNLLRL 350
++GRG + KV L + A+K +K+E E QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
T + V F+ G L Q Q L + + + L +LH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGD----LMFHMQRQRKLPEEHARFYSAEISLALNFLHER-- 115
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWDF 511
D + GV++ E++ G+ FD+ ++++ D D+ F
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 295 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
ILG G FG++ +G L S VA+ L+ + F E + H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
G ++V +M NG++ S LR+ GQ L + G A G+ YL +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM- 126
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLST 467
+H+ + A +L++ + + F +L + K + T + G + APE +
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAF 493
S +DV+ +G+++ E+++ G+R +
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 44/247 (17%)
Query: 293 RNILGRGGFGKVY--------------------KGRLTDGSLVAVKRLKEERTQGGELQF 332
+ LG G FG+V+ KGR LVAVK L+ + + F
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66
Query: 333 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER------------- 379
EV+++S N++RL G C+ ++ +M NG + L
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 380 GQSQ--PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437
+ P +++S +AL A G+ YL +HRD+ N L+ E + DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 438 LAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495
+++ + Y + R I +A E + GK + +DV+ +GV L E++ +
Sbjct: 184 MSRNL-YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 496 ARLANDD 502
L ++
Sbjct: 243 GELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 286 ATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
A ++ N LG G + VYKG +G LVA+K + + +G E ++ H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L T V+ +M ++ G P ++VR RGLAY
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP---YNVR-LFMFQLLRGLAY 118
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
+H I+HRD+K N+L+ E + DFGLA+ ++ V T+ + P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 465 L--STGKSSEKTDVFGYGVMLLELITGQRAF 493
L +T SS D++G G + +E++ GQ AF
Sbjct: 175 LLGATDYSSA-LDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 69/234 (29%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LGRG +G V K R + G+++AVKR++ V S R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR------------ATVN--SQEQKRLLMDL-DIS 53
Query: 355 MTPTERLLVYPFMVN--------GSVASCLR--------------ERGQSQPPLNWSVRK 392
M R + P+ V G V C+ ++G + P +
Sbjct: 54 M----RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE---DILG 106
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG--------LAKLMDY 444
+IA+ + L YLH +IHRDVK +N+L++ + + DFG +AK +D
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID- 163
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSE----KTDVFGYGVMLLELITGQRAFD 494
G ++APE ++ + + K+DV+ G+ ++EL TG+ +D
Sbjct: 164 ---------AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 283 LQVATDNFSNRNIL------GRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTE 335
L++ D R++L G G G V R G VAVK + + Q EL F E
Sbjct: 10 LRMVVDQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-E 68
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395
V ++ H+N++ + + E ++ F+ G++ + SQ LN +
Sbjct: 69 VVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVC 123
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
+ L YLH +IHRD+K+ +ILL + + DFG + KD ++ G
Sbjct: 124 ESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVG 179
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
T +APE +S + D++ G+M++E++ G+
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRN 346
+F LG G FG+V + G A+K L K E + ++Q + + I M +
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 347 LL--RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+ + F + F+V G + + LR+ G+ + ++ L Y
Sbjct: 79 FIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEY 133
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH D II+RD+K N+LLD + V DFG AK K T + GT ++APE
Sbjct: 134 LHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAPEV 186
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + + D + GV+L E I G F
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQFQTEVEMI----SMAVHRNLLR 349
+G+G FG+VY+ R D + A+K L K+E E+ I + ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L+ T ++ LV +M G + L++ G+ ++ L L +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA----LEHLHKY- 115
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
I++RD+K NILLD + DFGL+K + D T GT ++APE L K
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 470 SSEK-TDVFGYGVMLLELITGQRAF 493
K D + GV++ E+ G F
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 44/215 (20%)
Query: 298 RGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G FG VY K R T G A+K LK+ +MI+ N+ R M
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKS-------------DMIAKNQVTNVKAERAIMM 51
Query: 356 TPTE-----RL-----------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
E +L LV ++ G AS ++ G P +W+ KQ
Sbjct: 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL--PEDWA--KQYIAEVV 107
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
G+ LH IIHRD+K N+L+D+ + DFGL++ V GT +
Sbjct: 108 LGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDY 159
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+APE + + +D + G ++ E + G F
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 46/208 (22%), Positives = 93/208 (44%), Gaps = 7/208 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVHR 345
NF +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++ + E +V G ++ ++ + + + + + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H +++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF 493
+ K+D++ G +L E+ Q F
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 295 ILGRGGFGKVY-KGRLTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G FGKV R DG AVK L+++ R + + + V ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 350 LRGFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
L + TE+L VNG RER +P + + A L YLH
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-----IASALGYLHS 114
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLS 466
I++RD+K NILLD + V+ DFGL K + DT TT GT ++APE +
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIR 169
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
D + G +L E++ G F
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 50/231 (21%)
Query: 295 ILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLR 349
++G+GG G+VY D VA+K+++E+ ++ L+ F E ++ + +H ++
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 350 LRGFCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA------- 399
+ C ++ VY P++ ++ S L+ Q + S+ K++A +
Sbjct: 67 VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKE-----SLSKELAEKTSVGAFLSI 118
Query: 400 -----RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----------- 443
+ Y+H ++HRD+K NILL E V+ D+G A
Sbjct: 119 FHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 444 ------YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
Y + + GT ++APE L +SE TD++ GV+L +++T
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 10/204 (4%)
Query: 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR 351
++GRG + KV RL + + A+K +K+E E QTE + A L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
C T RL + VNG L Q Q L + A L +LH+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEICIALNFLHER--- 115
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
II+RD+K N+LLD + + D+G+ K T+ GT +IAPE L +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 472 EKTDVFGYGVMLLELITGQRAFDL 495
D + GV++ E++ G+ FD+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEER-TQGGELQFQ-TEVEMISMAVHRNLLRLR 351
+LG+G FGKV R G A+K LK+E E+ TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 352 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ +RL NG RER S+ + + ++ L YLH C
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALGYLHS-C 114
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
D +++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 D--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 470 SSEKTDVFGYGVMLLELITGQRAF 493
D +G GV++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 19/207 (9%)
Query: 295 ILGRGGFGKVY---KGRLTD-GSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLR 349
+LG+G FGKV+ K D G L A+K LK+ + ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L T + L+ F+ G + + L +E ++ + + + ++AL L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-AELALA----LDHLHSL 117
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDTHVTTAVRGTIGHIAPEYLS 466
II+RD+K NILLDEE + DFGL+K + K + + GT+ ++APE ++
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVN 171
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
++ D + +GV++ E++TG F
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EVE 337
D + N + +G G +G+V T G VA+K+L FQ+ E+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELR 66
Query: 338 MISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWSV 390
++ H N++ L TP L LV M + + ++ L+
Sbjct: 67 LLKHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLM-GADLNNIVK-----CQKLSDDH 119
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HV 449
+ + RGL Y+H IIHRD+K +NI ++E+ E + DFGLA+ D + T +V
Sbjct: 120 IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV 176
Query: 450 TTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T + APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 177 ATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 293 RNILGRGGFGKVYKGRLTDGS----LVAVKRLKEE---RTQGGELQFQTEVEMISMAVHR 345
+LG+GG+GKV++ R G+ + A+K LK+ R Q + E ++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
++ L T + L+ ++ G + L G +I+L L +L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHL 116
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H II+RD+K NILLD + + DFGL K ++ T VT GTI ++APE L
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF 493
+ D + G ++ +++TG F
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 296 LGRGGFGKVY------------KGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 338
LG G FG+V+ K D S LVAVK L+E+ + F E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPP------LNWSVR 391
+S N++RL C+T ++ +M NG + L R Q +++S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
+A A G+ YL +HRD+ N L+ + + + DFG+++ + Y +
Sbjct: 133 IFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YSGDYYRI 188
Query: 452 AVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R I ++ E + GK + +DV+ +GV L E++T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRG- 352
+GRG FG V K G+++AVKR++ + + + +++++ + +++ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 353 --------FCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
CM ++ Y + V + S + E + +IA+ +
Sbjct: 72 LFREGDCWICMELMDISLDKF--YKY-VYEVLKSVIPEE----------ILGKIAVATVK 118
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 459
L YL + + KIIHRDVK +NILLD + DFG++ +L+ D+ T G +
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPY 173
Query: 460 IAPEYLSTGKSSE---KTDVFGYGVMLLELITG 489
+APE + ++DV+ G+ L E+ TG
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMA 342
++ D+F + LG G G V+K L+ ++L E Q E++++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
++ G + E + M GS+ L++ G+ + + ++++ +GL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGL 116
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 461
YL + KI+HRDVK +NIL++ E + DFG++ +L+D + + GT +++
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 170
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
PE L S ++D++ G+ L+E+ G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 297 GRGGFGKVYKGRL---TDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLR 351
GRG +G+VYK + DG A+K+ K ++ Q + E+ ++ H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 352 GFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ ++ L++ + + R + + S+ K + G+ YLH +
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 410 DPKIIHRDVKAANILL--DEEFEAVV--GDFGLAKLMD------YKDTHVTTAVRGTIGH 459
++HRD+K ANIL+ + VV GD GLA+L + V TI +
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV----TIWY 181
Query: 460 IAPEYLSTGKSSEKT-DVFGYGVMLLELIT 488
APE L + K D++ G + EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G +G VYK R +T+ +A+K+++ E+ +G E+ ++ H N++RL+
Sbjct: 10 IGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR--KQIALGAARGLAYLHDHCD 410
+ LV+ ++ L++ S P + R K RG+AY H H
Sbjct: 69 VVHSEKRLYLVFEYL-----DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 411 PKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE L +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSR 179
Query: 470 S-SEKTDVFGYGVMLLELITGQRAF 493
S D++ G + E++ + F
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQFQTEVE 337
+R+LQ+ +++ ++GRG FG+V R V +L K E + + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 338 MISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNW----SVR 391
I MA + ++ FC ++ L V +M G + + + P W +
Sbjct: 95 DI-MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAE 150
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 450
+AL A + +IHRDVK N+LLD+ + DFG MD
Sbjct: 151 VVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 451 TAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 493
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLK---------EERTQGGE--LQFQT--EVEMI 339
LG G +GKV K T G +VA+K++K ++R G + F T E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
+ H N++ L + LV M AS L++ + L S K I L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LMDYKDTHVTTAV 453
GL LH +HRD+ ANI ++ + + DFGLA+ D T
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 454 RG-------TIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 493
R T+ + APE L K D++ G + EL+TG+ F
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRL---TDG---SLVAVKRLKEERTQGGELQFQTE 335
E+ ++T F LG FGKVYKG L G VA+K LK++ +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS------------- 382
M S H N++ L G +++ + + + L R
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 383 ---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439
+P + QIA G+ +L H ++H+D+ N+L+ ++ + D GL
Sbjct: 119 STLEPADFVHIVTQIA----AGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 440 KLM---DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ + DY + + I ++PE + GK S +D++ YGV+L E+ +
Sbjct: 172 REVYAADYYKLMGNSLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDG---------SLVAVKRLKEERTQGGELQFQTEVEM 338
D+ +G G FG+V+ R ++ V RLK+E+ E +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRV 54
Query: 339 ISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
+ H ++RL F +R L + ++ G + S LR G+ + S A
Sbjct: 55 LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYAS 108
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRG 455
L YLH +I++RD+K NILLD+E + DFG AK L D T + G
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCG 160
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T ++APE + + ++ D + G+++ E++ G F
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMA 342
++ D+F + LG G G V K + L+ ++L E Q E++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
++ G + E + M GS+ L+E + + + ++++ RGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGL 116
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 461
AYL + +I+HRDVK +NIL++ E + DFG++ +L+D + + GT +++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 170
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
PE L S ++D++ G+ L+EL G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 294 NILGRGGFGKVYKGR-LTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
+G+G FG+V+K R +VA+K+ L E +G + E++++ + H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 352 GFCMTPTER--------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
C T LV+ F + +A L S K++ GL
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS---NKNVKFTLSEIKKVMKMLLNGLY 133
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
Y+H + KI+HRD+KAANIL+ ++ + DFGLA+
Sbjct: 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRG 352
+G+G FGKV + R D + A+K +++ T E +A ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+P + LV F+ G + L+ G+ + S + L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR----FDLSRARFYTAELLCALENLHKF---N 113
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+I+RD+K NILLD + + DFGL KL + KD T GT ++APE L ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 473 KTDVFGYGVMLLELITG 489
D + GV+L E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 46/201 (22%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 296 LGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G+G G V+ D G VA+K++ ++ EL E+ ++ + N++
Sbjct: 27 IGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLD 83
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ E +V ++ GS+ + E + + R+ + + L +LH + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---Q 135
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+IHRD+K+ N+LL + + DFG + + + +T V GT +APE ++
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 473 KTDVFGYGVMLLELITGQRAF 493
K D++ G+M +E++ G+ +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVA---VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G G FGKV + + VA VK LK + + +F + + + H N+L+ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRE----RGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
C+ LLV+ + G + S L + R SQ L +++A A G+ ++H H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAAGVTHMHKH 118
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT------AVRGTIGHIAP 462
+H D+ N L + VGD+G+ YK+ ++ T +R +
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 463 EY---LSTGKSSEKTDVFGYGVMLLEL 486
E+ L T + ++ ++V+ GV L EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G +G VYK R + G L A+K +K E + + Q E+ M+ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ + + F GS+ G PL+ S ++ +GL YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST--- 467
HRD+K ANILL + + DFG++ + T A R GT +APE +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 468 GKSSEKTDVFGYGVMLLELITGQRA-FDL 495
G ++ D++ G+ +EL Q FDL
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 298 RGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFC 354
RG FGKVY GR + L AVK +K+ + Q + E ++A+ ++ ++ L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ LV +++ G V S L G + K I+ A L YLH H II
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVALALDYLHRH---GII 126
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKL 441
HRD+K N+L+ E + DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 15/217 (6%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL--VAVKRLKEERT--QGGELQFQTEV 336
R+ ++ ++F+ LG G FG+V + VA+KR ++ + Q +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
++++ H + L G + LV F++ G + LR + + QI L
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
YL I++RD+K N+LLD++ + DFG AK++D + T + GT
Sbjct: 143 I----FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGT 191
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+IAPE L + D + G+ + E++ G F
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 47/196 (23%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G+G G VY + G VA+K++ ++ EL E+ ++ + N++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 475 DVFGYGVMLLELITGQ 490
D++ G+M +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 40/150 (26%), Positives = 76/150 (50%), Gaps = 15/150 (10%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G G +G V+K + + +VA+KR++ ++ +G E+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 354 CMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
+ + LV+ + + SC G P + S Q+ +GLA+ H H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLL----KGLAFCHSH-- 118
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
++HRD+K N+L+++ E + DFGLA+
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G G +G VYKGR G +VA+K+++ E +G E+ ++ H N++ L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 354 CMTPTERLLVYPF--MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
M + L++ F M L + L S QI G + + H
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG----ILFCHSR--- 120
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKS 470
+++HRD+K N+L+D + + DFGLA+ V T T+ + APE L + +
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 471 SEKTDVFGYGVMLLELITGQRAF 493
S D++ G + E+ T + F
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 295 ILGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
++G G FG+ + + +D A+K ++ ++ + E +++ H N++ +
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPP---LNWSVRKQIALGAARGLAYLHDH 408
+V + G + ++ +RG+ P L W V Q+ LG H H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV--QMCLGVQ------HIH 117
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+ +++HRD+K+ NI L + + +GDFG A+L+ + T V GT ++ PE
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
+ K+D++ G +L EL T + F
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLR 351
+LG+G FGKV R G A+K LK+E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 352 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ +RL VNG RER S+ + + ++ L YLH
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLHSG- 114
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
KI++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 470 SSEKTDVFGYGVMLLELITGQRAF 493
D +G GV++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----HVTTAVRG 455
RGL Y+H +IHRD+K +N+L++E+ E +GDFG+A+ + T +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-A 173
Query: 456 TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELI 487
T + APE LS + + D++ G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 351
++G+G FGKV R + AVK L+++ + E +E ++ V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 352 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
F ++L +NG RER +P + A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----YAAEIASALGYLHSL- 115
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
I++RD+K NILLD + V+ DFGL K + + T+ GT ++APE L
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 470 SSEKTDVFGYGVMLLELITGQRAF 493
D + G +L E++ G F
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
R + YLH++ +IIHRD+KA NI ++ + +GDFG A + + GTI
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
APE L+ D++ G++L E+ T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 32/98 (32%), Positives = 58/98 (59%), Gaps = 7/98 (7%)
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTT 451
+I++ RGL YL + KI+HRDVK +NIL++ E + DFG++ +L+D +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN 156
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
+ GT +++PE L + ++D++ G+ L+E+ G
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 296 LGRGGFGKVYKG---RLTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLR 351
LG G FG V KG VAVK LK + + + E ++ + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----------QIALGAARG 401
G C + L++ L E G PLN ++K ++ + G
Sbjct: 63 GICEAESWMLVME-----------LAELG----PLNKFLQKNKHVTEKNITELVHQVSMG 107
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGH 459
+ YL + +HRD+ A N+LL + A + DFGL+K + + + G +
Sbjct: 108 MKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493
APE ++ K S K+DV+ +GV++ E + GQ+ +
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G+G G VY + G VA+K++ ++ EL E+ ++ H N++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 137
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 475 DVFGYGVMLLELITGQ 490
D++ G+M +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G+G G VY + G VA++++ ++ EL E+ ++ + N++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 474
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 475 DVFGYGVMLLELITGQRAF 493
D++ G+M +E+I G+ +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 46/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 318 KRLKEERTQGGE---LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV--------YPF 366
+RL +R + G +Q + E+ + H N+L++ + ++ Y F
Sbjct: 193 ERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSF 252
Query: 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 426
M + + ++R PL R I + Y+HD K+IHRD+K NI L+
Sbjct: 253 MYDEAFD--WKDR-----PLLKQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 427 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
+ + V+GDFG A + + GT+ +PE L+ E TD++ G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 487 IT 488
++
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERT------QGGE--LQFQTEVEMISMAVHRN 346
LG+G F +YKG L L V +E L F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L++L G C+ E ++V ++ G + L + L+W + +A A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNN-VSLHWKL--DVAKQLASALHYLE 118
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVR-GTIGHIAPE 463
D K++H +V NIL+ G KL D T ++ R I IAPE
Sbjct: 119 DK---KLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPE 174
Query: 464 YLSTGKSS--EKTDVFGYGVMLLEL 486
+ G++S D + +G LLE+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 356 TPTER--LLVYPFMVNG--SVASCLRERGQSQPPLNW--SVRKQIALGAARGLAYLHDHC 409
+ ++R L++ + + + R ++ P+ S+ K + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 410 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 463
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 464 YLSTGKSSEKT-DVFGYGVMLLELITGQRAF 493
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 48/210 (22%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVHR 345
NF +GRG F +VY+ L D VA+K+++ E E++++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLA 403
N+++ + E +V G ++ ++ ++ + P + + L +A +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
++H +++HRD+K AN+ + +GD GL + K T + V GT +++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + K+D++ G +L E+ Q F
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 33/85 (38%), Positives = 50/85 (58%), Gaps = 5/85 (5%)
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG 468
K++HRD+K+ANI L +GDFG +K Y D+ V ++ GT ++APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 469 KSSEKTDVFGYGVMLLELITGQRAF 493
+ S+K D++ GV+L EL+T R F
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLK------EERTQGGELQFQTEVEMISMAVHRNLL 348
+G G F +V K + G A+K +K E+ E+Q + ++ H N+L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ-----ALRRLSPHPNIL 61
Query: 349 RLRGFCM-TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLA 403
RL T RL LV+ M + ++ ++ R + P V+ Q+ + L
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK--RVKSYMYQLL----KSLD 114
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
++H + I HRD+K NIL+ ++ + DFG + + K + T T + APE
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPE 168
Query: 464 -YLSTGKSSEKTDVFGYGVMLLELIT 488
L+ G K D++ G + E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 296 LGRGGFGKV-YKGRLTDGSLVAVKRLKEERTQGGEL---QFQTEVEMISMAVHRNLLRLR 351
+G G +G V G+ VA+K+L R EL + E+ ++ H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 352 GFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
TP L LV PFM + ++ S+ + + V + + +GL Y
Sbjct: 81 D-VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQML-----KGLKY 133
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAP 462
+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R AP
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR------AP 184
Query: 463 EY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E L+ ++ D++ G ++ E++TG+ F
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 288 DNFSNRNILGRGGFG--KVYKGRLTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAV 343
+F ++++GRG FG +V + + T G + A+K +K+ E F+ E +++S++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 344 HRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQI--ALGAA 399
+ +L+ + + L LV + G + S L R Q + ++ A+ +
Sbjct: 60 SPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
+ Y +HRD+K N+L+D + DFG A + + GT +
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 460 IAPEYLSTGKSSEKT------DVFGYGVMLLELITGQRAF 493
IAPE L+T K D + GV+ E+I G+ F
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 295 ILGRGGFGKV--YKGRLTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRL 350
+LG+G FGKV K + T G A+K LK+E + TE ++ + H L L
Sbjct: 2 LLGKGTFGKVILVKEKAT-GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ T V + G + L RER S+ + + ++ L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALDYLH--S 113
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
+ +++RD+K N++LD++ + DFGL K KD GT ++APE L
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 470 SSEKTDVFGYGVMLLELITGQRAF 493
D +G GV++ E++ G+ F
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+D + +G+G +GKV+K +GS AVK L E++ + + + +++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHP 75
Query: 346 NLLRLRGF-----CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
N+++ G + LV GSV ++ + + + I A
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
GL +LH + K IHRDVK NILL E + DFG++ + T+V GT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191
Query: 461 APEYLSTGKS-----SEKTDVFGYGVMLLELITG 489
APE ++ + + DV+ G+ +EL G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 352
LG+G +G VYK + +KE R + E +F E++++ AV ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMA--MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ +M GS+ L G + + V ++I +GL +L + +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEYLSTGK 469
IIHRDVK N+L++ + + DFG++ + V + + IG ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 470 SSE------KTDVFGYGVMLLELITG 489
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 5/137 (3%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
+++ +DL +S L ++ L+ L+ L+L +N+I ++ L NL NL L+L N
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L +P ++G LS L L L+NN SL ++ +L+ LDLS N L+ +P
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLL 300
Query: 189 LFTPISFANNQLNNPPP 205
L +
Sbjct: 301 LLLELLLNLLLTLKALE 317
|
Length = 394 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGEL------QFQTEVEMISMAVHRNLL 348
LG+G FG VY + D VA +RLK + GEL Q E +++S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL------NWSVRKQIALGAARGL 402
+ + ++ + + L E + L W + Q+ L G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI--QLLL----GV 119
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
Y+H +I+HRD+KA NI L +GDFG+++L+ + T GT +++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSP 174
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E L K+D++ G +L E+ AF
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
M + N ++L T +L+ ++ +G L + + + L+ + K+I
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAEVKKIIRQLVE 120
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGH 459
L LH H IIH D+K N+L D + + + D+GL K++ + GT+ +
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDY 172
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506
+PE + D + GV+ EL+TG+ F D+D L
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-----EDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 296 LGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 351
+GRG VY R T G+LV V+ E L+ Q EV + H N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
T + ++ PFM GS S L+ G S+ ++ I GA RGL YLH +
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSE-----ALIGNILFGALRGLNYLHQN 120
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------YKDTHVTTAVRGTI 457
IHR++KA++IL+ + +V GL+ L Y +T+V +
Sbjct: 121 ---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---L 172
Query: 458 GHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF-DLAR 497
++PE L + K+D++ G+ EL TG+ F D+ R
Sbjct: 173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 64/260 (24%), Positives = 99/260 (38%), Gaps = 71/260 (27%)
Query: 296 LGRGGFGKVYK------GRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNL- 347
LGRG FGKV + + VAVK LKE T TE++ +I + H N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 348 ----------------------------LRLRGFCMTPT------ERLLVYPFMVNGSVA 373
LR + C +P +R + +
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 374 SC-----------LRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCD 410
S + ++ S + PL + ARG+ +L
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA-VRGTIGHIAPEYLSTG 468
K IHRD+ A NILL E + DFGLA+ + YKD +V R + +APE +
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 469 KSSEKTDVFGYGVMLLELIT 488
+ ++DV+ +GV+L E+ +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 296 LGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQT---------EVEMISMAV 343
+G G FG V+ +TD G VA+K++ FQ E++M+
Sbjct: 8 IGYGAFGVVWS--VTDPRDGKRVALKKMPN--------VFQNLVSCKRVFRELKMLCFFK 57
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H N+L P ++V + S L + S PL+ K RGL
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
YLH I+HRD+K N+L++ + DFGLA++ + ++ T T + APE
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 464 YLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
L + + D++ G + EL+ + F
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 66/262 (25%), Positives = 102/262 (38%), Gaps = 72/262 (27%)
Query: 295 ILGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNL 347
+LG G FGKV + + + + VAVK LKE T +E++ +I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 348 LRLRG--------------FCM---------------------TPTERLLVYPF------ 366
+ L G FC +P +R
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 367 --MVNGSVASCLRER------GQSQPPLN----WSVRKQI------ALGAARGLAYLHDH 408
+ AS L R G + PP W + + ARG+ +L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLS 466
K IHRD+ A NILL E + DFGLA+ + YKD + R + +APE +
Sbjct: 194 ---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARLPLKWMAPESIF 249
Query: 467 TGKSSEKTDVFGYGVMLLELIT 488
+ ++DV+ +GV+L E+ +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 59/259 (22%), Positives = 94/259 (36%), Gaps = 82/259 (31%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMA 342
D+F ++GRG FG+V+ R G + A+K L++ R Q + E ++++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADA 58
Query: 343 VHRNLLRLRGFC-MTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI------ 394
+++L + E L LV +M G + +N +RK +
Sbjct: 59 DSPWIVKL--YYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETA 103
Query: 395 ---------ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445
AL + L + IHRD+K NIL+D + + DFGL K
Sbjct: 104 RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCK--KMN 152
Query: 446 DTHVTTAVR------------------------------GTIGHIAPEYLSTGKS-SEKT 474
GT +IAPE L G +
Sbjct: 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLEC 211
Query: 475 DVFGYGVMLLELITGQRAF 493
D + GV+L E++ G F
Sbjct: 212 DWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 35/122 (28%), Positives = 62/122 (50%), Gaps = 7/122 (5%)
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRDVKAANILLDE 427
S + + S P L+ + + A+G+ +L +C IHRDV A N+LL +
Sbjct: 193 QSSDSKDEEDTEDSWP-LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTD 247
Query: 428 EFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 486
A + DFGLA+ +M+ + V R + +APE + + ++DV+ YG++L E+
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
Query: 487 IT 488
+
Sbjct: 308 FS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ + D +T V T +
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 460 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 356 TPTER--LLVYPFMVNG--SVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDHC 409
+ +R L++ + + + R ++ P L + K + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 410 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 463
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 464 YLSTGKSSEKT-DVFGYGVMLLELITGQRAF 493
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
RGL Y+H ++HRD+K +N+LL+ + + DFGLA+ K +T V T +
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 460 IAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAF 493
APE L SE T DV+ G + EL+ + F
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458
RGL Y+H ++HRD+K AN+ ++ E+ +GDFGLA+++D +H G +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 459 --HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ +P LS ++ D++ G + E++TG+ F
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQFQTEVE 337
+R+L++ +++ ++GRG FG+V R V +L K E + + F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 338 MISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNW----SVR 391
I MA + ++ F +R L V +M G + + + P W +
Sbjct: 95 DI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE 150
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-- 449
+AL A + + IHRDVK N+LLD+ + DFG M+ K+ V
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRC 200
Query: 450 TTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 493
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 47/210 (22%), Positives = 73/210 (34%), Gaps = 19/210 (9%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 353
+ K + T +LVAVK++ + +L+ Q E+ H N+L
Sbjct: 9 CFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66
Query: 354 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDP 411
L +V P M GS L+ L I L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSKGF-- 122
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI------APEYL 465
IHR VKA++ILL + + V+ + M + +PE L
Sbjct: 123 --IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 466 STGKS--SEKTDVFGYGVMLLELITGQRAF 493
+EK+D++ G+ EL G F
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK----LMDYKDTHVTTAVRG 455
+ L Y+H +IHRD+K +NILL+ + + DFGLA+ L + + V T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 456 TIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAF 493
T + APE L ST + ++ D++ G +L E++ G+ F
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK--EERTQGGELQFQTEVEMISMAVH 344
+ F ++G G +G V K R + +VA+K+ K EE + E + E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L+ + LV+ + V ++ L E PP VR I + + +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPEK--VRSYI-YQLIKAIHW 115
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPE 463
H + I+HRD+K N+L+ + DFG A+ L + + + T V T + +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPE 171
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
L + D++ G +L EL GQ F
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLR 351
+LG+G FGKV R G A+K L++E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 352 GFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
T V + G + L RER ++ + + ++ L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS-----ALEYLHSR-- 114
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
+++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 471 SEKTDVFGYGVMLLELITGQRAF 493
D +G GV++ E++ G+ F
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEV---------EMISMAVHR 345
+G G +G V G VA+K+L FQ+E+ ++ H
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--------FQSEIFAKRAYRELTLLKHMQHE 74
Query: 346 NLLRLRG-FCMTPTER-----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
N++ L F + LV P+M + S+ + + V + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQML----- 127
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTI 457
GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--- 181
Query: 458 GHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE L+ ++ D++ G ++ E++TG+ F
Sbjct: 182 ---APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ D + T T +
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 460 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE L+ ++ D++ G ++ EL+ G+ F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRL-KEERTQGGELQ-FQTEVEMISMAVH 344
++F ++GRG FG+V +L + V A+K L K E + E F+ E +++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---PLNWSVRKQIALGAARG 401
+ + L LV + V G + + L + P + IA+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGTIGHI 460
L Y +HRD+K NIL+D + DFG KLM+ + AV GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 461 APEYLST-----GKSSEKTDVFGYGVMLLELITGQRAF 493
+PE L GK + D + GV + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 456
A+G+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 244
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ +APE + + ++DV+ +GV+L E+ +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGT 456
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D + H +T V T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-AT 172
Query: 457 IGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAF 493
+ APE + K K D++ G +L E+++ + F
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 1e-05
Identities = 22/60 (36%), Positives = 29/60 (48%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
NL+ L+L +N ++ L NL LDL NNL P L LR L L+ N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 42/228 (18%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAV--- 343
D+F ++GRG FG+V AV ++K ER ++ + EM+ A
Sbjct: 1 DDFEIIKVIGRGAFGEV-----------AVVKMKHTERIYA--MKILNKWEMLKRAETAC 47
Query: 344 ---HRNLLRLRGFCMTPTER----------LLVYPFMVNGSVASCLRERGQSQPPLNWSV 390
RN+L + G C T LV + V G + + L + P
Sbjct: 48 FREERNVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP------ 100
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450
A + +H +HRD+K N+LLD + DFG M+ T +
Sbjct: 101 EDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160
Query: 451 TAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAF 493
+ GT +I+PE L GK + D + GV + E++ G+ F
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 330 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNW- 388
L F ++S H +L + G C+ +E ++V F+ +G + CLR + + + P+ W
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-KEKGRVPVAWK 119
Query: 389 -SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
+V +Q+ A L+YL D ++H +V A NILL + + G + + D
Sbjct: 120 ITVAQQL----ASALSYLEDK---NLVHGNVCAKNILLARLG---LAE-GTSPFIKLSDP 168
Query: 448 HVTTAVRG------TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLEL 486
V+ I IAPE + G S S D + +G LLE+
Sbjct: 169 GVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGT 456
R L Y+H + HRD+K NIL + + + + DFGLA++ + DT T T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 457 IGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAF 493
+ APE + K + D++ G + E++TG+ F
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 5e-05
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ +DL N L+ L NL+ L+L NN++ PE L +L SLDL NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 399 ARGLAYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 456
A+G+++L +C IHRD+ A NILL + DFGLA+ + +V R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ +APE + + ++DV+ YG++L E+ +
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 40/199 (20%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 304 VYKGRLTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361
+YKG + V ++ K+ L + E++ + N+L++ GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421
++ LRE + L++ + +A+ +GL L+ + ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSV 152
Query: 422 NILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAV---RGTIGHIAPEYLSTGKSSEKTD 475
+ L+ E ++ + GL K++ +K+ V V + I EY K D
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKN--VNFMVYFSYKMLNDIFSEYT------IKDD 204
Query: 476 VFGYGVMLLELITGQRAFD 494
++ GV+L E+ TG+ F+
Sbjct: 205 IYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTEVEMISMAVH 344
D+F ++GRG FG+V ++ + G + A+K L K E + E F+ E +++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 345 RNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAAR 400
R + L + L LV + V G + + L + P + +A+ +
Sbjct: 61 RWITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L Y +HRD+K N+LLD+ + DFG + T + GT +I
Sbjct: 120 QLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170
Query: 461 APEYL-----STGKSSEKTDVFGYGVMLLELITGQRAF 493
+PE L G+ + D + GV + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 33/226 (14%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLRG 352
+G+GG+G+V+ + D G +VA+KR+K+ TE ++++ L++L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI-----ALGAARGLAYLHD 407
L ++ G + L G R + A+ A L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS---EDHARFYMAEMFEAVDALHELGY--- 122
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYL 465
IHRD+K N L+D + DFGL+K + VT A V G+ ++APE L
Sbjct: 123 ------IHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYANSVVGSPDYMAPEVL 170
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM--LLDW 509
D + G ML E + G F + ++ L W
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS---GSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEE----RTQGGELQFQTEVEMISMA 342
++F ++ G +G VY R + A+K++ ++ R Q Q E ++++ A
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ--IQQVFVERDILTFA 58
Query: 343 VHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
N + FC T+R L V ++ G A+ L+ G L + +
Sbjct: 59 --ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVL 112
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDY----------KDTH 448
L YLH++ I+HRD+K N+L+ + DFGL+K LM KDT
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 449 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489
+ V GT +IAPE + + D + G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 66/237 (27%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 352
LG+G G+V+ RL G L A+K L K+E + ++ + TE E+++ H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--------GLAY 404
T T LV + G + L Q QP K ++ AR L Y
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLL----QRQP------GKCLSEEVARFYAAEVLLALEY 118
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR---------- 454
LH I++RD+K NILL E ++ DF L+K D + V+ A+R
Sbjct: 119 LHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 455 ------------------GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
GT +IAPE +S D + G++L E++ G F
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAVRG 455
GL Y+H ++HRD+K N+L++ + E + DFGLA+ +T V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 456 TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T + APE LS ++ DV+ G +L EL+ + F
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 27/147 (18%), Positives = 53/147 (36%), Gaps = 17/147 (11%)
Query: 299 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL--RLRGFCMT 356
G +VY D V LK ++ + EV ++ + + L ++ +
Sbjct: 9 GLTNRVYLLGTKDEDYV----LKINPSREKGADREREVAILQLLARKGLPVPKVLASGES 64
Query: 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 416
L+ ++ G++ ++ ++ IA A LA LH + H
Sbjct: 65 DGWSYLLMEWI-----------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 417 DVKAANILLDEEFEAVVGDFGLAKLMD 443
D+ NIL+D+ + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 59/243 (24%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKE-------------ERTQGGELQFQTEVEMISMA 342
+G G FG+V+ LV KR +E ER + Q EV ++
Sbjct: 21 IGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEVNVMREL 69
Query: 343 VHRNLLR-LRGFCMTPTERL-LVYPFMVNG----SVASCLRERGQSQPPLNWSVRKQIAL 396
H+N++R + F ++L ++ F G ++ C + G+ + + +Q+
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL- 128
Query: 397 GAARGLAYLHDHCD----PKIIHRDVKAANILLDEEFE-----------------AVVGD 435
LAY H+ D +++HRD+K NI L A +GD
Sbjct: 129 ---HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAF 493
FGL+K + + + + GT + +PE L T +K+D++ G ++ EL +G+ F
Sbjct: 186 FGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 494 DLA 496
A
Sbjct: 244 HKA 246
|
Length = 1021 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 30/100 (30%), Positives = 40/100 (40%), Gaps = 18/100 (18%)
Query: 94 NLQYLELYSNNISGKVPEELGNL----TNLVSLDLYLNNLNGPIPTTLGK----LSKLRF 145
L+ L L N + G E L +L L+L N + L + L
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197
Query: 146 LRLNNNSL-------MGEIPRSLTNVNSLQVLDLSNNKLT 178
L LNNN L + E SL SL+VL+L +N LT
Sbjct: 198 LDLNNNGLTDEGASALAETLASLK---SLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
G+ +LH IIHRD+K +NI++ + + DFGLA+ + T T +
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
APE + E D++ G ++ EL+ G F
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 2/79 (2%)
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLS 466
H + IIHRD+K N+L++ + +GDFG A T + GT+ APE L+
Sbjct: 277 HGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA 335
Query: 467 TGKSSEKTDVFGYGVMLLE 485
+ D++ G+++ E
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-- 456
ARG+ +L +HRD+ A N+LL + + DFGLA+ + + +V+ +G+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 457 --IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ +APE + + +DV+ YG++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.7 bits (86), Expect = 9e-04
Identities = 17/37 (45%), Positives = 24/37 (64%), Gaps = 2/37 (5%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
TNL+ L+L +N I+ +P L NL NL +LDL N +
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 294 NILGRGGFGKVYKGRLTDGS-LVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
NI+G G FG VY+ D S VA+K+ L++ + + EL + H N++ L+
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN------HINIIFLK 125
Query: 352 GFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+ T + L V + +V ++ ++ L + K + R LAY
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHI--- 460
+H I HRD+K N+L+D + + DFG AK + A + ++ +I
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LAGQRSVSYICSR 234
Query: 461 ---APEYLSTGKSSEKT--DVFGYGVMLLELITGQRAF 493
APE L G ++ T D++ G ++ E+I G F
Sbjct: 235 FYRAPE-LMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 296 LGRGGFGKVYKGRLTDGS------------LVAVKRLKEERTQGGELQFQTEVEMISMAV 343
LGRG ++Y G L + + ++ + + L F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---PLNWSVRKQIALGAAR 400
H++++ L G C+ E ++V F+ G + L +S P + V KQ+ A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL----AS 116
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGT--- 456
L+YL D ++H +V NILL E + G+ G KL D +T R
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAR--EGIDGECGPFIKLSD-PGIPITVLSRQECVE 170
Query: 457 -IGHIAPEYLSTGKS-SEKTDVFGYGVMLLEL 486
I IAPE + K+ S D + +G L E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 19/100 (19%)
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LM-DYKDTHVTTAV 453
G+ +LH IIHRD+K +NI++ + + DFGLA+ +M Y VT
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 183
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
R APE + E D++ G ++ E+I G F
Sbjct: 184 R------APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 36/128 (28%), Positives = 51/128 (39%), Gaps = 17/128 (13%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL----TNLQYLELYSNNISG----KVPEELGNLTNLVS 121
++ ++ LG L G L + +L+ L L +N I + E L NL
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197
Query: 122 LDLYLNNLN----GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN-----SLQVLDL 172
LDL N L + TL L L L L +N+L +L + SL L L
Sbjct: 198 LDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257
Query: 173 SNNKLTGD 180
S N +T D
Sbjct: 258 SCNDITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 54/251 (21%), Positives = 101/251 (40%), Gaps = 60/251 (23%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKE----ERTQGGELQFQTE--VEMIS 340
++F + ++GRG FG+V + D G + A+K L++ E+ Q G ++ + + VE S
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQI-ALGA 398
+ V + + L+ F+ G + + L ++ ++ + + + + A+ +
Sbjct: 61 LWVVKMFYSFQ----DKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR---- 454
L + IHRD+K N+LLD + + DFGL + K H T R
Sbjct: 117 IHQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGL--KKAHRTEFYRNLNH 165
Query: 455 --------------------------------GTIGHIAPEYLSTGKSSEKTDVFGYGVM 482
GT +IAPE ++ D + GV+
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 483 LLELITGQRAF 493
+ E++ G F
Sbjct: 226 MYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 25/231 (10%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRL----KEERTQGGELQFQTEV 336
++ V+T F ++LG G FGKV + AVK + K R E+QF +V
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV 182
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
A L++++ + T + + V CL + P + QI
Sbjct: 183 RQADPADRFPLMKIQRYFQNETGHMCI----VMPKYGPCLLDWIMKHGPFSHRHLAQIIF 238
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG---------DFGLAKLMDY--- 444
L Y H + ++H D+K NIL+ E + VV D ++ D
Sbjct: 239 QTGVALDYFHT--ELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGGC 295
Query: 445 -KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ H TA+ T + +PE + TD++ G ++ EL TG+ +D
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.49 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.42 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.41 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.4 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.33 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.32 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.3 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.3 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.29 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.05 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.04 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.02 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.0 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.99 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.98 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.97 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.92 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.86 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.82 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.82 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.79 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.79 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.78 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.57 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.56 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.55 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.55 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.54 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.43 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.41 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-55 Score=492.98 Aligned_cols=399 Identities=29% Similarity=0.506 Sum_probs=240.9
Q ss_pred eeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccC
Q 010429 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150 (511)
Q Consensus 71 l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 150 (511)
++.|+|++|++++..|..+.++++|+.|+|++|++++.+|..+.++++|++|+|++|.+++.+|..+.++++|+.|+|++
T Consensus 477 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 556 (968)
T PLN00113 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556 (968)
T ss_pred ceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCC
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred cccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCC-CCCCCCCCCCCCCCCCCCCCCCCccceee
Q 010429 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL-NNPPPSPPPPLQPTPPGASSGNSATGAIA 229 (511)
Q Consensus 151 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~-~~~~~~~~~~~~~~p~~~~~~~s~~~~i~ 229 (511)
|++++.+|..+.++++|+.|++++|++++.+|..+.+..+....+.+|+. |+..+.. ..++......+....++
T Consensus 557 N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~-----~~~~c~~~~~~~~~~~~ 631 (968)
T PLN00113 557 NQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS-----GLPPCKRVRKTPSWWFY 631 (968)
T ss_pred CcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc-----CCCCCccccccceeeee
Confidence 44444444444444444444444444444444444444444444444442 3322100 01111111111111222
Q ss_pred cccchhhHHHHHHhHHhhhhhhccCCCCCccCCCCCCCc-cc-ccC--cccccCHHHHHHHhhCCCCCCeeccccccEEE
Q 010429 230 GGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDP-EV-HLG--QLKRFSLRELQVATDNFSNRNILGRGGFGKVY 305 (511)
Q Consensus 230 ~~v~~~~~~l~~~~~~~~~~~r~~~~~~~~~~~~~~~~~-~~-~~~--~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy 305 (511)
++++.+++++++++++.+.++|+++... ....+.+... +. ... ....+.. ......+...+.||+|+||.||
T Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ig~G~~g~Vy 707 (968)
T PLN00113 632 ITCTLGAFLVLALVAFGFVFIRGRNNLE-LKRVENEDGTWELQFFDSKVSKSITI---NDILSSLKEENVISRGKKGASY 707 (968)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHhhhccc-ccccccccccccccccccccchhhhH---HHHHhhCCcccEEccCCCeeEE
Confidence 2222222222222333333333332211 1011100000 00 000 0111222 2334567788899999999999
Q ss_pred EEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCC
Q 010429 306 KGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 384 (511)
Q Consensus 306 ~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~ 384 (511)
+|+.. ++..||||+++..... ...|++.+++++|||||++++++.+++..++||||+++|+|.++++.
T Consensus 708 ~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------ 776 (968)
T PLN00113 708 KGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------ 776 (968)
T ss_pred EEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------
Confidence 99974 7899999998653321 23468889999999999999999999999999999999999999963
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeecccccccccccc
Q 010429 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464 (511)
Q Consensus 385 ~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~ 464 (511)
++|..+.+|+.|+++||+|||..+.++|+||||||+||+++.++.+++. ||........ ....+|+.|+|||+
T Consensus 777 -l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~ 849 (968)
T PLN00113 777 -LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPET 849 (968)
T ss_pred -CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCccc
Confidence 7899999999999999999997666699999999999999999888875 6655432211 12257899999999
Q ss_pred cccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 465 ~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+.+..++.++|||||||++|||+||+.||+..
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999999999999999643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=384.57 Aligned_cols=232 Identities=55% Similarity=0.930 Sum_probs=203.1
Q ss_pred cccccCHHHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccc
Q 010429 274 QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~ 353 (511)
..+.|++.++..++++|+..+.||+|+||.||+|...+|..||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567799999999999999999999999999999999988999999887655433 5569999999999999999999999
Q ss_pred cccCC-ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 354 CMTPT-ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 354 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
|.+.+ +.+||||||++|+|.++++..... +++|..|.+|+.++|+||+|||+.+++.|+||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 499999999999999999976543 689999999999999999999999988999999999999999999999
Q ss_pred EcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccccCCCCCeeeeccc
Q 010429 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWD 510 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~~~~~~~~~~~w~ 510 (511)
|+|||+|+..............||.+|+|||++..+..+.|+|||||||++.|++||+.|.+..+ ..++..+++|+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~ 293 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWA 293 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHH
Confidence 99999996554312222211169999999999999999999999999999999999999998766 22334477774
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=358.67 Aligned_cols=198 Identities=27% Similarity=0.476 Sum_probs=179.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.+|...+.||+|+||+||+|+++ ++..||||.+.+.. .....+-+..|+.+++.++|||||.+++++..++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777888999999999999986 68899999997664 34445568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC------CceEEcccccc
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLA 439 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfg~a 439 (511)
||.+|+|.+++++++. +++.+++.++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998763 89999999999999999999999 99999999999999875 45899999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
+.+.. .......+|++-|||||++..+.|+.|+|+||+|+|+|||++|++||+
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 98763 334456789999999999999999999999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=343.54 Aligned_cols=205 Identities=29% Similarity=0.420 Sum_probs=184.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch--hHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
..++|++.++||+|+||+||.++.+ +++.+|+|++++..... +.+...+|..++.+++||+||+++-.|++....|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999865 68899999998765333 35568899999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
|+||+.||.|..+|++.+. ++++.++.++..|+.||.|||++ +||||||||+|||+|++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999997654 89999999999999999999999 9999999999999999999999999999843
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 498 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~ 498 (511)
- .....+..++||+.|||||++.+..++..+|.||+|+++|||++|.+||...+.
T Consensus 176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 2 334455668999999999999999999999999999999999999999986653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=340.85 Aligned_cols=199 Identities=29% Similarity=0.449 Sum_probs=180.4
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC-ceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv~e~ 366 (511)
+.+..+.||+|..|+||+++++ +++.+|+|++.....+...+++.+|++++++++||+||.++|.|..+. +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3444578999999999999987 788999999977666777888999999999999999999999999988 59999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
|++|||++.+...+ .+++...-+|+.++++||.|||+.. +||||||||+|||++..|+|||+|||.+..+...
T Consensus 160 MDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999998764 3899999999999999999999632 9999999999999999999999999999876543
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||-..
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 446678999999999999999999999999999999999999999765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=348.65 Aligned_cols=202 Identities=36% Similarity=0.611 Sum_probs=174.6
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCE-EEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC-ceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv~ 364 (511)
++....+.+|+|+||+||+|.+. |.. ||||++.... ......+|.+|+.+|.+++|||||+++|+|.++. ..++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 33444566999999999999997 555 9999997543 2222567999999999999999999999999988 799999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCeeeCCCC-ceEEccccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-IIHRDVKAANILLDEEF-EAVVGDFGLAKLM 442 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 442 (511)
|||++|+|.++++.. ....+++..+.+++.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++..
T Consensus 120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 999999999999884 234599999999999999999999999 7 99999999999999998 9999999999876
Q ss_pred CCCCCceeeecccccccccccccc--cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ...+...||+.|||||+++ ...++.|+|||||||++|||+||+.||...
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~ 249 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL 249 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence 5432 2223356999999999999 668999999999999999999999999754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=325.95 Aligned_cols=208 Identities=24% Similarity=0.369 Sum_probs=181.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccc-ccccCCc-eeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRG-FCMTPTE-RLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~-~~~~~~~-~~lv 363 (511)
.+|++.++||+|+||+||++... +|..+|.|.++-+. .....++...|+.+|++++|||||++++ .+.++.+ .+++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45666789999999999999854 89999999986333 3445567899999999999999999999 4555555 7899
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
||||.+|+|...++..+.....+++.++++++.|+++||.++|++.+ + |+||||||.||+++.+|.+|++|||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999999887777789999999999999999999999422 4 88999999999999999999999999998
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+...... ..+.+|||.||+||.+.+..|+.||||||+||++|||+.-.+||....
T Consensus 178 l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 178 LSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred hcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 8765443 345679999999999999999999999999999999999999998653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.73 Aligned_cols=202 Identities=29% Similarity=0.510 Sum_probs=183.3
Q ss_pred hCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.+|...+.||+|+|+.||.+++ .+|+.||+|++.+.. .......+.+|+++.+.+.|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999998 789999999997643 3344556899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
|+|+.++|..++++.+ ++++.+++.++.||+.||.|||+. +|+|||||..|++++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998554 399999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
. .+...+.+|||-|.|||++....++..+||||+||++|-|+.|++||+...
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 3 234456789999999999999999999999999999999999999998653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=332.99 Aligned_cols=202 Identities=27% Similarity=0.454 Sum_probs=176.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch------hHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
.+.|.+.+.||+|+||.|-+|..+ +|+.||||++++..... .....++|+++|++++|||||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 456777899999999999999865 79999999997654322 22346799999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CceEEccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDF 436 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df 436 (511)
.|+|||||+||+|.+.+-..+. +.++..+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999987654 77788899999999999999999 99999999999999876 67999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCC---CcccCeehhhHHHHHHHhCCCcccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
|+|+... ......+.+|||.|.|||++.+... ..++|+||+||+||-+++|.+||....
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 9999765 4455677899999999999976543 458899999999999999999997544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=314.65 Aligned_cols=200 Identities=27% Similarity=0.405 Sum_probs=181.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|+..+.||.|+||+|.+++.+ +|..+|+|++.+...- ...+....|..+++.+.||+++++++.+.+....++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356788899999999999999976 6889999999765422 2344577899999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||.+||.|.+++++.+. +++..++.++.||+.|++|||+. +|++|||||+|||+|.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999998654 89999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.. +.+.+|||.|+|||.+....+..++|.|||||++|||+.|.+||...+
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 32 667889999999999999999999999999999999999999997654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=334.79 Aligned_cols=202 Identities=30% Similarity=0.486 Sum_probs=183.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. +.+.+...+.+|+++++.++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56788899999999999999876 6889999998654 344556679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+.| +|..+++..+. ++++.+..|+.|++.||.|||++ +|.|||+||.|||++.++.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9977 99999987654 99999999999999999999999 999999999999999999999999999998764
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 498 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~ 498 (511)
.....+.+.|||-|||||.+.++.|+..+|+||+|||+||+++|++||....+
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si 205 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI 205 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH
Confidence 45566678899999999999999999999999999999999999999976544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=328.77 Aligned_cols=202 Identities=26% Similarity=0.417 Sum_probs=177.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC--CceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 363 (511)
+.|+.+++||+|.||.||+|++. +|+.||+|+++.+. .+....-..+||.+|++++||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45777789999999999999865 79999999997655 334455578999999999999999999998876 689999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
+|||++ +|.-++...+. .+++.+++.++.|++.||+|+|+. +|+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 197 FeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999976 67766665332 499999999999999999999999 99999999999999999999999999999998
Q ss_pred CCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......+..+-|..|+|||.+.+. .|+.++|+||.|||+.||++|++.|...
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 8776667777789999999999875 5899999999999999999999999754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=332.71 Aligned_cols=205 Identities=25% Similarity=0.406 Sum_probs=181.8
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchh--HHHHHHHHHHHHhC-CCCceeccccccccCCcee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~ 361 (511)
...+|...+.||+|+|++|++|+.. +++.||||++.+.....+ .+-+..|-++|.++ .||.|++++-.|+++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467889999999999999999865 789999999976543222 33477899999999 7999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+|+||+++|+|.+++++.+. +++..++.++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999998864 99999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc------------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 442 MDYKDTH------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 442 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+.+.... ...+++||..|.+||++..+..++.+|+|+||||+|+|++|++||....
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 7542211 1245889999999999999999999999999999999999999998653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=333.18 Aligned_cols=204 Identities=34% Similarity=0.538 Sum_probs=176.8
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
++..+.+...+.||+|-||.||.|.+.....||+|.++... .....|.+|+++|++++|+|||+++|+|..+...+||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 34444455567899999999999999877799999998753 3345688999999999999999999999998899999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
||||+.|+|.++|+... ...+...+.+.++.|||+||+||+++ ++|||||..+|||++++..+||+|||+|+...
T Consensus 280 tE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999732 33489999999999999999999999 99999999999999999999999999999554
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~ 494 (511)
...........-...|.|||.+..+.++.|||||||||+||||+| |+.||.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 433333333334679999999999999999999999999999999 888875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.65 Aligned_cols=206 Identities=22% Similarity=0.341 Sum_probs=179.6
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
...++|++++.||+|+||.||+++-+ +|+.+|+|++++.. ...+...++.|..+|...++|.||+++-.|++.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 45688999999999999999999855 79999999998654 2334556889999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
|||||++||++..+|.+.+ .++++.++.++.+++-|++-+|+. |+|||||||+|+|||..|++||+|||++.-
T Consensus 218 LiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999998755 399999999999999999999999 999999999999999999999999999853
Q ss_pred cCC----------------------CCCc-----e-------------------eeecccccccccccccccCCCCcccC
Q 010429 442 MDY----------------------KDTH-----V-------------------TTAVRGTIGHIAPEYLSTGKSSEKTD 475 (511)
Q Consensus 442 ~~~----------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~D 475 (511)
+.. .+.. . ..+.+|||.|||||++.+..++..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 0000 0 01246999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCcccccc
Q 010429 476 VFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 476 v~s~Gvil~elltg~~pf~~~~ 497 (511)
.||+|||+|||+.|.+||....
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSET 392 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=328.22 Aligned_cols=208 Identities=31% Similarity=0.527 Sum_probs=180.3
Q ss_pred cCHHHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
.+..+|++..+.+.+.+.||+|.||+||+|+|. ..||||+++... +....+.|+.|+.++++.+|.||+-++|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 345778888888999999999999999999996 349999997655 33445679999999999999999999999998
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
+.. .+|+.||+|-+|+.+++..+ ..++..+...|+.||++||.|||.+ +|||||||+.||++++++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 877 99999999999999999765 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCC-CCCceeeecccccccccccccccC---CCCcccCeehhhHHHHHHHhCCCccc
Q 010429 437 GLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 437 g~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
|++..... ..........|...|||||+++.+ +|++++||||||+|+|||+||..||.
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 99975322 111222233488899999999865 57999999999999999999999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=301.16 Aligned_cols=200 Identities=23% Similarity=0.329 Sum_probs=173.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
+.|+.+.++|+|+||+||+.+++ +|+.||||++..... +.-.+-.++|+.++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46778889999999999999987 699999999976543 2334457899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
||+..-| +-|++... .++.+...+++.|+++|+.|+|++ +++||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~dhTvL-~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecchHHH-HHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9977444 44544332 389999999999999999999999 999999999999999999999999999998864
Q ss_pred CCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.....+..+.|..|+|||.+.+ ..|...+||||+||++.||++|.+.|-.
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 4445666779999999999987 5689999999999999999999988853
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=322.28 Aligned_cols=204 Identities=27% Similarity=0.429 Sum_probs=178.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc----hhHHHHHHHHHHHHhCC-CCceeccccccccCCc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~ 359 (511)
....|.+.+.||+|+||+|+.|... ++..||+|++...... .....+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4467888999999999999999865 7899999977654211 23445778999999999 9999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGL 438 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~ 438 (511)
.++||||+.+|+|.+++.+.+ ++.+..++.++.|+++|++|||+. ||+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999998843 388899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCceeeecccccccccccccccCC-C-CcccCeehhhHHHHHHHhCCCcccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-S-SEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+.... .........+||+.|+|||++.+.. | ..++||||+||+||-|++|+.||+...
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 98764 2334455678999999999999877 6 478999999999999999999998643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=311.33 Aligned_cols=201 Identities=30% Similarity=0.525 Sum_probs=172.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC--ceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv~ 364 (511)
.++...+.||+|+||+||++... +|...|||.+....... ...+.+|+.++.+++|||||+++|...... .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45666789999999999999976 48999999987653322 556899999999999999999999855544 588999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCceEEcccccccccC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD 443 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 443 (511)
||+++|+|.+++.+.+. .+++..++.++.||++||+|||++ ||+||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999998754 399999999999999999999999 9999999999999999 7999999999998766
Q ss_pred C--CCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 Y--KDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ..........||+.|||||++..+. ..+++||||+||++.||+||++||..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 3 2223344567999999999998643 34589999999999999999999974
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=308.56 Aligned_cols=197 Identities=34% Similarity=0.511 Sum_probs=165.6
Q ss_pred CCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHh--CCCCceeccccccccCC----ceeE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMTPT----ERLL 362 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~~~----~~~l 362 (511)
..+..++||+|.||.||+|.+. ++.||||++... +.+.|+.|.++.+. +.|+||++++++-.... ++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445678999999999999996 699999999743 34568888777764 67999999999876655 8999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH------CDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
|++|.+.|+|.++|..+- ++|....+|+..+++||+|||+. ++++|+|||||++|||+.+|++..|+||
T Consensus 286 Vt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999864 89999999999999999999974 4679999999999999999999999999
Q ss_pred ccccccCCCCC-ceeeecccccccccccccccCCC------CcccCeehhhHHHHHHHhCCCcccc
Q 010429 437 GLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|+|..+.+... ...-..+||.+|||||++.+... -.+.||||+|.|+|||+++...++.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 99988765322 22233679999999999976532 2468999999999999998876653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=306.68 Aligned_cols=204 Identities=26% Similarity=0.407 Sum_probs=181.3
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|++.+.||.|..++||+|+.. .++.||||++.-+....+...+++|+..|+.++||||++++..|..+.+.|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3467899999999999999999864 679999999998887777788999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
+||.+||+.+.++..-..+ +++..+..|+.++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999865443 99999999999999999999999 999999999999999999999999998765543
Q ss_pred CCCc--ee-eeccccccccccccccc--CCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 445 KDTH--VT-TAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 445 ~~~~--~~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.... .. ..+.||+.|||||++.. ..|+.|+|||||||...||.+|..||.
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 2211 11 44579999999999654 358999999999999999999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=334.55 Aligned_cols=209 Identities=31% Similarity=0.527 Sum_probs=182.5
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 357 (511)
+....+....+.||+|+||+||+|+.. +...||||.+++.......++|++|++++..++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344556666788999999999999753 35579999999888777888999999999999999999999999999
Q ss_pred CceeEEeecccCCCHHHHHHhcCC---------C-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQ---------S-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~---------~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 427 (511)
+..++|+|||..|+|.++|+.... . ..+++..+.+.|+.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 999999999999999999986321 1 34589999999999999999999999 9999999999999999
Q ss_pred CCceEEcccccccccCCCCCceee-ecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 428 EFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 428 ~~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
+..|||+|||+++..-..+.+... ...-..+|||||.|..++++.+||||||||+|||+++ |+-||..
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence 999999999999876554444322 3335779999999999999999999999999999999 9999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.95 Aligned_cols=198 Identities=24% Similarity=0.403 Sum_probs=177.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
..|...+.||+|+.|.||.|+.. +++.||||++.... +....-+.+|+.+|+..+|+|||++++.|...++.|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45677789999999999999854 78899999997544 23344578999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
|++|+|.+.+.... +++.++..|..++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999987653 89999999999999999999999 99999999999999999999999999998877654
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. .....+|||+|||||++....|.+|+||||||++++||+-|++||-.
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 4 34556799999999999999999999999999999999999999963
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=286.32 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=173.6
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchh-HHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|...+.+|+|.||.||+|++. +|+.||||+++.....+. .....+|++.++.++|+||+.++++|.......+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777889999999999999975 799999999986653333 4457899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
||+ .+|+..++.... .++....+.++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~-tdLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 995 488888876433 489999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
+...... +-|..|+|||.+.+. .|+..+|+||.|||+.||+-|.+-|.
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp 203 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP 203 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC
Confidence 4443333 579999999998775 48899999999999999999997664
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=318.87 Aligned_cols=195 Identities=31% Similarity=0.564 Sum_probs=172.3
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
++..+....++-||+|+.|.||+|+++ ++.||||+++... ..+|+-|++++||||+.+.|+|.....++||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 333344445677999999999999997 7899999886432 2578889999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
||||..|-|...|+... +++......+..+||.||.|||.+ .|||||||+-||||+.+..|||+|||.++...
T Consensus 191 MEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999998654 378888999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ....+++||..|||||+|+..+.++|+||||||||||||+||+.||..-
T Consensus 264 ~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 264 DK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 43 3345678999999999999999999999999999999999999999753
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=296.18 Aligned_cols=200 Identities=28% Similarity=0.406 Sum_probs=172.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccC--CceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 363 (511)
++|+.++.|++|+||.||+|+++ +++.||+|+++.+... .-...-.+||.++.+++|||||.+.++.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45666788999999999999986 7889999999755422 2234468999999999999999999887653 679999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
||||+. +|.+.++.-. .++...+++.++.|+++|++|||++ .|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999976 7888888654 4599999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... .+..+-|..|+|||.+.+.+ |+...|+||+|||+.||+++++-|..
T Consensus 229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 65333 34455799999999998764 89999999999999999999999964
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.79 Aligned_cols=205 Identities=27% Similarity=0.401 Sum_probs=182.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
...++|++.+.||+|.||.||.|+.+ ++..||+|++.+.... .-..++.+|+++...++||||+++++++.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 45578999999999999999999875 6788999999765422 23456899999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++||.++|++...|+..... ++++.....++.|+|.|+.|+|.. +++||||||+|+|++.++..||+|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999999864433 488999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
-. .......+||..|.+||+..+..++..+|+|++|++.||++.|.+||....
T Consensus 174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 32 445567789999999999999999999999999999999999999997543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.30 Aligned_cols=205 Identities=28% Similarity=0.416 Sum_probs=178.2
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCC-CCceeccccccccCCc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 359 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~ 359 (511)
....++|...++||+|.||+|+++..+ +++.+|||++++... .++....+.|..++...+ ||.+++++..++..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455678999999999999999999986 688999999987652 334455777877777664 9999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+.||||+.||++..+.+. ..+++..++.++..++.||.|||++ +||+||||.+|||+|.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 9999999999994433332 2499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+..- .....+.+++|||.|||||++.++.|+..+|.|||||+||||+.|..||...+
T Consensus 516 Ke~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 516 KEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred cccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 8543 23346778999999999999999999999999999999999999999997543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=311.19 Aligned_cols=203 Identities=29% Similarity=0.392 Sum_probs=179.2
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCC-cee
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT-ERL 361 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~-~~~ 361 (511)
...++|...+.||.|+||.||+|+.. +|+.||||+++.....-++..-.+|+..+++++ ||||+++.+++.+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34578888999999999999999864 789999999987665555556789999999999 999999999999988 899
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+||||| ..+|++.++.++ ..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.
T Consensus 87 fVfE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 999999 669999998763 3599999999999999999999999 999999999999999888999999999998
Q ss_pred cCCCCCceeeecccccccccccccc-cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+..... .+..+.|..|+|||++. .+.|+.+.|+||+|||++|+.+-++-|-..
T Consensus 160 v~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 160 VRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred cccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 765443 45667899999999875 566899999999999999999999999644
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=301.12 Aligned_cols=200 Identities=24% Similarity=0.427 Sum_probs=180.8
Q ss_pred hCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+++...+ .+...+.+|+++|..++||||+.++++|++.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999986 58999999999876643 34456899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||..+|.|++|+.+.+. +++.+++.++.||++|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999988764 99999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......++|++-|.+||++.+.+| .+.+|-||+||+||-|+.|..||+..
T Consensus 206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 333456889999999999999887 68899999999999999999999854
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.03 Aligned_cols=202 Identities=22% Similarity=0.336 Sum_probs=174.6
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|+..+.||+|+||+||+++.. +++.||+|+++.... ......+.+|++++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999875 688999999965331 223345788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCC
Q 010429 445 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490 (511)
Q Consensus 445 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~ 490 (511)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999989999999999999999999999
Q ss_pred Cccccc
Q 010429 491 RAFDLA 496 (511)
Q Consensus 491 ~pf~~~ 496 (511)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=316.34 Aligned_cols=206 Identities=24% Similarity=0.342 Sum_probs=176.6
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
.....++|++.+.||+|+||.||+++.. +++.+|+|++.+.. .......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999976 57899999986432 22234457889999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999999753 278899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCC----CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...............||+.|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 876433322233456999999999987543 678999999999999999999999743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=314.13 Aligned_cols=200 Identities=27% Similarity=0.404 Sum_probs=178.5
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
-|.+.+.||+|+.|.|-.|++. +|+.+|||++.+.. .+.....+.+|+.+|+.+.||||+++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4677889999999999999875 89999999997652 33345568999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|.|.+++-+.+. +.+.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus 93 yv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred ecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 9999999999987653 89999999999999999999999 99999999999999999999999999997543
Q ss_pred CCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCcccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
........||+|.|.|||++++..| ..++||||.|||||.|+||+.||++..
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 2334456789999999999999987 678999999999999999999998543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=316.33 Aligned_cols=202 Identities=23% Similarity=0.327 Sum_probs=173.1
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.|..++.||+|+||+||+|+.. +++.||+|+++... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999875 68899999996543 22334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997643 388999999999999999999999 9999999999999999999999999997543110
Q ss_pred CC----------------------------------------------ceeeecccccccccccccccCCCCcccCeehh
Q 010429 446 DT----------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 479 (511)
Q Consensus 446 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~ 479 (511)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999998889999999999
Q ss_pred hHHHHHHHhCCCcccccc
Q 010429 480 GVMLLELITGQRAFDLAR 497 (511)
Q Consensus 480 Gvil~elltg~~pf~~~~ 497 (511)
||++|||+||+.||....
T Consensus 235 G~il~elltG~~Pf~~~~ 252 (381)
T cd05626 235 GVILFEMLVGQPPFLAPT 252 (381)
T ss_pred hhHHHHHHhCCCCCcCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=312.62 Aligned_cols=211 Identities=28% Similarity=0.460 Sum_probs=175.1
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
++..++|++.+.||+|+||.||+|.+ .++..||||+++..........+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999974 235679999997655445556789999999999 89999999998876
Q ss_pred CC-ceeEEeecccCCCHHHHHHhcCCC-----------------------------------------------------
Q 010429 357 PT-ERLLVYPFMVNGSVASCLRERGQS----------------------------------------------------- 382 (511)
Q Consensus 357 ~~-~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 382 (511)
.+ ..+++|||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578999999999999999753211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc-eeeecccc
Q 010429 383 -----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 456 (511)
Q Consensus 383 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt 456 (511)
..++++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 23488899999999999999999999 9999999999999999999999999999865332221 12223356
Q ss_pred cccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 457 ~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 78999999998889999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=316.60 Aligned_cols=202 Identities=21% Similarity=0.324 Sum_probs=173.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||.||++... +++.||+|++.... .......+.+|++++.+++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999875 78899999986532 2223456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999864321
Q ss_pred CCCc----------------------------------------------eeeecccccccccccccccCCCCcccCeeh
Q 010429 445 KDTH----------------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 478 (511)
Q Consensus 445 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 478 (511)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245899999999999889999999999
Q ss_pred hhHHHHHHHhCCCccccc
Q 010429 479 YGVMLLELITGQRAFDLA 496 (511)
Q Consensus 479 ~Gvil~elltg~~pf~~~ 496 (511)
|||++|||++|++||...
T Consensus 234 lGvil~elltG~~Pf~~~ 251 (377)
T cd05629 234 LGAIMFECLIGWPPFCSE 251 (377)
T ss_pred cchhhhhhhcCCCCCCCC
Confidence 999999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=323.49 Aligned_cols=201 Identities=30% Similarity=0.530 Sum_probs=179.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.....+.++||.|.||.||+|+++ ....||||.++...+++.+.+|+.|..+|.+++||||+++.|+.......++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 344556789999999999999876 2447999999999988889999999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
|+|||++|+|+.+|+++.. ++++.+...++.+||.||+||-+. ++|||||..+|||++.+..+|++|||+++.+
T Consensus 708 iTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999998653 389999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCceeeeccc--ccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcc
Q 010429 443 DYKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493 (511)
Q Consensus 443 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf 493 (511)
........+..-| ..+|.|||.|..++++.+||||||||++||.++ |+.||
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 6544333333333 469999999999999999999999999999998 88887
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=314.97 Aligned_cols=202 Identities=22% Similarity=0.356 Sum_probs=174.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||+||+++.. +++.||||+++... .......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999976 68899999997532 1223445788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------------eeeecccccccccccccccCCCCcccCeehhhHHHHHHH
Q 010429 445 KDTH-------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487 (511)
Q Consensus 445 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ell 487 (511)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011245899999999999888999999999999999999
Q ss_pred hCCCccccc
Q 010429 488 TGQRAFDLA 496 (511)
Q Consensus 488 tg~~pf~~~ 496 (511)
+|+.||...
T Consensus 234 ~G~~Pf~~~ 242 (364)
T cd05599 234 VGYPPFCSD 242 (364)
T ss_pred cCCCCCCCC
Confidence 999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=304.23 Aligned_cols=198 Identities=26% Similarity=0.349 Sum_probs=174.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++.+....+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999976 688999999864321 223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.++++..+ .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 12345899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.36 Aligned_cols=198 Identities=27% Similarity=0.387 Sum_probs=174.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||.||++++. +++.||+|+++... .......+.+|++++++++||||+++++++..++..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999986 68899999986542 1223446889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999998643 378899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 22 2346899999999999988999999999999999999999999643
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=313.91 Aligned_cols=209 Identities=23% Similarity=0.338 Sum_probs=178.8
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
..+.....++|++.+.||+|+||.||+++.. +++.+|+|++.... .......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445566789999999999999999999976 68899999986432 12233457889999999999999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
+...++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998753 278889999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCC----CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 999876543332333456999999999987543 788999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.86 Aligned_cols=207 Identities=26% Similarity=0.313 Sum_probs=177.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
..+.|+.++.||.|.-|+||+++.. ++..+|+|++.+.... ....+.+.|.++|++++||.++.+++.++.+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3456667789999999999999987 4588999999765533 334467889999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+||||+||+|...++++... .+++..++.++..++-||+|||-. |||.|||||+|||+.++|++.|+||.++...
T Consensus 155 ~meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999876544 499999999999999999999999 9999999999999999999999999986432
Q ss_pred CC---------------------------------C-C---------------------Cceeeeccccccccccccccc
Q 010429 443 DY---------------------------------K-D---------------------THVTTAVRGTIGHIAPEYLST 467 (511)
Q Consensus 443 ~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~ 467 (511)
.. . . .....+++||-+|.|||++++
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0 0 011234679999999999999
Q ss_pred CCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 468 GKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 468 ~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
..++.++|.|+|||++|||+.|+.||....
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 999999999999999999999999998543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=300.42 Aligned_cols=200 Identities=29% Similarity=0.433 Sum_probs=173.3
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
|+..+.||+|+||.||++... +|+.||+|.+..... ......+.+|++++.+++|+||+++++++.+.+..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999874 789999999865432 22334578899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988865332 2489999999999999999999999 99999999999999999999999999997653221
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 223446899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.99 Aligned_cols=201 Identities=25% Similarity=0.356 Sum_probs=172.3
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999875 688999999875321 2334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|+|.+++.+.. .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997643 378999999999999999999999 9999999999999999999999999997532110
Q ss_pred C----------------------------------------------CceeeecccccccccccccccCCCCcccCeehh
Q 010429 446 D----------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 479 (511)
Q Consensus 446 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~ 479 (511)
. ........||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122468999999999999899999999999
Q ss_pred hHHHHHHHhCCCccccc
Q 010429 480 GVMLLELITGQRAFDLA 496 (511)
Q Consensus 480 Gvil~elltg~~pf~~~ 496 (511)
||++|||++|++||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ 251 (382)
T ss_pred hHHHHHHHhCCCCCCCC
Confidence 99999999999999743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=303.56 Aligned_cols=200 Identities=29% Similarity=0.414 Sum_probs=181.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
..|...+.||+|+||.||+|.+. .++.||+|++..+..+.+..++++|+.++.+++++||.+++|.+..+...|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45677789999999999999875 78899999999888788788899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
|.+|++.+.++.... +++....-|+.++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||.+-.+....
T Consensus 93 ~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999986542 47788888999999999999999 99999999999999999999999999998766443
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ...++||+.|||||++....|+.|+||||||++.+||.+|.+|+..
T Consensus 166 ~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 166 KR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred hc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 33 3678899999999999988999999999999999999999999963
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=298.88 Aligned_cols=205 Identities=27% Similarity=0.389 Sum_probs=168.5
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-------------hHHHHHHHHHHHHhCCCCceecc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------------GELQFQTEVEMISMAVHRNLLRL 350 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~~~h~niv~l 350 (511)
...+.|++.+.||+|.||.|-+|+.. +++.||||++.+..... ..+...+||.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999976 78999999996433111 12468899999999999999999
Q ss_pred ccccccC--CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 010429 351 RGFCMTP--TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (511)
Q Consensus 351 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 428 (511)
+++..++ +..|||+|||..|.+.. .....+.+++.++++++.+++.||+|||.+ +|+||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998765 57899999999887643 222223389999999999999999999999 99999999999999999
Q ss_pred CceEEcccccccccCCC----CCceeeecccccccccccccccCC----CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 429 FEAVVGDFGLAKLMDYK----DTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 429 ~~~kl~Dfg~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|++||+|||.+...... .........|||.|+|||...++. .+.+.||||+||+||.|+.|+.||...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 99999999998755221 111122356999999999987733 367789999999999999999999654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=306.36 Aligned_cols=195 Identities=26% Similarity=0.340 Sum_probs=169.6
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
+.||+|+||.||+++.. +|+.||+|+++... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 78899999997543 2233446788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCcee
Q 010429 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450 (511)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 450 (511)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 9999987643 389999999999999999999999 9999999999999999999999999998753222 1222
Q ss_pred eecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 451 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 3456999999999999989999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.22 Aligned_cols=200 Identities=27% Similarity=0.362 Sum_probs=174.5
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCC--CCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
..++|.+.+.||+|+||.||+|.+.. +..||+|++.... .......+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578889999999999999998643 3689999986432 2233446888999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
++|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999998653 388999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 5432 22346999999999999888999999999999999999999999753
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.63 Aligned_cols=197 Identities=25% Similarity=0.353 Sum_probs=174.6
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
+|++.+.||+|+||.||+|++. +++.||+|+++.... ......+.+|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888899999999999999986 588999999975432 2234468889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999997643 388999999999999999999999 999999999999999999999999999975543
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 223455899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.00 Aligned_cols=202 Identities=24% Similarity=0.349 Sum_probs=173.0
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
+|++.+.||+|+||.||+++.. +++.||+|++..... ......+.+|++++.+++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 688999999865321 2234457889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|+|.+++.+.+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997643 378899999999999999999999 9999999999999999999999999997532100
Q ss_pred C------------------------------------------CceeeecccccccccccccccCCCCcccCeehhhHHH
Q 010429 446 D------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483 (511)
Q Consensus 446 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil 483 (511)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134699999999999998999999999999999
Q ss_pred HHHHhCCCcccccc
Q 010429 484 LELITGQRAFDLAR 497 (511)
Q Consensus 484 ~elltg~~pf~~~~ 497 (511)
|||++|+.||....
T Consensus 235 yell~G~~Pf~~~~ 248 (376)
T cd05598 235 YEMLVGQPPFLADT 248 (376)
T ss_pred eehhhCCCCCCCCC
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.38 Aligned_cols=204 Identities=27% Similarity=0.409 Sum_probs=173.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCc-eeccccccccCC-----
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPT----- 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~----- 358 (511)
...|...++||+|+||+||+|+.. +|+.||+|+++.... +.......+|+.++++++|+| |+++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666778999999999999875 789999999976544 233344679999999999999 999999998877
Q ss_pred -ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 359 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 359 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
..++|+||+ .-+|..++.........++...++.++.|+++||+|||++ +|+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 678999999 5589999987654323477789999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+|+........ .+..++|..|+|||++.+. .|+...||||+|||+.||+++++-|..
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG 223 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence 99866533222 3445589999999999887 589999999999999999999999964
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.74 Aligned_cols=204 Identities=24% Similarity=0.333 Sum_probs=174.7
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
...++|++.+.||+|+||.||+++.. +++.||+|+++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568889999999999999999876 68899999986432 1223345778999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998753 278889999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeecccccccccccccccC----CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 643332223345699999999998653 3788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=293.24 Aligned_cols=197 Identities=27% Similarity=0.416 Sum_probs=165.6
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC-----ceeE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERLL 362 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~l 362 (511)
.|...+++|.|+||.||+|... +++.||||+.-.+..- -.+|+++|++++|||||++.-+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4556789999999999999875 5789999998654432 237999999999999999988876432 2348
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 441 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 441 (511)
|||||+. +|.+.++........++.-.++-++.||.+||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999965 89998887544455688889999999999999999998 99999999999999987 8999999999998
Q ss_pred cCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+...... .+...|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|...
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 7655443 334478899999999876 4899999999999999999999999753
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=305.82 Aligned_cols=203 Identities=24% Similarity=0.342 Sum_probs=174.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||+||+++.. +++.||+|++.+.. .......+.+|..++...+|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 67889999986532 1223345788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.+... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999986432 388999999999999999999999 999999999999999999999999999976654
Q ss_pred CCCceeeeccccccccccccccc-----CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 33333334569999999999875 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=303.10 Aligned_cols=195 Identities=26% Similarity=0.345 Sum_probs=169.0
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
+.||+|+||.||+++.. +|..||+|+++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999997543 2233445778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCcee
Q 010429 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450 (511)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 450 (511)
+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9998887643 389999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 451 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 3356899999999999889999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=301.27 Aligned_cols=192 Identities=28% Similarity=0.383 Sum_probs=168.1
Q ss_pred eccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
||+|+||.||+++.. +++.||+|+++... .......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 67899999986532 233345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeee
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 452 (511)
.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99997643 389999999999999999999999 99999999999999999999999999987543222 22334
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 5699999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=303.86 Aligned_cols=203 Identities=24% Similarity=0.356 Sum_probs=173.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||+||+++.. +++.||+|++.+.. .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999976 68899999986422 2223445888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.+... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999976322 388999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeeccccccccccccccc-----CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 33322233458999999999863 45688999999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.86 Aligned_cols=206 Identities=27% Similarity=0.440 Sum_probs=183.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCc-eeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~-~~lv~ 364 (511)
++|...+.+|+|+||.++.++.+ +++.+++|.+...+ +...+....+|+.++++++|||||.+.+.+..++. .+|+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888899999999999999876 67899999997554 33334467899999999999999999999999888 89999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
+|++||++.+.+.+.+ ..-++++.+..++.|++.|+.|||++ +|+|||||+.||+++.++.|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998865 23489999999999999999999998 999999999999999999999999999998876
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccccC
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~~ 499 (511)
.. ....+..||+.||.||.+.+.+|..|+|||||||++|||++-+++|+..+..
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~ 212 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS 212 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH
Confidence 54 2345567999999999999999999999999999999999999999876543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=302.12 Aligned_cols=195 Identities=27% Similarity=0.352 Sum_probs=169.4
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
+.||+|+||.||+++.. +++.||+|+++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999997543 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCcee
Q 010429 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450 (511)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 450 (511)
+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9998887643 389999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 451 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 3456999999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=309.94 Aligned_cols=202 Identities=22% Similarity=0.353 Sum_probs=174.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|+..+.||+|+||.||++... +++.||+|+++... .......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999876 68899999996432 1223456788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCC
Q 010429 445 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490 (511)
Q Consensus 445 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~ 490 (511)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred Cccccc
Q 010429 491 RAFDLA 496 (511)
Q Consensus 491 ~pf~~~ 496 (511)
.||...
T Consensus 234 ~Pf~~~ 239 (360)
T cd05627 234 PPFCSE 239 (360)
T ss_pred CCCCCC
Confidence 999644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.22 Aligned_cols=195 Identities=30% Similarity=0.441 Sum_probs=162.7
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHH--hCCCCceeccccccccC----C
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS--MAVHRNLLRLRGFCMTP----T 358 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~~~h~niv~l~~~~~~~----~ 358 (511)
....+..+.+.||+|.||.||+|+++ |+.||||++... ++..+.+|.++++ .++|+||+.+++.-..+ .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 34456778899999999999999997 999999999642 3445667777665 67999999999887654 3
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCeeeCCCCceEE
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-----HCDPKIIHRDVKAANILLDEEFEAVV 433 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl 433 (511)
+.|||++|.+.|||.++|.+. .++.+..++++..+|.||+|||. +.+|.|.|||||+.|||+.+++...|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 679999999999999999874 38999999999999999999995 46789999999999999999999999
Q ss_pred cccccccccCCCCCc---eeeecccccccccccccccCC------CCcccCeehhhHHHHHHHhC
Q 010429 434 GDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITG 489 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvil~elltg 489 (511)
+|+|+|...+..... .....+||.+|||||++...- .-..+||||||.|+||+.-+
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 999999876554322 234567999999999986542 12468999999999999863
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=307.46 Aligned_cols=202 Identities=26% Similarity=0.361 Sum_probs=176.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||+||+|+.. +++.||+|+++.... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999976 789999999975432 233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.+.. .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999998752 489999999999999999999998 999999999999999999999999999976543
Q ss_pred CC----------------------------CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KD----------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11123345899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=310.26 Aligned_cols=210 Identities=31% Similarity=0.468 Sum_probs=178.8
Q ss_pred CHHHHHHHhhCCCCCCeeccccccEEEEEEeCC--C--CE-EEEEEecc--cccchhHHHHHHHHHHHHhCCCCceeccc
Q 010429 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD--G--SL-VAVKRLKE--ERTQGGELQFQTEVEMISMAVHRNLLRLR 351 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~~~h~niv~l~ 351 (511)
....|+...++....+.||+|+||.||+|++.. + .. ||||..+. ........+|.+|.++|++++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 334556666777777999999999999998652 2 23 89999875 34455677899999999999999999999
Q ss_pred cccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
|++......++|||+|.||+|.++|++.+. .++..+...++.+.|+||+|||++ +++||||..+|+|++.++.+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence 999999999999999999999999998754 389999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceee-ecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 432 VVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
||+|||+++.-.. ..... .-.-..+|+|||.+..+.++.++|||||||++||+++ |..||..-
T Consensus 302 KISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 302 KISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred EeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 9999999875431 11111 1124679999999999999999999999999999999 88899643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.55 Aligned_cols=203 Identities=23% Similarity=0.340 Sum_probs=172.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||+||+++.. +++.+|+|++.+.. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999976 57789999986432 1222334788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.+... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999986432 389999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 3333333456999999999986 345788999999999999999999999743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=305.26 Aligned_cols=203 Identities=24% Similarity=0.348 Sum_probs=175.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||+||+++.. +++.||+|+++.... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999875 688999999975432 223456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.+... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999987522 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeecccccccccccccc------cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 4333333456899999999986 455788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=297.62 Aligned_cols=201 Identities=28% Similarity=0.440 Sum_probs=171.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|...+.||+|+||.||+|+.. ++..||+|.++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999876 68899999997554444445678999999999999999999999988899999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
++ ++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 489988875432 378999999999999999999999 99999999999999999999999999997654322
Q ss_pred Cceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....+++.|+|||.+.+ ..++.++||||+||++|||+||++||...
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 223457899999998865 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=303.02 Aligned_cols=200 Identities=29% Similarity=0.388 Sum_probs=171.6
Q ss_pred CCCCCCeeccccccEEEEEEeC----CCCEEEEEEeccccc---chhHHHHHHHHHHHHhCC-CCceeccccccccCCce
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 360 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~ 360 (511)
+|++.+.||+|+||.||+++.. +++.||+|++++... ......+..|++++.+++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998752 578999999864321 222345778999999994 89999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987643 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..............||+.|+|||++.+.. ++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 65444333344566999999999997654 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.91 Aligned_cols=207 Identities=32% Similarity=0.516 Sum_probs=179.5
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC--CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT--DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
..+..+..+.||+|.||.||.|... +|. .||||.+++..+.++..+|.+|..+|+.++|||||+++|++.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3556667789999999999999864 343 4999999988888888899999999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
.++++|||++|+|..+|++.+. ....++..+...++.|||+|++||+++ ++|||||..+|+|+++...|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 9999999999999999998522 234589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeec-ccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 437 GLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|+|+.+...+....... .-..+|||||.+..+.++.|+|||||||++||++| |..||..
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 99995443333222222 23579999999999999999999999999999999 8889854
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.72 Aligned_cols=195 Identities=28% Similarity=0.399 Sum_probs=168.0
Q ss_pred CeeccccccEEEEEEe----CCCCEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 294 NILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+.||+|+||.||+++. .+++.||+|+++.... ......+.+|++++++++||||+++++++..++..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 2578999999875321 22334578899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++.+.. .+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999997643 378889999999999999999999 99999999999999999999999999987533222
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 1223356899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=298.31 Aligned_cols=194 Identities=28% Similarity=0.415 Sum_probs=165.1
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHh-CCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|+.. +++.||+|+++.... ......+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 578999999975431 2223345566666664 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999987643 389999999999999999999999 99999999999999999999999999997543222 22
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 3345689999999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.32 Aligned_cols=201 Identities=21% Similarity=0.302 Sum_probs=172.6
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|++.+.||+|+||.||++++. +++.||+|+++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999986 678899999875432 2234567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|++++.+..+.+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99988776544322 2489999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.........|++.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 33333345689999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.38 Aligned_cols=195 Identities=27% Similarity=0.380 Sum_probs=168.4
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+++.. +++.||+|+++.... ......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 688999999975432 22334578899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|.+++...+ .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 99999887543 389999999999999999999999 9999999999999999999999999998743211 122
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence 23456899999999999989999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=299.29 Aligned_cols=200 Identities=28% Similarity=0.390 Sum_probs=170.9
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCC-ceeccccccccCCceeEEe
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~-niv~l~~~~~~~~~~~lv~ 364 (511)
+|++.+.||+|+||.||+|+.. +++.||+|+++... .......+..|.+++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999876 57899999997543 223345677899999988765 5888999998889999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987643 378999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 222 233456999999999999988999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=307.23 Aligned_cols=204 Identities=28% Similarity=0.393 Sum_probs=177.3
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC------CceeE
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERLL 362 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~~l 362 (511)
|...+.||+|+||.||+|+++ +|+.||||.++.........+..+|++++++++|+|||+++++-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344578999999999999965 89999999999877777777899999999999999999999986554 35689
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC--CC--ceEEccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EF--EAVVGDFGL 438 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~--~~kl~Dfg~ 438 (511)
+||||.+|||...+++-. ....+++.+.+.++.+++.||.|||++ +|+||||||.||++-. +| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998743 334599999999999999999999999 9999999999999843 33 479999999
Q ss_pred ccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccccccC
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~~ 499 (511)
|+.++.. ....+.+||..|.+||.+.. +.++..+|.|||||++||..||..||..-...
T Consensus 171 Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9987644 36677889999999999984 78899999999999999999999999765544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.11 Aligned_cols=201 Identities=26% Similarity=0.425 Sum_probs=171.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++..........+.+|+++++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999986 6889999999755433444467889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+. +++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 67888776543 2388899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 1223458899999998865 4578899999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=299.39 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=170.2
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEe
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+|.+.+.||+|+||.||+|+.. +++.||+|+++.... ......+..|..++... +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999876 578999999875432 22233466777777776 5789999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999887643 388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 22 2223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=300.04 Aligned_cols=201 Identities=26% Similarity=0.372 Sum_probs=176.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|+..+.||+|+||.||++++. ++..+|+|.+..........++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999976 6888999998765444445679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 3889999999999999999999852 6999999999999999999999999998755322
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 123345899999999999888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.90 Aligned_cols=195 Identities=26% Similarity=0.337 Sum_probs=168.1
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
+.||+|+||.||+++.. +|+.||+|+++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 788999999975432 223445778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
+|..++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 9999887643 38999999999999999999997 6 99999999999999999999999999987532221 12
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 23345999999999999889999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=298.38 Aligned_cols=194 Identities=28% Similarity=0.388 Sum_probs=166.9
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+++.. +++.||+|+++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 67899999997543 222344577888888776 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 99998887643 389999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=297.57 Aligned_cols=195 Identities=29% Similarity=0.403 Sum_probs=167.3
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|+.. +++.||+|+++.... ......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 578999999975432 22334567788888765 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|...+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 99999887643 388999999999999999999999 999999999999999999999999999875432222 2
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 23456899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=291.53 Aligned_cols=197 Identities=29% Similarity=0.406 Sum_probs=169.8
Q ss_pred eccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
||+|+||+||++.+. +++.||+|.+...... .....+..|++++++++|+||+++.+++......+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 6889999998654322 2234577899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeee
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 452 (511)
..++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444445689999999999999999999999 999999999999999999999999999976543322 2233
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 46899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=297.14 Aligned_cols=195 Identities=32% Similarity=0.453 Sum_probs=167.3
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|+.. +++.||+|+++... .......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 68899999987543 122344567788888766 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999887643 389999999999999999999999 99999999999999999999999999987533221 22
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 23456899999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=298.32 Aligned_cols=198 Identities=29% Similarity=0.393 Sum_probs=167.6
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHH---HhCCCCceeccccccccCCceeEE
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
|++.+.||+|+||.||+|.+. +++.||||+++... .......+.+|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999875 68999999997543 122233466666554 567899999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|...++.. .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999887642 389999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 221 2223456899999999999988999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=289.29 Aligned_cols=203 Identities=23% Similarity=0.374 Sum_probs=173.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|++.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888899999999999999753 3568999999876544555678999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 3222111122235678999999998999999999999999999875 9999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=293.32 Aligned_cols=206 Identities=26% Similarity=0.447 Sum_probs=172.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeCC-----------------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceec
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTD-----------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 349 (511)
.++|.+.+.||+|+||.||++.+.+ +..||+|.++.........++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997532 33699999976555555667999999999999999999
Q ss_pred cccccccCCceeEEeecccCCCHHHHHHhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 010429 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ---------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414 (511)
Q Consensus 350 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 414 (511)
+++++.+.+..+++|||+++|+|.+++..... ....+++.....++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999875321 113478889999999999999999999 999
Q ss_pred ecCCCCCCeeeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh--CCC
Q 010429 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQR 491 (511)
Q Consensus 415 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~ 491 (511)
||||||+||++++++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999765433221 1222345789999999988889999999999999999987 567
Q ss_pred cccc
Q 010429 492 AFDL 495 (511)
Q Consensus 492 pf~~ 495 (511)
||..
T Consensus 241 p~~~ 244 (304)
T cd05096 241 PYGE 244 (304)
T ss_pred CCCc
Confidence 7753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=298.17 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=176.8
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|++.+.||+|+||.||++.+. ++..+|+|.+...........+.+|++++++++|+||+++++++..++..+++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999986 688899998876544444567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.++++... .+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997643 3788999999999999999999742 799999999999999999999999999875532
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 122345899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=295.95 Aligned_cols=195 Identities=28% Similarity=0.376 Sum_probs=164.7
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHH-HHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|+.. +++.||+|++..... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 688999999865331 222334555554 57889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99998887543 378899999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 23456899999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=294.17 Aligned_cols=195 Identities=29% Similarity=0.403 Sum_probs=166.2
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHh-CCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|++. +++.||+|+++.... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 578999999975431 2233446667777775 5899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|.+++.... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 99999997643 388999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 33456899999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.62 Aligned_cols=212 Identities=27% Similarity=0.435 Sum_probs=176.6
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccc
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 354 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~ 354 (511)
.+....++|++.+.||+|+||.||+|+.. ++..||+|+++..........+.+|+++++.+ +|+||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 33455678999999999999999998742 34579999997655444555688999999999 899999999999
Q ss_pred ccCCceeEEeecccCCCHHHHHHhcCC-----------------------------------------------------
Q 010429 355 MTPTERLLVYPFMVNGSVASCLRERGQ----------------------------------------------------- 381 (511)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 381 (511)
...+..+++|||+++|+|.++++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999999865321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 382 -------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 382 -------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
...++++..+.+++.|+++||+|||++ +++||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 112478899999999999999999999 9999999999999999999999999999765432221
Q ss_pred -eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 449 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 449 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
......++..|||||++.+..++.++|||||||++|||++ |+.||...
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 1112235668999999988899999999999999999997 99999643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=295.82 Aligned_cols=200 Identities=28% Similarity=0.383 Sum_probs=170.0
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEe
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~ 364 (511)
+|+..+.||+|+||+||+|... +|+.||+|+++.... ......+..|.+++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999875 688999999875431 223345777888888876 467888999988889999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999987643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 21 2233455899999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=295.69 Aligned_cols=195 Identities=28% Similarity=0.384 Sum_probs=165.2
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHH-HHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||+||+|+.. +|+.||+|++..... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 689999999865321 222334555554 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 99999987643 388999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 23456899999999999988999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=293.73 Aligned_cols=195 Identities=29% Similarity=0.424 Sum_probs=166.2
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHh-CCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|++. +|+.||+|+++.... .........|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 688999999975431 2233446677777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|..++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 99999887643 388999999999999999999999 99999999999999999999999999987432222 22
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 33456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=295.37 Aligned_cols=195 Identities=28% Similarity=0.365 Sum_probs=164.0
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHH-HHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||+||++++. +++.||+|++..... ......+..|.. +++.++|+||+++++++...+..+++|||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 577899999865331 122233444444 56788999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|.+++.... .+.+..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 99999997643 378888999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 33456999999999999989999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=301.52 Aligned_cols=210 Identities=26% Similarity=0.410 Sum_probs=175.8
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
....++|++.+.||+|+||.||+|.+ .++..||||+++..........+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34456788899999999999999963 245689999997655445556788999999999 89999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCC-------------------------------------------------------
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------- 381 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 381 (511)
.+..++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999975321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 382 ----------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 382 ----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 012478899999999999999999999 9999999999999999999999999999765433
Q ss_pred CCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 446 DTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 446 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 2211 112234668999999999999999999999999999998 89999643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=300.42 Aligned_cols=197 Identities=25% Similarity=0.409 Sum_probs=166.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|+..+.||+|+||.||++++. +++.||||++...........+.+|+++++.++|+||+++++++...+..+++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 44556788999999999999875 68999999997655444556789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++|+|.... ..++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986421 256778889999999999999999 99999999999999999999999999998654321
Q ss_pred Cceeeeccccccccccccccc-----CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 12233468999999998743 23456899999999999999999999743
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=281.48 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=172.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEec-ccccchhHHHHHHHHHHHHhCCCCceecccccccc-----CC
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PT 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-----~~ 358 (511)
....|..++.||+|+||.|+.+.++ +|+.||||++. ........++-.+|+..++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999876 78999999986 33344456678899999999999999999988765 25
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..|+|+|+| +.+|...++... .++...+.-++.|+++||.|+|+. +++||||||+|++++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 689999999 668888887643 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-CCceeeecccccccccccccc-cCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 439 AKLMDYK-DTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 439 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
|+..+.. .....+..+.|..|+|||.+. ...|+...||||.|||+.||++|++-|-+.+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 9977542 122234556899999999875 4568999999999999999999999997554
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.55 Aligned_cols=194 Identities=27% Similarity=0.382 Sum_probs=167.7
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||+||+++.. +++.||+|+++.... ......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 678999999975432 22344578899988887 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|..++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 99999887543 389999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 3345699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=295.71 Aligned_cols=195 Identities=28% Similarity=0.378 Sum_probs=165.4
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHH-HHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||+||+++.. +|+.||+|++..... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 689999999865421 222334555655 46779999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|..++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998887543 389999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 23456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=295.97 Aligned_cols=195 Identities=29% Similarity=0.398 Sum_probs=169.0
Q ss_pred CeeccccccEEEEEEe----CCCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeeccc
Q 010429 294 NILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
+.||+|+||.||+++. .+|+.||+|+++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578999999975432 2234457789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+|+|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 999999987543 389999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 233456899999999998888899999999999999999999999743
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=287.35 Aligned_cols=201 Identities=28% Similarity=0.431 Sum_probs=173.2
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.|+..+.||+|+||+||++... +++.||+|.+...... .....+.+|+.++++++|+||+++++.+..++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999875 6889999998653322 223457789999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999998875422 3489999999999999999999999 9999999999999999999999999999765422
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 2 122345899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.44 Aligned_cols=200 Identities=22% Similarity=0.399 Sum_probs=167.3
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC-----Ccee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERL 361 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~~ 361 (511)
+|++.+.||+|+||.||+|+.. ++..||||+++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999875 68999999986432 223345688999999999999999999987543 2479
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
++|||+. ++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68988887543 389999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC--ceeeeccccccccccccccc--CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 432211 12234568999999999865 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=301.16 Aligned_cols=194 Identities=23% Similarity=0.307 Sum_probs=168.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..+|++.+.||+|+||.||++.+. +++.||+|.... ..+.+|++++++++||||+++++++......++++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 457999999999999999999875 688999996532 236789999999999999999999999899999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
++. ++|..++.... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 994 78888886543 388999999999999999999999 9999999999999999999999999999754332
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 22233345699999999999988899999999999999999999988753
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.33 Aligned_cols=197 Identities=26% Similarity=0.432 Sum_probs=176.7
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeeccc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
|.++++||+|+||.||+|.++ +|+.+|+|.+..+ .+.+++.+|+.+|++++.+++|+++|.+......|+|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 556788999999999999876 7999999998753 456678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
.|+..+.++.++. ++++.++..++...+.||+|||.. .-+|||||..|||++.+|.+|++|||.|-.+... -.
T Consensus 112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA 184 (502)
T KOG0574|consen 112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA 184 (502)
T ss_pred CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence 9999999987554 499999999999999999999998 8899999999999999999999999999765432 22
Q ss_pred eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....+.|||.|||||++..-.|+.++||||+|+...||..|++||...
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 345577999999999999999999999999999999999999999743
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=287.45 Aligned_cols=201 Identities=28% Similarity=0.471 Sum_probs=166.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC--CCCEEEEEEecccccc-hhHHHHHHHHHHHHhC---CCCceeccccccc-----c
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMA---VHRNLLRLRGFCM-----T 356 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~---~h~niv~l~~~~~-----~ 356 (511)
++|++.+.||+|+||+||+|++. ++..||+|+++..... .....+.+|+++++++ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 4678999998654322 2233456677776655 6999999999875 2
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
....+++|||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 356889999996 689998876432 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||...
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 999765433 2233445899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=291.28 Aligned_cols=194 Identities=31% Similarity=0.430 Sum_probs=167.0
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||+||++++. +++.||+|+++... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999997543 122344567888888877 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|..++.+.. .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 99999887653 389999999999999999999999 99999999999999999999999999986532221 12
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 2334589999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.14 Aligned_cols=208 Identities=25% Similarity=0.335 Sum_probs=177.0
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC-----
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----- 358 (511)
..++|.+.+.||+|+||+||+++.. +|+.||||++.... .......+.+|+..+..++|+||+++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999865 78999999986543 3344556889999999999999999887765432
Q ss_pred ---ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcc
Q 010429 359 ---ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (511)
Q Consensus 359 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 435 (511)
..++||||+++|+|.++++........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 25799999999999999987655555699999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC-CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 436 FGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 436 fg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99998654322 22233456999999999999989999999999999999999999999753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=284.97 Aligned_cols=192 Identities=17% Similarity=0.291 Sum_probs=164.7
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccch--hHHHHHHHHHHHHhCCCCceecccccccc----CCceeEEeecc
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPFM 367 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~e~~ 367 (511)
..||+|++|.||+|.+ +|+.||||+++...... ....+.+|++++.+++||||++++|++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 58999999997643222 13568899999999999999999999876 35678999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++|+|.+++.+.. .+++.....++.|++.||+|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999997643 3889999999999999999999732 78899999999999999999999999997654321
Q ss_pred ceeeeccccccccccccccc--CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||+..
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 12347899999999976 67899999999999999999999999754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=293.74 Aligned_cols=205 Identities=26% Similarity=0.416 Sum_probs=181.8
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
...+...+.++||+|.||.|.......+..||||.++.......+.+|.+|+++|.+++||||++++|+|..++..++++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 44566677899999999999999988779999999999888888889999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
|||++|+|.+++..+.... +......+|+.||+.||+||.+. ++|||||.++|+|++.++++||+|||+++.+-.
T Consensus 615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999998864332 56667788999999999999998 999999999999999999999999999986654
Q ss_pred CCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh--CCCccc
Q 010429 445 KDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFD 494 (511)
Q Consensus 445 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~pf~ 494 (511)
.+.+ .....+-..+|||||.+..++++.++|||+||+.+||+++ .+.||.
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 4433 3334456789999999999999999999999999999987 677885
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.30 Aligned_cols=204 Identities=22% Similarity=0.293 Sum_probs=175.8
Q ss_pred CCCCCCeeccccccEEEEEEeC-C-CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-D-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
.|.+.+.||+|++|.||+|... + +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3788899999999999999865 3 5778888764432 33345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++|+|.+++++......++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999876544445689999999999999999999999 99999999999999999999999999998764322
Q ss_pred C-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 2234456999999999999989999999999999999999999999743
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=280.87 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=173.3
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
++|++.+.||+|+||.||++.+.++..+|+|.++... .....+.+|++++++++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 5678889999999999999999888899999886443 23456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++|+|.++++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999875432 389999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22222235668999999988889999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=296.89 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=169.2
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC-----cee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 361 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~ 361 (511)
+|++.+.||+|+||.||++... +++.||+|++.... ......++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 78999999986432 2233456889999999999999999999988766 789
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++||+. ++|.+.+.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57877775432 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.............+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 544333333334578999999998774 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=291.42 Aligned_cols=202 Identities=27% Similarity=0.396 Sum_probs=181.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch--hHHHHHHHHHHHHhCC-CCceeccccccccCCcee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~ 361 (511)
..+.|++.+.||+|.||.||+++.+ +|+.+|+|.+++..... ....+.+|+.+|+++. |||||.+.+++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999987 59999999997655433 3457899999999998 999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC----CceEEcccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFG 437 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg 437 (511)
+|||++.||.|.+.+... .+++..+..++.|++.+++|||+. |++|||+||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999876 289999999999999999999999 99999999999999643 479999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
++..... .......+||+.|+|||++....++..+||||+||++|.|+.|.+||....
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 9998765 455667789999999999999999999999999999999999999998654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=289.21 Aligned_cols=203 Identities=28% Similarity=0.496 Sum_probs=171.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
..+|+..+.||+|+||.||+|++. ++. .||+|.++.........++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999864 333 48999987654445566788999999999999999999998764 577
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++||+++|+|.++++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999986432 378999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcee-eecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 442 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
......... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 654332221 12224678999999999999999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=263.67 Aligned_cols=211 Identities=27% Similarity=0.348 Sum_probs=179.1
Q ss_pred HHhhCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC-----C
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----T 358 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~ 358 (511)
+..++|.+++.+|+|||+-||.++. .+++.||+|++.... .++....++|++..++++|||+++++++...+ .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4567899999999999999999984 478899999997655 45566789999999999999999999987654 3
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
+.|++++|...|+|.+.++.....+..+++.+.+.|+.++++||++||+. .++++||||||.|||+++.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 48999999999999999998777777899999999999999999999998 33599999999999999999999999999
Q ss_pred ccccCCCCC--------ceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 439 AKLMDYKDT--------HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 439 a~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
++.....-. +.......|..|+|||.+. +...++++|||||||++|+|+.|..||+..-
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 875432111 1112234788999999875 4557899999999999999999999998544
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.33 Aligned_cols=212 Identities=25% Similarity=0.366 Sum_probs=187.8
Q ss_pred CHHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccc
Q 010429 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 355 (511)
..++++...++|.++++||+|+||.|..++.+ +++.||.|++++.. ......-|..|.++|...+.+=|+.+.-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35677778899999999999999999999986 68889999997632 2334456889999999999999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcc
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 435 (511)
+..+.|+|||||+||+|-.++.+.. +++++.++.++..|+-||.-+|+. |+|||||||+|||+|..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999998765 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeeeccccccccccccccc-----CCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
||.+-.++....-.....+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||....
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 99998777555555566779999999999852 568899999999999999999999998654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=281.92 Aligned_cols=203 Identities=27% Similarity=0.457 Sum_probs=175.3
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++|+||+++++.+...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 456788999999999999999998888899999986533 234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++.... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999976432 2478899999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.........++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 2222222335678999999988889999999999999999998 9999953
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.21 Aligned_cols=207 Identities=24% Similarity=0.344 Sum_probs=173.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCC-CEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccc-ccc------
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGF-CMT------ 356 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~-~~~------ 356 (511)
...++++.+.|.+|||+.||.|.+..+ ..||+|++-.. .+.....+.+|+++|+++. |+|||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 344566778999999999999998765 99999998765 4666778999999999997 9999999993 221
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
.-+.+|.||||.+|.|-+++..+.... |++.++++|+.|+++|+++||.. +++|||||||-+||||+.+++.|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 246789999999999999999876554 99999999999999999999986 678999999999999999999999999
Q ss_pred ccccccCCCC-C-ceee------eccccccccccccc---ccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKD-T-HVTT------AVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~-~-~~~~------~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|.|+...... . .... ...-|+.|+|||++ ++..+++|+|||||||+||-|+..+.||+..
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 9997432221 1 1100 12368999999987 4667899999999999999999999999754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.36 Aligned_cols=205 Identities=23% Similarity=0.361 Sum_probs=174.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||.||+|.+. +|+.||+|+++.... .....++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999876 688999999975432 233456899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 365 PFMVNGSVASCLRERGQ-------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
||+++|+|.+++..... .....++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999875311 123467788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDT-----------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9986521110 011124589999999999999999999999999999999999999965
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=289.07 Aligned_cols=201 Identities=26% Similarity=0.442 Sum_probs=171.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|++++++++||||+++++++..++..+++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999876 67889999997554444445678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++ ++.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88888765432 378999999999999999999999 99999999999999999999999999997543322
Q ss_pred Cceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||+||++||...
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 223347899999998865 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=296.95 Aligned_cols=210 Identities=24% Similarity=0.376 Sum_probs=176.2
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM 355 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~ 355 (511)
+....++|.+.+.||+|+||.||+|.+. .+..||||+++..........+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3345678889999999999999999853 234699999976555555567999999999996 999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCC------------------------------------------------------
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------ 381 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 381 (511)
+.+..++||||+++|+|.+++++...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999875321
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 010429 382 --------------------------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (511)
Q Consensus 382 --------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 423 (511)
....+++..+..++.|+++||+|||+. +++||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 012478888999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 9999999999999999765432221 1222346788999999988889999999999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=281.24 Aligned_cols=193 Identities=28% Similarity=0.398 Sum_probs=166.5
Q ss_pred eccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
||+|+||.||+++.. +|+.||+|++..... ......+..|++++++++||||+++++++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 689999999864332 12233456799999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeee
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 452 (511)
.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988865432 2488999999999999999999999 99999999999999999999999999987654322 2233
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..|+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4589999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=282.56 Aligned_cols=208 Identities=28% Similarity=0.452 Sum_probs=174.5
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 358 (511)
+..++|+..+.||+|+||.||+|.+. .+..||+|+++.........++.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 356799999865444444556889999999999999999999999989
Q ss_pred ceeEEeecccCCCHHHHHHhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQS------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
..+++|||+++++|.+++++.... ....++..+..++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999999764321 23467889999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 433 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|+|||+++......... .....+++.|+|||.+.++.++.++|||||||++|||++ |+.||..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~ 224 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999987554322211 112235778999999998889999999999999999999 7899864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=290.95 Aligned_cols=209 Identities=30% Similarity=0.457 Sum_probs=173.9
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
++..++|++.+.||+|+||.||+|... +++.||+|+++..........+.+|++++.++ +|+||+++++++..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 445678999999999999999999642 35789999997655444455688899999999 89999999998865
Q ss_pred C-CceeEEeecccCCCHHHHHHhcCCC-----------------------------------------------------
Q 010429 357 P-TERLLVYPFMVNGSVASCLRERGQS----------------------------------------------------- 382 (511)
Q Consensus 357 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 382 (511)
. ...+++|||+++++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5678999999999999998653210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce-eeeccccc
Q 010429 383 ----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTI 457 (511)
Q Consensus 383 ----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~ 457 (511)
..++++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++..+....... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12589999999999999999999999 99999999999999999999999999998764332221 22234567
Q ss_pred ccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 458 ~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 8999999999999999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=281.65 Aligned_cols=206 Identities=31% Similarity=0.522 Sum_probs=175.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|.+.+.||+|+||.||+|... ++..||+|.++..........+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346778899999999999999864 24789999997665444566799999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 010429 361 LLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 430 (511)
+++|||+++++|.++++..+. ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999986432 234578999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 431 AVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999754332211 1122335788999999999999999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=278.54 Aligned_cols=203 Identities=29% Similarity=0.423 Sum_probs=174.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..++|++.+.||+|++|.||+|.+.+++.||+|.++... ....++.+|++++++++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 456788899999999999999998778889999987543 234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997643 23489999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
..........+..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 2211111223457999999998889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.64 Aligned_cols=200 Identities=29% Similarity=0.425 Sum_probs=172.1
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.|+..+.||+|+||.||++... +++.||+|.+...... .....+.+|+.++++++|++|+++++.+...+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999876 6889999998654322 223457789999999999999999999999899999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998865432 2489999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 21 1234589999999999998999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.18 Aligned_cols=205 Identities=30% Similarity=0.515 Sum_probs=174.6
Q ss_pred hCCCCCCeeccccccEEEEEEeCC------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
++|++.+.||+|+||.||+|.... ...||+|.++.........++.+|++.+.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998642 25799999976554455567899999999999999999999999888999
Q ss_pred EEeecccCCCHHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 010429 362 LVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 429 (511)
++|||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999764221 13588999999999999999999999 999999999999999999
Q ss_pred ceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 430 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999976533221 12223346789999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.93 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=175.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.+.|++.+.||+|.|+.||+.... +|+.+|+|.++... +..+.+.+.+|+.+-+.++|||||++...+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456777889999999999998654 78889999885332 3345667899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~ 441 (511)
|+|+|++|..-+-.+ ...++..+-.++.||+++|.|+|.+ +|||||+||.|+++.. .--+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998765443 2378889999999999999999999 9999999999999953 44699999999987
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+. +........|||.|||||+++..+++..+|||+.|||||-|+.|.+||..
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 76 55666777899999999999999999999999999999999999999976
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=280.49 Aligned_cols=200 Identities=29% Similarity=0.421 Sum_probs=172.1
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
|+..+.||+|+||+||++.+. +++.||+|.+...... .....+.+|++++++++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 6889999998654322 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998875432 2489999999999999999999999 99999999999999999999999999987653222
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. .....|+..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 1 22345899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=276.86 Aligned_cols=202 Identities=29% Similarity=0.511 Sum_probs=174.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|++.+.||+|+||+||+|.+. +...||+|.++..........+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 457888999999999999999875 2457999998766555556678999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+++++|.+++..... .+++..+..++.|++.|++|||+. +|+|+||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999976432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccc
Q 010429 443 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494 (511)
Q Consensus 443 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~ 494 (511)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 522221 2222335678999999998889999999999999999998 999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=291.10 Aligned_cols=193 Identities=26% Similarity=0.344 Sum_probs=161.4
Q ss_pred eccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhC---CCCceeccccccccCCceeEEeecccC
Q 010429 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA---VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~---~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
||+|+||+||+|+.. +++.||+|++..... .........|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 689999999864321 12223355666666655 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|.+++.+.. .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999887643 389999999999999999999999 99999999999999999999999999987533222 12
Q ss_pred eeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 2345699999999998764 4789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=253.58 Aligned_cols=211 Identities=24% Similarity=0.371 Sum_probs=176.1
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccC
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 357 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 357 (511)
.+.+++..++...+..||+|+||.|-+.++. +|...|+|+++.....+..++..+|+.+..+. ..|.+|.++|.....
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 3345566666777788999999999888865 89999999998776666677788899876554 689999999999999
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
...|+.||.| .-||..+-++.-.....+++...-+|+..+.+||.|||++. .++|||+||+|||++.+|++||+|||
T Consensus 118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 9999999999 55787776654444556999999999999999999999986 89999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccccccccccccc----CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++-.+... -..+...|...|||||.+.. ..|+.|+||||+|+.+.||.++++||+.
T Consensus 195 IsG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 195 ISGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred cceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 98655321 12222458899999998853 3578999999999999999999999974
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.87 Aligned_cols=193 Identities=28% Similarity=0.456 Sum_probs=168.6
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
-++|+|.||+||.|++. +..++|||.+.... ....+-+..||...++++|.|||+++|.+.+++..-+.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 36999999999999976 45678999996543 34455688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCceEEcccccccccCCCCCce
Q 010429 373 ASCLRERGQSQPPL--NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 373 ~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
.+.++..-. ++ ++.+.-.+..||++||.|||++ .|||||||-+|||++ ..|.+||+|||.++.+..- ...
T Consensus 660 SsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 660 SSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred HHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 999987543 34 7888999999999999999999 999999999999996 5789999999999887543 334
Q ss_pred eeecccccccccccccccCC--CCcccCeehhhHHHHHHHhCCCccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
+..+.||..|||||++..+. |..++|||||||.+.||.||++||.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 55677999999999998654 7889999999999999999999996
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.10 Aligned_cols=200 Identities=26% Similarity=0.375 Sum_probs=173.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||+|+||.||++.+. ++..+|+|.++.........++.+|++++++++||||+++++++..++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999875 67889999987554444455688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.++++... .+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997652 3889999999999999999999732 8999999999999999999999999998754322
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 123345889999999998888899999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=277.59 Aligned_cols=205 Identities=20% Similarity=0.338 Sum_probs=176.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||.||+|+.. +++.||||.++... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999875 78999999876422 2333456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.........+++..+..++.|+++||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998876444344588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......+++.|+|||.+.+...+.++|+||||+++|||++|+.||...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 222 112345888999999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=275.78 Aligned_cols=200 Identities=29% Similarity=0.466 Sum_probs=172.0
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
++|.+.+.||+|+||+||+|++.++..+|+|.++.... ....+.+|+.++.+++||||+++++++...+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 46778899999999999999987777799999875432 2356889999999999999999999999888899999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++|+|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999976432 489999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 11122235678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=277.68 Aligned_cols=202 Identities=32% Similarity=0.470 Sum_probs=172.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..+|...+.||+|+||.||+|.+. .++.||+|.+.... ....++.+|++++++++|+||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345777889999999999999875 58899999986532 334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999976432 3489999999999999999999999 9999999999999999999999999999766433
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 2222222224568999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=298.45 Aligned_cols=199 Identities=24% Similarity=0.352 Sum_probs=163.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC--------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 357 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-------- 357 (511)
..+|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457899999999999999999875 68899999885432 1245799999999999999998876432
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDF 436 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df 436 (511)
...++||||++ +++.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 23568999997 478777765444445689999999999999999999999 999999999999999665 7999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99986543222 2234589999999998664 5899999999999999999999999743
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=278.85 Aligned_cols=194 Identities=26% Similarity=0.384 Sum_probs=170.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|+..+.||+|+||.||+|.+. +++.||+|.+..........++.+|++++.+++||||+++++++..++..+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999864 78899999987554444456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
++++++..+. .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 268888999999999999999999 99999999999999999999999999997553221
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2234589999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=275.56 Aligned_cols=200 Identities=28% Similarity=0.447 Sum_probs=171.0
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
.+|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 45778899999999999999988777899999864332 2345888999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999976432 489999999999999999999999 999999999999999999999999999876532222
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 11111223457999999998889999999999999999999 8999964
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=286.92 Aligned_cols=212 Identities=26% Similarity=0.452 Sum_probs=184.9
Q ss_pred cCHHHHHHHhhCCCCCCeeccccccEEEEEEeCC---CC--EEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccc
Q 010429 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD---GS--LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~ 352 (511)
.+.++.+...+.....++||.|-||.||+|.+.+ |+ .||||..+.+.+....+.|..|..+|+.++||||++++|
T Consensus 379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheee
Confidence 3444555666666777899999999999998642 33 589999988777777888999999999999999999999
Q ss_pred ccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 353 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
+|.+ ...|+|||.++-|.|..+|+..... ++..+...++.||+.||+|||+. .+|||||..+|||+....-||
T Consensus 459 v~~e-~P~WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 459 VCVE-QPMWIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred eeec-cceeEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceee
Confidence 9976 4589999999999999999986543 89999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
++|||+++.++.......+...-...|||||.+..++++.++|||.|||++||+++ |..||..-
T Consensus 532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 99999999887766655554445779999999999999999999999999999987 99999753
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=264.07 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=165.7
Q ss_pred CeeccccccEEEEEE-eCCCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEeecccCCC
Q 010429 294 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
+.||+|+|+.|.-.. ..+|..||||++.+.. ...+.++.+|++++.+++ |+||+.++++|+++..+|||||-|.||.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 679999999998876 4589999999997663 445667889999999885 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---ceEEcccccccccCC----
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDY---- 444 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~---- 444 (511)
|..+++++.. +++.++.+++.+|+.||.+||.+ ||.|||+||+|||...-. -+||+||.++.-+..
T Consensus 163 lLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999998764 89999999999999999999999 999999999999997544 489999998754321
Q ss_pred --CCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 --KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 --~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.......+.+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||..
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 1122223456899999999863 23578999999999999999999999964
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=274.81 Aligned_cols=201 Identities=27% Similarity=0.434 Sum_probs=173.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc----hhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
++|...+.||+|++|.||++... +++.+|+|.++..... .....+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999865 6899999998643321 123458889999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
++||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987643 378999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCcee--eecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 443 DYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 43222111 234578899999999998899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.25 Aligned_cols=199 Identities=24% Similarity=0.297 Sum_probs=167.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC-----
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----- 358 (511)
..++|+..+.||+|+||.||++... +|..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999875 68899999986533 2333456789999999999999999999886443
Q ss_pred -ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 359 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 359 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
..+++|||+++ ++.+.++. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999965 56665543 278899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99754322 1223345899999999999989999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=275.70 Aligned_cols=202 Identities=28% Similarity=0.466 Sum_probs=172.5
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..++|++.+.||+|+||.||+|...++..+|+|.++.... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 4567888999999999999999988888899999875433 2346889999999999999999999875 456889999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999997643 23489999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 2222222335668999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=275.29 Aligned_cols=204 Identities=29% Similarity=0.476 Sum_probs=174.6
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+..++|++.++||+|+||.||+|...+++.||+|.+..... ...++.+|++++++++|+||+++++++ ..+..+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEE
Confidence 45678899999999999999999988889999999875432 345688999999999999999999886 456789999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999876432 3489999999999999999999998 999999999999999999999999999976553
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
..........++..|+|||++....++.++||||||+++||+++ |+.||...
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 22222223345678999999988889999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=279.93 Aligned_cols=198 Identities=32% Similarity=0.581 Sum_probs=167.0
Q ss_pred CCeeccccccEEEEEEeC-----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 293 RNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
.+.||.|.||.||+|.+. .+..|+||.++..........+.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999876 356899999976555555778999999999999999999999999888899999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++|+|.++++... ...+++..+..|+.|+++||+|||+. +++|+||+++||++++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999862 23489999999999999999999999 999999999999999999999999999987632222
Q ss_pred c-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 448 H-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 448 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
. ..........|+|||.+....++.++||||||+++||+++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1 1222346789999999999889999999999999999999 7899864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=272.33 Aligned_cols=196 Identities=33% Similarity=0.513 Sum_probs=168.9
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCHH
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 373 (511)
++||+|+||.||+|...++..+|+|.++..........+.+|++++++++||||+++++++...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988889999999876554444556889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeec
Q 010429 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 453 (511)
Q Consensus 374 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 453 (511)
+++..... .+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+|++|||++..............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99875432 478999999999999999999999 999999999999999999999999999875432221111122
Q ss_pred ccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 454 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.++..|+|||++.+..++.++||||||+++||+++ |..||..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 34668999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=273.97 Aligned_cols=205 Identities=22% Similarity=0.353 Sum_probs=178.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||.||+|... +|+.||+|.++... .......+.+|++++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 78999999886422 2233557889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.........+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999976544445689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 3222 22345888999999998888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=278.46 Aligned_cols=205 Identities=28% Similarity=0.459 Sum_probs=173.5
Q ss_pred hCCCCCCeeccccccEEEEEEe-----CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
++|++.+.||+|+||.||+|.+ .++..+|+|.++..........+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5677889999999999999974 24678999999765544445678899999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 010429 363 VYPFMVNGSVASCLRERGQ-------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 429 (511)
+|||+++++|.+++..... ....+++.....++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999864321 123478899999999999999999999 999999999999999999
Q ss_pred ceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 430 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999976543221 12223345678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=276.76 Aligned_cols=201 Identities=29% Similarity=0.447 Sum_probs=171.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
.++|.+.+.||+|+||.||+|.+.++..||+|.++.... ...++.+|++++++++|+||+++++++. ....+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 467889999999999999999987777899999975332 2346889999999999999999998764 4567999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++|+|.+++.+.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997642 23478999999999999999999999 99999999999999999999999999997665433
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
........++..|+|||...+..++.++||||||+++|||+| |+.||..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 222223346778999999988889999999999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=269.32 Aligned_cols=205 Identities=28% Similarity=0.367 Sum_probs=181.1
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
+..++|..+++||+|.||.|.+.+-+ +++.+|+|+++++... .+.+.-..|-.+++..+||.+..+.-.++..+..+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 45577888899999999999999866 7999999999876532 23344667889999999999999988899999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
.||||..||.|.-+|.+.+ .++++..+.+-..|+.||.|||++ +||.||+|.+|.|+|+||++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999999988754 389999999999999999999999 999999999999999999999999999974
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
- .........++|||.|.|||++....|.+.+|.|.+||++|||+.|+.||...+
T Consensus 318 ~-I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 318 E-IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred c-ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 2 234455677899999999999999999999999999999999999999997543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=258.61 Aligned_cols=198 Identities=26% Similarity=0.439 Sum_probs=167.4
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEeecc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
.+.+..||.|+-|.|++++.. +|..+|||.+.......+.+++...+.++.+.. .|.||+.+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 334566999999999999987 588999999988777777778888888777665 899999999999999999999998
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
.. -+..++++.. .++++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|++|++|||++-++....
T Consensus 174 s~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 174 ST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 43 4555555533 24899999999999999999999886 99999999999999999999999999997664322
Q ss_pred ceeeeccccccccccccccc---CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 448 HVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..+...|.+.|||||.+.- ..|+.++||||||+.++||.||..||..
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 2233459999999999864 3578899999999999999999999976
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=280.67 Aligned_cols=203 Identities=28% Similarity=0.426 Sum_probs=179.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
..+.|..-++||+|+||.||-.... +|+.||.|++.+.+.. ..+.....|-.++.+++.+.||.+--.|++++..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4467888899999999999988755 7999999998655432 234457789999999999999999888999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
|+..|.||+|.-++.+.+. +.+++..+..++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|.|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999999987654 4599999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||..
T Consensus 338 ~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 338 PEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 54433 3344799999999999999999999999999999999999999964
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=276.99 Aligned_cols=202 Identities=26% Similarity=0.440 Sum_probs=168.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
++|+..+.||+|+||+||+|.+. ++. .+++|.+..........++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56778899999999999999874 344 4788887544333334567788889999999999999998754 55788
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999986432 489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 443 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 433221 2223446778999999988889999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=279.37 Aligned_cols=209 Identities=27% Similarity=0.464 Sum_probs=174.7
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 357 (511)
++..++|++.+.||+|+||.||+|..+ .+..||+|.++..........+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345688999999999999999999753 24579999987554444455688899999999999999999999999
Q ss_pred CceeEEeecccCCCHHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
...+++|||+++|+|.++++.... .....++..+..++.|++.||+|||++ +++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999976332 123467788899999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 432 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
+|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.||..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998765332221 1122235678999999988889999999999999999999 7889964
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=271.92 Aligned_cols=202 Identities=27% Similarity=0.410 Sum_probs=175.7
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|++|.||++... +++.|++|.+.... .......+.+|++++++++||||+++++++...+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999875 68899999986432 334456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998742 23489999999999999999999999 99999999999999999999999999988665432
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....|++.|+|||+..+..++.++|+||||+++|||++|+.||...
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 22 23345889999999999888999999999999999999999999744
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=288.20 Aligned_cols=199 Identities=25% Similarity=0.346 Sum_probs=170.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-C-----CceeccccccccCC
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-H-----RNLLRLRGFCMTPT 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h-----~niv~l~~~~~~~~ 358 (511)
..-+|.+.+.||+|+||.|.++.+. +++.||||+++... ....+-..|+.+|..++ | -|+|++++++.-.+
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3348899999999999999999865 69999999997643 33445677889999887 3 36999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC--CceEEccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDF 436 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Df 436 (511)
+.|||+|.+ .-+|.++++...-. .++...++.|+.||+.||.+||+. +|||+||||+|||+.+- ..+||+||
T Consensus 262 HlciVfELL-~~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEec
Confidence 999999988 66999999986544 499999999999999999999999 99999999999999654 37999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|.|+.....- . ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|-.+
T Consensus 336 GSSc~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 336 GSSCFESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccccccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 9998654322 2 445688999999999999999999999999999999998888543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=272.62 Aligned_cols=196 Identities=31% Similarity=0.499 Sum_probs=167.0
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
+.||+|+||.||+|.+. +++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 68899999887554444556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCcee-e
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-T 451 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 451 (511)
.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99997543 2489999999999999999999999 999999999999999999999999999875432111110 1
Q ss_pred ecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 452 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
....+..|+|||.+.++.++.++||||||+++|||++ |..||..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 1123457999999988889999999999999999998 9999963
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=279.79 Aligned_cols=210 Identities=31% Similarity=0.489 Sum_probs=176.8
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 355 (511)
+....++|+..+.||+|+||.||++... ....+|+|.+..........++.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3455677888999999999999999864 23679999987655445556688999999999 7999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 423 (511)
.++..+++|||+++|+|.++++... .....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999997632 2234589999999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
++++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 99999999999999998654332211 112224678999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=273.85 Aligned_cols=202 Identities=19% Similarity=0.329 Sum_probs=175.9
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
+|++.+.||+|+||.||++... ++..+|+|.++..........+.+|+.++++++|+||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777899999999999999876 688999999865544455667889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
+++++.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998875432 2478999999999999999999999 999999999999999999999999999976543222
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 223345889999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=290.06 Aligned_cols=210 Identities=24% Similarity=0.388 Sum_probs=176.4
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM 355 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~ 355 (511)
++...++|.+.+.||+|+||.||+|++. .+..||+|+++..........+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4556677888899999999999999863 346799999986544444556889999999997 999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCC------------------------------------------------------
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------ 381 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 381 (511)
.....++||||+++|+|.+++++.+.
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999976421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 010429 382 ----------------------------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (511)
Q Consensus 382 ----------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 421 (511)
....+++..+..++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 113467888899999999999999998 9999999999
Q ss_pred CeeeCCCCceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 422 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 422 NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999976532221 11122346789999999988889999999999999999998 8999964
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=280.54 Aligned_cols=204 Identities=29% Similarity=0.483 Sum_probs=170.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCC--EEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 362 (511)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.++..........+.+|++++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999875 444 45888776544445556788999999999 89999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 010429 363 VYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 430 (511)
+|||+++++|.+++++... ....+++.+++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999986432 123588999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||..
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 999999998632211 11111224668999999988888999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.06 Aligned_cols=194 Identities=32% Similarity=0.463 Sum_probs=169.7
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.|..++.||.|+||.||.|++. +.+.||||++.-.. +.....++.+|+..+.+++|||++.+.|+|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3555678999999999999875 78899999986332 23334579999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|| -||-.+.+.-.+. ++.+.++..|..+.++||+|||+. +.||||||..|||+++.|.||++|||.|....+.
T Consensus 107 YC-lGSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HH-hccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99 5688888876543 488999999999999999999999 9999999999999999999999999999876654
Q ss_pred CCceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.+++|||.|||||+|. .+.|+-|+||||+||+..||.-.++|+-
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 4567999999999985 5678999999999999999999999974
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=281.05 Aligned_cols=201 Identities=28% Similarity=0.453 Sum_probs=171.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.++++++||||+++++++..++..+++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999876 68899999987554444445678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
++ ++|.+++..... .+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 589888876432 378999999999999999999999 99999999999999999999999999987543322
Q ss_pred CceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....+++.|+|||.+.+. .++.++|||||||++|||+||++||...
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 2223478899999988654 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=277.37 Aligned_cols=208 Identities=28% Similarity=0.456 Sum_probs=176.1
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 358 (511)
...++|.+.+.||+|+||.||+|... .+..||+|.+...........+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 34567888999999999999999864 246899999876544455567889999999999999999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQS------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
..+++|||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999999764321 23478899999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 433 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|+|||+++....... .......++..|+|||.+.++.++.++|||||||++||++| |+.||..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 224 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence 999999876543222 11222346789999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=290.02 Aligned_cols=193 Identities=29% Similarity=0.490 Sum_probs=166.7
Q ss_pred CCeeccccccEEEEEEeC-CCCEEE---EEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc--eeEEeec
Q 010429 293 RNILGRGGFGKVYKGRLT-DGSLVA---VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--RLLVYPF 366 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-~~~~va---vK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~--~~lv~e~ 366 (511)
.++||+|+|-+||+|.+. +|..|| ||.-+..+.+....+|..|+.+|+.++|+||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 367999999999999876 577776 3333334445556789999999999999999999999987655 6789999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~ 445 (511)
|..|+|..|+++.+. ++....+.++.||++||.|||++ .|+|+|||||.+||+|+.+ |.|||+|.|+|+.....
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999998765 78889999999999999999997 6789999999999999864 89999999999986543
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.. ....|||.|||||++. ..|+..+||||||++++||+|+.+||.
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 32 3367999999999987 678999999999999999999999995
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=275.81 Aligned_cols=204 Identities=31% Similarity=0.477 Sum_probs=176.5
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
...+|+..+.||+|+||.||+|...++..+|+|.+.... ......+.+|+.+++.++|+||+++++++......+++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 456788889999999999999998888999999987543 2234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++.... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999986432 3489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 211 223336778999999988889999999999999999998 89999643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=275.93 Aligned_cols=202 Identities=29% Similarity=0.499 Sum_probs=170.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.++|+..+.||+|+||+||+|++. ++. .||+|.++..........+.+|+.++..+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467888899999999999999854 444 4899998765555556678899999999999999999999875 4578
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++||+++|+|.++++... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997643 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 442 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
........ .....++..|+|||...+..++.++|||||||++|||++ |+.||+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 64332211 111234678999999988889999999999999999998 9999974
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=276.62 Aligned_cols=208 Identities=26% Similarity=0.432 Sum_probs=176.9
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCC-----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc-CC
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PT 358 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~ 358 (511)
+..++|.+.+.||+|+||.||+|.+.+ +..|++|.++..........+.+|+.++++++|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345788889999999999999998765 688999998765555556678899999999999999999998766 56
Q ss_pred ceeEEeecccCCCHHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQS----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 434 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 434 (511)
..++++||+++++|.+++...... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999764322 14589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 435 DFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 435 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||+.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 999998654333221 122335678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=261.88 Aligned_cols=201 Identities=26% Similarity=0.386 Sum_probs=171.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-------hHHHHHHHHHHHHhC-CCCceeccccccccC
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------GELQFQTEVEMISMA-VHRNLLRLRGFCMTP 357 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 357 (511)
-+.|...+++|+|..++|.+...+ +|+..|+|++....... -..+-.+|+.+++++ -||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777889999999999888765 68889999885332111 122356789999987 599999999999999
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
...++|+|.|+.|.|.++|...- .+++...++|+.|+.+|++|||.. .||||||||+|||++++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999998643 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccc------cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+|+.+.+. ......+|||+|.|||.+. ...|+..+|+||.|||+|.|+.|.+||-..
T Consensus 169 Fa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 169 FACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred eeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 99877543 3345678999999999885 234788999999999999999999999643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=283.91 Aligned_cols=198 Identities=26% Similarity=0.358 Sum_probs=167.6
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccC-----
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 357 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~----- 357 (511)
...++|...+.||+|+||.||+|... +++.||||++...... .....+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34678999999999999999999865 6789999998654322 2334577899999999999999999887543
Q ss_pred -CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 358 -TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 358 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
...+++++++ +++|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 78898877542 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999865432 223458999999999876 4678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=271.03 Aligned_cols=194 Identities=28% Similarity=0.444 Sum_probs=163.6
Q ss_pred eeccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCC
Q 010429 295 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
.||+|+||.||+|.+. .+..||+|++...........+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355799999976554444567899999999999999999999875 457899999999999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceee
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 451 (511)
|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987533 2489999999999999999999999 9999999999999999999999999999765433222111
Q ss_pred --ecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 452 --AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 452 --~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 1223578999999988889999999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=275.86 Aligned_cols=208 Identities=30% Similarity=0.430 Sum_probs=173.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCC------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
..++|.+.+.||+|++|.||+|.+.+ +..||+|.++..........+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999998753 567899988765545555678999999999999999999999999889
Q ss_pred eeEEeecccCCCHHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---ceEE
Q 010429 360 RLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 433 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 433 (511)
.+++|||+++++|.+++++... ....+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999987532 123589999999999999999999999 999999999999998754 5999
Q ss_pred cccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 434 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999998653222111 111223568999999988889999999999999999997 99999743
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=276.08 Aligned_cols=206 Identities=29% Similarity=0.496 Sum_probs=173.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 357888899999999999999742 34568999886543 33455689999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 361 LLVYPFMVNGSVASCLRERGQ---------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
+++|||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999976431 223489999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 432 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999765332211 1122235778999999998889999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=287.15 Aligned_cols=199 Identities=23% Similarity=0.280 Sum_probs=168.0
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC------
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 357 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 357 (511)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999875 68899999986533 233345678899999999999999999887543
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346899999965 67776643 278899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 997653321 223345899999999999989999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=276.65 Aligned_cols=198 Identities=28% Similarity=0.394 Sum_probs=174.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||.||++.+. +++.+|+|+++.... ......+.+|++++++++||||+++++++...+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999876 688999999865332 233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.++++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. .....+++.|+|||.+.+...+.++||||||+++|||++|+.||...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 3 23345889999999998888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=273.78 Aligned_cols=204 Identities=22% Similarity=0.357 Sum_probs=176.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|++|.||++... +++.+|||.+.... ......++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778889999999999999964 78999999886432 2233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.........+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999876444444689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..||..
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 3221 2234588999999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=271.60 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=164.7
Q ss_pred CeeccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCC
Q 010429 294 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
+.||+|+||.||+|... ++..+|+|.++..........+.+|+.++++++||||+++++++.+....+++|||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 345799999876554445567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 371 SVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 371 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
+|.++++.... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 222467788889999999999999999 99999999999999999999999999987543222211
Q ss_pred -eeecccccccccccccccC-------CCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 450 -TTAVRGTIGHIAPEYLSTG-------KSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 450 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 1223467889999998643 34789999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=293.84 Aligned_cols=200 Identities=31% Similarity=0.503 Sum_probs=175.2
Q ss_pred CCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 291 SNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 291 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
...++||+|+||+||+|.+- .|+ +||+|++......+...++..|+-+|.+++|||+++++|+|..+. ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34578999999999999863 333 689999988777777788999999999999999999999998876 889999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
||+.|+|.++++..+. .+-....+.+..|||+||.|||++ ++|||||..+|||+.+-..+||.|||+++.+.+.
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999998544 488899999999999999999999 9999999999999999999999999999988765
Q ss_pred CCceeeec-ccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 446 DTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 446 ~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
........ .-.+.|||-|.++...++.++|||||||.+||++| |..|++.-.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 54433322 23568999999999999999999999999999999 999997544
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=280.61 Aligned_cols=208 Identities=31% Similarity=0.457 Sum_probs=173.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
..++|.+.+.||+|+||.||+++.. ++..+|+|.++.........++..|++++.++ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467899999999999999999753 23469999998654444555688899999999 79999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 424 (511)
.+..+++|||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999986432 123589999999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 425 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 425 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
+++++.+||+|||.++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999998765422111 1111224568999999988889999999999999999998 88998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=272.38 Aligned_cols=203 Identities=29% Similarity=0.480 Sum_probs=173.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
..+|.+.+.||+|+||.||+|.+. .+..+|+|.++..........+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356788899999999999999864 2337999998765544455678999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeee--cccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.......... ..++..|+|||.+.+..++.++||||||+++||+++ |+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 5433222211 123568999999998889999999999999999887 9999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=272.94 Aligned_cols=204 Identities=29% Similarity=0.485 Sum_probs=175.9
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+..++|.+.+.||+|+||.||+|...++..+|||.+..... ...++.+|++++++++|+||+++++++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678999999999999999999988788899999875432 3456889999999999999999999999888999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++..... ..+++..+..++.|++.|++|||++ +++|+||||+||++++++.+|++|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999976432 3489999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
..........++..|+|||.+.+...+.++||||+|+++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 22211122234678999999998889999999999999999999 9999954
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=275.75 Aligned_cols=199 Identities=28% Similarity=0.419 Sum_probs=164.0
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-hHHHHHHHHHHHHhC---CCCceecccccccc-----CC
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT-----PT 358 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~-----~~ 358 (511)
+|++.+.||+|+||+||+|+.. +++.||+|.++...... ....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 68899999987543222 223455677766654 79999999998764 24
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..+++|||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 4789999997 588888876432 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++....... .....||..|+|||++.+..++.++||||+||++|||++|++||..
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 976543221 2234578999999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=280.12 Aligned_cols=197 Identities=23% Similarity=0.370 Sum_probs=160.3
Q ss_pred CCeeccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc--CCceeEEeecc
Q 010429 293 RNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPFM 367 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~e~~ 367 (511)
.++||+|+||+||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 367999999999999864 467899999865432 2346789999999999999999998754 45678999998
Q ss_pred cCCCHHHHHHhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCceEEccccc
Q 010429 368 VNGSVASCLRERGQ-----SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGL 438 (511)
Q Consensus 368 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~ 438 (511)
. +++.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 578887764321 123489999999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCC--ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 987643221 122345689999999998764 5789999999999999999999999744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=274.07 Aligned_cols=199 Identities=31% Similarity=0.488 Sum_probs=172.4
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHH-HHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
|+..+.||+|+||+||+++.. +++.||+|++.......... ...+|+.++++++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999987 56689999997665333322 3456999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998433 389999999999999999999999 99999999999999999999999999997542 223
Q ss_pred ceeeecccccccccccccc-cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......++..|+|||++. +...+.++||||+|+++|+|++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3344556899999999998 788899999999999999999999999855
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=286.76 Aligned_cols=199 Identities=22% Similarity=0.278 Sum_probs=167.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC------
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 357 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 357 (511)
..++|+..+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 68899999987543 233345678899999999999999999987643
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
...+++|||+++ ++.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999965 66666643 278899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99765322 1223345899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.66 Aligned_cols=210 Identities=22% Similarity=0.357 Sum_probs=172.4
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc--CCc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTE 359 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~ 359 (511)
+...++|.+.+.||+|+||+||++.+. ++..+|+|.+.... .......+..|+.++.+++||||+++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999976 57789999886433 23345568899999999999999999998754 356
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeeeCCC-------
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD----PKIIHRDVKAANILLDEE------- 428 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~~------- 428 (511)
.++||||+++|+|.+++.........+++..++.|+.||+.||+|||+... .+|+||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 889999999999999998754444469999999999999999999998521 259999999999999642
Q ss_pred ----------CceEEcccccccccCCCCCceeeeccccccccccccccc--CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 429 ----------FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 429 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999997654322 1233468999999999854 4578899999999999999999999964
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=278.67 Aligned_cols=208 Identities=29% Similarity=0.467 Sum_probs=175.2
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 355 (511)
+..++|.+.+.||+|+||.||+++.. ++..||+|.++..........+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45677888999999999999999741 24579999987654445556789999999999 8999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 423 (511)
.....+++|||+++|+|.+++.+... ....+++.++..++.|+++||+|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999986432 123578899999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
++++++.+||+|||.++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999998664332221 222335678999999988889999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=276.82 Aligned_cols=204 Identities=27% Similarity=0.449 Sum_probs=169.6
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCC--EEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 363 (511)
++|++.+.||+|+||.||+|... ++. .+++|.++..........+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888899999999999999875 333 47888887544444556788999999999 799999999999999999999
Q ss_pred eecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 364 YPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
+||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999976431 113488999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999998643211 11111123557999999988889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=277.32 Aligned_cols=199 Identities=21% Similarity=0.390 Sum_probs=173.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
.+|+..+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++|+||+++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 47888899999999999999864 6889999998754433 345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++++. .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998653 378899999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 21 22335889999999998888899999999999999999999999644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=274.55 Aligned_cols=199 Identities=32% Similarity=0.455 Sum_probs=167.6
Q ss_pred CCCCCeeccccccEEEEEEe-----CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC--CceeE
Q 010429 290 FSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 362 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 362 (511)
|...+.||+|+||+||++.. .++..||+|.++..........+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 357789999997654444456788999999999999999999987653 45789
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+++++|.+++... .+++..+..++.|++.|++|||++ +++||||||+||++++++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999753 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCc--eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... ......++..|+|||.+.+...+.++||||||+++|||+||+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 432211 111223566799999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=278.57 Aligned_cols=207 Identities=27% Similarity=0.410 Sum_probs=175.5
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
....++|...+.||+|+||.||++... .+..||+|.++..........+.+|+++++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345567999999999999999999742 35579999987654444456789999999999 79999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
.+..+++|||+.+|+|.++++.... ..+++.++..++.|++.||+|||++ +++|+||||+||+++.++.++++||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999976432 2389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 437 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 999765432221 1122335778999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=271.73 Aligned_cols=200 Identities=28% Similarity=0.382 Sum_probs=171.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++.+++||||+++++++...+..+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 457888999999999999999974 68899999986443 2234457889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++... ++++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999999987543 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 21 122345889999999874 34467899999999999999999999953
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=273.90 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=176.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|+..+.||.|++|.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++.++...++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999876 68899999987654444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++... ++++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998764 489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......+++.|+|||.+.+..++.++||||||+++|||+||+.||+..
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 2 222345788999999999888999999999999999999999999743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=271.46 Aligned_cols=201 Identities=29% Similarity=0.455 Sum_probs=170.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
.++|.+.+.||+|++|.||++.+..+..+|+|.+..... ....+.+|++++++++|+|++++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 456888899999999999999987777899998865432 3456889999999999999999998875 4568899999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997643 23478999999999999999999999 99999999999999999999999999997654332
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
........++..|+|||...+...+.++||||||+++|||+| |+.||..
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222222336678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=274.14 Aligned_cols=202 Identities=24% Similarity=0.395 Sum_probs=172.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||+|+||.||++.+. ++..||+|.++..........+.+|++++++++|+||+++++.+...+..+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999986 78999999987544444456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|..+++... ....+++..+..++.|++.||.|||+.+ +++||||||+||+++.++.+||+|||.+..+...
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999887632 2235899999999999999999999632 8999999999999999999999999998755322
Q ss_pred CceeeecccccccccccccccCC------CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......+++.|+|||.+.+.. ++.++|+|||||++|||++|+.||..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 122234788999999986543 47899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=276.46 Aligned_cols=205 Identities=25% Similarity=0.394 Sum_probs=171.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.+|.+.+.||+|+||.||+|... .+..||+|+++..........+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34666788999999999999863 247899999976544444556889999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 010429 362 LVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 429 (511)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999986321 1123478899999999999999999999 999999999999999999
Q ss_pred ceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 430 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999876533221 11223345789999999988889999999999999999998 8889864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=270.61 Aligned_cols=200 Identities=27% Similarity=0.498 Sum_probs=172.5
Q ss_pred CCCCCCeeccccccEEEEEEeCCCCEEEEEEeccccc-----chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
+|...+.||+|+||+||+|...+++.+|+|.++.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999988899999998864321 12234588999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
+||+++++|.+++.+.. ++++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997643 378999999999999999999999 99999999999999999999999999987543
Q ss_pred CC-----CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YK-----DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. .........|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 21 11122334588999999999988889999999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=276.26 Aligned_cols=202 Identities=25% Similarity=0.351 Sum_probs=176.6
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.-|.+.+.||+|.|..|-+|++- +|..||||++.+.... -....+.+|+..|+.++|||||++|++...+...|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777789999999999999864 7999999999765432 234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCceEEcccccccccCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~ 444 (511)
.=.+|+|++|+-++.. .+.++.+.+++.||+.|+.|+|.. ++|||||||+||.+- +-|-||++|||++..+.+
T Consensus 98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999987544 399999999999999999999999 999999999998775 568999999999977654
Q ss_pred CCCceeeecccccccccccccccCCCC-cccCeehhhHHHHHHHhCCCcccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
. ......+|+..|.|||++.+..|+ +++||||+|||||-|+.|++||+-+.
T Consensus 172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 3 334567899999999999998874 78999999999999999999998654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.61 Aligned_cols=203 Identities=24% Similarity=0.380 Sum_probs=168.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHH-HHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|++.+.||+|+||.||++.+. +|+.||+|+++.........++..|+.. ++..+||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999976 6899999999765443444556667665 566789999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|++ |+|.+++.........+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 7888888764444456999999999999999999999854 8999999999999999999999999998765322
Q ss_pred CCceeeeccccccccccccccc----CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 1122457889999998865 3468899999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=270.59 Aligned_cols=201 Identities=26% Similarity=0.430 Sum_probs=169.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCceeccccccccC--Cce
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 360 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 360 (511)
++|++.+.||+|+||.||+|... ++..||+|.+..... ......+.+|++++++++||||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 588999998853221 12234688899999999999999999987764 457
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||+++++|.+++.+.. .+++....+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 79999999999999987643 378899999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCC--ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 6532211 112234588899999999888899999999999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=270.55 Aligned_cols=203 Identities=25% Similarity=0.453 Sum_probs=173.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+..++|.+.+.||+|+||.||++...++..+|+|.+.... .....+.+|++++++++|+||+++.+++.. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 4557888999999999999999998778889999886532 234568899999999999999999998877 7789999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999997643 23478899999999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
..........++..|+|||++....++.++|+|||||++||++| |+.||..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 22222222335678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=278.13 Aligned_cols=209 Identities=28% Similarity=0.461 Sum_probs=174.2
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 354 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~ 354 (511)
....++|.+.+.||+|+||.||++... ....+|+|.++..........+.+|++++.++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888999999999999999742 24579999987655445556788999999999 699999999999
Q ss_pred ccCCceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 010429 355 MTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (511)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 422 (511)
......+++|||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 988899999999999999999976421 123589999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 423 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 423 Ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|++++++.+||+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |+.||..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999997654322211 111224567999999988889999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=271.68 Aligned_cols=199 Identities=28% Similarity=0.410 Sum_probs=162.6
Q ss_pred eeccccccEEEEEEeCC---CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCC
Q 010429 295 ILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
.||+|+||.||+|...+ ...+|+|.+...........+.+|++.++.++|+||+++++.+......+++|||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997542 346888887655444445568899999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce-
Q 010429 372 VASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV- 449 (511)
Q Consensus 372 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~- 449 (511)
|.+++...... ....++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999875432 22356888899999999999999999 99999999999999999999999999986543222111
Q ss_pred eeeccccccccccccccc-------CCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 122335678999998753 346789999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=288.28 Aligned_cols=198 Identities=26% Similarity=0.335 Sum_probs=169.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
...+|.+.+.||+|+||.||++... .+..||+|.+.... ...+|++++++++||||+++++++......++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3457999999999999999999753 35789999886432 24589999999999999999999998899999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+||++. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++...
T Consensus 164 v~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 6888888543 2489999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 443 DYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 443 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 43322 12234569999999999998899999999999999999999999996543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=274.55 Aligned_cols=204 Identities=30% Similarity=0.446 Sum_probs=171.6
Q ss_pred CCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
+|++.+.||+|+||.||+|... ....+|+|.+..........++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999753 2356899988765544455678899999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 010429 363 VYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 422 (511)
++||+.+++|.+++..... ...++++..+..++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999875321 123478999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 423 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 423 Ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999997653322211 122335678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=282.51 Aligned_cols=205 Identities=26% Similarity=0.437 Sum_probs=181.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-hHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
...|.+.+.||+|.|+.|..|++. ++..||+|.+.+..... ..+.+.+|+++|..++|||||+++.+...+...++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 356888899999999999999875 78999999997665333 2345889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+.+|.+.+++.+.+. ..+.+++.++.|+.+|++|||++ .|+|||||.+|||++.+.++||+|||++.++..
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999998765 45588999999999999999999 999999999999999999999999999998874
Q ss_pred CCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCcccccccCC
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLAN 500 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~~~~~ 500 (511)
. ....+.+|++.|.|||++.+..+ .+++|+||+|+++|-|+.|..||+...+-+
T Consensus 208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence 3 33456789999999999988776 689999999999999999999999765544
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.49 Aligned_cols=209 Identities=28% Similarity=0.424 Sum_probs=171.7
Q ss_pred HHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccC
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 357 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 357 (511)
...++|++.+.||+|+||.||+|.+ .+++.||||+++..........+.+|++++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4457899999999999999999973 257789999997655444455688999999999 689999999988654
Q ss_pred -CceeEEeecccCCCHHHHHHhcCCC------------------------------------------------------
Q 010429 358 -TERLLVYPFMVNGSVASCLRERGQS------------------------------------------------------ 382 (511)
Q Consensus 358 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 382 (511)
...+++|||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999999999998753210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc-eeee
Q 010429 383 ---------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTA 452 (511)
Q Consensus 383 ---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 452 (511)
...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12368888999999999999999999 9999999999999999999999999999765322111 1112
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
..++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 235678999999988889999999999999999997 99999643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=274.06 Aligned_cols=206 Identities=27% Similarity=0.436 Sum_probs=175.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeCC-----------------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceec
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTD-----------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 349 (511)
..+|++.+.||+|+||.||++.... +..||+|.+...........+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999987642 24589999986655555667899999999999999999
Q ss_pred cccccccCCceeEEeecccCCCHHHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 010429 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ-------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (511)
Q Consensus 350 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 422 (511)
+++++..++..+++|||+++++|.+++.+... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999987542 122589999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh--CCCcccc
Q 010429 423 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDL 495 (511)
Q Consensus 423 Ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~pf~~ 495 (511)
|+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999876543222 12223346788999999988889999999999999999998 7788853
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=275.39 Aligned_cols=206 Identities=25% Similarity=0.420 Sum_probs=172.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-----------------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceec
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-----------------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 349 (511)
.++|++.+.||+|+||.||++... ++..+|+|+++.........++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998542 234689999976554555667999999999999999999
Q ss_pred cccccccCCceeEEeecccCCCHHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 010429 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQS-------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (511)
Q Consensus 350 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 422 (511)
+++++...+..+++|||+++++|.+++...... ...+++.++..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999999864322 12478889999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh--CCCcccc
Q 010429 423 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDL 495 (511)
Q Consensus 423 Ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~pf~~ 495 (511)
|+++.++.++|+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999997654322211 122234678999999888889999999999999999998 7788863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=270.98 Aligned_cols=202 Identities=29% Similarity=0.515 Sum_probs=170.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CC---CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.+|++.+.||+|+||.||+|... ++ ..||+|.++.........++..|+.++++++||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35777899999999999999875 23 369999987655455566799999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.++++.... .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999976432 489999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCce--eeecc--cccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 444 YKDTHV--TTAVR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 444 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
...... ..... .+..|+|||.+.+..++.++|||||||++||+++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 322211 11111 2457999999998889999999999999999987 9999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=275.41 Aligned_cols=206 Identities=26% Similarity=0.443 Sum_probs=172.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeCC---------------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTD---------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~ 351 (511)
.++|++.+.||+|+||.||++.... ...||+|.++..........+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987542 2358999997655455556799999999999999999999
Q ss_pred cccccCCceeEEeecccCCCHHHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 010429 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQ--------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (511)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 423 (511)
+++......+++|||+++++|.+++..... ....+++..+..++.|+++||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 112378899999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh--CCCcccc
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDL 495 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~pf~~ 495 (511)
++++++.+||+|||++......... ......++..|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999999765332211 1122335678999999988889999999999999999998 6778864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=267.59 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=175.8
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|+||.||.++.. +++.+++|.+.... ......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999999865 68899999886443 334455688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++.+.. ...+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999998653 23489999999999999999999999 99999999999999999999999999998664433
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||+..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 2 223345899999999998888899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=273.78 Aligned_cols=204 Identities=29% Similarity=0.495 Sum_probs=171.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.+|...+.||+|+||.||+++.. ++..+++|.++... ......+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777889999999999999742 34568999886443 333456889999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 010429 362 LVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 429 (511)
++|||+++++|.+++..... ....+++..+..++.|++.|++|||++ +++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999976431 123489999999999999999999999 999999999999999999
Q ss_pred ceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 430 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999765432211 1222346788999999998889999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=270.93 Aligned_cols=203 Identities=28% Similarity=0.520 Sum_probs=172.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CC---CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.++..........+..|++++++++|+||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456778899999999999999875 23 37999998765444455678999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCceee--ecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
......... ....+..|+|||++.++.++.++|||||||++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 432221111 1123457999999988889999999999999999998 9999954
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.71 Aligned_cols=201 Identities=22% Similarity=0.319 Sum_probs=162.4
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCC------Cceeccccccc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH------RNLLRLRGFCM 355 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h------~niv~l~~~~~ 355 (511)
+....++|++.+.||+|+||+||+|.+. .++.||||+++... ........|+++++.++| .+++++++++.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445678999999999999999999875 57889999996432 122335567776666654 45888888876
Q ss_pred cC-CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-----
Q 010429 356 TP-TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----- 429 (511)
Q Consensus 356 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----- 429 (511)
.. ...++|||++ +++|.+++.+.+ .+++..+..|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccc
Confidence 54 4678999988 778888887643 3899999999999999999999732 999999999999998765
Q ss_pred -----------ceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 430 -----------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 430 -----------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998754321 223456999999999999999999999999999999999999999743
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=272.12 Aligned_cols=201 Identities=29% Similarity=0.470 Sum_probs=170.4
Q ss_pred hCCCCCCeeccccccEEEEEEe-----CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC--Cce
Q 010429 288 DNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 360 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 360 (511)
..|++.+.||+|+||.||+++. .++..||+|.++..........+.+|++++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999974 257889999987654444556799999999999999999999988765 567
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||+++++|.+++.+... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 899999999999999875432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 441 LMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 441 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
........ ......++..|+|||.+.+..++.++||||||+++|||+|++.|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 66433221 1223446778999999988889999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=275.03 Aligned_cols=199 Identities=21% Similarity=0.394 Sum_probs=174.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
.+|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++...+..++++||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 45788899999999999999864 78999999986543 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988653 389999999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 22345888999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=268.92 Aligned_cols=203 Identities=30% Similarity=0.454 Sum_probs=168.2
Q ss_pred CCCCCeeccccccEEEEEEeCC----CCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCc-----
Q 010429 290 FSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 359 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----- 359 (511)
|.+.+.||+|+||.||+|.... +..||+|+++.... ......+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998642 36799999875432 3334568899999999999999999998766544
Q ss_pred -eeEEeecccCCCHHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 360 -RLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 360 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
.++++||+++|+|..++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999986542 2223589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 437 GLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9998654332211 112235678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=271.04 Aligned_cols=204 Identities=28% Similarity=0.510 Sum_probs=172.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
..+|+..+.||+|+||.||+|.+. +|. .+|+|.++.........++.+|++++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356788899999999999999864 233 5899988766554455678899999999999999999999887 7889
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
++|||+++|+|.+++.+... .+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999986433 389999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceee-ecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 442 MDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 442 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
.......... ...++..|+|||.+....++.++|+||||+++||+++ |+.||+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 6533222211 1223568999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=275.12 Aligned_cols=199 Identities=21% Similarity=0.384 Sum_probs=174.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
.+|...+.||+|+||.||++... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 67888899999999999999864 789999999865432 3345688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++.+. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998653 378899999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22 22345888999999999888999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=267.63 Aligned_cols=199 Identities=28% Similarity=0.430 Sum_probs=175.5
Q ss_pred hCCCCCCeeccccccEEEEEEeCC-CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|+..+.||+|+||.||+|...+ +..+|+|.++.... ..++.+|++++++++|+||+++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 578888999999999999999864 78999999865432 56789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999987543 3489999999999999999999999 99999999999999999999999999998665432
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 2 223344788999999998888999999999999999999999999743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=274.46 Aligned_cols=198 Identities=28% Similarity=0.433 Sum_probs=172.2
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
.|+..+.||+|+||.||+|.+. ++..||+|.++..........+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556678999999999999875 578899999875544445567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++++|.+++... .+++..+..++.|+++|++|||++ +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988642 388999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 12234578899999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.61 Aligned_cols=200 Identities=28% Similarity=0.387 Sum_probs=171.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346777788999999999999875 68899999986543 2333457889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++...+ .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999999987643 389999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. .......|+..|+|||++. .+.++.++|||||||++|||++|+.||..
T Consensus 160 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 160 I-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 2 2223345899999999874 44578899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=268.37 Aligned_cols=205 Identities=27% Similarity=0.427 Sum_probs=177.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||.|+||+||+|... ++..+|+|++...........+.+|+++++.++|+||+++++.+..++..++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999865 67899999997655444566799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 12489999999999999999999999 99999999999999999999999999987665432
Q ss_pred Cc---eeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 TH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ......|+..|+|||++... .++.++|+|||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 22 22334588999999998877 7899999999999999999999999743
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=265.56 Aligned_cols=197 Identities=25% Similarity=0.408 Sum_probs=164.7
Q ss_pred CCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHh-CCCCceeccccccccCCceeEEeecccCC
Q 010429 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
...||.|+||+|++..++ +|+..|||+++....+.+.+++..|.++..+ -+.||||+++|.+...+..|+.||.| .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 456999999999999876 7999999999988777778889999986554 56899999999999999999999999 45
Q ss_pred CHHHHHHh-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 371 SVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 371 sL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+..+-+. +......+++...-.|+..++.||.||.+.. .|+|||+||+|||++..|.+|++|||++-.+. +...
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~SiA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--DSIA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH--HHHH
Confidence 66554332 1222334899999999999999999999876 89999999999999999999999999986543 2222
Q ss_pred eeecccccccccccccccC--CCCcccCeehhhHHHHHHHhCCCccc
Q 010429 450 TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.+...|...|||||.+... .++.+|||||+|+.|||+.||+.|++
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 3344589999999999643 47899999999999999999999996
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.65 Aligned_cols=194 Identities=23% Similarity=0.290 Sum_probs=166.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
...|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|++++++++|+||+++++++......+++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 346888899999999999999976 578899996432 135689999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
++ .++|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~-~~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KY-RSDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99 4788888865432 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 446 DTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 446 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
... ......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 221 2223569999999999999899999999999999999999887654
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=280.72 Aligned_cols=193 Identities=25% Similarity=0.393 Sum_probs=164.8
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
....+|.+.+.||+|+||.||+|+.. ++..||+|...... ...|+.++++++|+||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 44567999999999999999999976 56789999754322 34689999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
+||+ .++|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9999 568888886533 2489999999999999999999999 99999999999999999999999999997533
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf 493 (511)
... ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 122345899999999999989999999999999999999865554
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=271.59 Aligned_cols=201 Identities=26% Similarity=0.375 Sum_probs=171.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.+.|++.+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|+++++.++|+||+++++.+..+...+++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 356888899999999999999876 58899999986542 3345568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|++++++..++.+... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999988765432 389999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
........+++.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 11122345788999999985 33467889999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.13 Aligned_cols=201 Identities=27% Similarity=0.455 Sum_probs=170.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999976 68899999987544333334567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+. ++|.+++..... .+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 489998876432 489999999999999999999999 99999999999999999999999999987543222
Q ss_pred Cceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 122346889999998865 45788999999999999999999999644
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=278.86 Aligned_cols=211 Identities=30% Similarity=0.455 Sum_probs=175.0
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGF 353 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~ 353 (511)
++....+|.+.+.||+|+||.||++... .+..||+|.++.........++.+|++++.++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3444567888999999999999999742 12368999887655445556789999999999 79999999999
Q ss_pred cccCCceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 010429 354 CMTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (511)
Q Consensus 354 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 421 (511)
+...+..++++||+++|+|.+++.+... ....+++.++..++.|++.||+|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9999999999999999999999976421 223588999999999999999999999 9999999999
Q ss_pred CeeeCCCCceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 422 NILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 422 NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
||++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999997654322111 111224568999999998889999999999999999998 88998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=271.99 Aligned_cols=202 Identities=29% Similarity=0.445 Sum_probs=169.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccC------
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP------ 357 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~------ 357 (511)
+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567888889999999999999875 67889999986432 3345688899999988 699999999988653
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
...+++|||+.+++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 457899999999999999986432 2488999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||+.
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9976543222 223345899999999986 33577899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=270.27 Aligned_cols=203 Identities=24% Similarity=0.382 Sum_probs=170.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeCC----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|.+.+.||+|+||.||+|.+.+ ...||+|.............+.+|+.++++++||||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4567788999999999999998643 246899988765444455678999999999999999999998765 56789
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997643 2489999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
............++..|+|||.+....++.++||||||+++||+++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 4432222222334568999999988889999999999999999986 99999644
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=272.08 Aligned_cols=202 Identities=27% Similarity=0.381 Sum_probs=173.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||.||++.+. ++..+|+|.++... ......+.+|++++++++|+||+++++++..+...+++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 356888899999999999999875 68899999986442 3344568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 9999999999876432 489999999999999999999999 9999999999999999999999999998755332
Q ss_pred CCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ......+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 22 223345899999999875 344678999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.98 Aligned_cols=210 Identities=26% Similarity=0.340 Sum_probs=173.7
Q ss_pred HHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccc---
Q 010429 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM--- 355 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~--- 355 (511)
+.+....++|++.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.++.++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 344456788999999999999999999875 67899999886432 2234578899999998 6999999999874
Q ss_pred --cCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEE
Q 010429 356 --TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433 (511)
Q Consensus 356 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 433 (511)
..+..+++|||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 34568999999999999998875433344589999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCceeeeccccccccccccccc-----CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+|||++........ ......|++.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999876543222 1223458999999998753 44688999999999999999999999643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=272.22 Aligned_cols=201 Identities=25% Similarity=0.413 Sum_probs=169.5
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|++|.||+|+.. ++..||+|.++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999875 688999999865432 22345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
++ +++.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 688888875432 23589999999999999999999999 99999999999999999999999999987554322
Q ss_pred CceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......+++.|+|||.+.+. .++.++|||||||++|||+||++||..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 12223468899999988654 468899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=277.96 Aligned_cols=199 Identities=22% Similarity=0.298 Sum_probs=164.9
Q ss_pred CCCeeccc--cccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 292 NRNILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 292 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
+.++||+| +|++||++..+ +|+.||+|+++..... .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 67899999875 7899999999765432 23345778999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999975432 2389999999999999999999999 999999999999999999999999986543321110
Q ss_pred c------eeeeccccccccccccccc--CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 448 H------VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 448 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112236778999999876 4578999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=270.71 Aligned_cols=198 Identities=26% Similarity=0.397 Sum_probs=168.5
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeeccc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
|++.+.||+|+||.||++... ++..+++|.+.... ......+.+|+++++.++||||+++++++..++..++++||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566788999999999999976 57788999886433 3345568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+++|..++.+.. .++++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 999998886532 2489999999999999999999999 99999999999999999999999999987543221 1
Q ss_pred eeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 449 VTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......++..|+|||++. +..++.++|||||||++|||++|++||..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 223345899999999874 34567899999999999999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=273.57 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=169.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|...+.||+|+||.||+|... +++.||+|++...........+.+|+++++.++|+||+++.+++...+..++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467888999999999999999875 6889999998755444444467889999999999999999999999899999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+. +++.+++.... ..+.+..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 67777765432 2378888999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||+.
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 12233478899999998754 478899999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=267.86 Aligned_cols=198 Identities=23% Similarity=0.398 Sum_probs=161.0
Q ss_pred eeccccccEEEEEEeCCC---CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCC
Q 010429 295 ILGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
.||+|+||.||++...++ ..+++|.++..........+.+|+.+++.++||||+++++.+......+++|||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 34667776655444455679999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC-Ccee
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 450 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~ 450 (511)
|.+++++........++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999987544334577788899999999999999999 99999999999999999999999999986432111 1112
Q ss_pred eeccccccccccccccc-------CCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 451 TAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 451 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
....++..|+|||++.. ..++.++|||||||++|||++ |+.||..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 23457889999998753 234778999999999999997 5778853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=268.66 Aligned_cols=197 Identities=30% Similarity=0.499 Sum_probs=164.4
Q ss_pred CeeccccccEEEEEEeC-CCC--EEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|.+. ++. .+|+|.++..........+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999875 343 46889887554445556788999999999 799999999999999999999999999
Q ss_pred CCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 370 GSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 370 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
|+|.+++..... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999976431 123478999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 98532211 11111223567999999988889999999999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=268.84 Aligned_cols=202 Identities=31% Similarity=0.459 Sum_probs=165.2
Q ss_pred CCCCeeccccccEEEEEEeCC-CC--EEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC------Cce
Q 010429 291 SNRNILGRGGFGKVYKGRLTD-GS--LVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 360 (511)
Q Consensus 291 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~ 360 (511)
.+.+.||+|+||.||+|.+.+ +. .+|+|.++... .......+.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999998763 32 58999886543 233355688999999999999999999976432 246
Q ss_pred eEEeecccCCCHHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 361 LLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
+++|||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999875422 2233589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 439 AKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 98664332211 122235778999999998889999999999999999999 8999964
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.15 Aligned_cols=202 Identities=24% Similarity=0.401 Sum_probs=175.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||+||++... +++.||+|++...........+.+|+++++.++||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356777889999999999999875 6889999988765544556678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++...+ ++++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999887643 3899999999999999999999732 8999999999999999999999999998654221
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
. .....|+..|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 1 123458999999999988888999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=267.13 Aligned_cols=201 Identities=27% Similarity=0.429 Sum_probs=169.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCceecccccccc--CCce
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 360 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~ 360 (511)
.+|+..+.||+|+||.||+|... ++..||+|++.... .......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999875 68899999886432 12233458889999999999999999998765 3567
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++++||+++++|.+++.... .+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997643 378899999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCC--CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 653211 1112234588899999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=271.01 Aligned_cols=199 Identities=27% Similarity=0.427 Sum_probs=174.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
..|+..+.||+|+||.||+|.+. ++..||+|.+...........+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45677789999999999999875 58899999987654445566789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++... ++++.....++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999988642 378899999999999999999999 99999999999999999999999999997654332
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......++..|+|||.+.+...+.++|+|||||++|||++|+.||..
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 22334578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=266.13 Aligned_cols=194 Identities=27% Similarity=0.429 Sum_probs=163.4
Q ss_pred eeccccccEEEEEEeC---CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCC
Q 010429 295 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
.||+|+||.||+|.++ ++..+|+|+++.... .....++.+|+.++++++|+||+++++++. .+..+++|||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 578899999864432 233556889999999999999999999875 45678999999999
Q ss_pred CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCcee
Q 010429 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450 (511)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 450 (511)
+|.+++.... .+++..+..++.|++.|++|||++ +++||||||+||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999997543 389999999999999999999999 999999999999999999999999999986644332211
Q ss_pred --eecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 451 --TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 451 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
....++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11224578999999988888999999999999999998 99999743
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=275.79 Aligned_cols=204 Identities=29% Similarity=0.373 Sum_probs=174.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|+..+.||+|++|.||++... +++.||+|.+...... .....+..|++++++++|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999876 5899999999754433 24456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987542 23589999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc----------------------------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTH----------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 111235788999999998888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=266.35 Aligned_cols=200 Identities=33% Similarity=0.539 Sum_probs=173.3
Q ss_pred CeeccccccEEEEEEeCC----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||++.... +..||+|.++..........+.+|++.+..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998763 7889999998665444466789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 370 GSVASCLRERGQS-----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 370 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
++|.+++...... ...+++..+..++.|+++||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875221 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 445 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 445 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 321 12233447889999999988889999999999999999999 69999754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=269.92 Aligned_cols=205 Identities=26% Similarity=0.447 Sum_probs=174.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
++|+..+.||+|+||.||+|+.+ +...+++|.+...........+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67888899999999999999864 346799998865443334567899999999999999999999999989999
Q ss_pred EEeecccCCCHHHHHHhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 362 LVYPFMVNGSVASCLRERGQS-----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
++|||+++|+|.++++..... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999865422 12589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|++...............++..|+|||.+.+...+.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9987543332223333446788999999988888999999999999999999 8889953
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=271.33 Aligned_cols=200 Identities=25% Similarity=0.354 Sum_probs=170.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|+..+.||+|++|.||+|++. +++.||+|++..... ......+.+|++++++++|+||+++++++..+...+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 688999999864432 2233457899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|++++++..+..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887765432 389999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 22 1223447889999999876 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=267.36 Aligned_cols=201 Identities=28% Similarity=0.388 Sum_probs=174.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|+..+.||+|+||.||+|... +++.+|+|.+...... ....+.+|++++++++||||+++++++......+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 57888899999999999999875 5788999998754432 456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999887642 2489999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeecccccccccccccccC---CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......++..|+|||.+.+. .++.++||||||+++|||+||+.||...
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1 22334578899999998776 7889999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=273.33 Aligned_cols=207 Identities=29% Similarity=0.502 Sum_probs=174.2
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
..++|+..+.||+|+||.||+|... ++..||+|.+..........++.+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999863 4678999999765544455678899999999999999999999999899
Q ss_pred eeEEeecccCCCHHHHHHhcC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 010429 360 RLLVYPFMVNGSVASCLRERG------------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 421 (511)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999997532 1123478899999999999999999999 9999999999
Q ss_pred CeeeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 422 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 422 NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998754332211 1112234667999999988889999999999999999998 8889853
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=266.77 Aligned_cols=196 Identities=32% Similarity=0.478 Sum_probs=168.5
Q ss_pred CeeccccccEEEEEEeCC--C--CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLTD--G--SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|++|.||+|.+.+ + ..||+|.+...........+.+|+.++++++|+||+++++++.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 36899999776544556679999999999999999999999888 889999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc-
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 448 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 448 (511)
++|.+++.+... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987542 3589999999999999999999999 9999999999999999999999999999876442221
Q ss_pred -eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 449 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 449 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1112346789999999998889999999999999999999 9999953
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=265.31 Aligned_cols=202 Identities=25% Similarity=0.379 Sum_probs=171.8
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc-CCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv~e 365 (511)
.|++.+.||+|++|.||++... +++.||+|++.... .......+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999876 57889999986543 23344568889999999999999999988764 345789999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999986422 3489999999999999999999999 9999999999999999999999999999766432
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||+..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 22 223345889999999999988999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=266.91 Aligned_cols=201 Identities=27% Similarity=0.426 Sum_probs=170.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCceeccccccccC--Cce
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 360 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 360 (511)
.+|++.+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999875 68999999875321 223345688999999999999999999988654 457
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++++||+++++|.+++.... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987643 378899999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCC--CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
...... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 653211 1112234588999999999888889999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=267.21 Aligned_cols=200 Identities=27% Similarity=0.500 Sum_probs=171.0
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--------hhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... .....+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999875 6789999988643221 112457889999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997643 378899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC-----ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 440 KLMDYKDT-----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 440 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 86642211 111223478899999999888889999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=272.09 Aligned_cols=203 Identities=26% Similarity=0.360 Sum_probs=174.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC--CceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 364 (511)
++|...+.||.|++|.||++.+. +++.+|+|.+..........++.+|++++++++||||+++++++... +..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999985 68899999987654444556789999999999999999999988653 4679999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.........+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998876443444589999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||+..
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1234788999999999888999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=269.97 Aligned_cols=205 Identities=29% Similarity=0.504 Sum_probs=171.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
..++...+.||+|+||.||++... ++..+|+|.++... ......+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 356777899999999999999642 35678999886543 44456799999999999999999999999998999
Q ss_pred eEEeecccCCCHHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 010429 361 LLVYPFMVNGSVASCLRERGQ-----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 429 (511)
+++|||+++++|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 999999999999999976432 113488999999999999999999999 999999999999999999
Q ss_pred ceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 430 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |++||..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999998755332211 1122235678999999998889999999999999999998 9999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=264.95 Aligned_cols=195 Identities=32% Similarity=0.507 Sum_probs=165.5
Q ss_pred CeeccccccEEEEEEeC--C--CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT--D--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|++. + +..+|+|.+..........++.+|+++++++.|+||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999754 2 36899999976654445667899999999999999999999875 4568999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|.+++.... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999998654 489999999999999999999999 99999999999999999999999999998664433222
Q ss_pred eee--cccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 450 TTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 450 ~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
... ..++..|+|||.+.+..++.++||||||+++|||++ |+.||+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 111 123468999999988889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=267.12 Aligned_cols=206 Identities=26% Similarity=0.377 Sum_probs=170.5
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
+.+++.+.....||+|+||.||+|.+. ++..||+|.+.... ......+.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344555666678999999999999865 57789999886543 3345578899999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCceEEcccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 441 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~ 441 (511)
++||+++++|.+++...... ...++..+..++.|+++||+|||+. +|+||||||+||+++. ++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999864221 1127888999999999999999999 9999999999999986 67999999999876
Q ss_pred cCCCCCceeeecccccccccccccccCC--CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
...... ......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 543222 122334789999999986543 78899999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=265.88 Aligned_cols=199 Identities=31% Similarity=0.534 Sum_probs=173.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..++|+..+.||+|+||.||++... |+.||+|.++.... ...++.+|+.++++++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 3467888899999999999999975 88999999976543 45678899999999999999999999998899999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 81 YMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999999986542 2489999999999999999999999 9999999999999999999999999999765322
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.. ....+..|+|||.+..+.++.++||||||+++|||++ |+.||...
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 11 2234668999999988888999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=266.62 Aligned_cols=200 Identities=27% Similarity=0.378 Sum_probs=175.5
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
+|++.+.||+|+||.||++.+. +++.||+|.+..... ......+.+|++++++++||||+++++.+.+....++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999986 689999999975432 2345678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+.+++|.+++... .++++..+..++.|+++||+|||++ +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999764 2489999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
. ......|+..|+|||.+.+...+.++|+||||+++|+|++|+.||...+
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2 2233458889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=265.81 Aligned_cols=200 Identities=28% Similarity=0.487 Sum_probs=171.3
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
.+|+..+.||+|+||.||++.+.++..+|+|.++.... ...++.+|++++++++|||++++++++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 46777899999999999999987788999998865432 2346889999999999999999999999889999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++++|.+++..... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999876432 378999999999999999999999 999999999999999999999999999875533221
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.......++..|+|||.+.++.++.++||||||+++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 11122234678999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=275.33 Aligned_cols=196 Identities=24% Similarity=0.373 Sum_probs=158.9
Q ss_pred CeeccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc--CCceeEEeeccc
Q 010429 294 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPFMV 368 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~e~~~ 368 (511)
..||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999865 45789999986543 22357789999999999999999998753 456789999986
Q ss_pred CCCHHHHHHhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCceEEcccccc
Q 010429 369 NGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 439 (511)
Q Consensus 369 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a 439 (511)
+++.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 47777765321 1223488999999999999999999999 99999999999999 56678999999999
Q ss_pred cccCCCCC--ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+....... .......||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86643221 122334589999999998764 5789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=271.50 Aligned_cols=200 Identities=27% Similarity=0.399 Sum_probs=170.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|+..+.||+|+||.||++.+. +++.||+|++...... .....+.+|+++++.++||||+++++++..++..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999986 5889999998654322 234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|++++++..+..... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999998887765432 389999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|++||..
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 22 2223457889999998865 3467889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=269.03 Aligned_cols=199 Identities=28% Similarity=0.412 Sum_probs=175.5
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
+|+..+.||+|++|.||++.+. +++.+|+|++..........++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999986 688999999876654555667899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
++++|.+++.... .++++.....++.|+++|++|||+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999998653 358999999999999999999999 7 99999999999999999999999999987553221
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11 155888999999999888999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=271.60 Aligned_cols=196 Identities=24% Similarity=0.387 Sum_probs=168.8
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeeccc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
|.....||+|+||.||++... ++..||||.+.... ......+.+|+..+++++|+||+++++.+...+..+++|||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333467999999999999875 68899999986433 3344568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 99999988542 378999999999999999999999 999999999999999999999999999875533222
Q ss_pred eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......|+..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12234588999999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=270.81 Aligned_cols=198 Identities=23% Similarity=0.389 Sum_probs=166.8
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|+||.||+|++. +|+.||+|.++.... ......+.+|++++++++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999975 688999999864322 22234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
++ +++.+++.... ..+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 57888776532 2489999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.. .....++..|+|||.+.+.. ++.++|||||||++|||+||+.||.
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 21 12234788999999987654 6889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=265.57 Aligned_cols=196 Identities=30% Similarity=0.492 Sum_probs=168.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccc-cCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~-~~~~~~lv~e 365 (511)
.++|.+.+.||+|+||.||++... |..+|+|.++... ....+.+|+.++++++|+|++++++++. .++..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 457888899999999999999875 7889999986432 2446889999999999999999999764 4567899999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++.... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+|++|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999976432 2488999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 2 12234668999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=268.62 Aligned_cols=201 Identities=29% Similarity=0.459 Sum_probs=167.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc--CCce
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 360 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~ 360 (511)
.+|++.+.||+|+||.||++... ++..||+|.++... ......+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999742 57899999986543 3445578899999999999999999997654 3567
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||+++++|.+++.+... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 899999999999999976432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......... .....++..|+|||.+.+..++.++|||||||++|||++|..|+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 764332211 1112234569999999888899999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=269.36 Aligned_cols=200 Identities=26% Similarity=0.394 Sum_probs=172.6
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|++.+.||+|++|.||+|.+. +|+.||+|++..... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 688999999875442 33355688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+ +++|.+++.... .++++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987644 3489999999999999999999999 99999999999999999999999999998665433
Q ss_pred CceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
........++..|+|||.+.+.. ++.++||||+|+++|||++|++||..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 22233345899999999986544 68899999999999999999888853
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=271.61 Aligned_cols=201 Identities=23% Similarity=0.350 Sum_probs=171.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999876 578999999875432 223446789999999999999999999999989999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.++++..+ .+++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999998864211
Q ss_pred CC--------------CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 KD--------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 00 0011123478899999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=267.61 Aligned_cols=200 Identities=26% Similarity=0.466 Sum_probs=173.0
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC---CCceeccccccccCCceeEEe
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv~ 364 (511)
.|+..+.||+|+||.||+|.+. +++.||+|.++.........++.+|++++++++ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677889999999999999974 789999999876544455567889999999886 999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.++++.. .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988653 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.... .....|+..|+|||.+.++ .++.++|||||||++|||++|+.||....
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3322 2334588999999988654 46889999999999999999999997543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=264.31 Aligned_cols=201 Identities=30% Similarity=0.504 Sum_probs=174.1
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|...+.||+|+||.||+|... +++.||+|.++..... .....+..|++++++++|+||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999865 6889999998755432 3556789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987642 378899999999999999999999 99999999999999999999999999998765433
Q ss_pred Cceee---ecccccccccccccccCC---CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTT---AVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..... ...++..|+|||.+.+.. .+.++||||||+++||+++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 22211 345788999999998766 789999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=263.64 Aligned_cols=199 Identities=28% Similarity=0.455 Sum_probs=172.3
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
+|+..+.||+|++|.||+|... ++..|++|.+..... +.....+.+|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999976 789999998854321 22345688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
+||+++++|.+++.+.. ++++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997643 388999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||...
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 332 223445889999999987766 889999999999999999999999643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=278.57 Aligned_cols=210 Identities=30% Similarity=0.458 Sum_probs=182.5
Q ss_pred HHHHHHhhCCCCCCeeccccccEEEEEEeCC-CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
++|+....+.....+||-|.||.||.|.|+. .-.||||.++.+.. ...+|.+|..+|+.+.|||+|+++|+|.....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 5667777777788899999999999999973 55799999987643 45679999999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
+|||+|||..|+|.+||++.... .++.-..+.++.||++||+||..+ ++|||||..+|+|+.++..||++|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999986544 377778899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
+++............-...|.|||.+-...++.|+|||+|||+|||+.| |-.||-..+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 9887554433222234678999999999999999999999999999998 888885443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=262.23 Aligned_cols=196 Identities=30% Similarity=0.488 Sum_probs=168.4
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCHH
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 373 (511)
+.||+|+||.||++.+.+++.||+|.+...........+.+|++++++++|+||+++++++......+++|||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999876554445567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCcee-ee
Q 010429 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TA 452 (511)
Q Consensus 374 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~~ 452 (511)
+++..... .+++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||.+........... ..
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99976432 478999999999999999999999 999999999999999999999999999975542211111 11
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
..++..|+|||.+.++.++.++|+||||+++|||+| |+.||..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 223567999999988889999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=272.33 Aligned_cols=202 Identities=29% Similarity=0.536 Sum_probs=168.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.++|+..+.||+|+||.||+|.+. +|. .+|+|.+..........++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356778889999999999999864 343 57899887655444455688999999999999999999988754 467
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999876432 378999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 442 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6433221 1122335678999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=271.42 Aligned_cols=193 Identities=24% Similarity=0.376 Sum_probs=167.8
Q ss_pred CCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCC
Q 010429 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
...||+|+||.||++... +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++++||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 457999999999999875 68899999986533 2334568899999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceee
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 451 (511)
|.+++... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........ ...
T Consensus 105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 99877542 378999999999999999999999 999999999999999999999999999875443221 223
Q ss_pred ecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 452 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
...|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 34589999999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.51 Aligned_cols=200 Identities=22% Similarity=0.396 Sum_probs=174.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|...+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 67888899999999999999864 67899999986433 23345688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++.+. .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999998753 278899999999999999999999 99999999999999999999999999987654333
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.. .....+++.|+|||.+.+..++.++||||||+++||+++|+.||...+
T Consensus 170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 223458889999999988888999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=264.05 Aligned_cols=201 Identities=29% Similarity=0.475 Sum_probs=171.7
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-----chhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
+|+..+.||+|++|.||++... +++.||+|.+..... ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4677889999999999999864 788999999864331 1124568899999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEcccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 441 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 441 (511)
++||+++++|.+++.+.. ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997643 488999999999999999999999 999999999999998776 599999999876
Q ss_pred cCCCCC---ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 643211 1122345788999999998888899999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=263.11 Aligned_cols=202 Identities=22% Similarity=0.352 Sum_probs=173.9
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|+||.||++... +|+.||+|.+.... ......++.+|++++++++|+||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 68899999986532 233445688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999876432 2478999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......|++.|+|||+..++..+.++|+|||||++|||++|+.||...
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 1 112334788999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=264.32 Aligned_cols=192 Identities=25% Similarity=0.368 Sum_probs=159.7
Q ss_pred CeeccccccEEEEEEeCC-------------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 294 NILGRGGFGKVYKGRLTD-------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
+.||+|+||.||+|+..+ ...||+|.+.... ......+.+|+.++..++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 2358899876543 33345688899999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc-------eEE
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-------AVV 433 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl 433 (511)
+++|||+++|+|..++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999998887533 2489999999999999999999999 9999999999999987664 899
Q ss_pred cccccccccCCCCCceeeecccccccccccccc-cCCCCcccCeehhhHHHHHHH-hCCCcccccc
Q 010429 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELI-TGQRAFDLAR 497 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~ell-tg~~pf~~~~ 497 (511)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||....
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999998654322 1234788999999886 456889999999999999998 6899986543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=270.64 Aligned_cols=208 Identities=29% Similarity=0.398 Sum_probs=172.2
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccC--
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP-- 357 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~-- 357 (511)
++..+.++|...+.||+|+||.||++... +++.+|+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 33345678999999999999999999875 68899999986532 2234577899999888 799999999988753
Q ss_pred ---CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEc
Q 010429 358 ---TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 434 (511)
Q Consensus 358 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 434 (511)
...+++|||+++++|.++++........+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEe
Confidence 357999999999999999876443444589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeecccccccccccccccCC-----CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 435 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-----SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 435 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|||++......... .....|+..|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus 171 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 171 DFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred ecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 99998765432211 22345788999999876432 57899999999999999999999964
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=264.63 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=174.4
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc--CCceeEEe
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVY 364 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~ 364 (511)
+|++.+.||+|+||.||++... ++..+|+|.++... ......++..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 67899999986533 33345568899999999999999999997754 34578999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
||+++++|.+++........++++..+..++.|++.||+||| +. +++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999875444556999999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 876543321 23345899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=263.64 Aligned_cols=202 Identities=27% Similarity=0.425 Sum_probs=178.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||+|++|.||++... +++.||+|++...........+.+|++++.+++|+|++++++++..++..+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999987 58999999987655434556799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
+++++|.+++... .++++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999865 348999999999999999999999 8 9999999999999999999999999999866443
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.... ....++..|+|||.+.+..++.++|+||||+++|||+||+.||....
T Consensus 154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 3221 23447889999999988889999999999999999999999997553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=266.73 Aligned_cols=209 Identities=29% Similarity=0.444 Sum_probs=172.3
Q ss_pred CHHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
++.+.......|+..+.||+|+||.||+|.+. +++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34444456678889999999999999999975 68899999985432 2344578899999888 69999999998853
Q ss_pred ------CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 010429 357 ------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (511)
Q Consensus 357 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 430 (511)
....+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 3567999999999999999876432 2478888999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 99999999875532211 122345889999999876 34578899999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=268.95 Aligned_cols=200 Identities=26% Similarity=0.368 Sum_probs=172.1
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|++.+.||+|++|.||+|.+. +++.||+|+++.... ......+.+|++++++++|+||+++++++..++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6788899999999999999876 588999999865432 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
++++.+..+.... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9987776655432 2389999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
........++..|+|||++.+. .++.++||||||+++|||++|++||..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3233345578899999999888 789999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=262.14 Aligned_cols=201 Identities=33% Similarity=0.532 Sum_probs=172.8
Q ss_pred CCCCCeeccccccEEEEEEeCC-----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 290 FSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+++.+.||.|+||.||++...+ +..||+|.++..........+..|++++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3467889999999999998763 37899999976654445667999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++...... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999764321 189999999999999999999999 999999999999999999999999999976654
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
..........+++.|+|||.+.+..++.++||||+|+++|||++ |++||+.
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 32222212336789999999988889999999999999999998 8899864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=266.09 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=173.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+-|+..+.||+|+||.||+|... ++..||+|.+...........+.+|++.+.+++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34677889999999999999865 68899999986554444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 9999999988642 388999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......++..|+|||.+.+...+.++|+|||||++|||++|+.||..
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 1 22234578899999999888889999999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=263.50 Aligned_cols=195 Identities=33% Similarity=0.505 Sum_probs=160.0
Q ss_pred CeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccc-cCCceeEEeeccc
Q 010429 294 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYPFMV 368 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~-~~~~~~lv~e~~~ 368 (511)
+.||+|+||.||+|.+. ++..+|+|.+...........+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799999865443444567889999999999999999999765 4556889999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+|+|.+++++... ..++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999976432 267788899999999999999999 9999999999999999999999999999755332111
Q ss_pred ---eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhC-CCccc
Q 010429 449 ---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFD 494 (511)
Q Consensus 449 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg-~~pf~ 494 (511)
......++..|+|||.+.+..++.++|||||||++|||++| .+||.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 11123357789999999888899999999999999999995 56664
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=266.32 Aligned_cols=199 Identities=34% Similarity=0.542 Sum_probs=166.8
Q ss_pred CeeccccccEEEEEEeCC-------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 294 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+.||+|+||.||+|+..+ +..+|+|.+...........+.+|++++++++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886654444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-----ceEEccccc
Q 010429 367 MVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-----EAVVGDFGL 438 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~ 438 (511)
+++++|.++++.... ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999976432 223478999999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 439 AKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
+......... ......++..|+|||.+.++.++.++|||||||++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 8755332211 1112235678999999998899999999999999999998 9999963
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=264.66 Aligned_cols=203 Identities=27% Similarity=0.387 Sum_probs=171.7
Q ss_pred CCCCCCeeccccccEEEEEEeCC--CCEEEEEEecccc---------cchhHHHHHHHHHHHHh-CCCCceecccccccc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEER---------TQGGELQFQTEVEMISM-AVHRNLLRLRGFCMT 356 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~ 356 (511)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... ......++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 6889999875321 12233456778887764 799999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCceEEcc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGD 435 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 435 (511)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886643344468999999999999999999996 5 899999999999999999999999
Q ss_pred cccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 99997654432 223445889999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=265.56 Aligned_cols=206 Identities=28% Similarity=0.388 Sum_probs=175.7
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchh--HHHHHHHHHHHHhC-CCCceeccccccccCCc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 359 (511)
.+...+|..+.+||+|+||.|.+|..+ +.+.+|||+++++...++ ..--+.|-.+|... +-|.++.+..+++.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344567888999999999999999866 567899999987653322 11134566666665 46789999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.|.||||+.||+|-.++++.+. +.+..+..++..||-||-+||++ ||+.||||.+||++|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999999998775 67778899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+.-- -+...+..++|||.|+|||++..++|+..+|.|||||+||||+.|++||+..+
T Consensus 498 KEni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 498 KENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred cccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 7432 23345677899999999999999999999999999999999999999998653
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=267.26 Aligned_cols=200 Identities=29% Similarity=0.403 Sum_probs=169.5
Q ss_pred CCCCCCeeccccccEEEEEEe----CCCCEEEEEEeccccc---chhHHHHHHHHHHHHhC-CCCceeccccccccCCce
Q 010429 289 NFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 360 (511)
+|++.+.||+|+||.||+++. .+|..||+|+++.... ......+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999986 3688999999875321 22345578899999999 589999999999888889
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||+++++|.+++.... ++++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997643 378999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCceeeecccccccccccccccC--CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..............|+..|+|||.+... ..+.++||||||+++|||++|+.||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 6544332223345588999999998753 367889999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=281.45 Aligned_cols=198 Identities=25% Similarity=0.382 Sum_probs=168.9
Q ss_pred CCCCCCeeccccccEEEEEEeCCCC-EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLTDGS-LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
.|.++..||.|+||.||+|..++.. ..|.|++.. .......++.-||++|..++||+||++++.|+..+..|++.|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3455667999999999999887433 456677643 34555667999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
.||-....+-..+. ++++.++.-+..|++.||.|||++ .|||||||..|||++-+|.++++|||.+-... ..-
T Consensus 112 ~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STR 184 (1187)
T ss_pred CCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHH
Confidence 99999888776543 499999999999999999999999 99999999999999999999999999875432 222
Q ss_pred ceeeeccccccccccccc-----ccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 448 HVTTAVRGTIGHIAPEYL-----STGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
....++.|||+|||||+. ..++|++++||||||+.|.||..+.+|-.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 334567899999999976 45679999999999999999999999974
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=264.13 Aligned_cols=200 Identities=28% Similarity=0.490 Sum_probs=169.1
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc---------hhHHHHHHHHHHHHhCCCCceeccccccccCC
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ---------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 358 (511)
+|...+.||+|+||.||+|... +|+.+|+|.++..... .....+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999865 6889999988532111 11235788999999999999999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||||+++++|.+++++.. .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997652 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-ceeeecccccccccccccccCC--CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 439 AKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++....... .......++..|+|||.+.... ++.++|+||||+++||+++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 875432211 1123345788999999987654 78899999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=266.66 Aligned_cols=202 Identities=27% Similarity=0.465 Sum_probs=171.6
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
+|+..+.||+|++|.||+|+.. +|..||+|+++..........+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999986 688999999976544444556778999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++ ++.+++..... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 88888876442 23589999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......++..|++||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11233478899999988654 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=272.14 Aligned_cols=195 Identities=27% Similarity=0.433 Sum_probs=170.2
Q ss_pred CCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCC
Q 010429 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
.+.||+|.||+||-|+++ +|+.||||++.+.+ ....+.++++|+.+++.+.||.||.+.--|+.++..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 378999999999999875 89999999997655 3344567999999999999999999999999999999999999 55
Q ss_pred CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CceEEcccccccccCCCCC
Q 010429 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~ 447 (511)
++.+.+-..... .+++...+.++.||+.||.|||.+ +|+|.||||+|||+... -.+||+|||+|+.+.. .
T Consensus 648 DMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--k 720 (888)
T KOG4236|consen 648 DMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--K 720 (888)
T ss_pred hHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--h
Confidence 666655443322 489999999999999999999999 99999999999999654 3799999999998764 3
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
....+++|||.|.|||+++.+.|.+.-|+||.|||+|--++|..||+-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 445678899999999999999999999999999999999999999973
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=266.41 Aligned_cols=200 Identities=27% Similarity=0.424 Sum_probs=169.0
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|++|.||+|+.. +++.||||.++.... ......+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 688999999865432 22334688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+. ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689888876432 3489999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 11 12234688999999887654 58889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=265.14 Aligned_cols=192 Identities=32% Similarity=0.445 Sum_probs=158.6
Q ss_pred eeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHH---HhCCCCceeccccccccCCceeEEeeccc
Q 010429 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l---~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
.||+|+||.||++... +++.+|+|.+...... .....+.+|..++ ...+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 6889999998654322 2222344444433 34479999999999998899999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999887643 389999999999999999999999 99999999999999999999999999987543222
Q ss_pred eeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 449 VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 122358999999998864 55789999999999999999999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=267.92 Aligned_cols=199 Identities=26% Similarity=0.374 Sum_probs=169.1
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc----hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
+|+..+.||+|++|.||+|... +++.||+|.++..... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999975 6889999999754422 2234567899999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+ +++|.+++.... ..+++..+..++.|+++||+|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997643 2489999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||..
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 43221 222346788999998855 4578899999999999999999888863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=264.97 Aligned_cols=195 Identities=29% Similarity=0.415 Sum_probs=167.1
Q ss_pred eccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
||+|+||+||++... +|+.||+|.+.... .......+..|++++++++||||+++++++...+..+++|||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999986432 122344567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeee
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 452 (511)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 999976543 3489999999999999999999999 9999999999999999999999999998765431 11223
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 347889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=261.62 Aligned_cols=193 Identities=26% Similarity=0.388 Sum_probs=169.1
Q ss_pred eccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
||+|++|.||+++.. +++.+|+|++..... ......+.+|++++++++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 588999999865432 23445689999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeee
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 452 (511)
.+++.+.. .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997643 388999999999999999999998 99999999999999999999999999998664432 1223
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
..+++.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 458899999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=264.41 Aligned_cols=204 Identities=29% Similarity=0.432 Sum_probs=171.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCC-----
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT----- 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~----- 358 (511)
..++|++.+.||+|++|.||+|... +++.+++|++..... ...++.+|+++++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3578999999999999999999985 678899999875432 345688999999998 6999999999987644
Q ss_pred -ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 359 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 359 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
..+++|||+++++|.++++........+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999999876543344589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccccccccccccc-----CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 9876543222 2233458899999998753 3467889999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=289.08 Aligned_cols=205 Identities=21% Similarity=0.325 Sum_probs=161.6
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC--CCCEEEEEE--------------ecc--cccchhHHHHHHHHHHHHhCCCCc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKR--------------LKE--ERTQGGELQFQTEVEMISMAVHRN 346 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~--------------~~~--~~~~~~~~~~~~e~~~l~~~~h~n 346 (511)
...++|++.+.||+|+||+||++..+ .+...++|. +.+ .........+.+|++++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998754 222222221 100 011223445889999999999999
Q ss_pred eeccccccccCCceeEEeecccCCCHHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 010429 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (511)
Q Consensus 347 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 425 (511)
|+++++++...+..+++++++. +++.+++...... ........+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999984 5677766543211 12234667788999999999999999 99999999999999
Q ss_pred CCCCceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcc
Q 010429 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493 (511)
Q Consensus 426 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf 493 (511)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999876543333333456999999999999999999999999999999999988644
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=262.22 Aligned_cols=189 Identities=26% Similarity=0.424 Sum_probs=161.0
Q ss_pred CeeccccccEEEEEEeCCCC-----------EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 294 NILGRGGFGKVYKGRLTDGS-----------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. +..++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46999999999999986432 5788877644322 5678899999999999999999999888 78899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-------ceEEcc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-------EAVVGD 435 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~D 435 (511)
+|||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999987542 489999999999999999999999 999999999999999887 799999
Q ss_pred cccccccCCCCCceeeecccccccccccccccC--CCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 999976543 1223467789999998876 78899999999999999999 68888654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=255.47 Aligned_cols=209 Identities=25% Similarity=0.365 Sum_probs=171.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC--C---CCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceecccccccc-C
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT--D---GSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT-P 357 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~ 357 (511)
.....|+..+.||+|.||.||+|.-. + .+.+|+|.++.+... .......+|+..++.++|||++.+..++.+ +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 44567889999999999999999643 2 236899999765322 223346789999999999999999999887 7
Q ss_pred CceeEEeecccCCCHHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC----CceE
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAV 432 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~k 432 (511)
...++++||.+. +|...++-.+. ....++....+.|+.||+.|+.|||++ =|+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 889999999977 57776664322 234689999999999999999999999 89999999999999877 8999
Q ss_pred EcccccccccCCCCC--ceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 433 VGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
|+|||+++.+...-. .....++-|..|+|||.+.+.+ |+.+.||||.|||+.||+|-++-|...+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999999998754322 2234456799999999998765 7999999999999999999999997544
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=273.45 Aligned_cols=200 Identities=23% Similarity=0.383 Sum_probs=166.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC-----Cce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 360 (511)
.++|++.+.||+|+||.||+|.+. +|+.||+|++...........+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 367899999999999999999865 68999999987544344455688899999999999999999876543 357
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++++||++ +++.+.+... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 89999996 4787777543 389999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCc--eeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
........ ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 65432211 1123457899999998754 4678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=259.69 Aligned_cols=201 Identities=28% Similarity=0.460 Sum_probs=172.5
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|+||.||++... +++.+|+|.+.... .......+.+|++++++++||||+++++.+...+..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 68899999986543 233455688999999999999999999999888999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 445 (511)
+++++|.+++.... ...+++..+..++.|+++|++|||++ +++|+||+|+||++++++ .+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999998643 23489999999999999999999999 999999999999998654 6899999999866433
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....++..|+|||.+.+...+.++||||||+++|+|++|+.||+..
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 22 12245788999999998888899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=279.50 Aligned_cols=200 Identities=29% Similarity=0.432 Sum_probs=173.1
Q ss_pred CCCCCeeccccccEEEEEEeC--CCC--EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 290 FSNRNILGRGGFGKVYKGRLT--DGS--LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
....|+||+|.||.|++|.|+ +|+ .||||+++.........+|.+|+.+|.+++|+|++++||+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344578999999999999986 444 5899999877655566789999999999999999999999887 66789999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
.++.|+|.+.|++ .....+-......++.|||.||.||.++ ++|||||..+|+|+-....|||+|||+.+.+...
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999998 3445688899999999999999999999 9999999999999999889999999999987654
Q ss_pred CCceeee--cccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 446 DTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
+...... ..-...|+|||.++...++.++|||+|||.+|||+| |+.||-.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 4433221 223568999999999999999999999999999999 8889864
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.66 Aligned_cols=200 Identities=31% Similarity=0.443 Sum_probs=170.4
Q ss_pred hCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
-+++-...||.|.||.||-+.. .+|+..|+|-++-.... .......+|+.++..++|||+|+++|+-...+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3555667899999999999985 47999999988643322 223457889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
||++|+|.+.++..+. .++.....+..|++.|++|||++ |||||||||.||+++.+|-+|++|||.|..+...
T Consensus 1315 yC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999986543 67778888999999999999999 9999999999999999999999999999877543
Q ss_pred CC---ceeeecccccccccccccccCC---CCcccCeehhhHHHHHHHhCCCccc
Q 010429 446 DT---HVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 446 ~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.. .......||+.|||||++.+.. ...++||||+|||+.||+||+.||.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 21 1123456999999999997654 4678999999999999999999996
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=262.75 Aligned_cols=192 Identities=32% Similarity=0.457 Sum_probs=159.0
Q ss_pred eeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHH---HHHhCCCCceeccccccccCCceeEEeeccc
Q 010429 295 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~---~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
.||+|+||.||++... +++.||+|.+...... .....+..|.. .++...||+|+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 6889999998654322 11222333433 4445679999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+++|.+++.... .+++..+..++.|+++|++|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999999887542 489999999999999999999999 999999999999999999999999999875533221
Q ss_pred eeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 449 VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 234589999999998754 5789999999999999999999999755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=264.25 Aligned_cols=203 Identities=30% Similarity=0.443 Sum_probs=172.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc--CCce
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 360 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~ 360 (511)
++|+..+.||+|+||.||++.+. ++..+|||.++..........+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777789999999999999854 3678999999765443345679999999999999999999998877 5578
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......... .....++..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 765322211 11223456799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=260.01 Aligned_cols=195 Identities=33% Similarity=0.536 Sum_probs=166.7
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++.+++|||++++++++.. +..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECC
Confidence 5688889999999999999986 57889999986532 23468899999999999999999998865 4579999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999986432 3488999999999999999999998 99999999999999999999999999987543211
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.....+..|+|||.+.+..++.++|+|||||++|||++ |+.||...
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 11224568999999988889999999999999999998 99999644
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=263.34 Aligned_cols=201 Identities=25% Similarity=0.419 Sum_probs=175.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..+.|+..+.||+|++|.||+|.+. ++..+++|++..... ....+.+|++++++++|+|++++++++......++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 3456777889999999999999986 688999999975443 4556889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998754 2489999999999999999999998 999999999999999999999999999875543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 221 12233478899999999888899999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=268.66 Aligned_cols=203 Identities=24% Similarity=0.365 Sum_probs=171.3
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEeccc-ccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeE
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~l 362 (511)
+....|++++.||+||.+.||++...+...||+|++... ........|..|++.|.+++ |.+|+++++|-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345678889999999999999999887788888877543 34444556999999999996 8999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||= ..+|..+|++..... ..| .++.+..||+.++.++|.. ||||.||||.|+|+-++ .+||+|||+|..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~--~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSID--PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhccCCC--chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhccc
Confidence 99975 679999999865442 234 8899999999999999999 99999999999999855 9999999999987
Q ss_pred CCCCCc-eeeecccccccccccccccC-----------CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 443 DYKDTH-VTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 443 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
...... .....+||+-||+||.+... ..++++||||+|||||+|+.|++||..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 765443 44567799999999988532 246889999999999999999999963
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=263.29 Aligned_cols=190 Identities=27% Similarity=0.398 Sum_probs=156.8
Q ss_pred eeccccccEEEEEEeC-------------------------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceec
Q 010429 295 ILGRGGFGKVYKGRLT-------------------------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 349 (511)
.||+|+||.||+|... ....||+|.+.... ......+.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 5999999999999742 12358899886543 223446788899999999999999
Q ss_pred cccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 010429 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (511)
Q Consensus 350 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 429 (511)
+++++......++||||+++|+|..++.+.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 9999999999999999999999999887532 2488999999999999999999999 999999999999997643
Q ss_pred -------ceEEcccccccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHH-HhCCCccccc
Q 010429 430 -------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLEL-ITGQRAFDLA 496 (511)
Q Consensus 430 -------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el-ltg~~pf~~~ 496 (511)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||| ++|+.||...
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3899999988643221 12247788999998865 4578999999999999999 4799999643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=262.45 Aligned_cols=197 Identities=23% Similarity=0.378 Sum_probs=170.1
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeeccc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
|...+.||+|++|.||++... +++.+++|+++... ......+.+|+.++++++|+||+++++++...+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 444578999999999999864 68899999886432 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+++|.+++... ++++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 99999998762 388999999999999999999999 999999999999999999999999998875433222
Q ss_pred eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 223345889999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=264.92 Aligned_cols=203 Identities=26% Similarity=0.377 Sum_probs=167.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCC-CCceeccccccccCCc-----
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE----- 359 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~----- 359 (511)
++|+..+.||+|+||.||+|.+. +++.||+|.++..... .....+.+|++++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999975 6889999988654322 22346788999999995 6999999998877655
Q ss_pred eeEEeecccCCCHHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCceEEcccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 437 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 437 (511)
.+++|||+++ ++.+++...... ...+++..+..++.||+.||+|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 788888764332 34589999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++..+...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 98765432211 122346888999998865 4568999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=264.50 Aligned_cols=196 Identities=31% Similarity=0.461 Sum_probs=167.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ......++.+|+++++.++||||+++.+++..++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999875 68899999986432 2233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||++ |++.+.+..... ++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 677777654322 489999999999999999999999 999999999999999999999999999875543
Q ss_pred CCCceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ....++..|+|||++. .+.++.++||||||+++|||+||+.||..
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 2 2234788999999874 35678899999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=265.02 Aligned_cols=200 Identities=29% Similarity=0.403 Sum_probs=168.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccC--CceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 363 (511)
++|+..+.||+|+||.||+|.+. +++.+|+|.++.... ......+.+|++++.+++||||+++++++..+ ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999986 688999999964432 22233567899999999999999999998877 889999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||++ ++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 589988876432 489999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... .....+++.|+|||.+.+.. .+.++|+||||+++|||++|++||..
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43211 22334788999999887644 68899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=258.89 Aligned_cols=202 Identities=26% Similarity=0.405 Sum_probs=176.0
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|++.+.||+|+||.||++... +++.+|+|.+.... .......+.+|++++++++|+||+++.+++......++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 68899999987543 233345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++.+.......+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999977544445689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......++..|+|||...+..++.++|+||+|+++|||++|+.||+..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 222345788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=256.79 Aligned_cols=204 Identities=25% Similarity=0.389 Sum_probs=178.1
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|+||.||++.+. ++..+|+|++..... ......+.+|++++++++|+|++++.+.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999976 688999999875432 24455688999999999999999999999988999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++++.......+++..+..++.++++||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543345699999999999999999999999 99999999999999999999999999997665432
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||+..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 2233345889999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=264.83 Aligned_cols=205 Identities=27% Similarity=0.427 Sum_probs=170.0
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCC----
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT---- 358 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~---- 358 (511)
...++|++.+.||+|+||.||+|... +|+.||+|+++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 588999999865432 233446778999999999999999999887654
Q ss_pred ------ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 359 ------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 359 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
..++++||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 677766653 22489999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+|||.+...............++..|+|||.+.+. .++.++|||||||++|||++|++||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999986654332222223467889999988653 4688999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=264.57 Aligned_cols=202 Identities=24% Similarity=0.376 Sum_probs=165.2
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|...+.||+|+||.||++.+. +++.+|+|.+...........+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999875 688999999876544445567889999999996 99999999999999999999999
Q ss_pred ccCCCHHHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 367 MVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
+. +++.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4555443221 111235899999999999999999999743 8999999999999999999999999999755322
Q ss_pred CCceeeecccccccccccccccC---CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. .....|+..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 21 1223478899999998766 688999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=270.60 Aligned_cols=199 Identities=24% Similarity=0.303 Sum_probs=168.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC------
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 357 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 357 (511)
..++|+..+.||+|+||.||++... +++.||+|.+.... .......+.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 78999999986432 223344577899999999999999999987643
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
...++||||+. +++.+.+... +++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34689999995 5888777542 78889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 9986543221 22345788999999999989999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=271.36 Aligned_cols=205 Identities=24% Similarity=0.335 Sum_probs=179.6
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCC-EEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGS-LVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
+...++..+..||-|+||.|-+++..+.. .+|+|++++... ......+..|..+|..++.|.||++|-.|.++...|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 33445566678999999999999876433 389999876553 233445778999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+.||-|-||.+...++.++. ++..+++.++..+.+|++|||++ +||.|||||+|.+++.+|-+||.|||+|+.
T Consensus 497 mLmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence 99999999999999998765 88899999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 498 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~ 498 (511)
+... ..+-.++|||.|.|||++....++..+|.||+|+++|||++|++||...+.
T Consensus 570 i~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 570 IGSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred hccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 7644 345668899999999999999999999999999999999999999986654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=258.33 Aligned_cols=202 Identities=23% Similarity=0.353 Sum_probs=172.5
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|+..+.||+|+||.||++... +|..+|+|.+..... ......+.+|++++++++|+||+++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999976 588999999865321 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 445 (511)
+++++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999976432 2479999999999999999999999 999999999999999886 4699999999766432
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ......|++.|+|||...+..++.++|+||||+++|||++|+.||...
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 22 222345889999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=254.82 Aligned_cols=199 Identities=31% Similarity=0.480 Sum_probs=175.7
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
+|+..+.||+|++|.||++... ++..+++|+++.... .....+.+|++++++++|+|++++++++..+...++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677889999999999999986 688999999976543 34567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987653 3489999999999999999999998 999999999999999999999999999976654332
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....++..|+|||.+.+...+.++||||||+++|+|++|+.||+..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23345889999999998888899999999999999999999999754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=257.50 Aligned_cols=195 Identities=25% Similarity=0.344 Sum_probs=163.1
Q ss_pred HHHhhCCCCCCee--ccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHh-CCCCceeccccccccCCc
Q 010429 284 QVATDNFSNRNIL--GRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 284 ~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~ 359 (511)
....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+....... .|...... .+|+||+++++.+...+.
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3344667777776 99999999999875 67889999986533211 12222222 279999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGL 438 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~ 438 (511)
.++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999997653 489999999999999999999999 999999999999999998 999999999
Q ss_pred ccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+....... ...++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 87654322 234889999999999888999999999999999999999999743
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=266.06 Aligned_cols=202 Identities=29% Similarity=0.426 Sum_probs=167.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccC--CceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 362 (511)
.++|++.+.||+|+||.||+|.+. +|+.||+|.++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999975 6899999998644322 2233466899999999999999999998754 46799
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+...
T Consensus 86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 47888887543 3489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... .....++..|+|||.+.+ ..++.++||||+||++|||++|++||...
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 543222 122235788999999865 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=259.26 Aligned_cols=204 Identities=28% Similarity=0.443 Sum_probs=166.1
Q ss_pred CCCCCeeccccccEEEEEEeC----CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC------
Q 010429 290 FSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 358 (511)
|.+.+.||+|+||.||+|.+. ++..||+|+++... ......++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999753 46789999987543 2334556889999999999999999999876532
Q ss_pred ceeEEeecccCCCHHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
..++++||+.+|+|.+++.... .....+++.....++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875432 1223478999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 437 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
|+++........ ......+++.|++||.+.+..++.++||||||+++|||++ |++||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 999865432211 1222335678999999988888999999999999999999 89998643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=258.18 Aligned_cols=194 Identities=28% Similarity=0.412 Sum_probs=167.9
Q ss_pred eccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
||+|+||.||+++.. +|+.+|+|.+..... ......+.+|++++++++|+||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 589999999865432 23445688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-----
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----- 447 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 447 (511)
.+++.+.. .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99998654 489999999999999999999999 999999999999999999999999999875432211
Q ss_pred --ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 --HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......++..|+|||.......+.++||||||+++||+++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1223345788999999998888899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=262.02 Aligned_cols=200 Identities=27% Similarity=0.434 Sum_probs=169.1
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC--CceeEEee
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYP 365 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~e 365 (511)
|++.+.||+|++|.||+|+.. +++.+|+|+++... .......+.+|++++++++|+|++++++++... +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999876 58899999997653 223345688899999999999999999999887 78999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++ +|.+++.... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 8888876542 2489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||+..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3222233346888999998765 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=257.06 Aligned_cols=191 Identities=25% Similarity=0.350 Sum_probs=161.2
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHH-HHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|... +++.||+|.++.... ......+..|..+ ....+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999875 688999999865432 1222234455444 3455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
++|.++++... ++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997643 388999999999999999999999 999999999999999999999999999875432
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 12345788999999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=262.80 Aligned_cols=201 Identities=25% Similarity=0.399 Sum_probs=166.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|+..+.||+|++|.||+|... +++.||+|.+..... ......+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999976 688999999865332 2233467889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCceEEcccccccccCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 444 (511)
|++ +++.+++..... ..+++..+..++.|++.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 578887765332 2368888999999999999999999 9999999999999985 55799999999976543
Q ss_pred CCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... ......+++.|+|||.+.+. .++.++||||+||++|||+||++||..
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 211 11223478899999988664 478899999999999999999999964
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=266.56 Aligned_cols=205 Identities=25% Similarity=0.391 Sum_probs=168.2
Q ss_pred CCCCCCeeccccccEEEEEEeC---CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccC--Ccee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT---DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERL 361 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~ 361 (511)
+|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|++++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999975 37899999997632 122234577899999999999999999999887 7899
Q ss_pred EEeecccCCCHHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC----CCceEEccc
Q 010429 362 LVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE----EFEAVVGDF 436 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 436 (511)
+||||+++ ++.+.+...... ...+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677766543322 23689999999999999999999999 9999999999999999 899999999
Q ss_pred ccccccCCCCC--ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 437 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 437 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
|++........ .......++..|+|||.+.+. .++.++|||||||++|||++|++||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986543222 112234578899999988764 47889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=260.52 Aligned_cols=197 Identities=25% Similarity=0.316 Sum_probs=164.0
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccC--CceeEEee
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLVYP 365 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~--~~~~lv~e 365 (511)
|++.+.||+|+||.||+|... +++.||+|+++............+|+.++.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999875 688999999876543333344567888888885 99999999999887 88999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|++ +++.+.+.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 58888776543 2489999999999999999999999 9999999999999999 99999999999765432
Q ss_pred CCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ....++..|+|||.+.+ +.++.++|||||||++|||++|+.||...
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 221 22347889999997654 55788999999999999999999999643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=260.72 Aligned_cols=190 Identities=25% Similarity=0.393 Sum_probs=158.4
Q ss_pred CeeccccccEEEEEEeCC--------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
+.||+|+||.||+|.... ...+|+|.+.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999997642 2348888875432 3334568889999999999999999999999899999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--------eEEcccc
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--------AVVGDFG 437 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfg 437 (511)
|+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999986533 489999999999999999999999 9999999999999987765 6999999
Q ss_pred cccccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCC-Ccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQ-RAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~-~pf~~ 495 (511)
.+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .||..
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 88654321 223478899999999764 5788999999999999999994 66643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=260.42 Aligned_cols=199 Identities=26% Similarity=0.414 Sum_probs=167.9
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
|+..+.||+|++|.||+|.+. +|..||+|++..... ......+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999875 789999999865432 222345788999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689998876542 3489999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1222468899999987654 468899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=268.97 Aligned_cols=214 Identities=24% Similarity=0.370 Sum_probs=176.9
Q ss_pred CCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
-|..++.||-|+||+|.+++- ++...||.|.+++.. ........+.|.++|...+.+=||+++-.|++++..|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 455678899999999999963 456789999986543 22234457889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC-
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY- 444 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 444 (511)
|++||++-.+|-+.+. +.++.++.++..+..|+++.|.. |+|||||||+|||||.+|++||+|||+++-+.-
T Consensus 710 YIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999887654 88999999999999999999999 999999999999999999999999999853210
Q ss_pred -------CCCce---------------------------------eeecccccccccccccccCCCCcccCeehhhHHHH
Q 010429 445 -------KDTHV---------------------------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 484 (511)
Q Consensus 445 -------~~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ 484 (511)
...+. ....+||+.|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 01245999999999999999999999999999999
Q ss_pred HHHhCCCcccccccCCCCCeeeeccc
Q 010429 485 ELITGQRAFDLARLANDDDVMLLDWD 510 (511)
Q Consensus 485 elltg~~pf~~~~~~~~~~~~~~~w~ 510 (511)
||+.|++||-.....+ .+--+.+|.
T Consensus 863 em~~g~~pf~~~tp~~-tq~kv~nw~ 887 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE-TQYKVINWR 887 (1034)
T ss_pred HHhhCCCCccCCCCCc-ceeeeeehh
Confidence 9999999997554443 333345774
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=259.66 Aligned_cols=202 Identities=26% Similarity=0.435 Sum_probs=175.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv 363 (511)
++|.+.+.||+|+||.||++... ++..||+|++.... .......+.+|.+++.+++ |+||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999876 78999999986532 2233456888999999998 99999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.+.. .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999998653 489999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC-------------------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDT-------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... .......++..|+|||.......+.++||||||++++|+++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3221 1222345788999999998888899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=289.13 Aligned_cols=198 Identities=28% Similarity=0.410 Sum_probs=164.1
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC------
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 357 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 357 (511)
....+|+.++.||+||||.||+++.+ ||..||||++....+......+.+|+..+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45677888999999999999999988 89999999998765555556689999999999999999998654100
Q ss_pred --------------------------------------------------------------------------------
Q 010429 358 -------------------------------------------------------------------------------- 357 (511)
Q Consensus 358 -------------------------------------------------------------------------------- 357 (511)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010429 358 ---------------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404 (511)
Q Consensus 358 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 404 (511)
...||-||||+...+.+++++.... -.....++++.+|++||+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHH
Confidence 0126889999998888888765422 1578889999999999999
Q ss_pred HHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC-----------------CCCCceeeeccccccccccccccc
Q 010429 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------------YKDTHVTTAVRGTIGHIAPEYLST 467 (511)
Q Consensus 405 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~ 467 (511)
+|++ |+|||||||.||++|++..|||+|||+|+... .......+..+||.-|+|||.+.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 011113345679999999999876
Q ss_pred CC---CCcccCeehhhHHHHHHHh
Q 010429 468 GK---SSEKTDVFGYGVMLLELIT 488 (511)
Q Consensus 468 ~~---~~~~~Dv~s~Gvil~ellt 488 (511)
.. |+.|+|+||+|||++||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 54 8999999999999999985
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=230.29 Aligned_cols=201 Identities=25% Similarity=0.417 Sum_probs=167.8
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|...++||+|.||+||+|+.. +++.||+|+++.+... .-.....+|+-+++.++|.|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999965 6889999999754433 2344578999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
| ..+|..+...... .++.+.++.++.|+++|+.++|++ .+.|||+||.|.|++.+|+.|++|||+++.+...-
T Consensus 83 c-dqdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred h-hHHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9 4577777765433 389999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
. -.+..+-|..|++|+++.+.. |+...|+||.|||+.|+.. |++.|-.++
T Consensus 156 r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 2 233445799999999998765 7888999999999999987 555554443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=260.78 Aligned_cols=202 Identities=24% Similarity=0.436 Sum_probs=166.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv 363 (511)
..++|++.+.||+|+||.||+|.+. +++.||||.++..........+..|++++.+.. |+||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3466788899999999999999987 488999999976544444455677877676665 99999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||++ +++.+....... .+++..+..++.|++.||+|||+.. +++||||+|+||++++++.+||+|||++..+.
T Consensus 93 ~e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 577776655322 5899999999999999999999732 89999999999999999999999999987654
Q ss_pred CCCCceeeecccccccccccccccCC----CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 32221 2234788999999987554 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=266.28 Aligned_cols=201 Identities=23% Similarity=0.372 Sum_probs=167.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceecccccccc----CCcee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERL 361 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~ 361 (511)
++|++.+.||+|+||.||+|... +|..||+|++..... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888999999999999999875 689999999875432 2334567789999999999999999998763 34578
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 68888886532 389999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCc---eeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 5432211 1123458889999998865 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=257.33 Aligned_cols=199 Identities=29% Similarity=0.421 Sum_probs=169.0
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEeecc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
|++.+.||+|++|+||+|... +++.||+|++.............+|+..+.+++ |+||+++++++..++..+++|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999986 578899999876543333444567899999999 999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
+|++.+++.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887654 23489999999999999999999999 999999999999999999999999999976543222
Q ss_pred ceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|++||...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 122447889999998754 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=260.62 Aligned_cols=207 Identities=27% Similarity=0.394 Sum_probs=172.2
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchh------HHHHHHHHHHHHhCCCCceecccccccc-
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG------ELQFQTEVEMISMAVHRNLLRLRGFCMT- 356 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~~~h~niv~l~~~~~~- 356 (511)
...++|-.+.+||+|+|+.||+|.+- ..+.||||+-.......+ .+...+|..+.+.++||-||++++++.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34567777889999999999999854 577889998643332222 2336789999999999999999999874
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEE
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVV 433 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 433 (511)
.+.++-|+|||+|.+|.-+|++.+. +++.+++.|+.||+.||.||.+. +++|+|-||||.|||+.. .|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 5778999999999999999998764 89999999999999999999987 678999999999999954 478999
Q ss_pred cccccccccCCCCC------ceeeecccccccccccccccC----CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 434 GDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+|||+++.++.... ..+....||..|.+||++--+ ..+.|+||||+|||+|+.+.|+.||...
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 99999998865432 234556799999999987533 4688999999999999999999999643
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=260.92 Aligned_cols=192 Identities=24% Similarity=0.393 Sum_probs=167.0
Q ss_pred CeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
..||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++...+..+++|||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57999999999999875 78899999885432 33455688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeee
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 452 (511)
.+++... .+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9987542 378999999999999999999999 999999999999999999999999999875543221 2233
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..|+..|+|||.+.+..++.++|+||+|+++|||++|+.||..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4588999999999888889999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.89 Aligned_cols=203 Identities=19% Similarity=0.219 Sum_probs=152.8
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCC----CCEEEEEEecccccchh-H---------HHHHHHHHHHHhCCCCceeccc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGG-E---------LQFQTEVEMISMAVHRNLLRLR 351 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-~---------~~~~~e~~~l~~~~h~niv~l~ 351 (511)
..++|.+.+.||+|+||+||+|...+ +..+|+|.......... + .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34678999999999999999998764 34566665432221110 0 0112233445667899999999
Q ss_pred cccccCC----ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC
Q 010429 352 GFCMTPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427 (511)
Q Consensus 352 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 427 (511)
+++.... ..+++++++. .++.+.+.... ..++..+..++.|+++||+|||+. +++||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8765443 3367777763 45666655432 256788899999999999999999 9999999999999999
Q ss_pred CCceEEcccccccccCCCCC------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 428 EFEAVVGDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 428 ~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++.++|+|||+|+.+..... .......||+.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999986543221 1112245999999999999999999999999999999999999999754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=266.60 Aligned_cols=204 Identities=25% Similarity=0.361 Sum_probs=169.5
Q ss_pred CHHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
...++....++|.+.+.||+|+||.||++... +++.||+|+++... .......+.+|++++.+++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34556667899999999999999999999864 78899999987533 22234457789999999999999999988753
Q ss_pred C------CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 010429 357 P------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (511)
Q Consensus 357 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 430 (511)
. ...+++++++ +++|.++++.. .+++..+..++.|+++||+|||+. +++||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 2 3467888876 78998877642 389999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999998754321 123457889999998866 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=262.17 Aligned_cols=203 Identities=27% Similarity=0.420 Sum_probs=166.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCC------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 358 (511)
.++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999875 688999998864332 222334678999999999999999999876554
Q ss_pred --ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 359 --ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 359 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
..+++|||+. +++.+.+.... ..+++.++..++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 3499999996 57888776543 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc---eeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|++......... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999765432211 112234788999999876643 688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=259.91 Aligned_cols=200 Identities=31% Similarity=0.404 Sum_probs=168.9
Q ss_pred CCCCCCeeccccccEEEEEEeC----CCCEEEEEEeccccc---chhHHHHHHHHHHHHhC-CCCceeccccccccCCce
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 360 (511)
+|++.+.||+|++|.||++... ++..||||.++.... ......+.+|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999998742 578899999864321 22334578899999999 599999999999888899
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999887532 388999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCceeeecccccccccccccccCC--CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 65443332333445889999999987655 68899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=260.67 Aligned_cols=194 Identities=31% Similarity=0.471 Sum_probs=164.9
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
|...+.||+|+||.||+++.. ++..+|+|.+.... .......+.+|++++++++|+|++++++++..++..+++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556788999999999999875 68899999986432 222344688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+. |++.+.+.... .++++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 57777775432 2489999999999999999999999 9999999999999999999999999998654322
Q ss_pred Cceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
....++..|+|||.+. .+.++.++|||||||++|||++|+.||..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2235888999999974 45678899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=251.75 Aligned_cols=199 Identities=29% Similarity=0.499 Sum_probs=174.2
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+|++.+.||+|++|.||++... +++.|++|.+...... .....+.+|++++.+++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999875 6789999999765421 3445689999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998765 2489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. .....++..|+|||...+...+.++||||+|+++|+|++|+.||..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22 2334588899999999887888999999999999999999999964
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=252.06 Aligned_cols=202 Identities=30% Similarity=0.464 Sum_probs=175.8
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccC--CceeEEe
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 364 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 364 (511)
+|...+.||+|++|.||+|... +++.|++|++..... ......+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999986 688999999865432 23455688999999999999999999999888 8899999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.+.. .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999998754 489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 445 KDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 445 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 1223458899999999988889999999999999999999999997553
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=264.54 Aligned_cols=201 Identities=23% Similarity=0.381 Sum_probs=167.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC-----Cc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 359 (511)
.++|.+.+.||+|+||+||+++.. ++..||||.++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999875 68999999986532 222344577899999999999999999987654 34
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68888886532 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....... .......++..|+|||.+.. ..++.++|||||||++|||++|++||...
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 8654332 12223457889999998765 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=264.94 Aligned_cols=201 Identities=24% Similarity=0.377 Sum_probs=167.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhC-CCCceeccccccccC--Cce
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP--TER 360 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~--~~~ 360 (511)
..++|++.+.||+|+||.||+|.+. +++.+|+|++.... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999876 68899999885432 223344577899999999 999999999987653 357
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||++ ++|.++++.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 5898888653 378999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----ceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
....... .......|+..|+|||.+.+ ...+.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 6543322 12223458899999998765 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=254.19 Aligned_cols=202 Identities=24% Similarity=0.352 Sum_probs=168.5
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
+|.+.+.||+|+||.||++++. .+..+++|.++... ......++..|+.++++++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999875 34456666654321 223344577889999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.........+++..++.++.|+++|++|||+. +++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999987554455699999999999999999999999 9999999999999986 579999999987654
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... .......|++.|+|||...+..++.++|+||||+++|+|++|..||+.
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 122334578899999999888888999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=263.53 Aligned_cols=200 Identities=25% Similarity=0.376 Sum_probs=171.2
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCC-----cee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 361 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~ 361 (511)
+|.+.+.||+|++|.||+|+.. +++.+|+|++..... ......+.+|+++++.++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999976 589999999875432 334456889999999999999999999988765 789
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
++|||++ ++|.+++.+.. ++++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 57888886543 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 654321 122334578899999999887 7899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=255.87 Aligned_cols=199 Identities=28% Similarity=0.392 Sum_probs=170.2
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
|+..+.||+|++|.||++... +++.+++|.++..... .....+.+|++++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999875 6889999998754322 33456888999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++ ++.+++.... .++++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 8888887643 2489999999999999999999999 99999999999999999999999999997665433
Q ss_pred ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 112234478899999998876 6889999999999999999999999643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=260.64 Aligned_cols=196 Identities=23% Similarity=0.278 Sum_probs=160.8
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
+.+|.|+++.||++.. +++.||+|+++.. ........+.+|++++++++|+||+++++++..++..+++|||+++|++
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344555555555554 6899999999754 2344556799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-----
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----- 447 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 447 (511)
.++++..... .+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHFPE--GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999864322 388999999999999999999999 999999999999999999999999998865432111
Q ss_pred -ceeeecccccccccccccccC--CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 448 -HVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 448 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.......++..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 111233467889999998763 478899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=262.26 Aligned_cols=198 Identities=26% Similarity=0.362 Sum_probs=162.2
Q ss_pred Ceeccc--cccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+| +||+||++.+. +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999875 789999999875432 23345688999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
+++.+++.+... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999887532 2488999999999999999999998 99999999999999999999999998654321111000
Q ss_pred ------eeecccccccccccccccC--CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 ------TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0111246679999998764 4688999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=260.69 Aligned_cols=202 Identities=28% Similarity=0.422 Sum_probs=164.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCC------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 358 (511)
.++|++.+.||+|+||.||+|... +++.+|+|++...... .....+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999976 6889999998644322 22335678999999999999999999875443
Q ss_pred --ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 359 --ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 359 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
..++++||+.+ ++...+.... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 45899999964 6766665432 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc----------eeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 437 GLAKLMDYKDTH----------VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|++......... ......+++.|+|||.+.+. .++.++|||||||++|||++|++||..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 999765432211 11223468889999987654 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=263.26 Aligned_cols=198 Identities=25% Similarity=0.386 Sum_probs=166.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCC-----
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----- 358 (511)
..++|+..+.||+|+||.||++... ++..||||++..... ......+.+|++++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999865 789999999864332 223445789999999999999999999887543
Q ss_pred -ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 359 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 359 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
..+++|||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 77898887642 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++...... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99765322 122347889999999876 45788999999999999999999999743
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=254.06 Aligned_cols=199 Identities=28% Similarity=0.467 Sum_probs=166.0
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-hHHHHHHHHHHHHhC---CCCceeccccccccCCc-----
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMTPTE----- 359 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~~~~----- 359 (511)
|++.+.||+|+||.||+|+.+ +++.||+|+++...... ....+.+|++++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999987 58999999997543222 233466777766655 69999999999987776
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+++|||+. ++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 589888876432 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......... ....++..|+|||.+.+..++.++|+|||||++|||++|++||+..
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 776433221 2234788999999999888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=262.24 Aligned_cols=196 Identities=25% Similarity=0.386 Sum_probs=163.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccC------C
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~ 358 (511)
.++|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 467888999999999999999875 689999999865322 22334578999999999999999999988654 2
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++++||+.. ++..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 6665542 1388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 87543221 22347889999999876 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=261.06 Aligned_cols=198 Identities=26% Similarity=0.409 Sum_probs=167.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc-CCcee
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERL 361 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~ 361 (511)
...++|+..+.||+|+||.||++... +++.||+|++.... .......+.+|++++.+++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45678999999999999999999865 78999999886432 22334567889999999999999999998865 45788
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++||+ +++|.++++.. ++++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 87 lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 56888887642 378888999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 158 QDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred cCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 43221 22347889999998766 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=279.51 Aligned_cols=211 Identities=27% Similarity=0.428 Sum_probs=181.7
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeC----C----CCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccc
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT----D----GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRG 352 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~ 352 (511)
.+++..++..+.+.+|+|.||.|++|... . ...||||.++......+...+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56666777777789999999999999743 1 4579999999888777788899999999988 5999999999
Q ss_pred ccccCCceeEEeecccCCCHHHHHHhcC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 010429 353 FCMTPTERLLVYPFMVNGSVASCLRERG---Q-------SQ--PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 420 (511)
Q Consensus 353 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 420 (511)
+|......++|+||+..|+|.++++..+ . .. ..++......++.|||.||+||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999999866 0 01 2388999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEcccccccccCCCCCceeeeccc--ccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 421 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 421 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
+|||+.++..+||+|||+|+..............| ..+|||||.+....++.|+|||||||++||++| |..||..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999998765555444332223 456999999999999999999999999999999 8888863
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=255.88 Aligned_cols=195 Identities=31% Similarity=0.450 Sum_probs=164.7
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
|...+.||+|+||+||+|+.. ++..||+|++..... ......+.+|++++++++|||++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999875 688999999864322 22334678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+. |++.+.+.... .++++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 57777776533 2489999999999999999999999 999999999999999999999999999864322
Q ss_pred Cceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....|+..|+|||.+. ...++.++|||||||++|||++|++||...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12345888999999984 356788999999999999999999999643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=243.52 Aligned_cols=197 Identities=26% Similarity=0.330 Sum_probs=165.2
Q ss_pred hhCCCCC-CeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccC----Cc
Q 010429 287 TDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP----TE 359 (511)
Q Consensus 287 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~----~~ 359 (511)
+++|++- ++||-|-.|.|.....+ +++.+|+|++.... ..++|++..-+. .|||||.++++|.+. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4555543 67999999999988765 78999999986432 245788876555 599999999998753 45
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEEccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 436 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 436 (511)
..+|||.|+||.|.+.+++++.. .+++.++-+|+.||+.|+.|||+. .|.||||||+|+|.+. +..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 67999999999999999987654 499999999999999999999999 9999999999999964 457999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+|+.-.. .....+.+-||.|.|||++...+++...|+||+||++|-|+.|.+||...
T Consensus 209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 99986442 22334456799999999999999999999999999999999999999754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=247.15 Aligned_cols=193 Identities=32% Similarity=0.407 Sum_probs=168.4
Q ss_pred eccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCH
Q 010429 296 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 372 (511)
||+|+||.||++... +++.+|+|.++..... .....+..|++++++++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 5889999998754322 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeee
Q 010429 373 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452 (511)
Q Consensus 373 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 452 (511)
.+++.... .+++..+..++.|+++|+.|||+. +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99998653 389999999999999999999998 99999999999999999999999999987654332 12233
Q ss_pred cccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 453 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..++..|+|||...+...+.++|+||||+++||+++|+.||...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 45788999999998888899999999999999999999999644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=260.26 Aligned_cols=201 Identities=27% Similarity=0.358 Sum_probs=165.1
Q ss_pred hCCCC-CCeeccccccEEEEEEeC-CCCEEEEEEecccccchh-------------HHHHHHHHHHHHhCCCCceecccc
Q 010429 288 DNFSN-RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-------------ELQFQTEVEMISMAVHRNLLRLRG 352 (511)
Q Consensus 288 ~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~e~~~l~~~~h~niv~l~~ 352 (511)
++|.. .+.||+|+||+||+|.+. +++.||+|.++....... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 467999999999999875 689999999864432210 124678999999999999999999
Q ss_pred ccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 353 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
++...+..+++|||+. |+|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 68998886532 389999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCC-------------CceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 433 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 433 l~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+|||.+....... ........++..|+|||.+.+.. ++.++|||||||++|||++|++||...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999987654110 11112234678899999987644 688999999999999999999999643
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=252.42 Aligned_cols=199 Identities=30% Similarity=0.453 Sum_probs=169.8
Q ss_pred CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... .......+..|++++++++|+|++++++++...+..++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999976 58999999997643 2223456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
+ ++|.+++.+.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999998753 2489999999999999999999999 999999999999999999999999999976543322
Q ss_pred ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......++..|+|||.+.+. .++.++|||||||++|||++|++||...
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 12223367789999998766 7889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=255.76 Aligned_cols=195 Identities=33% Similarity=0.480 Sum_probs=164.8
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.|+..+.||+|+||.||+|+.. ++..+|+|.+.... ......++.+|+++++.++|+|++++.+++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3566678999999999999975 67889999886432 22334467889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+. |++.+.+.... .++++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 68877775433 2488999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
....++..|+|||.+. ....+.++|||||||++|||++|+.||..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2234788999999874 34578899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.08 Aligned_cols=198 Identities=24% Similarity=0.379 Sum_probs=162.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC---------
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--------- 357 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--------- 357 (511)
.+|...+.||+|+||.||+|... +|..||+|.+..... .....+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999875 688999999865433 3445688899999999999999999876643
Q ss_pred -----CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCce
Q 010429 358 -----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEA 431 (511)
Q Consensus 358 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~ 431 (511)
...+++|||++ ++|.+++... .+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34689999996 5888877542 388999999999999999999999 9999999999999974 5678
Q ss_pred EEcccccccccCCCCCc--eeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 432 VVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|++|||.+......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999765432111 1122347889999998654 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=258.36 Aligned_cols=200 Identities=24% Similarity=0.329 Sum_probs=162.7
Q ss_pred CCCCCCeeccccccEEEEEEeC-C--CCEEEEEEeccccc-chhHHHHHHHHHHHHhC-CCCceecccccccc----CCc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-D--GSLVAVKRLKEERT-QGGELQFQTEVEMISMA-VHRNLLRLRGFCMT----PTE 359 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~----~~~ 359 (511)
+|.+.+.||+|+||.||++... . +..||+|++..... ......+.+|+++++++ .||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999976 3 77899999864322 22344678899999998 59999999986543 245
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+++++|+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678889885 68888886532 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---eeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|++||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 765432211 1223458999999998765 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=241.04 Aligned_cols=206 Identities=26% Similarity=0.373 Sum_probs=178.6
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchh--HHHHHHHHHHHHhC-CCCceeccccccccCCc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 359 (511)
.....+|.++++||+|+|++|..+++. +.+.||+|+++++--..+ ..=.+.|-.+..+. +||.+|-+..+++....
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 345678999999999999999999876 678899999976542222 22256676666655 69999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++|.||++||+|--++++++. ++++.++.+...|.-||.|||+. ||+.||||.+|+|+|..|++|++|+|++
T Consensus 326 lffvieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred EEEEEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchh
Confidence 9999999999999888877654 99999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+.- ..+...++.++|||.|.|||.+++..|...+|.|++||+++||+.|+.||+.--
T Consensus 399 ke~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 399 KEG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred hcC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 742 244556778899999999999999999999999999999999999999998543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=239.05 Aligned_cols=197 Identities=27% Similarity=0.350 Sum_probs=164.2
Q ss_pred CCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC-----CceeEEe
Q 010429 292 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVY 364 (511)
Q Consensus 292 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~~lv~ 364 (511)
..+.||-|+||.||.+.+. +|+.||.|++..-. .-...+++.+|+.++..++|.|++..++..+-. .+.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3478999999999999875 89999999985432 222345688999999999999999988876654 3567888
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
|.|+. +| ++...+...++.+.++-++.||++||+|||+. +|.||||||.|.|++.+..+||+|||+++..+.
T Consensus 137 ELmQS-DL----HKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELMQS-DL----HKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHh-hh----hheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 88733 44 44444555689999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.+....+..+-|..|+|||.+.+.+ |+.+.||||.|||+.|++..+..|...
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 6655556666799999999998764 799999999999999999999999743
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=259.28 Aligned_cols=197 Identities=27% Similarity=0.388 Sum_probs=167.0
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCc----
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE---- 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~---- 359 (511)
..++|+..+.||+|++|.||+|+.. ++..||+|++.... .......+.+|+.++++++|+|++++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999986 67899999986532 22234457789999999999999999998776554
Q ss_pred --eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 360 --RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 360 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
.++++||+ +++|.+++... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 67999888752 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++...... .....++..|+|||.+.+. ..+.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99765332 2233578899999988653 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=243.12 Aligned_cols=181 Identities=22% Similarity=0.214 Sum_probs=154.7
Q ss_pred ccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCHHHHHH
Q 010429 299 GGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377 (511)
Q Consensus 299 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 377 (511)
|.+|.||++++. +++.||+|+++... .+.+|...+....||||+++++++...+..+++|||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999975 78899999997542 13345555556679999999999999999999999999999999987
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeeccccc
Q 010429 378 ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457 (511)
Q Consensus 378 ~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~ 457 (511)
+.. .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 643 389999999999999999999999 9999999999999999999999999987654322 12233577
Q ss_pred ccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 458 ~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.|+|||.+.+..++.++||||+|+++|||++|+.||+..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 899999998888899999999999999999999988643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=264.22 Aligned_cols=202 Identities=29% Similarity=0.436 Sum_probs=173.0
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc-----CC
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT-----PT 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~-----~~ 358 (511)
.++.|++.+.||.|.+|.||+++.. +++.+|+|++......+ .+++.|.++++.. +|||++.++|++.. ++
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 4567888999999999999999865 78899999987654433 3467788888766 69999999999863 57
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
+.|||||||.+||..++++... ...+.|..+.-|+..+++|+.+||.+ .++|||+|-.|||++.++.||+.|||.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeee
Confidence 8999999999999999999865 45699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccccccccccccc-----CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+..++.. -..+....||+.|||||++.- ..++.++|+||+|++..||--|.+|+.+
T Consensus 170 SaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 170 SAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred eeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 9876643 233445669999999999852 3467889999999999999999999953
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=275.74 Aligned_cols=146 Identities=32% Similarity=0.458 Sum_probs=130.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||.||+|.+. +++.||+|+++... .......+.+|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999986 68899999997533 2223456889999999999999999999999899999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
||+.+++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 378899999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=260.19 Aligned_cols=205 Identities=23% Similarity=0.295 Sum_probs=155.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEe-----------------CCCCEEEEEEecccccchhHH--------------HHHH
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL-----------------TDGSLVAVKRLKEERTQGGEL--------------QFQT 334 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~~ 334 (511)
..++|++.++||+|+||+||+|.. ..++.||||+++.... .... ....
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence 467899999999999999999964 2356799999864321 1111 2334
Q ss_pred HHHHHHhCCCCce-----ecccccccc--------CCceeEEeecccCCCHHHHHHhcCC--------------------
Q 010429 335 EVEMISMAVHRNL-----LRLRGFCMT--------PTERLLVYPFMVNGSVASCLRERGQ-------------------- 381 (511)
Q Consensus 335 e~~~l~~~~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 381 (511)
|+.++.+++|.++ ++++++|.. ..+.++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777776654 677777653 3568999999999999999875321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeeccccccccc
Q 010429 382 SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461 (511)
Q Consensus 382 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 461 (511)
....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112357888999999999999999999 99999999999999999999999999997654322221222235789999
Q ss_pred ccccccCCC----------------------CcccCeehhhHHHHHHHhCCC-ccc
Q 010429 462 PEYLSTGKS----------------------SEKTDVFGYGVMLLELITGQR-AFD 494 (511)
Q Consensus 462 PE~~~~~~~----------------------~~~~Dv~s~Gvil~elltg~~-pf~ 494 (511)
||.+..... ..+.||||+||++|||++|.. ||.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 134799999999999999985 775
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=254.82 Aligned_cols=197 Identities=22% Similarity=0.318 Sum_probs=168.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchh-------HHHHHHHHHHHHhCC---CCceecccccccc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAV---HRNLLRLRGFCMT 356 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~~~---h~niv~l~~~~~~ 356 (511)
.+|...+.+|+|+||.|+.+.++ +...|+||.+.+++.-.+ .-..-.||.+|+.++ |+||++++.+|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35788899999999999999987 456789999876652111 112567999999998 9999999999999
Q ss_pred CCceeEEeecc-cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcc
Q 010429 357 PTERLLVYPFM-VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (511)
Q Consensus 357 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 435 (511)
++.+|++||-. ++-+|.++++... .+++.++.-|+.|++-|+++||++ +|||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999986 3558899988654 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
||.|....... ...++||..|.|||++.+..| ...-|||++|++||.++..+.||.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987543322 334679999999999998887 566799999999999999999996
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=231.59 Aligned_cols=200 Identities=34% Similarity=0.505 Sum_probs=171.8
Q ss_pred CCCCCeeccccccEEEEEEeCC-CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeeccc
Q 010429 290 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
|...+.||+|++|.||++.... ++.+|+|.+...........+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999874 889999999765433245678899999999999999999999999899999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+++|.+++...... +++.....++.++++++.+||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999999864321 78899999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeeeccccccccccccc-ccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 449 VTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334578889999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=240.30 Aligned_cols=199 Identities=26% Similarity=0.336 Sum_probs=168.5
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCC--Cc----eeccccccccC
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RN----LLRLRGFCMTP 357 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~n----iv~l~~~~~~~ 357 (511)
...++|.+...+|+|.||.|-...+. .+..||||+++.-. ......+-|+++++++.+ |+ +|.+.+|+...
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 34788999999999999999998765 57899999987532 233446678999998842 33 78899999999
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-----------
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD----------- 426 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~----------- 426 (511)
+..++|+|.+ |-|+.+++..+.. .+++.+.++.|+.|++++++|||+. +++|-||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999988 7799999987543 3589999999999999999999999 999999999999983
Q ss_pred ---------CCCceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 427 ---------EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 427 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++..+|++|||.|+.-.... ...+.|.-|+|||++.+-.+++.+||||+||||+|+.||...|.-
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 13458999999998644332 456689999999999999999999999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=253.69 Aligned_cols=194 Identities=25% Similarity=0.368 Sum_probs=163.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.+.|.....+|.|+|+.|-..... +++..+||++.+... +-.+|+.++.+. +||||+++.+.+.+..+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 466777888999999999888765 678899999976521 234677666555 6999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee-CCCCceEEcccccccccC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~ 443 (511)
|.+.++-+.+.+...+. .. ..+.+|+.+|+.|+.|||++ |+|||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988887765432 22 67788999999999999999 99999999999999 588999999999998665
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.. ....+-|..|.|||++....+++++|+||||++||+|++|+.||....
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 43 222235789999999999999999999999999999999999998544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=260.98 Aligned_cols=201 Identities=21% Similarity=0.232 Sum_probs=144.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-C----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccc------c
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-D----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF------C 354 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~------~ 354 (511)
..++|.+.+.||+|+||.||+|++. + +..||+|++...... .....| .+....+.++..+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4578999999999999999999976 4 689999988643211 111111 1222222233222221 2
Q ss_pred ccCCceeEEeecccCCCHHHHHHhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 010429 355 MTPTERLLVYPFMVNGSVASCLRERGQS----------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418 (511)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 418 (511)
....+.+++|||+.+++|.++++..... ........+..++.|+++||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 3556789999999999999998754210 00112345668999999999999999 9999999
Q ss_pred CCCCeeeCC-CCceEEcccccccccCCCCCceeeecccccccccccccccC----------------------CCCcccC
Q 010429 419 KAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----------------------KSSEKTD 475 (511)
Q Consensus 419 kp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 475 (511)
||+|||+++ ++.+||+|||+|+.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986654433334456689999999965322 1334679
Q ss_pred eehhhHHHHHHHhCCCccc
Q 010429 476 VFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 476 v~s~Gvil~elltg~~pf~ 494 (511)
||||||++|||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999887765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=233.21 Aligned_cols=213 Identities=26% Similarity=0.363 Sum_probs=181.1
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccc
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~ 353 (511)
..++.+..++++....+-+|.||.||+|.+. +.+.|-||.++...++-....+..|.-.+....|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4567777888888899999999999999654 3445788888877777677778899988999999999999998
Q ss_pred cccC-CceeEEeecccCCCHHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 010429 354 CMTP-TERLLVYPFMVNGSVASCLRERGQ----SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (511)
Q Consensus 354 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 428 (511)
+.++ ...+++|+++.-|+|..++...+. ....++..+...++.|++.|++|||+. ++||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8764 567899999999999999985332 223478888899999999999999999 99999999999999999
Q ss_pred CceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 429 FEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 429 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.++||+|=.+++.+.+.+.+- ........+||+||.+....++.++|||||||++|||+| |+.|+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 999999999999876655442 233346779999999999999999999999999999999 9999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=230.68 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=162.6
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecc-cccchhHHHHHHHHHHHHhCCCCceeccccccccC--------C
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--------T 358 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--------~ 358 (511)
.|....+||+|.||.||+|+.+ +|+.||+|++-- ...+.-.....+|+.++..+.|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999876 577788876532 22333344577999999999999999999988642 3
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||.+|+. +|.-.+..... .++..++.+++.++..||.|+|++ .|+|||+|+.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 47899999976 67766655322 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC---ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 439 AKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++.+..... ...+..+-|..|++||.+.+. .+++..|||..|||+.||.||.+-|..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 976543322 223344569999999998875 588999999999999999999998864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=255.34 Aligned_cols=197 Identities=30% Similarity=0.409 Sum_probs=161.7
Q ss_pred CCCCCeeccccccE-EEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecc
Q 010429 290 FSNRNILGRGGFGK-VYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 290 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
|...+++|.|+-|+ ||+|.+. |+.||||++-.+. ....++|+..++.- +|||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44456789999876 6999996 8899999985432 33467899998887 4999999999988888999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---C--CceEEccccccccc
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---E--FEAVVGDFGLAKLM 442 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfg~a~~~ 442 (511)
..+|.++++................++.|+++|+++||+. +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6799999987422222222255678899999999999998 9999999999999976 3 47899999999988
Q ss_pred CCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHhC-CCcccc
Q 010429 443 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDL 495 (511)
Q Consensus 443 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg-~~pf~~ 495 (511)
....... .....||-+|+|||++....-+..+||||+||++|+.++| ++||..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 7654433 2345599999999999999888999999999999999996 999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=226.15 Aligned_cols=187 Identities=35% Similarity=0.510 Sum_probs=164.6
Q ss_pred cccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCHHHHHHh
Q 010429 300 GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE 378 (511)
Q Consensus 300 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 378 (511)
+||.||++... +++.+|+|++...........+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 58999999997654433256789999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeecccccc
Q 010429 379 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458 (511)
Q Consensus 379 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~ 458 (511)
... +++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 432 78999999999999999999999 99999999999999999999999999998765432 2233457889
Q ss_pred cccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 459 y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|++||...+...+.++||||||+++|++++|+.||+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888889999999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=224.65 Aligned_cols=195 Identities=26% Similarity=0.328 Sum_probs=164.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC------C
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~ 358 (511)
..+|..++.+|.|.. .|..+.+. .+++||+|++.... .....++..+|...+..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777888999998 66666654 68899999874332 223345678999999999999999999988643 4
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
+.|+|||+| ..+|...+... ++..+...|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 678999999 66888887732 78889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
|+.-+.. ...+..+.|..|.|||++.+..+...+||||+||++.||++|+.-|.
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 9864432 34556678999999999998889999999999999999999999996
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=212.11 Aligned_cols=195 Identities=22% Similarity=0.334 Sum_probs=164.6
Q ss_pred hhCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccC--CceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~--~~~~l 362 (511)
.++|++.+.+|+|.|+.||.|.. .+.+.++||.+++-. .+.+.+|+.++..++ ||||+++++...++ ....+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 46788889999999999999984 478899999998643 345889999999998 99999999998876 45679
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 441 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 441 (511)
|+||+.+.+....-.. ++.-.++.++.+++.||.|+|+. ||+|||+||.|+++|.. -.++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999998877655433 77788899999999999999999 99999999999999865 4799999999998
Q ss_pred cCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+.+... ..-.+.+..|..||.+-. +.++..-|+|||||++.+|+..+.||-...
T Consensus 183 YHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 183 YHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred cCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 865433 333446788999998754 457888999999999999999999997654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-28 Score=239.55 Aligned_cols=198 Identities=28% Similarity=0.395 Sum_probs=170.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|+....+|+|.||.|||+++. +++..|+|+++-+.. ....-.++|+-+++..+||||+.++|.+...+..|++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 467888899999999999999976 789999999986543 334457889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
||.+|+|++.-+.. .++++.++..+.+...+|++|||++ +-+|||||-.||++++.|.+|++|||.+-.+..
T Consensus 93 ycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred ecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-
Confidence 99999998865543 3589999999999999999999999 999999999999999999999999999865542
Q ss_pred CCceeeeccccccccccccc---ccCCCCcccCeehhhHHHHHHHhCCCcc
Q 010429 446 DTHVTTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAF 493 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gvil~elltg~~pf 493 (511)
.-....++.||++|||||+. +.+.|.+++|||+.|+...|+---++|.
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 22234567799999999975 4567899999999999999998777665
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=213.42 Aligned_cols=199 Identities=21% Similarity=0.371 Sum_probs=157.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHH-HhCCCCceeccccc-cccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLRLRGF-CMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~~~-~~~~~~~~lv~ 364 (511)
+.|.+.+.+|+|.||.+-+++++ +...+++|.+..... ..++|.+|..-- ..-.|.||+.-++. |+..+.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 56888899999999999999987 677899999876543 345688887643 33458999887654 55667788999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCCceEEccccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLM 442 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~ 442 (511)
||++.|+|.+-+...+ +.+...+.++.|+++|+.|+|++ .+||||||.+||||- +..++|++|||..+..
T Consensus 102 E~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999998777643 78899999999999999999999 999999999999993 3348999999998754
Q ss_pred CCCCCceeeecccccccccccccccC-----CCCcccCeehhhHHHHHHHhCCCcccccccCC
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~elltg~~pf~~~~~~~ 500 (511)
+..-. ...-+..|.+||..... ...+.+|+|.||++++.++||++||+.+.+.+
T Consensus 174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d 232 (378)
T KOG1345|consen 174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD 232 (378)
T ss_pred Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence 32111 11235678999976432 23677899999999999999999998655443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=220.97 Aligned_cols=132 Identities=23% Similarity=0.349 Sum_probs=112.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-----CC---ceecccccccc-
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----HR---NLLRLRGFCMT- 356 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h~---niv~l~~~~~~- 356 (511)
..+|..+++||-|-|++||++.+. +.+.||+|+.+... ...+....||+++++++ |+ .||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 468889999999999999999875 67789999987543 33445678999998875 33 49999999874
Q ss_pred ---CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 010429 357 ---PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (511)
Q Consensus 357 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 425 (511)
..+.++|+|++ |.+|..+++.....+ ++...+++|+.||+.||.|||+.| ||||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999998 889999998865544 899999999999999999999999 99999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=203.19 Aligned_cols=184 Identities=36% Similarity=0.544 Sum_probs=159.5
Q ss_pred eccccccEEEEEEeCC-CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCHHH
Q 010429 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 374 (511)
||+|++|.||++...+ ++.+++|++...........+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999765443234578999999999999999999999999899999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCceEEcccccccccCCCCCceeeec
Q 010429 375 CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAV 453 (511)
Q Consensus 375 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 453 (511)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 998653 2489999999999999999999999 9999999999999999 89999999999976544321 12234
Q ss_pred ccccccccccccccC-CCCcccCeehhhHHHHHH
Q 010429 454 RGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLEL 486 (511)
Q Consensus 454 ~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el 486 (511)
.+...|++||..... ..+.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 478899999998877 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=215.10 Aligned_cols=200 Identities=27% Similarity=0.390 Sum_probs=166.6
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCC
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT 358 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~ 358 (511)
....+.|...++||+|.|++||++.+. ..+.||+|.+..... ..++..|++++..+. +.||+++.+++...+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 345677888999999999999999754 467899999876443 345889999999986 899999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFG 437 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 437 (511)
...+|+||+++....++... ++..++..++..+..||+++|.+ |||||||||+|+|.+.. +.-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 99999999999998888775 67889999999999999999999 99999999999999864 678999999
Q ss_pred cccccCCC-------C--------------------------C----------ceeeecccccccccccccccCC-CCcc
Q 010429 438 LAKLMDYK-------D--------------------------T----------HVTTAVRGTIGHIAPEYLSTGK-SSEK 473 (511)
Q Consensus 438 ~a~~~~~~-------~--------------------------~----------~~~~~~~gt~~y~aPE~~~~~~-~~~~ 473 (511)
+|...+.. . . ...-...||++|+|||++.... -+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 98732100 0 0 0001235999999999987654 5788
Q ss_pred cCeehhhHHHHHHHhCCCccccc
Q 010429 474 TDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 474 ~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+||||.|||+..++++++||--+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred cceeeccceeehhhccccccccC
Confidence 99999999999999999999644
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=222.37 Aligned_cols=208 Identities=22% Similarity=0.243 Sum_probs=173.5
Q ss_pred CHHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC------CCceeccc
Q 010429 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNLLRLR 351 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~------h~niv~l~ 351 (511)
.+.-.++...+|.+....|+|-|++|.+|.+. -|..||||+++.... -.+.=++|+++|++++ .-+.++++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 34445567788999999999999999999876 578999999975432 1223467999999986 34689999
Q ss_pred cccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-c
Q 010429 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-E 430 (511)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~ 430 (511)
-.|...++.|||+|-+ .-+|.+.|+.++... .+....+..++.|+.-||..|... +|+|.||||.|||+++.. .
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nv-GL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNV-GLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCccc-ceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 9999999999999977 668999999876543 488999999999999999999987 999999999999999864 6
Q ss_pred eEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+||||||.|....... .+...-+..|.|||++.+-+|+...|+||+||+||||.||+..|-..
T Consensus 576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 8999999997654322 23333566899999999999999999999999999999999999643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=216.37 Aligned_cols=166 Identities=22% Similarity=0.213 Sum_probs=129.2
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC--CCCEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCceec-cccccccC
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLR-LRGFCMTP 357 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~-l~~~~~~~ 357 (511)
...+.|...+.||+|+||+||+|.+. +++.||||++.... .......+.+|++++++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 45578999999999999999999875 57778999875331 1223456899999999999999885 4432
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeeeCCCCceEEccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDF 436 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Df 436 (511)
+..++||||+++++|.. ... .. ...++.|+++||+|||+. ||+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45799999999999963 211 11 146788999999999999 9999999 999999999999999999
Q ss_pred ccccccCCCCCc-------eeeecccccccccccccccC
Q 010429 437 GLAKLMDYKDTH-------VTTAVRGTIGHIAPEYLSTG 468 (511)
Q Consensus 437 g~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 468 (511)
|+|+.+...... ......+++.|+|||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999876443211 11345688899999998644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=238.99 Aligned_cols=185 Identities=34% Similarity=0.616 Sum_probs=131.2
Q ss_pred HHHhhhhccCCcHHHHHHHHHHhcCCCCCCCCCCCCCCCCCccccceEeCCCCCeeEEecCCCCcceecchhhcCCCCCc
Q 010429 17 FFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQ 96 (511)
Q Consensus 17 ~~~~~~~~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~ 96 (511)
++.+......+.|++||++||+++.||.+.+.+|+.. .+||.|.||+|+..++|+.|+|++|++++.++..|..+++|+
T Consensus 18 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~ 96 (968)
T PLN00113 18 FLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQ 96 (968)
T ss_pred HHHHHccCCCHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCC
Confidence 3334445557789999999999998898889999753 589999999998778999999999999999999999999999
Q ss_pred EEEeeccCCCCCCCchhc-CCccccccccccccccCCCC----------------------cccccccccceeeccCccc
Q 010429 97 YLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLNGPIP----------------------TTLGKLSKLRFLRLNNNSL 153 (511)
Q Consensus 97 ~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~i~~~~p----------------------~~~~~l~~L~~L~L~~N~l 153 (511)
.|+|++|++++.+|..+. .+++|++|+|++|++++.+| ..++++++|++|+|++|.+
T Consensus 97 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l 176 (968)
T PLN00113 97 TINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176 (968)
T ss_pred EEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcc
Confidence 999999999988887654 77777777777777765544 4444445555555555555
Q ss_pred CCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCCCC
Q 010429 154 MGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 154 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~~ 202 (511)
.+.+|..+.++++|++|+|++|.+++.+| .+..+++|+.|++++|.+.+
T Consensus 177 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 44445555555555555555555544433 23444555555555555443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=204.70 Aligned_cols=202 Identities=21% Similarity=0.253 Sum_probs=164.3
Q ss_pred CCCCCCeeccccccEEEEEEeCCC--CEEEEEEecccccchhHHHHHHHHHHHHhCCC----Cceecccccc-ccCCcee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLTDG--SLVAVKRLKEERTQGGELQFQTEVEMISMAVH----RNLLRLRGFC-MTPTERL 361 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h----~niv~l~~~~-~~~~~~~ 361 (511)
+|.+.+.||+|+||.||.+..... ..+|+|........... .+..|..++..+.. +++..++... ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999997643 47888887654333222 57778888887763 5788888877 4677889
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-----CceEEccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDF 436 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df 436 (511)
+||+.+ |.+|.++..... ...++..+..+|+.|++.+|+++|+. |++||||||.|+++... ..+.+.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999977 889999887655 34599999999999999999999999 99999999999999865 46999999
Q ss_pred cccc--ccCCCCCc------e-eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 437 GLAK--LMDYKDTH------V-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 437 g~a~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
|+++ .+...... . .....||.+|+++++..+...+++.|+||++.++.|++.|..||....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 9998 33222111 1 123459999999999999999999999999999999999999996544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=230.43 Aligned_cols=147 Identities=13% Similarity=0.096 Sum_probs=113.5
Q ss_pred CCC-Cceeccccccc-------cCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 010429 342 AVH-RNLLRLRGFCM-------TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413 (511)
Q Consensus 342 ~~h-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 413 (511)
.+| +||+++++++. ....++.++||+ +++|.++++... ..+++.+++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 445 57888888772 234567788887 669999997532 3489999999999999999999999 99
Q ss_pred EecCCCCCCeeeCC-------------------CCceEEcccccccccCCCC---------------Cceeeeccccccc
Q 010429 414 IHRDVKAANILLDE-------------------EFEAVVGDFGLAKLMDYKD---------------THVTTAVRGTIGH 459 (511)
Q Consensus 414 vH~Dlkp~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~gt~~y 459 (511)
+||||||+|||++. ++.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666777665321100 0001113478899
Q ss_pred ccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 460 ~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
||||++.+..++.++|||||||++|||++|.+|+..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999999999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-23 Score=181.81 Aligned_cols=205 Identities=20% Similarity=0.249 Sum_probs=168.8
Q ss_pred HhhCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCC-CceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~~~lv 363 (511)
....|..++.||+|+||.+|.|.. .+|+.||||+-..... ..++..|..+...+++ ..|..+..+..+.....+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 446789999999999999999974 5899999998654332 2246788889998886 5688888888888999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CceEEccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAK 440 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~ 440 (511)
|+.+ |-||++.+.-... .++..+.+-++.|++.-++|+|.. +++||||||+|+|..-+ ..+.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9988 8899998876543 288899999999999999999999 99999999999999644 468999999998
Q ss_pred ccCCCCC------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccccCC
Q 010429 441 LMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500 (511)
Q Consensus 441 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~~~ 500 (511)
.+..... .......||.+|.+-....+-..+++.|+-|+|.++.++--|..||+.-..++
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 7643211 12233559999999888777788899999999999999999999998655443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=193.18 Aligned_cols=202 Identities=33% Similarity=0.496 Sum_probs=171.0
Q ss_pred CCCCCeeccccccEEEEEEeCCCCEEEEEEecccccch--hHHHHHHHHHHHHhCCCC-ceeccccccccCCceeEEeec
Q 010429 290 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~-niv~l~~~~~~~~~~~lv~e~ 366 (511)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|...+..+.|+ +++++...+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999986 889999997665444 366799999999999988 799999999766678999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 445 (511)
+.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654321 2488999999999999999999999 999999999999999998 7999999999855443
Q ss_pred CCc-----eeeeccccccccccccccc---CCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 446 DTH-----VTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 446 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 2355669999999999987 577889999999999999999999976554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-22 Score=180.71 Aligned_cols=141 Identities=18% Similarity=0.186 Sum_probs=108.8
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccccch-h------------------------HHHHHHHHHHHHhCCCCce
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-G------------------------ELQFQTEVEMISMAVHRNL 347 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~e~~~l~~~~h~ni 347 (511)
.+.||+|++|.||+|...+|+.||||+++...... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999997543211 0 0122458899999988776
Q ss_pred eccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeeeC
Q 010429 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRDVKAANILLD 426 (511)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~NIll~ 426 (511)
.....+. ....++||||++++++....... .+++...+..++.|++.+|+|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 4433322 23348999999988776543222 2488899999999999999999 688 999999999999998
Q ss_pred CCCceEEcccccccccC
Q 010429 427 EEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 427 ~~~~~kl~Dfg~a~~~~ 443 (511)
+ +.++|+|||+|...+
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 4 689999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=182.90 Aligned_cols=202 Identities=18% Similarity=0.270 Sum_probs=168.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e 365 (511)
-.|.+.++||+|+||+.+.|+.- +++.||||.-.. .++.-++..|....+.+. .+.|..++-+..+.....||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 46888999999999999999853 799999997542 222345788888888886 5888888877788888899999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-----CCceEEccccccc
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLAK 440 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~ 440 (511)
.+ |-||+++..-.+. .++..++..||.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+
T Consensus 105 LL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 88 8899998876554 389999999999999999999999 9999999999999964 3468999999999
Q ss_pred ccCCCCC------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccccC
Q 010429 441 LMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 499 (511)
Q Consensus 441 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~~ 499 (511)
.+..... ....+..||.+||+-....+++-+++.|+-|+|-++.+.+-|..||..-..+
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 8743322 1233456999999999999999999999999999999999999999865544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-22 Score=181.33 Aligned_cols=173 Identities=10% Similarity=0.096 Sum_probs=133.2
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhH--HH------HHHHHHHHHhCCCCceecccccccc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE--LQ------FQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
....+|...+++|.|+||.||.+.. ++..+|+|.+++....... .. +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 5678999999999999999999766 5778999999765432221 12 5789999999999999998887553
Q ss_pred C--------CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 010429 357 P--------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (511)
Q Consensus 357 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 428 (511)
. ...+++|||++|.+|.++.. ++. ....+++.++..+|+. |++|||++|+||+++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 2 35789999999999977632 222 2456889999999999 99999999999999999
Q ss_pred CceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHH
Q 010429 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 487 (511)
Q Consensus 429 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ell 487 (511)
+ ++++|||........... ......+.+..++|+||||+.+..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988644211110 11334445667899999999887654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=204.09 Aligned_cols=148 Identities=34% Similarity=0.617 Sum_probs=120.5
Q ss_pred ccCCcHHHHHHHHHHhcCCCCCCCCCCCCCCCCCc-----cccceEeCCC-----CCeeEEecCCCCcceecchhhcCCC
Q 010429 24 VASNAEGDALNALKTNLADPNNVLQSWDATLVNPC-----TWFHVTCNSE-----NSVTRVDLGNANLSGQLVSQLGQLT 93 (511)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c-----~w~gv~c~~~-----~~l~~l~L~~~~l~~~~~~~~~~l~ 93 (511)
.+.+.|.+||+++|.++.+|.. .+|++ +|| .|.||.|... ..|+.|+|++|+++|.+|..+..++
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 3466799999999999976643 48965 456 7999999521 1488999999999999999999999
Q ss_pred CCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccC-CCCceEec
Q 010429 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNV-NSLQVLDL 172 (511)
Q Consensus 94 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l 172 (511)
+|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+++|.+|..+..+ .++..+++
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~ 522 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence 99999999999998999889999999999999999998899999999999999999999988888877643 34445555
Q ss_pred cccc
Q 010429 173 SNNK 176 (511)
Q Consensus 173 ~~N~ 176 (511)
.+|.
T Consensus 523 ~~N~ 526 (623)
T PLN03150 523 TDNA 526 (623)
T ss_pred cCCc
Confidence 5543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=173.64 Aligned_cols=141 Identities=18% Similarity=0.201 Sum_probs=110.8
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccccch--------------------h-----HHHHHHHHHHHHhCCCCce
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG--------------------G-----ELQFQTEVEMISMAVHRNL 347 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~e~~~l~~~~h~ni 347 (511)
.+.||+|++|.||+|...+|+.||||+++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987542110 0 1124578899999999987
Q ss_pred eccccccccCCceeEEeecccCCCHHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeee
Q 010429 348 LRLRGFCMTPTERLLVYPFMVNGSVASC-LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILL 425 (511)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll 425 (511)
.....+... ..++||||++++++... +... .++......++.|++.++.++|+ . ||+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 544433322 35899999998855433 3321 36788999999999999999999 8 99999999999999
Q ss_pred CCCCceEEcccccccccCC
Q 010429 426 DEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 426 ~~~~~~kl~Dfg~a~~~~~ 444 (511)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-22 Score=180.10 Aligned_cols=191 Identities=24% Similarity=0.389 Sum_probs=153.0
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCC
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
..+|.+...|..|+|+++ |..+++|+++... +.....+|..|.-.++.+.||||++++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346888999999999997 6777788876433 33344569999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEc--ccccccccCCCCCce
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG--DFGLAKLMDYKDTHV 449 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfg~a~~~~~~~~~~ 449 (511)
|+..+++.. ...++..++.+++.++|+|++|||+. .+-|.---|.+..+++|++.+++|+ |--++. ..
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf---qe---- 343 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QE---- 343 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee---ec----
Confidence 999999753 33478899999999999999999996 3334445689999999999888774 321111 01
Q ss_pred eeecccccccccccccccCCC---CcccCeehhhHHHHHHHhCCCcccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
....-.|.||+||.++..+. -+.+|+|||++++||+.|.+.||..
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 11113678999999987654 3578999999999999999999964
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=173.12 Aligned_cols=106 Identities=27% Similarity=0.320 Sum_probs=93.9
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|.++++..+. ++++.++..++.|+++||+|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 688999986432 499999999999999999999998 6 999999999999999 99987654322
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 2489999999999999999999999999999999999999964
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=167.46 Aligned_cols=187 Identities=17% Similarity=0.068 Sum_probs=138.2
Q ss_pred CCCeeccccccEEEEEEeCCCCEEEEEEecccccchh---HHHHHHHHHHHHhCCC-CceeccccccccCCceeEEeecc
Q 010429 292 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---ELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 292 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
....|++|+||+||.+.. .+.+++.+.+........ ...+.+|+++++++.| +++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346899999999998876 578888887764432111 2247899999999964 778888876 4579999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeeeCCCCceEEcccccccccCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
.|.+|...... ....++.|++++++++|+. ||+|||| ||+|||+++++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99988653321 1135778999999999999 9999999 7999999999999999999998554322
Q ss_pred Cc----ee--------eecccccccccccccccC-CCC-cccCeehhhHHHHHHHhCCCcccccc
Q 010429 447 TH----VT--------TAVRGTIGHIAPEYLSTG-KSS-EKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 447 ~~----~~--------~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.. .. .-...++.|++|+....- ..+ .+.+.++-|.-+|.++|+..|+-...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 00 001256777888754322 222 45789999999999999998875443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-21 Score=200.67 Aligned_cols=202 Identities=22% Similarity=0.321 Sum_probs=159.9
Q ss_pred CCCeeccccccEEEEEEeC-CCCEEEEEEec----ccccchh-HHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 292 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLK----EERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 292 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..+++|.|++|.|+..... ..+..+.|.++ ....... ...+..|+-+-..+.|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988777543 34444455433 1111111 1125567777778899999988888887777776799
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
||++ +|...+.... .++..++..++.|+..|++|+|+. |+.|||+|++|++++.++.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999888652 278889999999999999999999 9999999999999999999999999999765443
Q ss_pred CC---ceeeecccccccccccccccCCCCc-ccCeehhhHHHHHHHhCCCcccccccCCC
Q 010429 446 DT---HVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLAND 501 (511)
Q Consensus 446 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~elltg~~pf~~~~~~~~ 501 (511)
.. ......+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||..+...++
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 22 3445577999999999999988854 57999999999999999999998776654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-20 Score=196.15 Aligned_cols=202 Identities=21% Similarity=0.236 Sum_probs=164.0
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCC---CCceecccccccc
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMT 356 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~ 356 (511)
..+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+...... |.-=.+++.|++ -+-|..+...+..
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 445667788899999999999999999998889999999877654332 222223344444 2445666666677
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-------CC
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-------EF 429 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~ 429 (511)
.+.-++|+||.+.|+|.+++...+ .++|.....+..|+++-+++||.. +|||+||||+|+++.. ..
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred CCcceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 888899999999999999998433 489999999999999999999999 9999999999999942 34
Q ss_pred ceEEcccccccccCCC-CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCc
Q 010429 430 EAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 492 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p 492 (511)
-++|+|||.+-.+..- +.......++|-.+-.+|+..++.+++++|.|.++-+++-|+.|++-
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 5899999999765432 33355667789999999999999999999999999999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.6e-21 Score=190.96 Aligned_cols=187 Identities=27% Similarity=0.318 Sum_probs=156.4
Q ss_pred eeccccccEEEEEE----eCCCCEEEEEEecccccchh-HHHHHHHHHHHHhCC-CCceeccccccccCCceeEEeeccc
Q 010429 295 ILGRGGFGKVYKGR----LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMV 368 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~ 368 (511)
.+|+|.||.|+.++ .+.|..+|.|+.++...... ......|..++...+ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999764 23577899998865442221 224556788888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
+|.+...+..... +++.....+...++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988876443 77788888888899999999999 9999999999999999999999999999865332221
Q ss_pred eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999987 566789999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=161.97 Aligned_cols=138 Identities=20% Similarity=0.241 Sum_probs=105.5
Q ss_pred CCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhC-----CCCceeccccccccCC---c-ee
Q 010429 291 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLRGFCMTPT---E-RL 361 (511)
Q Consensus 291 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-----~h~niv~l~~~~~~~~---~-~~ 361 (511)
...+.||+|+||.||. ++.....+||++.... ......+.+|+.++..+ +||||++++|++.++. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4457899999999996 4333334789886543 22345689999999999 5799999999998864 3 33
Q ss_pred EEeec--ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeeeCCC----CceEEc
Q 010429 362 LVYPF--MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL-AYLHDHCDPKIIHRDVKAANILLDEE----FEAVVG 434 (511)
Q Consensus 362 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~ 434 (511)
+|+|| +.+|+|.+++++.. +++. ..++.+++.++ +|||++ +|+||||||+|||++.. ..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 55899999997632 4444 35677888777 999999 99999999999999743 379999
Q ss_pred c-cccccc
Q 010429 435 D-FGLAKL 441 (511)
Q Consensus 435 D-fg~a~~ 441 (511)
| ||....
T Consensus 152 Dg~G~~~~ 159 (210)
T PRK10345 152 DNIGESTF 159 (210)
T ss_pred ECCCCcce
Confidence 9 554433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=160.99 Aligned_cols=143 Identities=15% Similarity=0.104 Sum_probs=110.3
Q ss_pred CCCCCCeeccccccEEEEEE--eCCCCEEEEEEecccccch-----------------------hHHHHHHHHHHHHhCC
Q 010429 289 NFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQG-----------------------GELQFQTEVEMISMAV 343 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~~~ 343 (511)
.|.+.+.||+|++|.||+|. ..+|+.||+|+++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 4589999999987532110 1123568999999987
Q ss_pred CCc--eeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCC
Q 010429 344 HRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-IIHRDVKA 420 (511)
Q Consensus 344 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp 420 (511)
+.. +.+++++ ...++||||++++++....... ..........++.|++.++++||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3333332 3458999999998887654221 1255667789999999999999999 8 99999999
Q ss_pred CCeeeCCCCceEEcccccccccC
Q 010429 421 ANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 421 ~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
+||+++ ++.++++|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 7899999999987544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=161.95 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=129.2
Q ss_pred CCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCC-----------Cceeccccccc--
Q 010429 292 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVH-----------RNLLRLRGFCM-- 355 (511)
Q Consensus 292 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h-----------~niv~l~~~~~-- 355 (511)
..+.||.|+++.||.+.+. +|+.+|||++.... .....+++++|.-....+.+ ..++++ +...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~i~ 94 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLRIP 94 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEEET
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEEEc
Confidence 3468999999999999987 58999999874332 33344556666655444322 112221 1111
Q ss_pred -------cC---C-----ceeEEeecccCCCHHHHHHh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 010429 356 -------TP---T-----ERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417 (511)
Q Consensus 356 -------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 417 (511)
.. . ..+++|+-+ .++|.+.+.. .......+....+..+..|+++.+++||+. |++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 11 1 235677877 6688777543 222222345566678889999999999999 999999
Q ss_pred CCCCCeeeCCCCceEEcccccccccCCCCCceeeecccccccccccccccC--------CCCcccCeehhhHHHHHHHhC
Q 010429 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--------KSSEKTDVFGYGVMLLELITG 489 (511)
Q Consensus 418 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~s~Gvil~elltg 489 (511)
|+|+|++++++|.++|+||+.....+. .......+..|.+||..... .++.+.|.|++|+++|.|..|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999998764332 12213356789999976432 367889999999999999999
Q ss_pred CCcccccccC
Q 010429 490 QRAFDLARLA 499 (511)
Q Consensus 490 ~~pf~~~~~~ 499 (511)
..||+.....
T Consensus 247 ~lPf~~~~~~ 256 (288)
T PF14531_consen 247 RLPFGLSSPE 256 (288)
T ss_dssp S-STCCCGGG
T ss_pred cCCCCCCCcc
Confidence 9999865444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.6e-18 Score=155.09 Aligned_cols=141 Identities=20% Similarity=0.135 Sum_probs=109.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccc---------------------hhHHHHHHHHHHHHhCCCC
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---------------------GGELQFQTEVEMISMAVHR 345 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~~~h~ 345 (511)
...|...+.||+|+||.||++...+|+.||||+++..... ........|+..+..+.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 3347778999999999999999888999999987643210 0112356788888888777
Q ss_pred c--eeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 010429 346 N--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (511)
Q Consensus 346 n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 423 (511)
+ +...++ ....+++|||++++++...... .....++.+++.++.++|+. +++||||||+||
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni 156 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI 156 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence 4 344433 2456899999999988764321 34567889999999999998 999999999999
Q ss_pred eeCCCCceEEcccccccccCC
Q 010429 424 LLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~ 444 (511)
++++++.++|+|||.+...+.
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-18 Score=156.44 Aligned_cols=136 Identities=19% Similarity=0.299 Sum_probs=114.1
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccch-------hHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+.||+|++|.||+|.. .|..+++|+........ ...++.+|++++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 57889999865432111 123577899999999999988777777777888999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
++|++|.+.+... .. .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988642 12 7889999999999999999 999999999999999 789999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.8e-18 Score=153.70 Aligned_cols=132 Identities=18% Similarity=0.299 Sum_probs=107.5
Q ss_pred eeccccccEEEEEEeCCCCEEEEEEecccccc-------hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
.||+|++|.||+|.+ +|..+++|........ ....++.+|++++..++|+++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 4788999986532211 11245778999999999887665555566677789999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
++++|.+.+.... ..++.+++++|+++|+. +++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875421 07899999999999999 999999999999999 789999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=174.23 Aligned_cols=140 Identities=18% Similarity=0.256 Sum_probs=112.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEe-cccccc------hhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEERTQ------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
...|...+.||+|+||+||++.+... .+++|+. .+.... ....++.+|++++.+++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999988643 3444432 221111 123458899999999999999887777777778
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+++|||+++++|.+++. ....++.+++++|+|||+. +++|||+||+||++ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999998875 3467899999999999999 99999999999999 5779999999999
Q ss_pred cccC
Q 010429 440 KLMD 443 (511)
Q Consensus 440 ~~~~ 443 (511)
+..+
T Consensus 475 ~~~~ 478 (535)
T PRK09605 475 KYSD 478 (535)
T ss_pred ccCC
Confidence 7643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-18 Score=182.26 Aligned_cols=200 Identities=24% Similarity=0.285 Sum_probs=151.7
Q ss_pred CCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHH---HHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~---e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++...+.+|++.|=+|.++++++|. |+||++.+....-....|.+ |++ ...++|||.+++.-+-..+...|+|=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556688999999999999998777 89999865543333333433 444 556789999999888777777888888
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc--cC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~--~~ 443 (511)
|.. -+|++.+.. ++-+...+.+-|+.|++.|+.-+|.. ||+|||||.+|||++.-.=+.|+||-.-+. +.
T Consensus 102 yvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 874 467776654 34578888999999999999999999 999999999999999988899999976542 12
Q ss_pred CCCCcee----eecccccccccccccccCC-----------CCcccCeehhhHHHHHHHh-CCCccccccc
Q 010429 444 YKDTHVT----TAVRGTIGHIAPEYLSTGK-----------SSEKTDVFGYGVMLLELIT-GQRAFDLARL 498 (511)
Q Consensus 444 ~~~~~~~----~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~s~Gvil~ellt-g~~pf~~~~~ 498 (511)
.++.... .+...-..|.|||.+-... .+++.||||+||++.||++ |++||+.+++
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL 244 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL 244 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH
Confidence 2221111 1122345799999874311 3678999999999999998 7999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.2e-17 Score=154.10 Aligned_cols=145 Identities=25% Similarity=0.354 Sum_probs=107.8
Q ss_pred CCCCceeccccccccC---------------------------CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHH
Q 010429 342 AVHRNLLRLRGFCMTP---------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 394 (511)
Q Consensus 342 ~~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i 394 (511)
.+|||||++.++|.+. ...|+||.-. ..+|..++..+. .+.....-+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~ 346 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVI 346 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHH
Confidence 4599999999887531 2347787766 447787776543 566677888
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCC--ceEEcccccccccCCC-----CCceeeeccccccccccccc
Q 010429 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEF--EAVVGDFGLAKLMDYK-----DTHVTTAVRGTIGHIAPEYL 465 (511)
Q Consensus 395 ~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfg~a~~~~~~-----~~~~~~~~~gt~~y~aPE~~ 465 (511)
+.|+++|+.|||.+ ||.|||+|++|||+. +|+ ...|+|||++-.-+.. .....-...|.-.-||||+.
T Consensus 347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 99999999999999 999999999999984 443 4678999987422110 01111122377789999987
Q ss_pred ccCC------CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 466 STGK------SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 466 ~~~~------~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
...+ .-.|+|.|+.|-+.||+++...||..
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 6432 13689999999999999999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.5e-17 Score=163.95 Aligned_cols=155 Identities=25% Similarity=0.470 Sum_probs=128.9
Q ss_pred HhCCCCceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecCC
Q 010429 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI-IHRDV 418 (511)
Q Consensus 340 ~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dl 418 (511)
+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..... .+++.....++.+++.||+|+|+. .| .|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~---~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI---KLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc---CccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 567899999999999999999999999999999999987332 489999999999999999999997 55 89999
Q ss_pred CCCCeeeCCCCceEEcccccccccCC-CCCceeeecccccccccccccccCC-------CCcccCeehhhHHHHHHHhCC
Q 010429 419 KAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGK-------SSEKTDVFGYGVMLLELITGQ 490 (511)
Q Consensus 419 kp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~s~Gvil~elltg~ 490 (511)
+++|+++|....+|++|||+...... ..........-..-|.|||.++... .++++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999876532 1111111222455799999987642 467799999999999999999
Q ss_pred CcccccccCC
Q 010429 491 RAFDLARLAN 500 (511)
Q Consensus 491 ~pf~~~~~~~ 500 (511)
.||+......
T Consensus 156 ~~~~~~~~~~ 165 (484)
T KOG1023|consen 156 GPFDLRNLVE 165 (484)
T ss_pred CccccccccC
Confidence 9998654443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=173.48 Aligned_cols=165 Identities=25% Similarity=0.396 Sum_probs=121.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|..++.|..|+||.||.++++ ..++.|.| +++... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc--cccccCCccee-----------------
Confidence 357888999999999999999987 46678884 443221 1110 22233333333
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+-...++..+. ++.+ ++.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++..-..
T Consensus 136 ----gDc~tllk~~g~----lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP----LPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhcccCCC----Ccch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 444555544322 2222 26789999999 9999999999999999999999999998653110
Q ss_pred --------------CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 --------------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......++||+.|.|||++..+.|...+|.|++|+|+||.+-|+.||...
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 011223467999999999999999999999999999999999999999765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=142.15 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=97.3
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccccchhH-HH----------------------HHHHHHHHHhCCCCc--e
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE-LQ----------------------FQTEVEMISMAVHRN--L 347 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~----------------------~~~e~~~l~~~~h~n--i 347 (511)
.+.||+|+||+||+|...+++.||||+++........ .. ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998654321111 11 124455555554332 3
Q ss_pred eccccccccCCceeEEeecccCCCHHH-HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeee
Q 010429 348 LRLRGFCMTPTERLLVYPFMVNGSVAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILL 425 (511)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll 425 (511)
.+.++. ...+++|||++++.+.. .+.... .. ..+..++.+++.++.++|. . +++||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 34689999999864432 122111 11 5678899999999999999 7 99999999999999
Q ss_pred CCCCceEEcccccccccC
Q 010429 426 DEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 426 ~~~~~~kl~Dfg~a~~~~ 443 (511)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=133.84 Aligned_cols=135 Identities=17% Similarity=0.126 Sum_probs=112.8
Q ss_pred CCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCC--CceeccccccccCCceeEEeecccC
Q 010429 292 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 292 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.+.||+|.++.||++... +..+++|....... ...+.+|+..+..++| .++.+++++...++..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3567999999999999986 47899999865432 4568899999999976 4888888888877889999999988
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+.+... +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766543 4566778899999999999986334799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-17 Score=159.65 Aligned_cols=123 Identities=27% Similarity=0.421 Sum_probs=107.2
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++.|++|..++|.+++.+.. ..+..++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 5689999999999999998643 33447889999999999999999 6 899999999999999999999999999
Q ss_pred ccccCCCC-----CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh
Q 010429 439 AKLMDYKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488 (511)
Q Consensus 439 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt 488 (511)
........ ....+...||..||+||.+.++.++.|+||||||+|++|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98765433 223344569999999999999999999999999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-15 Score=141.10 Aligned_cols=137 Identities=19% Similarity=0.204 Sum_probs=105.6
Q ss_pred CCeec-cccccEEEEEEeCCCCEEEEEEecccc------------cchhHHHHHHHHHHHHhCCCCce--eccccccccC
Q 010429 293 RNILG-RGGFGKVYKGRLTDGSLVAVKRLKEER------------TQGGELQFQTEVEMISMAVHRNL--LRLRGFCMTP 357 (511)
Q Consensus 293 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~~~h~ni--v~l~~~~~~~ 357 (511)
...|| .|+.|+||.+... +..++||.+.... ......++.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999885 7889999885321 01223457889999999998875 5666654332
Q ss_pred C----ceeEEeecccC-CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 358 T----ERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 358 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
. ..++||||+++ .+|.+++... +++.. .+.+++.++.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 6898887642 24443 356889999999999 999999999999999999999
Q ss_pred Eccccccccc
Q 010429 433 VGDFGLAKLM 442 (511)
Q Consensus 433 l~Dfg~a~~~ 442 (511)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-17 Score=138.49 Aligned_cols=130 Identities=27% Similarity=0.463 Sum_probs=101.1
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..++|.|.|++|+|+ ..|+.+.++.+|+.|++++|+|+ .+|..++.|++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 457788888888888 66777888888888888888888 77777888888888888888887 7888888888888888
Q ss_pred ccCcccCC-CCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCC
Q 010429 148 LNNNSLMG-EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 148 L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 200 (511)
|.+|++.. ..|..|..++.|+.|+|++|.+.-.++..+.+.+|+.|.+..|.+
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCch
Confidence 88888764 567777677777777777777776666667777777777766655
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.6e-16 Score=162.66 Aligned_cols=207 Identities=24% Similarity=0.325 Sum_probs=165.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC--CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv 363 (511)
..|...+.||+|+|+.|-..... ....+|+|.+.... ..........|..+-..+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34666677999999999888653 34456777665432 2223334556777777777 99999999999999999999
Q ss_pred eecccCCCHHHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeeeCCCC-ceEEccccccc
Q 010429 364 YPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 440 (511)
Q Consensus 364 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 440 (511)
++|..++++.+.+ +... ...+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999998877 3321 13566778889999999999999 77 999999999999999999 99999999998
Q ss_pred ccCC--CCCceeeeccc-ccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccccccCC
Q 010429 441 LMDY--KDTHVTTAVRG-TIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500 (511)
Q Consensus 441 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~~~~~ 500 (511)
.+.. .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.+...+
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 7765 22223344568 9999999998774 45678999999999999999999998766554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.6e-16 Score=132.39 Aligned_cols=135 Identities=26% Similarity=0.446 Sum_probs=125.6
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccccccc-CCCCccccccccccee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN-GPIPTTLGKLSKLRFL 146 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L 146 (511)
..+++.|++.+|+|. .+|..++.++.|+.|+++-|++. .+|..|+.++.|+.|||++|++. ..+|..|..|+.|+-|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 357899999999999 68899999999999999999999 89999999999999999999986 4589999999999999
Q ss_pred eccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+|++|.+. .+|..++++++|+.|.+.+|.+-..+..++.+..|++|++.||.+.-.||
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeeecCh
Confidence 99999998 88999999999999999999999888889999999999999999866554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.7e-14 Score=143.12 Aligned_cols=142 Identities=23% Similarity=0.247 Sum_probs=100.1
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchh---------------------------------------HHHHHH
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---------------------------------------ELQFQT 334 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 334 (511)
+.||+|++|.||+|+.++|+.||||+.++...+.- +.+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865421110 012444
Q ss_pred HHHHHHhCC-----CCceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 010429 335 EVEMISMAV-----HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR-GLAYLHDH 408 (511)
Q Consensus 335 e~~~l~~~~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~ 408 (511)
|...+.+++ ++++.-..-+.......+++|||++|+++.+........ . ...+++.++++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHhC
Confidence 555444442 333322222222345679999999999998876532111 2 23456666665 46788988
Q ss_pred CCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 409 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
|++|+|++|.||++++++.++++|||++..++.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.2e-15 Score=147.73 Aligned_cols=131 Identities=22% Similarity=0.261 Sum_probs=78.2
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
.++.|+|+.|.|+.+.+.......+|+.|+|++|+|+...++.|..|.+|+.|+|++|+|+......|..+++|+.|||+
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 44555666666655555556666666666666666665555556666666666666666665555556666666666666
Q ss_pred CcccCCCCCc---ccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCC
Q 010429 150 NNSLMGEIPR---SLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQL 200 (511)
Q Consensus 150 ~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~ 200 (511)
+|.|++.|.+ .|.+|++|+.|+|.+|+|..++. .+.++..|++|+|.+|.+
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 6666554433 45556666666666666664443 235566666666666665
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.7e-15 Score=147.27 Aligned_cols=135 Identities=24% Similarity=0.241 Sum_probs=116.4
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.++++|+|..|+++..-...+.+|+.|+.|+||+|.|...-++.+.-.++|++|+||+|+|+...++.|..|..|+.|+|
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 36788899999998777788888999999999999998888888888899999999999999888888999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCC----CCCCCcccceeccCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT----NGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l~~N~~~~~ 203 (511)
++|.|+..-...|..+.+|+.|||++|.|+..+++ +.++++|+.|.|.||++-..
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I 407 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSI 407 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeec
Confidence 99999877777889999999999999999977764 35688999999999988443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.9e-13 Score=140.89 Aligned_cols=147 Identities=22% Similarity=0.229 Sum_probs=93.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeCC-CCEEEEEEecccccch---------------------------------hH---
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQG---------------------------------GE--- 329 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~--- 329 (511)
-.+|+. +.||+|++|.||+|+.++ |+.||||+.++...+. ..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999986 9999999997542110 01
Q ss_pred ---HHHHHHHHHHHhCC----CCceeccccccc-cCCceeEEeecccCCCHHHH--HHhcCCCCCCCCHHHHHHHHHHHH
Q 010429 330 ---LQFQTEVEMISMAV----HRNLLRLRGFCM-TPTERLLVYPFMVNGSVASC--LRERGQSQPPLNWSVRKQIALGAA 399 (511)
Q Consensus 330 ---~~~~~e~~~l~~~~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~ 399 (511)
.++.+|...+.+++ +.+.+.+-.++. -....+++|||++|+.+.+. +...+.....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 11333443333332 222222222221 13456799999999999774 33222111113333333333333
Q ss_pred HHHHHHHhCCCCCeEecCCCCCCeeeCCCC----ceEEcccccccccCC
Q 010429 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFGLAKLMDY 444 (511)
Q Consensus 400 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 444 (511)
... |++|+|++|.||+++.++ .++++|||++..++.
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 999999999877653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.1e-13 Score=144.07 Aligned_cols=110 Identities=32% Similarity=0.560 Sum_probs=100.6
Q ss_pred CCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecc
Q 010429 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS 173 (511)
Q Consensus 94 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 173 (511)
.++.|+|++|.++|.+|..+..|++|+.|+|++|+|+|.+|..+..+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-CC-CCcccceeccCCCC-CCC
Q 010429 174 NNKLTGDIPTN-GS-FSLFTPISFANNQL-NNP 203 (511)
Q Consensus 174 ~N~l~~~~~~~-~~-~~~l~~l~l~~N~~-~~~ 203 (511)
+|+++|.+|.. .. +.++..+++.+|+. |+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 99999998854 22 34567889999986 654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.2e-14 Score=141.65 Aligned_cols=130 Identities=32% Similarity=0.448 Sum_probs=91.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccccccc------------------
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN------------------ 130 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~------------------ 130 (511)
++...|+|++|+|..++...|-+|+.|-+||||+|++. .+|+.+..|.+|+.|+||+|.+.
T Consensus 126 Kn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 126 KNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred cCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 35667777777777555566778888888888888887 66667888888888888887664
Q ss_pred -------CCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCC
Q 010429 131 -------GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 131 -------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 200 (511)
..+|.++..|.+|..+|||.|.+. ..|+.+-++++|+.|+|++|.|+...-..+...+|+.|+++.|.+
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchh
Confidence 245677777778888888888887 677777777777777777777765544334444444555544444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.4e-14 Score=135.78 Aligned_cols=116 Identities=31% Similarity=0.479 Sum_probs=105.1
Q ss_pred ecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCccccc
Q 010429 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTN 163 (511)
Q Consensus 84 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 163 (511)
..|..+..+++|+.|+|++|-+. .+|..++.+..|+.||+|+|+|. .+|..+-.+..|+.+-.++|++....|+.+.+
T Consensus 426 fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~n 503 (565)
T KOG0472|consen 426 FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKN 503 (565)
T ss_pred cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhh
Confidence 34556778899999999999998 88999999999999999999998 78998888888888888889999777778999
Q ss_pred CCCCceEecccccccCCCCCCCCCCcccceeccCCCCC
Q 010429 164 VNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 164 l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 201 (511)
|.+|++|||.+|.+...||..+++.+|++|.++||+|.
T Consensus 504 m~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 504 MRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 99999999999999999999999999999999999996
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-14 Score=135.81 Aligned_cols=131 Identities=27% Similarity=0.381 Sum_probs=93.8
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
+++.|++.+|.++...+..+. ++.|+.||...|-++ .+|..++.|.+|+.|||.+|+|. ..| .|.++..|++|+++
T Consensus 161 ~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g 236 (565)
T KOG0472|consen 161 KLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVG 236 (565)
T ss_pred HHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhc
Confidence 466778888888754444444 777888888888777 67777888888888888888877 566 67777777777777
Q ss_pred CcccCCCCCccc-ccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 150 NNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 150 ~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
.|+|+ .+|... ..+++|.+|||.+|+++..|..+.-+++|..|++++|.+++.|+
T Consensus 237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~ 292 (565)
T KOG0472|consen 237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPY 292 (565)
T ss_pred ccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCc
Confidence 77777 455443 37777777777777777666666666777777777777766554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.4e-12 Score=116.19 Aligned_cols=131 Identities=20% Similarity=0.160 Sum_probs=96.3
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceec-cccccccCCceeEEeecccCCC
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR-LRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~-l~~~~~~~~~~~lv~e~~~~gs 371 (511)
.+.++.|.++.||+++.. +..+++|....... ....+.+|+++++.+.+.++++ ++.+ .....++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCc
Confidence 357899999999999875 78899998765432 1234678888888886655443 4433 2334689999999987
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+... . .....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~----~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE----D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6542 0 111345678999999999982 12369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-11 Score=111.44 Aligned_cols=137 Identities=15% Similarity=0.123 Sum_probs=99.1
Q ss_pred CeeccccccEEEEEEeCC-------CCEEEEEEeccccc---------------------chhHHHH----HHHHHHHHh
Q 010429 294 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERT---------------------QGGELQF----QTEVEMISM 341 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~----~~e~~~l~~ 341 (511)
..||.|.-+.||.|...+ +..+|||+.+.... ......+ ++|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998653 47899998752110 0112223 378888888
Q ss_pred CCCC--ceeccccccccCCceeEEeecccCCCHHH-HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecC
Q 010429 342 AVHR--NLLRLRGFCMTPTERLLVYPFMVNGSVAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRD 417 (511)
Q Consensus 342 ~~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~D 417 (511)
+... ++..++++ ...++||||+.++.+.. .+++. .++......+..+++.+|..+ |+. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 8643 45555543 56789999997654422 23321 245566778889999999999 787 999999
Q ss_pred CCCCCeeeCCCCceEEcccccccccC
Q 010429 418 VKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 418 lkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|++.||++++ +.+.|+|||.+...+
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.4e-13 Score=125.97 Aligned_cols=130 Identities=26% Similarity=0.300 Sum_probs=113.4
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
.+++|||++|.|+ .+..+..-++.++.|+||+|+|+ .+-+ +..|++|+.||||+|.++ .+...-.+|.+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 5889999999999 67788889999999999999999 4444 899999999999999999 667777889999999999
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCC--CCCCCCCCcccceeccCCCCCCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD--IPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
.|.|.+. ..+..+-+|.+||+++|+|... +.++++++.|+.+.|.+|++.+.+.
T Consensus 361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 9999732 4678889999999999999854 4577999999999999999976543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.6e-13 Score=117.66 Aligned_cols=121 Identities=26% Similarity=0.345 Sum_probs=45.4
Q ss_pred CeeEEecCCCCcceecchhhc-CCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccc-ccccccceee
Q 010429 70 SVTRVDLGNANLSGQLVSQLG-QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-GKLSKLRFLR 147 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~ 147 (511)
+++.|+|++|+|+.+ +.++ .+.+|+.|+|++|.|+ .++ .+..|++|+.|+|++|+|+. +++.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 567888888888743 3454 5778888888888888 444 37778888888888888884 44444 4578888888
Q ss_pred ccCcccCCC-CCcccccCCCCceEecccccccCCCC----CCCCCCcccceec
Q 010429 148 LNNNSLMGE-IPRSLTNVNSLQVLDLSNNKLTGDIP----TNGSFSLFTPISF 195 (511)
Q Consensus 148 L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~l 195 (511)
|++|+|... .-..+..+++|+.|+|.+|+++.... -+..+++|+.||.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 888888752 22456778888888888888875422 0134566666653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-13 Score=140.89 Aligned_cols=129 Identities=27% Similarity=0.401 Sum_probs=115.5
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
..|+.|.|.+|.|+...-+.+.++.+|+.|+|++|+|.......+.++..|++|+||+|+++ .+|+.+.+++.|++|..
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 46899999999999988899999999999999999999555566899999999999999999 89999999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCC-CCCCCCCCcccceeccCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD-IPTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~~~l~~l~l~~N~~ 200 (511)
.+|+|. ..| .+..++.|+.+|++.|+|+.. ++.....++|++|+++||..
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999998 667 899999999999999999854 34444448999999999984
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.5e-11 Score=123.32 Aligned_cols=165 Identities=19% Similarity=0.214 Sum_probs=123.9
Q ss_pred CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHH
Q 010429 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWS 389 (511)
Q Consensus 310 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 389 (511)
.++.+|.|...+.... .......+.++.++.++||||++++......+..|+|+|-+. -|..++++. ...
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3678888888765433 223346677889999999999999999999999999999874 356666653 355
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeecccccccccccccccCC
Q 010429 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469 (511)
Q Consensus 390 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 469 (511)
...-.+.||+.||.+||+.| +++|+++.-.-|++++.|+.||++|.++...+.... ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 66777899999999999776 999999999999999999999999998864432221 001111122456666543333
Q ss_pred CCcccCeehhhHHHHHHHhC
Q 010429 470 SSEKTDVFGYGVMLLELITG 489 (511)
Q Consensus 470 ~~~~~Dv~s~Gvil~elltg 489 (511)
+ ..|.|-||++++|++.|
T Consensus 182 ~--s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 W--SIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--chhhhhHHHHHHHHhCc
Confidence 2 36999999999999999
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.8e-13 Score=117.02 Aligned_cols=112 Identities=32% Similarity=0.397 Sum_probs=43.5
Q ss_pred hhhcCCCCCcEEEeeccCCCCCCCchhc-CCccccccccccccccCCCCcccccccccceeeccCcccCCCCCccc-ccC
Q 010429 87 SQLGQLTNLQYLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL-TNV 164 (511)
Q Consensus 87 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l 164 (511)
..+.+..+++.|+|++|.|+ .+. .++ .+.+|+.||||+|.|+.. +.+..+++|+.|+|++|+|+. +...+ ..+
T Consensus 13 ~~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~l 87 (175)
T PF14580_consen 13 AQYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNL 87 (175)
T ss_dssp -------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-
T ss_pred cccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhC
Confidence 34566778999999999999 454 466 689999999999999954 468999999999999999994 44444 479
Q ss_pred CCCceEecccccccCCC--CCCCCCCcccceeccCCCCCCC
Q 010429 165 NSLQVLDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 165 ~~L~~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
++|+.|+|++|+|...- .....+++|+.|++.+|++|..
T Consensus 88 p~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~ 128 (175)
T PF14580_consen 88 PNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK 128 (175)
T ss_dssp TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred CcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence 99999999999998543 2346789999999999999743
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.6e-13 Score=134.28 Aligned_cols=132 Identities=27% Similarity=0.375 Sum_probs=70.0
Q ss_pred eeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccC-CCCcccccccccceeecc
Q 010429 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 71 l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~L~ 149 (511)
++.|+|++|.|+ .+....+.-.+|+.|+||.|+++ .+|+++..|++|+.|++.+|+++- -+|..+++|.+|+.+..+
T Consensus 247 LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aa 324 (1255)
T KOG0444|consen 247 LRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAA 324 (1255)
T ss_pred hheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhh
Confidence 444444444444 22333333344444444444444 445555555555555555554431 245555555555555555
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+|.+. .+|..++.|..|+.|.|++|++-..+..+--++.|+.|++..|+---.||
T Consensus 325 nN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 325 NNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred ccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCC
Confidence 55554 45566666666666666666666666655556667777777765544433
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.6e-13 Score=126.96 Aligned_cols=132 Identities=27% Similarity=0.339 Sum_probs=120.7
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccc-ccccCCCCcccccccccceee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL-NNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~ 147 (511)
...+.|+|..|+|+.+.+.+|+.+++|+.||||+|+|+.+-|++|.+|.+|..|-+-+ |+|+......|.+|..|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 3678999999999999999999999999999999999999999999999999887766 999977777899999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQL 200 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~ 200 (511)
++-|++.-...+.|..+++|..|.+.+|.+..... .+..+..++.+.++.|++
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ 200 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPF 200 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcc
Confidence 99999997777899999999999999999997766 457788899999999995
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.8e-12 Score=116.57 Aligned_cols=157 Identities=20% Similarity=0.340 Sum_probs=120.8
Q ss_pred HHHHHHHhCCCCceeccccccccC-----CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 010429 334 TEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408 (511)
Q Consensus 334 ~e~~~l~~~~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 408 (511)
.-+..+-++.|.|||++..|+.+. .+..++.|||..|++..+|++.......+.....+++..||..||.|||+
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs- 194 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS- 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence 344556677899999999998654 35689999999999999999866666668888899999999999999998
Q ss_pred CCCCeEecCCCCCCeeeCCCCceEEcccccccccCC----CCCceeeecccccccccccccccCCCCcccCeehhhHHHH
Q 010429 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY----KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 484 (511)
Q Consensus 409 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ 484 (511)
|.|.|+|+++..+-|++..++-+||.----. ...+ ..........+-++|.+||.-.....+..+|||+||+...
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 5789999999999999999988887431111 0000 0011111122567899999866666778899999999999
Q ss_pred HHHhCCCc
Q 010429 485 ELITGQRA 492 (511)
Q Consensus 485 elltg~~p 492 (511)
||..++.-
T Consensus 274 emailEiq 281 (458)
T KOG1266|consen 274 EMAILEIQ 281 (458)
T ss_pred HHHHheec
Confidence 99988754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.1e-12 Score=126.11 Aligned_cols=201 Identities=22% Similarity=0.214 Sum_probs=155.8
Q ss_pred hCCCCCCeecc--ccccEEEEEEe--C-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCC-CCceeccccccccCCce
Q 010429 288 DNFSNRNILGR--GGFGKVYKGRL--T-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 360 (511)
Q Consensus 288 ~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~ 360 (511)
..+...+.+|+ |.+|.||.+.. . ++..+|+|+-+... ......+-.+|+...++++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45566778999 99999999987 3 67889999843222 1222233456777777775 99999988888999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR----GLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGD 435 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D 435 (511)
++-+|++ +.++.++.+..... ++....+.+..+..+ |+.++|.. .++|-|+||.||+...+ ...+++|
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~---~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNF---LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeeccc-cchhHHhhhccccc---CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 9999988 57788777654332 566777788888888 99999999 99999999999999999 8899999
Q ss_pred cccccccCCCCCc----eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 436 FGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 436 fg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
||+...+....-. ......|...|++||.. .+.++..+|+|++|.++.+..++..++...
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 9999877544311 11222478899999986 445678899999999999999988877544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.9e-11 Score=101.32 Aligned_cols=144 Identities=17% Similarity=0.254 Sum_probs=107.0
Q ss_pred CCCeeccccccEEEEEEeCCCCEEEEEEe-cccc------cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 292 NRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEER------TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 292 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~------~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
....+-+|+-+.|+++.+. |+...||.= .+.. .+-...+..+|+..+.+++--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999986 777777743 2211 1112445788999999887666665555667777889999
Q ss_pred ecccC-CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---ceEEccccccc
Q 010429 365 PFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAK 440 (511)
Q Consensus 365 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~ 440 (511)
||+++ .++.+++....... ....-....+..|-+.+.-||.+ +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 47777777643321 22223367888888999999999 999999999999997655 35899999985
Q ss_pred c
Q 010429 441 L 441 (511)
Q Consensus 441 ~ 441 (511)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.4e-11 Score=110.79 Aligned_cols=143 Identities=20% Similarity=0.246 Sum_probs=108.1
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCC--ceeccccccccC---CceeEEeeccc
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR--NLLRLRGFCMTP---TERLLVYPFMV 368 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~l~~~~~~~---~~~~lv~e~~~ 368 (511)
+.++.|..+.||++...+|..+++|.............+.+|.++++.+.+. ++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999988767899999976543322344688999999998763 356666666553 25689999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH---------------------------------------- 408 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------- 408 (511)
+.++.+.+.. ..++......++.+++++|++||+.
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9887664421 2367777778888888888888842
Q ss_pred -------------CCCCeEecCCCCCCeeeCC--CCceEEcccccccc
Q 010429 409 -------------CDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKL 441 (511)
Q Consensus 409 -------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~ 441 (511)
....++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246899999999999998 66789999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.5e-11 Score=101.69 Aligned_cols=132 Identities=20% Similarity=0.311 Sum_probs=101.0
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEE-ecccccchh------HHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKR-LKEERTQGG------ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~------~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
..+++|+-+.+|.+.+. |..+++|. +++...... ..+-.+|..++.+++--.|.-..-+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999875 44566664 322221111 22456788899888766666666677788889999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
++|..|.+.+... ...++..+-+-+.-||.. ||+|+||.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888764 245566677778899999 999999999999999774 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.8e-11 Score=120.94 Aligned_cols=197 Identities=20% Similarity=0.233 Sum_probs=147.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC--CCCEEEEEEecccccch-hHHHHHHHHHHHHhC-CCCceeccccccccCCce
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 360 (511)
....+|..+..||.|.|+.|+....+ ++..|++|.+....... +...-..|+.+...+ .|.+++++...+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 45567888999999999999987643 67889999886544222 222234555555555 488889888777777777
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 439 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 439 (511)
++--||+++++......- ...+++...+++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 899999999988776622 12378888999999999999999998 99999999999999886 78899999999
Q ss_pred cccCCCCCceeeecccccccc--cccccccCCCCcccCeehhhHHHHHHHhCCCc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHI--APEYLSTGKSSEKTDVFGYGVMLLELITGQRA 492 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p 492 (511)
+.+..... .....-+++ +++......+..+.|++|||.-+.|..++..-
T Consensus 415 t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 415 TRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccceecc----cccccccccccchhhccccccccccccccccccccccccCccc
Confidence 75321111 111233344 45555556678899999999999999998743
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.2e-10 Score=98.78 Aligned_cols=127 Identities=21% Similarity=0.218 Sum_probs=83.9
Q ss_pred EEEEEEeCCCCEEEEEEeccccc-------------------------chhHHHHHHHHHHHHhCCCCc--eeccccccc
Q 010429 303 KVYKGRLTDGSLVAVKRLKEERT-------------------------QGGELQFQTEVEMISMAVHRN--LLRLRGFCM 355 (511)
Q Consensus 303 ~Vy~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~ 355 (511)
.||.|...+|..+|||..+.... .......++|.+.|.++.... +.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988899999998753210 001234678999999998764 4555543
Q ss_pred cCCceeEEeeccc--CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 356 TPTERLLVYPFMV--NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY-LHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 356 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
....+||||++ |..+..+.... ++......++.+++..+.. +|.. |++|+|+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 35689999998 54554433321 2234567777888886666 4677 99999999999999988 999
Q ss_pred EcccccccccC
Q 010429 433 VGDFGLAKLMD 443 (511)
Q Consensus 433 l~Dfg~a~~~~ 443 (511)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=7.4e-11 Score=85.39 Aligned_cols=59 Identities=42% Similarity=0.563 Sum_probs=27.7
Q ss_pred cccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEeccccc
Q 010429 118 NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNK 176 (511)
Q Consensus 118 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 176 (511)
+|++|+|++|+|+...++.|.++++|++|+|++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444444444444444444444444555555554444
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6e-11 Score=125.71 Aligned_cols=209 Identities=20% Similarity=0.220 Sum_probs=150.0
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
.....+.+.+.+-+-+|.++.++.++-. .|...+.|+...... .........+-.+.-..++|.++...--+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3455677778888999999999987643 344444444322110 0011112233333334456777766555555667
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+++++|..++++...++..+ ..+.+.++.....+..+.+|||.. .+.|+|++|.|++...++..+++|||..
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccc
Confidence 789999999999999998755 356666677777888999999997 7999999999999999999999999843
Q ss_pred cccCC------C-------------------CC-----ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhC
Q 010429 440 KLMDY------K-------------------DT-----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 489 (511)
Q Consensus 440 ~~~~~------~-------------------~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg 489 (511)
..... . .. .......||+.|.+||...+......+|.|++|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 32110 0 00 001234589999999999999999999999999999999999
Q ss_pred CCccccccc
Q 010429 490 QRAFDLARL 498 (511)
Q Consensus 490 ~~pf~~~~~ 498 (511)
.+||+...-
T Consensus 1032 ~pp~na~tp 1040 (1205)
T KOG0606|consen 1032 IPPFNAETP 1040 (1205)
T ss_pred CCCCCCcch
Confidence 999986543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-10 Score=84.42 Aligned_cols=61 Identities=41% Similarity=0.636 Sum_probs=55.1
Q ss_pred CCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCccc
Q 010429 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153 (511)
Q Consensus 93 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l 153 (511)
++|+.|+|++|+|+...+..|.++++|++|+|++|+|+...|+.|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999966667899999999999999999988888999999999999999986
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-09 Score=100.91 Aligned_cols=142 Identities=14% Similarity=0.105 Sum_probs=101.8
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccch----------hHHHHHHHHHHHHhCCCCce--ecccccccc-----
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRNL--LRLRGFCMT----- 356 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~~~h~ni--v~l~~~~~~----- 356 (511)
+.+-.-....|++... +|+.|.||+........ ....+.+|...+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455555556777776 47889999875433111 11136788888888754443 334445432
Q ss_pred CCceeEEeecccCC-CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-------C
Q 010429 357 PTERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-------E 428 (511)
Q Consensus 357 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~ 428 (511)
...-++|+|++++. +|.+++..... .+.+......++.+++..+.-||+. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 88888864321 2356677889999999999999999 9999999999999985 4
Q ss_pred CceEEcccccccc
Q 010429 429 FEAVVGDFGLAKL 441 (511)
Q Consensus 429 ~~~kl~Dfg~a~~ 441 (511)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998854
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.6e-10 Score=121.50 Aligned_cols=118 Identities=25% Similarity=0.369 Sum_probs=57.7
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
+++.|+|++|+|+. +|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 200 ~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 34445555555542 222221 34555555555555 3444332 24555555555555 4444443 356666666
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 201 (511)
+|+|+ .+|..+. ++|+.|+|++|+|++.++... ++|+.|++++|.+.
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT 317 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc
Confidence 66665 3454432 356666666666665433211 23444445544443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-10 Score=122.85 Aligned_cols=102 Identities=25% Similarity=0.267 Sum_probs=58.4
Q ss_pred CCcEEEeeccCCCCCCCchhcC-----------------CccccccccccccccCCCCcccccccccceeeccCcccCCC
Q 010429 94 NLQYLELYSNNISGKVPEELGN-----------------LTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGE 156 (511)
Q Consensus 94 ~L~~L~L~~N~l~~~~p~~~~~-----------------l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~ 156 (511)
+|+.|+|++|+|+ .+|....+ ..+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|++
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss- 416 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS- 416 (788)
T ss_pred ccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-
Confidence 5777777777777 34432211 123455555555555 23332 1345566666666652
Q ss_pred CCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 157 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 157 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+|.. ..+|+.|+|++|+|+..+..+..+++|..|++++|++++..
T Consensus 417 IP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~ 461 (788)
T PRK15387 417 LPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERT 461 (788)
T ss_pred CCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchH
Confidence 4432 23566677777777755555666777888888888876543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.4e-10 Score=120.86 Aligned_cols=120 Identities=28% Similarity=0.446 Sum_probs=77.5
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 241 ~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~L 311 (754)
T PRK15370 241 DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNV 311 (754)
T ss_pred ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHh
Confidence 36788889998888 4555553 47888888888888 5676554 47888888888887 4555443 35667777
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
++|+++. +|..+ .++|+.|++++|.+++.+..+ .++|+.|++++|++..
T Consensus 312 s~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~LP~~l--~~sL~~L~Ls~N~L~~ 360 (754)
T PRK15370 312 QSNSLTA-LPETL--PPGLKTLEAGENALTSLPASL--PPELQVLDVSKNQITV 360 (754)
T ss_pred cCCcccc-CCccc--cccceeccccCCccccCChhh--cCcccEEECCCCCCCc
Confidence 7777763 44333 245666666666666543322 1456666666666543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.8e-09 Score=97.08 Aligned_cols=136 Identities=21% Similarity=0.182 Sum_probs=99.4
Q ss_pred CCCCeeccccccEEEEEEeCCCCEEEEEEecccccc---------------------hhHHHHHHHHHHHHhCCCC--ce
Q 010429 291 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---------------------GGELQFQTEVEMISMAVHR--NL 347 (511)
Q Consensus 291 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~~~h~--ni 347 (511)
.+.+.||-|.-+.||.|..++|..+|||.-+..+++ -.....++|+++|.++... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 455789999999999999999999999975422211 1123467899999998755 56
Q ss_pred eccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC
Q 010429 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427 (511)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 427 (511)
.+.+++ +...+||||+++--|...- ++......++..|++-+.-.-.. |+||+|+++-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 666654 6778999999886554311 12334445555555555555566 9999999999999999
Q ss_pred CCceEEccccccccc
Q 010429 428 EFEAVVGDFGLAKLM 442 (511)
Q Consensus 428 ~~~~kl~Dfg~a~~~ 442 (511)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.99 E-value=8e-11 Score=116.86 Aligned_cols=125 Identities=32% Similarity=0.474 Sum_probs=68.9
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
.++.|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.|. .+|..++.+.+|+.|++.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 4555666666665 4444444443 556666666665 55555665556666666666655 455555555555555555
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 200 (511)
.|++. ..|..+..| .|..||++.|+++.++-.+..++.|++|.|.+|++
T Consensus 198 Rn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred hhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCC
Confidence 55555 334444422 35555555555555544555555555555555554
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.4e-10 Score=74.53 Aligned_cols=40 Identities=45% Similarity=0.939 Sum_probs=31.1
Q ss_pred CcHHHHHHHHHHhcC-CCCCCCCCCCCCC-CCCccccceEeC
Q 010429 27 NAEGDALNALKTNLA-DPNNVLQSWDATL-VNPCTWFHVTCN 66 (511)
Q Consensus 27 ~~~~~~l~~~k~~~~-~~~~~l~~w~~~~-~~~c~w~gv~c~ 66 (511)
+.|++||++||+++. ||.+++.+|+.+. .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998 5778999998764 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4e-11 Score=125.22 Aligned_cols=133 Identities=26% Similarity=0.310 Sum_probs=111.1
Q ss_pred CCeeEEecCCCCcceecchhhc-------------------------CCCCCcEEEeeccCCCCCCCchhcCCccccccc
Q 010429 69 NSVTRVDLGNANLSGQLVSQLG-------------------------QLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~-------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 123 (511)
++|++|+|..|+|....+..+. .++.|+.|+|.+|.++...-..+.+..+|+.|+
T Consensus 310 ~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 310 KSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred ceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 5689999999988743332221 234478899999999977666799999999999
Q ss_pred cccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 124 Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|+|.......+.++..|++|+||+|+++ .+|..+.+++.|++|...+|+|...| .+.+++.|+.+|++.|++...
T Consensus 390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhh
Confidence 9999999555556788999999999999999 78899999999999999999999665 788899999999999998553
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.8e-10 Score=105.82 Aligned_cols=109 Identities=26% Similarity=0.313 Sum_probs=94.8
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
+.++.|+|++|+|..+ ..+..|++|+.||||+|.++ .+-+.-..|-|.+.|.|++|.|... ..+.+|-+|..||+
T Consensus 307 Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 307 PKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDL 381 (490)
T ss_pred cceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccc
Confidence 5799999999999844 34899999999999999999 6666777889999999999999844 66888999999999
Q ss_pred cCcccCCC-CCcccccCCCCceEecccccccCCCC
Q 010429 149 NNNSLMGE-IPRSLTNVNSLQVLDLSNNKLTGDIP 182 (511)
Q Consensus 149 ~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (511)
++|+|... -...++++|.|+.|.|.+|++++.+.
T Consensus 382 ~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 382 SSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred cccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999842 23589999999999999999998765
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.6e-09 Score=112.59 Aligned_cols=84 Identities=23% Similarity=0.375 Sum_probs=45.2
Q ss_pred HHHHHHHHhcCCCCCCCC-CCCC-CCCCCccccceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCC
Q 010429 31 DALNALKTNLADPNNVLQ-SWDA-TLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK 108 (511)
Q Consensus 31 ~~l~~~k~~~~~~~~~l~-~w~~-~~~~~c~w~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 108 (511)
.|...++.-+.+....+. +.+. +...+|- ..+++.|+|.+|+|+. +|. .+++|++|+|++|+|+ .
T Consensus 190 ~a~~r~~~Cl~~~~~~LdLs~~~LtsLP~~l--------~~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-s 256 (788)
T PRK15387 190 AVVQKMRACLNNGNAVLNVGESGLTTLPDCL--------PAHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-S 256 (788)
T ss_pred HHHHHHHHHhcCCCcEEEcCCCCCCcCCcch--------hcCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-c
Confidence 467777777654443331 2211 1112221 1256777777777774 333 2467777777777777 4
Q ss_pred CCchhcCCcccccccccccccc
Q 010429 109 VPEELGNLTNLVSLDLYLNNLN 130 (511)
Q Consensus 109 ~p~~~~~l~~L~~L~Ls~N~i~ 130 (511)
+|.. .++|+.|+|++|.|+
T Consensus 257 LP~l---p~sL~~L~Ls~N~L~ 275 (788)
T PRK15387 257 LPVL---PPGLLELSIFSNPLT 275 (788)
T ss_pred ccCc---ccccceeeccCCchh
Confidence 4532 234555555555544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.92 E-value=2e-10 Score=113.37 Aligned_cols=134 Identities=28% Similarity=0.360 Sum_probs=100.1
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCC---CcEEEeeccCCCC----CCCchhcCC-ccccccccccccccCC----CCc
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTN---LQYLELYSNNISG----KVPEELGNL-TNLVSLDLYLNNLNGP----IPT 135 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~i~~~----~p~ 135 (511)
..+++.|+|++|.+.+..+..+..+.+ |+.|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 458999999999998766666666665 9999999999873 333456667 8899999999998843 344
Q ss_pred ccccccccceeeccCcccCCC----CCcccccCCCCceEecccccccCCCC-----CCCCCCcccceeccCCCCC
Q 010429 136 TLGKLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDIP-----TNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~~~~l~~l~l~~N~~~ 201 (511)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++... .+..+++|+.|++++|++.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 566777899999999998853 33345566799999999998874321 2345678999999998764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.4e-08 Score=100.53 Aligned_cols=169 Identities=21% Similarity=0.253 Sum_probs=127.9
Q ss_pred cccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc----CCceeEEeecccC-CCHH
Q 010429 300 GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPFMVN-GSVA 373 (511)
Q Consensus 300 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 373 (511)
.-.+.|++... +|..|++|+++..+.... .....-+++++++.|.|||++.+++.. +...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34678888754 899999999954443221 123356788999999999999998873 4567899999986 4665
Q ss_pred HHHHhc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 374 SCLRER-----------GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 374 ~~l~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
++--.. .......++...+.++.|+..||.++|+. |+..+-|.+++|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 533221 12234578899999999999999999999 9999999999999999999999999988766
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCC
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~ 490 (511)
..+.. |.+. .-++-|.=.||.++..|.||.
T Consensus 444 ~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 444 QEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred cCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 54331 1111 124678889999999999995
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.5e-09 Score=120.42 Aligned_cols=126 Identities=23% Similarity=0.280 Sum_probs=96.7
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 367888888887777788888888888888888875444677655 6888888888887544455553 357888888
Q ss_pred cCcccCCCCCcccccCCCCceEeccc-ccccCCCCCCCCCCcccceeccCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSN-NKLTGDIPTNGSFSLFTPISFANNQ 199 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~l~~l~l~~N~ 199 (511)
++|.|+ .+|..+..+++|+.|+|++ |++.+.+.....+++|+.++++++.
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 888887 6788888888888888887 6777766666777888888887764
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.8e-10 Score=110.60 Aligned_cols=133 Identities=25% Similarity=0.252 Sum_probs=96.3
Q ss_pred CCeeEEecCCCCcce------ecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcc---ccccccccccccC----CCCc
Q 010429 69 NSVTRVDLGNANLSG------QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTN---LVSLDLYLNNLNG----PIPT 135 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~i~~----~~p~ 135 (511)
++++.|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 457888888887762 33456777888999999999888766666666666 9999999988873 3334
Q ss_pred ccccc-cccceeeccCcccCCC----CCcccccCCCCceEecccccccCCC-----CCCCCCCcccceeccCCCCC
Q 010429 136 TLGKL-SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDI-----PTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 136 ~~~~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N~~~ 201 (511)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.. .....+++|+.|++++|.+.
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 206 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT 206 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence 55666 8889999999988843 3345666778999999998887421 12234468888999888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=9e-10 Score=104.97 Aligned_cols=95 Identities=25% Similarity=0.278 Sum_probs=82.0
Q ss_pred chhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCC
Q 010429 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165 (511)
Q Consensus 86 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 165 (511)
...|..|++|+.|+|++|+|+++-+.+|.++..|++|+|..|+|..+-...|.++..|+.|+|.+|+|+..-|.+|..+.
T Consensus 267 ~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~ 346 (498)
T KOG4237|consen 267 AKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLF 346 (498)
T ss_pred HHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccc
Confidence 35688899999999999999988888899999999999999998877777888899999999999999888888888889
Q ss_pred CCceEecccccccCC
Q 010429 166 SLQVLDLSNNKLTGD 180 (511)
Q Consensus 166 ~L~~L~l~~N~l~~~ 180 (511)
+|.+|+|-.|++.+.
T Consensus 347 ~l~~l~l~~Np~~Cn 361 (498)
T KOG4237|consen 347 SLSTLNLLSNPFNCN 361 (498)
T ss_pred eeeeeehccCcccCc
Confidence 999999888888654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.9e-08 Score=92.35 Aligned_cols=197 Identities=18% Similarity=0.222 Sum_probs=129.3
Q ss_pred CCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHh-CCCCceeccccc----cc--cCC-ceeEE
Q 010429 292 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGF----CM--TPT-ERLLV 363 (511)
Q Consensus 292 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~----~~--~~~-~~~lv 363 (511)
..+.||+|+-+.+|-.--- +. .+.|++....... +- +..+.|.. -.||-+-.=+.| .. +.. ...+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~---~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAA---QA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchH---HH-HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3567999999999965321 12 3446664332111 11 22233333 346543321111 11 112 25577
Q ss_pred eecccCCCHHHHHHh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 364 YPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
|+.+.+..--..+.+ ++.+.+..+|...++++..++.+.+-||+. |.+-+|+.++|+|+++++.+.+.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 887766532222221 334556689999999999999999999999 99999999999999999999998854322
Q ss_pred ccCCCCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhC-CCcccccccC
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITG-QRAFDLARLA 499 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg-~~pf~~~~~~ 499 (511)
.. .........+|...|.+||... +..-+...|.|.+|+++++++.| ++||......
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~ 228 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI 228 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence 21 2333444556899999999765 22346678999999999999997 9999854433
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.3e-08 Score=116.52 Aligned_cols=124 Identities=23% Similarity=0.289 Sum_probs=56.2
Q ss_pred eeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccC
Q 010429 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150 (511)
Q Consensus 71 l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 150 (511)
++.|++.++.++ .+|..| .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|.....+|. ++.+++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 444444444443 233333 2344555555555554 3444445555555555554432223442 44455555555555
Q ss_pred cccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCC
Q 010429 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN 198 (511)
Q Consensus 151 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N 198 (511)
|.....+|..+.++++|+.|++++|..-+.+|....+++|+.|++++|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc 714 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGC 714 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCC
Confidence 443334555555555555555554322222222223444445555444
|
syringae 6; Provisional |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.1e-10 Score=93.46 Aligned_cols=138 Identities=22% Similarity=0.242 Sum_probs=98.7
Q ss_pred EeCCCCCeeEEecCCCCcceecchh---hcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccc
Q 010429 64 TCNSENSVTRVDLGNANLSGQLVSQ---LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL 140 (511)
Q Consensus 64 ~c~~~~~l~~l~L~~~~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l 140 (511)
+|.....+-.++|++|.|- .++.. +.....|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|+.+..+
T Consensus 22 rcedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 22 RCEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hhHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 4555556677888888886 34443 445566777899999998444443344568899999999999 788889999
Q ss_pred cccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 141 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+.|+.|++++|.+. ..|.-+..|.+|-.|+..+|.+..++-...--+......+.++++.+..
T Consensus 100 ~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~ 162 (177)
T KOG4579|consen 100 PALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDET 162 (177)
T ss_pred HHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccC
Confidence 99999999999998 6777777789999999998888755444222223334456666664443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.6e-10 Score=114.74 Aligned_cols=129 Identities=29% Similarity=0.419 Sum_probs=65.9
Q ss_pred eEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccC--------------------
Q 010429 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-------------------- 131 (511)
Q Consensus 72 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~-------------------- 131 (511)
+..||+.|++. .+|..+..+..|+.|.|..|.|. .+|..+.+|..|++|||+.|+++.
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~sNNkl 155 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVSNNKL 155 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEecCcc
Confidence 44555555555 34444444444555555555554 444445555555555555555540
Q ss_pred -CCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 132 -PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 132 -~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
.+|+.++.++.|..||.+.|++. .+|..++++.+|+.|++..|++...++.... -.|..||++.|++...|
T Consensus 156 ~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~-LpLi~lDfScNkis~iP 227 (722)
T KOG0532|consen 156 TSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCS-LPLIRLDFSCNKISYLP 227 (722)
T ss_pred ccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhC-CceeeeecccCceeecc
Confidence 44444444455555555555554 3444455555555555555555544444442 23566777777765443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.3e-09 Score=109.14 Aligned_cols=129 Identities=33% Similarity=0.558 Sum_probs=100.2
Q ss_pred CCeeEEecCCCCcceecchhhcCCC-CCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLT-NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..++.|++.+|+++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 46889999999998 5666677774 8999999999998 67667889999999999999998 6777766888899999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 201 (511)
+++|+++ .+|..+..+..|++|.+++|++...+.....+.++..+.+.+|.+.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee
Confidence 9999988 6666655666688888888865545555566666666667777653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.2e-10 Score=116.62 Aligned_cols=126 Identities=29% Similarity=0.319 Sum_probs=100.6
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcc-cccccccceeec
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTT-LGKLSKLRFLRL 148 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~L 148 (511)
.+...+.+.|.|. ....++.-++.|+.|+|++|+++..- .+..|++|++|||++|++. .+|.. ...+ +|+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 4566677778887 56778888999999999999999543 7899999999999999999 55543 3334 4999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCC--CCCCCCcccceeccCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~~ 202 (511)
.+|.++.. ..+.+|.+|+.|||++|-|.+--. ..+.+..|..|+|.||++|.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99999842 357889999999999999986533 34667889999999999954
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.2e-08 Score=89.46 Aligned_cols=106 Identities=20% Similarity=0.197 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhCCCCc--eeccccccccC----CceeEEeecccCC-CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH
Q 010429 330 LQFQTEVEMISMAVHRN--LLRLRGFCMTP----TERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGL 402 (511)
Q Consensus 330 ~~~~~e~~~l~~~~h~n--iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L 402 (511)
.+..+|...+.++.... +.+.+++.... ...++|+|++++. +|.+++..... .+......++.++++.+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence 35778888877775443 44555555442 2347999999884 78988876432 56667889999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCeeeCCCC---ceEEccccccccc
Q 010429 403 AYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLM 442 (511)
Q Consensus 403 ~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~ 442 (511)
+-||+. ||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.6e-09 Score=105.29 Aligned_cols=131 Identities=37% Similarity=0.531 Sum_probs=105.2
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
+++.|++++|++. .++..+..+++|+.|++++|+++ .+|.....+++|+.|++++|+++ .+|.....+..|++|.++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 7999999999998 45578899999999999999999 77776668899999999999999 778776666779999999
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+|.+. ..+..+.++.++..|.+.+|++...+.....+++++.|++++|.++..+
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~ 271 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSIS 271 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceeccccccccccc
Confidence 99654 4566677777777777888877765555566677778888877775543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.3e-07 Score=97.28 Aligned_cols=140 Identities=21% Similarity=0.280 Sum_probs=92.3
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchh---------------------------------------HHHHHH
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---------------------------------------ELQFQT 334 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 334 (511)
+.|+.++-|.||+|++++|+.||||+.++.-.+.- +.++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999764332110 112334
Q ss_pred HHHHHHhCC-----CCceeccccccccCCceeEEeecccCCCHHHHH--HhcCCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 010429 335 EVEMISMAV-----HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGAARG-LAYLH 406 (511)
Q Consensus 335 e~~~l~~~~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH 406 (511)
|...+.+++ .+++.=..-|..-.....++|||++|-.+.+.. +..+ ++ +..++..++++ +..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-----~d---~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG-----ID---RKELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC-----CC---HHHHHHHHHHHHHHHHH
Confidence 444444332 233222222233356778999999999888774 3322 33 23333333332 23333
Q ss_pred hCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 407 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
.. |+.|.|..|.||+++.++++.+.|||+...++.
T Consensus 283 ~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 34 899999999999999999999999999876653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=6e-07 Score=80.88 Aligned_cols=138 Identities=21% Similarity=0.170 Sum_probs=102.4
Q ss_pred eccccccEEEEEEeCCCCEEEEEEecccc-----cchhHHHHHHHHHHHHhCCCCc--eeccccccc-c----CCceeEE
Q 010429 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEER-----TQGGELQFQTEVEMISMAVHRN--LLRLRGFCM-T----PTERLLV 363 (511)
Q Consensus 296 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~-~----~~~~~lv 363 (511)
-|+||-+.|++.... |..+-+|+-.... .+..+..|.+|+..+.++...+ +.++. ++. . ...-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 577899999998875 5578888763111 1335667999999999886443 44444 322 1 1235799
Q ss_pred eecccC-CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--eEEccccccc
Q 010429 364 YPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 440 (511)
Q Consensus 364 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 440 (511)
+|-+.+ -+|.+++.+.... +.+......++.++++.++-||+. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997754 5888888654322 367788889999999999999999 9999999999999986666 9999998765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.5e-07 Score=84.39 Aligned_cols=155 Identities=20% Similarity=0.220 Sum_probs=98.5
Q ss_pred cCHHHHHHHhhCCCCCC---eeccccccEEEEEEeCCCCEEEEEEecccccchhH------------------HH-----
Q 010429 278 FSLRELQVATDNFSNRN---ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE------------------LQ----- 331 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------~~----- 331 (511)
.++..+....+...+.+ .|.+|.-+.||+|...++..+|||+++........ .+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34444444555555444 46678888899999888999999998643211110 00
Q ss_pred HHHHHHHHHhCCC--CceeccccccccCCceeEEeecccCCC-HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 010429 332 FQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408 (511)
Q Consensus 332 ~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 408 (511)
..+|+.-|.++.. -.+.+.+++ ....|+|||+.... -.-.|+.. ++...++..+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHh
Confidence 2344444554432 222333332 24579999996541 11122221 133336778888888888888763
Q ss_pred CCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 409 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
+ ++||+||+.-|||+. ++.+.|+|||-|...++
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 3 999999999999999 77999999999876553
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.3e-08 Score=96.74 Aligned_cols=135 Identities=23% Similarity=0.206 Sum_probs=68.7
Q ss_pred CCCCCeeEEecCCCCcceec-chhhcCCCCCcEEEeeccCCCC-CCCchhcCCccccccccccccccCCCCccccccccc
Q 010429 66 NSENSVTRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISG-KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143 (511)
Q Consensus 66 ~~~~~l~~l~L~~~~l~~~~-~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 143 (511)
...++++.|+|+.|++.--. ...-..+++|+.|.|+.|.|+. .+-..+..+++|+.|+|..|.....-.....-+..|
T Consensus 169 eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L 248 (505)
T KOG3207|consen 169 EQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTL 248 (505)
T ss_pred HhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHH
Confidence 34556666666666665211 1112245566666666666652 122223445666666666664222333334445556
Q ss_pred ceeeccCcccCCCC-CcccccCCCCceEecccccccCC-CCCC------CCCCcccceeccCCCC
Q 010429 144 RFLRLNNNSLMGEI-PRSLTNVNSLQVLDLSNNKLTGD-IPTN------GSFSLFTPISFANNQL 200 (511)
Q Consensus 144 ~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~-~~~~------~~~~~l~~l~l~~N~~ 200 (511)
+.|||++|++.+.. -...+.++.|..|+++.+.++.. .|.. ..+++|++|++..|++
T Consensus 249 ~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 249 QELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred hhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 66666666655321 12345566666666666665532 1111 3355666666666655
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.2e-08 Score=83.42 Aligned_cols=111 Identities=28% Similarity=0.343 Sum_probs=90.6
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
..++.++|++|.+....+..-..++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 47899999999999665555567789999999999999 88999999999999999999999 78888888999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (511)
.+|.+. .+|-.+---..+-..++.+|++.+..+
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 999998 455433222333444567778876654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2e-08 Score=97.15 Aligned_cols=132 Identities=24% Similarity=0.240 Sum_probs=74.8
Q ss_pred CCeeEEecCCCCcceec--chhhcCCCCCcEEEeeccCCCCCCCch-hcCCccccccccccccccCC-CCcccccccccc
Q 010429 69 NSVTRVDLGNANLSGQL--VSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGP-IPTTLGKLSKLR 144 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~ 144 (511)
.+|+.|||++|-+.... -.....|++|+.|+|+.|++.-...+. -..+++|+.|.|+.+.|+-. +-..+..+|+|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 45677777776665322 234456777777777777765222211 22456677777777766621 122334566777
Q ss_pred eeeccCcccCCCCCcccccCCCCceEecccccccCCC--CCCCCCCcccceeccCCCC
Q 010429 145 FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDI--PTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 145 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~~ 200 (511)
.|+|..|.....-......+..|+.|||++|++-... +..+.++.|..|+++.+.+
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi 283 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGI 283 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCc
Confidence 7777777433233334445666777777777666443 3445566666666666655
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.7e-08 Score=100.92 Aligned_cols=182 Identities=21% Similarity=0.160 Sum_probs=133.2
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCc-eeccccccccCCceeEEeecccCC-C
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVYPFMVNG-S 371 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-s 371 (511)
...++|++++++|.+....+...++.+... ....-++++|.+++||| .++.++-+...+..++.++++.++ +
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 347899999999998754444446665432 23557899999999999 788888888888899999999877 2
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceee
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 451 (511)
...... .....+..-+...+...-+++++|+|+. .-+|+| ||+..+ +..+..||+....+.... ..+
T Consensus 322 ~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 322 SALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred ccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 111110 0011122233344455567889999987 568998 888776 589999999987665433 344
Q ss_pred ecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 452 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
...+++.|+|||++....+..+.|+|+.|+-..++--|.+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 5669999999999999999999999999998888888877754
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.8e-08 Score=101.53 Aligned_cols=125 Identities=28% Similarity=0.442 Sum_probs=77.3
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
.+..+.+..|.+.. +-..+..+++|..|+|.+|+|. .+...+..+++|++|+|++|.|+.. ..+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhheec
Confidence 34445555665552 3344666677777777777776 3333366677777777777777754 445666667777777
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQL 200 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~ 200 (511)
+|.|+. + ..+..+++|+.+++++|++....+. ...+.+++.+.+.+|.+
T Consensus 149 ~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i 198 (414)
T KOG0531|consen 149 GNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSI 198 (414)
T ss_pred cCcchh-c-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCch
Confidence 777763 2 3345567777777777777654432 34556667777777766
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.5e-06 Score=80.75 Aligned_cols=139 Identities=13% Similarity=0.113 Sum_probs=84.4
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCc--eeccccccccCCceeEEeecccCCC
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...++||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 25567889876533 2334688999988876443 4556666666667789999998863
Q ss_pred -HH--------------HH-------HHhcCCCCCCCCHHHH-HHHHHH----------HHH-HHHHHHhC-CCCCeEec
Q 010429 372 -VA--------------SC-------LRERGQSQPPLNWSVR-KQIALG----------AAR-GLAYLHDH-CDPKIIHR 416 (511)
Q Consensus 372 -L~--------------~~-------l~~~~~~~~~l~~~~~-~~i~~~----------i~~-~L~~LH~~-~~~~ivH~ 416 (511)
+. .. ++...... ...... ..+..+ +.+ ..++|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 11 11 11110011 111110 011000 001 12223221 12367899
Q ss_pred CCCCCCeeeCCCCceEEcccccccc
Q 010429 417 DVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 417 Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
|+.|.||++++++ +.++||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999988 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.2e-08 Score=99.56 Aligned_cols=127 Identities=27% Similarity=0.301 Sum_probs=99.5
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|.+|+|..+. ..+..+++|+.|+|++|.|+...+ +..|+.|+.|++++|.|+.. ..+..+++|+.++
T Consensus 94 ~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchhhcc-cchhhhhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhccc
Confidence 467999999999999543 338889999999999999995443 78889999999999999954 6677799999999
Q ss_pred ccCcccCCCCC-cccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCC
Q 010429 148 LNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 148 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 201 (511)
+++|++...-+ . ...+.+|+.+.+.+|.+... .....+..+..+++..|.+.
T Consensus 169 l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i-~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 169 LSYNRIVDIENDE-LSELISLEELDLGGNSIREI-EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred CCcchhhhhhhhh-hhhccchHHHhccCCchhcc-cchHHHHHHHHhhcccccce
Confidence 99999985433 2 57889999999999998743 22333344455566666663
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-07 Score=81.31 Aligned_cols=122 Identities=23% Similarity=0.257 Sum_probs=81.8
Q ss_pred eEEecCCCCcceecchhhc-CCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccC
Q 010429 72 TRVDLGNANLSGQLVSQLG-QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150 (511)
Q Consensus 72 ~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 150 (511)
.+++|.+.++..+. . ++ -+.+...+||++|.+. .++ .|..++.|.+|.|++|+|+...|.--.-+++|+.|.|.+
T Consensus 22 ~e~~LR~lkip~ie-n-lg~~~d~~d~iDLtdNdl~-~l~-~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Ltn 97 (233)
T KOG1644|consen 22 RELDLRGLKIPVIE-N-LGATLDQFDAIDLTDNDLR-KLD-NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTN 97 (233)
T ss_pred cccccccccccchh-h-ccccccccceecccccchh-hcc-cCCCccccceEEecCCcceeeccchhhhccccceEEecC
Confidence 44555555554211 1 22 2345777888888887 333 377888888888888888876666666678888888888
Q ss_pred cccCCC-CCcccccCCCCceEecccccccCCCC----CCCCCCcccceeccC
Q 010429 151 NSLMGE-IPRSLTNVNSLQVLDLSNNKLTGDIP----TNGSFSLFTPISFAN 197 (511)
Q Consensus 151 N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~l~~ 197 (511)
|.|... .-+.+..||.|++|.+-+|+++..-. -+..+++|+.||+.+
T Consensus 98 Nsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~k 149 (233)
T KOG1644|consen 98 NSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQK 149 (233)
T ss_pred cchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhh
Confidence 888632 12356778888888888888874422 124567777777764
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.7e-07 Score=102.68 Aligned_cols=106 Identities=29% Similarity=0.409 Sum_probs=91.3
Q ss_pred CeeEEecCCCC--cceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 70 SVTRVDLGNAN--LSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 70 ~l~~l~L~~~~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
.+++|-+..|. +.....+.|..++.|+.|||++|.=-+.+|..+++|-+|++|+|++..|+ .+|..+.+|++|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 58888888886 55555667889999999999988766689999999999999999999999 8999999999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEeccccc
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNK 176 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 176 (511)
+..+.-...+|.....|.+|++|.+..-.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccc
Confidence 99998766677777779999999997655
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 511 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-143 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-138 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-35 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-14 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 501 bits (1292), Expect = e-178
Identities = 237/251 (94%), Positives = 246/251 (98%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVK 318
FFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL DG+LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 319 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE 378
RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRE
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 379 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438
R +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 498
AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 499 ANDDDVMLLDW 509
ANDDDVMLLDW
Sbjct: 241 ANDDDVMLLDW 251
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 369 bits (950), Expect = e-126
Identities = 99/255 (38%), Positives = 146/255 (57%), Gaps = 20/255 (7%)
Query: 265 EEDPEVHLGQLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVK 318
+ EV + FS EL+ T+NF R N +G GGFG VYKG + + + VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 319 RLKEERTQG---GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASC 375
+L + QF E+++++ H NL+ L GF + LVY +M NGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 376 LRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435
L PPL+W +R +IA GAA G+ +LH++ IHRD+K+ANILLDE F A + D
Sbjct: 121 LSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 436 FGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
FGLA+ + + T +T+ + GT ++APE L G+ + K+D++ +GV+LLE+ITG A D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 495 LARLANDDDVMLLDW 509
R + +LLD
Sbjct: 236 EHR----EPQLLLDI 246
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-114
Identities = 100/248 (40%), Positives = 148/248 (59%), Gaps = 7/248 (2%)
Query: 263 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE 322
A + + R L +L+ AT+NF ++ ++G G FGKVYKG L DG+ VA+KR
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 323 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS 382
E +QG +F+TE+E +S H +L+ L GFC E +L+Y +M NG++ L
Sbjct: 74 ESSQG-IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 383 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442
++W R +I +GAARGL YLH IIHRDVK+ NILLDE F + DFG++K
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 443 DYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 501
D TH++T V+GT+G+I PEY G+ +EK+DV+ +GV+L E++ + A +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PR 247
Query: 502 DDVMLLDW 509
+ V L +W
Sbjct: 248 EMVNLAEW 255
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-70
Identities = 66/234 (28%), Positives = 98/234 (41%), Gaps = 25/234 (10%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE 337
L + + RG FG V+K +L VAVK + Q Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ--SWQNEYEVY 70
Query: 338 MISMAVHRNLLRLRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 393
+ H N+L+ G + L+ F GS++ L+ ++W+
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 394 IALGAARGLAYLHDH-------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YK 445
IA ARGLAYLH+ P I HRD+K+ N+LL A + DFGLA + K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 446 DTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFD 494
T GT ++APE L + + D++ G++L EL + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 8e-60
Identities = 68/243 (27%), Positives = 120/243 (49%), Gaps = 6/243 (2%)
Query: 254 KPEDHFFDVPAEEDPEVHLGQLK-RFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDG 312
K H + + P + ++ + + + + +G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 313 SLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371
S VAVK L E+ + F EV ++ H N++ G P +V ++ GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431
+ L + G ++ L+ R +A A+G+ YLH + +P I+HR++K+ N+L+D+++
Sbjct: 121 LYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491
V DFGL++L + + GT +APE L S+EK+DV+ +GV+L EL T Q+
Sbjct: 179 KVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 492 AFD 494
+
Sbjct: 238 PWG 240
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-57
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
++GRG FG V K + VA+K+++ E + F E+ +S H N+++L G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK---AFIVELRQLSRVNHPNIVKLYGA 69
Query: 354 CMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
C+ P E + GS+ + L P + L ++G+AYLH
Sbjct: 70 CLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 410 DPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+IHRD+K N+LL + + DFG A + T +G+ +APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGS 178
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFD 494
SEK DVF +G++L E+IT ++ FD
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD 204
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-57
Identities = 64/239 (26%), Positives = 100/239 (41%), Gaps = 37/239 (15%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE 337
+ E + DN ++GRG +G VYKG L D VAVK Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ----NFINEKN 57
Query: 338 MISMAV--HRNLLRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSV 390
+ + + H N+ R E LLV + NGS+ L +W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 391 RKQIALGAARGLAYLH------DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444
++A RGLAYLH DH P I HRD+ + N+L+ + V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 445 -------KDTHVTTAVRGTIGHIAPEYL-------STGKSSEKTDVFGYGVMLLELITG 489
++ + + GTI ++APE L + ++ D++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-56
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL---QFQTEVEMISMAVHRNLLRL 350
I+G GGFGKVY+ G VAVK + + + + E ++ +M H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
RG C+ LV F G + L + + + A+ ARG+ YLHD
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 411 PKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
IIHRD+K++NIL+ ++ E + DFGLA+ T +A G +AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAWMAP 183
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
E + S+ +DV+ YGV+L EL+TG+ F
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-56
Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 32/219 (14%)
Query: 294 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL------QFQTEVEMISMAVHRN 346
+G+GGFG V+KGR + D S+VA+K L ++G +FQ EV ++S H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 347 LLRLRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
+++L G P E F+ G + L ++ P+ WSV+ ++ L A G+
Sbjct: 85 IVKLYGLMHNPPRMVME------FVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGI 135
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTI 457
Y+ + +P I+HRD+++ NI L E V DFGL++ H + + G
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNF 190
Query: 458 GHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFD 494
+APE + +EK D + + ++L ++TG+ FD
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-53
Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 25/254 (9%)
Query: 255 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL 314
PE + + A P L+E + + ++G+G FG+VY GR G
Sbjct: 2 PEMNLSLLSARSFPRKA--SQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE- 57
Query: 315 VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373
VA++ + ER +L+ F+ EV H N++ G CM+P ++ ++
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433
S +R+ L+ + +QIA +G+ YLH I+H+D+K+ N+ D + V+
Sbjct: 118 SVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVI 170
Query: 434 GDFGLAKLMD----YKDTHVTTAVRGTIGHIAPEYLSTGKS---------SEKTDVFGYG 480
DFGL + + G + H+APE + S+ +DVF G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 481 VMLLELITGQRAFD 494
+ EL + F
Sbjct: 231 TIWYELHAREWPFK 244
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-52
Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 355 MTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
P T+ + S+ L IA ARG+ YLH
Sbjct: 90 TAPQLAIVTQ------WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPE---YL 465
IIHRD+K+ NI L E+ +GDFGLA +H + G+I +APE
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 466 STGKSSEKTDVFGYGVMLLELITGQ 490
+ S ++DV+ +G++L EL+TGQ
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-52
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 352
L G+++KGR G+ + VK LK + + F E + + H N+L + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 353 FCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 410
C +P + +M GS+ + L E + ++ S + AL ARG+A+LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 470
P I + + ++++DE+ A + + + +APE L
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPE 185
Query: 471 ---SEKTDVFGYGVMLLELITGQRAFD 494
D++ + V+L EL+T + F
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFA 212
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-51
Identities = 58/190 (30%), Positives = 93/190 (48%), Gaps = 10/190 (5%)
Query: 26 SNAEGDALNALKTNLADPNNVLQSWDATL-VNPCTWFHVTCNSENSVTRV---DLGNANL 81
+ + AL +K +L +P L SW T TW V C+++ RV DL NL
Sbjct: 4 NPQDKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 82 SGQLV--SQLGQLTNLQYLELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138
S L L L +L + NN+ G +P + LT L L + N++G IP L
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 139 KLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSF-SLFTPISFA 196
++ L L + N+L G +P S++++ +L + N+++G IP + GSF LFT ++ +
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 197 NNQLNNPPPS 206
N+L P
Sbjct: 183 RNRLTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 2/133 (1%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
+ T + + L+G++ L NL +++L N + G G+ N + L
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
N+L + +G L L L NN + G +P+ LT + L L++S N L G+IP G
Sbjct: 230 KNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 186 SFSLFTPISFANN 198
+ F ++ANN
Sbjct: 289 NLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 2/130 (1%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV-SLDLYLNNLN 130
+D LSG L + L NL + N ISG +P+ G+ + L S+ + N L
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF 190
G IP T L+ L F+ L+ N L G+ + + Q + L+ N L D+ G
Sbjct: 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 191 TPISFANNQL 200
+ NN++
Sbjct: 247 NGLDLRNNRI 256
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 1e-08
Identities = 20/67 (29%), Positives = 30/67 (44%), Gaps = 3/67 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ +DL N + G L L QL L L + NN+ G++P+ GNL N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKC 303
Query: 130 --NGPIP 134
P+P
Sbjct: 304 LCGSPLP 310
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-51
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 21/215 (9%)
Query: 294 NILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+LG+G FG+ K G ++ +K L + + F EV+++ H N+L+ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ ++ G++ ++ WS R A A G+AYLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------YKDTHVTTAVRGTIGH 459
IIHRD+ + N L+ E VV DFGLA+LM D V G
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+APE ++ EK DVF +G++L E+I A
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 351
+G+G +G+V++G G VAVK E + E E+ + + H N+L
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 352 GFCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 406
MT T+ L+ + GS+ L+ L+ +I L A GLA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 407 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 459
P I HRD+K+ NIL+ + + + D GLA + + GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 460 IAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+APE + S ++ D++ +G++L E+ +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 30/216 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 351
+G+G +G+V+ G+ G VAVK E + E E+ + H N+L
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 352 GFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 406
+ T+ L+ + NGS+ L+ L+ ++A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 407 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 459
P I HRD+K+ NIL+ + + D GLA V GT +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 460 IAPE------YLSTGKSSEKTDVFGYGVMLLELITG 489
+ PE + +S D++ +G++L E+
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 30/221 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 351
+G+G FG+V++G+ G VAVK E + E E+ + H N+L
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 352 GFCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 406
T T+ LV + +GS+ L + + ++AL A GLA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 407 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGTIGH 459
P I HRD+K+ NIL+ + + D GLA D + GT +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 460 IAPEYL------STGKSSEKTDVFGYGVMLLELITGQRAFD 494
+APE L +S ++ D++ G++ E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 296 LGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+GRG FG+V+ GRL + VAVK +E + +F E ++ H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+V + G + LR G L Q+ AA G+ YL I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA------VRGTIGHIAPEYLSTG 468
HRD+ A N L+ E+ + DFG+++ + + V+ T APE L+ G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWT----APEALNYG 290
Query: 469 KSSEKTDVFGYGVMLLELIT 488
+ S ++DV+ +G++L E +
Sbjct: 291 RYSSESDVWSFGILLWETFS 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 266 EDP-EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-----VAVKR 319
E P + L LK ++++V LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 320 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 379
L+E + + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 380 GQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436
+ LNW V QIA +G+ YL D +++HRD+ A N+L+ + DF
Sbjct: 111 KDNIGSQYLLNWCV--QIA----KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161
Query: 437 GLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 490
GLAKL+ ++ ++ A E + + ++DV+ YGV + EL+T G
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 491 R 491
+
Sbjct: 218 K 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 348
ILG G FG V +G L VAVK +K + + E++ F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 349 RLRGFC-----MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARG 401
RL G C + +++ PFM G + + L P + ++ + + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI- 460
+ YL + +HRD+ A N +L ++ V DFGL+K + D + +G I +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 461 ----APEYLSTGKSSEKTDVFGYGVMLLELIT 488
A E L+ + K+DV+ +GV + E+ T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 70/203 (34%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 350 LRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L G C+ L+V P+M +G + + +R L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEYL 465
K +HRD+ A N +LDE+F V DFGLA+ M +Y H T + + +A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 466 STGKSSEKTDVFGYGVMLLELIT 488
T K + K+DV+ +GV+L EL+T
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 348
+LG+G FG V + +L VAVK LK + +++ F E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 349 RLRGFC------MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAAR 400
+L G +++ PFM +G + + L + P N ++ + + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRG 455
G+ YL IHRD+ A N +L E+ V DFGL++ + D + V+
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
A E L+ + +DV+ +GV + E++T
Sbjct: 206 L----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G FG VY G D + A+K L F E ++ H N+L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 350 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
L G P E ++ P+M +G + +R L ARG+ YL +
Sbjct: 87 LIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE 142
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----AP 462
K +HRD+ A N +LDE F V DFGLA+ + ++ + + + A
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTAL 197
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELIT 488
E L T + + K+DV+ +GV+L EL+T
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 69/204 (33%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 350 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
L G C +E L+V P+M +G + + +R L A+G+ +L
Sbjct: 155 LLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 464
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +A E
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 465 LSTGKSSEKTDVFGYGVMLLELIT 488
L T K + K+DV+ +GV+L EL+T
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-38
Identities = 51/142 (35%), Positives = 75/142 (52%), Gaps = 1/142 (0%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
N +N++ + L N +G++ L + L L L N +SG +P LG+L+ L L L+
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN- 184
LN L G IP L + L L L+ N L GEIP L+N +L + LSNN+LTG+IP
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 185 GSFSLFTPISFANNQLNNPPPS 206
G + +NN + P+
Sbjct: 511 GRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-38
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 13/158 (8%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ ++ + G ++ +L++ N +SG +P+E+G++ L L+L N++
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+G IP +G L L L L++N L G IP++++ + L +DLSNN L+G IP G F
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728
Query: 190 FTPISFANNQLNNPPPSPP----PPLQPTPPGASSGNS 223
F P F NN P PL P + G +
Sbjct: 729 FPPAKFLNN---------PGLCGYPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 1/133 (0%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ + L LSG + S LG L+ L+ L+L+ N + G++P+EL + L +L L N+L
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFS 188
G IP+ L + L ++ L+NN L GEIP+ + + +L +L LSNN +G+IP G
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538
Query: 189 LFTPISFANNQLN 201
+ N N
Sbjct: 539 SLIWLDLNTNLFN 551
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 60/139 (43%), Positives = 82/139 (58%), Gaps = 3/139 (2%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQ--LTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
N S+ +DL + N SG ++ L Q LQ L L +N +GK+P L N + LVSL
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L N L+G IP++LG LSKLR L+L N L GEIP+ L V +L+ L L N LTG+IP+
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 184 N-GSFSLFTPISFANNQLN 201
+ + IS +NN+L
Sbjct: 485 GLSNCTNLNWISLSNNRLT 503
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 3/160 (1%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ + L L G++ +L + L+ L L N+++G++P L N TNL + L N L
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
G IP +G+L L L+L+NNS G IP L + SL LDL+ N G IP +
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFK 560
Query: 190 FTPISFANNQLNNPPPS-PPPPLQPTPPGASSGNSATGAI 228
+ AN ++ GA + G
Sbjct: 561 QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-36
Identities = 51/237 (21%), Positives = 90/237 (37%), Gaps = 59/237 (24%)
Query: 25 ASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCN------------------ 66
+ E L + K L D N +L W + NPCT+ VTC
Sbjct: 9 SLYREIHQLISFKDVLPDKN-LLPDWSSN-KNPCTFDGVTCRDDKVTSIDLSSKPLNVGF 66
Query: 67 ------------------SEN-------------SVTRVDLGNANLSGQL--VSQLGQLT 93
S + S+T +DL +LSG + ++ LG +
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 94 NLQYLELYSNNISGKVP-EELGNLTNLVSLDLYLNNLNGPIPTTL---GKLSKLRFLRLN 149
L++L + SN + L +L LDL N+++G +L+ L ++
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
N + G++ ++ +L+ LD+S+N + IP G S + + N+L+
Sbjct: 187 GNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR 241
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 6/136 (4%)
Query: 72 TRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ L +G++ G L L+L N+ G VP G+ + L SL L NN +
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
Query: 131 GPIPT-TLGKLSKLRFLRLNNNSLMGEIPRSLTNV-NSLQVLDLSNNKLTGDIPT---NG 185
G +P TL K+ L+ L L+ N GE+P SLTN+ SL LDLS+N +G I
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391
Query: 186 SFSLFTPISFANNQLN 201
+ + NN
Sbjct: 392 PKNTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-34
Identities = 46/137 (33%), Positives = 69/137 (50%), Gaps = 5/137 (3%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
++T +DL + G + G + L+ L L SNN SG++P + L + L LDL N
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 129 LNGPIPTTLGKLS-KLRFLRLNNNSLMGEIPRSLTNV--NSLQVLDLSNNKLTGDIPTN- 184
+G +P +L LS L L L++N+ G I +L N+LQ L L NN TG IP
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 185 GSFSLFTPISFANNQLN 201
+ S + + N L+
Sbjct: 415 SNCSELVSLHLSFNYLS 431
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 5/134 (3%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ +D+ + N S + LG + LQ+L++ N +SG + T L L++ N
Sbjct: 201 NLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLT-NVNSLQVLDLSNNKLTGDIPTN-GSF 187
GPIP L L++L L N GEIP L+ ++L LDLS N G +P GS
Sbjct: 260 VGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 188 SLFTPISFANNQLN 201
SL ++ ++N +
Sbjct: 318 SLLESLALSSNNFS 331
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 22/112 (19%), Positives = 44/112 (39%), Gaps = 2/112 (1%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSN--NISGKVPEELGNLTNLVSLDLYLNNLNGP 132
+ ++G+ + + N G E+L L+ ++ G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
T + FL ++ N L G IP+ + ++ L +L+L +N ++G IP
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 7/140 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ + L N L+G++ +G+L NL L+L +N+ SG +P ELG+ +L+ LDL N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN--KLTGDIPTN-GS 186
NG IP + K S + N + G+ + N + + N + G
Sbjct: 551 NGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 187 FSLFTPISFANNQLNNPPPS 206
S P + +
Sbjct: 607 LSTRNPCNITSRVYGGHTSP 626
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 14/71 (19%), Positives = 29/71 (40%)
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
K++ + N + SL ++ L+ L LSN+ + G + + T + +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 198 NQLNNPPPSPP 208
N L+ P +
Sbjct: 110 NSLSGPVTTLT 120
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 294 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV R G VAVK LK E + E+E++ H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ +G C L+ F+ +GS+ L + +N + + A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLG 143
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 463
+ +HRD+ A N+L++ E + +GDFGL K + D T + APE
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPE 199
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT 488
L K +DV+ +GV L EL+T
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 19/205 (9%)
Query: 294 NILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV G +VAVK LK + ++ E++++ H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+ +G C LV ++ GS+ L L A G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 463
IHRD+ A N+LLD + +GDFGLAK + + + APE
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPE 207
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT 488
L K +DV+ +GV L EL+T
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 352
+GRG F VYKG VA L++ + E +F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 353 FCMTPTE---RLLVYP-FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
+ + +++ M +G++ + L+ + V + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR 148
Query: 409 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
P IIHRD+K NI + +V +GD GLA L AV GT +APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 468 GKSSEKTDVFGYGVMLLELITGQ 490
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 294 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+ LG+G FG V R G+LVAVK+L+ + FQ E++++ ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIV 87
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 403
+ RG P + LV ++ +G + L+ L +S QI +G+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS--QIC----KGME 141
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIA 461
YL + +HRD+ A NIL++ E + DFGLAKL+ + V + I A
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELIT 488
PE LS S ++DV+ +GV+L EL T
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 266 EDP-EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS-----LVAVKR 319
E P + L LK ++++V LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 320 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 379
L+E + + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 380 GQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436
+ LNW V QIA +G+ YL D +++HRD+ A N+L+ + DF
Sbjct: 111 KDNIGSQYLLNWCV--QIA----KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161
Query: 437 GLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 490
GLAKL+ ++ ++ A E + + ++DV+ YGV + EL+T G
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 491 R 491
+
Sbjct: 218 K 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 294 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG+G FG V R G +VAVK+L+ T+ F+ E+E++ H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 74
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 403
+ +G C + R L+ ++ GS+ L++ + L ++ QI +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--QIC----KGME 128
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHI 460
YL + IHRD+ NIL++ E +GDFGL K++ D I
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWY 184
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT 488
APE L+ K S +DV+ +GV+L EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGSL-----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+LG G FG V+KG V +K ++++ + + I H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYL 405
RL G C + LV ++ GS+ +R+ + P LNW V QIA +G+ YL
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV--QIA----KGMYYL 131
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHI 460
+H ++HR++ A N+LL + V DFG+A L+ D + + ++
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM---- 184
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT-GQR 491
A E + GK + ++DV+ YGV + EL+T G
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 294 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG+G FG V R G +VAVK+L+ T+ F+ E+E++ H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 105
Query: 349 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 403
+ +G C + R L+ ++ GS+ L++ + L ++ QI +G+
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--QIC----KGME 159
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHI 460
YL + IHRD+ NIL++ E +GDFGL K++ D I
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWY 215
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT 488
APE L+ K S +DV+ +GV+L EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 293 RNILGRGGFGKVYKGRLTDGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FG V +G VA+K LK+ + + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G C +LV G + L + + + S ++ + G+ YL +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 129
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLST 467
+HRD+ A N+LL A + DFGL+K + D++ T G + APE ++
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQR 491
K S ++DV+ YGV + E ++ GQ+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG+G FG VY+G VA+K + E + ++F E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRER------GQSQPPLNWSVRKQIALGAARG 401
+RL G L++ M G + S LR P + S Q+A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI- 460
+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + D + +G G +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203
Query: 461 ----APEYLSTGKSSEKTDVFGYGVMLLELIT 488
+PE L G + +DV+ +GV+L E+ T
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 262 VPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLK 321
+ ++ P ++ + + LG G FG V G+ VA+K +K
Sbjct: 3 LGSKNAP-----STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK 57
Query: 322 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ 381
E E +F E +++ H L++L G C ++ +M NG + + LRE
Sbjct: 58 EGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR- 114
Query: 382 SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441
++ + YL + +HRD+ A N L++++ V DFGL++
Sbjct: 115 --HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 442 MDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ D + ++ VR + PE L K S K+D++ +GV++ E+ +
Sbjct: 170 V-LDDEYTSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 66/242 (27%), Positives = 104/242 (42%), Gaps = 24/242 (9%)
Query: 264 AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS------LVAV 317
+P +V N + LG G FG+VY+G+++ VAV
Sbjct: 6 HHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 65
Query: 318 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
K L E ++ EL F E +IS H+N++R G + R ++ M G + S LR
Sbjct: 66 KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 378 E-RGQSQPPLNWSVRK--QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV- 433
E R + P + ++ +A A G YL ++ IHRD+ A N LL V
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182
Query: 434 --GDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGVMLLEL 486
GDFG+A+ + + +G + PE G + KTD + +GV+L E+
Sbjct: 183 KIGDFGMARDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 487 IT 488
+
Sbjct: 239 FS 240
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 48/213 (22%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQF-QTEVEMISMAVH 344
NF +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 400
N+++ + E +V G ++ ++ + + + W Q+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--- 148
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L ++H +++HRD+K AN+ + +GD GL + K T + V GT ++
Sbjct: 149 -LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+PE + + K+D++ G +L E+ Q F
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 68/310 (21%), Positives = 117/310 (37%), Gaps = 26/310 (8%)
Query: 188 SLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIAL 247
L ++ + +P P P+ T G I
Sbjct: 249 CLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDG-------YTPEPARITS 301
Query: 248 AYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
+ P D DPE +LK L + + LG G FG V +G
Sbjct: 302 PDKPRPMPMDTSVFESPFSDPE----ELKDKKLFLKR--DNLLIADIELGCGNFGSVRQG 355
Query: 308 RLTDGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364
VA+K LK+ + + E +++ + ++RL G C +LV
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVM 414
Query: 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
G + L + + + S ++ + G+ YL + +HR++ A N+L
Sbjct: 415 EMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVL 468
Query: 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVM 482
L A + DFGL+K + D++ T G + APE ++ K S ++DV+ YGV
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 483 LLELIT-GQR 491
+ E ++ GQ+
Sbjct: 529 MWEALSYGQK 538
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 295 ILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
ILG G FG+VY+G T+ VAVK K++ T + +F +E ++ H ++++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 351 RGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
G PT ++ G + L S L +L + +AYL
Sbjct: 79 IGIIEEEPT--WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESI- 132
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----VRGTIGHIAPEYL 465
+HRD+ NIL+ +GDFGL++ ++ +D + + ++ +PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 466 STGKSSEKTDVFGYGVMLLELIT-GQR 491
+ + + +DV+ + V + E+++ G++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 60/254 (23%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 256 EDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL- 314
+ H + +P+ + +++ ++++G G FG+V K R+ L
Sbjct: 2 KKHHHHHHGKNNPDPTI--YPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR 52
Query: 315 --VAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371
A+KR+KE ++ F E+E + + H N++ L G C L + +G+
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 372 VASCLRERGQSQPPLNWSVRK------------QIALGAARGLAYLHDHCDPKIIHRDVK 419
+ LR+ + +++ A ARG+ YL + IHRD+
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLA 169
Query: 420 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKT 474
A NIL+ E + A + DFGL++ + V+ T+G + A E L+ + +
Sbjct: 170 ARNILVGENYVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 475 DVFGYGVMLLELIT 488
DV+ YGV+L E+++
Sbjct: 223 DVWSYGVLLWEIVS 236
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G G FG V+ G + VA+K ++E E F E E++ H L++L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
C+ LV FM +G ++ LR + + L G+AYL + +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTG 468
IHRD+ A N L+ E V DFG+ + + D + ++ V+ +PE S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 469 KSSEKTDVFGYGVMLLELIT 488
+ S K+DV+ +GV++ E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG+G FG+V+ G + VA+K LK F E +++ H L++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
+ +V +M GS+ L+ L V +A A G+AY+
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERM---NY 301
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 474 TDVFGYGVMLLELIT 488
+DV+ +G++L EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 295 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG G FG V G+ VAVK +KE E +F E + + H L++ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+V ++ NG + + LR G+ L S ++ G+A+L H + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGK 469
HRD+ A N L+D + V DFG+ + + D +V++ V+ + APE K
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 470 SSEKTDVFGYGVMLLELIT 488
S K+DV+ +G+++ E+ +
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-35
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 295 ILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRL 350
LG G FG V KG + VAVK LK E E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDH 408
G C + +LV G + L++ + + Q++ G+ YL +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH--QVS----MGMKYLEES 136
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLS 466
+HRD+ A N+LL + A + DFGL+K + + + G + APE ++
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 467 TGKSSEKTDVFGYGVMLLELIT-GQR 491
K S K+DV+ +GV++ E + GQ+
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 345
+ + +G G FGK + DG +K + R E + + EV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP----LNWSVRKQIALGAARG 401
N+++ R +V + G + + + L+W V QI L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA---- 137
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L ++HD KI+HRD+K+ NI L ++ +GDFG+A++++ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE + K+D++ G +L EL T + AF+
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-35
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG+G FG+V+ G + VA+K LK F E +++ H L++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 354 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
+E +V +M GS+ L+ L V +A A G+AY+
Sbjct: 331 V---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERM--- 382
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 472 EKTDVFGYGVMLLELIT 488
K+DV+ +G++L EL T
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-35
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G FG+V+ G + VAVK LK+ F E ++ H+ L+RL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAV 76
Query: 354 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 411
T+ ++ +M NGS+ L+ + +N + +A A G+A++ +
Sbjct: 77 V---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL--DMAAQIAEGMAFIEER--- 128
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLS 466
IHRD++AANIL+ + + DFGLA+L+ + + ++ T APE ++
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 183
Query: 467 TGKSSEKTDVFGYGVMLLELIT 488
G + K+DV+ +G++L E++T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-35
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 345
+++ +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 346 NLLRLRGFCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPPLN----WSVRKQIAL 396
N++R + T L ++V G +AS + + + + L+ V Q+ L
Sbjct: 66 NIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 397 GAARGLAYLHDHCDP--KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 454
L H D ++HRD+K AN+ LD + +GDFGLA+++++ + T V
Sbjct: 123 A----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 455 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
GT +++PE ++ +EK+D++ G +L EL F
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-35
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 354 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ L +V +M GS+ LR RG+S + + + +L + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---N 137
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 193
Query: 473 KTDVFGYGVMLLELIT 488
K+DV+ +G++L E+ +
Sbjct: 194 KSDVWSFGILLWEIYS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-35
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 12/219 (5%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQ 333
S R+ ++ + +G G FG V++G VA+K K + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 393
E + H ++++L G ++ G + S L+ R L+ +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---YSLDLASLIL 120
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 453
A + LAYL + +HRD+ A N+L+ +GDFGL++ M+ + +
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQR 491
+ I +APE ++ + + +DV+ +GV + E++ G +
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 67/209 (32%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 295 ILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLL 348
LG G FG V +G S VAVK LK + E F EV + HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYL 405
RL G +TP +V GS+ LR+ ++V Q+A G+ YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA----EGMGYL 137
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPE 463
+ IHRD+ A N+LL +GDFGL + + D H APE
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQR 491
L T S +D + +GV L E+ T GQ
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 53/234 (22%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+F ++G GGFG+V+K + DG +KR+K + + EV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVN 65
Query: 347 LLRLRGF-------------CMTPTERLLVYPFM---VNGSVASCLRERGQSQPP--LNW 388
++ G + ++ ++ M G++ + +R + L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448
+ +QI G + Y+H K+I+RD+K +NI L + + +GDFGL +
Sbjct: 126 ELFEQITKG----VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-AFDLARLAND 501
+ GT+ +++PE +S+ ++ D++ G++L EL+ AF+ ++ D
Sbjct: 179 TRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG G FG+VY+G+++ VAVK L E ++ EL F E +IS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRK--QIALGAARGLAY 404
+R G + R ++ M G + S LRE R + P + ++ +A A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVV---GDFGLAKLM---DY--KDTHVTTAVRGT 456
L ++ IHRD+ A N LL V GDFG+A+ + Y K V+
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
PE G + KTD + +GV+L E+ +
Sbjct: 254 ----PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 20/220 (9%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEV 336
R+ ++ + +G G FG V++G VA+K K + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
+ H ++++L G ++ G + S L+ R L+ + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAY 498
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTA 452
+ LAYL + +HRD+ A N+L+ +GDFGL++ M+ YK +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQR 491
++ APE ++ + + +DV+ +GV + E++ G +
Sbjct: 556 IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 70/254 (27%), Positives = 112/254 (44%), Gaps = 26/254 (10%)
Query: 249 YWRKRKPEDHFFDVPAE-EDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
Y++ + PE F+ P E+P + R RE++ I+G G G+V G
Sbjct: 15 YFQGKLPEPQFYAEPHTYEEPG----RAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYG 68
Query: 308 RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363
RL VA+K LK T+ F +E ++ H N++RL G ++V
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423
+M NGS+ + LR + G G+ YL D +HRD+ A N+
Sbjct: 129 TEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNV 182
Query: 424 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFG 478
L+D V DFGL++++ D G G I APE ++ S +DV+
Sbjct: 183 LVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTG--GKIPIRWTAPEAIAFRTFSSASDVWS 239
Query: 479 YGVMLLELIT-GQR 491
+GV++ E++ G+R
Sbjct: 240 FGVVMWEVLAYGER 253
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 62/261 (23%), Positives = 88/261 (33%), Gaps = 25/261 (9%)
Query: 240 FAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRG 299
+ + +P F A E + R Q +F + LG G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ----SFQRLSRLGHG 68
Query: 300 GFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCM 355
+G+V+K R DG L AVKR + + E+ S H +RL
Sbjct: 69 SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 356 TPTERLLVYPFM--VNGSVASCLRERGQSQP-PLNWSVRKQIALGAARGLAYLHDHCDPK 412
+Y S+ G S P W + L LA+LH
Sbjct: 128 EGGI---LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHSQ---G 177
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
++H DVK ANI L +GDFGL + G ++APE L G
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAPELLQ-GSYGT 234
Query: 473 KTDVFGYGVMLLELITGQRAF 493
DVF G+ +LE+
Sbjct: 235 AADVFSLGLTILEVACNMELP 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG FGKVYKG L + VA+K LK++ +F+ E + + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QIA 395
+ L G +++ + +G + L R + + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--- 452
A G+ YL H ++H+D+ N+L+ ++ + D GL + + D +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 453 --VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+R APE + GK S +D++ YGV+L E+ +
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 344
LG G FG+V VAVK LK++ T+ +E+E M + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------ 392
+N++ L G C ++ + G++ LR R ++ + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 453 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V+ APE L + ++DV+ +GV++ E+ T
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 354 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ L +V +M GS+ LR RG+S + + + +L + YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---N 309
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 365
Query: 473 KTDVFGYGVMLLELIT 488
K+DV+ +G++L E+ +
Sbjct: 366 KSDVWSFGILLWEIYS 381
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 62/196 (31%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 294 NILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+ LG G +G+VY+G SL VAVK LKE+ + +F E ++ H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
C ++ FM G++ LRE + + + +A + + YL
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYLEKK---N 338
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
IHR++ A N L+ E V DFGL++LM + I APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 473 KTDVFGYGVMLLELIT 488
K+DV+ +GV+L E+ T
Sbjct: 399 KSDVWAFGVLLWEIAT 414
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 294 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
LGRG FG+V + VAVK LKE T +E++ +I + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 347 LLRLRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------Q 393
++ L G C P +++ F G++++ LR + P +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 452
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 453 ----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
++ APE + + ++DV+ +GV+L E+ +
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-34
Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 294 NILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL++L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLG 76
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
C ++ FM G++ LRE + + + +A + + YL
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYLEKK---N 131
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLST 467
IHRD+ A N L+ E V DFGL++LM DT+ A ++ T APE L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT----APESLAY 186
Query: 468 GKSSEKTDVFGYGVMLLELIT 488
K S K+DV+ +GV+L E+ T
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G FG+V+ + VAVK +K F E ++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413
T ++ FM GS+ L+ S+ PL + + A G+A++
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQR---NY 305
Query: 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G + K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 474 TDVFGYGVMLLELIT 488
+DV+ +G++L+E++T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 296 LGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
LG G FG+V + VAVK LK + T+ +E+E M + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QI 394
++ L G C ++ + G++ L+ R +++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 452
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D + T
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 453 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V+ APE L + ++DV+ +GV+L E+ T
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 344
LG G FG+V VAVK LK++ T+ +E+E M + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------ 392
+N++ L G C ++ + G++ LR R ++ + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 453 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V+ APE L + ++DV+ +GV++ E+ T
Sbjct: 264 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 53/248 (21%), Positives = 96/248 (38%), Gaps = 19/248 (7%)
Query: 250 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR- 308
W + E++ V L + + E + +++ +GRG FG+V++ +
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79
Query: 309 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
G AVK+++ E + E+ + ++ L G + +
Sbjct: 80 KQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
GS+ +++ G Q L GL YLH +I+H DVKA N+LL +
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQA-L---EGLEYLHTR---RILHGDVKADNVLLSSD 186
Query: 429 FEAV-VGDFGLAKLMDYKDTHVTTA----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483
+ DFG A + + + GT H+APE + K D++ M+
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 484 LELITGQR 491
L ++ G
Sbjct: 247 LHMLNGCH 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 296 LGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ + S LVAVK LK+ T FQ E E+++ H ++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QIALG 397
G C ++V+ +M +G + LR G L + IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----- 452
A G+ YL +HRD+ N L+ +GDFG+++ + D +
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+R PE + K + ++DV+ +GV+L E+ T
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 295 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+VYKG L S VA+K LK T+ + F E ++ H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G +++ +M NG++ LRE+ + + G A G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTA-----VRGTIGHIAPE 463
+HRD+ A NIL++ V DFGL++++ D + TT+ +R T APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 464 YLSTGKSSEKTDVFGYGVMLLELIT-GQR 491
+S K + +DV+ +G+++ E++T G+R
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 29/217 (13%)
Query: 294 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
LG G FGKV + VAVK LK + +E++ M + H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----------QIAL 396
++ L G C L++ + G + + LR + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA---- 452
A+G+A+L IHRDV A N+LL A +GDFGLA+ + ++
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 453 -VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V+ APE + + ++DV+ YG++L E+ +
Sbjct: 229 PVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-33
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 294 NILGRGGFGKVYKGRLTDG------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG G FGKV K + VAVK LKE + +E ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--------------- 392
++L G C LL+ + GS+ LRE + P S
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 393 -----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
A ++G+ YL + K++HRD+ A NIL+ E + + DFGL++ + +D+
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 448 HVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGVMLLELIT 488
+ V+ + G I A E L + ++DV+ +GV+L E++T
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-33
Identities = 63/238 (26%), Positives = 98/238 (41%), Gaps = 22/238 (9%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMI 339
+ + ++ LG GGF V L DG A+KR+ Q E + Q E +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMH 80
Query: 340 SMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395
+ H N+LRL +C+ L+ PF G++ + + L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR- 454
LG RGL +H HRD+K NILL +E + V+ D G A+
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 455 -------GTIGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLAND 501
TI + APE L + +S E+TDV+ G +L ++ G+ +D+ D
Sbjct: 198 QDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 47/211 (22%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 295 ILGRGGFGKVYKGRLTDGSL--------VAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
LG+G F K++KG + V +K L + + F M+S H++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKH 73
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L+ G C+ E +LV F+ GS+ + L++ + + W + ++A A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKL--EVAKQLAAAMHFLE 130
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIG 458
++ +IH +V A NILL E + + D G++ + + +
Sbjct: 131 EN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV-- 184
Query: 459 HIAPEYLSTGKS-SEKTDVFGYGVMLLELIT 488
PE + K+ + TD + +G L E+ +
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 340
E D +R +LG+G +G VY GR L++ +A+K + E ++ + E+ +
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHK 74
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQIALG 397
H+N+++ G + + GS+++ LR + ++ KQI L
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-L- 132
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGT 456
GL YLHD+ +I+HRD+K N+L++ + + DFG +K + + T GT
Sbjct: 133 --EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186
Query: 457 IGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQR 491
+ ++APE + G + D++ G ++E+ TG+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V GRL S VA+K LK T+ F E ++ H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
L G ++V +M NGS+ S LR+ + G A G+ YL D
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 467
+HRD+ A NIL++ V DFGL +++ D + + T + I +PE ++
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQR 491
K + +DV+ YG++L E+++ G+R
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER 249
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG G FGKV+ + LVAVK LKE ++ FQ E E+++M H+++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHI 105
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRER-----------GQSQPPLNWSVRKQIAL 396
+R G C L+V+ +M +G + LR + PL +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTT 451
A G+ YL +HRD+ N L+ + +GDFG+++ + DY
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+R PE + K + ++DV+ +GV+L E+ T
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 55/221 (24%), Positives = 86/221 (38%), Gaps = 33/221 (14%)
Query: 294 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
LG G FGKV + VAVK LK +E++ + + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------------- 392
++ L G C L++ + G + + LR + S S
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
+ A+G+A+L IHRD+ A NILL + DFGLA+ + +V
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 453 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
V+ APE + + ++DV+ YG+ L EL +
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 61/268 (22%), Positives = 106/268 (39%), Gaps = 48/268 (17%)
Query: 252 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 311
+ P + +P +P+ L L+ +N +G G FG+V++ R
Sbjct: 21 RLHPNPMYQRMPLLLNPK----------LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70
Query: 312 G------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365
++VAVK LKEE + + FQ E +++ + N+++L G C L++
Sbjct: 71 LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130
Query: 366 FMVNGSVASCLRERGQSQPPLNWSVRK--------------------QIALGAARGLAYL 405
+M G + LR IA A G+AYL
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI----- 460
+ K +HRD+ N L+ E + DFGL++ + D + I
Sbjct: 191 SER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWM 243
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELIT 488
PE + + + ++DV+ YGV+L E+ +
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 40/233 (17%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+F +LG+G FG+V K R D A+K+++ T+ +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 346 NLLRLRGF--------CMTPTERLLVYPFMV-----NGSVASCLRERGQSQPP-LNWSVR 391
++R + F+ NG++ + +Q W +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY------- 444
+QI L+Y+H IIHRD+K NI +DE +GDFGLAK +
Sbjct: 123 RQILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 445 -------KDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITG 489
++T+A+ GT ++A E L TG +EK D++ G++ E+I
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 34/228 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+F LGRGGFG V++ + D A+KR++ + + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 347 LLRLRG-------FCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPP---LNWSVR 391
++R VY ++ ++ + R + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
QIA + +LH ++HRD+K +NI + VGDFGL MD + T
Sbjct: 125 LQIAEA----VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 452 AVR-----------GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
GT +++PE + S K D+F G++L EL+
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 38/226 (16%)
Query: 294 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
+LG G FGKV S VAVK LKE+ +E++ M + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------------- 392
++ L G C L++ + G + + LR + +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 393 -----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
A A+G+ +L +HRD+ A N+L+ + DFGLA+ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 448 HVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
+V V+ APE L G + K+DV+ YG++L E+ +
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 52/241 (21%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEERTQGGELQFQT 334
+ + + V +S +G GG KV++ + A+K + EE ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 335 EVEMISMAVHRNL--LRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSV 390
E+ ++ + +RL + +T +Y M N + S L+++ P
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---R 129
Query: 391 R---KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYK 445
+ K + + +H H I+H D+K AN L+ + ++ DFG+A M
Sbjct: 130 KSYWKNM----LEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPD 179
Query: 446 DTHVT-TAVRGTIGHIAPEYL-----------STGKSSEKTDVFGYGVMLLELITGQRAF 493
T V + GT+ ++ PE + S K S K+DV+ G +L + G+ F
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
Query: 494 D 494
Sbjct: 240 Q 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG+GGF K ++ D + A K L + + + E+ + H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 406
GF +V S+ + R P R QI G YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIV----LGCQYLH 132
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ ++IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 188
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
S + DV+ G ++ L+ G+ F+ +
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 38/223 (17%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNL--LRL 350
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 351 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYL 405
+ +T +Y M N + S L+++ P + K + + +
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---RKSYWKNMLE----AVHTI 124
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAP 462
H H I+H D+K AN L+ + ++ DFG+A M T V + GT+ ++ P
Sbjct: 125 HQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 463 EYL-----------STGKSSEKTDVFGYGVMLLELITGQRAFD 494
E + S K S K+DV+ G +L + G+ F
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 6e-31
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGG-ELQFQTEVEMISMAVHRNLLRLRG 352
LG+G F VY+ + G VA+K + K+ + G + Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN-WSVRK---QIALGAARGLAYLHDH 408
+ LV NG + L+ R + P + R QI G+ YLH H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQII----TGMLYLHSH 131
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I+HRD+ +N+LL + DFGLA + T GT +I+PE +
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS 187
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
++DV+ G M L+ G+ FD D V
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD------TDTVKNT 220
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 38/223 (17%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNL--LRL 350
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 351 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYL 405
+ +T +Y M N + S L+++ P + K + + +
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---RKSYWKNMLE----AVHTI 171
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAP 462
H H I+H D+K AN L+ + ++ DFG+A M T V + G + ++ P
Sbjct: 172 HQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 463 EYLS-----------TGKSSEKTDVFGYGVMLLELITGQRAFD 494
E + K S K+DV+ G +L + G+ F
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG+GGF K ++ D + A K L + + + E+ + H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 406
GF +V S+ + R P R QI G YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIV----LGCQYLH 158
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ ++IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 214
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
S + DV+ G ++ L+ G+ F+ +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 13/213 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D++ + ++G G V VA+KR+ E+ Q + E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR-KQIAL---GAARGL 402
++ + E LV + GSV ++ + + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH-- 459
YLH + IHRDVKA NILL E+ + DFG++ + VR T +G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 460 -IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
+APE + + K D++ +G+ +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 27/247 (10%), Positives = 59/247 (23%), Gaps = 40/247 (16%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVK--RLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
L G V+ R + A+K + E ++ + + + + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 352 GFC--------------------------MTPTERLLVYPFMV--NGSVASCLRERGQSQ 383
LL+ P + S L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443
+ R A L ++H N+ + + ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 444 YKDTHVTTAVRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFDLARLAND 501
K A + + E+L+ + + + + G+ + + F L
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 502 DDVMLLD 508
Sbjct: 302 GSWKRPS 308
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 45/243 (18%), Positives = 76/243 (31%), Gaps = 47/243 (19%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-- 343
T F +G G FG V+K DG + A+KR K+ + Q E+ + AV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLG 68
Query: 344 -HRNLLRLRGFCMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLN----WSVRKQIA 395
H +++R E + GS+A + E + + Q+
Sbjct: 69 QHSHVVRYFSAWA---EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV-------------------GDF 436
G L Y+H ++H D+K +NI + GD
Sbjct: 126 RG----LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDL 495
G + G +A E L + K D+F + ++ +
Sbjct: 179 GHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233
Query: 496 ARL 498
Sbjct: 234 GDQ 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 402
+ + G + T+ ++ ++ GS L + QIA +GL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--------QIATILREILKGL 132
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
YLH K IHRD+KAAN+LL E E + DFG+A + T V GT +AP
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQ 490
E + K D++ G+ +EL G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGG-ELQFQTEVEMIS 340
Q A ++F LG+G FG VY R ++A+K L K + + G E Q + EVE+ S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
H N+LRL G+ T L+ + G+V L++ + + ++A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--- 121
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
L+Y H ++IHRD+K N+LL E + DFG + GT+ ++
Sbjct: 122 -LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC--GTLDYL 174
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE + EK D++ GV+ E + G+ F+
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 38/260 (14%), Positives = 76/260 (29%), Gaps = 56/260 (21%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVK--------------RLKEERTQGGELQ-------- 331
+LG+ + G V ++KEE + L+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 332 -----FQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPFMV--NGSVASCLRERGQS 382
F +++ + ++R+R R +YP M + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 383 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442
L R Q+ L R LA LH + ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 443 DYKDTHVTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQR 491
+ + G PE + + D + G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 492 AFDLARLANDDDVMLLDWDF 511
D + +W F
Sbjct: 312 PIT-----KDAALGGSEWIF 326
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 43/254 (16%), Positives = 84/254 (33%), Gaps = 24/254 (9%)
Query: 260 FDVPAEEDPEVHLGQLKRFSL-RELQVATDNFSNRNILGRGGFGKVYKGRLTD------G 312
V + + +L E Q+ + ++LG G F +VY+ D
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 313 SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
+K K + Q +E + ++ ++ + +LV G++
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 373 ASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------ 425
+ + + + + A+ + +HD +IIH D+K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 426 -----DEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 479
D + D G + M + + TA T G E LS + + D FG
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 480 GVMLLELITGQRAF 493
+ ++ G
Sbjct: 272 AATVYCMLFGTYMK 285
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 23/235 (9%)
Query: 271 HLGQLKRFSLRELQVATDNFSNRNILGRG--GFGKVYKGR-LTDGSLVAVKRLKEERTQG 327
H+ L + + ++G+G V R G V V+R+ E
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 328 GELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL 386
+ F Q E+ + + H N++ R + E +V FM GS + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GM 125
Query: 387 NWSVRKQIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443
N IA G + L Y+H +HR VKA++IL+ + + + M
Sbjct: 126 N---ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 444 ---YKDTHVTTAVRGTIGHI---APEYLSTGKS--SEKTDVFGYGVMLLELITGQ 490
+ V + ++ + +PE L K+D++ G+ EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 8e-29
Identities = 37/254 (14%), Positives = 71/254 (27%), Gaps = 45/254 (17%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVK--------------RLKEERTQGGELQ-------- 331
+LG+ + G V ++KEE + L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 332 -----FQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYPFMV--NGSVASCLRERGQS 382
F +++ + ++R+R R +YP M + L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 383 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442
L R Q+ L R LA LH + ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 443 DYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-- 319
Query: 498 LANDDDVMLLDWDF 511
D + +W F
Sbjct: 320 ---DAALGGSEWIF 330
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMA 342
V +F +++LG G G + + D VAVKR+ E EV+ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESD 75
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLN-WSVRKQIALGAA 399
H N++R Y + ++ + ++ + L ++ +Q
Sbjct: 76 EHPNVIRYFCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQT----T 128
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLAKLMD---YKDTHVTT 451
GLA+LH I+HRD+K NIL+ A++ DFGL K + + + +
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 452 AVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITG 489
GT G IAPE LS + D+F G + +I+
Sbjct: 186 VP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 352
LG+G FG VY R + ++A+K L + + + + Q + E+E+ S H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
+ L+ F G + L++ G+ + + +++A L Y H+ K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA----LHYCHER---K 134
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+IHRD+K N+L+ + E + DFG + T GT+ ++ PE + E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TMC--GTLDYLPPEMIEGKTHDE 191
Query: 473 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
K D++ GV+ E + G FD
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD------SPSHTET 220
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 43/225 (19%), Positives = 83/225 (36%), Gaps = 36/225 (16%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLK----------------EERTQGGELQFQTEVEMI 339
L +G F K+ A+K+ + + + F+ E+++I
Sbjct: 39 LNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG-----QSQPPLNWSVRK-- 392
+ + L G E ++Y +M N S+ + ++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 393 -QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
+ +Y+H+ + I HRDVK +NIL+D+ + DFG ++ M D +
Sbjct: 158 KSVLNS----FSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 452 AVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFD 494
+ GT + PE+ S + K D++ G+ L + F
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-28
Identities = 24/140 (17%), Positives = 53/140 (37%), Gaps = 2/140 (1%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
S +DL L LQ L+L I +L++L +L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG-DIPTN-GS 186
+ LS L+ L +L + ++ +L+ L++++N + +P +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 187 FSLFTPISFANNQLNNPPPS 206
+ + ++N++ + +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCT 167
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 29/115 (25%), Positives = 49/115 (42%), Gaps = 1/115 (0%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYLNN 128
++ +D+ + + L++L+ L++ N+ P+ L NL LDL
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L PT LS L+ L +++N+ +NSLQVLD S N +
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 22/110 (20%), Positives = 43/110 (39%), Gaps = 2/110 (1%)
Query: 75 DLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
+ + + +L NL +L+L + P +L++L L++ NN
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNV-NSLQVLDLSNNKLTGDIP 182
L+ L+ L + N +M + L + +SL L+L+ N
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-22
Identities = 30/143 (20%), Positives = 53/143 (37%), Gaps = 8/143 (5%)
Query: 70 SVTRVDLGNANLS--GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
S+ +DL LS G T+L+YL+L N + + L L LD +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 128 NLNGPIPT-TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-- 184
NL L L +L +++ ++SL+VL ++ N + +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 185 -GSFSLFTPISFANNQLNNPPPS 206
+L + + QL P+
Sbjct: 467 TELRNLTF-LDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 11/143 (7%)
Query: 70 SVTRVDL-GNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL----VSLDL 124
++ +++ N S +L LTNL++L+L SN I +L L + +SLDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDI-- 181
LN +N P ++ L L L NN + + + + L+V L + +
Sbjct: 185 SLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 182 --PTNGSFSLFTPISFANNQLNN 202
+ ++ +L
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAY 266
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 25/166 (15%), Positives = 46/166 (27%), Gaps = 12/166 (7%)
Query: 57 PCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGN 115
CT V +DL ++ + + L L L +N S V + +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 116 LTNLVSLDLYLNNLNG------PIPTTLGKLSKLRFLRLNNNSL---MGEIPRSLTNVNS 166
L L L L + L L L L + +I + +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 167 LQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+ L + + + +F + N + P L+
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQH-LELVNCKFGQFPTLKLKSLK 328
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 26/143 (18%), Positives = 44/143 (30%), Gaps = 14/143 (9%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
E + +D ++ LTN+ L S I ++ L+L
Sbjct: 260 EEFRLAYLDY----YLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVN 313
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
L L +L F S ++ SL+ LDLS N L+ + S
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 187 FSLFTP---ISFANNQLNNPPPS 206
T + + N + +
Sbjct: 369 DFGTTSLKYLDLSFNGVITMSSN 391
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 47/245 (19%), Positives = 90/245 (36%), Gaps = 35/245 (14%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPPLN----WSVRKQ 393
H+N+++L T R + ++ GS+ + L E + L V +
Sbjct: 65 NHKNIVKLFAIEEETTTR---HKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRD 120
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMDYKDTHV 449
+ G+ +L ++ I+HR++K NI+ D + + DFG A+ ++ D
Sbjct: 121 V----VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQF 172
Query: 450 TTAVRGTIGHIAPEYLSTGKS--------SEKTDVFGYGVMLLELITGQRAFDLARLAND 501
+ GT ++ P+ D++ GV TG F
Sbjct: 173 VSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 502 DDVML 506
+ ++
Sbjct: 232 NKEVM 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 76/261 (29%), Positives = 111/261 (42%), Gaps = 38/261 (14%)
Query: 253 RKPEDHFFDVPAEEDP-----------EVHLGQLKRFSLRELQVATD---NFSNRNILGR 298
H +D+P E+ G LK + EL D FS+ +G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 299 GGFGKVYKGR-LTDGSLVAVKR--LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
G FG VY R + + +VA+K+ +++ EV + H N ++ RG +
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCDPK 412
LV + GS + L + PL +IA GA +GLAYLH H
Sbjct: 125 REHTAWLVMEYC-LGSASDLLEVHKK---PLQ---EVEIAAVTHGALQGLAYLHSH---N 174
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
+IHRDVKA NILL E +GDFG A +M ++ V GT +APE + +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 229
Query: 473 ---KTDVFGYGVMLLELITGQ 490
K DV+ G+ +EL +
Sbjct: 230 YDGKVDVWSLGITCIELAERK 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + LG GGFG V + G VA+K+ ++E + ++ E++++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 346 NLLRLRGFCMTPTE-RLLVYPFMV-----NGSVASCLRERGQSQPPLNWSVR---KQIAL 396
N++ R + P + G + L + +R I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAV 453
L YLH++ +IIHRD+K NI+L + + + D G AK +D + T V
Sbjct: 133 A----LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV 184
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491
GT+ ++APE L K + D + +G + E ITG R
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 32/240 (13%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL---KEERTQGGELQFQTEV 336
+ +++ R +L GGF VY+ + + G A+KRL +EE+ + EV
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR----AIIQEV 76
Query: 337 E-MISMAVHRNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNW 388
M ++ H N+++ E L+ + G + L++ +S+ PL+
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSC 135
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448
+I R + ++H P IIHRD+K N+LL + + DFG A + + +
Sbjct: 136 DTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 449 VTTA-----------VRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFD 494
+A T + PE + + EK D++ G +L L Q F+
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 41/205 (20%), Positives = 77/205 (37%), Gaps = 21/205 (10%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+ GG G +Y +G V +K L + E + ++ VH +++++ F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 354 CMTPTERLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
++V G L+ + P+ ++ L L+YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQS---LKRSKGQKLPVAEAIA--YLLEILPALSYLHSI- 201
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
+++ D+K NI+L EE + + D G ++ + GT G APE +
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE-IVRTG 252
Query: 470 SSEKTDVFGYGVMLLELITGQRAFD 494
+ TD++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 331
L L L+ F ++G G +G+VYKGR + G L A+K + G E +
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEE 65
Query: 332 -FQTEVEMIS-MAVHRNLLR-----LRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQ 383
+ E+ M+ + HRN+ ++ ++L LV F GSV ++
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKG 123
Query: 384 PPLNWSVRKQIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
L + IA RGL++LH H K+IHRD+K N+LL E E + DFG++
Sbjct: 124 NTLK---EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 490
+D T + GT +APE ++ ++ + K+D++ G+ +E+ G
Sbjct: 178 QLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 296 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 350
LG GG VY D L VA+K + + E F+ EV S H+N++ +
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 351 --RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
E Y M + G L E +S PL+ G+ + H
Sbjct: 77 IDVD-----EEDDCYYLVMEYIEGPT---LSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
D +I+HRD+K NIL+D + DFG+AK + T V GT+ + +PE
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ E TD++ G++L E++ G+ F+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 46/241 (19%), Positives = 87/241 (36%), Gaps = 27/241 (11%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 343 VHRNLLRLRGFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQIALG 397
H+N+++L T R L+ F GS+ + L E + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG- 123
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDYKDTHVTTAV 453
G+ +L ++ I+HR++K NI+ + + DFG A+ ++ D +
Sbjct: 124 ---GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY 176
Query: 454 RGTIGHIAPEYLSTGKS--------SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
GT ++ P+ D++ GV TG F + +
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 506 L 506
+
Sbjct: 236 M 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + LG G FGKVYK + G+L A K ++ + + E + E+E+++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 402
+++L G + ++ F G+V + + E + L QI + L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLT---EPQIQVVCRQMLEAL 130
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIG 458
+LH +IIHRD+KA N+L+ E + + DFG K + +D+ + GT
Sbjct: 131 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182
Query: 459 HIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 490
+APE + + K D++ G+ L+E+ +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 28/211 (13%)
Query: 296 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 350
+GRGG G VY+ D VA+K + E + + Q E +++ +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 351 --RGFCMTPTERLLVYPFM--VNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
G +Y M +NG +A+ LR +G PL I L
Sbjct: 100 HDFG-----EIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAA 150
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPE 463
H HRDVK NIL+ + A + DFG+A D +T GT+ ++APE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPE 205
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
S ++ + D++ +L E +TG +
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 32/149 (21%), Positives = 56/149 (37%), Gaps = 5/149 (3%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++T ++L + L + + + L L++ N IS PE L L L+L N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L+ T + L L L +NS+ +L LDLS+N L+ G+
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL--GTQV 142
Query: 189 LFTP---ISFANNQLNNPPPSPPPPLQPT 214
+ +NN++ +
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANS 171
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 6/143 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++T + L + ++ + + NL L+L N +S L NL L L N +
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 130 NGPIPTTLG--KLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L S L+ L L++N + P + L L L+N +L +
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 188 SLFTP----ISFANNQLNNPPPS 206
L +S +N+QL+ +
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 38/137 (27%), Positives = 54/137 (39%), Gaps = 7/137 (5%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
+L + LS TNL L L SN+I NL++LDL N L+
Sbjct: 79 NLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPTNGSFSLFTP 192
T +L L+ L L+NN + L SL+ L+LS+N++ P G F
Sbjct: 139 GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP--GCFHAIGR 196
Query: 193 ---ISFANNQLNNPPPS 206
+ N QL
Sbjct: 197 LFGLFLNNVQLGPSLTE 213
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-22
Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 17/153 (11%)
Query: 70 SVTRVDLGNANLSGQLVSQLG---QLTNLQYLELYSNNISGKVPEELGNL--TNLVSLDL 124
+ + L N L L +L T+++ L L ++ +S L TNL LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
NNLN + L +L + L N++ SL + +++ L+L + I
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 185 GSFSLFTPISFAN-----------NQLNNPPPS 206
S SF N + +
Sbjct: 316 -SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-22
Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 14/151 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY---- 125
++T +DL NL+ L L+Y L NNI L L N+ L+L
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308
Query: 126 -----LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
L +L + L L L + +N + G T + +L+ L LSN+ +
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 181 IPTNGSFSLFTPIS-----FANNQLNNPPPS 206
TN +F N+++
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESD 399
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-21
Identities = 35/145 (24%), Positives = 56/145 (38%), Gaps = 10/145 (6%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS--------GKVPEELGNLTNLVSLD 123
T +DL N N++ L L L+ L+L NN++ G L L++L L+
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L N + L +L+ + L N+L N SL+ L+L N +T
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 184 --NGSFSLFTPISFANNQLNNPPPS 206
+F T + N + S
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-21
Identities = 31/146 (21%), Positives = 53/146 (36%), Gaps = 8/146 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
S D + L+ Q+ L TN+ L L N + + L SLD+ N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+ P KL L+ L L +N L ++ +L L L +N + F
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN--NPFVK 119
Query: 190 FT---PISFANNQLNNPPPSPPPPLQ 212
+ ++N L++ L+
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLE 145
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-21
Identities = 30/156 (19%), Positives = 51/156 (32%), Gaps = 12/156 (7%)
Query: 69 NSVTRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+ +DLG + +L + L N+ + L N + +L L L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 128 NLNG--PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT---GDIP 182
L P+ L L L L+NN++ L + L++LDL +N L
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHAN 524
Query: 183 TNGSFSLFTP------ISFANNQLNNPPPSPPPPLQ 212
G ++ +N + P L
Sbjct: 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 28/114 (24%), Positives = 40/114 (35%), Gaps = 1/114 (0%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
L G + L L++L L L SN E +L L +DL LNNLN
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPTNGSF 187
+ L+ L L N + + +L LD+ N + F
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 28/119 (23%), Positives = 41/119 (34%), Gaps = 4/119 (3%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP-TTLGKLSKLRFLRLNN 150
+ L L L N IS + L +L LDL LN + + L + + L+
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPPS 206
N + S V SLQ L L L + F + +NN + N
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 20/112 (17%), Positives = 38/112 (33%), Gaps = 6/112 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ ++L + V L L+ ++L NN++ N +L SL+L N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 130 NGPIPTTLGK-LSKLRFLRLNNNSLMGEIP-----RSLTNVNSLQVLDLSNN 175
G L L + N + N + +LS++
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSH 648
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI 339
+ ++ D+F + LG G G V+K G ++A K + E Q E++++
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
++ G + E + M GS+ L++ G + + ++++
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVI 141
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYK-DTHVTTAVRGTI 457
+GL YL + KI+HRDVK +NIL++ E + DFG++ +L+D ++ V GT
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 194
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
+++PE L S ++D++ G+ L+E+ G+
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 296 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 350
LG GG +V+ R D VAVK L+ + + F+ E + + H ++ +
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 351 --RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
G TP L Y M V+G LR+ ++ P+ ++ A + L + H
Sbjct: 78 YDTGEAETPAGP-LPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEY 464
+ IIHRDVK ANI++ V DFG+A+ + VT AV GT +++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
++DV+ G +L E++TG+ F
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+ F LG G +G VYK G +VA+K++ E Q + E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDS 83
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARG 401
++++ G T+ +V + GSV+ +R R + L +IA +G
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLT---EDEIATILQSTLKG 137
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L YLH + IHRD+KA NILL+ E A + DFG+A + T + GT +A
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMA 193
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
PE + + D++ G+ +E+ G+
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 20/229 (8%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 331
G+LK + ++ + +GRG +G V K G ++AVKR++ + + Q
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 332 FQTEVEMI-SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP-PLNWS 389
+++++ + +++ G + + M + S + +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEE 125
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTH 448
+ +I L + L +L + + KIIHRD+K +NILLD + DFG+ +L+D
Sbjct: 126 ILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----- 178
Query: 449 VTTAVRGTIG---HIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQ 490
+ A G ++APE + S ++DV+ G+ L EL TG+
Sbjct: 179 -SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
++ +G+G G VY + G VA++++ ++ EL E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 402
N++ + E +V ++ GS+ + E + QIA + L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAVCRECLQAL 129
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
+LH + ++IHRD+K+ NILL + + DFG + + + +T V GT +AP
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQ 490
E ++ K D++ G+M +E+I G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ +G G G V R G VAVK + + Q EL EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 402
N++ + + E ++ F+ G++ + + LN +QIA + L
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLN---EEQIATVCEAVLQAL 154
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
AYLH +IHRD+K+ +ILL + + DFG + + V GT +AP
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 210
Query: 463 EYLSTGKSSEKTDVFGYGVMLLELITGQ 490
E +S + + D++ G+M++E++ G+
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 52/235 (22%), Positives = 100/235 (42%), Gaps = 21/235 (8%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
++V D+ LGRG +G V K R G ++AVKR++ + + +++ ISM
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISM 60
Query: 342 AV--HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
+ G + + M + S+ ++ + + +IA+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMD--YKDTHVTTAVRGT 456
+ L +LH +IHRDVK +N+L++ + + DFG+ L+D KD G
Sbjct: 120 KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GC 172
Query: 457 IGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
++APE ++ + S K+D++ G+ ++EL + F +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQ 225
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 57/242 (23%), Positives = 90/242 (37%), Gaps = 50/242 (20%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 346
+ + ILG G G V G VAVKR+ + E++ + H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPN 70
Query: 347 LLRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR-------KQIALG 397
++R T + + N ++ + + S L +QI
Sbjct: 71 VIRYYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI--- 124
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLD-------------EEFEAVVGDFGLAKLMD- 443
A G+A+LH KIIHRD+K NIL+ E ++ DFGL K +D
Sbjct: 125 -ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 444 ---YKDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGVMLLELIT-GQRA 492
T++ GT G APE L + + D+F G + +++ G+
Sbjct: 181 GQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 493 FD 494
F
Sbjct: 240 FG 241
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 31/152 (20%), Positives = 54/152 (35%), Gaps = 13/152 (8%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
N + A L +L +ELY+ ++P+ L +L L SL++
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 126 LNNLNGP---------IPTTLGKLSKLRFLRLNNNSLMGEIPRS--LTNVNSLQVLDLSN 174
N + K++ + N+L E P S L + L +LD +
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVH 582
Query: 175 NKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
NK+ + G+ T + NQ+ P
Sbjct: 583 NKVR-HLEAFGTNVKLTDLKLDYNQIEEIPED 613
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 20/142 (14%), Positives = 41/142 (28%), Gaps = 15/142 (10%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
N + + +LT LQ + ++ + + +
Sbjct: 431 GNLTNRITFISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEEL 485
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP--- 192
+ L L + L N M ++P L ++ LQ L+++ N+ ++
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545
Query: 193 -------ISFANNQLNNPPPSP 207
N L P S
Sbjct: 546 TGPKIQIFYMGYNNLEEFPASA 567
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 29/151 (19%), Positives = 53/151 (35%), Gaps = 10/151 (6%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG-KVPEELGNLTNLVSLDLY 125
+ N A+ + +L +Q + NN+ L + L LD
Sbjct: 523 ACNRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPTN 184
N + G KL L+L+ N + EIP + ++ L S+NKL IP
Sbjct: 582 HNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
Query: 185 GSFSLFTP---ISFANNQLNNPPPSPPPPLQ 212
+ + F+ N++ + + +
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 2e-20
Identities = 27/156 (17%), Positives = 58/156 (37%), Gaps = 16/156 (10%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEEL--GNLTNLVSLDL 124
S N +T + N L ++L N ++ + ++ L L ++D+
Sbjct: 705 SNNLMTSI---PENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDV 760
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRL------NNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
N + PT S+L+ + N ++ + P +T SL L + +N +
Sbjct: 761 SYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR 819
Query: 179 GDIPTNGSFSLFTPISFANNQLNN-PPPSPPPPLQP 213
+ + L+ + A+N + S P ++
Sbjct: 820 K-VDEKLTPQLYI-LDIADNPNISIDVTSVCPYIEA 853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 1e-19
Identities = 22/160 (13%), Positives = 48/160 (30%), Gaps = 19/160 (11%)
Query: 64 TCNSENSVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELG------NL 116
C + V + + L + + + ++ N I +
Sbjct: 614 FCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKG 672
Query: 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL-------MGEIPRSLTNVNSLQV 169
N ++ L N + S + + L+NN + + + N L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 170 LDLSNNKLTGDIPTNGSFSLFT---PISFANNQLNNPPPS 206
+DL NKLT + + + + + N ++ P
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSFPTQ 771
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-18
Identities = 28/180 (15%), Positives = 49/180 (27%), Gaps = 15/180 (8%)
Query: 25 ASNAEGDALNALKTNLADPNNVLQSWDA-TLVNPCTWFHVTCNSENSVTRVDLGNANLSG 83
+ AL A+ L N S ++ W +
Sbjct: 266 EYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW------------NFNKELDMWGD 313
Query: 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143
Q L + L L G+VP+ +G LT L L ++ +
Sbjct: 314 QPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373
Query: 144 RFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
+ + + L L + DL + + P + IS + Q+ N
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQIGN 432
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 17/115 (14%), Positives = 40/115 (34%), Gaps = 10/115 (8%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLEL------YSNNISGKVPEELGNLTNLVSLD 123
++ +D+ S +Q + L+ + N I + P + +L+ L
Sbjct: 754 YLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ N++ + L +L L + +N + S+ + L +K
Sbjct: 813 IGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-25
Identities = 72/253 (28%), Positives = 113/253 (44%), Gaps = 18/253 (7%)
Query: 260 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK 318
F E D Q K L + ++FS I+GRGGFG+VY R D G + A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 319 RLKEER--TQGGELQFQTE---VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 373
L ++R + GE E + ++S ++ + TP + + M G +
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 374 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433
L + G +I LG L ++H+ +++RD+K ANILLDE +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILG----LEHMHNR---FVVYRDLKPANILLDEHGHVRI 333
Query: 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRA 492
D GLA K H +V GT G++APE L G + + + D F G ML +L+ G
Sbjct: 334 SDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
Query: 493 FDLARLANDDDVM 505
F + + ++
Sbjct: 391 FRQHKTKDKHEID 403
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 14/216 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMIS 340
V + F +LG+GGFG+V ++ G + A K+L+++R + GE E +++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGA 398
R ++ L T LV M G + + GQ+ P +V +I G
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458
L LH +I++RD+K NILLD+ + D GLA + T GT+G
Sbjct: 299 ---LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 350
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
++APE + + + D + G +L E+I GQ F
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMIS 340
+ D F + +LGRGGFG+V+ ++ G L A K+L ++R + G E ++++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 341 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIA 395
R ++ L + L LV M G + + + P QI
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVR 454
G L +LH II+RD+K N+LLD++ + D GLA L + T
Sbjct: 300 SG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 455 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
GT G +APE L + D F GV L E+I + F
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMISM----AVHR 345
LG+GGFG V+ G LTD VA+K R+ + EV ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
++RL + T +LV + + + E+G + Q+ + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAIQH 154
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
H ++HRD+K NIL+D + DFG L+ D T GT + PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVYSPPE 208
Query: 464 YLSTGK-SSEKTDVFGYGVMLLELITGQRAFD 494
++S + + V+ G++L +++ G F+
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 30/147 (20%), Positives = 55/147 (37%), Gaps = 15/147 (10%)
Query: 72 TRVDLGNANL-SGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ +G NL + + + L ++ L LE N + G G+ L SL+L N +
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQIT 366
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL--TNVNSLQVLDLSNNKLTGDIPTNGSFS 188
G ++ L +N L IP +V+ + +D S N++ +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGS-VDGKNFDP 424
Query: 189 LFTPI---------SFANNQLNNPPPS 206
L + +NNQ++ P
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKE 451
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 15/148 (10%), Positives = 40/148 (27%), Gaps = 20/148 (13%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ + + + + + SNNI+ V + + LT L + +
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218
Query: 130 NGPIPTT-------------------LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVL 170
L L + + N + ++P L + +Q++
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 171 DLSNNKLTGDIPTNGSFSLFTPISFANN 198
+++ N+ +
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 23/156 (14%), Positives = 48/156 (30%), Gaps = 19/156 (12%)
Query: 69 NSVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISG-------KVPEELGNLTNLV 120
V + + L + ++ + ++ N I + N+
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 121 SLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL-------MGEIPRSLTNVNSLQVLDLS 173
S++L N ++ S L + L N L + + + N L +DL
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 174 NNKLTGDIPTNGSFSLFTPISF---ANNQLNNPPPS 206
NKLT + + + + + N + P
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 23/191 (12%), Positives = 45/191 (23%), Gaps = 7/191 (3%)
Query: 23 RVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLS 82
+ +A + L+ L + +
Sbjct: 11 ALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWG 70
Query: 83 GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP----IPTTLG 138
Q L + L L SG+VP+ +G LT L L L + P +
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 139 KLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPT-NGSFSLFTPISF 195
+ + L ++++ I + T I
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ 190
Query: 196 ANNQLNNPPPS 206
+N + +
Sbjct: 191 LSNNITFVSKA 201
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 23/121 (19%), Positives = 45/121 (37%), Gaps = 11/121 (9%)
Query: 70 SVTRVDLGNANLSGQLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL------ 122
+T +DL L+ + L L ++L N+ S P + N + L
Sbjct: 489 LLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
D N P + L L++ +N + ++ +T ++ VLD+ +N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITP--NISVLDIKDNPNISIDL 604
Query: 183 T 183
+
Sbjct: 605 S 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 15/110 (13%), Positives = 35/110 (31%), Gaps = 10/110 (9%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLEL------YSNNISGKVPEELGNLTNLVSLDLYLNN 128
DL + S +Q + L+ + N + PE + +L L + N+
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ + + + L + +N + + + L +K
Sbjct: 578 IRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 30/145 (20%), Positives = 50/145 (34%), Gaps = 1/145 (0%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
NS ++ L + +L NL +L+L I + + L +L L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG-DIPTNGSF 187
L T L L+ L + L N +L+ L L +N ++ +P
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 188 SLFTPISFANNQLNNPPPSPPPPLQ 212
+ F NN ++ LQ
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQ 177
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-22
Identities = 30/145 (20%), Positives = 57/145 (39%), Gaps = 7/145 (4%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
E SV ++L + + LQ L+L + ++S ++P L L+ L L L
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEI-PRSLTNVNSLQVLDLSNNKLTGDIPTN 184
N + L L + N+ E+ L N+ +L+ LDLS++ + N
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 185 GSF----SLFTPISFANNQLNNPPP 205
L + ++ + N+ +
Sbjct: 370 LQLRNLSHLQS-LNLSYNEPLSLKT 393
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 26/150 (17%), Positives = 45/150 (30%), Gaps = 6/150 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ + +S L L+ L L SN+IS + L LD N +
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
Query: 130 NGPIPTTLGKLSKLR--FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+ + L + L LN N + I + Q L+ + I
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 188 SLFT---PISFANNQLNNPPPSPPPPLQPT 214
S +F + + P+ L
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-20
Identities = 26/143 (18%), Positives = 52/143 (36%), Gaps = 7/143 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
++ ++ L +L +L + N ++ L NL NL LDL ++
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361
Query: 129 LN--GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
+ L LS L+ L L+ N + + L++LDL+ +L
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSP 420
Query: 187 FSLFT---PISFANNQLNNPPPS 206
F ++ +++ L+
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQ 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 28/145 (19%), Positives = 45/145 (31%), Gaps = 13/145 (8%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
S + + D N L L++LQ L L N E L LDL
Sbjct: 358 SHDDIETSDCCNLQLRN--------LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 127 NNLNG-PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TN 184
L + L L+ L L+++ L + + +LQ L+L N
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 185 GSFSLFTPISF---ANNQLNNPPPS 206
S + + L++
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 25/151 (16%), Positives = 46/151 (30%), Gaps = 10/151 (6%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
N + N L+ ++ L + + LE N + L NL LD
Sbjct: 9 IEKEVNKT--YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLD 63
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L + T +L L L N L+ +L+ +L+ L ++ I
Sbjct: 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-ID- 121
Query: 184 NGSFSLFTP---ISFANNQLNNPPPSPPPPL 211
+ +N +++ P
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 2/134 (1%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
L L + L L++L IS L N L SL L N+++
Sbjct: 87 VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL 146
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV--LDLSNNKLTGDIPTNGSFSLFTP 192
KL+ L NN++ ++++ L+L+ N + G P ++F
Sbjct: 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQS 206
Query: 193 ISFANNQLNNPPPS 206
++F Q
Sbjct: 207 LNFGGTQNLLVIFK 220
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 4/144 (2%)
Query: 72 TRVDLGNANLSGQLV-SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+DL L + S L L+ L L + + + L L L+L N+
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462
Query: 131 GPI---PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+L L +L L L+ L + T++ + +DLS+N+LT S
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 188 SLFTPISFANNQLNNPPPSPPPPL 211
++ A+N ++ PS P L
Sbjct: 523 LKGIYLNLASNHISIILPSLLPIL 546
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 25/136 (18%), Positives = 54/136 (39%), Gaps = 6/136 (4%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
D+ + ++S + L ++ +++ + L + + L LDL +L+ +P
Sbjct: 237 DMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LP 294
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN---GSFSLFT 191
+ L LS L+ L L+ N S +N SL L + N ++ T +L
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 192 PISFANNQLNNPPPSP 207
+ +++ +
Sbjct: 355 -LDLSHDDIETSDCCN 369
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 23/115 (20%), Positives = 44/115 (38%), Gaps = 4/115 (3%)
Query: 69 NSVTRVDLGNANLSG---QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
++ ++L + Q + L L L+ L L ++S +L + +DL
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
N L L L + L L +N + +P L ++ + ++L N L
Sbjct: 509 HNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 21/135 (15%), Positives = 41/135 (30%), Gaps = 8/135 (5%)
Query: 78 NANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN--LTNLVSLDLYLNNLNGPIPT 135
N N + Q L + + L N + +L + P
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 136 TLGKLSK--LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF--T 191
L + + + L + + + LQ LDL+ L+ ++P +G L
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP-SGLVGLSTLK 304
Query: 192 PISFANNQLNNPPPS 206
+ + N+ N
Sbjct: 305 KLVLSANKFENLCQI 319
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHR--NL 347
LG GGFG VY G ++D VA+K R+ + + EV ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 348 LRLRGFCMTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+RL + P +L+ + + ERG Q L S Q+ + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRHCH 166
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
+ ++HRD+K NIL+D + + DFG L+ KDT T GT + PE++
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSPPEWI 220
Query: 466 STGK-SSEKTDVFGYGVMLLELITGQRAFD 494
+ V+ G++L +++ G F+
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 28/151 (18%), Positives = 53/151 (35%), Gaps = 4/151 (2%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
+S +DL L + LQ+L+L I + L +L +L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ P + L+ L L L + + +L+ L++++N + FS
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFS 150
Query: 189 LFT---PISFANNQLNNPPPSPPPPLQPTPP 216
T + + N + + L+ P
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 29/136 (21%), Positives = 49/136 (36%), Gaps = 6/136 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
+ +D+ N LT+L L++ N+ N TNL LDL
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L L +L+ L +++N+L+ + SL LD S N++
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET--SKGILQH 542
Query: 189 LFTPISF---ANNQLN 201
++F NN +
Sbjct: 543 FPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 28/149 (18%), Positives = 51/149 (34%), Gaps = 8/149 (5%)
Query: 70 SVTRVDLGNANLS--GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
S++ +DL LS G +L++L+L N + L L LD +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHS 409
Query: 128 NLNGPIPT-TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-- 184
L L KL +L ++ + + + SL L ++ N + +N
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 185 -GSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+ +L + + QL L
Sbjct: 470 ANTTNLTF-LDLSKCQLEQISWGVFDTLH 497
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 28/165 (16%), Positives = 48/165 (29%), Gaps = 11/165 (6%)
Query: 57 PCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGN 115
+ +D+ N + Q Q L L L N S + + L N
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSL-NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
Query: 116 LTNLVSLDLY------LNNLNGPIPTTLGKLSKLRF--LRLNNNSLMGEIPRSLTNVNSL 167
L L L NL P+ + L + RL + + + ++
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287
Query: 168 QVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+ L+ + F + +S QL P P L+
Sbjct: 288 SAMSLAGVSIKYLEDVPKHFKWQS-LSIIRCQLKQFPTLDLPFLK 331
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 29/143 (20%), Positives = 55/143 (38%), Gaps = 11/143 (7%)
Query: 70 SVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL----VSLDL 124
++ ++++ + + +L + LTNL +++L N I +L L +SLD+
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGD--- 180
LN ++ I + KL L L N I + L N+ L V L + +
Sbjct: 189 SLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 181 -IPTNGSFSLFTPISFANNQLNN 202
I ++ +L
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTY 270
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 29/139 (20%), Positives = 52/139 (37%), Gaps = 11/139 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+V+ + L ++ + + + Q L + + +L L SL L +N
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPT---LDLPFLKSLTLTMNKG 340
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPT-NGS 186
+ I L L +L L+ N+L S +++ SL+ LDLS N G
Sbjct: 341 S--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGL 398
Query: 187 FSLFTPISFANNQLNNPPP 205
L + F ++ L
Sbjct: 399 EELQH-LDFQHSTLKRVTE 416
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 344
++ + LG G +G+V R A+K +++ EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 400
N+++L F LV G L + + N + KQ+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQV----LS 147
Query: 401 GLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
G+ YLH H I+HRD+K N+LL +++ + DFGL+ + +++ GT
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTA 202
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+IAPE L K EK DV+ GV+L L+ G F
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 64/303 (21%), Positives = 111/303 (36%), Gaps = 44/303 (14%)
Query: 194 SFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKR 253
S +N+ N ++ P + + + A A L + +
Sbjct: 9 SGVDNKFNKERRRARREIRHLP-NLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 254 KPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG--RLTD 311
E+ +F ED K F + ++++GRG V + R T
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGRGVSSVVRRCVHRAT- 118
Query: 312 GSLVAVK-------RLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLV 363
G AVK RL E+ + + E + +A H +++ L + + LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 364 YPFMVNGS-----VAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417
+ M G L E+ S+ + + +++LH + I+HRD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETR------SIMRSLL----EAVSFLHAN---NIVHRD 225
Query: 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 477
+K NILLD+ + + DFG + + + + GT G++APE L K S
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEIL---KCSMDETHP 280
Query: 478 GYG 480
GYG
Sbjct: 281 GYG 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 51/220 (23%), Positives = 100/220 (45%), Gaps = 17/220 (7%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE 337
+ Q ++ N +G G G+V+K R G ++AVK+++ + + +++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 338 MISMAV--HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395
+ + +++ G +T T+ + M + R +G P+ + ++
Sbjct: 76 -VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMT 130
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
+ + L YL + +IHRDVK +NILLDE + + DFG++ + D G
Sbjct: 131 VAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAG 186
Query: 456 TIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 490
++APE + ++ + DV+ G+ L+EL TGQ
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEER-------TQGGELQFQTEVEMISMAVHRNL 347
LG G FG V+ V VK +K+E+ + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 348 LRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++ LV +G + + + + PL + +Q+ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLR 147
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
IIHRD+K NI++ E+F + DFG A ++ + T GTI + APE L
Sbjct: 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTFC-GTIEYCAPEVLM 202
Query: 467 TGKSSE--KTDVFGYGVMLLELITGQRAFD 494
G + +++ GV L L+ + F
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAV 343
+D + + +LG+G FG+V + G AVK + + + + EV+++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAA 399
H N+++L F LV G L + S+ + + +Q+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQV----L 136
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
G+ Y+H + KI+HRD+K N+LL ++ + DFGL+ ++ + GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGT 191
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+IAPE L G EK DV+ GV+L L++G F+
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 50/220 (22%), Positives = 84/220 (38%), Gaps = 39/220 (17%)
Query: 287 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK--------RLKEERTQGGELQFQTEV 336
+N+ + ILGRG V + + T AVK E Q EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 337 E-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VAS-CLRERGQSQPPLNWS 389
+ + ++ H N+++L+ T T LV+ M G L E+
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------K 128
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
+ + + + LH I+HRD+K NILLD++ + DFG + +
Sbjct: 129 IMRALL----EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEK 179
Query: 450 TTAVRGTIGHIAPEYLSTGKSSEKT------DVFGYGVML 483
V GT ++APE + + D++ GV++
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 33/227 (14%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK---RLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
LG G +GKV + AVK + K R GE + E++++ H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--------GLA 403
++ + +MV ++E L+ K+ + A GL
Sbjct: 73 DVLYNEEKQKM---YMVMEYCVCGMQEM------LDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAP 462
YLH I+H+D+K N+LL + G+A+ + + +G+ P
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 463 EYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
E + S K D++ GV L + TG F+ D++ L
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKL 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 34/234 (14%)
Query: 279 SLRELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ 333
S RE + LG G FG V+ + G +K + ++R+Q Q +
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG----------SVASCLRERGQSQ 383
E+E++ H N++++ +V G + L E ++
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 440
+ KQ+ LAY H ++H+D+K NIL + DFGLA+
Sbjct: 129 ------LMKQMM----NALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
L D H T A GT ++APE + K D++ GV++ L+TG F
Sbjct: 176 LFK-SDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 344
+ ++ +LG+G FG+V K + AVK + + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 400
N+++L + +V G L + + + + KQ+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVF----S 132
Query: 401 GLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
G+ Y+H H I+HRD+K NILL +++ + + DFGL+ ++ GT
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA 187
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+IAPE L G EK DV+ GV+L L++G F
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 27/147 (18%), Positives = 53/147 (36%), Gaps = 3/147 (2%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ + L + L + + L NL+ L++ ++ +S + + +L L LDL
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTA 241
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
P G + L+ L L + S + +P + + L+ LDL +P+
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 189 LFTPISFANNQLNNPPPSPPPPLQPTP 215
I + P P
Sbjct: 302 ANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 30/151 (19%), Positives = 54/151 (35%), Gaps = 18/151 (11%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLT--NLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
N+ L L T LEL S + + P++ L++L + +
Sbjct: 56 NNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS-NNKLTGDIPTN- 184
L +P T+ + + L L L N L +P S+ ++N L+ L + +LT ++P
Sbjct: 114 AGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-ELPEPL 170
Query: 185 GSFSLFTPISF---------ANNQLNNPPPS 206
S + + P S
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIRSLPAS 201
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 25/116 (21%), Positives = 49/116 (42%), Gaps = 15/116 (12%)
Query: 80 NLSG-QLVS---QLGQLTNLQYLELYSNNISGKVPEELGN---------LTNLVSLDLYL 126
L+ L + + L L+ L + + ++PE L + L NL SL L
Sbjct: 133 TLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
+ +P ++ L L+ L++ N+ L + ++ ++ L+ LDL + P
Sbjct: 193 TGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 6/106 (5%)
Query: 76 LGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT--NLVSLDLYLNNLNGP 132
NA+ + + N Q + + L + T V+L+L L
Sbjct: 38 HYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ- 95
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
P +LS L+ + ++ LM E+P ++ L+ L L+ N L
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 12/121 (9%), Positives = 27/121 (22%), Gaps = 9/121 (7%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
+ + L + + L + D + + +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETR 63
Query: 149 NNNSLMGEIPRSLTNVNS--LQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205
+L L + L+L + L P S ++ L P
Sbjct: 64 TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPD 121
Query: 206 S 206
+
Sbjct: 122 T 122
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-21
Identities = 65/331 (19%), Positives = 113/331 (34%), Gaps = 57/331 (17%)
Query: 197 NNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPE 256
N + P P P+ G + G +
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGT------------VSSNYD 133
Query: 257 DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG--RLTDGSL 314
++ FD+ + P+ + D++ LG G FG V++ R T G+
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVL--------DHYDIHEELGTGAFGVVHRVTERAT-GNN 184
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG---- 370
A K + E + E++ +S+ H L+ L E +++Y FM G
Sbjct: 185 FAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243
Query: 371 ---SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427
+ + E + +Q+ +GL ++H++ +H D+K NI+
Sbjct: 244 KVADEHNKMSEDEAVE------YMRQV----CKGLCHMHEN---NYVHLDLKPENIMFTT 290
Query: 428 EFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 485
+ + DFGL +D V GT APE TD++ GV+
Sbjct: 291 KRSNELKLIDFGLTAHLD-PKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 486 LITGQRAFDLARLANDDD-----VMLLDWDF 511
L++G F +DD V DW+
Sbjct: 349 LLSGLSPF----GGENDDETLRNVKSCDWNM 375
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 34/227 (14%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK------------EERTQGGELQFQ 333
+++ LG G +G+V + S A+K +K + + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WS 389
E+ ++ H N+++L LV F G L E+ ++ + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAAN 150
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 446
+ KQI G+ YLH H I+HRD+K NILL + + DFGL+ +
Sbjct: 151 IMKQI----LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSK 201
Query: 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ GT +IAPE L K +EK DV+ GV++ L+ G F
Sbjct: 202 DYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 287 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK-------RLKEERTQGGELQFQTEVE 337
D + LG G G+V R T VA++ + R L +TE+E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFM--VNGS------VAS-CLRERGQSQPPLNW 388
++ H +++++ F Y + + G V + L+E
Sbjct: 193 ILKKLNHPCIIKIKNFFDAED----YYIVLELMEGGELFDKVVGNKRLKEATCK------ 242
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYK 445
Q+ L + YLH++ IIHRD+K N+LL +E+ + DFG +K++
Sbjct: 243 LYFYQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 293
Query: 446 DTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITG 489
+T + + GT ++APE L + + + D + GV+L ++G
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-21
Identities = 21/107 (19%), Positives = 49/107 (45%), Gaps = 3/107 (2%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ + N + + + + L+NL+ L + +++ L LT+L LD+ + +
Sbjct: 69 KDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
I T + L K+ + L+ N + +I L + L+ L++ + +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-20
Identities = 23/134 (17%), Positives = 58/134 (43%), Gaps = 4/134 (2%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
NS+T + L N N++ ++ + N++ L + + + + + L+NL L + +
Sbjct: 44 NSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKD 99
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ L L+ L L +++++ I + + + +DLS N DI +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP 159
Query: 189 LFTPISFANNQLNN 202
++ + +++
Sbjct: 160 ELKSLNIQFDGVHD 173
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-15
Identities = 21/95 (22%), Positives = 42/95 (44%), Gaps = 4/95 (4%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
Q+ +L Y+ L + N++ + N+ L + + P + LS L LR+
Sbjct: 41 AQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
+ + +L+ + SL +LD+S++ I T
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 14/118 (11%), Positives = 41/118 (34%), Gaps = 8/118 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L ++ + + +L + L N+ + ++ L +NN
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPSP 207
P ++ +++L+ L + +T D N + T + +++ ++ +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+G+G F KV R LT G VA+K + K + + EV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHC 409
T L+ + G V L G+ + R QI + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE---ARSKFRQIV----SAVQYCHQKR 134
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
I+HRD+KA N+LLD + + DFG + + G + APE GK
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFC-GAPPYAAPELFQ-GK 188
Query: 470 SSE--KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ + DV+ GV+L L++G FD ++ L
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKEL 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 26/141 (18%), Positives = 52/141 (36%), Gaps = 4/141 (2%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
S +DL L LQ L+L I +L++L +L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ LS L+ L +L + ++ +L+ L++++N + FS
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
Query: 189 LFT---PISFANNQLNNPPPS 206
T + ++N++ + +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCT 167
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 25/125 (20%), Positives = 46/125 (36%), Gaps = 8/125 (6%)
Query: 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRF 145
T+L+YL+L N + + L L LD +NL + L L +
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLN 201
L +++ ++SL+VL ++ N + F +L + + QL
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELRNLTF-LDLSQCQLE 483
Query: 202 NPPPS 206
P+
Sbjct: 484 QLSPT 488
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 1/114 (0%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
++ +D+ + + L++L+ L++ N+ + L NL LDL
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L PT LS L+ L + +N L + SLQ + L N P
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 31/148 (20%), Positives = 58/148 (39%), Gaps = 11/148 (7%)
Query: 70 SVTRVDLGNANL-SGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL----VSLDL 124
++ +++ + + S +L LTNL++L+L SN I +L L + +SLDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGD--- 180
LN +N I K +L L L NN + + + + L+V L + +
Sbjct: 185 SLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 181 -IPTNGSFSLFTPISFANNQLNNPPPSP 207
+ ++ +L
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYL 271
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 40/172 (23%), Positives = 58/172 (33%), Gaps = 17/172 (9%)
Query: 38 TNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQY 97
NL L D L + F+ N V+ L + + V Q+
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTN----VSSFSLVSVTIER--VKDFSYNFGWQH 308
Query: 98 LELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL--MG 155
LEL + P L +L L N + L L FL L+ N L G
Sbjct: 309 LELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKG 363
Query: 156 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNPPP 205
+S SL+ LDLS N + + +N G L + F ++ L
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLKQMSE 413
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 29/160 (18%), Positives = 52/160 (32%), Gaps = 14/160 (8%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQ-LGQLTNLQYLELY------SNNISGK 108
NP + E + ++ L N S ++ + L L+ L N+
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 109 VPEELGNLTNLVSLDLYLNNLNG---PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165
L L NL + L L+ I L+ + L + ++ + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNF 304
Query: 166 SLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
Q L+L N K PT ++F +N+ N
Sbjct: 305 GWQHLELVNCKFG-QFPTL-KLKSLKRLTFTSNKGGNAFS 342
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 37/129 (28%), Positives = 60/129 (46%), Gaps = 7/129 (5%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ +GN ++ +S L L+ L +LE+ +N IS + +LT L L++ N ++
Sbjct: 224 NSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
L LS+L L LNNN L E + + +L L LS N +T P + +
Sbjct: 280 ISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDS 337
Query: 192 PISFANNQL 200
FAN +
Sbjct: 338 -ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 32/137 (23%), Positives = 62/137 (45%), Gaps = 8/137 (5%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
S+T++ + ++ + + LTNL+YL L N I+ L NL L +L + N
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNK 99
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ + L L+ LR L LN +++ P L N+ + L+L N D+ + +
Sbjct: 100 IT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMT 155
Query: 189 LFTPISFANNQLNNPPP 205
++ +++ + P
Sbjct: 156 GLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 29/134 (21%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ + + + V+ + LT+L L L N I L +LT+L Y+N +
Sbjct: 158 NYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD 213
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
P + +++L L++ NN + P L N++ L L++ N+++ DI +
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DINAVKDLTKLK 268
Query: 192 PISFANNQLNNPPP 205
++ +NQ+++
Sbjct: 269 MLNVGSNQISDISV 282
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
T +++G +S ++ + LT L+ L + SN IS L NL+ L SL L N L
Sbjct: 246 TWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGN 301
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+G L+ L L L+ N + P L +++ + D +N +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 9e-16
Identities = 21/120 (17%), Positives = 44/120 (36%), Gaps = 7/120 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+ L L +++ L ++ L + + + L+ L +
Sbjct: 15 IFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEY 70
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L LN N + P L+N+ L L + NK+T DI + + + + +++ P
Sbjct: 71 LNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 9e-13
Identities = 16/111 (14%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
L I+ +L + L ++ + +L + L + +
Sbjct: 2 AATLATLPAPIN--QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
I + + +L+ L+L+ N++T DI + T + N++ +
Sbjct: 57 ASIQ-GIEYLTNLEYLNLNGNQIT-DISPLSNLVKLTNLYIGTNKITDISA 105
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 57/233 (24%), Positives = 110/233 (47%), Gaps = 25/233 (10%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQF-QTEVEMIS 340
V D+F +G+G FGKV + D + A+K + K++ + E++ E++++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 341 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQ-SQPPLNWSVR---KQIA 395
H L+ L + E + +V ++ G + L++ + +V+ ++
Sbjct: 71 GLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE----TVKLFICELV 125
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
+ L YL + +IIHRD+K NILLDE + DF +A ++ + T A G
Sbjct: 126 MA----LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--G 176
Query: 456 TIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T ++APE S+ K + + D + GV EL+ G+R + + + +++
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 52/248 (20%), Positives = 81/248 (32%), Gaps = 53/248 (21%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
+G+G +G V ++ A+K + + +TEV ++ H N+ RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG------------- 397
LV G + L + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 398 ----------------AAR-------GLAYLHDHCDPKIIHRDVKAANILL--DEEFEAV 432
+ L YLH+ I HRD+K N L ++ FE
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 433 VGDFGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLEL 486
+ DFGL+K + +TT GT +APE L+T K D + GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 487 ITGQRAFD 494
+ G F
Sbjct: 270 LMGAVPFP 277
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 33/224 (14%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EV---E 337
AT + +G G +G VYK R G VA+K ++ GG + EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 338 MISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSVRK 392
+ H N++RL C T LV+ + + + + L + P L K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKA--PPPGLPAETIK 123
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTH 448
+ RGL +LH + I+HRD+K NIL+ + DFGLA++ M T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TP 178
Query: 449 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
VT R APE L + D++ G + E+ +
Sbjct: 179 VVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 9/136 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ LG N++ L + L+ I + + L NL ++ N L
Sbjct: 25 EKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQL 80
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
P L L+KL + +NNN + P L N+ +L L L NN++T DI + +
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT-DIDPLKNLTN 135
Query: 190 FTPISFANNQLNNPPP 205
+ ++N +++
Sbjct: 136 LNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 9/134 (6%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
T +DL N +S ++ L LT L L+L +N IS L LT L +L+L N L
Sbjct: 246 TDLDLANNQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED 301
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
P + L L +L L N++ P ++++ LQ L NNK++ D+ + + +
Sbjct: 302 ISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLANLTNIN 356
Query: 192 PISFANNQLNNPPP 205
+S +NQ+++ P
Sbjct: 357 WLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 10/136 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ R++L + +S +S L LT+LQ L N ++ + L NLT L LD+ N +
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTD--LKPLANLTTLERLDISSNKV 189
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+ L KL+ L L NN + P L + +L L L+ N+L DI T S +
Sbjct: 190 SDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIGTLASLTN 244
Query: 190 FTPISFANNQLNNPPP 205
T + ANNQ++N P
Sbjct: 245 LTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 32/136 (23%), Positives = 52/136 (38%), Gaps = 8/136 (5%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++T ++L L +S + L NL YL LY NNIS + +LT L L Y N
Sbjct: 287 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNK 342
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
++ L L+ + +L +N + P L N+ + L L++ T +
Sbjct: 343 VSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANV 398
Query: 189 LFTPISFANNQLNNPP 204
P
Sbjct: 399 SIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 24/120 (20%), Positives = 47/120 (39%), Gaps = 7/120 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+ L L N++ V +L + +L + + L+ L
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQ 72
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
+ +NN L P L N+ L + ++NN++ DI + + T ++ NNQ+ + P
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 28/132 (21%), Positives = 49/132 (37%), Gaps = 6/132 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ R+ N +S VS L LTN+ +L N IS L NLT + L L
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAW 387
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+S ++ +L+ P ++++ S D++ N + + +FS
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQ 445
Query: 190 FTPISFANNQLN 201
I +
Sbjct: 446 PVTIGKGTTTFS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 19/107 (17%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 99 ELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP 158
+ + L + L N+ + L ++ L+ + + +
Sbjct: 6 ATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSI 61
Query: 159 RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
+ +N+L ++ SNN+LT DI + + I NNQ+ + P
Sbjct: 62 DGVEYLNNLTQINFSNNQLT-DITPLKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 13/114 (11%), Positives = 32/114 (28%), Gaps = 5/114 (4%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++ + G+ +S ++ L LT + L L + N++ ++
Sbjct: 353 TNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L P T+ + N + + +G +
Sbjct: 411 LI--APATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 58/276 (21%), Positives = 102/276 (36%), Gaps = 38/276 (13%)
Query: 251 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-L 309
+ P+ + +D E+ + ++ Q + D + LG G FG V++
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSV---YDYYDILEELGSGAFGVVHRCVEK 73
Query: 310 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369
G + K + + E+ +++ H L+ L E +L+ F+
Sbjct: 74 ATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 370 G-------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422
G + + E +Q GL ++H+H I+H D+K N
Sbjct: 133 GELFDRIAAEDYKMSEAEVIN------YMRQAC----EGLKHMHEH---SIVHLDIKPEN 179
Query: 423 ILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 480
I+ + + + V DFGLA ++ D V T APE + TD++ G
Sbjct: 180 IMCETKKASSVKIIDFGLATKLN-PDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 481 VMLLELITGQRAFDLARLANDDD-----VMLLDWDF 511
V+ L++G F DD V DW+F
Sbjct: 238 VLGYVLLSGLSPF----AGEDDLETLQNVKRCDWEF 269
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 65/335 (19%), Positives = 116/335 (34%), Gaps = 54/335 (16%)
Query: 198 NQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPED 257
+ ++ L S + + + ++
Sbjct: 6 HHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPV----KSKRTSA 61
Query: 258 HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN------RNILGRGGFGKVYKGR-LT 310
D+PA P F R + ++ ILG G FG+V+K
Sbjct: 62 LAVDIPAPPAP---------FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112
Query: 311 DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370
G +A K +K + E + + E+ +++ H NL++L + + +LV ++ G
Sbjct: 113 TGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 371 -------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423
+ L E KQI G+ ++H I+H D+K NI
Sbjct: 172 ELFDRIIDESYNLTELDTI------LFMKQIC----EGIRHMHQM---YILHLDLKPENI 218
Query: 424 LLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 481
L + DFGLA+ + GT +APE ++ S TD++ GV
Sbjct: 219 LCVNRDAKQIKIIDFGLARRYK-PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 482 MLLELITGQRAFDLARLANDDD-----VMLLDWDF 511
+ L++G F L ++D ++ WD
Sbjct: 277 IAYMLLSGLSPF----LGDNDAETLNNILACRWDL 307
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 344
+ ++ +LG+G FG+V K + AVK + + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGA 398
N+++L + +V G E ++ + KQ+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVF--- 131
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
G+ Y+H H I+HRD+K NILL +++ + + DFGL+ ++T + + G
Sbjct: 132 -SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-G 185
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
T +IAPE L G EK DV+ GV+L L++G F
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 49/226 (21%), Positives = 100/226 (44%), Gaps = 20/226 (8%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTE 335
++++++ ++F ++GRG FG+V +L + + A+K L K E + E F+ E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSV--RK 392
+++ + + L + L LV + V G + + L + + + P +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFYLA 182
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
++ + + +H +HRD+K NIL+D + DFG + T ++
Sbjct: 183 EMVIA----IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235
Query: 453 VRGTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQRAF 493
GT +I+PE L + + D + GV + E++ G+ F
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ L + G + + P Q+ G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLHGI---GIT 127
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGK--S 470
HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE L +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK-RREFH 185
Query: 471 SEKTDVFGYGVMLLELITGQRAFD 494
+E DV+ G++L ++ G+ +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 58/246 (23%), Positives = 93/246 (37%), Gaps = 40/246 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 340
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 394
+H N++ L T+ +L+ + G L E + KQI
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 450
G+ YLH KI H D+K NI+L + + + DFGLA +D
Sbjct: 125 L----DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL--- 507
+ GT +APE ++ + D++ GV+ L++G F L + L
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTKQETLANIT 231
Query: 508 --DWDF 511
+DF
Sbjct: 232 SVSYDF 237
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 58/246 (23%), Positives = 93/246 (37%), Gaps = 40/246 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 340
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VAS-CLRERGQSQPPLNWSVRKQI 394
+H N++ L T+ +L+ + G L E + KQI
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 450
G+ YLH KI H D+K NI+L + + + DFGLA +D
Sbjct: 125 L----DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL--- 507
+ GT +APE ++ + D++ GV+ L++G F L + L
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTKQETLANIT 231
Query: 508 --DWDF 511
+DF
Sbjct: 232 AVSYDF 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 287 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK-------RLKEERTQGGELQFQTEVE 337
D + LG G G+V R T VA+K + R L +TE+E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVR 391
++ H +++++ F + +V M G L+E
Sbjct: 68 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKL------YF 120
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 448
Q+ L + YLH++ IIHRD+K N+LL +E+ + DFG +K++ +T
Sbjct: 121 YQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETS 171
Query: 449 VTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVML 483
+ + GT ++APE L + + + D + GV+L
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 19/216 (8%)
Query: 287 TDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
+ + N +GRG +G+V A K++ + + + +F+ E+E++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKS 62
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H N++RL T+ LV G + + + + + K +
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL----SA 118
Query: 402 LAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458
+AY H + HRD+K N L + + DFGLA + GT
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPY 173
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+++P+ L G + D + GVM+ L+ G F
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 33/135 (24%), Positives = 55/135 (40%), Gaps = 21/135 (15%)
Query: 369 NGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425
++ + R + + + QIA + +LH ++HRD+K +NI
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLHSK---GLMHRDLKPSNIFF 197
Query: 426 DEEFEAVVGDFGLAKLMDYKDTHVTTAVR-----------GTIGHIAPEYLSTGKSSEKT 474
+ VGDFGL MD + T GT +++PE + S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 475 DVFGYGVMLLELITG 489
D+F G++L EL+
Sbjct: 258 DIFSLGLILFELLYS 272
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 57/246 (23%), Positives = 93/246 (37%), Gaps = 40/246 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 340
D++ LG G F V K R G A K RL R + + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 394
H N++ L T+ +L+ + G L E +Q KQI
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQI 117
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 450
G+ YLH +I H D+K NI+L + + + DFG+A ++
Sbjct: 118 L----DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFK 169
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-----VM 505
GT +APE ++ + D++ GV+ L++G F L +
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF----LGETKQETLTNIS 224
Query: 506 LLDWDF 511
+++DF
Sbjct: 225 AVNYDF 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 34/234 (14%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGEL-QFQTE 335
L+E+++ D+F ++GRG F +V ++ G + A+K + K + + GE+ F+ E
Sbjct: 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 394
+++ R + +L F L LV + V G + + L + G ++I
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG-----------ERI 159
Query: 395 ALGAAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
AR + +H +HRD+K NILLD + DFG +
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG-------YGVMLLELITGQRAF 493
T + GT +++PE L T +G GV E+ GQ F
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 49/201 (24%), Positives = 78/201 (38%), Gaps = 20/201 (9%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G+G F V + G AVK + E + M H +++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAARGLAYL 405
L + +V+ FM + + +R + + +QI L A L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI-LEA---LRYC 146
Query: 406 HDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
HD+ IIHRDVK +LL + +G FG+A + V GT +AP
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 463 EYLSTGKSSEKTDVFGYGVML 483
E + + DV+G GV+L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 25/239 (10%)
Query: 263 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL- 320
AE P Q + + + ++F ILG G F V R A+K L
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 321 KEERTQGGELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 379
K + ++ + E +++S H ++L + + NG + +R+
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI 124
Query: 380 GQSQPPLNWSVRK----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435
G + + + +I L YLH IIHRD+K NILL+E+ + D
Sbjct: 125 GS----FDETCTRFYTAEIVSA----LEYLHGK---GIIHRDLKPENILLNEDMHIQITD 173
Query: 436 FGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQ 490
FG AK L + GT +++PE L+ KSS D++ G ++ +L+ G
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVH 344
+ + N ++G G +G V K R G +VA+K+ E ++ E++++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRH 83
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
NL+ L C LV+ F+ + ++ L L++ V ++ G+ +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN---GLDYQVVQKYLFQIINGIGF 139
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGH 459
H H IIHRD+K NIL+ + + DFG A+ + T R
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR----- 191
Query: 460 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
APE L + DV+ G ++ E+ G+
Sbjct: 192 -APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 41/229 (17%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKR-LKEERTQGGELQFQTEVEMI 339
+ + ++N ++G G FG V++ +L + VA+K+ L+++R + ELQ V+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK-- 90
Query: 340 SMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRK- 392
H N++ L+ F + ++ LV ++ +V R + + + + K
Sbjct: 91 ----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKL 145
Query: 393 ---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTH 448
Q+ R LAY+H I HRD+K N+LLD + + DFG AK
Sbjct: 146 YMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK-------- 190
Query: 449 VTTAVRGTIGHI------APEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
+ A + +I APE + + + D++ G ++ EL+ GQ
Sbjct: 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 3e-19
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 32/213 (15%)
Query: 287 TDNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMI 339
+ FS+ LG+G F V + + T G A K + ++ + Q + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLSARDFQKLEREARIC 59
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQ 393
H N++RL + LV+ + G E S +Q
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQ 113
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVT 450
I +AY H + I+HR++K N+LL + + DFGLA + D+
Sbjct: 114 IL----ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAW 164
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483
GT G+++PE L S+ D++ GV+L
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 42/208 (20%), Positives = 79/208 (37%), Gaps = 25/208 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 344
T+ + LG+G F V + + G A + ++ + Q + E + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGA 398
N++RL L++ + G E S +QI
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH------CIQQIL--- 120
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
+ + H ++HR++K N+LL + + DFGLA ++ + G
Sbjct: 121 -EAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 456 TIGHIAPEYLSTGKSSEKTDVFGYGVML 483
T G+++PE L + D++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
F +LG G F +V+ + G L A+K +K+ + + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGAA 399
N++ L + T LV + G E+ S V +Q+
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQVL---- 116
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
+ YLH++ I+HRD+K N+L +E + ++ DFGL+K+ ++ ++TA GT
Sbjct: 117 SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GT 170
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVML 483
G++APE L+ S+ D + GV+
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 50/241 (20%), Positives = 92/241 (38%), Gaps = 35/241 (14%)
Query: 281 RELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTE 335
++L + F++ +G G + + AVK + + + E E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----E 65
Query: 336 VEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNW 388
+E++ H N++ L+ +V M G + ER S
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA----- 120
Query: 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDY 444
V I + + YLH ++HRD+K +NIL E++ + DFG AK +
Sbjct: 121 -VLFTIT----KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 504
++ + T T +APE L D++ GV+L ++TG F +++
Sbjct: 173 ENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
Query: 505 M 505
+
Sbjct: 232 L 232
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 50/245 (20%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVK-------------------------RLKEERTQGGE 329
+G+G +G V D + A+K + +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 330 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV----NGSVASCLRERGQSQPP 385
Q E+ ++ H N+++L P E L +MV N +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSED 137
Query: 386 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445
+ + G + YLH KIIHRD+K +N+L+ E+ + DFG++
Sbjct: 138 QARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 446 DTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDD 502
D ++ V GT +APE LS + S + DV+ GV L + GQ F D+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM------DE 243
Query: 503 DVMLL 507
+M L
Sbjct: 244 RIMCL 248
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 35/137 (25%), Positives = 57/137 (41%), Gaps = 9/137 (6%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
N + +++L L S N++ L+L N +S +L T L L+L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L + L LS LR L LNNN + + L S++ L +NN ++ + +
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS-RGQ 120
Query: 189 LFTPISFANNQLNNPPP 205
I ANN++
Sbjct: 121 GKKNIYLANNKITMLRD 137
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 4/114 (3%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L++L L N I V ++ L +LDL N L + + + ++ L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
NN L+ I ++L +L+ DL N + + A +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 6/121 (4%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ ++ +++ + + N+ LDL N L+ L +KL L L++N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 211
L E L ++++L+ LDL+NN + ++ S+ + ANN ++ S
Sbjct: 69 VL-YETL-DLESLSTLRTLDLNNNYVQ-ELLVGP--SI-ETLHAANNNISRVSCSRGQGK 122
Query: 212 Q 212
+
Sbjct: 123 K 123
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 5/120 (4%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFLR 147
+ + + L +N I+ + G + + LDL LN ++ L L
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 206
L N + ++ L+ LDLS+NKL + S + T IS NN+L +
Sbjct: 176 LQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA 232
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 19/98 (19%), Positives = 34/98 (34%), Gaps = 1/98 (1%)
Query: 110 PEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169
E N + ++L + + ++ L L+ N L L L++
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 170 LDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207
L+LS+N L + S S + NN + P
Sbjct: 63 LNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELLVGP 99
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 14/76 (18%), Positives = 32/76 (42%), Gaps = 5/76 (6%)
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT- 191
I ++ + ++ ++SL + + +++ LDLS N L+ I + FT
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QIS-AADLAPFTK 59
Query: 192 --PISFANNQLNNPPP 205
++ ++N L
Sbjct: 60 LELLNLSSNVLYETLD 75
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTE 335
+R+L++ +++ ++GRG FG+V R + A+K L K E + + F E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR---K 392
++++ A +++L +V +M G + + + + R
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTA 175
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
++ L L +H IHRDVK N+LLD+ + DFG M+ +
Sbjct: 176 EVVLA----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 453 VRGTIGHIAPEYLSTGKSSEK----TDVFGYGVMLLELITGQRAF 493
GT +I+PE L + D + GV L E++ G F
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 345
+ + +G G +G VYK + + G +VA+KR++ + G + E+ ++ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHP 79
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N++ L + LV+ FM + L E L S K RG+A+
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHC 135
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGHI 460
H H +I+HRD+K N+L++ + + DFGLA+ TH VT R
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------ 186
Query: 461 APEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
AP+ L K S D++ G + E+ITG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 26/223 (11%)
Query: 272 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL 330
+G+ F + +DN+ + LG+G F V + T G A K + ++ +
Sbjct: 13 MGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF 72
Query: 331 Q-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQ 383
Q + E + H N++RL + LV+ + G E S
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS- 131
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 440
+QI +AY H + I+HR++K N+LL + + DFGLA
Sbjct: 132 -----HCIQQIL----ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483
+ D+ GT G+++PE L S+ D++ GV+L
Sbjct: 180 EV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 8e-19
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 352
LG G FGKV G G VAVK L ++ + ++ + + E++ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
TPT+ +V ++ G + + + G+ + + +QI + Y H H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA----VDYCHRH---M 131
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--S 470
++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE +S G+ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVIS-GRLYA 188
Query: 471 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ D++ GV+L L+ G FD D+ V L
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD------DEHVPTL 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
+ L + G + + P Q+ G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLHGI---GIT 127
Query: 415 HRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGK--S 470
HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE L +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK-RREFH 185
Query: 471 SEKTDVFGYGVMLLELITGQRAFD 494
+E DV+ G++L ++ G+ +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 29/220 (13%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G FG R LVAVK + ER + Q E+ H N++R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCDP 411
+TPT ++ + G + + G+ R Q+ G++Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLS----GVSYCHSM--- 135
Query: 412 KIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 469
+I HRD+K N LLD + DFG +K + + V GT +IAPE L +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTV-GTPAYIAPEVLL-RQ 192
Query: 470 --SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ DV+ GV L ++ G F+ D +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRD 226
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 35/137 (25%), Positives = 56/137 (40%), Gaps = 9/137 (6%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
N + +++L L S N++ L+L N +S +L T L L+L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L + L LS LR L LNNN + + L S++ L +NN ++ +
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSC-SRGQ 120
Query: 189 LFTPISFANNQLNNPPP 205
I ANN++
Sbjct: 121 GKKNIYLANNKITMLRD 137
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 23/124 (18%), Positives = 41/124 (33%), Gaps = 4/124 (3%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L++L L N I V ++ L +LDL N L + + + ++ L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
NN L+ I ++L +L+ DL N + + A +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280
Query: 209 PPLQ 212
Sbjct: 281 EECT 284
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 26/121 (21%), Positives = 52/121 (42%), Gaps = 6/121 (4%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ ++ +++ + + N+ LDL N L+ L +KL L L++N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 211
L E L ++++L+ LDL+NN + ++ S + ANN ++ S
Sbjct: 69 VL-YETL-DLESLSTLRTLDLNNNYVQ-ELLVGPS---IETLHAANNNISRVSCSRGQGK 122
Query: 212 Q 212
+
Sbjct: 123 K 123
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 22/135 (16%), Positives = 49/135 (36%), Gaps = 14/135 (10%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
+L + L L L+ L+ L+L +N + EL ++ +L NN++ +
Sbjct: 64 NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VS 115
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT--- 191
+ + + L NN + + +Q LDL N++ + +
Sbjct: 116 --CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLE 172
Query: 192 PISFANNQLNNPPPS 206
++ N + +
Sbjct: 173 HLNLQYNFIYDVKGQ 187
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG-KVPEELGNLTNLVSLDLYLN 127
+ L N ++ G + +QYL+L N I E + L L+L N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ + + +KL+ L L++N L + + + + L NNKL
Sbjct: 180 FIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 1/99 (1%)
Query: 109 VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQ 168
+ E N + ++L + + ++ L L+ N L L L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 169 VLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207
+L+LS+N L + S S + NN + P
Sbjct: 62 LLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELLVGP 99
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 12/102 (11%), Positives = 25/102 (24%), Gaps = 1/102 (0%)
Query: 78 NANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL-NNLNGPIPTT 136
L+GQ + T Y ++ + L L L + +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 137 LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
++ R + I + + L+ L
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 13/158 (8%), Positives = 40/158 (25%), Gaps = 1/158 (0%)
Query: 21 LLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNAN 80
+ VA + P P + + + G +
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323
Query: 81 LSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL 140
+ +L + + ++ + + ++L+ L+ +
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383
Query: 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
++L + E+ + + LQ+L +
Sbjct: 384 AELDGTLQQAVGQI-ELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 16/146 (10%), Positives = 36/146 (24%), Gaps = 4/146 (2%)
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELY-SNNISGKVPEELGNLTNLVSLD 123
C +L +L L ++ L + + ++ E N +D
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREID 342
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP---RSLTNVNSLQVLDLSNNKLTGD 180
I + L +L ++ R+ ++ + +L
Sbjct: 343 ALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHA 402
Query: 181 IPTNGSFSLFTPISFANNQLNNPPPS 206
L I ++ S
Sbjct: 403 TEEQSPLQLLRAIVKRYEEMYVEQQS 428
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+ + + LG G + VYKG+ +LVA+K ++ E +G EV ++ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++ L T LV+ ++ + + L + G +N K RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCH 117
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIGH 459
K++HRD+K N+L++E E + DFGLA+ Y + VT R
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYR----- 167
Query: 460 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
P+ L S + D++G G + E+ TG+
Sbjct: 168 -PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 40/223 (17%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVH 344
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 345 RNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QI 394
N++RLR F + E+ LV ++ +V R +++ L K Q+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV 453
R LAY+H I HRD+K N+LLD + + + DFG AK + + + +
Sbjct: 166 F----RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYI 217
Query: 454 -----RGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
R APE + + DV+ G +L EL+ GQ
Sbjct: 218 CSRYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 38/235 (16%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 352
LGRG F V + + G A K L K R Q + E+ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 353 FCMTPTERLLVYPFMVNG--------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+E +L+ + G +A + E + + KQI G+ Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR------LIKQIL----EGVYY 146
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
LH + I+H D+K NILL + + DFG+++ + + + GT ++A
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM-GTPEYLA 201
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL-----DWDF 511
PE L+ + TD++ G++ L+T F + D+ L + D+
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSPF----VGEDNQETYLNISQVNVDY 252
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 58/246 (23%), Positives = 92/246 (37%), Gaps = 40/246 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 340
D + LG G F V K R + G A K R K R + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 394
H N++ L T+ +L+ + G L E ++ KQI
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQI 123
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 450
G+ YLH +I H D+K NI+L + + + DFGLA +D
Sbjct: 124 L----NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFK 175
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL--- 507
GT +APE ++ + D++ GV+ L++G F L + L
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTKQETLANVS 230
Query: 508 --DWDF 511
+++F
Sbjct: 231 AVNYEF 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLRG 352
LG G FGKV VA+K + + + ++ + E+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
TPT+ ++V + G + + E+ + +QI + Y H H K
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRH---K 128
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
I+HRD+K N+LLD+ + DFGL+ +M + T+ G+ + APE ++ GK
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVIN-GKLYA 185
Query: 473 --KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ DV+ G++L ++ G+ FD D+ + L
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNL 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGG-------E---LQFQTE 335
+ +G G +GKV+K R G VA+KR++ + + G E L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR---- 66
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSV 390
+ H N++RL C LV+ + + + + L + + P +
Sbjct: 67 --HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE--PGVPTET 121
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKD 446
K + RGL +LH H +++HRD+K NIL+ + + DFGLA++ M
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 447 TH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
T VT R APE L + D++ G + E+ +
Sbjct: 177 TSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 47/211 (22%), Positives = 82/211 (38%), Gaps = 29/211 (13%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 352
LG G F K AVK + + E Q E+ + H N+++L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73
Query: 353 FCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
LV + G E S + +++ ++++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY------IMRKLV----SAVSHMH 123
Query: 407 DHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
D ++HRD+K N+L ++ E + DFG A+L + + T T+ + APE
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPE 179
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
L+ E D++ GV+L +++GQ F
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 35/218 (16%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAV 343
+ + +G G +G V+K R G +VA+K+ E + E+ M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALREIRMLKQLK 60
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H NL+ L LV+ + + +V L + + + K I + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR---GVPEHLVKSITWQTLQAVN 116
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-----RGTIG 458
+ H H IHRDVK NIL+ + + DFG A+L+ + V R
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR---- 169
Query: 459 HIAPEYL------STGKSSEKTDVFGYGVMLLELITGQ 490
+PE L DV+ G + EL++G
Sbjct: 170 --SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 4e-18
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 27/217 (12%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVH 344
+ +G G +G V+K + +VA+KR++ + G + E+ ++ H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
+N++RL + + LV+ F + + L+ + K +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGF 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTI 457
H ++HRD+K N+L++ E + +FGLA+ + Y + VT R
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYR--- 168
Query: 458 GHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
P+ L K S D++ G + EL R
Sbjct: 169 ---PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 39/246 (15%)
Query: 268 PEVHLGQLKRFSLRELQVAT--DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEER 324
E S+ AT D + LG G +G+VYK VA+KR++ E
Sbjct: 12 LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71
Query: 325 TQGGELQF-QT---EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG 380
+ G T EV ++ HRN++ L+ L++ + + L++
Sbjct: 72 EEEG---VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYM 123
Query: 381 QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----D 435
P ++ V K G+ + H + +HRD+K N+LL + D
Sbjct: 124 DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 436 FGLAKLM-----DYKDTH--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELI 487
FGLA+ + TH +T R PE L + S D++ + E++
Sbjct: 181 FGLARAFGIPIRQF--THEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 488 TGQRAF 493
F
Sbjct: 233 MKTPLF 238
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 5e-18
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 345
+ + +G G +G VYK + G A+K+++ E+ G + T E+ ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHS 60
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++L T +LV+ + + + L L K L G+AY
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYC 116
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIG 458
HD +++HRD+K N+L++ E E + DFGLA+ + Y TH VT R
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR---- 167
Query: 459 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
AP+ L K S D++ G + E++ G
Sbjct: 168 --APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVH 344
D F + G+G FG V G+ G VA+K+ +++ R + ELQ ++ +++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78
Query: 345 RNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----Q 393
N+++L+ + T ER +V ++ ++ C R + Q + K Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 394 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA 452
+ R + LH + HRD+K N+L++E + DFG AK + + +V
Sbjct: 138 LI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 453 V----RGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
R APE + + + D++ G + E++ G+
Sbjct: 193 CSRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 50/240 (20%), Positives = 94/240 (39%), Gaps = 36/240 (15%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + LGRG FG V++ + K +K ++ + E+ ++++A HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNG-------SVASCLRERGQSQPPLNWSVRKQIALGA 398
N+L L + E ++++ F+ + A L ER S Q+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV------SYVHQVC--- 112
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGT 456
L +LH H I H D++ NI+ + + +FG A+ + +
Sbjct: 113 -EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLF-TA 166
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-----VMLLDWDF 511
+ APE S TD++ G ++ L++G F LA + +M ++ F
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF----LAETNQQIIENIMNAEYTF 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
++ F LG G + VYKG T G VA+K +K + +G E+ ++ H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGAARGL 402
N++RL T + LV+ FM + + + R G + L ++ K +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTH--VTTAVRG 455
A+ H++ KI+HRD+K N+L+++ + +GDFGLA+ + + VT R
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYR- 175
Query: 456 TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
AP+ L ++ S D++ G +L E+ITG+
Sbjct: 176 -----APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 47/234 (20%), Positives = 84/234 (35%), Gaps = 42/234 (17%)
Query: 271 HLGQLKRFSLRELQVATDNFSN-----RNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEE 323
H + + ++ + +LG G GKV + G A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP 66
Query: 324 RTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRE 378
+ + EV+ + +++ + L++ M G L
Sbjct: 67 K-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE----LFS 115
Query: 379 RGQSQPPLNWSVR------KQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEF 429
R Q + ++ R + I + +LH H I HRDVK N+L +++
Sbjct: 116 RIQERGDQAFTEREAAEIMRDIG----TAIQFLHSH---NIAHRDVKPENLLYTSKEKDA 168
Query: 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 483
+ DFG AK + T T ++APE L K + D++ GV++
Sbjct: 169 VLKLTDFGFAKETT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 50/214 (23%), Positives = 80/214 (37%), Gaps = 38/214 (17%)
Query: 293 RNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRL 350
++LG G +V L AVK ++++ + EVE + HRN+L L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLEL 76
Query: 351 RGFCMTPTERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAY 404
F LV+ M GS+ S + +R S V + +A L +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------VVQDVA----SALDF 126
Query: 405 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV-------TTAVR 454
LH+ I HRD+K NIL ++ + DF L + T
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC- 182
Query: 455 GTIGHIAPEYLSTGKSSEKT-----DVFGYGVML 483
G+ ++APE + D++ GV+L
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 39/226 (17%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EVEMISMA 342
+ +G+G FG+V+K R G VA+K++ E + G F T E++++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 343 VHRNLLRLRGFCMTPTERL--------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 394
H N++ L C T LV+ F + +A L S K++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRV 129
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-------T 447
GL Y+H + KI+HRD+KAAN+L+ + + DFGLA+ T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 448 H--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
+ VT R PE L + D++G G ++ E+ T
Sbjct: 187 NRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EVEMISMA 342
+ + LG G F VYK R +VA+K++K + +T E++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
H N++ L + LV+ FM + +++ L S K L +GL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGL 125
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
YLH H I+HRD+K N+LLDE + DFGLAK
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 352
LG G FGKV G+ G VAVK L ++ + ++ + + E++ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 412
TP++ +V ++ G + + + G+ + + +QI G + Y H H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG----VDYCHRH---M 136
Query: 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 472
++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE +S G+
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVIS-GRLYA 193
Query: 473 --KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 507
+ D++ GV+L L+ G FD DD V L
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFD------DDHVPTL 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 61/266 (22%), Positives = 108/266 (40%), Gaps = 36/266 (13%)
Query: 252 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 311
K+ E + E L + + S Q+ D F LG G FG+V + +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 312 -GSLVAVKRL-KEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 368
G+ A+K L K++ + +++ E ++ L++L + +V ++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 369 NGSVASCLRERGQSQPPLNWSVRK----QIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
G + S LR G+ + + QI L YLH +I+RD+K N+L
Sbjct: 125 GGEMFSHLRRIGR----FSEPHARFYAAQIVLT----FEYLHSL---DLIYRDLKPENLL 173
Query: 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGV 481
+D++ V DFG AK + T + GT +APE + + K+ D + GV
Sbjct: 174 IDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA---VDWWALGV 226
Query: 482 MLLELITGQRAFDLARLANDDDVMLL 507
++ E+ G F D + +
Sbjct: 227 LIYEMAAGYPPFF------ADQPIQI 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 4e-17
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 339
++ +F+ +LG+G FGKV L AVK LK++ + T VE +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 340 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
L +L C +RL V + VNG G L + +++
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEY-VNG---------GD----LMYHIQQVGRFKE 441
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
GL +L II+RD+K N++LD E + DFG+ K + T
Sbjct: 442 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T GT +IAPE ++ + D + +GV+L E++ GQ F+ D+D +
Sbjct: 499 --TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 550
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+D F + LGRG VY+ + A+K LK + +TE+ ++ H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHP 108
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQIALGAA 399
N+++L+ TPTE LV + G V ER + KQI
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD------AVKQIL---- 158
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
+AYLH++ I+HRD+K N+L + + DFGL+K+++++ T GT
Sbjct: 159 EAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GT 213
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVML 483
G+ APE L + D++ G++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 48/279 (17%)
Query: 253 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRN------------ILGRGG 300
H +D+P E+ + + T + ++GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 301 FGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRLRGFCMT 356
+ KV RL + A++ +K+E E + E + H L+ L C
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQ 123
Query: 357 PTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR----------GLAYL 405
RL V + VNG G L + +++Q L L YL
Sbjct: 124 TESRLFFVIEY-VNG---------GD----LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEY 464
H+ II+RD+K N+LLD E + D+G+ K + DT T+ GT +IAPE
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 224
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 503
L D + GV++ E++ G+ FD+ +++ D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 37/150 (24%), Positives = 61/150 (40%), Gaps = 8/150 (5%)
Query: 70 SVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLN 127
+ + L L ++ L ++ +LQ L L N S ++ +L L L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 128 NLNGPIPT-----TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L T LS L+ L LN+N L P +++ +L+ L L++N+LT +
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 183 TNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
N + + + NQL P P L
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVSLS 550
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 30/148 (20%), Positives = 50/148 (33%), Gaps = 10/148 (6%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
+C+ + + NL+ V Q+ L + L L N I L L L+
Sbjct: 1 SCSFDGRI--AFYRFCNLTQ--VPQV--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54
Query: 124 LYLNNLNGPI-PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L I L LR L L ++ + P + + L L L L+ +
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114
Query: 183 TNGSFSLFT---PISFANNQLNNPPPSP 207
+G F + + NQ+ + P
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHP 142
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 4/135 (2%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+SV +DL + + L +L+ L L N I+ E L NL L+L N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L + L K+ ++ L N + ++ + LQ LDL +N LT
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIP 384
Query: 188 SLFTPISFANNQLNN 202
+F + N+L
Sbjct: 385 DIF----LSGNKLVT 395
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 30/153 (19%), Positives = 51/153 (33%), Gaps = 9/153 (5%)
Query: 67 SENSVTRVDLGNA--NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNL--TNLVSL 122
S N T GN +S L ++ +NI L +++ L
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
DL + L L+ L L N + + +++LQVL+LS N L ++
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELY 330
Query: 183 TNGSFSLFTP---ISFANNQLNNPPPSPPPPLQ 212
+ +F I N + L+
Sbjct: 331 -SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 23/133 (17%), Positives = 50/133 (37%), Gaps = 19/133 (14%)
Query: 91 QLTNLQYLELYSNNISGKVP------------EELGNLTNLVSLDLYLNNLNGPIPTTLG 138
+ L+ L++ N + + L +++ +N+ P T
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 139 KLSK--LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---I 193
L++ +R L L++ + R + L+VL+L+ NK+ I + +F +
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIA-DEAFYGLDNLQVL 319
Query: 194 SFANNQLNNPPPS 206
+ + N L S
Sbjct: 320 NLSYNLLGELYSS 332
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 29/163 (17%), Positives = 53/163 (32%), Gaps = 28/163 (17%)
Query: 70 SVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT--NLVSLDLYL 126
++TR+DL + L G+L +L+ ++ SN I EL L L L
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 127 NNLNGPIPTTLGKLSK------LRFLRLNNNSLMGEIPR------------SLTNVNSLQ 168
N+L + GK L L ++ N +I SL + +
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 169 VLDLSNNKLTGDIPTNGSFSLFTPIS-----FANNQLNNPPPS 206
+ + P +F+ S ++ + +
Sbjct: 244 GAGFGFHNIK--DPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 26/136 (19%), Positives = 48/136 (35%), Gaps = 14/136 (10%)
Query: 44 NNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSN 103
N+LQ T + + ++ + + L + L+ LT L+ L L SN
Sbjct: 460 ENMLQLAWETELCWDVFEGLS-----HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514
Query: 104 NISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP----R 159
++ + NL LD+ N L P P L L + +N + E
Sbjct: 515 RLT-VLSHND-LPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECELSTFI 569
Query: 160 SLTNVNSLQVLDLSNN 175
+ N ++ + +
Sbjct: 570 NWLNHTNVTIAGPPAD 585
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 296 LGRGGFGKVYKGR---LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+GRG +G VYK + D A+K+++ G + E+ ++ H N++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85
Query: 353 FCMTPTERL--LVYPFM---VNGSVASCLRERGQSQP-PLNWSVRKQIALGAARGLAYLH 406
++ +R L++ + + + + +P L + K + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDY---KDTHVTTAVRGTIGH 459
+ ++HRD+K ANIL+ E + D G A+L + + V T +
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 460 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 490
APE L + ++ D++ G + EL+T +
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 63/263 (23%), Positives = 106/263 (40%), Gaps = 28/263 (10%)
Query: 253 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD- 311
+P++ P Q+ +F ++G+G FGKV R
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 312 GSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERL-LVYPFM 367
AVK L+++ + + E ++ H L+ L F ++L V ++
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYI 121
Query: 368 VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424
G + L+ P R +IA L YLH I++RD+K NIL
Sbjct: 122 NGGELFYHLQRERCFLEPR---ARFYAAEIASA----LGYLHSL---NIVYRDLKPENIL 171
Query: 425 LDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVM 482
LD + V+ DFGL K +++ T T+ GT ++APE L + ++T D + G +
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAV 228
Query: 483 LLELITGQRAFDLARLANDDDVM 505
L E++ G F + + M
Sbjct: 229 LYEMLYGLPPFY----SRNTAEM 247
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 26/264 (9%)
Query: 251 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT 310
+K+ + F + D + + +V + F +LG+G FGKV +
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170
Query: 311 D-GSLVAVKRLKEERTQGGELQFQTEVE--MISMAVHRNLLRLRGFCMTPTERL-LVYPF 366
G A+K LK+E + T E ++ + H L L+ + +RL V +
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEY 229
Query: 367 MVNGSVASCL-RERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422
G + L RER S+ R +I L YLH + +++RD+K N
Sbjct: 230 ANGGELFFHLSRERVFSED----RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLEN 279
Query: 423 ILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 481
++LD++ + DFGL K + T GT ++APE L D +G GV
Sbjct: 280 LMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 482 MLLELITGQRAFDLARLANDDDVM 505
++ E++ G+ F D + +
Sbjct: 338 VMYEMMCGRLPFY----NQDHEKL 357
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 36/126 (28%), Positives = 53/126 (42%), Gaps = 7/126 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+S L L L+ L L N IS L +L L SL L N + T L +L+KL
Sbjct: 105 LSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDT 160
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L L +N + +I L + LQ L LS N ++ D+ + + + N P
Sbjct: 161 LSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPI 217
Query: 206 SPPPPL 211
+ L
Sbjct: 218 NHQSNL 223
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 27/135 (20%), Positives = 57/135 (42%), Gaps = 9/135 (6%)
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ +L +++ +L ++ + +++I V + + L N+ L L N L
Sbjct: 26 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 81
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF 190
P L L L +L L+ N + ++ SL ++ L+ L L +N ++ DI
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQL 136
Query: 191 TPISFANNQLNNPPP 205
+ NN++ +
Sbjct: 137 ESLYLGNNKITDITV 151
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 20/117 (17%), Positives = 43/117 (36%), Gaps = 7/117 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+ L +++ V L ++ + +++ + L +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTK 72
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
L LN N L +I L N+ +L L L NK+ D+ + +S +N +++
Sbjct: 73 LFLNGNKL-TDIK-PLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGISD 126
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ LGN ++ ++ L +LT L L L N IS + L LT L +L L N+++
Sbjct: 137 ESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISD 192
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L L L L L + + + +N+ + ++ L
Sbjct: 193 LRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 55/252 (21%), Positives = 90/252 (35%), Gaps = 41/252 (16%)
Query: 253 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNR-----NILGRGGFGKVYKG 307
+ P PA+ P + LQ+ + + +LG G GKV +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 308 R-LTDGSLVAVKRL-KEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER---- 360
A+K L + + EVE + +++R+
Sbjct: 82 FNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 361 LLVYPFMVNGSVASCLRERGQSQPPLNWS------VRKQIALGAARGLAYLHDHCDPKII 414
L+V + G L R Q + ++ + K I + YLH I
Sbjct: 135 LIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIG----EAIQYLHSI---NIA 183
Query: 415 HRDVKAANILL-DEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 471
HRDVK N+L + A++ DFG AK +TT T ++APE L K
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC-YTPYYVAPEVLGPEKYD 241
Query: 472 EKTDVFGYGVML 483
+ D++ GV++
Sbjct: 242 KSCDMWSLGVIM 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 9/143 (6%)
Query: 63 VTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
VT + +T + ++ + + L NL LEL N I+ L NLT + L
Sbjct: 35 VTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQIT--DLAPLKNLTKITEL 90
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
+L N L + L ++ L L + + P L +++LQVL L N++T +I
Sbjct: 91 ELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS 145
Query: 183 TNGSFSLFTPISFANNQLNNPPP 205
+ +S N Q+++ P
Sbjct: 146 PLAGLTNLQYLSIGNAQVSDLTP 168
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 30/136 (22%), Positives = 60/136 (44%), Gaps = 9/136 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ ++ G +N++ L + L + ++ E + L NL+ L+L N +
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
P L L+K+ L L+ N L + ++ + S++ LDL++ ++T D+ S
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT-DVTPLAGLSN 130
Query: 190 FTPISFANNQLNNPPP 205
+ NQ+ N P
Sbjct: 131 LQVLYLDLNQITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
+++ + L ++ +S L LTNLQYL + + +S L NL+ L +L N
Sbjct: 129 SNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNK 184
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
++ P L L L + L NN + P L N ++L ++ L+N +T + P + +
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT-NQPVFYNNN 239
Query: 189 LFTPISFANNQLNNPPPS 206
L P P+
Sbjct: 240 LVVPNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 19/120 (15%), Positives = 44/120 (36%), Gaps = 7/120 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+ L N + +N++ +L + +L + + + L+ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIG 67
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L L +N + ++ L N+ + L+LS N L ++ + + Q+ + P
Sbjct: 68 LELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 28/121 (23%), Positives = 52/121 (42%), Gaps = 8/121 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ + +GNA +S ++ L L+ L L+ N IS L +L NL+ + L N +
Sbjct: 152 NLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQI 207
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT--GDIPTNGSF 187
+ P L S L + L N ++ + N+ V+ + I NG++
Sbjct: 208 SDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTY 265
Query: 188 S 188
+
Sbjct: 266 A 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 339
++ +F+ +LG+G FGKV L AVK LK++ + T VE +
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 340 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
L +L C +RL V + VNG G L + +++
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDRLYFVMEY-VNG---------GD----LMYHIQQVGRFKE 120
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
GL +L II+RD+K N++LD E + DFG+ K + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T GT +IAPE ++ + D + +GV+L E++ GQ F+ D+D +
Sbjct: 178 --TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 229
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 27/137 (19%), Positives = 52/137 (37%), Gaps = 12/137 (8%)
Query: 80 NLSGQLVSQL-----GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PI 133
L ++ + L +L++L+L N++S G L++L L+L N +
Sbjct: 56 ILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP 192
+ L+ L+ LR+ N EI R + SL L++ L + + S
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQ-SQSLKSIRD 173
Query: 193 I---SFANNQLNNPPPS 206
I + ++
Sbjct: 174 IHHLTLHLSESAFLLEI 190
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 44/159 (27%), Positives = 67/159 (42%), Gaps = 28/159 (17%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS--GKVPEELGNLTNLVSLDL 124
SEN + L N+ G +LQ L L N++ K E L L NL SLD+
Sbjct: 342 SENLMVEEYLKNSAC-------KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 125 YLNNLNGPIPTTLGKLSKLRFLRLNNN---SLMGEIPRSLTNVN--------------SL 167
N + P+P + K+RFL L++ + IP++L ++ L
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRL 453
Query: 168 QVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
Q L +S NKL +P F + + + NQL + P
Sbjct: 454 QELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDG 491
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 26/126 (20%), Positives = 48/126 (38%), Gaps = 7/126 (5%)
Query: 63 VTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
++C++ D + + + + S L ++ L+L N I+ +L NL L
Sbjct: 2 LSCDASGVC---DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVL 55
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L + +N L L L L++N L ++SL+ L+L N +
Sbjct: 56 ILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLG 114
Query: 183 TNGSFS 188
F
Sbjct: 115 VTSLFP 120
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 28/151 (18%), Positives = 55/151 (36%), Gaps = 11/151 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ R+ + L L + L ++ + + ++ + +L +L LDL N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 130 NGPIPTT---LGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
G L+ L L+ N L M + L + +L LD+S N +P
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP-- 403
Query: 185 GSFSLFTPISF---ANNQLNNPPPSPPPPLQ 212
S + F ++ + P L+
Sbjct: 404 DSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE 434
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 22/134 (16%), Positives = 54/134 (40%), Gaps = 3/134 (2%)
Query: 70 SVTRVDLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++ + +GN ++ LT+L LE+ + ++ + L ++ ++ L L+L+
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ LS +R+L L + +L L + + + + T+ SF+
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS--VLTDESFN 241
Query: 189 LFTPISFANNQLNN 202
+ +L+
Sbjct: 242 ELLKLLRYILELSE 255
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 30/197 (15%), Positives = 65/197 (32%), Gaps = 11/197 (5%)
Query: 22 LRVASNAEGDALNALKT-NLADPN-NVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNA 79
D L++++ L D N Q + + + +T
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 80 NLSGQLVSQLGQLT----NLQYLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLNGPIP 134
+ + +L ++ L L ++ + S V E + L + L +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP-- 192
T L K++ + + N+ + ++ SL+ LDLS N + + N + P
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 193 --ISFANNQLNNPPPSP 207
+ + N L + +
Sbjct: 364 QTLVLSQNHLRSMQKTG 380
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 22/125 (17%), Positives = 42/125 (33%), Gaps = 9/125 (7%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN 115
N +C + ++L + + V + L+ L++ +NN+
Sbjct: 397 NTFHPMPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLD-SFSL---F 449
Query: 116 LTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175
L L L + N L +L L ++++ N L + SLQ + L N
Sbjct: 450 LPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 176 KLTGD 180
Sbjct: 508 PWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 16/144 (11%), Positives = 50/144 (34%), Gaps = 11/144 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
S+ +++ +L L + ++ +L L+ + + + L+++ L+L NL
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSL----------MGEIPRSLTNVNSLQVLDLSNNKLTG 179
+ L ++ + ++ R + ++ ++ D + N L
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 180 -DIPTNGSFSLFTPISFANNQLNN 202
+ + S + + +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLH 292
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 25/259 (9%)
Query: 261 DVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD----GSLVA 316
D + H + + +V +NF +LG G +GKV+ R G L A
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 317 VKRLKEER-TQGGELQFQTEVE-MISMAVHRN--LLRLRGFCMTPTERL-LVYPFMVNGS 371
+K LK+ Q + T E + + ++ L+ L + +L L+ ++ G
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGE 145
Query: 372 VASCLRERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428
+ + L +R + V+ +I L L +LH II+RD+K NILLD
Sbjct: 146 LFTHLSQRERFTEHE---VQIYVGEIVLA----LEHLHKL---GIIYRDIKLENILLDSN 195
Query: 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV--FGYGVMLLEL 486
V+ DFGL+K +T GTI ++AP+ + G S V + GV++ EL
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 487 ITGQRAFDLARLANDDDVM 505
+TG F + N +
Sbjct: 256 LTGASPFTVDGEKNSQAEI 274
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 48/241 (19%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK---------EERTQGGELQFQ 333
+ + +F LG G FG+V+ R G A+K LK E T
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK- 392
E M+S+ H ++R+ G + ++ ++ G + S LR+ + P V K
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKF 110
Query: 393 ---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
++ L L YLH II+RD+K NILLD+ + DFG AK V
Sbjct: 111 YAAEVCLA----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDV 159
Query: 450 TTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 506
T + GT +IAPE +ST KS D + +G+++ E++ G F D + M
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFY------DSNTMK 210
Query: 507 L 507
Sbjct: 211 T 211
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 8e-16
Identities = 27/135 (20%), Positives = 57/135 (42%), Gaps = 9/135 (6%)
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ +L +++ +L ++ + +++I V + + L N+ L L N L
Sbjct: 23 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 78
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF 190
I L L L +L L+ N + ++ SL ++ L+ L L +N ++ DI
Sbjct: 79 D-I-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQL 133
Query: 191 TPISFANNQLNNPPP 205
+ NN++ +
Sbjct: 134 ESLYLGNNKITDITV 148
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 7/126 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+S L L L+ L L N IS L +L L SL L N + L +L+KL
Sbjct: 102 LSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDT 157
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L L +N + +I L + LQ L LS N ++ D+ + + + N P
Sbjct: 158 LSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPI 214
Query: 206 SPPPPL 211
+ L
Sbjct: 215 NHQSNL 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 4e-15
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 63 VTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
VT N NS+ ++ N+++ V + L N+ L L N ++ + L NL NL L
Sbjct: 37 VTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLT--DIKPLTNLKNLGWL 92
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L N + L L KL+ L L +N + +I L ++ L+ L L NNK+T DI
Sbjct: 93 FLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DIT 147
Query: 183 TNGSFSLFTPISFANNQLNNPPP 205
+ +S +NQ+++ P
Sbjct: 148 VLSRLTKLDTLSLEDNQISDIVP 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 17/168 (10%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C V C+ T +DL N ++S L +L L L +N IS
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSL 167
+ L L L + N+L IP L S L LR+++N + + + ++
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 168 QVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNNPPPSPPPPLQ 212
+++ N L G+F L + + +L P P L
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNY-LRISEAKLTGIPKDLPETLN 196
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 27/121 (22%), Positives = 42/121 (34%), Gaps = 12/121 (9%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L + + L L L N I L L L L L N L+ +P L L L+ + L
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYL 271
Query: 149 NNNSLMGEIP-------RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT---PISFANN 198
+ N++ ++ + L NN + +F T I F N
Sbjct: 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
Query: 199 Q 199
+
Sbjct: 331 K 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 8/121 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNI-SGKVPEELGNLTNLVSLDLYLNN 128
S+ + + + + L N+ +E+ N + + + L L +
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L G IP L L L L++N + I L + L L L +N++ I NGS
Sbjct: 184 LTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIE-NGSL 237
Query: 188 S 188
S
Sbjct: 238 S 238
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 27/232 (11%)
Query: 284 QVATDNFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+ F +LG+G FGKV+ L A+K LK+ ++ + E ++
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 339 ISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQI 394
+ H +++L + +L L+ F+ G + + L + V+ ++
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED---VKFYLAEL 135
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAV 453
AL L +LH II+RD+K NILLDEE + DFGL+K +D++ +
Sbjct: 136 ALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSF 186
Query: 454 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
GT+ ++APE ++ ++ D + +GV++ E++TG F D
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ----GKDRKET 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 73/239 (30%), Positives = 106/239 (44%), Gaps = 42/239 (17%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
++ DNF +LG+G FGKV R+ + G L AVK LK++ + T E ++
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 343 VHRN---LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
+ RN L +L C +RL V F VNG G L + ++K
Sbjct: 79 LARNHPFLTQLF-CCFQTPDRLFFVMEF-VNG---------GD----LMFHIQKSRRFDE 123
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
AR L +LHD II+RD+K N+LLD E + DFG+ K + T
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T GT +IAPE L D + GV+L E++ G F+ A ++D +
Sbjct: 181 --TATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFE----AENEDDL 232
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 36/149 (24%), Positives = 61/149 (40%), Gaps = 11/149 (7%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG---NLTNLVSLDLYL 126
+D N L+ + G LT L+ L L N + ++ + + +L LD+
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQ 383
Query: 127 NNLN-GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
N+++ L L +++N L I R L ++VLDL +NK+ IP
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIP-KQ 439
Query: 186 SFSL--FTPISFANNQLNNPPPSPPPPLQ 212
L ++ A+NQL + P L
Sbjct: 440 VVKLEALQELNVASNQLKSVPDGIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 25/124 (20%), Positives = 43/124 (34%), Gaps = 7/124 (5%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
L + N IS ++ +L+ L L + N + + +L +L L++N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT---PISFANNQLNNPPPSPPP 209
L+ N L+ LDLS N +P F + + + L P
Sbjct: 81 LVKISCHPTVN---LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 210 PLQP 213
L
Sbjct: 137 HLNI 140
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 28/135 (20%), Positives = 46/135 (34%), Gaps = 11/135 (8%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
T +++ +S S + L+ L+ L + N I L LDL N L
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRS--LTNVNSLQVLDLSNNKLTGDIPTNGSF 187
I L+ L L+ N+ +P N++ L+ L LS L S
Sbjct: 82 VK-IS--CHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHL-----EKSSV 132
Query: 188 SLFTPISFANNQLNN 202
++ + L
Sbjct: 133 LPIAHLNISKVLLVL 147
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 30/158 (18%), Positives = 57/158 (36%), Gaps = 7/158 (4%)
Query: 61 FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV 120
F + S +++ + + +N+ + ++ +
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 121 SLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLT 178
LD N L + G L++L L L N L + +I T + SLQ LD+S N ++
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 179 GDIPTNGSFSLFTPISF---ANNQL-NNPPPSPPPPLQ 212
D G S + ++N L + PP ++
Sbjct: 388 YDEK-KGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK 424
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 27/117 (23%), Positives = 41/117 (35%), Gaps = 5/117 (4%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFLRLN 149
L+YL+L N + K+ NL LDL N + PI G +S+L+FL L+
Sbjct: 67 FNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
L + ++N +VL + F S N
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP-EGLQDFNTESLHIVFPTNKEFH 179
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 27/198 (13%), Positives = 55/198 (27%), Gaps = 5/198 (2%)
Query: 12 LVSILFFDLLLRVASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSV 71
+ +L + S N +NL N + W T S+
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVW--HTTVWYFSI 254
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+ V L L L ++ S+ +N+ + ++
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT 191
K+S L +NN L + + ++ L+ L L N+L +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 192 P---ISFANNQLNNPPPS 206
+ + N ++
Sbjct: 375 SLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 26/108 (24%), Positives = 47/108 (43%), Gaps = 6/108 (5%)
Query: 70 SVTRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
S+ ++D+ ++S +L L + SN ++ + L + LDL+ N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNK 432
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
+ IP + KL L+ L + +N L +P + SLQ + L N
Sbjct: 433 IKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 19/90 (21%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
C+ S+ +++ + L+ + L ++ L+L+SN I +P+++ L L L+
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
+ N L +L+ L+ + L+ N
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 12/106 (11%), Positives = 34/106 (32%), Gaps = 2/106 (1%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
G ++ L++L L + ++ + +L L + L L
Sbjct: 111 FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESL 168
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS 194
+ + + +V+ V +L + + + N + ++
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TT 451
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 197 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 488
R + +APE + + ++DV+ +GV+L E+ +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 31/108 (28%), Positives = 46/108 (42%), Gaps = 8/108 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MIS 340
D LGRG FG+V + VAVK LKE T +E++ +I
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 341 MAVHRNLLRLRGFCMTPTERLLV-YPFMVNGSVASCLRERGQSQPPLN 387
+ H N++ L G C P L+V F G++++ LR + P
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 40/238 (16%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE-MISM 341
++ ++F +LG+G FGKV+ A+K LK++ + T VE +
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 342 AVHRN--LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
+ L + E L V + +NG G L + ++
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEY-LNG---------GD----LMYHIQSCHKFDL 117
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
+R GL +LH I++RD+K NILLD++ + DFG+ K M
Sbjct: 118 SRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
T GT +IAPE L K + D + +GV+L E++ GQ F D++ +
Sbjct: 175 --TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEEL 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 339
+ +F ++GRG + KV RL + A+K +K+E E + E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 340 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
+ H L+ L C RL V + VNG G L + +++Q L
Sbjct: 65 QASNHPFLVGLH-SCFQTESRLFFVIEY-VNG---------GD----LMFHMQRQRKLPE 109
Query: 399 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 447
L YLH+ II+RD+K N+LLD E + D+G+ K + DT
Sbjct: 110 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 448 HVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAFDLARLANDDD 503
T+ GT +IAPE L G+ + D + GV++ E++ G+ FD+ +++ D
Sbjct: 167 --TSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 41/238 (17%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER-TQGGELQF-QTEVEMIS 340
+V ++F +LG+G FGKV R G A+K L++E E+ TE ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 341 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
H L L+ + +RL V + NG G+ L + + ++
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEY-ANG---------GE----LFFHLSRERVFTEE 105
Query: 400 R----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTH 448
R L YLH +++RD+K N++LD++ + DFGL K + T
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 161
Query: 449 VTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAFDLARLANDDDVM 505
GT ++APE L + D +G GV++ E++ G+ F D + +
Sbjct: 162 -MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDHERL 213
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 41/170 (24%), Positives = 63/170 (37%), Gaps = 20/170 (11%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C V C+ +DL N ++ L NL L L +N IS
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNS 166
P L L L L N L +P + L+ LR++ N + ++ + +N
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEI-TKVRKSVFNGLNQ 146
Query: 167 LQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPSPPPPLQ 212
+ V++L N L NG+F L + I A+ + P PP L
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKL-SYIRIADTNITTIPQGLPPSLT 195
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 90 GQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
G +L L L N I+ KV L L NL L L N+++ +L LR L L
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
NNN L+ ++P L + +QV+ L NN ++
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 27/107 (25%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L L NL L L N+IS L N +L L L N L +P L ++ + L
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYL 270
Query: 149 NNNSLMGEIPRS-------LTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+NN++ I + T S + L +N + +F
Sbjct: 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 9/93 (9%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG------PIPTTLGKLSKLRF 145
+L+ L L +N + KVP L + + + L+ NN++ P K +
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297
Query: 146 LRLNNNSL-MGEIPRSL-TNVNSLQVLDLSNNK 176
+ L +N + EI S V + L N K
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 14/143 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNI-SGKVPEE-LGNLTNLVSLDLYLN 127
++ + + ++ S L + +EL +N + S + + L + +
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
N+ IP L L L L+ N + ++ SL +N+L L LS N ++ + NGS
Sbjct: 182 NITT-IPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSIS-AVD-NGS 235
Query: 187 F----SLFTPISFANNQLNNPPP 205
L + NN+L P
Sbjct: 236 LANTPHLRE-LHLNNNKLVKVPG 257
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 5/114 (4%)
Query: 92 LTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L++L+ L++ N+ + L NL LDL L PT LS L+ L +++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF---ANNQLN 201
N+ +NSLQVLD S N + + ++F N
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 7/121 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
S T + + L+ V G ++ LEL SN + LT L L L N L
Sbjct: 8 SGTEIRCNSKGLTS--VPT-GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 130 N--GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+ G + + L++L L+ N + + + + L+ LD ++ L + F
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 122
Query: 188 S 188
Sbjct: 123 L 123
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 30/142 (21%), Positives = 56/142 (39%), Gaps = 8/142 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE--LGNLTNLVSLDLYLN 127
S+ +DL + + S L L++L+ +N+ ++ E +L NL+ LD+
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGS 186
+ LS L L++ NS T + +L LDLS +L +
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195
Query: 187 FSLF--TPISFANNQLNNPPPS 206
SL ++ ++N +
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTF 217
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 27/120 (22%), Positives = 51/120 (42%), Gaps = 8/120 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN-LNGPIPTTLGKLSKLRFLRLNN 150
L NL YL++ + L++L L + N+ +P +L L FL L+
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 151 NSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTN---GSFSLFTPISFANNQLNNPPPS 206
L ++ + +++SLQVL++S+N + T SL + ++ N +
Sbjct: 185 CQL-EQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQV-LDYSLNHIMTSKKQ 241
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 30/133 (22%), Positives = 52/133 (39%), Gaps = 12/133 (9%)
Query: 58 CTW--FHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNI 105
C+ V C+ + +DLG + + +L+ LEL N +
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 106 SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165
S P NL NL +L L N L LS L L ++ N ++ + ++
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 166 SLQVLDLSNNKLT 178
+L+ L++ +N L
Sbjct: 129 NLKSLEVGDNDLV 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 7/125 (5%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L NL+ L L SN + L+NL LD+ N + + L L+ L + +N
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 152 SLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT---PISFANNQLNNPPPSP 207
L+ I R+ + +NSL+ L L LT IPT + S + + +N
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPT-EALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 208 PPPLQ 212
L
Sbjct: 196 FKRLY 200
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 27/135 (20%), Positives = 56/135 (41%), Gaps = 9/135 (6%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLN 130
+++ + + NL L + N++ VP + +L L L+L N ++
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSL 189
+ L +L +L+ ++L L + + +N L+VL++S N+LT + F
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHS 318
Query: 190 FTP---ISFANNQLN 201
+ +N L
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 21/93 (22%), Positives = 43/93 (46%), Gaps = 1/93 (1%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L +L+ L L N++ E L +L L+ L L N+N + +L +L+ L +++
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
+ + + +L L +++ LT +P
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 25/121 (20%), Positives = 45/121 (37%), Gaps = 4/121 (3%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
NS+ ++ L NL+ L L L L L NI+ L L L++
Sbjct: 152 NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
+ L L + + +L +P ++ ++ L+ L+LS N ++ I
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIE-GSML 268
Query: 188 S 188
Sbjct: 269 H 269
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 15/152 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQ--LGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYL 126
+DL + NLS +L ++ +LTNL L L N+++ + E + NL LDL
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNG 185
N+L+ L L L L NN + + R + ++ LQ L LS N+++ P
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFP-VE 154
Query: 186 SFSLFTPISF------ANNQLNNPPPSPPPPL 211
+ ++N+L P + L
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 10/119 (8%)
Query: 91 QLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
+ NL+YL+L SN++ + E +L L L LY N++ +++L+ L L+
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144
Query: 150 NNSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL-NNP 203
N + P + + L +LDLS+NKL +P L NNP
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP-LTDLQKLPAWVKNGLYLHNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 10/119 (8%)
Query: 93 TNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ L+L NN+S E LTNL SL L N+LN + LR+L L++N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPP 205
L + +++ +L+VL L NN + + +F L + + NQ++ P
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVD-RNAFEDMAQL-QKLYLSQNQISRFPV 153
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 25/68 (36%), Positives = 29/68 (42%), Gaps = 7/68 (10%)
Query: 92 LTNLQYLELYSNNISGKVPEE----LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL--RF 145
+ LQ L L N IS + P E L L+ LDL N L T L KL
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 146 LRLNNNSL 153
L L+NN L
Sbjct: 194 LYLHNNPL 201
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 32/158 (20%), Positives = 53/158 (33%), Gaps = 15/158 (9%)
Query: 69 NSVTRVDLGNANLSG--QLVSQLGQL--TNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124
+ ++L N + + +++L Q L+ L + + E++ L +LDL
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 125 YLNNLNGPIP----TTLGKLSKLRFLRLNNN---SLMGEIPRSLTNVNSLQVLDLSNNKL 177
N G K L+ L L N + G LQ LDLS+N L
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 178 TGDIPTNGSFSLFTPISF---ANNQLNNPPPSPPPPLQ 212
S + ++ + L P P L
Sbjct: 241 RD-AAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS 277
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 33/143 (23%), Positives = 52/143 (36%), Gaps = 12/143 (8%)
Query: 69 NSVTRVDLGNANLSGQL----VSQLGQLTNLQYLELYSNN---ISGKVPEELGNLTNLVS 121
+++ +DL + G+ + LQ L L + SG L
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232
Query: 122 LDLYLNNLNG-PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
LDL N+L + S+L L L+ L ++P+ L L VLDLS N+L
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGLPA--KLSVLDLSYNRLDR- 288
Query: 181 IPTNGSFSLFTPISFANNQLNNP 203
P+ +S N +
Sbjct: 289 NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 30/169 (17%), Positives = 51/169 (30%), Gaps = 13/169 (7%)
Query: 57 PCTWFHVTCNSENSVTRVDLGNAN--LSGQLVSQLGQLTNLQYLELYSNNISGKVP-EEL 113
PC +C+ S + D +A L V G +L+YL + + ++
Sbjct: 5 PCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDI 64
Query: 114 GNLTNLVSLDLYLNNLNGPIPTTLGKL---SKLRFLRLNNNSLMGEIPRSLTNV--NSLQ 168
+L L + + I ++ S L+ L L N + G P L L
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 169 VLDLSNNKLTGDIPTNGSFSLFTP-----ISFANNQLNNPPPSPPPPLQ 212
+L+L N + +S A N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 31/139 (22%), Positives = 50/139 (35%), Gaps = 15/139 (10%)
Query: 62 HVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPE 111
+C + + R+ L +S + NL L L+SN ++
Sbjct: 15 TTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 112 ELGNLTNLVSLDLYLNNLNGPIP-TTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQV 169
L L LDL N + T L +L L L+ L E+ + +LQ
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 170 LDLSNNKLTGDIPTNGSFS 188
L L +N L +P + +F
Sbjct: 134 LYLQDNALQ-ALP-DDTFR 150
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 25/88 (28%), Positives = 39/88 (44%), Gaps = 2/88 (2%)
Query: 92 LTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L LQYL L N + +P++ +L NL L L+ N ++ L L L L+
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
N + P + ++ L L L N L+
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 26/84 (30%), Positives = 38/84 (45%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L NL +L L+ N IS L +L L L+ N + P L +L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNN 175
+L +L + +LQ L L++N
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 21/62 (33%), Positives = 33/62 (53%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L +L L L+ N ++ P +L L++L L+ NNL+ L L L++LRLN+N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
Query: 152 SL 153
Sbjct: 236 PW 237
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 29/234 (12%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER-TQGGELQFQTEVE- 337
++ + F +LG+GG+GKV++ R G + A+K LK+ + + T+ E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 338 -MISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVR---K 392
++ H ++ L + +L L+ ++ G + L G
Sbjct: 73 NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT---ACFYLA 128
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTT 451
+I++ L +LH II+RD+K NI+L+ + + DFGL K + T
Sbjct: 129 EISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--TH 179
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
GTI ++APE L + D + G ++ +++TG F +
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT----GENRKKT 229
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 32/124 (25%), Positives = 52/124 (41%), Gaps = 5/124 (4%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
L L+L NN++ L N LV +DL N L + K+ +L L ++
Sbjct: 223 PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPSPP 208
NN L+ + + +L+VLDLS+N L + N F + +N + S
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTH 338
Query: 209 PPLQ 212
L+
Sbjct: 339 HTLK 342
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 27/176 (15%), Positives = 55/176 (31%), Gaps = 26/176 (14%)
Query: 39 NLADPNNVLQSWDATLVNPCTW--FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQ 96
N+ + D+ L C + H+ +++ + L N +
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDIT-------------LNNQK 48
Query: 97 YLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGE 156
+ ++ + L + + L+L + ++ L + N++
Sbjct: 49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 108
Query: 157 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP------ISFANNQLNNPPPS 206
P NV L VL L N L+ +P +F +S +NN L
Sbjct: 109 PPHVFQNVPLLTVLVLERNDLS-SLPRG----IFHNTPKLTTLSMSNNNLERIEDD 159
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 24/109 (22%), Positives = 47/109 (43%), Gaps = 5/109 (4%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
VDL L + ++ L+ L + +N + + + L LDL N+L
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH 309
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+ + +L L L++NS++ + S ++L+ L LS+N +
Sbjct: 310 -VERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 10/116 (8%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L L + +NN+ + T+L +L L N L + L + L +
Sbjct: 137 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANV 193
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204
+ N L +L +++ LD S+N + + + L T + +N L +
Sbjct: 194 SYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVEL-TILKLQHNNLTDTA 242
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 8/144 (5%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+V +D + +++ V + L L+L NN++ L N LV +DL N L
Sbjct: 212 AVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
+ K+ +L L ++NN L+ + + +L+VLDLS+N L + N F
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 324
Query: 189 LFTPISFANNQLNNPPPSPPPPLQ 212
+ +N + S L+
Sbjct: 325 RLENLYLDHNSIVTLKLSTHHTLK 348
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 24/109 (22%), Positives = 48/109 (44%), Gaps = 5/109 (4%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
VDL L + ++ L+ L + +N + + + L LDL N+L
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH 315
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+ + +L L L++NS++ + L+ ++L+ L LS+N +
Sbjct: 316 -VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 360
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 16/87 (18%), Positives = 31/87 (35%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L N + + ++ + L + + L+L + ++ L + N
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLT 178
++ P NV L VL L N L+
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 10/116 (8%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L L + +NN+ + T+L +L L N L + L + L +
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANV 199
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204
+ N L +L +++ LD S+N + + + L T + +N L +
Sbjct: 200 SYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVEL-TILKLQHNNLTDTA 248
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 3/105 (2%)
Query: 75 DLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI 133
DLG + L NL+YL L NI +P L L L L++ N+
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIR 234
Query: 134 PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
P + LS L+ L + N+ + + + SL L+L++N L+
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 34/127 (26%), Positives = 55/127 (43%), Gaps = 11/127 (8%)
Query: 65 CNSENSVTRVDLGNANLSG--QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
C+ N ++V LS Q + +N +YL L NNI + +L +L L
Sbjct: 50 CSCSNQFSKVVCTRRGLSEVPQGIP-----SNTRYLNLMENNIQMIQADTFRHLHHLEVL 104
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDI 181
L N++ L+ L L L +N L IP + ++ L+ L L NN + I
Sbjct: 105 QLGRNSIRQIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SI 162
Query: 182 PTNGSFS 188
P + +F+
Sbjct: 163 P-SYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 34/151 (22%), Positives = 63/151 (41%), Gaps = 13/151 (8%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNN 128
+ + L N + ++ +L L+L + E L NL L+L + N
Sbjct: 148 KLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF- 187
+ +P L L L L ++ N P S ++SL+ L + N++++ I +F
Sbjct: 208 IKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIE-RNAFD 263
Query: 188 ---SLFTPISFANNQLNNPPP---SPPPPLQ 212
SL ++ A+N L++ P +P L
Sbjct: 264 GLASLVE-LNLAHNNLSSLPHDLFTPLRYLV 293
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 2/101 (1%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
+LG N+ + L L L+ LE+ N+ P L++L L + + ++
Sbjct: 202 NLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175
L+ L L L +N+L T + L L L +N
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 28/163 (17%), Positives = 55/163 (33%), Gaps = 18/163 (11%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C N S +DL L LQ L+L I
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 108 KVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166
+ + +L++L +L L N + LS L+ L +L + ++ +
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 167 LQVLDLSNNKLTGDIPTNGSFS----LFTPISFANNQLNNPPP 205
L+ L++++N + FS L + ++N++ +
Sbjct: 126 LKELNVAHNLIQ-SFKLPEYFSNLTNL-EHLDLSSNKIQSIYC 166
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 31/94 (32%), Positives = 41/94 (43%), Gaps = 6/94 (6%)
Query: 90 GQLTNLQYLELYSNNI-SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF--- 145
G L L+ L + N I S K+PE NLTNL LDL N + T L L ++
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 146 -LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L L+ N + I L+ L L N+L
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 1e-13
Identities = 45/273 (16%), Positives = 87/273 (31%), Gaps = 76/273 (27%)
Query: 260 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNIL--GRGGFGKVYKGRLTDGSLVAV 317
++V + +L++ +L EL+ +N+L G G GK + VA+
Sbjct: 129 YNVSRLQ----PYLKLRQ-ALLELR------PAKNVLIDGVLGSGK---------TWVAL 168
Query: 318 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSV 372
+ Q + ++ +++ C +P L L+Y N
Sbjct: 169 DVCLSYKVQ---CKMDFKIFWLNL----------KNCNSPETVLEMLQKLLYQIDPNW-- 213
Query: 373 ASCLRERGQSQPPLNW-SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431
R S L S++ ++ R L + + ++ +V+ A F
Sbjct: 214 --TSRSDHSSNIKLRIHSIQAEL-----RRLLKSKPYENCLLVLLNVQNAKAW--NAF-- 262
Query: 432 VVGDFGLAKLMDYKDTHVTTAVRG-TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490
+ L+ + VT + T HI+ ++ S + ++ LL
Sbjct: 263 ---NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV------KSLLLKYLDC 313
Query: 491 RAFDLARLANDDDVMLLD------------WDF 511
R DL R + L WD
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDN 346
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 4e-07
Identities = 77/510 (15%), Positives = 144/510 (28%), Gaps = 163/510 (31%)
Query: 37 KTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQ 96
KT +A +V S+ V C + + ++L N N + L L L
Sbjct: 163 KTWVA--LDVCLSYK-----------VQCKMDFKIFWLNLKNCNSPETV---LEMLQKLL 206
Query: 97 YLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGE 156
Y I N S + +N+ I + +L +L + N L+
Sbjct: 207 Y------QIDP----------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL-- 248
Query: 157 IPRSLTNVNSLQVL-------------------DLSNNKLTGDIPTNGSFSLFTPIS--- 194
+ L NV + + D + T I + TP
Sbjct: 249 V---LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 195 -FANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKR 253
L+ P L P + N +I + A W+
Sbjct: 306 LLLKY-LDCRPQD----L---PREVLTTNPRRLSIIA------ESIRDGLAT-WDNWKHV 350
Query: 254 KPE------DHFFDV--PAE------------ED---PEVHLGQL-KRFSLRELQVATDN 289
+ + +V PAE P + L + ++ V +
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 290 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLL 348
SLV K+ KE + + +V++ + A+HR+++
Sbjct: 411 LHKY-------------------SLVE-KQPKESTISIPSIYLELKVKLENEYALHRSIV 450
Query: 349 R----LRGFC----MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
+ F + P Y + L+ + ++ + + L
Sbjct: 451 DHYNIPKTFDSDDLIPPYLDQYFYSH-----IGHHLKNIEHPE---RMTLFRMVFL---- 498
Query: 401 GLAYLHDHCDPKIIHRDV--KAANILLDEEFEAVVGDFGLAKLMDYKDTHVT------TA 452
+L + KI H A+ +L+ L +L YK ++
Sbjct: 499 DFRFL----EQKIRHDSTAWNASGSILNT----------LQQLKFYKP-YICDNDPKYER 543
Query: 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 482
+ I P+ S+ TD+ +M
Sbjct: 544 LVNAILDFLPKIEENLICSKYTDLLRIALM 573
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 3/108 (2%)
Query: 72 TRVDLGNANLSGQLVSQ-LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
R+DLG + L+NL+YL L N+ ++P L L L LDL N+L+
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS 220
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
P + L L+ L + + + + N+ SL ++L++N LT
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 27/122 (22%), Positives = 46/122 (37%), Gaps = 2/122 (1%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L NL LEL+ N ++ L+ L L L N + ++ LR L L
Sbjct: 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL 170
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPP 210
+ I + +++L+ L+L+ L +IP + + N L+ P
Sbjct: 171 KRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 211 LQ 212
L
Sbjct: 230 LM 231
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 31/126 (24%), Positives = 51/126 (40%), Gaps = 9/126 (7%)
Query: 65 CNSENSVTRVDLGNANLSG--QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122
C+ N ++V NL +S TN + L L+ N I +L +L L
Sbjct: 39 CSCSNQFSKVICVRKNLREVPDGIS-----TNTRLLNLHENQIQIIKVNSFKHLRHLEIL 93
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L N++ L+ L L L +N L + ++ L+ L L NN + IP
Sbjct: 94 QLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIP 152
Query: 183 TNGSFS 188
+ +F+
Sbjct: 153 S-YAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 35/124 (28%), Positives = 52/124 (41%), Gaps = 8/124 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
+ +L+ L+L + E L+NL L+L + NL IP L L KL L L+
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSG 216
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPPSP 207
N L P S + LQ L + +++ I +F I+ A+N L P
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE-RNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 208 PPPL 211
PL
Sbjct: 275 FTPL 278
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 2/106 (1%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
++ ++L NL + L L L L+L N++S P L +L L + + +
Sbjct: 186 NLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175
L L + L +N+L T ++ L+ + L +N
Sbjct: 244 QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 17/62 (27%), Positives = 26/62 (41%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L +LQ L + + I NL +LV ++L NNL L L + L++N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 152 SL 153
Sbjct: 290 PW 291
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
++T +D N++++ ++ + +LT L L SNNI+ +L TNL L N
Sbjct: 42 ATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNK 96
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L + + L+KL +L + N L ++ ++ L L+ + N LT +I + +
Sbjct: 97 LTN-LD--VTPLTKLTYLNCDTNKL-TKLD--VSQNPLLTYLNCARNTLT-EIDVSHNTQ 149
Query: 189 LFTPISFANNQLNNPPP 205
L T + N+
Sbjct: 150 L-TELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 11/145 (7%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+N + V + +S QL L L+ ++++I+ + LT L L N
Sbjct: 18 DNFASEVAAAFEMQATDTIS-EEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSN 74
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
N+ + L + + L +L ++N L + +T + L L+ NKLT + + +
Sbjct: 75 NITT-LD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-KLDVSQNP 127
Query: 188 SLFTPISFANNQLNNPPPSPPPPLQ 212
L T ++ A N L S L
Sbjct: 128 LL-TYLNCARNTLTEIDVSHNTQLT 151
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 32/154 (20%), Positives = 54/154 (35%), Gaps = 18/154 (11%)
Query: 67 SENSVTRVDLGNA------NLSG-QLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
N +T++D+ N + L + T L L+ + N ++ T
Sbjct: 114 DTNKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQ 171
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L +LD N + + + L L + N++ ++ L L LD S+NKLT
Sbjct: 172 LTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+I L + N L S L
Sbjct: 226 -EIDVTPLTQLTY-FDCSVNPLTELDVSTLSKLT 257
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 31/148 (20%), Positives = 53/148 (35%), Gaps = 17/148 (11%)
Query: 67 SENSVTRVDLG-NANL------SGQLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
S N +T +D+ + L L+ L T L Y + ++ ++ + T
Sbjct: 241 SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQ 298
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L LD + + L + KL +L LNN L E+ +++ L+ L N +
Sbjct: 299 LYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPS 206
D + G A Q P
Sbjct: 353 -DFSSVGKIPALNNNFEAEGQTITMPKE 379
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 29/154 (18%), Positives = 59/154 (38%), Gaps = 18/154 (11%)
Query: 67 SENSVTRVDLGNA------NLSG-QLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
+ N++T +DL +L + + LT L YL +N ++ ++
Sbjct: 72 TSNNITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L L+ N L + ++L L + N + ++ +T L LD S NK+T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
++ + + L ++ N + + L
Sbjct: 184 -ELDVSQNKLL-NRLNCDTNNITKLDLNQNIQLT 215
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 26/142 (18%), Positives = 48/142 (33%), Gaps = 17/142 (11%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL--GKLSKLRFL 146
+ T L L+ + I+ +L LV L L L T L +KL+ L
Sbjct: 293 VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL-----TELDVSHNTKLKSL 344
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
N + + S+ + +L + + +P + I+ + + L+
Sbjct: 345 SCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQ---- 397
Query: 207 PPPPLQPTPPGASSGNSATGAI 228
P+ P + AT I
Sbjct: 398 FGNPMNIEPGDGGVYDQATNTI 419
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 29/154 (18%), Positives = 62/154 (40%), Gaps = 18/154 (11%)
Query: 67 SENSVTRVDLGNA------NLSG-QLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTN 118
N++T++DL + S +L + LT L Y + N ++ ++ + L+
Sbjct: 199 DTNNITKLDLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLT-ELD--VSTLSK 255
Query: 119 LVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L +L +L I L ++L + + + E+ +T+ L +LD +T
Sbjct: 256 LTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310
Query: 179 GDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
++ + + L + N +L S L+
Sbjct: 311 -ELDLSQNPKLVY-LYLNNTELTELDVSHNTKLK 342
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 19/111 (17%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 102 SNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL 161
+ + + P++ N + V+ + + + +L+ L L +N+S+ ++ +
Sbjct: 8 TQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSI-TDMT-GI 60
Query: 162 TNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
+ L L ++N +T + + + +L T ++ +N+L N +P L
Sbjct: 61 EKLTGLTKLICTSNNIT-TLDLSQNTNL-TYLACDSNKLTNLDVTPLTKLT 109
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 12/122 (9%)
Query: 61 FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV 120
V V + L + +L+ ++ L QL + +L+L N + +P L L L
Sbjct: 433 NSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLE 489
Query: 121 SLDL---YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVLDLSNNK 176
L L N++G + L +L+ L L NN L + L + L +L+L N
Sbjct: 490 VLQASDNALENVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
Query: 177 LT 178
L
Sbjct: 545 LC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 5e-08
Identities = 24/130 (18%), Positives = 49/130 (37%), Gaps = 2/130 (1%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
L + Q S L + ++ L + + + L+L + + +
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL 456
Query: 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS 194
L +L + L L++N L +P +L + L+VL S+N L ++ + +
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELL 514
Query: 195 FANNQLNNPP 204
NN+L
Sbjct: 515 LCNNRLQQSA 524
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 28/131 (21%), Positives = 45/131 (34%), Gaps = 21/131 (16%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS--------- 141
T LQ +S+N++ ++P E N+ + + P G+
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 142 ----KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
+ L LNN L +P + L+ L S N LT ++P + N
Sbjct: 68 CLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPE--LPQSLKSLLVDN 120
Query: 198 NQLNNPPPSPP 208
N L PP
Sbjct: 121 NNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 13/120 (10%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-GKLSKLRFLRL 148
+L+++ +N + ++PE L NL L ++ N+L L L +
Sbjct: 170 DLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSL-----KKLPDLPLSLESIVA 222
Query: 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
NN L E L N+ L + NN L +P ++ +N L + P P
Sbjct: 223 GNNIL--EELPELQNLPFLTTIYADNNLLK-TLPD--LPPSLEALNVRDNYLTDLPELPQ 277
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 31/143 (21%), Positives = 52/143 (36%), Gaps = 24/143 (16%)
Query: 80 NLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138
L + +L+ L + N ++ +PE +LT L + + L+ +P L
Sbjct: 243 YADNNLLKTLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLY 300
Query: 139 KL--------------SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
L L L ++NN L+ E+P L+ L S N L ++P
Sbjct: 301 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL 355
Query: 185 GSFSLFTPISFANNQLNNPPPSP 207
+L + N L P P
Sbjct: 356 PQ-NL-KQLHVEYNPLREFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 34/195 (17%), Positives = 68/195 (34%), Gaps = 34/195 (17%)
Query: 38 TNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRV--DLGNANLSG-QLVSQLGQLTN 94
L +N L + T+ V+ N + ++ + +L N S ++ S +
Sbjct: 260 EALNVRDNYLTDLPELPQS-LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPS 318
Query: 95 LQYLELYSNNISGKVPEELGNLT-----------------NLVSLDLYLNNLNGPIPTTL 137
L+ L + +N + ++P L NL L + N L P
Sbjct: 319 LEELNVSNNKLI-ELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLRE-FPDIP 376
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
+ LR +N++ E+P N L+ L + N L + P + S+ + +
Sbjct: 377 ESVEDLR---MNSHL--AEVPELPQN---LKQLHVETNPLR-EFP-DIPESV-EDLRMNS 425
Query: 198 NQLNNPPPSPPPPLQ 212
++ +P
Sbjct: 426 ERVVDPYEFAHETTD 440
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 39/129 (30%), Positives = 58/129 (44%), Gaps = 13/129 (10%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
L N + + +S L L+YL + +N + K+PE L N + L +D+ N+L +P
Sbjct: 116 LLVDNNNLKALSDL--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPD 170
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF 195
L F+ NN L E+P L N+ L + NN L +P + SL I
Sbjct: 171 LPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLP-DLPLSL-ESIVA 222
Query: 196 ANNQLNNPP 204
NN L P
Sbjct: 223 GNNILEELP 231
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 29/172 (16%), Positives = 51/172 (29%), Gaps = 35/172 (20%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNL--------- 116
S + ++NL+ ++ + + + + P G
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 117 ----TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDL 172
L+L L+ +P L L + NSL E+P ++ SL V +
Sbjct: 67 DCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 173 SNNKLTG----------------DIPTNGSFSLFTPISFANNQLNNPPPSPP 208
+ L+ +P + S I NN L P PP
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPP 173
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 20/168 (11%)
Query: 44 NNVLQSWDATLVNPCTWFHVTCNSENSVTRV--DLGNANLSGQLVSQLGQL-TNLQYLEL 100
NN+L++ + +V N + + L ++S + S L +L NL YL
Sbjct: 246 NNLLKTLPDLPPS-LEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 304
Query: 101 YSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRS 160
SN I + + +L L++ N L +P +L +L + N L E+P
Sbjct: 305 SSNEIR-SLCDLPPSLE---ELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPEL 355
Query: 161 LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
N L+ L + N L + P + N+ L P P
Sbjct: 356 PQN---LKQLHVEYNPLR-EFPD--IPESVEDLRM-NSHLAEVPELPQ 396
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 13/105 (12%), Positives = 34/105 (32%), Gaps = 23/105 (21%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL---------- 140
NL+ L + N + + P+ ++ +L +N+ +P L
Sbjct: 355 LPQNLKQLHVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVPELPQNLKQLHVETNPL 408
Query: 141 -------SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ LR+N+ ++ + + L+ ++
Sbjct: 409 REFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 23/206 (11%), Positives = 56/206 (27%), Gaps = 48/206 (23%)
Query: 296 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 350
G + ++ D +L VA+ + + ++ + +S + R+
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 351 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
T L+V + G L+E + P ++R A H
Sbjct: 97 LDVVHTRAGGLVV---AEWIRGGS---LQEVADTSPSPVGAIR--AMQSLAAAADAAHRA 148
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
+ + + + + + V+ +
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD- 178
Query: 469 KSSEKTDVFGYGVMLLELITGQRAFD 494
++ + D+ G G L L+ +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLP 203
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 30/141 (21%), Positives = 53/141 (37%), Gaps = 18/141 (12%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
N +++G + L+ L L ++ L + NN++ +P L L++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L +P L +L L P + L L + N+LT +P
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHL----PALPSG---LCKLWIFGNQLT-SLPV--LP 140
Query: 188 SLFTPISFANNQLNNPPPSPP 208
+S ++NQL + P P
Sbjct: 141 PGLQELSVSDNQLASLPALPS 161
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 32/125 (25%), Positives = 46/125 (36%), Gaps = 15/125 (12%)
Query: 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143
L S L+ LE+ N ++ +P L L L +L L S L
Sbjct: 72 NLTSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL-----PAL--PSGL 123
Query: 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203
L + N L +P LQ L +S+N+L +P S + NNQL +
Sbjct: 124 CKLWIFGNQL-TSLPVLPPG---LQELSVSDNQLA-SLP--ALPSELCKLWAYNNQLTSL 176
Query: 204 PPSPP 208
P P
Sbjct: 177 PMLPS 181
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 22/136 (16%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL----------- 140
+ LQ L + N ++ +P L L + + L +L +P+ L +L
Sbjct: 180 PSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLP-ALPSGLKELIVSGNRLTSLP 237
Query: 141 ---SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFA 196
S+L+ L ++ N L +P + L L + N+LT +P + S T ++
Sbjct: 238 VLPSELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 197 NNQLNNPPPSPPPPLQ 212
N L+ +
Sbjct: 293 GNPLSERTLQALREIT 308
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 15/125 (12%)
Query: 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143
QL S + L L Y+N ++ +P L L + N L +PT +L K
Sbjct: 152 QLASLPALPSELCKLWAYNNQLT-SLPMLPSGLQ---ELSVSDNQLAS-LPTLPSELYK- 205
Query: 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203
L NN L +P + L+ L +S N+LT +P S + + N+L +
Sbjct: 206 --LWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPV--LPSELKELMVSGNRLTSL 256
Query: 204 PPSPP 208
P P
Sbjct: 257 PMLPS 261
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 21/115 (18%), Positives = 38/115 (33%), Gaps = 9/115 (7%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ L+ L + N ++ +P L SL +Y N L +P +L LS + L N
Sbjct: 240 PSELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLTR-LPESLIHLSSETTVNLEGN 294
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLT-GDIPTNGSFSLFTPISFANNQLNNPPP 205
L E + + + + D+ + + A P
Sbjct: 295 PLS-ERTLQ--ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 31/142 (21%), Positives = 54/142 (38%), Gaps = 9/142 (6%)
Query: 72 TRVDLGNANLSGQLVSQL-GQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNL 129
+ + + + L++L L+L N ++ L NL L L NL
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNL 115
Query: 130 NGPI--PTTLGKLSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLT---GDIPT 183
+G + L+ L L L +N++ P S N+ VLDL+ NK+ +
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175
Query: 184 NGSFSLFTPISFANNQLNNPPP 205
N FT + ++ L +
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNE 197
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 28/142 (19%), Positives = 53/142 (37%), Gaps = 7/142 (4%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNN 128
V VDL +++ + +L +LQ+L++ + L++L+ L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEI--PRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
L+ L L L +L G + + SL++L L +N + I
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASF 149
Query: 187 FSL---FTPISFANNQLNNPPP 205
F F + N++ +
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICE 171
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 6/124 (4%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLY 125
+ V DL + + L S T+L+ L L N I+ K+ + LT+L+ L+L
Sbjct: 273 EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLS 331
Query: 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTN 184
N L L KL L L+ N + + +S + +L+ L L N+L +P +
Sbjct: 332 QNFLGSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVP-D 388
Query: 185 GSFS 188
G F
Sbjct: 389 GIFD 392
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 25/114 (21%), Positives = 47/114 (41%), Gaps = 8/114 (7%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLNNN 151
++ Y++L N+I+ L +L L + I T LS L L+L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 152 SLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQL 200
++ + + +L+VL L+ L G + + F SL + +N +
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL-EMLVLRDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 34/147 (23%), Positives = 48/147 (32%), Gaps = 14/147 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQ--LGQLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYL 126
++ + L NL G ++S LT+L+ L L NNI P N+ LDL
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 127 NNLNGPIPTTLGKLSKLRFLRL----------NNNSLMGEIPRSLTNVNSLQVLDLSNNK 176
N + L F L N L E + S+ LDLS N
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 177 LTGDIPTNGSFSLFTPISFANNQLNNP 203
+ F + L+N
Sbjct: 224 FK-ESMAKRFFDAIAGTKIQSLILSNS 249
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 25/86 (29%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
LT+L L L N + NL L LDL N++ + L L+ L L+
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380
Query: 151 NSLMGEIPRS-LTNVNSLQVLDLSNN 175
N L +P + SLQ + L N
Sbjct: 381 NQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 29/198 (14%), Positives = 63/198 (31%), Gaps = 31/198 (15%)
Query: 31 DALNALKT-NLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQL 89
+ +L N ++S + H T +S+T D+ L +
Sbjct: 151 LNMRRFHVLDLT--FNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSL-------------DLYLNNLNGPIPTT 136
+ T++ L+L N + + + + N P T
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 137 LGKL--SKLRFLRLNNNSLM---GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF---- 187
L S ++ L+ + + + T+ L+ L L+ N++ I + +F
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTD---LEQLTLAQNEIN-KID-DNAFWGLT 323
Query: 188 SLFTPISFANNQLNNPPP 205
L ++ + N L +
Sbjct: 324 HL-LKLNLSQNFLGSIDS 340
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 17/63 (26%), Positives = 26/63 (41%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L L+ L+L N+I + L NL L L N L +L+ L+ + L+
Sbjct: 345 NLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404
Query: 151 NSL 153
N
Sbjct: 405 NPW 407
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 24/123 (19%), Positives = 51/123 (41%), Gaps = 8/123 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
LT L+ LE+ ++++ P+ L ++ N+ L L++ + + S + L L +
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 152 SL----MGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203
L E+ SL + + + +++ L + S + F+ NQL +
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSV 292
Query: 204 PPS 206
P
Sbjct: 293 PDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 7/118 (5%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
++ L+L +N I+ +L NL +L L N +N + L L L L+ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 153 LMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPP 205
L + S ++SL L+L N + F L +
Sbjct: 112 L-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 19/113 (16%), Positives = 48/113 (42%), Gaps = 9/113 (7%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
++ ++L L + N+ +L L+ + + +++ L+L +L+
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239
Query: 135 T--------TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
+ +L K R +++ + SL ++ + L ++ L L+ S N+L
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 7/125 (5%)
Query: 92 LTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLN 149
L++L +L L N L +LT L L + + I L+ L L ++
Sbjct: 123 LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPPS 206
+ L P+SL ++ ++ L L + + + + + + L+ S
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL-EIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 207 PPPPL 211
Sbjct: 241 ELSTG 245
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 39/140 (27%), Positives = 59/140 (42%), Gaps = 5/140 (3%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+V +DL N ++ S L + NLQ L L SN I+ + +L +L LDL N L
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPTNGSFS 188
+ + LS L FL L N SL +++ LQ+L + N I F+
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ-RKDFA 171
Query: 189 LFT---PISFANNQLNNPPP 205
T + + L + P
Sbjct: 172 GLTFLEELEIDASDLQSYEP 191
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 11/96 (11%)
Query: 92 LTNLQYLELYSNNISGK--------VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143
++++ LEL ++ L ++ + +L + L ++S L
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL 279
Query: 144 RFLRLNNNSLMGEIPRS-LTNVNSLQVLDLSNNKLT 178
L + N L +P + SLQ + L N
Sbjct: 280 LELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 31/119 (26%), Positives = 45/119 (37%), Gaps = 8/119 (6%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
+S L LT L+ L + N + + + L L L N L L L L
Sbjct: 78 LSPLKDLTKLEELSVNRNRLK--NLNGIPSA-CLSRLFLDNNELRDTDS--LIHLKNLEI 132
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204
L + NN L I L ++ L+VLDL N++T + I + N P
Sbjct: 133 LSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQKCVNEP 188
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 33/135 (24%), Positives = 59/135 (43%), Gaps = 14/135 (10%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ + +LG +++ + +L+ +Q ++NI + + TNL L L N +
Sbjct: 20 NAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQI 75
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIPTNGSF 187
+ P L L+KL L +N N L ++L + L L L NN+L D +
Sbjct: 76 SDLSP--LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELR-DTDSLIHL 127
Query: 188 SLFTPISFANNQLNN 202
+S NN+L +
Sbjct: 128 KNLEILSIRNNKLKS 142
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 21/120 (17%), Positives = 50/120 (41%), Gaps = 8/120 (6%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRF 145
V L N L +++ V L+ + + + +N+ + + L+
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKE 67
Query: 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
L L++N + ++ L ++ L+ L ++ N+L ++ S L + + NN+L +
Sbjct: 68 LHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNGIPSACL-SRLFLDNNELRDTDS 123
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 10/158 (6%)
Query: 61 FHVTC-NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS--GKVPEELGNLT 117
H+ C S +S T ++ + + L LQ L L N + KV N++
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403
Query: 118 NLVSLDLYLNNLN-GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNK 176
+L +LD+ LN+LN T + L L++N L G + R L ++VLDL NN+
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNR 461
Query: 177 LTGDIPTNGSFSLF--TPISFANNQLNNPPPSPPPPLQ 212
+ IP L ++ A+NQL + P L
Sbjct: 462 IM-SIP-KDVTHLQALQELNVASNQLKSVPDGVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 28/124 (22%), Positives = 44/124 (35%), Gaps = 9/124 (7%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
+ L L N+IS ++ L+ L L L N + L +L +++N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPSPP 208
L I + SL+ LDLS N +P F L T + + + P
Sbjct: 112 L-QNISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKL-TFLGLSAAKFRQLDLLPV 166
Query: 209 PPLQ 212
L
Sbjct: 167 AHLH 170
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 15/145 (10%), Positives = 35/145 (24%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126
++ + + + L +L + + + L +
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338
Query: 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGS 186
++ S FL N + + + + LQ L L N L
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398
Query: 187 FSLFTPISFANNQLNNPPPSPPPPL 211
+ + + LN+
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRT 423
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 24/85 (28%), Positives = 39/85 (45%), Gaps = 5/85 (5%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
++ L L SN ++G V L + LDL+ N + IP + L L+ L + +N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASN 483
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNN 175
L +P + SLQ + L +N
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 2/115 (1%)
Query: 90 GQLTNLQYLELYSNNI-SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS-KLRFLR 147
+ +L++L+L N+ V +E GNLT L L L + L L
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
L + + G SL N+ + + + + N S + + +N +LN+
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLND 232
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 46/260 (17%), Positives = 93/260 (35%), Gaps = 68/260 (26%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT-EVEMIS 340
L+ ++ +S LG G FG V + + G A+K++ ++ +++ E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------- 392
+ H N+++L + T + P + + G + + V
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 393 ---------------------------------QIALGAARGLAYLHDHCDPKIIHRDVK 419
Q+ R + ++H I HRD+K
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIK 168
Query: 420 AANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV----RGTIGHIAPEYLSTGKS-SEK 473
N+L++ + + + DFG AK + + V R APE + +
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPS 222
Query: 474 TDVFGYGVMLLELITGQRAF 493
D++ G + ELI G+ F
Sbjct: 223 IDLWSIGCVFGELILGKPLF 242
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 1e-12
Identities = 32/223 (14%), Positives = 55/223 (24%), Gaps = 45/223 (20%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF 332
Q + T+ +G G FG+V++ D + VA+K + E
Sbjct: 6 SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 333 QTEVEMISMAV----------------HRNLLRLRGFCM----TPTERLLVYPFM--VNG 370
Q E I + + L P L + G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 371 SVASCLRERGQSQPPL-------------------NWSVRKQIALGAARGLAYLHDHCDP 411
S Q + + + K I LA
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 454
+ HRD+ N+LL + + K + ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 45/233 (19%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQT---------EV 336
++ + + G +G V G ++G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSV 390
+++ H N+L LR E LV M +A + ++ + ++
Sbjct: 81 RLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ---RIVISPQH 135
Query: 391 RK----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
+ I GL LH+ ++HRD+ NILL + + + DF LA+ D
Sbjct: 136 IQYFMYHIL----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT-AD 187
Query: 447 THVTTAV-----RGTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ T V R APE + ++ D++ G ++ E+ + F
Sbjct: 188 ANKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 6/116 (5%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTNLVSL 122
+ + + G + + L NL L + + + L L L +L
Sbjct: 6 CPHGSSGLRCTRDGALDS----LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
+ + L P +L L L+ N+L + SLQ L LS N L
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 23/148 (15%), Positives = 49/148 (33%), Gaps = 14/148 (9%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
C+ E + ++ + L + Q L+L ++ NL N+ +
Sbjct: 9 ECHQE---EDFRVTCKDIQR--IPSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 124 LYLNNLNGPIPT-TLGKLSKLRFLRLNNNSLMGEIPRS-LTNVNSLQVLDLSNNKLTGDI 181
+ ++ + + + LSK+ + + N + I L + L+ L + N L
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120
Query: 182 PTNGSF----SLFTPISFANNQLNNPPP 205
P F N + + P
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 24/104 (23%), Positives = 43/104 (41%), Gaps = 6/104 (5%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEE-LGNLTN-LVSLDLYLNNLNGPIPTTLGKLSKL 143
++++ LE+ N +P L N ++L LY N + +KL
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKL 181
Query: 144 RFLRLNNNSLMGEIPR-SLTNVNS-LQVLDLSNNKLTGDIPTNG 185
+ LN N + I + + V S +LD+S +T +P+ G
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 38/142 (26%), Positives = 55/142 (38%), Gaps = 18/142 (12%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
T+++L A L + G L L L+L N + +P L L LD+ N L
Sbjct: 58 TQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS 114
Query: 132 PIPTTLGKLSKLRFLRLNNNSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
L L +L+ L L N L +P L+ L L+NN LT ++P G
Sbjct: 115 LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK---LEKLSLANNNLT-ELP-AGLL 168
Query: 188 ----SLFTPISFANNQLNNPPP 205
+L + N L P
Sbjct: 169 NGLENL-DTLLLQENSLYTIPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 35/145 (24%), Positives = 54/145 (37%), Gaps = 11/145 (7%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
+ S V+ NL+ + + L L N + L T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA--LPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L L + G L L L L++N L +P + +L VLD+S N+LT +P
Sbjct: 62 LDRAELTK-LQ-VDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLP- 116
Query: 184 NGSFSLFTPI---SFANNQLNNPPP 205
G+ + N+L PP
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPP 141
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 27/85 (31%), Positives = 30/85 (35%), Gaps = 1/85 (1%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L LQ L L N + P L L L L NNL L L L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNN 175
NSL IP+ + L L N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 344
D++ LGRG + +V++ +T+ V VK LK + + + + E++ + ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGG 90
Query: 345 RNLLRLRGFCMTPTERLLVYPFM-VNGSVASCLRERGQSQPPLNWSVR---KQIALGAAR 400
N++ L P R F VN + ++ Q+ + +R +I +
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTD---FKQLYQTLTDYD--IRFYMYEIL----K 141
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGH 459
L Y H I+HRDVK N+++D E + + D+GLA+ + V +
Sbjct: 142 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYF 196
Query: 460 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 493
PE L + D++ G ML +I + F
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 46/225 (20%), Positives = 84/225 (37%), Gaps = 39/225 (17%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83
Query: 354 CMTPTERLLVYPFMVNGSVAS--C---------LRE--RGQSQPPLNWSVRKQIALGAAR 400
+LL + F G L + + KQI+
Sbjct: 84 GANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 401 GLAYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLAKLMDYKDTHVTTAV- 453
GL Y+H C IIH D+K N+L++ + + D G A + D H T ++
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197
Query: 454 ----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
R +PE L D++ ++ ELITG F+
Sbjct: 198 TREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 37/140 (26%), Positives = 56/140 (40%), Gaps = 18/140 (12%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128
N + + L NLS L L + LE+ N + +PE +L L D N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYL---DACDNR 111
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L+ +P L L ++NN L +P L+ ++ NN+LT +P +
Sbjct: 112 LST-LPELPASLKHLD---VDNNQLT-MLPELPAL---LEYINADNNQLT-MLPE--LPT 160
Query: 189 LFTPISFANNQLNNPPPSPP 208
+S NNQL P P
Sbjct: 161 SLEVLSVRNNQLTFLPELPE 180
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 27/142 (19%), Positives = 50/142 (35%), Gaps = 11/142 (7%)
Query: 80 NLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138
N QL T+L+ L + +N ++ +PE +L +LD+ N L +P
Sbjct: 146 NADNNQLTMLPELPTSLEVLSVRNNQLT-FLPELPESLE---ALDVSTNLLES-LPAVPV 200
Query: 139 KLSKLR----FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS 194
+ F R N + IP ++ +++ + L +N L+ I + S P
Sbjct: 201 RNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259
Query: 195 FANNQLNNPPPSPPPPLQPTPP 216
+ L
Sbjct: 260 HGPRIYFSMSDGQQNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 15/120 (12%), Positives = 35/120 (29%), Gaps = 6/120 (5%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL----NNLNGPIPTTLGKLSKLRFL 146
+L+ L++ +N + +P + +++ N + IP + L +
Sbjct: 178 LPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTI 235
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 206
L +N L I SL+ + + + + N
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSD 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 9/113 (7%)
Query: 98 LELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL--GKLSKLRFLRLNNNSLMG 155
+ N ISG + L N N + L +++ L+LN +L
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNE-AVSLLKECLINQFSELQLNRLNLS- 72
Query: 156 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
+P +L + VL+++ N L +P + + +N+L+ P P
Sbjct: 73 SLPDNLP--PQITVLEITQNALI-SLPE--LPASLEYLDACDNRLSTLPELPA 120
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 15/101 (14%), Positives = 33/101 (32%), Gaps = 6/101 (5%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQ----YLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+D+ L L + + + + + N I+ +PE + +L ++ L N
Sbjct: 183 EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240
Query: 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQ 168
L+ I +L + + + T L
Sbjct: 241 PLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 19/97 (19%), Positives = 32/97 (32%), Gaps = 6/97 (6%)
Query: 114 GNLTNLVSLDLY--LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLD 171
N +L Y ++ + K K N N + + L +N L
Sbjct: 8 NNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQ 65
Query: 172 LSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 208
L+ L+ +P N + T + N L + P P
Sbjct: 66 LNRLNLS-SLPDNLPPQI-TVLEITQNALISLPELPA 100
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ N +G G G V VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H+N++ L TP + L +V M + ++ ++ L+
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELM-DANLCQVIQM------ELDHE 127
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 182
Query: 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T T + APE + E D++ G ++ E+I G F
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 38/123 (30%), Positives = 54/123 (43%), Gaps = 15/123 (12%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
+L NL+ L + N + +P + L NL L L N L P L+KL +L L
Sbjct: 83 ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG 141
Query: 150 NNSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNN 202
N L +P LT+ L+ L L NN+L +P G+F + + NNQL
Sbjct: 142 YNEL-QSLPKGVFDKLTS---LKELRLYNNQLKR-VP-EGAFDKLTELKTLKLDNNQLKR 195
Query: 203 PPP 205
P
Sbjct: 196 VPE 198
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 39/123 (31%), Positives = 52/123 (42%), Gaps = 15/123 (12%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
+LT L+ L L N + +P + L NL +L + N L +L L LRL+
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117
Query: 150 NN---SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNN 202
N SL + SLT L L L N+L +P G F SL + NNQL
Sbjct: 118 RNQLKSLPPRVFDSLTK---LTYLSLGYNELQ-SLP-KGVFDKLTSL-KELRLYNNQLKR 171
Query: 203 PPP 205
P
Sbjct: 172 VPE 174
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 30/119 (25%), Positives = 46/119 (38%), Gaps = 11/119 (9%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
+ + L+L SN +S + LT L L L N L +L L L + +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 153 LM---GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF---ANNQLNNPPP 205
L + L N L L L N+L +P F T +++ N+L + P
Sbjct: 97 LQALPIGVFDQLVN---LAELRLDRNQLK-SLP-PRVFDSLTKLTYLSLGYNELQSLPK 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 92 LTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
LT L YL L N + +P+ + LT+L L LY N L KL++L+ L+L+N
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNN 175
N L + ++ L++L L N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
+LT+L+ L LY+N + +VPE LT L +L L N L L KL+ L+L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 150 NN 151
N
Sbjct: 214 EN 215
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 7/114 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L+ ++L +N IS P+ L +L SL LY N + + L L+ L LN N
Sbjct: 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNAN 114
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL-NNP 203
+ + + ++++L +L L +NKL I G+FS I L NP
Sbjct: 115 KI-NCLRVDAFQDLHNLNLLSLYDNKLQT-IA-KGTFSPLRAIQTM--HLAQNP 163
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 22/85 (25%), Positives = 34/85 (40%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L +L L LY N I+ L +L L L N +N L L L L +
Sbjct: 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNN 175
N L + + + ++Q + L+ N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 28/121 (23%), Positives = 45/121 (37%), Gaps = 15/121 (12%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
+ + L N I P L +DL N ++ P L L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 153 LMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPP 204
+ E+P L + LQ+L L+ NK+ + +F +L +S +N+L
Sbjct: 92 I-TELPKSLFEGLFS---LQLLLLNANKINC-LR-VDAFQDLHNL-NLLSLYDNKLQTIA 144
Query: 205 P 205
Sbjct: 145 K 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 30/160 (18%), Positives = 60/160 (37%), Gaps = 20/160 (12%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNIS 106
C V C+++ + L N + + +L L+ + +N I+
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 107 GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVN 165
+ + + L N L L L+ L L +N + + S ++
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLS 129
Query: 166 SLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLN 201
S+++L L +N++T + G+F SL T ++ N N
Sbjct: 130 SVRLLSLYDNQITT-VA-PGAFDTLHSLST-LNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 24/121 (19%), Positives = 43/121 (35%), Gaps = 14/121 (11%)
Query: 93 TNLQYLELYSNNISGKVPE-ELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L L +N + L L ++ N + S + + L +N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 152 SLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNNPP 204
L + + L + L+ L L +N++T + N SF S +S +NQ+
Sbjct: 92 RL-ENVQHKMFKGLES---LKTLMLRSNRIT-CVG-NDSFIGLSSVRLLSLYDNQITTVA 145
Query: 205 P 205
P
Sbjct: 146 P 146
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 51/230 (22%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ + +G G +G V G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H N++ L TP L LV PFM + +
Sbjct: 75 LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMG-----LKFSEEK 127
Query: 390 VRK---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
++ Q+ +GL Y+H ++HRD+K N+ ++E+ E + DFGLA+ D +
Sbjct: 128 IQYLVYQML----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 447 TH--VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T VT R APE LS ++ D++ G ++ E++TG+ F
Sbjct: 181 TGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 38/161 (23%), Positives = 58/161 (36%), Gaps = 32/161 (19%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 352
+LG G GKV + A+K L++ + + EVE + +++R+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 78
Query: 353 FCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGAARGL 402
L+V + G L R Q + ++ R K I +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIG----EAI 130
Query: 403 AYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 440
YLH I HRDVK N+L + DFG AK
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 43/193 (22%), Positives = 66/193 (34%), Gaps = 31/193 (16%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEV-------EMISMAVHRNL 347
+G GGFG +Y A +K E + G L + + + I + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 348 LRLRGF-----CMTPTERLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGA 398
L G + Y FMV + + G S Q+ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKSTVLQLGIRM 160
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--THVTTAVR 454
L Y+H++ +H D+KAAN+LL + V D+GL+ Y H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR--YCPNGNHKQYQEN 215
Query: 455 GTIGHI-APEYLS 466
GH E+ S
Sbjct: 216 PRKGHNGTIEFTS 228
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 26/166 (15%), Positives = 52/166 (31%), Gaps = 19/166 (11%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C+ C + + L +L+ +E+ N++
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 108 KVPEE-LGNLTNLVSLDL-YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNV 164
+ + NL L + + NNL P L L++L ++N + +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHS 127
Query: 165 NSLQVLDLSNNKLTGDIPTNGSFSLFTP----ISFANNQLNNPPPS 206
+LD+ +N I SF + + N + S
Sbjct: 128 LQKVLLDIQDNINIHTIE-RNSFVGLSFESVILWLNKNGIQEIHNS 172
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 26/122 (21%), Positives = 42/122 (34%), Gaps = 12/122 (9%)
Query: 92 LTNLQYLEL-YSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L L + + +NN+ PE NL NL L + + + L + +
Sbjct: 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137
Query: 151 NSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNNP 203
N + I L+ +L L+ N + +I N +F L NN L
Sbjct: 138 NINIHTIERNSFVGLS--FESVILWLNKNGIQ-EIH-NSAFNGTQLDELNLSDNNNLEEL 193
Query: 204 PP 205
P
Sbjct: 194 PN 195
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 20/118 (16%), Positives = 38/118 (32%), Gaps = 5/118 (4%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL--GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148
L++ N + G V L L N + +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 149 NNNSLMGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
+NN+L E+P + +LD+S ++ +P+ G +L + + L P
Sbjct: 186 DNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPT 241
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 5/86 (5%)
Query: 91 QLTNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
T L L L NN ++P + + V LD+ ++ L L KLR
Sbjct: 175 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNN 175
N ++P +L + +L L+
Sbjct: 235 NLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 9e-04
Identities = 16/61 (26%), Positives = 21/61 (34%), Gaps = 4/61 (6%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+ L++ I L NL L + NL +PT L KL L L
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK-LPT-LEKLVALMEASLTYP 256
Query: 152 S 152
S
Sbjct: 257 S 257
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 48/224 (21%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ N +G G G V VA+K+L FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H+N++ L TP + L LV M + ++ ++ L+
Sbjct: 113 VLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELM-DANLCQVIQM------ELDHE 164
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 165 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 219
Query: 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T T + APE + E D++ G ++ E++ + F
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 11/95 (11%)
Query: 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146
+ L L ++L L +NNI K+ L + NL L L N + I L L
Sbjct: 42 ATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEEL 98
Query: 147 RLNNNSLMGEIPRSLTNVN---SLQVLDLSNNKLT 178
++ N + SL+ + +L+VL +SNNK+T
Sbjct: 99 WISYNQI-----ASLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 14/106 (13%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTN-LVSLDLYLNN---LNGPIPTTLGKLSKLR 144
L + NL+ L L N I K E L + + L L + N L+G + KL LR
Sbjct: 66 LSGMENLRILSLGRNLI--KKIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLR 118
Query: 145 FLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS 188
L ++NN + GEI L ++ L+ L L+ N L D N + S
Sbjct: 119 VLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 23/91 (25%), Positives = 37/91 (40%), Gaps = 10/91 (10%)
Query: 92 LTNLQYLELY--SNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT--TLGKLSKLRFLR 147
T + +EL+ I K+ L L L L NN I +L + LR L
Sbjct: 22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILS 76
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L N + +I ++L+ L +S N++
Sbjct: 77 LGRNLIK-KIENLDAVADTLEELWISYNQIA 106
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 50/230 (21%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ + N + +G G +G V T G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H N++ L TP L LV M + L + Q +
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 390 VRK---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
V+ QI RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ +
Sbjct: 134 VQFLIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 447 T--HVTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
T T R APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 187 TGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
+ + +G G +G V G+ VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 389
++ H N++ L TP E L LV PFM + L + + + L
Sbjct: 76 RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEK-LGED 128
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 448
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 449 -VTTAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
VT R APE L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 186 VVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 35/212 (16%), Positives = 72/212 (33%), Gaps = 51/212 (24%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---------EV 336
D + R+++G G +G V + + +VA+K++ F+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSVR 391
+++ H +++++ + +V R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFR 148
Query: 392 KQIALGAA----------RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441
+ L G+ Y+H I+HRD+K AN L++++ V DFGLA+
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 473
+DY + + + K
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG---NLTNLVSL 122
N NS+ ++ N+++ + V + L N++YL L N + ++ LTNL L
Sbjct: 38 NELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYL 90
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNN---SLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
L N L KL+ L+ L L N SL + LTN L L+L++N+L
Sbjct: 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN---LTYLNLAHNQLQ- 146
Query: 180 DIPTNGSF-SL--FTPISFANNQLNNPPP 205
+P G F L T + + NQL + P
Sbjct: 147 SLP-KGVFDKLTNLTELDLSYNQLQSLPE 174
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 12/121 (9%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN-LTNLVSLDLYLNNLN 130
T + L L +LTNL+ L L N + +P+ + + LTNL L+L N L
Sbjct: 88 TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 131 GPIPTTLGKLSKLRFLRLNNNSLMGEIPR----SLTNVNSLQVLDLSNNKLTGDIPTNGS 186
KL+ L L L+ N L +P LT L+ L L N+L +P +G
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQ---LKDLRLYQNQLKS-VP-DGV 200
Query: 187 F 187
F
Sbjct: 201 F 201
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 16/93 (17%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLG---KLSKLRFL 146
+LTNL YL L N + +P+ + LTNL LDL N L +P G KL++L+ L
Sbjct: 131 KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPE--GVFDKLTQLKDL 186
Query: 147 RLNNNSLMGEIPR----SLTNVNSLQVLDLSNN 175
RL N L +P LT SLQ + L +N
Sbjct: 187 RLYQNQLKS-VPDGVFDRLT---SLQYIWLHDN 215
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 64/267 (23%)
Query: 255 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GS 313
H A PE+ GQ F + ++N + +G G +G V
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQ--VFDV------GPRYTNLSYIGEGAYGMVCSAYDNLNKV 53
Query: 314 LVAVKRLKEERTQGGELQFQT---------EVEMISMAVHRNLLRLRGFCMTPTERL--- 361
VA+K++ F+ E++++ H N++ + +
Sbjct: 54 RVAIKKIS---------PFEHQTYCQRTLREIKILLRFRHENIIGIND-IIRAPTIEQMK 103
Query: 362 ---LVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCDPKIIH 415
+V M + L + ++Q N + QI RGL Y+H ++H
Sbjct: 104 DVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL----RGLKYIHS---ANVLH 151
Query: 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTTAVRGTIGHIAPEY-LS 466
RD+K +N+LL+ + + DFGLA++ D H T R APE L+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR------APEIMLN 205
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
+ ++ D++ G +L E+++ + F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 59/236 (25%)
Query: 288 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 339
D+ + R ++G+G FG+V K VA+K ++ E Q E+ ++
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-----AEEIRIL 147
Query: 340 SMAVHR------NLLRL------RG-FCMTPTERLLVYPFMVNGSVASCLRE--RGQSQP 384
+ N++ + R CMT E L + L E +
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMT-FELL-----------SMNLYELIKKNKFQ 195
Query: 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLM 442
+ + ++ A + L LH + +IIH D+K NILL ++ + V DFG +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC-- 250
Query: 443 DYKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
Y+ V T + R APE + + D++ G +L EL+TG
Sbjct: 251 -YEHQRVYTYIQSRFYR------APEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 27/125 (21%), Positives = 46/125 (36%), Gaps = 14/125 (11%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQ-LTNLQYLELYSNNISGK----VPEELGNLTNLVSLDL 124
+ +D+ LS ++L L Q + L ++ + L L L+L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 125 YLNNLNGPIPTTLGKL-----SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNN 175
N L + + K++ L L N L G + +L + +LQ L LS+N
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 176 KLTGD 180
L
Sbjct: 124 LLGDA 128
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 28/127 (22%), Positives = 49/127 (38%), Gaps = 18/127 (14%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGK----VPEELGNLTNLV 120
+ + N +++ V L Q L+ L+L S ++ + + + +L
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLR 230
Query: 121 SLDLYLNNLNGP-----IPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLD 171
L L N L P L S+LR L + + G++ R L SL+ L
Sbjct: 231 ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290
Query: 172 LSNNKLT 178
L+ N+L
Sbjct: 291 LAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 23/98 (23%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLN----GPIPTTLGKLSKLRFLR 147
++Q L++ +S EL L + L L I + L L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 148 LNNNSL----MGEIPRSLTNVN-SLQVLDLSNNKLTGD 180
L +N L + + + L + +Q L L N LTG
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 100
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 6e-06
Identities = 28/128 (21%), Positives = 45/128 (35%), Gaps = 18/128 (14%)
Query: 69 NSVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGK----VPEELGNLTNL 119
S+ + L L + L + L+ L + S + + L L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 120 VSLDLYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVL 170
+ L + N L L + S LR L L + + + +L +SL+ L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 171 DLSNNKLT 178
DLSNN L
Sbjct: 404 DLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 23/134 (17%), Positives = 45/134 (33%), Gaps = 18/134 (13%)
Query: 65 CNSENSVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEELGN----- 115
+S + + L + ++ L + +L+ L L SN + EL
Sbjct: 195 KDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHP 254
Query: 116 LTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSLMGE----IPRSLTNVN-S 166
+ L +L ++ + + L L+ L L N L E + +L
Sbjct: 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314
Query: 167 LQVLDLSNNKLTGD 180
L+ L + + T
Sbjct: 315 LESLWVKSCSFTAA 328
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 22/134 (16%), Positives = 48/134 (35%), Gaps = 18/134 (13%)
Query: 65 CNSENSVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEELGNL---- 116
+ + + + + ++ + L L +L+ L L N + + L
Sbjct: 252 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 311
Query: 117 -TNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGE----IPRSLTNVNS- 166
L SL + + + L + L L+++NN L + + L S
Sbjct: 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371
Query: 167 LQVLDLSNNKLTGD 180
L+VL L++ ++
Sbjct: 372 LRVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 26/127 (20%), Positives = 45/127 (35%), Gaps = 18/127 (14%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQ-----LTNLQYLELYSNNISGK----VPEELGNLTNLV 120
S+ + LG+ L +++L + L+ L ++ I+ K + L +L
Sbjct: 228 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLK 287
Query: 121 SLDLYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLD 171
L L N L L + +L L + + S L L L
Sbjct: 288 ELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 347
Query: 172 LSNNKLT 178
+SNN+L
Sbjct: 348 ISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 18/127 (14%)
Query: 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEELG-----NLTNLV 120
+ + + + + + S L Q L L++ +N + EL + L
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373
Query: 121 SLDLYLNNLN----GPIPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVNS-LQVLD 171
L L +++ + TL LR L L+NN L + ++ S+ L+ L
Sbjct: 374 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 433
Query: 172 LSNNKLT 178
L + +
Sbjct: 434 LYDIYWS 440
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 51/229 (22%), Positives = 86/229 (37%), Gaps = 47/229 (20%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKR---LKEERTQGGELQFQTEV-------EMISMAVHR 345
+G+GGFG +Y + V +K E + G L + + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 346 NLLRLRGFCM-----TPTERLLVYPFMVNGSVASCLRER-GQS-QPPLNWSVRK------ 392
L+ G + Y FM+ +R G Q + ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI--------MDRFGSDLQKIYEANAKRFSRKTV 154
Query: 393 -QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--T 447
Q++L L Y+H+H +H D+KA+N+LL+ + V D+GLA Y
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY--RYCPEGV 209
Query: 448 HVTTAVRGTIGHI-APEYLST----GKS-SEKTDVFGYGVMLLELITGQ 490
H A H E+ S G + S + D+ G +++ +TG
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-09
Identities = 25/103 (24%), Positives = 41/103 (39%), Gaps = 8/103 (7%)
Query: 80 NLSGQLV---SQLGQLTNLQYLELYSNNISGKVPEELG-NLTNLVSLDLYLNNLNGPIPT 135
L+ +L+ +Q + L+L I V E LG L ++D N + +
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR-KL-D 58
Query: 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L +L+ L +NNN + + L L L+NN L
Sbjct: 59 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L ++ N I K+ + L L +L + N + L L L L NN
Sbjct: 41 LDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
Query: 152 SL--MGEIPRSLTNVNSLQVLDLSNNKLT 178
SL +G++ L ++ SL L + N +T
Sbjct: 99 SLVELGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-06
Identities = 16/67 (23%), Positives = 24/67 (35%), Gaps = 1/67 (1%)
Query: 86 VSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP-IPTTLGKLSKLR 144
+ L L+ L + +N I L +L L L N+L L L L
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 145 FLRLNNN 151
+L + N
Sbjct: 117 YLCILRN 123
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (135), Expect = 8e-09
Identities = 25/138 (18%), Positives = 46/138 (33%), Gaps = 16/138 (11%)
Query: 59 TWFHVTCNSENSVTRVDLGNANLS--GQLVSQLGQLTNLQYLELYSNNISGKVPEELG-- 114
+W S L N + L NL+ LE+ S + V E++
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS 216
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLS---------KLRFLRLNNNSLMGEIPRSL---T 162
+L NL L LY+ + + L++L + + +
Sbjct: 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESD 276
Query: 163 NVNSLQVLDLSNNKLTGD 180
+ L+ +D+S LT +
Sbjct: 277 ILPQLETMDISAGVLTDE 294
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 1e-06
Identities = 20/164 (12%), Positives = 50/164 (30%), Gaps = 21/164 (12%)
Query: 38 TNLADPNNVLQSWDA---TLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLG--QL 92
D + VL + + + ++ +++ + L +V + L
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 93 TNLQYLELY---SNNISGKVPEEL------GNLTNLVSLDLYLNNLNGPIPTTLGK---L 140
NL+ L LY + NL L + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 141 SKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+L + ++ L + + + L+ +++ N L+ +
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 21/101 (20%), Positives = 42/101 (41%), Gaps = 10/101 (9%)
Query: 88 QLGQLTNLQYLELYSNNISGKVPEELGN---LTNLVSLDLYLNNLNG----PIPTTLGKL 140
+ NL++L + V E L L ++D+ L + + K+
Sbjct: 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKI 306
Query: 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQV-LDLSNNKLTGD 180
L+F+ + N L E+ + L SL + +D+S+++ D
Sbjct: 307 KHLKFINMKYNYLSDEMKKELQ--KSLPMKIDVSDSQEYDD 345
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-09
Identities = 24/105 (22%), Positives = 46/105 (43%), Gaps = 5/105 (4%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135
+ + G+L + L++L + ++ + L L L L+L N ++G +
Sbjct: 25 DNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEV 82
Query: 136 TLGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLT 178
K L L L+ N + + I L + +L+ LDL N ++T
Sbjct: 83 LAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-06
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 92 LTNLQYLELYSNNIS-GKVPEELGNLTNLVSLDL---YLNNLNGPIPTTLGKLSKLRFLR 147
++++ L L ++ + GK+ L L L ++ L KL+KL+ L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-----LPKLNKLKKLE 70
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
L++N + G + +L L+LS NK+
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 20/94 (21%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 115 NLTNLVSLDLYLNNLN-GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNV---NSLQVL 170
+++ L L + N G + + +L FL N L S+ N+ N L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKL 69
Query: 171 DLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203
+LS+N+++G + T ++ + N++ +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 32/114 (28%), Positives = 45/114 (39%), Gaps = 11/114 (9%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN- 151
+ + L+L S ++ LT L L+L N L L++L L L NN
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 152 --SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF-SL--FTPISFANNQL 200
SL + LT L L L N+L +P +G F L + NQL
Sbjct: 95 LASLPLGVFDHLTQ---LDKLYLGGNQLKS-LP-SGVFDRLTKLKELRLNTNQL 143
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
LT L L L +N ++ +P + +LT L L L N L +L+KL+ LRLN
Sbjct: 81 DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN 139
Query: 150 NNSLMGEIP----RSLTNVNSLQVLDLSNNKLTGDIPTNGSF 187
N L IP LTN LQ L LS N+L +P +G+F
Sbjct: 140 TNQLQ-SIPAGAFDKLTN---LQTLSLSTNQLQS-VP-HGAF 175
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 28/88 (31%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRL 148
LT L L L N + +P + LT L L L N L IP KL+ L+ L L
Sbjct: 105 HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSL 162
Query: 149 NNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
+ N L +P + + LQ + L N
Sbjct: 163 STNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 28/96 (29%), Positives = 38/96 (39%), Gaps = 13/96 (13%)
Query: 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR----SLTNVNSLQVLDL 172
+ LDL L T L+KL +L L+ N L + LT L L L
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTE---LGTLGL 90
Query: 173 SNNKLTGDIPTNGSFSLFTPI---SFANNQLNNPPP 205
+NN+L +P G F T + NQL + P
Sbjct: 91 ANNQLA-SLP-LGVFDHLTQLDKLYLGGNQLKSLPS 124
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 30/117 (25%), Positives = 54/117 (46%), Gaps = 16/117 (13%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
++ L L N + VP+EL N +L +DL N ++ + +++L L L+ N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 153 LMGEIPR----SLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLN 201
L IP L + L++L L N ++ +P G+F +L + ++ N L
Sbjct: 90 LR-CIPPRTFDGLKS---LRLLSLHGNDISV-VP-EGAFNDLSAL-SHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 9e-08
Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 3/107 (2%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
VT + L + N + +L +L ++L +N IS + N+T L++L L N L
Sbjct: 32 DVTELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
P T L LR L L+ N + +P + ++++L L + N
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 77 GNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTT 136
+ G++ + NL++L L + + V L L L L+L N + G +
Sbjct: 33 NCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDML 90
Query: 137 LGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLSNNKLT 178
KL L L L+ N L + + L + L+ LDL N ++T
Sbjct: 91 AEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-07
Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 7/101 (6%)
Query: 78 NANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL 137
+ L + + + +L L+ +N GK+ NL L L L + L
Sbjct: 15 HLELRNRTPAAVRELV----LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI--SVSNL 67
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
KL KL+ L L+ N + G + + +L L+LS NKL
Sbjct: 68 PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 115 NLTNLVSLDLYLNNLN-GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS 173
+ L L N G I + L FL L N L+ + +L + L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 174 NNKLTGDIPTNG-SFSLFTPISFANNQLNNP 203
N++ G + T ++ + N+L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 38/201 (18%), Positives = 66/201 (32%), Gaps = 45/201 (22%)
Query: 280 LRELQVATDNFSNR----NILGRGGFGKVYKGR---------LTDGSLVAVKRLKEERTQ 326
L V TD + + R G +Y+ ++K ++
Sbjct: 30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL 89
Query: 327 GGELQF-QTEVEMISMAVHRNLLRLRGFCMTPT-----ERLLVYPFMVNGSVASCLRER- 379
E F Q + + + + L + PT Y F+V
Sbjct: 90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAI-PTCMGFGVHQDKYRFLV--------LPSL 140
Query: 380 GQS-QPPLNWSVRK--------QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430
G+S Q L+ S + Q+A L +LH++ +H +V A NI +D E +
Sbjct: 141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQ 197
Query: 431 AVV--GDFGLAKLMDYKDTHV 449
+ V +G A Y +
Sbjct: 198 SQVTLAGYGFAFR--YCPSGK 216
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 47/236 (19%), Positives = 91/236 (38%), Gaps = 57/236 (24%)
Query: 288 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 339
+ + +R +++G+G FG+V K + VA+K +K + Q Q EV ++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLL 104
Query: 340 SM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQP 384
+ + ++ L+ C+ E L + L + R +
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLV-FEML-----------SYNLYDLLRNTNFR 152
Query: 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLM 442
++ ++ ++ A L +L + IIH D+K NILL + + DFG +
Sbjct: 153 GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-- 209
Query: 443 DYKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ + R +PE L D++ G +L+E+ TG+ F
Sbjct: 210 -QLGQRIYQYIQSRFYR------SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 44/248 (17%), Positives = 77/248 (31%), Gaps = 71/248 (28%)
Query: 288 DNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEE---RTQGGELQFQTEVEM 338
D R LG G FGKV + S VA+K ++ R + E+ +
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINV 69
Query: 339 ISM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQ 383
+ + + + C+ E L E + +
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIA-FELL-----------GKNTFEFLKENNF 117
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---- 439
P + +A L +LH++ ++ H D+K NIL + + +
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 440 -------KLMD-----YKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVM 482
++ D + H TT V R PE + ++ DV+ G +
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCI 228
Query: 483 LLELITGQ 490
L E G
Sbjct: 229 LFEYYRGF 236
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 19/104 (18%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTH--------VT 450
RGL Y+H ++HRD+K AN+ ++ E +GDFGLA++MD +H VT
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 451 TAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
R +P LS ++ D++ G + E++TG+ F
Sbjct: 188 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 29/87 (33%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 92 LTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L NL+ L L SN + +P + +LT L LDL N L +L L+ L +
Sbjct: 63 LINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNNKL 177
N L E+PR + + L L L N+L
Sbjct: 122 NKL-TELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 23/86 (26%), Positives = 39/86 (45%), Gaps = 3/86 (3%)
Query: 91 QLTNLQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
LT L L+L +N ++ +P + L +L L + N L +P + +L+ L L L+
Sbjct: 86 SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALD 143
Query: 150 NNSLMGEIPRSLTNVNSLQVLDLSNN 175
N L + ++SL L N
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 37/122 (30%), Positives = 49/122 (40%), Gaps = 20/122 (16%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-----GKLSKLRFLR 147
TN Q L L+ N I+ P +L NL L L N L L L++L L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-----GALPVGVFDSLTQLTVLD 94
Query: 148 LNNNSLMGEIPR---SLTNVNSLQVLDLSNNKLTGDIPTNGSFSL--FTPISFANNQLNN 202
L N L L + L+ L + NKLT +P G L T ++ NQL +
Sbjct: 95 LGTNQLTVLPSAVFDRLVH---LKELFMCCNKLTE-LP-RGIERLTHLTHLALDQNQLKS 149
Query: 203 PP 204
P
Sbjct: 150 IP 151
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
R + LH +IHRD+K +N+L++ + V DFGLA+++D + + G
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-ESAADNSEPTGQQSG 178
Query: 460 I----------APEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ APE L++ K S DV+ G +L EL + F
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 44/258 (17%), Positives = 80/258 (31%), Gaps = 87/258 (33%)
Query: 288 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 339
+N +G G FG+V + + + AVK ++ + E +++
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-----KIEADIL 85
Query: 340 SM-----AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQPP 385
+ N+++ G C+ E L L E +
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLI-FEPL-----------GPSLYEIITRNNYNG 133
Query: 386 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA------ 439
+ K + + L YL + H D+K NILLD+ +
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 440 -----------KLMD-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSE 472
KL+D +K + + + R APE +
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DV 238
Query: 473 KTDVFGYGVMLLELITGQ 490
+D++ +G +L EL TG
Sbjct: 239 SSDMWSFGCVLAELYTGS 256
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 4/87 (4%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLN 149
+L +L LEL N ++G P +++ L L N + I L +L+ L L
Sbjct: 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLY 110
Query: 150 NNSLMGEIPR-SLTNVNSLQVLDLSNN 175
+N + + S ++NSL L+L++N
Sbjct: 111 DNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 38/123 (30%), Positives = 55/123 (44%), Gaps = 12/123 (9%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN-LTNLVSLDLYLNN 128
T +DL +L +LT+L L L N + +P + N LT+L L+L N
Sbjct: 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQ 87
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR----SLTNVNSLQVLDLSNNKLTGDIPTN 184
L KL++L+ L LN N L +P LT L+ L L N+L +P +
Sbjct: 88 LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ---LKDLRLYQNQLKS-VP-D 141
Query: 185 GSF 187
G F
Sbjct: 142 GVF 144
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 33/119 (27%), Positives = 50/119 (42%), Gaps = 13/119 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
YL+L +N++ LT+L L L N L KL+ L +L L+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 153 LMGEIPR----SLTNVNSLQVLDLSNNKLTGDIPTNGSF---SLFTPISFANNQLNNPP 204
L +P LT L+ L L+ N+L +P +G F + + NQL + P
Sbjct: 88 LQ-SLPNGVFDKLTQ---LKELALNTNQLQS-LP-DGVFDKLTQLKDLRLYQNQLKSVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 29/87 (33%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLN 149
+LT+L YL L +N + LT L L L N L +P KL++L+ LRL
Sbjct: 74 KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLY 132
Query: 150 NNSLMGEIPR-SLTNVNSLQVLDLSNN 175
N L +P + SLQ + L +N
Sbjct: 133 QNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 46/254 (18%), Positives = 89/254 (35%), Gaps = 75/254 (29%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 336
DN+ ++++GRG +G VY + VA+K++ F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76
Query: 337 EMISMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSV 390
+++ ++RL + P + L +V L
Sbjct: 77 TILNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIA---------------DSDLKKLF 120
Query: 391 RKQIALGAA----------RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440
+ I L G ++H+ IIHRD+K AN LL+++ V DFGLA+
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 441 LMDYKDTHVTTAVRGTIGHI---------------------APEYLSTGKS-SEKTDVFG 478
++ + APE + ++ ++ D++
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 479 YGVMLLELITGQRA 492
G + EL+ ++
Sbjct: 238 TGCIFAELLNMLQS 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 49/254 (19%), Positives = 85/254 (33%), Gaps = 83/254 (32%)
Query: 288 DNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEE---RTQGGELQFQTEVEM 338
D S R + LG G FGKV + G VAVK +K ++E+++
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-----RSEIQV 64
Query: 339 ISM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQ 383
+ +++ + C+ E L + +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIV-FELL-----------GLSTYDFIKENGF 112
Query: 384 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---- 439
P +++A + + +LH + K+ H D+K NIL + + +
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 440 -------KLMD-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSEKTDV 476
K++D Y D H +T V R APE + S+ DV
Sbjct: 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVILALGW------SQPCDV 217
Query: 477 FGYGVMLLELITGQ 490
+ G +L+E G
Sbjct: 218 WSIGCILIEYYLGF 231
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 22/131 (16%), Positives = 46/131 (35%), Gaps = 22/131 (16%)
Query: 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVS 121
S+ L ++ + + + L + +++ + L N I + + E + + +L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 122 LDLYLNNLNGPIPTT----------LGKLSKLRFLRLNNNSL----MGEIPRSLTNVNSL 167
+ L K KL +RL++N+ + L+ L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 168 QVLDLSNNKLT 178
+ L L NN L
Sbjct: 125 EHLYLHNNGLG 135
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 15/118 (12%), Positives = 40/118 (33%), Gaps = 13/118 (11%)
Query: 76 LGNANLSGQLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLN- 130
+ A + + L+ + N + + + L ++ + N +
Sbjct: 142 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201
Query: 131 ----GPIPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+ L +L+ L L +N+ + +L + +L+ L L++ L+
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 25/131 (19%), Positives = 40/131 (30%), Gaps = 21/131 (16%)
Query: 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGK-----VPEELGNLTNLV 120
+ + G L L +++ N I + + E L L
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219
Query: 121 SLDLYLNNLNGP-----IPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVN--SLQV 169
LDL N + L LR L LN+ L + + + + LQ
Sbjct: 220 VLDLQDNTF-THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278
Query: 170 LDLSNNKLTGD 180
L L N++ D
Sbjct: 279 LRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 24/135 (17%), Positives = 39/135 (28%), Gaps = 21/135 (15%)
Query: 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNL----TNLVSL 122
S+ RV L+ L + L + L N E L + T L L
Sbjct: 68 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 127
Query: 123 DLYLNNL-------------NGPIPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVN 165
L+ N L + LR + N L M E ++ +
Sbjct: 128 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 187
Query: 166 SLQVLDLSNNKLTGD 180
L + + N + +
Sbjct: 188 LLHTVKMVQNGIRPE 202
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 23/119 (19%), Positives = 43/119 (36%), Gaps = 15/119 (12%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLN 130
+ + L+ L L+ L+L N + + L + NL L L L+
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 131 GP----IPTTLGKLS--KLRFLRLNNNSLMGE----IPRSL-TNVNSLQVLDLSNNKLT 178
+ KL L+ LRL N + + + + + L L+L+ N+ +
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 459
+ + YLH ++HRD+K +NILL+ E V DFGL++ +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 460 I--------------------APEY-LSTGKSSEKTDVFGYGVMLLELITGQ 490
APE L + K ++ D++ G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 52/276 (18%), Positives = 78/276 (28%), Gaps = 83/276 (30%)
Query: 288 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
D F+ R LG G F V+ + VA+K +K E+ + +
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIR-LLKS 89
Query: 343 VHRNLLRLRGFCMTPTER-------------LLVYPFMVNGSVASCLRERGQSQPPLNWS 389
V + M +V+ + G + Q L
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQG-LPLP 146
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------------------------ 425
K+I +GL YLH C +IIH D+K NILL
Sbjct: 147 CVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 426 -------------------------DEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTIG 458
E+ + + D G A + T T R
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR---- 260
Query: 459 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ E L + D++ M EL TG F+
Sbjct: 261 --SLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 32/129 (24%), Positives = 49/129 (37%), Gaps = 20/129 (15%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELG-----NLTNL 119
VT +DL NL +L Q ++ L L N++ K +EL N+
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 120 VSLDLYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSL----MGEIPRSLTNVN-SLQV 169
SL+L N L+ L K + L L N E ++ +N+ S+
Sbjct: 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142
Query: 170 LDLSNNKLT 178
L+L N L
Sbjct: 143 LNLRGNDLG 151
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 15/105 (14%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELG-----NLTNLVSLDLYLNNLNGPIPTTLGKL--- 140
+ L+L NN+ EL ++ SL+L N+L L ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 141 --SKLRFLRLNNNSL----MGEIPRSLTNVN-SLQVLDLSNNKLT 178
+ + L L+ N L E+ ++L + ++ VLDL N +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 25/132 (18%), Positives = 57/132 (43%), Gaps = 21/132 (15%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELG-----NLTNL 119
+V ++L NL+ + ++L + ++ L+L +N + K EL ++
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227
Query: 120 VSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSL-------MGEIPRSLTNVNSLQ 168
VSL+L LN L+GP + L L+ + L+ + + + + N+ +
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287
Query: 169 VLDLSNNKLTGD 180
++D + ++
Sbjct: 288 LVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 28/128 (21%), Positives = 50/128 (39%), Gaps = 19/128 (14%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELGNL-----TNL 119
S+T ++L +L + +L Q+ N+ L L NN++ K EL ++
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV 198
Query: 120 VSLDLYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSL----MGEIPRSLTNVNSLQVL 170
SLDL N L L + + + L L N L + + ++ LQ +
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTV 258
Query: 171 DLSNNKLT 178
L + +
Sbjct: 259 YLDYDIVK 266
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 9e-06
Identities = 28/87 (32%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLN 149
+LT L L L N I LT L L L+ N L +P KL++L+ L L+
Sbjct: 50 KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALD 108
Query: 150 NNSLMGEIPR-SLTNVNSLQVLDLSNN 175
N L +P + SLQ + L N
Sbjct: 109 TNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 6e-04
Identities = 26/94 (27%), Positives = 39/94 (41%), Gaps = 11/94 (11%)
Query: 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR---SLTNVNSLQVLDLS 173
++ L+L N L KL++L L L+ N + LT L +L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTK---LTILYLH 84
Query: 174 NNKLTGDIPTNGSF---SLFTPISFANNQLNNPP 204
NKL +P NG F + ++ NQL + P
Sbjct: 85 ENKLQS-LP-NGVFDKLTQLKELALDTNQLKSVP 116
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 36/92 (39%), Positives = 43/92 (46%), Gaps = 12/92 (13%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-----GKLSKLR 144
G T Q L LY N I+ P LT L LDL N L T L KL++L
Sbjct: 27 GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-----TVLPAGVFDKLTQLT 81
Query: 145 FLRLNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
L LN+N L IPR + N+ SL + L NN
Sbjct: 82 QLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 31/89 (34%), Positives = 42/89 (47%), Gaps = 12/89 (13%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL-----GKLSKLRFLR 147
T+ Q L L +N I+ P +L NL L N L T + KL++L L
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-----TAIPTGVFDKLTQLTQLD 87
Query: 148 LNNNSLMGEIPR-SLTNVNSLQVLDLSNN 175
LN+N L IPR + N+ SL + L NN
Sbjct: 88 LNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 24/124 (19%), Positives = 42/124 (33%), Gaps = 15/124 (12%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELGN-LTNLVSLD 123
S+ +++L ++ + + + L + L S + L L
Sbjct: 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLG 132
Query: 124 LYLNNLNGPIPTTLGKL-----SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSN 174
L LN+L L L ++ LRL+NN L + L S+ L L +
Sbjct: 133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLH 192
Query: 175 NKLT 178
L
Sbjct: 193 TGLG 196
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 24/126 (19%), Positives = 46/126 (36%), Gaps = 17/126 (13%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGK----VPEELGNLTNLV 120
++ L +L + L L + L L +N ++ + E L T++
Sbjct: 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186
Query: 121 SLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDL 172
L L L + L + +L+ L + N + R+ SL++L L
Sbjct: 187 HLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHL 246
Query: 173 SNNKLT 178
N+L+
Sbjct: 247 YFNELS 252
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 35/166 (21%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGF 353
+G G FG +++G L + VA+K E + Q + E + + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK-------QIALGAARGLAYL 405
+LV + G S L + RK A + +
Sbjct: 75 GQEGLHNVLVIDLL------------GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKD 446
H+ +++RD+K N L+ V DFG+ K Y+D
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRD 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 41/183 (22%), Positives = 61/183 (33%), Gaps = 36/183 (19%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE 337
S+ L V NF +G G FG++ G+ L VA+K E + Q E
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYR 56
Query: 338 MISMAVH-RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK--- 392
+ ++ F +V + G S L + R
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL------------GPSLEDLFDLCDRTFSL 104
Query: 393 ----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----DFGLAKLMD 443
IA+ + Y+H +I+RDVK N L+ DF LAK +
Sbjct: 105 KTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--E 159
Query: 444 YKD 446
Y D
Sbjct: 160 YID 162
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 42/167 (25%), Positives = 61/167 (36%), Gaps = 39/167 (23%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G FG +Y G + G VA+K E + Q E + +++ + G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESK-----IYKMMQGGVGIP 68
Query: 355 MTPTERLLVYPFMVNGS----VASCLRERGQSQPPL-NWSVRK-------QIALGAARGL 402
+ G V L G S L N+ RK +A +
Sbjct: 69 T-------IRWCGAEGDYNVMVMELL---GPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 403 AYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 446
Y+H IHRDVK N L+ + + DFGLAK Y+D
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRD 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 39/166 (23%), Positives = 64/166 (38%), Gaps = 33/166 (19%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRGF 353
+G G FG++Y G + VA+K E + Q E ++ + + +R F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK-------QIALGAARGLAYL 405
+ +LV + G S L N+ RK +A + ++
Sbjct: 72 GVEGDYNVLVMDLL------------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 406 HDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 448
H +HRD+K N L+ + + DFGLAK Y+DT
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTS 160
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.89 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.8 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.79 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.78 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.76 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.75 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.75 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.75 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.73 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.73 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.73 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.72 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.72 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.72 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.72 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.72 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.71 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.71 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.71 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.7 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.7 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.7 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.69 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.69 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.69 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.69 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.67 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.67 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.67 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.67 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.67 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.67 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.66 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.66 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.65 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.65 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.64 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.64 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.64 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.63 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.63 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.63 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.62 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.62 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.62 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.62 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.62 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.62 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.62 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.62 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.62 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.61 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.61 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.61 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.61 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.61 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.6 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.6 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.6 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.6 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.6 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.59 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.59 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.59 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.58 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.58 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.58 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.58 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.57 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.57 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.56 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.56 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.56 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.55 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.55 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.55 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.54 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.53 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.53 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.52 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.5 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.5 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.44 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.41 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.4 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.39 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.38 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.37 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.36 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.35 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.34 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.32 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.31 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.3 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.29 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.05 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.99 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.97 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.79 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.78 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.72 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.7 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.65 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.56 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.44 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.29 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.26 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.05 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.04 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.59 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.58 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.49 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.37 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.3 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.27 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.24 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.22 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.13 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.05 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.01 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.76 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.72 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.6 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.3 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.21 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.08 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.49 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.5 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.56 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.01 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=387.64 Aligned_cols=202 Identities=24% Similarity=0.405 Sum_probs=182.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||+||+|++. +|+.||||++++.. .......+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 78999999997543 2334567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
|||++|+|.+++++.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998764 389999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .......+||+.|||||++.+..++.++||||+||++|||+||++||...
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 33 23345678999999999999999999999999999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=393.29 Aligned_cols=203 Identities=24% Similarity=0.378 Sum_probs=174.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|++++.||+|+||+||+|++. +|+.||||+++... ......++.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 67999999999999999999975 79999999997544 33345679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
||++|+|.++++..+. ..+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999986432 2478999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......+||+.|||||++.+..++.++|||||||++|||+||++||...
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12234467999999999999999999999999999999999999999753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=385.47 Aligned_cols=205 Identities=29% Similarity=0.496 Sum_probs=177.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|.+.+.||+|+||+||+|++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 356778899999999999999864 47789999997543 44566799999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 361 LLVYPFMVNGSVASCLRERG---------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
++|||||++|+|.++++..+ .....++|.++..|+.||++||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999998643 2334699999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCcee-eecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 432 VVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
||+|||+|+.....+.... ....||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999987654333222 23458999999999999999999999999999999999 9999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=388.51 Aligned_cols=198 Identities=24% Similarity=0.380 Sum_probs=178.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+.|+..+.||+|+||+||+|++. +|+.||||+++... ......+.+|++++++++|||||++++++.+++..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888899999999999999986 79999999996543 22344588999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
|++|+|.+++++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999999763 389999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......+||+.|||||++.+..++.++||||+||++|||++|++||..
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 234456799999999999999999999999999999999999999964
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=385.10 Aligned_cols=205 Identities=25% Similarity=0.402 Sum_probs=178.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
+++++.+.||+|+||+||+|++. +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 44566789999999999999863 467899999987655556678999999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 010429 362 LVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 429 (511)
+|||||++|+|.++|+.... ....+++..+.+|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999976432 123589999999999999999999999 999999999999999999
Q ss_pred ceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 430 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.+||+|||+|+.....+. .......||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 999999999987644322 22344569999999999999999999999999999999999 8999964
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=383.44 Aligned_cols=203 Identities=31% Similarity=0.478 Sum_probs=170.6
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
++..+++.+.+.||+|+||+||+|+++ ..||||+++... ......+|.+|++++++++|||||+++|++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 445577888899999999999999975 359999997543 33445679999999999999999999998764 56899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
|||||++|+|.++++.... ++++.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999986432 499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-Cceeeeccccccccccccccc---CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 443 DYKD-THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 443 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.... ........||+.|||||++.+ +.++.++|||||||++|||+||+.||..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 5322 223445679999999999864 3588999999999999999999999964
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=383.89 Aligned_cols=204 Identities=30% Similarity=0.527 Sum_probs=171.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
++|.+.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45677789999999999999864 4778999999754 3445667999999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 010429 362 LVYPFMVNGSVASCLRERGQ-----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 430 (511)
+|||||++|+|.++++.... ...+++|.++..|+.||++||+|||++ +|+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999987532 224699999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 431 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
+||+|||+|+.....+. .......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence 99999999987644332 23344569999999999999999999999999999999999 9999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=389.93 Aligned_cols=198 Identities=24% Similarity=0.380 Sum_probs=178.6
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+.|+..+.||+|+||+||+|++. +|+.||||+++... ......+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56899999999999999999986 79999999996543 22344588999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
|++|+|.++++.. .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999764 289999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......+||+.|||||++.+..++.++|||||||++|||++|++||..
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 234456799999999999999999999999999999999999999964
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=380.62 Aligned_cols=196 Identities=25% Similarity=0.329 Sum_probs=171.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+.|.+.+.||+|+||+||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999986 689999999975432 24799999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 445 (511)
|++|+|.+++++.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998764 389999999999999999999999 999999999999999987 6999999999876543
Q ss_pred CCc----eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... .....+||+.|||||++.+..++.++|||||||++|||+||++||...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 221 123357999999999999999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=370.87 Aligned_cols=194 Identities=30% Similarity=0.456 Sum_probs=168.7
Q ss_pred CCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc----CCceeEEe
Q 010429 291 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 364 (511)
Q Consensus 291 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~ 364 (511)
...+.||+|+||+||+|.+. ++..||+|++.... ......+|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999976 68899999996543 33445679999999999999999999999865 34579999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeC-CCCceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~ 441 (511)
|||++|+|.+++++.. .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999998754 389999999999999999999998 6 99999999999998 478999999999986
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... ......+||+.|||||++.+ .++.++|||||||++|||+||++||..
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 432 23445679999999999865 689999999999999999999999964
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=368.05 Aligned_cols=199 Identities=25% Similarity=0.419 Sum_probs=163.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||+||+|++. +|+.||||++++... .....++.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 799999999965432 233556899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+ +|+|.+++.+.+ ++++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999998754 399999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||...
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 2 22345679999999999988876 57999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=380.41 Aligned_cols=201 Identities=27% Similarity=0.371 Sum_probs=171.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC----CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
++|++.+.||+|+||+||+|+.. +++.||||++++... .....++.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 478999999975432 2233458889999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
|||||++|+|.+++++.+ .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998764 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ......+||+.|||||++.+..++.++||||+||++|||+||++||...
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 4322 2234567999999999999999999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=380.16 Aligned_cols=216 Identities=27% Similarity=0.413 Sum_probs=187.4
Q ss_pred cCHHHHHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCC-Cceecc
Q 010429 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRL 350 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l 350 (511)
+...+|++..++|++.+.||+|+||+||+|++. .++.||||+++.........+|.+|++++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 455678888899999999999999999999864 2357999999877666667789999999999976 899999
Q ss_pred ccccccC-CceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 010429 351 RGFCMTP-TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417 (511)
Q Consensus 351 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 417 (511)
+|+|.++ +..++|||||++|+|.++++.... ....+++..+..++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9998765 568999999999999999986422 134589999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 418 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544333 3344669999999999999999999999999999999998 9999975
Q ss_pred c
Q 010429 496 A 496 (511)
Q Consensus 496 ~ 496 (511)
.
T Consensus 291 ~ 291 (353)
T 4ase_A 291 V 291 (353)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=366.55 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=164.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC--------
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-------- 358 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-------- 358 (511)
++|++.+.||+|+||+||+|++. +|+.||||+++....+....++.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46889999999999999999976 789999999976555555667999999999999999999999987544
Q ss_pred ----ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEc
Q 010429 359 ----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 434 (511)
Q Consensus 359 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 434 (511)
..+++||||++|+|.++++..... ...++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999875432 2356777899999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCc-----------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 435 DFGLAKLMDYKDTH-----------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 435 Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
|||+|+.+...... .....+||+.|||||++.+..++.++|||||||++|||++ ||.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 99999876543221 1234569999999999999999999999999999999996 775
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=367.45 Aligned_cols=200 Identities=27% Similarity=0.375 Sum_probs=164.5
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC----ceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~lv 363 (511)
.+|.+.+.||+|+||+||+|+++ |+.||||+++... .....++.|+..+.+++|||||+++|++.+++ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45677889999999999999985 8999999996542 22223445666667889999999999998654 57899
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
||||++|+|.+++++. ++++..+.+++.|+++||+|||+++ .++|+||||||+|||++.++++||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999864 3899999999999999999999762 45899999999999999999999999999
Q ss_pred ccccCCCCCc---eeeecccccccccccccccC------CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 439 AKLMDYKDTH---VTTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|+........ .....+||+.|||||++.+. .++.++|||||||++|||+||++||..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 9876544332 12345699999999998764 367899999999999999999988753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.12 Aligned_cols=201 Identities=22% Similarity=0.377 Sum_probs=172.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceecccccccc------CCc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 359 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~ 359 (511)
++|++.+.||+|+||+||+|++. +|+.||||+++.... .....++.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 799999999975432 3345568899999999999999999998654 356
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.|+|||||+ |+|.+++.+.+ ++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 67999887643 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC---CCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYK---DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+.+... ........+||+.|||||++.+. .++.++||||+||++|||++|++||...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 866432 12233456799999999998775 4689999999999999999999999643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=354.19 Aligned_cols=243 Identities=94% Similarity=1.427 Sum_probs=205.9
Q ss_pred CCCCCCCcccccCcccccCHHHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHH
Q 010429 261 DVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 340 (511)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~ 340 (511)
+.+.++++....+..+.++..+++...++|+..+.||+|+||.||+|+..+|+.||||+++..........+.+|+++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~ 82 (326)
T 3uim_A 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82 (326)
T ss_dssp ------------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGG
T ss_pred CCCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHH
Confidence 44556667777788899999999999999999999999999999999988899999999986654444446899999999
Q ss_pred hCCCCceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 010429 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 420 (511)
Q Consensus 341 ~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 420 (511)
+++||||+++++++..+...++||||+++|+|.++++.......++++..+..++.|++.||+|||+.+.++|+||||||
T Consensus 83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 99999999999999999999999999999999999998776667799999999999999999999998777899999999
Q ss_pred CCeeeCCCCceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccccCC
Q 010429 421 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 500 (511)
Q Consensus 421 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~~~~ 500 (511)
+||+++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||+......
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999998876655555666679999999999988889999999999999999999999997555444
Q ss_pred CCC
Q 010429 501 DDD 503 (511)
Q Consensus 501 ~~~ 503 (511)
+.+
T Consensus 243 ~~~ 245 (326)
T 3uim_A 243 DDD 245 (326)
T ss_dssp TSC
T ss_pred ccc
Confidence 333
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=374.13 Aligned_cols=201 Identities=30% Similarity=0.445 Sum_probs=173.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHH---HHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|++.+.||+|+||+||+|+.. +|+.||+|++++... ........+ ++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999976 799999999965431 112222333 45667778999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
|+|||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998764 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.+.... ....+||+.|||||++.+ ..++.++|+||+||++|||++|++||....
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765332 345679999999999965 578999999999999999999999997543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=354.33 Aligned_cols=198 Identities=24% Similarity=0.399 Sum_probs=169.8
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCce
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 360 (511)
..++|++.+.||+|+||+||+|+.+ +++.||+|++.... ...++.+|+++++++ +||||+++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999753 46789999986543 344678999999988 699999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 439 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 439 (511)
++||||+++|+|.++++. +++.+++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999998842 89999999999999999999999 99999999999999877 79999999999
Q ss_pred cccCCCCC---------------------------ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCC
Q 010429 440 KLMDYKDT---------------------------HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQR 491 (511)
Q Consensus 440 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~ 491 (511)
+....... ......+||+.|||||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 76532211 112335699999999999775 48999999999999999999999
Q ss_pred ccccc
Q 010429 492 AFDLA 496 (511)
Q Consensus 492 pf~~~ 496 (511)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 99643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=364.98 Aligned_cols=201 Identities=23% Similarity=0.358 Sum_probs=179.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||+||+|++. +|+.||+|+++... ......+.+|+++|+.++|||||++++++.++...++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999986 79999999996543 3345568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC--CceEEcccccccccC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~ 443 (511)
||++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 235 ~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999986532 2489999999999999999999999 99999999999999854 799999999998875
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ......+||+.|||||++.+..++.++||||+||++|||++|++||...
T Consensus 309 ~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 309 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp TT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 43 2344567999999999999999999999999999999999999999743
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=343.58 Aligned_cols=211 Identities=22% Similarity=0.339 Sum_probs=182.6
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
..+.....++|++.+.||+|+||+||+|+.. +++.||+|++++... ......+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455566789999999999999999999987 578899999965321 1122238899999999999999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
.+..++|||||++|+|.+++++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999998642 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+++.............+||+.|+|||++. ...++.++|||||||++|||++|++||...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 999876554444444567999999999987 456899999999999999999999999743
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=340.61 Aligned_cols=208 Identities=23% Similarity=0.334 Sum_probs=181.0
Q ss_pred HHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccC
Q 010429 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 357 (511)
.++....++|.+.+.||+|+||+||+|+.. +++.||+|++++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344556788999999999999999999986 688999999965321 11223478899999999999999999999999
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
...++||||+++|+|.+++++. .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999764 289999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCC----CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|++||...
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 99876554433444667999999999998765 788999999999999999999999743
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=325.86 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=178.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|++.+.||+|+||+||+++.. +|+.||+|++++.. .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367888999999999999999976 68999999997543 223455688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999998754 389999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 22 22234566999999999999999999999999999999999999999643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.97 Aligned_cols=211 Identities=24% Similarity=0.353 Sum_probs=182.7
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
+++.....++|++.+.||+|+||+||+++.. +|+.||+|++++... ......+.+|.+++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4455566789999999999999999999986 789999999965321 1222347889999999999999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
.+..++||||+++|+|.+++.+.+. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999987532 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeecccccccccccccc-------cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 999876554433334467999999999987 356899999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.67 Aligned_cols=200 Identities=21% Similarity=0.382 Sum_probs=178.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|+..+.||+|+||+||+|.+. +++.||||++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 467999999999999999999864 789999999865442 335568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|+|.+++.+. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999864 289999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32 233456999999999999999999999999999999999999999643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.54 Aligned_cols=204 Identities=31% Similarity=0.428 Sum_probs=173.7
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCceeccccccccCCce
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 360 (511)
...++|++.+.||+|+||+||+|+.. +|+.||+|++++.. .......+.+|.+++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999976 68999999997543 223345678899999988 699999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++|+|.+++++.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999998754 389999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 54322 22334567999999999999888999999999999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=322.68 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=178.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ......++.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 457889999999999999999974 79999999996543 2334556889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++...+ .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999998754 389999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCceeeecccccccccccccccCCCC-cccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ......||+.|+|||++.+..++ .++||||+||++|||++|+.||+..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 32 23445699999999999887764 7899999999999999999999754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=323.31 Aligned_cols=210 Identities=44% Similarity=0.761 Sum_probs=184.7
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
+....++|+..+.||+|+||.||+|++.+++.||||++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 334567899999999999999999998889999999987553 3445678999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.+++.........+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999987655555699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC-CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 4322 22233445899999999999889999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=317.73 Aligned_cols=203 Identities=26% Similarity=0.390 Sum_probs=173.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|++.+.||+|+||.||++++. ++..||+|++.... ......++.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467889999999999999999975 68899999985433 233345789999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.... ++++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998754 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...........||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 44433444556999999999999999999999999999999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=331.61 Aligned_cols=203 Identities=27% Similarity=0.379 Sum_probs=176.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch--hHHHHHHHHHHHHhC-CCCceeccccccccCCcee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~ 361 (511)
..++|++.+.||+|+||+||+++.. +++.||+|++++..... ....+.+|..++.++ +||||+++++++.+....+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467999999999999999999976 67889999997643222 223477899988876 8999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+||||+++|+|..++.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999998754 389999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 203 ~~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 203 GLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCC-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccc-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 322 222344567999999999999999999999999999999999999999743
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.41 Aligned_cols=199 Identities=30% Similarity=0.427 Sum_probs=177.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|++.+.||+|+||+||+++.. +|+.||+|++++... ......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367888999999999999999976 789999999975431 22345678899999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++|+|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999998753 389999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 32 23456999999999999999999999999999999999999999643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=323.59 Aligned_cols=205 Identities=28% Similarity=0.412 Sum_probs=177.8
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhC-CCCceeccccccccCCc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 359 (511)
....++|.+.+.||+|+||.||+|+.. +|+.||+|+++.... ......+..|.+++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999986 688999999975431 23345577888888876 89999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999998754 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 7543222 2234567999999999999999999999999999999999999999743
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.70 Aligned_cols=201 Identities=27% Similarity=0.381 Sum_probs=177.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhC-CCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 362 (511)
.++|++.+.||+|+||.||+++.. +++.||+|+++.... ......+.+|..++.++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357888999999999999999986 688999999975532 23345588899999887 89999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999998754 389999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 161 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 322 2223456799999999999999999999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=324.67 Aligned_cols=208 Identities=29% Similarity=0.467 Sum_probs=180.2
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
..++|.+.+.||+|+||.||+|++. ++..||||+++.........++.+|+++++++ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3467888999999999999999852 35579999998766555667799999999999 89999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 424 (511)
.+..++||||+++|+|.++++.... ....+++..+..++.|+++||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999987542 123589999999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 425 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 425 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999866443221 2223447889999999999999999999999999999999 99999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=323.79 Aligned_cols=201 Identities=25% Similarity=0.386 Sum_probs=176.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|.+.+.||+|+||.||++... +++.||+|+++... .......+.+|+++++.++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467889999999999999999976 68899999996543 223345688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+.+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999998643 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeeccccccccccccccc---CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 33 22345679999999999874 35789999999999999999999999743
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=313.64 Aligned_cols=203 Identities=30% Similarity=0.468 Sum_probs=177.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|...+.||+|+||+||+|.+. +++.||+|++... .......+.+|++++++++||||+++++++.++...++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 457888899999999999999976 6899999998653 34456679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++|+|.++++.... .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999987432 489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCce-------------eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHV-------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 2211 11456999999999999999999999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=321.30 Aligned_cols=201 Identities=25% Similarity=0.354 Sum_probs=177.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-----hHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
..+.|.+.+.||+|+||.||+++.. +|+.||+|+++...... ....+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467889999999999999999986 68999999997544221 24578999999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----ceEEcc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGD 435 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 435 (511)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999997543 489999999999999999999999 999999999999998877 799999
Q ss_pred cccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99998765432 23345699999999999988999999999999999999999999964
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=321.09 Aligned_cols=198 Identities=25% Similarity=0.352 Sum_probs=177.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||.||+++.. +|+.||+|+++... .......+.+|+++++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 68999999996543 2233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998754 389999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 2 23456999999999999999999999999999999999999999743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=322.13 Aligned_cols=204 Identities=26% Similarity=0.368 Sum_probs=177.6
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCceeccccccccCCce
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 360 (511)
...++|.+.+.||+|+||+||+|+.. +++.||+|+++... .......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999986 57889999997543 223345678899999887 799999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++|+|.+++++.+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999998754 389999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 54322 22334567999999999999999999999999999999999999999743
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=324.37 Aligned_cols=205 Identities=18% Similarity=0.228 Sum_probs=176.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEE------eCCCCEEEEEEecccccchhHHHHHHHHHHHHhCC---CCceeccccccc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCM 355 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~ 355 (511)
...++|.+.+.||+|+||+||+|. ..+++.||||+++... ..++..|++++.+++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 445778899999999999999994 3468899999997542 345778888888777 999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-------
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE------- 427 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------- 427 (511)
..+..++||||+++|+|.++++.... ....+++..+..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999986432 234599999999999999999999999 9999999999999998
Q ss_pred ----CCceEEcccccccccCC-CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 428 ----EFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 428 ----~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++.+||+|||+|+.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 89999999999976542 2333445567999999999999999999999999999999999999999644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=321.88 Aligned_cols=206 Identities=24% Similarity=0.331 Sum_probs=178.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.++|++.+.||+|+||+||++... +|+.||||+++.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467899999999999999999875 689999999864321 113567899999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---eEEccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGL 438 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~ 438 (511)
+||||+++++|.+.+.........+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988876543444589999999999999999999999 9999999999999987654 99999999
Q ss_pred ccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 987654322 233456999999999999988999999999999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.98 Aligned_cols=210 Identities=23% Similarity=0.346 Sum_probs=181.7
Q ss_pred cccCHHHHHHHhhC----------CCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCC
Q 010429 276 KRFSLRELQVATDN----------FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 344 (511)
Q Consensus 276 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h 344 (511)
..++.+++..+.+. |...+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 34566666665543 566678999999999999986 79999999997543 3345568899999999999
Q ss_pred CceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 010429 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (511)
Q Consensus 345 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 424 (511)
|||+++++++...+..++||||+++++|.+++.+. .+++..+..++.|+++||+|||+. +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999998753 389999999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 425 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999987654322 23345699999999999998999999999999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=317.24 Aligned_cols=202 Identities=26% Similarity=0.367 Sum_probs=168.3
Q ss_pred hhCCCCCCeeccccccEEEEEEe----CCCCEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
.++|++.+.||+|+||.||+++. .+++.||+|+++.... ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999987 4789999999976432 2234457889999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999998754 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 169 KESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 754322 12233456999999999999888999999999999999999999999743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.04 Aligned_cols=210 Identities=30% Similarity=0.493 Sum_probs=171.7
Q ss_pred HHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
.++.+..++|++.+.||+|+||+||+|++. |..||||++..... .....++.+|++++++++||||+++++++...+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 344455678899999999999999999884 88999999975542 3334568999999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCceEEcccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
.++||||+++|+|.++++.... ...+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999986431 12389999999999999999999999 8 9999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 185 LSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 997543321 2233456999999999999999999999999999999999999999743
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.37 Aligned_cols=202 Identities=25% Similarity=0.406 Sum_probs=173.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||+|+||+||+|++. +++.||||++...........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999976 78999999997555444455688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++|+|.++++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999886543 389999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-ceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22234569999999999987775 78899999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=316.13 Aligned_cols=203 Identities=29% Similarity=0.466 Sum_probs=175.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|.+.+.||+|+||.||+|++. .+..||||+++..........+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888899999999999999975 3456999999876556666779999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.++++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 543222 2222346788999999998899999999999999999999 9999964
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.23 Aligned_cols=203 Identities=28% Similarity=0.399 Sum_probs=172.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|++.+.||+|+||+||+|++.+|+.||+|+++..... .....+.+|++++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34678899999999999999999988999999999754322 23456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||++ +++.+.+.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9997 47888877543 2489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 322 2233458999999999876 55799999999999999999999999743
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=313.82 Aligned_cols=205 Identities=28% Similarity=0.448 Sum_probs=163.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||.||+|... +|+.||+|+++..........+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457889999999999999999875 6899999999765544445568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 366 FMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|++ |+|.+++.... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999887642 2233589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3222 22334589999999998764 5799999999999999999999999643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=333.70 Aligned_cols=206 Identities=30% Similarity=0.425 Sum_probs=182.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|...+.||+|+||.||+++.. +|+.||+|++++... ......+.+|++++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999986 699999999965432 22345688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999987655455699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 4322 233457999999999999999999999999999999999999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.83 Aligned_cols=200 Identities=22% Similarity=0.301 Sum_probs=177.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|.+.+.||+|+||.||++.+. +++.||+|.++... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 367888999999999999999976 68899999987542 344568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC--CCceEEcccccccccC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~ 443 (511)
|+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999997543 2489999999999999999999999 9999999999999997 7899999999998765
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 432 334456999999999999888899999999999999999999999643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.82 Aligned_cols=202 Identities=27% Similarity=0.350 Sum_probs=169.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHH-HHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|++.+.||+|+||.||+++.. +++.||+|++++.... .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999986 6889999999765422 223446667766 567899999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.+++++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999998754 388999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 322 22334567999999999999999999999999999999999999999643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.59 Aligned_cols=202 Identities=24% Similarity=0.359 Sum_probs=177.2
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
..++|.+.+.||+|+||.||++.+. +|+.||+|+++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999976 68999999997543 233445688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---ceEEccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAK 440 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~ 440 (511)
|||+++|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999887543 489999999999999999999999 999999999999998654 59999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... ......||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 665322 223456999999999999988999999999999999999999999643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=321.75 Aligned_cols=218 Identities=27% Similarity=0.421 Sum_probs=185.9
Q ss_pred ccCHHHHHHHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceec
Q 010429 277 RFSLRELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLR 349 (511)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~ 349 (511)
.+...+++...++|.+.+.||+|+||.||+|++ .+++.||||+++..........+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 355667778889999999999999999999973 256789999998766555667799999999999 7899999
Q ss_pred cccccccCCc-eeEEeecccCCCHHHHHHhcCCC----------------------------------------------
Q 010429 350 LRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQS---------------------------------------------- 382 (511)
Q Consensus 350 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 382 (511)
+++++...+. .++||||+++|+|.++++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 89999999999999999875421
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 383 ----------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 383 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12289999999999999999999999 99999999999999999999999999998664332
Q ss_pred C-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 447 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 447 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 2 23334558999999999999999999999999999999999 999997543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.53 Aligned_cols=203 Identities=28% Similarity=0.460 Sum_probs=179.5
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..++|++.+.||+|+||.||++++.++..||+|+++.... ...++.+|++++.+++||||+++++++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3567888999999999999999998888999999976443 34568999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999987532 389999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 4333334446788999999998889999999999999999999 99999643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=321.17 Aligned_cols=203 Identities=31% Similarity=0.498 Sum_probs=166.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|.+.+.||+|+||.||+|++. ++..||||+++.........++.+|++++++++||||+++++++......++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467899999999999999999864 5678999999876555566779999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.++++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999998643 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~ 253 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 5432211 122235778999999999999999999999999999998 9999964
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=307.30 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=178.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..++|++.+.||+|+||.||+|++.+++.||+|+++.... ...++.+|++++++++||||+++++++.+....++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3467888999999999999999998889999999976543 23568999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999976432 489999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 2222233446788999999998899999999999999999999 99999743
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.88 Aligned_cols=202 Identities=20% Similarity=0.304 Sum_probs=176.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
..++|++.+.||+|+||+||++... +|+.+|+|++..... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999875 788999999975442 33455689999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC---CCCceEEccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 440 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~ 440 (511)
|||+++|+|.+.+.... .+++..+..++.|+++||+|||++ +|+||||||+|||++ +++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999998753 389999999999999999999999 999999999999998 56789999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
....... ......||+.|+|||++.+..++.++||||+||++|||++|++||..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 7654322 22345699999999999998999999999999999999999999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.57 Aligned_cols=204 Identities=24% Similarity=0.379 Sum_probs=174.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC-------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------- 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------- 358 (511)
.++|++.+.||+|+||.||+|++. +|+.||||+++..........+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888999999999999999986 799999999976555556677999999999999999999999875543
Q ss_pred --------------------------------------------------ceeEEeecccCCCHHHHHHhcCCCCCCCCH
Q 010429 359 --------------------------------------------------ERLLVYPFMVNGSVASCLRERGQSQPPLNW 388 (511)
Q Consensus 359 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 388 (511)
..+++|||+++++|.++++.... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 27899999999999999987543 234677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-----------ceeeeccccc
Q 010429 389 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-----------HVTTAVRGTI 457 (511)
Q Consensus 389 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~gt~ 457 (511)
..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999999 999999999999999999999999999987654321 1123345999
Q ss_pred ccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 458 ~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999998874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.54 Aligned_cols=200 Identities=27% Similarity=0.388 Sum_probs=176.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.+.|.+.+.||+|+||.||++... +|+.||+|+++..... .....+.+|++++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888999999999999999986 6899999998654322 1356789999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----ceEEccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 436 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 436 (511)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999997542 489999999999999999999999 999999999999999887 7999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 99987653322 2345699999999999988999999999999999999999999964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=311.94 Aligned_cols=203 Identities=24% Similarity=0.343 Sum_probs=176.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC--ceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv 363 (511)
.++|.+.+.||+|+||+||+|++. +++.||||+++..........+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357888999999999999999986 589999999986555555667889999999999999999999987655 67999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCceEEcccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 439 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a 439 (511)
|||+++++|.++++..... ..+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999875332 2389999999999999999999999 99999999999999 77888999999999
Q ss_pred cccCCCCCceeeecccccccccccccc--------cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLS--------TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 87654332 23456999999999986 46788999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.12 Aligned_cols=204 Identities=28% Similarity=0.417 Sum_probs=179.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
..++|...+.||+|+||.||+++.. +|+.||+|++.... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467888999999999999999986 79999999996543 22334568899999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999986532 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 5332 233457999999999999988999999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.41 Aligned_cols=200 Identities=25% Similarity=0.433 Sum_probs=174.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+++++.++||||+++++++..+...++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57888999999999999999974 789999999865321 122346889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+ +|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 789999887654 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCcccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||+...
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 32 2234569999999999988776 689999999999999999999997644
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=317.50 Aligned_cols=211 Identities=29% Similarity=0.494 Sum_probs=181.5
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
+....++|.+.+.||+|+||.||+|++. +++.||||+++..........+.+|++++++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445688999999999999999999874 3478999999876555556679999999999999999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQS--------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 416 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 416 (511)
.+..++||||+++|+|.++++..... ...+++..++.++.|+++||+|||++ +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 99999999999999999999874321 14689999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccc
Q 010429 417 DVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494 (511)
Q Consensus 417 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~ 494 (511)
||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986543222 22233457899999999998899999999999999999999 999996
Q ss_pred cc
Q 010429 495 LA 496 (511)
Q Consensus 495 ~~ 496 (511)
..
T Consensus 279 ~~ 280 (343)
T 1luf_A 279 GM 280 (343)
T ss_dssp TS
T ss_pred CC
Confidence 43
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=323.11 Aligned_cols=206 Identities=29% Similarity=0.468 Sum_probs=177.8
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
....++|.+.+.||+|+||.||+|++. +++.||||+++.........++.+|++++++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344567888999999999999999986 7899999999765444445568899999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.++++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999986432 389999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCCcee-eecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
........ ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 32211111 11225778999999998889999999999999999998 9999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.94 Aligned_cols=200 Identities=26% Similarity=0.407 Sum_probs=170.4
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||+|+||+||+|+..+|+.||+|+++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999998899999999965432 22235688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 8998887643 2489999999999999999999999 99999999999999999999999999998664322
Q ss_pred CceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 22334589999999998764 589999999999999999999999964
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.70 Aligned_cols=207 Identities=30% Similarity=0.444 Sum_probs=178.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|.+.+.||+|+||+||+|++. ++..||||+++.........++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999843 46689999998666666667799999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---ceEEc
Q 010429 361 LLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVG 434 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 434 (511)
++||||+++|+|.++++.... ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999987542 224589999999999999999999999 999999999999999555 59999
Q ss_pred ccccccccCCC-CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 435 DFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 435 Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999754321 1122233458999999999999999999999999999999998 99999643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=329.58 Aligned_cols=202 Identities=25% Similarity=0.335 Sum_probs=168.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|++.+.||+|+||.||+++.. +|+.||||+++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999975 68999999997542 223344578899999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999998754 38999999999999999999998 7 9999999999999999999999999999754
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 300 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 300 IKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 322 22234467999999999999999999999999999999999999999643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=313.88 Aligned_cols=203 Identities=27% Similarity=0.397 Sum_probs=168.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCce---
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER--- 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~--- 360 (511)
.++|++.+.||+|+||.||++++. +++.||||+++.... ......+.+|++++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467889999999999999999974 788999999976432 23345688999999999999999999998765544
Q ss_pred -eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 361 -LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 361 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
++||||+++++|.++++... ++++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999998754 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 86644322 2223356899999999999999999999999999999999999999643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=308.88 Aligned_cols=205 Identities=23% Similarity=0.374 Sum_probs=166.0
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCC----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
+..++|++.+.||+|+||.||+|.+.. +..||+|+++..........+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345688889999999999999998752 45799999876555555667999999999999999999999874 5678
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++++|.++++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999999986532 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 765443333334457889999999998899999999999999999997 99999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=315.47 Aligned_cols=210 Identities=21% Similarity=0.297 Sum_probs=183.5
Q ss_pred cccccCHHHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-----CCce
Q 010429 274 QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----HRNL 347 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h~ni 347 (511)
+...+++.+.....++|.+.+.||+|+||+||+|++. +++.||||+++.. ......+..|+++++++. ||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 4556677777778899999999999999999999985 7889999999743 233445778999999886 9999
Q ss_pred eccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC
Q 010429 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 427 (511)
Q Consensus 348 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 427 (511)
+++++++...+..++||||+ +++|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD 172 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence 99999999999999999999 99999999875432 489999999999999999999999 9999999999999975
Q ss_pred -------------------------CCceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHH
Q 010429 428 -------------------------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 482 (511)
Q Consensus 428 -------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvi 482 (511)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 7899999999998644322 23468999999999999999999999999999
Q ss_pred HHHHHhCCCcccc
Q 010429 483 LLELITGQRAFDL 495 (511)
Q Consensus 483 l~elltg~~pf~~ 495 (511)
+|||++|+.||..
T Consensus 249 l~ell~g~~pf~~ 261 (360)
T 3llt_A 249 LAELYTGSLLFRT 261 (360)
T ss_dssp HHHHHHSSCSCCC
T ss_pred HHHHHHCCCCCCC
Confidence 9999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=316.08 Aligned_cols=201 Identities=22% Similarity=0.323 Sum_probs=176.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 467899999999999999999976 68899999987543 2344568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC--CCceEEcccccccccC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~ 443 (511)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999987542 2489999999999999999999999 9999999999999974 4679999999998765
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 4322 33446999999999999988999999999999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=307.98 Aligned_cols=201 Identities=26% Similarity=0.409 Sum_probs=167.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-------------------------hhHHHHHHHHHHHH
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------------------------GGELQFQTEVEMIS 340 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~ 340 (511)
.++|.+.+.||+|+||.||+|++. +++.||||++...... .....+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467888999999999999999875 6889999998654311 11245889999999
Q ss_pred hCCCCceecccccccc--CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 010429 341 MAVHRNLLRLRGFCMT--PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418 (511)
Q Consensus 341 ~~~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 418 (511)
+++||||+++++++.. ....++||||+++++|.+++.. .++++..+..++.|+++||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999886 5678999999999998875432 2489999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEcccccccccCCCCCceeeecccccccccccccccCC---CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 419 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 233456999999999997665 37789999999999999999999974
Q ss_pred c
Q 010429 496 A 496 (511)
Q Consensus 496 ~ 496 (511)
.
T Consensus 243 ~ 243 (298)
T 2zv2_A 243 E 243 (298)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=302.02 Aligned_cols=218 Identities=43% Similarity=0.705 Sum_probs=188.0
Q ss_pred cccccCHHHHHHHhhCCCCC------CeeccccccEEEEEEeCCCCEEEEEEecccc---cchhHHHHHHHHHHHHhCCC
Q 010429 274 QLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVKRLKEER---TQGGELQFQTEVEMISMAVH 344 (511)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~h 344 (511)
....++..++..++++|... +.||+|+||.||+|.. +++.||||++.... .......+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678899999999998877 8999999999999997 58899999986532 23345678999999999999
Q ss_pred CceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 010429 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (511)
Q Consensus 345 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 424 (511)
|||+++++++...+..+++|||+++++|.+++..... ..++++..+..++.|+++||+|||+. +++||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999976432 23589999999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 425 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 425 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||+...
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999999999866543222 2233568999999998865 57889999999999999999999997543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=317.06 Aligned_cols=208 Identities=30% Similarity=0.448 Sum_probs=180.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
..++|.+.+.||+|+||+||+|++. .+..||||+++.........++.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4467888999999999999999852 24579999998766666667799999999999 89999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 424 (511)
.+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+. +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999987542 123589999999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 425 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 425 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
+++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999986654322 22233447889999999999999999999999999999999 99999643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.93 Aligned_cols=212 Identities=27% Similarity=0.435 Sum_probs=178.6
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccc
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 354 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~ 354 (511)
+++...++|.+.+.||+|+||.||+|++ .++..||||+++..........+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455678899999999999999999986 245689999997655444556799999999999 899999999999
Q ss_pred ccCCceeEEeecccCCCHHHHHHhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 010429 355 MTPTERLLVYPFMVNGSVASCLRERGQS-------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415 (511)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 415 (511)
...+..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||+. +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999875321 13479999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcc
Q 010429 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 493 (511)
Q Consensus 416 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf 493 (511)
|||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999866443322 2333457889999999998899999999999999999998 99999
Q ss_pred ccc
Q 010429 494 DLA 496 (511)
Q Consensus 494 ~~~ 496 (511)
...
T Consensus 276 ~~~ 278 (344)
T 1rjb_A 276 PGI 278 (344)
T ss_dssp TTC
T ss_pred ccC
Confidence 754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.49 Aligned_cols=209 Identities=29% Similarity=0.431 Sum_probs=180.7
Q ss_pred HHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 358 (511)
...++|.+.+.||+|+||.||+|.+ .++..||||+++..........+.+|++++++++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3457888899999999999999986 2457899999987655556677999999999999999999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 418 (511)
..++||||+++++|.+++..... ....+++..+..++.|+++||+|||++ +|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999987543 123489999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 419 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
||+||+++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765433221 223347889999999998889999999999999999999 99999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=305.72 Aligned_cols=203 Identities=25% Similarity=0.434 Sum_probs=175.5
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
...++|++.+.||+|+||.||++.+.++..||+|+++.... ...++.+|++++.+++||||+++++++.+....++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34568888999999999999999998888999999976543 2456899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999986332 389999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
..........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 32222233346788999999998899999999999999999998 9999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=304.35 Aligned_cols=199 Identities=23% Similarity=0.384 Sum_probs=170.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|++.+.||+|+||+||+|++. +++.||+|+++.... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999986 689999999975443 3334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++ ++.+.+.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 5555555432 2489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 22 223446899999999997766 7999999999999999999988863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=311.28 Aligned_cols=200 Identities=20% Similarity=0.234 Sum_probs=174.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.++|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 467888999999999999999974 7899999998654322 2478999999999 9999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc-----eEEcccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLA 439 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a 439 (511)
||+ +++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 999999998642 2499999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCCc------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 876433221 123456999999999999999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=315.79 Aligned_cols=203 Identities=25% Similarity=0.383 Sum_probs=163.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCC-CCceeccccccccCC--c
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--E 359 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~--~ 359 (511)
...++|++.+.||+|+||.||+|.+. +|+.||||++.... ......++.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35678999999999999999999875 78999999986443 2334556889999999997 999999999987543 6
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++|||||+ ++|.++++.. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 6899988763 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC--------------------CCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYK--------------------DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+.+... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 865321 1112234569999999999876 56899999999999999999999999643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.04 Aligned_cols=205 Identities=21% Similarity=0.293 Sum_probs=176.6
Q ss_pred hhCCCCCCeeccc--cccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|++.+.||+| +||.||++++. +|+.||||+++..... .....+.+|++++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678899999999 99999999986 7899999999765432 334568889999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999987532 2389999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCC------Cceeeeccccccccccccccc--CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKD------THVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 2211 011122358999999999987 57899999999999999999999999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=304.37 Aligned_cols=204 Identities=25% Similarity=0.348 Sum_probs=174.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|.+.+.||+|+||.||++... ++..+|+|++...........+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467889999999999999999975 6889999999876655566789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCceEEccccccccc
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 442 (511)
|+++|+|.+++.........+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999876433334599999999999999999999999 99999999999999 45678999999999765
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 4322 223455899999999875 56789999999999999999999999643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=307.95 Aligned_cols=211 Identities=27% Similarity=0.417 Sum_probs=182.6
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
+...++|.+.+.||+|+||.||+|++ .+++.||+|+++..........+.+|++++.++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 44567889999999999999999985 256789999998665555567799999999999 99999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQS--------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 422 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 422 (511)
.+..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||++ +++||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 99999999999999999999875421 23489999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccccccccCCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 423 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 423 Ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
|+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999998765443322 223447889999999999899999999999999999999 999997543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=329.28 Aligned_cols=206 Identities=25% Similarity=0.447 Sum_probs=178.0
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
++++..++|.+.+.||+|+||.||+|.+.++..||||+++... .....+.+|++++++++||||+++++++. .+..+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 3455677889999999999999999999888899999997643 23567999999999999999999999986 56789
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+||||+++|+|.++++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 259 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 99999999999999985421 1378899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.............+++.|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 64322112223346789999999998899999999999999999999 9999964
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=311.67 Aligned_cols=203 Identities=29% Similarity=0.500 Sum_probs=168.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.++|+..+.||+|+||+||+|++. +++ .||+|.++.........++.+|++++++++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 357888899999999999999864 344 36888887655555667799999999999999999999998875 478
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999987543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 442 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
....... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 6543322 2233447889999999999999999999999999999999 99999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=307.69 Aligned_cols=192 Identities=24% Similarity=0.365 Sum_probs=151.7
Q ss_pred CCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEeecccCC
Q 010429 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
.+.||+|+||+||++.+. +++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 378999999999999986 6899999998643 3445788999999997 999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---ceEEcccccccccCCCCC
Q 010429 371 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 371 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~ 447 (511)
+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999998753 489999999999999999999999 999999999999998765 899999999986543322
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 233455899999999999999999999999999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.88 Aligned_cols=203 Identities=32% Similarity=0.439 Sum_probs=171.5
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC----cee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERL 361 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~ 361 (511)
..++|++.+.||+|+||+||+|++. ++.||||+++... .......+|+.++.+++||||+++++++.... ..+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3467889999999999999999986 7999999996543 33345667888999999999999999988754 369
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEecCCCCCCeeeCCCCceEEc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-------DPKIIHRDVKAANILLDEEFEAVVG 434 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~ 434 (511)
+||||+++|+|.++++.. .+++..+..++.|+++||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999999864 2899999999999999999999862 2389999999999999999999999
Q ss_pred ccccccccCCCCCc-eeeecccccccccccccccC-----CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 435 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 435 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999876543222 22335689999999998763 4567899999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=336.12 Aligned_cols=204 Identities=26% Similarity=0.368 Sum_probs=178.1
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCceeccccccccCCce
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 360 (511)
...++|++.+.||+|+||.||+|+.. +++.||||++++.. .......+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 45578999999999999999999976 68899999997542 223345578899999887 699999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++|+|.++++..+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998764 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 491 ~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 491 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp ECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 64322 22344567999999999999999999999999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=312.12 Aligned_cols=199 Identities=28% Similarity=0.412 Sum_probs=161.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|.+.+.||+|+||.||+|++. +++.||||+++... ....+.+|++++++++||||+++++++..+...++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3467889999999999999999986 57899999997543 2345889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~ 441 (511)
||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999997643 389999999999999999999999 9999999999999975 88999999999986
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 54322 223456899999999999989999999999999999999999999643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=312.75 Aligned_cols=199 Identities=26% Similarity=0.363 Sum_probs=165.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|.+.+.||+|+||+||+++.. +++.||||++...... ...+.+|+.++++++||||+++++++......++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467889999999999999999986 7899999999754322 3458899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--eEEcccccccccC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~ 443 (511)
|+++|+|.+++...+ .+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999997654 389999999999999999999999 9999999999999987765 9999999997433
Q ss_pred CCCCceeeecccccccccccccccCCCCcc-cCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 22 12234469999999999988877555 89999999999999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.55 Aligned_cols=203 Identities=29% Similarity=0.394 Sum_probs=174.3
Q ss_pred hhCCCCCCeeccccccEEEEEEe----CCCCEEEEEEeccccc---chhHHHHHHHHHHHHhC-CCCceeccccccccCC
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~ 358 (511)
.++|.+.+.||+|+||.||+++. .+++.||||+++.... ......+.+|++++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788999999999999999987 3689999999875431 22234467899999999 6999999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999998754 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeecccccccccccccccC--CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 986654333334456799999999999853 4688999999999999999999999743
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=326.84 Aligned_cols=205 Identities=30% Similarity=0.461 Sum_probs=178.8
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
...++|.+.+.||+|+||.||+|.+. ++..||||.++.... ...++.+|++++++++||||+++++++......++|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34567888899999999999999987 478999999976432 356799999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++|+|.++++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 295 ~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999987433 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
...........+++.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 433222223346789999999998899999999999999999999 99999753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=303.86 Aligned_cols=203 Identities=24% Similarity=0.331 Sum_probs=167.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|.+.+.||+|+||.||++.+. +++.||+|+++..... .....+.+|+.++++++||||+++++++..++..+++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467889999999999999999976 6889999999754322 2245688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.++++... ++++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998753 389999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...........|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 44333334456899999999999988999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=312.76 Aligned_cols=211 Identities=25% Similarity=0.293 Sum_probs=174.1
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
++....++|.+.+.||+|+||.||+|... ++..||+|++.... .......+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556788999999999999999999875 68899999986542 23445678999999999999999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQS------------------------------------QPPLNWSVRKQIALGAAR 400 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~ 400 (511)
.+..++||||+++|+|.+++...... ...+++..+..++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998631110 112467788899999999
Q ss_pred HHHHHHhCCCCCeEecCCCCCCeeeCCCC--ceEEcccccccccCCCCC---ceeeeccccccccccccccc--CCCCcc
Q 010429 401 GLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLST--GKSSEK 473 (511)
Q Consensus 401 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~ 473 (511)
||+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... .......||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 899999999986543221 12344569999999999875 568899
Q ss_pred cCeehhhHHHHHHHhCCCcccc
Q 010429 474 TDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 474 ~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+|||||||++|||++|+.||..
T Consensus 257 ~DiwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.32 Aligned_cols=200 Identities=27% Similarity=0.470 Sum_probs=176.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||.||+|++. +|+.||||+++.... ......+.+|+++++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888899999999999999986 799999999965432 223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999997543 489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+..
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 32 2334569999999999988765 68999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=305.14 Aligned_cols=209 Identities=30% Similarity=0.454 Sum_probs=183.4
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
+++...++|.+.+.||+|+||.||+|.+. ++..||+|.++... .....+.+|++++++++||||+++++++......
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 33445678889999999999999999986 48889999997543 3456789999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999987433 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 776554444444557889999999998899999999999999999999 999997543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=306.93 Aligned_cols=217 Identities=27% Similarity=0.424 Sum_probs=185.0
Q ss_pred cCHHHHHHHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecc
Q 010429 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRL 350 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l 350 (511)
+...++....++|.+.+.||+|+||.||+|++ .+++.||||+++..........+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45556667788999999999999999999974 256889999998766555566799999999999 68999999
Q ss_pred ccccccCC-ceeEEeecccCCCHHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 010429 351 RGFCMTPT-ERLLVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417 (511)
Q Consensus 351 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 417 (511)
++++...+ ..+++|||+++|+|.+++...... ...+++..+..++.|+++||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987754 489999999999999999875432 22378999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 418 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999866543322 2333457889999999999999999999999999999998 9999975
Q ss_pred cc
Q 010429 496 AR 497 (511)
Q Consensus 496 ~~ 497 (511)
..
T Consensus 254 ~~ 255 (316)
T 2xir_A 254 VK 255 (316)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.07 Aligned_cols=212 Identities=27% Similarity=0.420 Sum_probs=181.6
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeCC------CCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccc
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 354 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~ 354 (511)
+++...++|.+.+.||+|+||.||+|.+.. +..||+|.++..........+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455667889999999999999999998642 2479999998765555667799999999999 899999999999
Q ss_pred ccCCceeEEeecccCCCHHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 010429 355 MTPTERLLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (511)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 424 (511)
...+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999976421 123589999999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 425 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 425 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999865433322 2233447889999999998899999999999999999999 99999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.06 Aligned_cols=203 Identities=28% Similarity=0.476 Sum_probs=157.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|.+.+.||+|+||.||+|+.. +|+.||+|++..... ......+.+|++++++++||||+++++++.+.+..+++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888899999999999999974 789999999964431 122456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.... .++++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998643 2489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 222 1223458999999999998889999999999999999999999997544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.52 Aligned_cols=201 Identities=28% Similarity=0.447 Sum_probs=166.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|.+.+.||+|+||+||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999986 78999999997554333223456799999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
++ |+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 589988876532 489999999999999999999999 99999999999999999999999999997654322
Q ss_pred Cceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 2233458999999999876 56799999999999999999999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=299.23 Aligned_cols=203 Identities=27% Similarity=0.452 Sum_probs=177.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..++|.+.+.||+|+||.||++.+.+++.||+|+++.... ....+.+|++++++++||||+++++++..++..+++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3467888899999999999999998888999999976543 23568999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999986532 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 2222223447789999999998889999999999999999999 99999753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.54 Aligned_cols=209 Identities=29% Similarity=0.469 Sum_probs=179.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 355 (511)
...++|.+.+.||+|+||.||+|++. ++..||+|+++..........+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578999999999999999999863 46789999998765555667799999999999 8999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 423 (511)
..+..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||+. +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 999999999999999999999875421 23489999999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999999999999999876543322 1223347889999999988889999999999999999999 99999643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.99 Aligned_cols=195 Identities=25% Similarity=0.325 Sum_probs=166.5
Q ss_pred CCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCC
Q 010429 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 567999999999999875 68999999997643 2345678999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee--CCCCceEEcccccccccCCCCCce
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999887543 2389999999999999999999999 99999999999999 6678999999999987654322
Q ss_pred eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 450 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 450 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23345999999999999888999999999999999999999999643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.76 Aligned_cols=197 Identities=28% Similarity=0.432 Sum_probs=165.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHh--CCCCceecccccccc----CCc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMT----PTE 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~----~~~ 359 (511)
..++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 356899999999999999999998 5899999998643 23345667776665 799999999998654 345
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeeeCCCCce
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--------DHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
.++||||+++|+|.++++.. .+++..+..++.|+++||+||| +. +|+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 78999999999999999643 3899999999999999999999 77 99999999999999999999
Q ss_pred EEcccccccccCCCCCce---eeecccccccccccccccC------CCCcccCeehhhHHHHHHHhC----------CCc
Q 010429 432 VVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITG----------QRA 492 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~elltg----------~~p 492 (511)
||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997665433322 2234699999999999876 455789999999999999999 888
Q ss_pred ccc
Q 010429 493 FDL 495 (511)
Q Consensus 493 f~~ 495 (511)
|..
T Consensus 233 f~~ 235 (301)
T 3q4u_A 233 FYD 235 (301)
T ss_dssp TTT
T ss_pred ccc
Confidence 854
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=304.38 Aligned_cols=201 Identities=25% Similarity=0.358 Sum_probs=177.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-----hHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
..++|.+.+.||+|+||.||+++.. +|+.||+|+++...... ....+.+|++++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467889999999999999999976 68999999996543221 35678999999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----ceEEcc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGD 435 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 435 (511)
.++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999999999997643 489999999999999999999999 999999999999999888 799999
Q ss_pred cccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 99998765432 22344589999999999988999999999999999999999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=303.15 Aligned_cols=203 Identities=29% Similarity=0.429 Sum_probs=168.9
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc----chhHHHHHHHHHHHHhCC---CCceecccccccc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAV---HRNLLRLRGFCMT 356 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~ 356 (511)
...++|++.+.||+|+||+||+|++. +++.||+|+++.... ......+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45678999999999999999999974 789999999864321 111234667777766654 9999999999876
Q ss_pred CC-----ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 357 PT-----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 357 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
.. ..+++|||+. ++|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 54 4789999996 699999987543 2389999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999998664322 22445689999999999999999999999999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=298.77 Aligned_cols=201 Identities=30% Similarity=0.463 Sum_probs=173.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ......+.+|++++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888999999999999999876 577999999865432 2224568899999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999998754 389999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 322 223446899999999999988999999999999999999999999743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=302.81 Aligned_cols=201 Identities=24% Similarity=0.335 Sum_probs=169.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|++.+.||+|+||+||+|++. +|+.||+|++...... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999986 5899999998654433 234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999887543 389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 22 2234468999999999876 56799999999999999999999999643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.95 Aligned_cols=198 Identities=22% Similarity=0.278 Sum_probs=165.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC------C
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~ 358 (511)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ......++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999876 68899999997543 233455688999999999999999999998654 3
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||||++++ +.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 569999999765 6655543 289999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 2234456999999999999999999999999999999999999999753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=303.34 Aligned_cols=205 Identities=28% Similarity=0.484 Sum_probs=176.9
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
+++..++|++.+.||+|+||.||+|...++..||+|.++.... ....+.+|++++++++||||+++++++. .+..++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3445678889999999999999999998888999999975432 3456899999999999999999999876 456899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+++++|.+++..... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 9999999999999975321 1389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 5443332333446789999999988889999999999999999999 9999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=309.25 Aligned_cols=210 Identities=26% Similarity=0.435 Sum_probs=162.6
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeCCC----CEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 358 (511)
.+..++|++.+.||+|+||.||+|++... ..||||+++... ......++.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34557899999999999999999987632 279999997543 3344567999999999999999999999998766
Q ss_pred ce------eEEeecccCCCHHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc
Q 010429 359 ER------LLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 430 (511)
Q Consensus 359 ~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 430 (511)
.. +++|||+++|+|.+++.... .....+++..+..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 55 99999999999999997643 2223589999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 431 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 99999999986643322 12223447889999999999999999999999999999999 99999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=302.14 Aligned_cols=199 Identities=26% Similarity=0.285 Sum_probs=166.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 362 (511)
..++|+..+.||+|+||+||+|++. +|+.||||++.... ......+...|+..+.+. +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4468999999999999999999986 79999999986543 223334455666555554 89999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+ +++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 7799998887542 489999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4322 2334459999999999876 68999999999999999999977664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=296.78 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=176.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|++++++++||||+++++++...+..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999876 68899999997544 2334456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---eEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~ 441 (511)
||+++++|.+.+.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887653 389999999999999999999999 9999999999999987655 99999999976
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 643322 2345699999999999999999999999999999999999999954
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=324.69 Aligned_cols=205 Identities=28% Similarity=0.450 Sum_probs=171.8
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
+++..++|.+.+.||+|+||.||+|.+.++..||||+++.... ...++.+|++++++++||||+++++++.+ +..++
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 3445677888999999999999999998778899999976442 34568999999999999999999999876 67899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.++++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 256 v~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 9999999999999975321 2389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
............++..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 5433222333447889999999998999999999999999999999 9999964
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.95 Aligned_cols=199 Identities=29% Similarity=0.489 Sum_probs=173.0
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC-ceeEE
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLV 363 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv 363 (511)
...++|.+.+.||+|+||.||+|.+. |+.||||+++... ....+.+|++++++++||||+++++++.... ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 34567888899999999999999986 7899999997643 3456899999999999999999999987655 78999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++|+|.++++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999987543 2378999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 12247889999999999999999999999999999999 99999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.98 Aligned_cols=203 Identities=25% Similarity=0.407 Sum_probs=177.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||.||+|... +++.||+|++...........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999986 7899999999765555556678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999988653 2489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CC-ceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DT-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 21 12234568999999999987665 78899999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=308.78 Aligned_cols=197 Identities=25% Similarity=0.384 Sum_probs=165.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 358 (511)
.++|...+.||+|+||.||+|.+. +|+.||||++.... ......++.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357888999999999999999975 78999999996533 2334556889999999999999999999987653
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||||+ +++|.++++.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999999763 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9875432 233568999999999887 67899999999999999999999999743
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=304.20 Aligned_cols=204 Identities=28% Similarity=0.475 Sum_probs=171.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEe-----CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc--CC
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PT 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~ 358 (511)
..++|++.+.||+|+||+||++++ .+++.||||+++... ......+.+|++++++++||||+++++++.. ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 346788899999999999999984 268899999997543 3445678999999999999999999998864 35
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 58999999999999999987532 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC--ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+........ .......++..|+|||.+.+..++.++||||||+++|||+||..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 987643322 1222344778899999999999999999999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=295.44 Aligned_cols=200 Identities=23% Similarity=0.309 Sum_probs=175.3
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|.+.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|++++++++||||+++++++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3467889999999999999999976 577899999875442 34567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 441 (511)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++ +.++.+||+|||++..
T Consensus 86 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 9999999999987754 389999999999999999999999 99999999999999 7888999999999987
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 159 FKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp CCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 65332 22344599999999998654 889999999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=309.34 Aligned_cols=202 Identities=24% Similarity=0.316 Sum_probs=175.8
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-------hhHHHHHHHHHHHHhCCCCceeccccccccC
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 357 (511)
..++|.+.+.||+|+||.||+|++. +++.||||+++..... .....+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999865 7889999999754311 1223477899999999999999999999999
Q ss_pred CceeEEeecccCC-CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 358 TERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 358 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999998653 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|++........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 99987654332 234569999999999988776 78999999999999999999999743
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=309.06 Aligned_cols=202 Identities=27% Similarity=0.466 Sum_probs=169.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCE----EEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
++|++.+.||+|+||+||+|++. +++. ||+|.+...........+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888899999999999999875 4443 78888765443333345778999999999999999999886 567899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999997642 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 443 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
...... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 543322 2334557889999999998999999999999999999999 99999754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.45 Aligned_cols=203 Identities=25% Similarity=0.413 Sum_probs=172.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCC----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
..++|.+.+.||+|+||.||+|++.+ +..||+|.++..........+.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999998642 336999999876555566779999999999999999999999764 4578
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
++|||+++++|.++++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999987532 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.............+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 65443333344457889999999998889999999999999999998 9999964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=307.63 Aligned_cols=216 Identities=27% Similarity=0.439 Sum_probs=183.8
Q ss_pred cCHHHHHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccc
Q 010429 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~ 351 (511)
+...++++..++|.+.+.||+|+||.||+|.+. +++.||+|.++.........++.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455667788999999999999999999764 36789999998665555666799999999999999999999
Q ss_pred cccccCCceeEEeecccCCCHHHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 010429 352 GFCMTPTERLLVYPFMVNGSVASCLRERG------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (511)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 425 (511)
+++...+..++||||+++|+|.++++... ....++++..+..++.|+++||+|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999997632 1123479999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 426 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 426 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 99999999999999765432221 1122346889999999998889999999999999999999 89999643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.82 Aligned_cols=203 Identities=29% Similarity=0.454 Sum_probs=173.3
Q ss_pred hhCCCCCCeeccccccEEEEEEe-----CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC--Cc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~ 359 (511)
...|++.+.||+|+||.||++++ .+++.||+|+++..........+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34578889999999999999983 368899999998665555567799999999999999999999998876 66
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+++|||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999976532 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 440 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 440 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......... ......||..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 876544332 22334588899999999998899999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.25 Aligned_cols=197 Identities=22% Similarity=0.335 Sum_probs=170.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 363 (511)
..++|++.+.||+|+||.||++.+. +++.||+|+++..... ..+|++++.++ +||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999986 6889999999754322 34688888777 799999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC----CceEEcccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLA 439 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a 439 (511)
|||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+||++.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 99999999999997643 389999999999999999999999 99999999999998543 35999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 87654322 23345689999999999888889999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=316.36 Aligned_cols=204 Identities=24% Similarity=0.334 Sum_probs=175.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC--ceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv 363 (511)
.++|.+.+.||+|+||+||+|++. +|+.||||+++..........+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357888999999999999999986 589999999986555555667889999999999999999999987655 67999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCceEEcccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 439 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a 439 (511)
|||+++|+|.++++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999864322 2389999999999999999999999 99999999999999 77788999999999
Q ss_pred cccCCCCCceeeeccccccccccccccc--------CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 8764332 2234569999999999865 46788999999999999999999999743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.22 Aligned_cols=194 Identities=24% Similarity=0.366 Sum_probs=154.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc-----CCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-----~~~ 359 (511)
.++|.+.+.||+|+||+||+|++. +++.||||++.... ......++.+|++++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999876 78999999986543 23345678999999999999999999999843 356
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++||||+ +++|.++++... .+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 578999887543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--------------------------ceeeeccccccccccccc-ccCCCCcccCeehhhHHHHHHHh
Q 010429 440 KLMDYKDT--------------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELIT 488 (511)
Q Consensus 440 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~ellt 488 (511)
+....... ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 87643211 122345689999999986 45668999999999999999999
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=306.96 Aligned_cols=196 Identities=33% Similarity=0.482 Sum_probs=170.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+.|...+.||+|+||+||+|+.. +++.||||++..... .....++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999974 789999999965432 223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+. |++.+++..... ++++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 688888865432 489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 2346999999999984 56688999999999999999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=297.50 Aligned_cols=202 Identities=25% Similarity=0.425 Sum_probs=177.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|.+.+.||+|+||.||++.+. +++.||+|++.... .......+.+|+.++++++||||+++++++...+..+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888899999999999999986 57899999986543 233455688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999987653 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3222 223456899999999999888999999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=299.19 Aligned_cols=200 Identities=28% Similarity=0.437 Sum_probs=178.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.+.|...+.||+|+||.||+|... +++.||+|+++..........+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999875 6889999999766555566779999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.+++... ++++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999998652 489999999999999999999999 9999999999999999999999999999766433
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 21 22345689999999999998899999999999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=311.87 Aligned_cols=197 Identities=25% Similarity=0.329 Sum_probs=161.6
Q ss_pred hCCCCC-CeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHH-HhCCCCceecccccccc----CCce
Q 010429 288 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 360 (511)
Q Consensus 288 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~~~~~~----~~~~ 360 (511)
++|.+. +.||+|+||+||++.+. +++.||||+++.. ..+.+|++++ +..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456555 68999999999999976 6889999998632 2366788876 45589999999998865 5668
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEEcccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 437 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg 437 (511)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999986432 3489999999999999999999999 9999999999999998 7899999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 998654322 2234568999999999999999999999999999999999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=303.56 Aligned_cols=202 Identities=25% Similarity=0.425 Sum_probs=177.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|.+.+.||+|+||.||++.+. +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..+++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888899999999999999986 57899999986543 223455688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987653 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 3322 233456899999999999888999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.37 Aligned_cols=206 Identities=24% Similarity=0.399 Sum_probs=175.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccc--cCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~~~l 362 (511)
.++|++.+.||+|+||.||+++.. +++.||+|.+.... .......+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999986 78999999997543 2334556899999999999999999999874 4567899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCeeeCCCCceEEcccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-----IIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
||||+++++|.+++.........+++..+..++.|+++||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999987554445699999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 9987643321 122345899999999999888999999999999999999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=296.58 Aligned_cols=200 Identities=29% Similarity=0.454 Sum_probs=176.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|.+.+.||+|+||.||+|+.. ++..||+|++..... ......+.+|++++++++||||+++++++.+.+..+++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367888999999999999999986 577899999865431 22345688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999998754 389999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 322 23456899999999999988999999999999999999999999753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=295.53 Aligned_cols=198 Identities=33% Similarity=0.595 Sum_probs=168.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhH------HHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGE------LQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
.++|++.+.||+|+||+||+|++. +++.||+|++......... ..+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888899999999999999975 7899999998654322221 56889999999999999999999987654
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCc-----eE
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFE-----AV 432 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~k 432 (511)
++||||+++|+|.+++.... .++++..+..++.|++.||+|||+. + ++||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999887643 2489999999999999999999999 8 999999999999988876 99
Q ss_pred EcccccccccCCCCCceeeecccccccccccccc--cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+|||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999974332 234456999999999984 445788999999999999999999999743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=310.67 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=177.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||.||++.+. ++..||+|+++..........+.+|++++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467888999999999999999986 7899999999876555556679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+++++|.++++... .+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998754 3899999999999999999999832 7999999999999999999999999999754322
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123346899999999999999999999999999999999999999753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=297.80 Aligned_cols=201 Identities=17% Similarity=0.241 Sum_probs=174.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 363 (511)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.++.++ +|+|++++++++......+++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 346788999999999999999996 4789999999864432 23478899999999 799999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc-----eEEccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGL 438 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~ 438 (511)
|||+ +++|.++++.... ++++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 9999999987532 489999999999999999999999 9999999999999987776 99999999
Q ss_pred ccccCCCCCc------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 9876543221 223456999999999999989999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=301.31 Aligned_cols=202 Identities=26% Similarity=0.345 Sum_probs=168.3
Q ss_pred hCCCCC-CeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEe
Q 010429 288 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+.|.+. +.||+|+||+||+|... +++.||||+++... ......+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 567774 78999999999999965 78999999997543 33456788999999884 7999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---eEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~ 441 (511)
||+++|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999998753 389999999999999999999999 9999999999999998776 99999999876
Q ss_pred cCCCCC------ceeeeccccccccccccccc-----CCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 442 MDYKDT------HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 442 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 532211 11223459999999999875 457889999999999999999999997543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.97 Aligned_cols=203 Identities=19% Similarity=0.245 Sum_probs=167.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCC------CCEEEEEEecccccchh-H---------HHHHHHHHHHHhCCCCceec
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGG-E---------LQFQTEVEMISMAVHRNLLR 349 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-~---------~~~~~e~~~l~~~~h~niv~ 349 (511)
..++|.+.+.||+|+||.||+|.+.. ++.||||++........ + ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578899999999999999998764 47899999865432110 0 12334556677888999999
Q ss_pred cccccccC----CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 010429 350 LRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 425 (511)
Q Consensus 350 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 425 (511)
+++++... ...++||||+ +++|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998765 4479999999 999999998743 2499999999999999999999999 99999999999999
Q ss_pred C--CCCceEEcccccccccCCCCCc------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 426 D--EEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 426 ~--~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9 8899999999999876432211 11334599999999999999999999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=313.34 Aligned_cols=200 Identities=23% Similarity=0.319 Sum_probs=167.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC-----Cc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 359 (511)
.++|.+.+.||+|+||.||+|++. +++.||||+++... ......++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 68899999997543 233456789999999999999999999998765 56
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++||||++ ++|.++++... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 69999997642 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---------------------ceeeeccccccccccccc-ccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 440 KLMDYKDT---------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 440 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
+....... .......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87643321 122456699999999986 45668999999999999999999766664
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=294.45 Aligned_cols=201 Identities=25% Similarity=0.371 Sum_probs=174.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|.+.+.||+|+||.||+++.. +++.||+|+++..... .....+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467888999999999999999986 6899999998654322 1356789999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----ceEEccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 436 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 436 (511)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997643 389999999999999999999999 999999999999999877 8999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 9998654322 223445899999999999888999999999999999999999999643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=297.35 Aligned_cols=203 Identities=27% Similarity=0.434 Sum_probs=174.5
Q ss_pred hhCCCCCC-eeccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|.+.+ .||+|+||.||+|.+. ++..||||+++.........++.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566665 8999999999999864 57789999998765555667799999999999999999999998 5567899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999997532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 443 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
....... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 5433222 122346889999999988889999999999999999999 99999753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=301.38 Aligned_cols=199 Identities=30% Similarity=0.434 Sum_probs=173.8
Q ss_pred CCCCCeeccccccEEEEEEeC-----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC--CceeE
Q 010429 290 FSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 362 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 362 (511)
|++.+.||+|+||+||++.+. +++.||||+++..........+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988643 68899999998766555667799999999999999999999999874 56789
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
||||+++|+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999997643 89999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... ......+|..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 544322 123345788999999999888999999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=307.37 Aligned_cols=200 Identities=24% Similarity=0.337 Sum_probs=167.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCC--CceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~lv 363 (511)
.++|++.+.||+|+||.||++...+++.||||+++.... ......+.+|++++.+++| +||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 456888999999999999999998899999999875432 3334568999999999987 9999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|| +.+++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 56889999998753 389999999999999999999999 999999999999997 5689999999998765
Q ss_pred CCCCc-eeeeccccccccccccccc-----------CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 43222 2334569999999999865 6678899999999999999999999964
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=303.54 Aligned_cols=203 Identities=29% Similarity=0.507 Sum_probs=169.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeCC-----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.++|...+.||+|+||.||+|.+.. +..||||.++..........+.+|++++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778899999999999998642 23599999987655555667999999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+||||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999986432 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 442 MDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 6433221 1222336789999999998899999999999999999999 9999964
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=295.26 Aligned_cols=197 Identities=33% Similarity=0.545 Sum_probs=162.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccc---hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|+..+.||+|+||.||+|.+. ++.||||+++..... .....+.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888899999999999999986 899999998654322 2245688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEecCCCCCCeeeCC--------CCceE
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK---IIHRDVKAANILLDE--------EFEAV 432 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~k 432 (511)
|||+++++|.++++.. .+++..+..++.|+++||+|||++ + ++||||||+||+++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999998642 489999999999999999999999 7 999999999999986 67899
Q ss_pred EcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|+|||++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 157 l~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred EccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999976543222 234589999999999998899999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=305.73 Aligned_cols=201 Identities=23% Similarity=0.365 Sum_probs=173.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC-----Cce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 360 (511)
.++|++.+.||+|+||.||+|++. ++..||||++...........+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357899999999999999999876 68899999997655555556789999999999999999999998654 367
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||++ |+|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 5899988764 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
......... .....||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 765332211 2334699999999987554 4899999999999999999999999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=294.01 Aligned_cols=197 Identities=24% Similarity=0.368 Sum_probs=171.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC--CceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 363 (511)
.++|.+.+.||+|+||.||+|+++ ++.||||+++... .......+.+|+.++++++||||+++++++... ...+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467888999999999999999986 8899999997654 233455689999999999999999999999876 778999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
|||+++|+|.++++.... ..+++..+..++.|+++||+|||+. + ++||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986432 2489999999999999999999998 7 99999999999999999999999988754
Q ss_pred cCCCCCceeeecccccccccccccccCCCCc---ccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.... ...||+.|+|||.+.+...+. ++||||||+++|||++|+.||..
T Consensus 163 ~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 163 FQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp TSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred eccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 3221 235899999999998765544 79999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=315.94 Aligned_cols=202 Identities=15% Similarity=0.159 Sum_probs=162.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHH---HHHHhCCCCceeccccc-------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEV---EMISMAVHRNLLRLRGF------- 353 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~---~~l~~~~h~niv~l~~~------- 353 (511)
.++|.+.+.||+|+||.||+|++. +|+.||||+++... .......+.+|+ +.+++++||||+++++.
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 356888899999999999999974 68999999997432 233456788999 45556689999999844
Q ss_pred cccCC-----------------ceeEEeecccCCCHHHHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 010429 354 CMTPT-----------------ERLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413 (511)
Q Consensus 354 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 413 (511)
+..++ ..+++|||+ +|+|.++++..... ...+++..+..|+.|+++||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 33332 278999999 68999999864321 11244688889999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeecccccccccccccccC-----------CCCcccCeehhhHH
Q 010429 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVM 482 (511)
Q Consensus 414 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gvi 482 (511)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985322 3344567 999999999887 78999999999999
Q ss_pred HHHHHhCCCcccccc
Q 010429 483 LLELITGQRAFDLAR 497 (511)
Q Consensus 483 l~elltg~~pf~~~~ 497 (511)
+|||++|+.||....
T Consensus 303 l~elltg~~Pf~~~~ 317 (377)
T 3byv_A 303 IYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHSSCCC----
T ss_pred HHHHHHCCCCCcccc
Confidence 999999999997543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=310.88 Aligned_cols=200 Identities=24% Similarity=0.331 Sum_probs=168.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccc-cchhHHHHHHHHHHHHhCC--CCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~~~lv 363 (511)
..+|.+.+.||+|+||.||++...+++.||||++.... .......+.+|++++.+++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35688999999999999999998889999999996543 2334567899999999997 59999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|| +.+++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 56889999998754 388999999999999999999999 999999999999996 5799999999998765
Q ss_pred CCCCc-eeeeccccccccccccccc-----------CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 43222 2334569999999999865 3678899999999999999999999964
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=304.30 Aligned_cols=203 Identities=29% Similarity=0.500 Sum_probs=168.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.++|++.+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367888999999999999999875 444 358888766555556778999999999999999999999988654 78
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++||+.+|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999987533 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 442 MDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 643322 12223446889999999999999999999999999999999 99999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.39 Aligned_cols=202 Identities=23% Similarity=0.367 Sum_probs=163.8
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-------chhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
...++|.+.+.||+|+||+||+|.+. +++.||||++..... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999876 688999999865431 111224789999999999999999999975
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---ceEE
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 433 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 433 (511)
.+..++||||+++|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++ .+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 455899999999999998886543 489999999999999999999999 999999999999997544 5999
Q ss_pred cccccccccCCCCCceeeeccccccccccccccc---CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999999876432 22344569999999999853 56788999999999999999999999743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=304.76 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=165.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-hHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
..++|.+.+.||+|+||+||+|++. +++.||||+++...... ....+.+|++++++++||||+++++++......++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4568999999999999999999875 78899999997544322 234578999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee-----CCCCceEEccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGL 438 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~Dfg~ 438 (511)
|||++ |+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||++ ++++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99997 59999998754 389999999999999999999999 99999999999999 4555699999999
Q ss_pred ccccCCCCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 987653322 223345899999999998754 799999999999999999999999643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=302.37 Aligned_cols=202 Identities=26% Similarity=0.406 Sum_probs=170.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.++|++.+.||+|+||.||++++. +|+.||+|++...... .....+.+|++++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888899999999999999986 5899999998654433 23455789999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||++++++.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988766433 389999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222 22344589999999999775 6789999999999999999999999644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=308.96 Aligned_cols=202 Identities=35% Similarity=0.525 Sum_probs=162.5
Q ss_pred CCCCCCeeccccccEEEEEEeC--CC--CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc-CCceeEE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT--DG--SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLV 363 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv 363 (511)
.|...+.||+|+||.||+|++. ++ ..||||.++.........++.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999864 22 36899999765555666789999999999999999999998654 5678999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++|+|.++++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999976432 478999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 444 YKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 444 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
..... ......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 32211 1223447889999999999999999999999999999999 78888643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=299.63 Aligned_cols=206 Identities=21% Similarity=0.352 Sum_probs=167.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|.+.+.||+|+||.||+|... +|+.||+|+++... ......++.+|++++++++||||+++++++...+..+++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 356888999999999999999974 78999999997532 233455688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.........+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999986443444589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 3322 223345899999999999988999999999999999999999999643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.20 Aligned_cols=202 Identities=35% Similarity=0.519 Sum_probs=170.0
Q ss_pred hCCCCCCeeccccccEEEEEEeCC----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccc-cCCceeE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLL 362 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~-~~~~~~l 362 (511)
.+|.+.+.||+|+||+||+|.+.+ +..+|+|.++..........+.+|++++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998642 23589999987665566677999999999999999999999854 4567899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+++|+|.++++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC---ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 43221 12233457889999999999999999999999999999999 6666654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.94 Aligned_cols=209 Identities=21% Similarity=0.288 Sum_probs=171.1
Q ss_pred CHHHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccc----------hhHHHHHHHHHHHHhCCCCcee
Q 010429 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ----------GGELQFQTEVEMISMAVHRNLL 348 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~~~h~niv 348 (511)
...++....++|.+.+.||+|+||.||+|.+.+|..||||++...... .....+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456777888999999999999999999999888999999998653321 1135689999999999999999
Q ss_pred cccccccc-----CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 010429 349 RLRGFCMT-----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (511)
Q Consensus 349 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 423 (511)
++++++.. ....++||||++ |+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 99999843 345799999997 68888887532 2489999999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999997543322 2234458999999999877 66899999999999999999999999754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=298.86 Aligned_cols=198 Identities=31% Similarity=0.488 Sum_probs=164.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
.++|++.+.||+|+||+||++++. ++.||||++... .....+.+|++++++++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 356788899999999999999986 789999998643 345578999999999999999999998874 57999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc-eEEcccccccccCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~ 445 (511)
+++|+|.++++.... ...+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999986432 234789999999999999999999932128999999999999998886 799999999755322
Q ss_pred CCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 1233589999999999998999999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=295.84 Aligned_cols=202 Identities=23% Similarity=0.322 Sum_probs=173.2
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 362 (511)
..++|++.+.||+|+||+||+|.+. +++.||+|+++... ......++.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467889999999999999999986 78999999997543 233456688999999998 89999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC--------------
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-------------- 428 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------- 428 (511)
||||+++++|.+++.........+++..+..++.|+++||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999987543334589999999999999999999999 99999999999999844
Q ss_pred -----CceEEcccccccccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 429 -----FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 429 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|||++|++|+..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999998765432 23489999999999766 567899999999999999999988753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=303.42 Aligned_cols=203 Identities=28% Similarity=0.365 Sum_probs=167.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchh----HHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
..++|.+.+.||+|+||.||+|++. +|+.||||+++....... ...+.+|++++++++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3468999999999999999999986 689999999975432211 23578999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999976 8888887543 2488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 7643322 23345689999999998764 4789999999999999999999999653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=303.36 Aligned_cols=204 Identities=29% Similarity=0.492 Sum_probs=171.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCE--EEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSL--VAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 363 (511)
++|.+.+.||+|+||.||+|++. ++.. +|+|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67888999999999999999875 4554 4999987655455556789999999999 899999999999999999999
Q ss_pred eecccCCCHHHHHHhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 364 YPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
|||+++|+|.+++.... .....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999998754 2334589999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 999999997433211 1122346889999999988889999999999999999998 99999643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=309.12 Aligned_cols=202 Identities=21% Similarity=0.313 Sum_probs=167.3
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC-----
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 357 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~----- 357 (511)
+...++|.+.+.||+|+||+||+|.+. +|+.||||++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999874 7899999998654322 34799999999999999999988443
Q ss_pred ---------------------------------CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010429 358 ---------------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404 (511)
Q Consensus 358 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 404 (511)
...++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 33789999997 58888877643344469999999999999999999
Q ss_pred HHhCCCCCeEecCCCCCCeeeC-CCCceEEcccccccccCCCCCceeeecccccccccccccccCC-CCcccCeehhhHH
Q 010429 405 LHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVM 482 (511)
Q Consensus 405 LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvi 482 (511)
||+. +|+||||||+||+++ +++.+||+|||+++....... .....||+.|+|||.+.+.. ++.++||||+||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999997 688999999999987643322 23345899999999987654 8999999999999
Q ss_pred HHHHHhCCCccccc
Q 010429 483 LLELITGQRAFDLA 496 (511)
Q Consensus 483 l~elltg~~pf~~~ 496 (511)
+|||++|+.||...
T Consensus 232 l~ell~g~~pf~~~ 245 (383)
T 3eb0_A 232 FGELILGKPLFSGE 245 (383)
T ss_dssp HHHHHHSSCSSCCS
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.25 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=174.0
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
..++|.+.+.||+|+||+||+++.. +++.||||++.... .......+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999986 78999999986433 233456789999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC---CCCceEEccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 440 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~ 440 (511)
|||+++|+|.+.+.... .+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999887654 389999999999999999999999 999999999999995 45679999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... ......||+.|+|||++.+ .++.++||||+||++|||++|++||...
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 664332 2334569999999999875 5889999999999999999999999643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=302.63 Aligned_cols=206 Identities=23% Similarity=0.379 Sum_probs=177.6
Q ss_pred HHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-------hhHHHHHHHHHHHHhC-CCCceeccc
Q 010429 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMA-VHRNLLRLR 351 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~~-~h~niv~l~ 351 (511)
.......++|.+.+.||+|+||.||+|++. +|+.||||+++..... .....+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999986 7999999998654311 1134578899999998 799999999
Q ss_pred cccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 352 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 352 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
+++......++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999998653 389999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeeccccccccccccccc------CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999999987654322 234569999999999863 3578899999999999999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=328.23 Aligned_cols=206 Identities=28% Similarity=0.448 Sum_probs=177.2
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
.+++..++|.+.+.||+|+||.||+|.+.++..||||+++.... ...++.+|++++++++|+||+++++++.+ ...+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34456678889999999999999999998778899999976542 34568999999999999999999999876 6789
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+||||+++|+|.++++.... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 99999999999999975321 2389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
.............++..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 54321111223346789999999998899999999999999999999 9999964
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=295.82 Aligned_cols=202 Identities=32% Similarity=0.498 Sum_probs=162.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
+..++|++.+.||+|+||+||+|++. ..||+|+++.... ......+.+|++++++++||||++++++. .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 44578999999999999999999875 3599999975542 33456789999999999999999999965 55678999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999997543 2489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC-Cceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKD-THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 322 22233456899999999986 55678899999999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.52 Aligned_cols=202 Identities=27% Similarity=0.410 Sum_probs=170.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccC--------
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 357 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-------- 357 (511)
++|++.+.||+|+||.||+|++. +|+.||+|++..... ......+.+|++++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57889999999999999999985 789999999865432 22344678999999999999999999998763
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
+..++||||+++ ++.+.+..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 77777765432 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC---Cceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKD---THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 998764321 222234568999999999876 45799999999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=305.83 Aligned_cols=197 Identities=26% Similarity=0.373 Sum_probs=154.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccC------C
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~ 358 (511)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ......++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999865 68899999996543 233455688999999999999999999988654 5
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++++||+ +++|.++++.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 78998888652 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9765422 234568999999999877 67899999999999999999999999653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=296.37 Aligned_cols=199 Identities=26% Similarity=0.435 Sum_probs=173.3
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|.+.+.||+|+||.||+++.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+....+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 3467889999999999999999976 789999999975432 23446889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 441 (511)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++ +.++.+||+|||++..
T Consensus 86 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 9999999999987654 389999999999999999999999 99999999999999 7888999999999875
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 159 EQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp CCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4322 12334589999999999998899999999999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.73 Aligned_cols=201 Identities=27% Similarity=0.376 Sum_probs=172.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc------------hhHHHHHHHHHHHHhCCCCceecccc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ------------GGELQFQTEVEMISMAVHRNLLRLRG 352 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~~~h~niv~l~~ 352 (511)
..++|.+.+.||+|+||+||+|+.. ++..||+|+++..... .....+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999986 6789999998754321 23456889999999999999999999
Q ss_pred ccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC---
Q 010429 353 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF--- 429 (511)
Q Consensus 353 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 429 (511)
++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999987753 389999999999999999999999 999999999999999876
Q ss_pred ceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|++||...
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 69999999998765432 233456999999999986 46899999999999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.19 Aligned_cols=208 Identities=30% Similarity=0.447 Sum_probs=174.5
Q ss_pred HhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
..++|.+.+.||+|+||.||+|++ .++..||||++..........++.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999984 25778999999765555666679999999999999999999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEE
Q 010429 360 RLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVV 433 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 433 (511)
.++||||+++++|.+++...... ...+++..+..++.|+++||+|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999875432 23489999999999999999999999 9999999999999994 446999
Q ss_pred cccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 434 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
+|||++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 99999975533221 22233457899999999998899999999999999999998 99999643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=299.62 Aligned_cols=206 Identities=30% Similarity=0.410 Sum_probs=172.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccc----cCCce
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTER 360 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~----~~~~~ 360 (511)
..++|.+.+.||+|+||.||+++. .+++.||||++.... ......+.+|++++++++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 456899999999999999999997 478999999986532 344567899999999999999999999987 34578
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++|+|.+++.........+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999987544455699999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc--------eeeecccccccccccccccCC---CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDTH--------VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 54321110 011234799999999987554 68899999999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=317.33 Aligned_cols=201 Identities=28% Similarity=0.422 Sum_probs=176.4
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
..++|.+.+.||+|+||.||+++.. +|+.||||++..... ......+.+|++++++++||||+++++++......++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467899999999999999999986 789999999865432 3345678999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCceEEcccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 439 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 439 (511)
||||+.+|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999987643 389999999999999999999999 99999999999999 56789999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+....... .....||+.|+|||++.+ .++.++||||+||++|||++|++||...
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 87654322 234569999999999866 6889999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.44 Aligned_cols=210 Identities=27% Similarity=0.404 Sum_probs=159.2
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCcee
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 361 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 361 (511)
+.+..++|.+.+.||+|+||.||+|.+. +++.||||++..........++.+|++++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455678999999999999999999875 688999999876554445567889999999999999999999999999999
Q ss_pred EEeecccCCCHHHHHHhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 362 LVYPFMVNGSVASCLRER----GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
+||||+++++|.+++... ......+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998752 11233589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC----ceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9976543221 12233468999999999876 5678999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=291.35 Aligned_cols=201 Identities=26% Similarity=0.452 Sum_probs=168.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|++++++++||||+++++++...+..+++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467888999999999999999986 78999999986543 122345688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++.... .+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998753 389999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||+..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 322 2233458999999999987765 68999999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.14 Aligned_cols=198 Identities=23% Similarity=0.290 Sum_probs=162.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 358 (511)
.++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367889999999999999999875 68899999996543 2334456889999999999999999999987654
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 6799999996 478887753 289999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 1223456899999999999988999999999999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=295.63 Aligned_cols=205 Identities=21% Similarity=0.302 Sum_probs=160.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHH-HHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
..++|++.+.||+|+||+||++++. +|+.||+|+++.........+ +.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3567889999999999999999975 789999999976544443333 44445557888999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||++ |+|.+++.........+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 5888887764333446999999999999999999999853 89999999999999999999999999997654
Q ss_pred CCCCceeeeccccccccccccc----ccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||+.
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 3322 2234589999999996 456688999999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.20 Aligned_cols=211 Identities=22% Similarity=0.303 Sum_probs=176.9
Q ss_pred CHHHHHHHhhCCCCC-CeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCC-CCceecccccc
Q 010429 279 SLRELQVATDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV-HRNLLRLRGFC 354 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~-h~niv~l~~~~ 354 (511)
.+...+...++|.+. +.||+|+||.||+|... +++.||+|+++.... ......+.+|+.++.++. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344445566777777 88999999999999876 689999999975442 233567889999999985 69999999999
Q ss_pred ccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCce
Q 010429 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEA 431 (511)
Q Consensus 355 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~ 431 (511)
......++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999886532 23489999999999999999999999 9999999999999998 7899
Q ss_pred EEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998764322 223456999999999999999999999999999999999999999643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.60 Aligned_cols=195 Identities=27% Similarity=0.439 Sum_probs=165.9
Q ss_pred eeccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccCCC
Q 010429 295 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
.||+|+||.||+|.+. ++..||||+++.........++.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4567999999876555567789999999999999999999999876 56899999999999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCcee-
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT- 450 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~- 450 (511)
|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 999997542 3489999999999999999999999 999999999999999999999999999987643322211
Q ss_pred -eecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 451 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 451 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22235689999999999999999999999999999998 99999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=291.20 Aligned_cols=196 Identities=30% Similarity=0.449 Sum_probs=168.9
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc----CCceeE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLL 362 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~l 362 (511)
.|.+.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999875 68899999987544 33445668999999999999999999998765 355799
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeC-CCCceEEcccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLA 439 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a 439 (511)
||||+++++|.+++.... .+++..+..++.|+++||+|||+. + ++||||||+||+++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999998753 389999999999999999999998 7 99999999999998 7889999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||..
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 754432 223456999999999886 4588999999999999999999999964
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=315.43 Aligned_cols=200 Identities=28% Similarity=0.411 Sum_probs=169.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.++|.+.+.||+|+||+||+|+.. ++..||+|+++... .......+.+|++++++++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999986 78899999997543 2233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~ 441 (511)
||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887653 389999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..... ......||+.|+|||++. +.++.++||||+||++|||++|++||...
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 65332 233456999999999886 56899999999999999999999999643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=292.87 Aligned_cols=199 Identities=29% Similarity=0.436 Sum_probs=169.0
Q ss_pred CCCCCCeeccccccEEEEEEeC-C---CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce-eEE
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-D---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-LLV 363 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~-~lv 363 (511)
.|...+.||+|+||+||+|.+. + +..||+|.++..........+.+|++++++++||||+++++++...+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455688999999999999853 2 2379999998665555667799999999999999999999999876655 999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+.+|+|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997633 2489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC---CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcc
Q 010429 444 YKD---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493 (511)
Q Consensus 444 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf 493 (511)
... ........+++.|+|||.+.+..++.++||||||+++|||++|..||
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 321 12223345789999999999999999999999999999999955554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=300.34 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=171.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC-----Cce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 360 (511)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.........++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999976 68899999997655555566788999999999999999999987654 678
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||+. ++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 6899988763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---------eeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTH---------VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 76432211 1123468999999998765 67899999999999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=311.31 Aligned_cols=198 Identities=28% Similarity=0.424 Sum_probs=163.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC------Cce
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 360 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~ 360 (511)
.+|...+.||+|+||.||+|++. +|+.||||++..... ...+|++++++++||||+++++++... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35788899999999999999986 689999999865432 134799999999999999999988542 235
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 439 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 439 (511)
++||||+++ ++.+.+.........+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999975 66666654333334599999999999999999999999 99999999999999965 57899999999
Q ss_pred cccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 87643322 2335689999999998765 6899999999999999999999999753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.38 Aligned_cols=203 Identities=29% Similarity=0.419 Sum_probs=175.2
Q ss_pred hhCCCCCCeeccccccEEEEEEe-----CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccc--cCCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~ 359 (511)
.++|++.+.||+|+||.||++++ .+++.||||++.... ......+.+|++++++++||||+++++++. +...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 46788899999999999999984 368899999997643 344556899999999999999999999876 4456
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++||||+++++|.++++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 8899999999999999987432 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 8765433221 22344788899999999888999999999999999999999999643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=295.19 Aligned_cols=200 Identities=28% Similarity=0.412 Sum_probs=171.0
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ....+.+|++++.+++||||+++++++......+++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567889999999999999999986 58999999997543 2346889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999997533 2489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 222 22344589999999999998899999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.16 Aligned_cols=213 Identities=27% Similarity=0.444 Sum_probs=168.0
Q ss_pred HHHHHHhhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccc
Q 010429 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 355 (511)
.+.....++|.+.+.||+|+||.||+|.+. ++..||+|+++... .......+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344456678999999999999999999764 34589999997543 2334456899999999999999999999988
Q ss_pred cCCc-----eeEEeecccCCCHHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 010429 356 TPTE-----RLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (511)
Q Consensus 356 ~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 428 (511)
.... .+++|||+++|+|.+++.... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7543 499999999999999986532 2334599999999999999999999999 99999999999999999
Q ss_pred CceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 429 FEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 429 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
+.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 9999999999986643322 12233447889999999999999999999999999999999 99999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=295.83 Aligned_cols=203 Identities=26% Similarity=0.399 Sum_probs=171.1
Q ss_pred HhhCCCCCC-eeccccccEEEEEEeC---CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 286 ATDNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 286 ~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
..++|.+.+ .||+|+||.||+|.+. +++.||||+++.... .....++.+|++++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 9999999999999642 467899999975432 23356799999999999999999999998 56778
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++++|.++++... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999998743 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcee--eecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 441 LMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 7654433222 22336789999999988889999999999999999999 99999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.64 Aligned_cols=195 Identities=26% Similarity=0.387 Sum_probs=168.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CC-------CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DG-------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 358 (511)
.++|.+.+.||+|+||+||+|++. ++ ..||+|++.... ......+.+|++++++++||||+++++++..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 467888899999999999999865 23 479999996543 344567999999999999999999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--------
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-------- 430 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------- 430 (511)
..++||||+++|+|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999987432 389999999999999999999999 9999999999999998887
Q ss_pred eEEcccccccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcc
Q 010429 431 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAF 493 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf 493 (511)
+||+|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 999999998654321 23448899999999987 66899999999999999999955444
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=291.30 Aligned_cols=202 Identities=21% Similarity=0.276 Sum_probs=168.0
Q ss_pred HhhCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccc-ccCCceeEE
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLV 363 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~-~~~~~~~lv 363 (511)
..++|++.+.||+|+||.||+|++ .+++.||||++...... .++.+|++++++++|++++..+.++ ...+..+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999997 47889999987543322 2478899999999998877766655 556778999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCceEEccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 440 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 440 (511)
|||+ +++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 9999999985432 389999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCCc------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 441 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 441 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 76543221 2234568999999999999999999999999999999999999997543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=307.37 Aligned_cols=198 Identities=20% Similarity=0.262 Sum_probs=171.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC------CCCceeccccccccCCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA------VHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~------~h~niv~l~~~~~~~~~ 359 (511)
..+|++.+.||+|+||+||+|.+. +++.||||+++... ....++.+|+++++.+ +|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457889999999999999999876 58899999997542 3344577788877766 57799999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc--eEEcccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFG 437 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg 437 (511)
.+++|||+. ++|.+++...... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999995 6899998875432 389999999999999999999999 9999999999999999987 9999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99764332 22346899999999999999999999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=290.18 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=170.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|.....||+|+||.||+|.+. ++..||||.++... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34555678999999999999975 68899999987543 33455688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-CCceEEcccccccccCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~ 445 (511)
+++++|.+++..... ...+++..+..++.|+++||+|||+. +++||||||+||+++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999987532 23467899999999999999999999 9999999999999987 889999999999866432
Q ss_pred CCceeeecccccccccccccccCC--CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.. ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 22 223445899999999987654 78899999999999999999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.13 Aligned_cols=204 Identities=23% Similarity=0.347 Sum_probs=170.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCceeccccccc--cCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~~ 360 (511)
.++|.+.+.||+|+||.||++.+. +++.||+|+++.... ......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999975 688999999975431 234567999999999999999999999984 45678
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||++++ +.+++..... ..+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999877 7777766432 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CceeeecccccccccccccccCC--CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKD-THVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... ........||+.|+|||++.+.. .+.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 765322 22333456899999999987644 377999999999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=304.83 Aligned_cols=201 Identities=20% Similarity=0.241 Sum_probs=164.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccch----------hHHHHHHHHHHHHhCCCCceecccc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRNLLRLRG 352 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~~~h~niv~l~~ 352 (511)
.++|.+.+.||+|+||.||+|.+. ++..+|+|++....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999975 57789999987543211 1123567888899999999999999
Q ss_pred cccc----CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 010429 353 FCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (511)
Q Consensus 353 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 428 (511)
++.. ....++||||+ +++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 67889999999 999999998654 489999999999999999999999 99999999999999988
Q ss_pred C--ceEEcccccccccCCCCCc------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 429 F--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 429 ~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 9999999999876432111 11334689999999999998899999999999999999999999964
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.25 Aligned_cols=198 Identities=12% Similarity=0.060 Sum_probs=151.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhC--CCCceecccccc-------c
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA--VHRNLLRLRGFC-------M 355 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~--~h~niv~l~~~~-------~ 355 (511)
.+|...+.||+|+||.||+|++. +|+.||||+++.... ......+.+|+++++.+ +||||++++..+ .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45788899999999999999976 789999999976542 23344577785444443 699988755332 2
Q ss_pred cC-----------------CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 010429 356 TP-----------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGAARGLAYLHDHCDPK 412 (511)
Q Consensus 356 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ 412 (511)
.+ ...++||||++ |+|.++++.... .+.+..+ ..++.|+++||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 11 33799999998 899999987532 2455555 77889999999999999 9
Q ss_pred eEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeeccccccccccccccc--CCCCcccCeehhhHHHHHHHhCC
Q 010429 413 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQ 490 (511)
Q Consensus 413 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~ 490 (511)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 2224457799999999987 67899999999999999999999
Q ss_pred Cccccc
Q 010429 491 RAFDLA 496 (511)
Q Consensus 491 ~pf~~~ 496 (511)
.||...
T Consensus 291 ~Pf~~~ 296 (371)
T 3q60_A 291 LPFGLV 296 (371)
T ss_dssp CSTTBC
T ss_pred CCCCCc
Confidence 999865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=295.60 Aligned_cols=192 Identities=22% Similarity=0.319 Sum_probs=168.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceecccccccc--CCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~--~~~~~lv 363 (511)
++|++.+.||+|+||+||+|++. +++.||||+++... ...+.+|++++++++ ||||+++++++.. ....+++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 67888999999999999999874 78999999997432 346889999999997 9999999999987 5678999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEccccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 442 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 442 (511)
|||+++++|.++++. +++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999998864 78999999999999999999999 999999999999999776 8999999999876
Q ss_pred CCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 54332 233458999999999877 6689999999999999999999999953
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=290.70 Aligned_cols=201 Identities=21% Similarity=0.276 Sum_probs=170.9
Q ss_pred hhCCCCCCeeccccccEEEEEEe-CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccc-ccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~-~~~~~~~lv~ 364 (511)
.++|.+.+.||+|+||.||+|++ .+++.||||++...... .++.+|++++++++|++++..+.++ ......+++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788999999999999999997 47899999998654322 2488999999999998877666655 4566779999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC---CCCceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~ 441 (511)
||+ +++|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 9999999985432 489999999999999999999999 999999999999994 788999999999987
Q ss_pred cCCCCCc------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 442 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 442 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 6543321 1234569999999999999999999999999999999999999998644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.84 Aligned_cols=204 Identities=29% Similarity=0.438 Sum_probs=168.0
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc-----
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT----- 356 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~----- 356 (511)
....++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 345678999999999999999999985 78999999986543 2345688999999998 79999999999876
Q ss_pred -CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcc
Q 010429 357 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (511)
Q Consensus 357 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 435 (511)
....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 457899999999999999998743 22489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
||++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 173 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 173 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999976543221 223345899999999987 55688999999999999999999999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=291.23 Aligned_cols=197 Identities=25% Similarity=0.452 Sum_probs=172.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc--------
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-------- 356 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-------- 356 (511)
...+|+..+.||+|+||.||+|++. +++.||+|+++... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567899999999999999999986 78999999997543 236789999999999999999998754
Q ss_pred --------CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 010429 357 --------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (511)
Q Consensus 357 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 428 (511)
....+++|||+++++|.++++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 3457899999999999999986432 2489999999999999999999999 99999999999999999
Q ss_pred CceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 429 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 429 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
+.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..||.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999999987654322 233458999999999999889999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=301.48 Aligned_cols=201 Identities=25% Similarity=0.394 Sum_probs=174.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccch----------------hHHHHHHHHHHHHhCCCCceecc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG----------------GELQFQTEVEMISMAVHRNLLRL 350 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~e~~~l~~~~h~niv~l 350 (511)
.++|.+.+.||+|+||.||+|.. +++.||+|++....... ....+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788999999999999999999 79999999986443211 11678999999999999999999
Q ss_pred ccccccCCceeEEeecccCCCHHHH------HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCe
Q 010429 351 RGFCMTPTERLLVYPFMVNGSVASC------LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANI 423 (511)
Q Consensus 351 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NI 423 (511)
++++...+..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ . +++||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 4432 13459999999999999999999999 8 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCCceeeecccccccccccccccC-CCCc-ccCeehhhHHHHHHHhCCCccccc
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSE-KTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||...
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999865432 33445689999999999877 5655 999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=296.46 Aligned_cols=201 Identities=25% Similarity=0.377 Sum_probs=167.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-------chhHHHHHHHHHHHHhCCCCceeccccccccC
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 357 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 357 (511)
..++|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999876 678999999865321 11223488999999999999999999998665
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---eEEc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVG 434 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 434 (511)
. .++||||+++++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999887543 489999999999999999999999 9999999999999987664 9999
Q ss_pred ccccccccCCCCCceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 435 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 435 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|||++...... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999865432 2223355899999999974 456789999999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.21 Aligned_cols=202 Identities=26% Similarity=0.400 Sum_probs=164.7
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHh--CCCCceeccccccccC
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP 357 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~~ 357 (511)
........++|++.+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++.. ++||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3344456688999999999999999999986 8999999986432 2334556665554 4899999999998876
Q ss_pred ----CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeeeCCC
Q 010429 358 ----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEE 428 (511)
Q Consensus 358 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~ 428 (511)
...++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 6789999999999999999764 3899999999999999999999752 3389999999999999999
Q ss_pred CceEEcccccccccCCCCCce---eeecccccccccccccccCCCCcc------cCeehhhHHHHHHHhCCC
Q 010429 429 FEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTGKSSEK------TDVFGYGVMLLELITGQR 491 (511)
Q Consensus 429 ~~~kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~Gvil~elltg~~ 491 (511)
+.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||+||..
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence 999999999997664332221 123469999999999987766554 999999999999999933
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=295.44 Aligned_cols=206 Identities=27% Similarity=0.376 Sum_probs=174.5
Q ss_pred cCHHHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHh--CCCCceeccccccc
Q 010429 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCM 355 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~ 355 (511)
.+........++|.+.+.||+|+||.||+|++. ++.||||+++.. ....+.+|.+++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344445667789999999999999999999985 899999999643 23457788888887 78999999999988
Q ss_pred cCC----ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCe
Q 010429 356 TPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--------DHCDPKIIHRDVKAANI 423 (511)
Q Consensus 356 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NI 423 (511)
... ..++||||+++|+|.+++++. .+++..+..++.|+++||+||| +. +|+||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 775 789999999999999999864 3899999999999999999999 77 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCCc---eeeecccccccccccccccCC------CCcccCeehhhHHHHHHHhC-----
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITG----- 489 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvil~elltg----- 489 (511)
+++.++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999876544332 123346899999999987652 34789999999999999999
Q ss_pred -----CCccccc
Q 010429 490 -----QRAFDLA 496 (511)
Q Consensus 490 -----~~pf~~~ 496 (511)
+.||...
T Consensus 259 ~~~~~~~p~~~~ 270 (342)
T 1b6c_B 259 IHEDYQLPYYDL 270 (342)
T ss_dssp BCCCCCCTTTTT
T ss_pred cccccccCcccc
Confidence 7788643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=294.71 Aligned_cols=203 Identities=24% Similarity=0.367 Sum_probs=170.2
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|++++++++||||+++++++..++..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3467889999999999999999986 58899999986543 334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++..... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999876432 389999999999999999999999 999999999999999999999999998754321
Q ss_pred CCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ........||+.|+|||.+. +..++.++||||||+++|||++|+.||...
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 1 11122345899999999983 567889999999999999999999999743
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=299.67 Aligned_cols=201 Identities=30% Similarity=0.467 Sum_probs=161.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHH--HHhCCCCceeccccccc-----cCCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM--ISMAVHRNLLRLRGFCM-----TPTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~~~h~niv~l~~~~~-----~~~~ 359 (511)
.++|++.+.||+|+||.||+|+. +++.||||+++... ...+..|.++ +..++||||+++++.+. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788899999999999999987 58999999996432 2234444444 45689999999987432 3345
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCeeeCCCCceEE
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------DPKIIHRDVKAANILLDEEFEAVV 433 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl 433 (511)
.++||||+++|+|.++++... .++..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 689999999999999997653 588999999999999999999863 238999999999999999999999
Q ss_pred cccccccccCCCC-------Cceeeeccccccccccccccc-------CCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 434 GDFGLAKLMDYKD-------THVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 434 ~Dfg~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999998764322 112224469999999999876 356678999999999999999988885443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.02 Aligned_cols=199 Identities=24% Similarity=0.388 Sum_probs=163.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc------e
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------R 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~------~ 360 (511)
..+|.+.+.||+|+||+||+|++..+..||+|++...... ..+|+++++.++||||+++++++..... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3568889999999999999999987777999988543322 2369999999999999999999865433 7
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCceEEcccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLA 439 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a 439 (511)
++||||++++.+. .+.........+++..++.++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999775444 3332222233589999999999999999999999 999999999999999 7899999999999
Q ss_pred cccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 87643322 2345689999999998765 5899999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.21 Aligned_cols=200 Identities=27% Similarity=0.374 Sum_probs=174.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--------chhHHHHHHHHHHHHhCC-CCceecccccccc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--------QGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 356 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~ 356 (511)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.... ......+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467889999999999999999986 688999999864421 122345789999999996 9999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
....++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999998753 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeecccccccccccccc------cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 9998765432 223456899999999885 44578899999999999999999999964
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=304.12 Aligned_cols=198 Identities=20% Similarity=0.264 Sum_probs=167.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeCC---------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecc-------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTD---------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL------- 350 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l------- 350 (511)
.++|.+.+.||+|+||.||+|++.. ++.||+|++... ..+.+|++++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3678899999999999999999763 789999998654 247799999999999999984
Q ss_pred --------cccccc-CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 010429 351 --------RGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (511)
Q Consensus 351 --------~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 421 (511)
++++.. ....++||||+ +++|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 445544 57789999999 999999998752 12489999999999999999999999 9999999999
Q ss_pred CeeeCCCC--ceEEcccccccccCCCCCc------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcc
Q 010429 422 NILLDEEF--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493 (511)
Q Consensus 422 NIll~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf 493 (511)
||+++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 9999999999866432211 123346999999999999989999999999999999999999999
Q ss_pred ccc
Q 010429 494 DLA 496 (511)
Q Consensus 494 ~~~ 496 (511)
...
T Consensus 269 ~~~ 271 (352)
T 2jii_A 269 TNC 271 (352)
T ss_dssp GGG
T ss_pred ccC
Confidence 754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.61 Aligned_cols=202 Identities=24% Similarity=0.376 Sum_probs=154.7
Q ss_pred hCCCC-CCeeccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccc--cCCcee
Q 010429 288 DNFSN-RNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTERL 361 (511)
Q Consensus 288 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~~~ 361 (511)
+.|.+ .++||+|+||+||+|++. +++.||||++..... ...+.+|++++++++||||+++++++. .....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34555 458999999999999965 578899999975432 235789999999999999999999984 467789
Q ss_pred EEeecccCCCHHHHHHhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----CCCCceE
Q 010429 362 LVYPFMVNGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAV 432 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~k 432 (511)
+||||++ ++|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 57877775421 1223489999999999999999999999 99999999999999 7778999
Q ss_pred EcccccccccCCCCC--ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 433 VGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999987643221 223345689999999999874 4899999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=299.08 Aligned_cols=196 Identities=23% Similarity=0.366 Sum_probs=166.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCce----
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER---- 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~---- 360 (511)
.++|...+.||+|+||.||+|.+. +|+.||||++..... .....++.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999876 689999999975432 23355688999999999999999999999876654
Q ss_pred --eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 361 --LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 361 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 678777643 289999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9755432 234568999999999887 67899999999999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=295.14 Aligned_cols=203 Identities=28% Similarity=0.465 Sum_probs=174.1
Q ss_pred HhhCCCCCCeeccccccEEEEEEe-----CCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC--
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-- 358 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-- 358 (511)
..++|++.+.||+|+||.||++++ .+++.||||++.... ......+.+|++++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 346688889999999999999984 368899999997643 444567999999999999999999999887644
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||||+++++|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 68999999999999999987532 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 439 AKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+.......... .....++..|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 98765443321 1223467889999999988899999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.29 Aligned_cols=209 Identities=23% Similarity=0.379 Sum_probs=175.2
Q ss_pred HHHHHHhhCCCCCCeeccccccEEEEEEeC----CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc
Q 010429 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 356 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 356 (511)
.+.++..++|.+.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 344455678888999999999999999874 245799999876555555667999999999999999999999985
Q ss_pred CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccc
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 436 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 436 (511)
.+..++||||+++|+|.++++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence 4668999999999999999986432 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
|+++..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9998765443333334457889999999998899999999999999999997 99999743
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=298.34 Aligned_cols=208 Identities=22% Similarity=0.334 Sum_probs=160.6
Q ss_pred HHHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc
Q 010429 281 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 359 (511)
Q Consensus 281 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 359 (511)
.......++|.+.+.||+|+||.||+|++. +|+.||||++...... .....+|++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 344566789999999999999999999985 6899999998654322 2246678888889999999999999865433
Q ss_pred -------eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeeeCC-CC
Q 010429 360 -------RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--DHCDPKIIHRDVKAANILLDE-EF 429 (511)
Q Consensus 360 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~ 429 (511)
.++||||+++ ++...+.........+++..+..++.|++.||+||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999976 555555443333445899999999999999999999 87 9999999999999997 89
Q ss_pred ceEEcccccccccCCCCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 999999999987654322 23456899999999986654 799999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=295.93 Aligned_cols=205 Identities=25% Similarity=0.336 Sum_probs=156.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccc--------
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM-------- 355 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~-------- 355 (511)
...+|++.+.||+|+||.||++++. +++.||||++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3457888999999999999999975 78999999985543 344556889999999996 999999999883
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeCCCCceEE
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVV 433 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl 433 (511)
.....+++|||+. |+|.+++..... ..++++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3445789999995 799998876322 22489999999999999999999998 8 999999999999999999999
Q ss_pred cccccccccCCCCCce-----------eeeccccccccccccc---ccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 434 GDFGLAKLMDYKDTHV-----------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+|||+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||...
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999998765432211 1134589999999998 5666889999999999999999999999743
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=319.73 Aligned_cols=195 Identities=27% Similarity=0.416 Sum_probs=164.5
Q ss_pred CeeccccccEEEEEEeC---CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||.||+|.+. .++.||||+++.... .....++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 467899999976443 234567999999999999999999999986 4568899999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc-
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 448 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 448 (511)
|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997643 389999999999999999999999 9999999999999999999999999999876543321
Q ss_pred -eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 449 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 449 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2223346789999999999999999999999999999998 99999643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=290.94 Aligned_cols=198 Identities=29% Similarity=0.486 Sum_probs=165.5
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC-CceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-~~~~lv~ 364 (511)
..++|++.+.||+|+||.||+++.. |+.||||+++... ....+.+|++++++++||||+++++++.+. +..+++|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3567888999999999999999985 8899999997543 345688999999999999999999986554 5789999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++++|.+++..... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999986432 1278899999999999999999999 999999999999999999999999999875443
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
.. ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 22347889999999998889999999999999999998 99999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=301.73 Aligned_cols=200 Identities=23% Similarity=0.278 Sum_probs=169.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC--------CCceeccccccc--
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--------HRNLLRLRGFCM-- 355 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--------h~niv~l~~~~~-- 355 (511)
.++|.+.+.||+|+||+||+|++. +++.||||+++.. ......+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 478999999999999999999875 6889999999753 234456889999998885 788999999987
Q ss_pred --cCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----
Q 010429 356 --TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---- 429 (511)
Q Consensus 356 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 429 (511)
.....++||||+ ++++.+.+..... ..+++..++.++.||++||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 556789999999 5666666655322 24899999999999999999999964 899999999999999775
Q ss_pred ---------------------------------------------ceEEcccccccccCCCCCceeeecccccccccccc
Q 010429 430 ---------------------------------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464 (511)
Q Consensus 430 ---------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~ 464 (511)
.+||+|||++...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999865432 233458999999999
Q ss_pred cccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 465 ~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+.+..++.++|||||||++|||+||+.||....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=294.46 Aligned_cols=203 Identities=28% Similarity=0.458 Sum_probs=170.0
Q ss_pred HhhCCCCCCeeccccccEEEEEEe--CCCCEEEEEEecccccch-hHHHHHHHHHHHHhC---CCCceeccccccc----
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRL--TDGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCM---- 355 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~---- 355 (511)
..++|++.+.||+|+||.||+|++ .+|+.||+|+++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346899999999999999999997 367899999986443221 122356777766655 8999999999987
Q ss_pred -cCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEc
Q 010429 356 -TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 434 (511)
Q Consensus 356 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 434 (511)
.....++||||++ |+|.+++..... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 699999987543 2489999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 435 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 435 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999997654322 223355899999999999888999999999999999999999999743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.03 Aligned_cols=196 Identities=23% Similarity=0.362 Sum_probs=165.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCc-----
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----- 359 (511)
.++|...+.||+|+||.||+|.+. +|+.||||++..... .....++.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888899999999999999975 689999999975432 2334568899999999999999999999887654
Q ss_pred -eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 360 -RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 360 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
.+++|||++ ++|.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 677776642 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9764422 233468999999999877 67899999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=292.39 Aligned_cols=198 Identities=24% Similarity=0.332 Sum_probs=171.9
Q ss_pred hhCCCCCCeeccccccEEEEEEe-C-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCc------eeccccccccCC
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRL-T-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN------LLRLRGFCMTPT 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n------iv~l~~~~~~~~ 358 (511)
.++|++.+.||+|+||.||++.+ . +++.||||+++.. ......+.+|+++++.++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 46889999999999999999987 3 6889999999753 233456888999998887765 999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-----------
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE----------- 427 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----------- 427 (511)
..++||||+ +++|.+++..... .++++..+..++.|+++||+|||++ +|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 8999999987543 2489999999999999999999999 9999999999999987
Q ss_pred --------CCceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 428 --------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 428 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999864432 23346899999999999989999999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.28 Aligned_cols=200 Identities=25% Similarity=0.371 Sum_probs=162.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccc----------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM---------- 355 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~---------- 355 (511)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... .....++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 367888999999999999999987 58899999986543 344567889999999999999999998763
Q ss_pred ----cCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCc
Q 010429 356 ----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFE 430 (511)
Q Consensus 356 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 430 (511)
.....++||||++ |+|.+++++. ++++..+..++.|+++||+|||++ +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3467799999997 6999988642 389999999999999999999999 999999999999997 5679
Q ss_pred eEEcccccccccCCCCC--ceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 431 AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 431 ~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+||+|||+++....... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999999987643211 12233457899999998865 67899999999999999999999999754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=289.02 Aligned_cols=203 Identities=32% Similarity=0.456 Sum_probs=163.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC--CCC--EEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT--DGS--LVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|++.+.||+|+||+||+|++. +++ .||||+++... .......+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467888999999999999999853 333 68999987543 2334567899999999999999999999987754 8
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|||+++++|.+++..... .+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999986432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 765433321 223447889999999988889999999999999999999 99999643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.59 Aligned_cols=200 Identities=21% Similarity=0.289 Sum_probs=170.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCC-ceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~-niv~l~~~~~~~~~~~lv~ 364 (511)
.++|.+.+.||+|+||.||+|++. +++.||||+++..... .++.+|++++..++|+ ++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 467999999999999999999974 7899999988654322 2478899999999875 4555666666778889999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---CCCCceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 441 (511)
||+ +++|.++++.... .+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 9999999986432 489999999999999999999999 99999999999999 5888999999999987
Q ss_pred cCCCCCc------eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 6543321 122456999999999999999999999999999999999999999754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=284.02 Aligned_cols=202 Identities=27% Similarity=0.393 Sum_probs=174.6
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
...++|.+.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 789999999865432 3345678999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC---CceEEcccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLA 439 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a 439 (511)
+|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999887653 389999999999999999999999 99999999999999764 46999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 86543322 223458999999999865 4889999999999999999999999643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.73 Aligned_cols=203 Identities=27% Similarity=0.393 Sum_probs=175.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc------CCc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~ 359 (511)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.........++.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999875 6899999999876555566779999999999999999999998765 677
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCc---eEEccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDF 436 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 436 (511)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999987542 23489999999999999999999999 9999999999999997765 999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 99987654322 2345699999999999999999999999999999999999999964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=295.38 Aligned_cols=202 Identities=24% Similarity=0.315 Sum_probs=169.7
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CC-----ceeccccccccC
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HR-----NLLRLRGFCMTP 357 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~-----niv~l~~~~~~~ 357 (511)
...++|.+.+.||+|+||+||+|.+. +++.||||+++... ....++..|+.+++.++ |+ +|+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34578999999999999999999876 68899999997532 33445777888887775 44 499999999999
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCCceEEcc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGD 435 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D 435 (511)
+..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||++ +.+|+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999995 599999987542 2489999999999999999999952 12899999999999995 477899999
Q ss_pred cccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||++||...
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876432 23356899999999999999999999999999999999999999753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.28 Aligned_cols=204 Identities=25% Similarity=0.402 Sum_probs=164.7
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-----hHHHHHHHHHHHHhC----CCCceeccc
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMA----VHRNLLRLR 351 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~----~h~niv~l~ 351 (511)
+.+...++|.+.+.||+|+||.||+|++. +++.||||+++...... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44556788999999999999999999875 68899999996543221 222366789988888 899999999
Q ss_pred cccccCCceeEEeec-ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCC
Q 010429 352 GFCMTPTERLLVYPF-MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEF 429 (511)
Q Consensus 352 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 429 (511)
+++...+..++++|| +.+++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 78999999998754 389999999999999999999999 999999999999999 889
Q ss_pred ceEEcccccccccCCCCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCcccc
Q 010429 430 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.+||+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999999998765432 234458999999999877665 4589999999999999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=293.56 Aligned_cols=203 Identities=24% Similarity=0.400 Sum_probs=172.7
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch-----hHHHHHHHHHHHHhCC--CCceecccccc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAV--HRNLLRLRGFC 354 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~--h~niv~l~~~~ 354 (511)
.+...++|.+.+.||+|+||.||+|++. +++.||||+++...... ....+.+|++++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445678999999999999999999875 68899999996543221 2234678999999986 59999999999
Q ss_pred ccCCceeEEeecccC-CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC-CCCceE
Q 010429 355 MTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAV 432 (511)
Q Consensus 355 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 432 (511)
..++..++++||+.+ ++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999976 89999998753 389999999999999999999999 999999999999999 788999
Q ss_pred EcccccccccCCCCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCcccc
Q 010429 433 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 433 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
|+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99999998765322 233458999999999887665 7889999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=290.14 Aligned_cols=204 Identities=24% Similarity=0.365 Sum_probs=153.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHH-HHHhCCCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.++|...+.||+|+||.||+|... +|+.||||+++.........++..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999985 789999999976554444555666666 677789999999999999999999999
Q ss_pred ecccCCCHHHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 365 PFMVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 365 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
||+++ +|.+++... ......+++..+..++.|+++||+|||+.. +++||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 787777642 112345899999999999999999999853 79999999999999999999999999997654
Q ss_pred CCCCceeeeccccccccccccc----ccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 322 12233589999999998 456688999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=294.06 Aligned_cols=208 Identities=27% Similarity=0.478 Sum_probs=170.1
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCC
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 358 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 358 (511)
..++.+..++|++.+.||+|+||.||+|++.. .+|+|+++.... ......+.+|+.++++++||||+++++++...+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445566789999999999999999999863 499999875432 222335778999999999999999999999999
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..+++|||+++++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999997643 2489999999999999999999999 999999999999998 67999999999
Q ss_pred ccccCCCC----Cceeeeccccccccccccccc---------CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKD----THVTTAVRGTIGHIAPEYLST---------GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++...... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 87543211 112223458999999999864 34688999999999999999999999743
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=285.12 Aligned_cols=194 Identities=26% Similarity=0.427 Sum_probs=161.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc---------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------- 356 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--------- 356 (511)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. ......+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467889999999999999999975 7899999999643 3345568899999999999999999998754
Q ss_pred ----CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceE
Q 010429 357 ----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432 (511)
Q Consensus 357 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 432 (511)
....++||||+++|+|.++++... ..+++..+..++.|+++||+|||++ +++||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 356789999999999999998643 2378899999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCC-------------CceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHh
Q 010429 433 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELIT 488 (511)
Q Consensus 433 l~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~ellt 488 (511)
|+|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999997654221 1122344589999999999764 68999999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=287.24 Aligned_cols=203 Identities=24% Similarity=0.334 Sum_probs=168.6
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccc-cchhHHHHHHHHHHHHhCC--CCceeccccccccCCce
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTER 360 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~~ 360 (511)
....++|.+.+.||+|+||.||++.+.+++.||||++.... .......+.+|++++.+++ |+||+++++++...+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34557799999999999999999999889999999996543 2334567899999999997 49999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++|| +.+++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++ +.+||+|||+++
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 56889999998753 489999999999999999999999 9999999999999975 799999999998
Q ss_pred ccCCCCCc-eeeeccccccccccccccc-----------CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 441 LMDYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 66433221 2234458999999999865 4678899999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.52 Aligned_cols=199 Identities=26% Similarity=0.326 Sum_probs=156.1
Q ss_pred CCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEeecc
Q 010429 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
.|...+.||+|+||+||.+...+|+.||||++.... ...+.+|++++.++ +||||+++++++.+....++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 344567899999999987766679999999986532 23577899999876 8999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-------------Cce
Q 010429 368 VNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-------------FEA 431 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~ 431 (511)
. |+|.+++......... .++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999875433221 24445678999999999999999 99999999999999754 489
Q ss_pred EEcccccccccCCCCCc---eeeeccccccccccccccc-------CCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 432 VVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||..
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999999876543222 1234569999999999875 568899999999999999999 9999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=296.85 Aligned_cols=194 Identities=18% Similarity=0.172 Sum_probs=162.7
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccc-------cchhHHHHHHHHHHHHhCC---------------
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-------TQGGELQFQTEVEMISMAV--------------- 343 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~~~--------------- 343 (511)
..++|++.+.||+|+||+||+|++ +|+.||||+++... .......+.+|++++++++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788899999999999999998 58999999997543 1223356889999988886
Q ss_pred -----------CCceecccccccc-------------CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 010429 344 -----------HRNLLRLRGFCMT-------------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399 (511)
Q Consensus 344 -----------h~niv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~ 399 (511)
||||+++++++.+ ....++||||+++|++.+.+.+ ..+++..++.++.|++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 6777777777665 6789999999999977666643 2389999999999999
Q ss_pred HHHHHHH-hCCCCCeEecCCCCCCeeeCCCC--------------------ceEEcccccccccCCCCCceeeecccccc
Q 010429 400 RGLAYLH-DHCDPKIIHRDVKAANILLDEEF--------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 458 (511)
Q Consensus 400 ~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~ 458 (511)
.||+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999865432 2369999
Q ss_pred cccccccccCCCCcccCeehhhHH-HHHHHhCCCcccc
Q 010429 459 HIAPEYLSTGKSSEKTDVFGYGVM-LLELITGQRAFDL 495 (511)
Q Consensus 459 y~aPE~~~~~~~~~~~Dv~s~Gvi-l~elltg~~pf~~ 495 (511)
|+|||++.+.. +.++||||++++ .+++++|..||..
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99999998766 889999998777 8889999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=289.28 Aligned_cols=198 Identities=25% Similarity=0.308 Sum_probs=146.8
Q ss_pred HhhCCCCCC-eeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc----CCc
Q 010429 286 ATDNFSNRN-ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTE 359 (511)
Q Consensus 286 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~ 359 (511)
..++|.+.+ .||+|+||+||+|.+. +++.||||++.... ....+....+..+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 346788754 6999999999999986 78999999986432 112223334667899999999999876 445
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEEccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 436 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 436 (511)
.++||||+++|+|.+++..... ..+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 7999999999999999987532 3489999999999999999999999 9999999999999986 445999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 999765432 223345899999999998888999999999999999999999999654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=289.83 Aligned_cols=199 Identities=21% Similarity=0.308 Sum_probs=169.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CC-CEEEEEEecccccchhHHHHHHHHHHHHhCCCCc------eeccccccccC
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DG-SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN------LLRLRGFCMTP 357 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n------iv~l~~~~~~~ 357 (511)
..++|.+.+.||+|+||+||++.+. ++ ..||+|+++.. ......+.+|++++++++|++ ++.+.+++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3468999999999999999999875 34 68999999753 233456888999999888766 88899999989
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee------------
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------------ 425 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll------------ 425 (511)
+..++||||+ ++++.+++..... .++++..+..++.|+++||+|||++ +|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 9999999999 6677777765432 2489999999999999999999999 99999999999999
Q ss_pred -------CCCCceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 426 -------DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 426 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999864432 23346899999999999989999999999999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=293.12 Aligned_cols=200 Identities=22% Similarity=0.329 Sum_probs=167.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-----------CCceecccccc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----------HRNLLRLRGFC 354 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~niv~l~~~~ 354 (511)
.++|.+.+.||+|+||+||+|++. +++.||||+++... .....+.+|++++++++ |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 357889999999999999999974 78899999997532 33456788999888876 88999999998
Q ss_pred ccCC----ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC----
Q 010429 355 MTPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---- 426 (511)
Q Consensus 355 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---- 426 (511)
.... ..+++|||+ +++|.+++...... .+++..+..++.|++.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7654 688999999 99999999875432 3899999999999999999999954 899999999999994
Q ss_pred --CCCceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 427 --EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 427 --~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999866432 223458999999999999999999999999999999999999997543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.97 Aligned_cols=194 Identities=22% Similarity=0.313 Sum_probs=168.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC--CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCc-----
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----- 359 (511)
.++|.+.+.||+|+||+||++.+. +|+.||||++...........+.+|++++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 5889999999765544555678999999999999999999999987665
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++||||+++++|.+++.. .+++..+..++.||++||+|||++ +|+||||||+||+++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999887654 389999999999999999999999 99999999999999986 9999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+..... ....||+.|+|||++.+.. +.++|||||||++|||++|.+||...
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence 876433 3345999999999987654 88999999999999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.12 Aligned_cols=198 Identities=26% Similarity=0.379 Sum_probs=158.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e 365 (511)
..+|...+.||+|+||+||.....+++.||||++....... +.+|+++++++ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~----~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF----ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEE----CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHH----HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34678889999999999665555579999999997543322 45899999998 79999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-----CCceEEccccccc
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLAK 440 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~ 440 (511)
|+. |+|.+++...... ..+..+..++.||++||+|||+. +|+||||||+||+++. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 996 6999999865432 45556789999999999999999 9999999999999953 2368899999998
Q ss_pred ccCCCCC--ceeeecccccccccccccc---cCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 441 LMDYKDT--HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 7653321 2233456999999999997 3556789999999999999999 9999963
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.23 Aligned_cols=200 Identities=24% Similarity=0.400 Sum_probs=152.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHH-HHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
.++|+..+.||+|+||.||+|.+. +|+.||||+++.........+ +.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999986 789999999976544433334 444455788889999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
||+ ++.+........ ..+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 555655554432 248999999999999999999998 5 89999999999999999999999999997654
Q ss_pred CCCCceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 322 223345899999999984 45678899999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=290.53 Aligned_cols=201 Identities=16% Similarity=0.147 Sum_probs=154.7
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccch--hHHHHHHHHHHHHhCCC-Cceeccccc-----------
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVH-RNLLRLRGF----------- 353 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h-~niv~l~~~----------- 353 (511)
.|...+.||+|+||+||+|.+. +|+.||||+++...... ....+.+|+.+++.++| +|......+
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 4666789999999999999965 79999999987433222 24568899999999987 322111111
Q ss_pred ----------ccc-----CCceeEEeecccCCCHHHHHHhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 010429 354 ----------CMT-----PTERLLVYPFMVNGSVASCLRER---GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 415 (511)
Q Consensus 354 ----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 415 (511)
+.. ....+++|+++ +++|.++++.. ......+++..+..++.|+++||+|||++ +|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 111 12356677765 78999888532 22333578889999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCceEEcccccccccCCCCCceeeeccccccccccccc----------ccCCCCcccCeehhhHHHHH
Q 010429 416 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL----------STGKSSEKTDVFGYGVMLLE 485 (511)
Q Consensus 416 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~Gvil~e 485 (511)
|||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++||
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999999998764322 344567 999999999 55567889999999999999
Q ss_pred HHhCCCccccccc
Q 010429 486 LITGQRAFDLARL 498 (511)
Q Consensus 486 lltg~~pf~~~~~ 498 (511)
|++|+.||.....
T Consensus 310 lltg~~Pf~~~~~ 322 (413)
T 3dzo_A 310 IWCADLPNTDDAA 322 (413)
T ss_dssp HHHSSCCCCTTGG
T ss_pred HHHCCCCCCCcch
Confidence 9999999976543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=271.20 Aligned_cols=174 Identities=11% Similarity=0.044 Sum_probs=151.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|++.+.||+|+||.||+|++. +++.||||+++.... ......+.+|+.++.+++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357888999999999999999986 589999999976543 23346689999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.+++++. ....++.+++.|+++||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999998542 35567889999999999999999 99999999999999999999998543
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
|++ .++.++|||||||++|||+||+.||....
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 333 25788999999999999999999998544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=264.13 Aligned_cols=175 Identities=25% Similarity=0.353 Sum_probs=149.9
Q ss_pred hCCCCC-CeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHH-HhCCCCceecccccccc----CCce
Q 010429 288 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 360 (511)
Q Consensus 288 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~~~~~~----~~~~ 360 (511)
++|.+. +.||+|+||.||++... +++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 78999999999999975 7899999998642 2366788877 66789999999999876 6678
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEEcccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 437 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg 437 (511)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999987532 3489999999999999999999999 9999999999999998 7899999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
++.... +..++.++|||||||++|||++|+.||...
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 986432 234677899999999999999999999643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=281.59 Aligned_cols=187 Identities=15% Similarity=0.067 Sum_probs=131.2
Q ss_pred eeccccccEEEEEEe-CCCCEEEEEEecccc---------cchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEE
Q 010429 295 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEER---------TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 295 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 363 (511)
..+.|+.|.+..++. -.|+.+|+|++.... .+...+++.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 355666666665542 258889999996432 223345699999999999 699999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||++|++|.+.+.+.+ +++. .+|+.||++||+|+|++ |||||||||+|||+++++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999998753 2544 35899999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf 493 (511)
... ......+||+.|||||++.+. +..++|+||+|++++++.++..||
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCC-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 332 233456799999999998764 567899999999988887665554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=237.13 Aligned_cols=179 Identities=32% Similarity=0.603 Sum_probs=164.0
Q ss_pred ccCCcHHHHHHHHHHhcCCCCCCCCCCCCCCCCCcc--ccceEeCCC---CCeeEEecCCCCcce--ecchhhcCCCCCc
Q 010429 24 VASNAEGDALNALKTNLADPNNVLQSWDATLVNPCT--WFHVTCNSE---NSVTRVDLGNANLSG--QLVSQLGQLTNLQ 96 (511)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~--w~gv~c~~~---~~l~~l~L~~~~l~~--~~~~~~~~l~~L~ 96 (511)
.|.+.|++||++||+++.||. .+.+|+.+ .+||. |.||+|+.. .+|+.|+|++|++++ .+|..|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 367789999999999999887 78999764 58998 999999764 689999999999999 8999999999999
Q ss_pred EEEeec-cCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccc
Q 010429 97 YLELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175 (511)
Q Consensus 97 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 175 (511)
.|+|++ |.+++.+|..+.++++|++|+|++|+|++.+|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-CCCCCC-cccceeccCCCCCCCC
Q 010429 176 KLTGDIP-TNGSFS-LFTPISFANNQLNNPP 204 (511)
Q Consensus 176 ~l~~~~~-~~~~~~-~l~~l~l~~N~~~~~~ 204 (511)
++++.+| .+..++ +|+.|++++|.+.+..
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~ 190 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEEC
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccC
Confidence 9997666 456776 8999999999986543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=254.91 Aligned_cols=186 Identities=14% Similarity=0.198 Sum_probs=147.7
Q ss_pred CCCCeeccccccEEEEEEeCCCCEEEEEEecccccc-------hhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 291 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 291 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
...+.||+|+||+||++.. .+..+++|+....... ....++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 4788999986432211 1134589999999999999999777777778888999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 458999999999999999 9999999999999999 99999999998765
Q ss_pred CCCCce------eeeccccccccccccccc--CCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 444 YKDTHV------TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 444 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
...... .....||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432211 235669999999999986 557788999999999999998887774
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-25 Score=243.22 Aligned_cols=174 Identities=29% Similarity=0.409 Sum_probs=126.7
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCCCCCCCCCCccccceEeCCCCCeeEEecCCCCccee---cch--------------
Q 010429 25 ASNAEGDALNALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQ---LVS-------------- 87 (511)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~l~L~~~~l~~~---~~~-------------- 87 (511)
+.+.|++||++||+++.||. .+++|.. ..+||.|.||+|+ .++|+.|+|++++++|. +++
T Consensus 9 ~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~ 85 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECT
T ss_pred CCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCc
Confidence 34679999999999999998 8999974 4689999999998 78999999999999987 544
Q ss_pred ---------hhcCCCCCcEEEeeccCCCCCCCc--hhcCCccccccccccccccCCCCccc-ccccccceeeccCcccCC
Q 010429 88 ---------QLGQLTNLQYLELYSNNISGKVPE--ELGNLTNLVSLDLYLNNLNGPIPTTL-GKLSKLRFLRLNNNSLMG 155 (511)
Q Consensus 88 ---------~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~L~~N~l~~ 155 (511)
.|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|++++
T Consensus 86 ~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 165 (768)
T 3rgz_A 86 NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165 (768)
T ss_dssp TSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEE
T ss_pred CCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCC
Confidence 566677777777777777777776 77777777777777777777766655 667777777777777766
Q ss_pred CCCcc---cccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 156 EIPRS---LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 156 ~~~~~---~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
..|.. +.++++|++|++++|.+++.++. ..+++|+.|++++|.+.+
T Consensus 166 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~l~~L~~L~Ls~n~l~~ 214 (768)
T 3rgz_A 166 ANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVNLEFLDVSSNNFST 214 (768)
T ss_dssp ETHHHHHHTTCCTTCCEEECCSSEEESCCBC-TTCTTCCEEECCSSCCCS
T ss_pred cCChhhhhhccCCCCCEEECCCCcccccCCc-ccCCcCCEEECcCCcCCC
Confidence 55544 45555555555555555544432 445555555555555544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.3e-25 Score=210.21 Aligned_cols=164 Identities=14% Similarity=0.056 Sum_probs=128.0
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccc-----------------hhHHHHHHHHHHHHhCCC
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----------------GGELQFQTEVEMISMAVH 344 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~h 344 (511)
.+......|.+.+.||+|+||.||+|.+.+|+.||+|.++..... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 333444556677999999999999999977999999999643321 13456889999999998
Q ss_pred CceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 010429 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 424 (511)
Q Consensus 345 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 424 (511)
| +++.+++ +.+..++||||+++++|.+ +.. .....++.|+++||+|||+. +|+||||||+|||
T Consensus 163 -~-~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVY-AWEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEE-EEETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred -C-CCcCeEE-eccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 5 6777754 3466799999999999987 421 23557999999999999999 9999999999999
Q ss_pred eCCCCceEEcccccccccCCCCCceeeeccccccccccccccc----------CCCCcccCeeh
Q 010429 425 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST----------GKSSEKTDVFG 478 (511)
Q Consensus 425 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~s 478 (511)
++ ++.+||+|||+|+ .+..|+|||.+.. ..+...+|+|.
T Consensus 226 l~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSV--------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EE-TTEEEECCCTTCE--------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EE-CCcEEEEECCCCe--------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99 9999999999986 3445788888753 34455667654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=237.69 Aligned_cols=171 Identities=20% Similarity=0.261 Sum_probs=149.6
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCCCCCCC----CCC--ccc------------cceEeCCCCCeeEEecCCCCcceecchh
Q 010429 27 NAEGDALNALKTNLADPNNVLQSWDATL----VNP--CTW------------FHVTCNSENSVTRVDLGNANLSGQLVSQ 88 (511)
Q Consensus 27 ~~~~~~l~~~k~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~c~~~~~l~~l~L~~~~l~~~~~~~ 88 (511)
..|++||++||+++.|| +|+.+. .+| |.| .||+|+..++|+.|+|++|+|+|.+|+.
T Consensus 268 ~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~ 342 (876)
T 4ecn_A 268 IKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342 (876)
T ss_dssp HHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGG
T ss_pred hHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchH
Confidence 46999999999999877 786553 466 999 9999987789999999999999999999
Q ss_pred hcCCCCCcEEEe-eccCCCCC-----------------------------------------------------------
Q 010429 89 LGQLTNLQYLEL-YSNNISGK----------------------------------------------------------- 108 (511)
Q Consensus 89 ~~~l~~L~~L~L-~~N~l~~~----------------------------------------------------------- 108 (511)
|++|++|+.|+| ++|.++|.
T Consensus 343 l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~ 422 (876)
T 4ecn_A 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422 (876)
T ss_dssp GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCC
T ss_pred HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccc
Confidence 999999999999 77765443
Q ss_pred -----------------CCchhcCCccccccccccccccC-----------------CCCcccc--cccccceeeccCcc
Q 010429 109 -----------------VPEELGNLTNLVSLDLYLNNLNG-----------------PIPTTLG--KLSKLRFLRLNNNS 152 (511)
Q Consensus 109 -----------------~p~~~~~l~~L~~L~Ls~N~i~~-----------------~~p~~~~--~l~~L~~L~L~~N~ 152 (511)
+|..+++|++|++|+|++|+|++ .+|+.++ ++++|++|+|++|+
T Consensus 423 l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred cchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 88889999999999999999998 3899987 99999999999999
Q ss_pred cCCCCCcccccCCCCceEeccccc-ccC-CCC-CC-------CCCCcccceeccCCCCCC
Q 010429 153 LMGEIPRSLTNVNSLQVLDLSNNK-LTG-DIP-TN-------GSFSLFTPISFANNQLNN 202 (511)
Q Consensus 153 l~~~~~~~~~~l~~L~~L~l~~N~-l~~-~~~-~~-------~~~~~l~~l~l~~N~~~~ 202 (511)
+.+.+|..|.++++|+.|+|++|+ +++ .+| .+ ..+++|+.|++++|.+..
T Consensus 503 l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ 562 (876)
T 4ecn_A 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562 (876)
T ss_dssp TCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCB
T ss_pred CCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCc
Confidence 999999999999999999999998 887 443 22 344588899999988873
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.5e-24 Score=228.17 Aligned_cols=173 Identities=23% Similarity=0.288 Sum_probs=152.2
Q ss_pred cHHHHHHHHHHhcCCCCCC--------CCCCCCCCCCCccc---cceEeCCCCCeeEEecCCCCcceecchhhcCCCCCc
Q 010429 28 AEGDALNALKTNLADPNNV--------LQSWDATLVNPCTW---FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQ 96 (511)
Q Consensus 28 ~~~~~l~~~k~~~~~~~~~--------l~~w~~~~~~~c~w---~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~ 96 (511)
.|++||.+|++++.++... ..+|+.. .+||.| .||+|+..++|+.|+|++|+++|.+|+.+++|++|+
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L~ 108 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELE 108 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTCC
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccce
Confidence 5899999999998755322 3479864 789999 999998878999999999999999999999999999
Q ss_pred EEEeeccC------------------------------------------------------------------------
Q 010429 97 YLELYSNN------------------------------------------------------------------------ 104 (511)
Q Consensus 97 ~L~L~~N~------------------------------------------------------------------------ 104 (511)
.|+|++|.
T Consensus 109 ~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l 188 (636)
T 4eco_A 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188 (636)
T ss_dssp EEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTT
T ss_pred EEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhh
Confidence 99999984
Q ss_pred ------CCCCCCchhcCCccccccccccccccCC-----------------CCcccc--cccccceeeccCcccCCCCCc
Q 010429 105 ------ISGKVPEELGNLTNLVSLDLYLNNLNGP-----------------IPTTLG--KLSKLRFLRLNNNSLMGEIPR 159 (511)
Q Consensus 105 ------l~~~~p~~~~~l~~L~~L~Ls~N~i~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~~~ 159 (511)
++| +|..++++++|++|+|++|+|++. +|+.++ ++++|++|+|++|++.+.+|.
T Consensus 189 ~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~ 267 (636)
T 4eco_A 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267 (636)
T ss_dssp TCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCT
T ss_pred ccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChH
Confidence 345 888999999999999999999986 999999 999999999999999999999
Q ss_pred ccccCCCCceEeccccc-ccC-CCC-CCCCC------CcccceeccCCCCCC
Q 010429 160 SLTNVNSLQVLDLSNNK-LTG-DIP-TNGSF------SLFTPISFANNQLNN 202 (511)
Q Consensus 160 ~~~~l~~L~~L~l~~N~-l~~-~~~-~~~~~------~~l~~l~l~~N~~~~ 202 (511)
.|.++++|+.|+|++|+ +++ .+| .+..+ ++|+.|++++|.+..
T Consensus 268 ~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ 319 (636)
T 4eco_A 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319 (636)
T ss_dssp TTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSS
T ss_pred HHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCc
Confidence 99999999999999998 987 444 34444 889999999998873
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-24 Score=209.79 Aligned_cols=177 Identities=20% Similarity=0.282 Sum_probs=153.7
Q ss_pred cCCcHHHHHHHHHHhc-CCCCCCCCCCC---CCCCCCccccceEeC---------CCCCeeEEecCCCCcceecchhhcC
Q 010429 25 ASNAEGDALNALKTNL-ADPNNVLQSWD---ATLVNPCTWFHVTCN---------SENSVTRVDLGNANLSGQLVSQLGQ 91 (511)
Q Consensus 25 ~~~~~~~~l~~~k~~~-~~~~~~l~~w~---~~~~~~c~w~gv~c~---------~~~~l~~l~L~~~~l~~~~~~~~~~ 91 (511)
+..+|++||++||..+ .||.+.+.+|. ....++|.|.|+.|+ ...+|+.|+|++|+++ .+|..+.+
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 4568999999999988 58888888994 445789999999994 2468999999999999 67788888
Q ss_pred CCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCccccc--------
Q 010429 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTN-------- 163 (511)
Q Consensus 92 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-------- 163 (511)
+++|++|+|++|.++ .+|..++++++|++|+|++|+|+ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 999999999999999 88999999999999999999999 78999999999999999999888888887654
Q ss_pred -CCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 164 -VNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 164 -l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+++|+.|+|++|+++..+..+..+++|+.|++++|.+.+.+
T Consensus 181 ~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~ 222 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALG 222 (328)
T ss_dssp ESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCC
T ss_pred cCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCc
Confidence 89999999999999866656778889999999999887543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=179.53 Aligned_cols=147 Identities=24% Similarity=0.264 Sum_probs=134.0
Q ss_pred CCCccccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccc
Q 010429 55 VNPCTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124 (511)
Q Consensus 55 ~~~c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 124 (511)
...|.|.+|.|.. ..+++.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 16 ~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 3679999999964 247999999999999998999999999999999999999766677899999999999
Q ss_pred ccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCC
Q 010429 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 125 s~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~ 202 (511)
++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. +..+++|+.|++++|++..
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 999999877788999999999999999999 7889999999999999999999988764 5778999999999999854
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=6.7e-21 Score=176.24 Aligned_cols=143 Identities=22% Similarity=0.323 Sum_probs=132.3
Q ss_pred ccccceEeCCC----------CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccc
Q 010429 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127 (511)
Q Consensus 58 c~w~gv~c~~~----------~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 127 (511)
|.|..|.|... .+++.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 68999999642 37999999999999988889999999999999999999888999999999999999999
Q ss_pred cccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCC
Q 010429 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQL 200 (511)
Q Consensus 128 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~ 200 (511)
+|+...+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..+++|+.|++++|++
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 99976667789999999999999999998899999999999999999999998875 57789999999999998
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=172.54 Aligned_cols=147 Identities=24% Similarity=0.266 Sum_probs=132.3
Q ss_pred CccccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccc
Q 010429 57 PCTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (511)
Q Consensus 57 ~c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (511)
.|.|.+|.|+. ..+++.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 47999999964 23699999999999988888899999999999999999977777789999999999999
Q ss_pred ccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCC
Q 010429 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 127 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~ 203 (511)
|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++.++. +..+++|+.|++++|++.+.
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence 999977777789999999999999999987777899999999999999999988876 57789999999999988543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-20 Score=174.83 Aligned_cols=137 Identities=23% Similarity=0.275 Sum_probs=125.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..|.++++|+.|+|++|+|++..|..+.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 36889999999999988889999999999999999999888888999999999999999999888888999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
++|+|++..+..|..+++|+.|+|++|+|++.++. +..+++|+.|++++|.+...++
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 99999977777789999999999999999988874 6788999999999999976654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=172.40 Aligned_cols=145 Identities=18% Similarity=0.268 Sum_probs=131.5
Q ss_pred ccccceEeCCC----------CCeeEEecCCCCcceecc-hhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccc
Q 010429 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLV-SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (511)
Q Consensus 58 c~w~gv~c~~~----------~~l~~l~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (511)
|.|..+.|+.. ..++.|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 68889999642 357899999999998854 5689999999999999999988888999999999999999
Q ss_pred ccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCCCC
Q 010429 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 127 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~~ 202 (511)
|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+| .+..+++|+.|++++|++..
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 99998888889999999999999999999889999999999999999999999866 56789999999999999843
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=177.18 Aligned_cols=138 Identities=17% Similarity=0.190 Sum_probs=107.2
Q ss_pred CCCCCeeccccccEEEEEEe-CCCCE--EEEEEecccccc-----------------------hhHHHHHHHHHHHHhCC
Q 010429 290 FSNRNILGRGGFGKVYKGRL-TDGSL--VAVKRLKEERTQ-----------------------GGELQFQTEVEMISMAV 343 (511)
Q Consensus 290 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~~~ 343 (511)
|.+.+.||+|+||.||+|.+ .+|+. ||||+++..... .....+.+|+..+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678999999999999998 57888 999987543211 11235788999999998
Q ss_pred CCce--eccccccccCCceeEEeecccC-C----CHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEe
Q 010429 344 HRNL--LRLRGFCMTPTERLLVYPFMVN-G----SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDPKIIH 415 (511)
Q Consensus 344 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH 415 (511)
|+++ ..++.+ ...++||||+.+ | +|.+.... .++..+..++.|++.||+||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 233322 467899999943 4 66665432 235567899999999999999 88 9999
Q ss_pred cCCCCCCeeeCCCCceEEcccccccccC
Q 010429 416 RDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 416 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||||+|||+++ .++|+|||+|....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999998 99999999997653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-19 Score=171.26 Aligned_cols=136 Identities=26% Similarity=0.292 Sum_probs=101.8
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
+++.|+|++|++++..+..|.++++|+.|+|++|.+++..+..+.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 46777777777776666677788888888888888875555556778888888888888876666667778888888888
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+|++++..+..|..+++|+.|+|++|.+++.++. +..+++|+.|++++|.+...++
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 8888776666777788888888888888776654 4667778888888877765443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.8e-20 Score=191.05 Aligned_cols=131 Identities=27% Similarity=0.181 Sum_probs=97.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccc-cccccceee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG-KLSKLRFLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~ 147 (511)
.+++.|+|++|.|++..+. .+++|+.|+|++|.|++..|..++++++|++|+|++|.|++.+|..+. .+++|+.|+
T Consensus 99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 4667777777777765543 356788888888888877777778888888888888888877777775 678888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
|++|.|++..+ +..+++|+.|+|++|.|++.++.+..+++|+.|++++|.+.+.|
T Consensus 176 Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp 230 (487)
T 3oja_A 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIE 230 (487)
T ss_dssp CTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEEC
T ss_pred cCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccc
Confidence 88888875522 33577888888888888877777777778888888888776543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-19 Score=163.85 Aligned_cols=125 Identities=25% Similarity=0.360 Sum_probs=89.8
Q ss_pred ccccceEeCCC----------CCeeEEecCCCCcceecch-hhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccc
Q 010429 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLVS-QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (511)
Q Consensus 58 c~w~gv~c~~~----------~~l~~l~L~~~~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (511)
|.|..+.|+.. .+++.|+|++|+|++..+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57777777531 2577777777777765553 467777777777777777766677777777777777777
Q ss_pred ccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCC
Q 010429 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (511)
Q Consensus 127 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (511)
|+|++..|..|.++++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77777666667777777777777777777777777777777777777777776544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=165.05 Aligned_cols=136 Identities=26% Similarity=0.280 Sum_probs=125.5
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 46899999999999998889999999999999999999988888899999999999999999987777889999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|+|++..+..|..+++|+.|+|++|++++.++ .+..+++|+.|++++|++...
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999998777789999999999999999998887 457889999999999999543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=5.7e-19 Score=189.18 Aligned_cols=163 Identities=18% Similarity=0.204 Sum_probs=131.1
Q ss_pred CCCCCCCCCCCC---CCCCccc----cceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccC
Q 010429 42 DPNNVLQSWDAT---LVNPCTW----FHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNN 104 (511)
Q Consensus 42 ~~~~~l~~w~~~---~~~~c~w----~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~ 104 (511)
|+...+++|+.+ ..+||.+ ..|.|.. +.+++.|||++|+|++..+..|.++++|++|+|++|+
T Consensus 8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 334445555432 1245654 2478863 2479999999999999888999999999999999999
Q ss_pred CCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCC-CC-
Q 010429 105 ISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD-IP- 182 (511)
Q Consensus 105 l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~- 182 (511)
|++..|++|.+|++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|.+++. .|
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 9988888899999999999999999987778899999999999999999987777899999999999999999864 33
Q ss_pred CCCCCCcccceeccCCCCCCCC
Q 010429 183 TNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 183 ~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
.+..+++|+.|++++|.+.+.+
T Consensus 168 ~~~~l~~L~~L~L~~N~l~~~~ 189 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQSIY 189 (635)
T ss_dssp GGGGCTTCCEEECCSSCCCEEC
T ss_pred hhccchhhhhhcccCccccccc
Confidence 3467899999999999986654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.3e-18 Score=163.53 Aligned_cols=136 Identities=29% Similarity=0.345 Sum_probs=94.5
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++. ..+..+++|+.|+|++|.+++..+..+.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 34677777777777653 3667777777777777777766666667777777777777777766666677777777777
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCC-CCCCcccceeccCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|++|++++..+..+..+++|+.|++++|++++.++.. ..+++|+.|++++|.+.+.++
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 7777777666666677777777777777777666543 556777777777777765444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=173.46 Aligned_cols=147 Identities=25% Similarity=0.272 Sum_probs=131.3
Q ss_pred ccccceEeCC----------CCCeeEEecCCCCcceecchhhc-CCCCCcEEEeeccCCCCCCCchhcCCcccccccccc
Q 010429 58 CTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLG-QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (511)
Q Consensus 58 c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (511)
|.+..+.|.. ...++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 6788888854 23588999999999998888888 999999999999999988888899999999999999
Q ss_pred ccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCC----CCCCcccceeccCCCCCC
Q 010429 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN----GSFSLFTPISFANNQLNN 202 (511)
Q Consensus 127 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~~~l~~l~l~~N~~~~ 202 (511)
|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++.. ..+++|+.|++++|.+..
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 9999888888999999999999999999888999999999999999999999877654 468999999999999875
Q ss_pred CC
Q 010429 203 PP 204 (511)
Q Consensus 203 ~~ 204 (511)
.+
T Consensus 178 l~ 179 (361)
T 2xot_A 178 LP 179 (361)
T ss_dssp CC
T ss_pred cC
Confidence 44
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-18 Score=189.57 Aligned_cols=115 Identities=37% Similarity=0.650 Sum_probs=108.9
Q ss_pred cCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCce
Q 010429 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169 (511)
Q Consensus 90 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 169 (511)
..+++|+.|+|++|+++|.+|..++++++|+.|+|++|+|+|.+|..++++++|+.|||++|+++|.+|..+.++++|++
T Consensus 629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 708 (768)
T 3rgz_A 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708 (768)
T ss_dssp SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 34577999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCCcccceeccCCCC-CCCC
Q 010429 170 LDLSNNKLTGDIPTNGSFSLFTPISFANNQL-NNPP 204 (511)
Q Consensus 170 L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~-~~~~ 204 (511)
|+|++|+++|.+|..+.+..+...++.+|+. ||.|
T Consensus 709 L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 709 IDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp EECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred EECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 9999999999999988999999999999985 8865
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=170.30 Aligned_cols=132 Identities=28% Similarity=0.467 Sum_probs=71.5
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
+++.|+|++|++++..|..+..++ |+.|+|++|.+++.+|..+..+++|++|+|++|.+++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 344444444444444444444443 44444444444444444455555555555555555543333 4555566666666
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCC-CCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQ-LNNP 203 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~-~~~~ 203 (511)
+|+|++.+|..+..+++|+.|+|++|++++.+|....+++|+.+++++|+ +|+.
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCC
Confidence 66666566666666666666666666666666555556666666666666 3543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-18 Score=152.50 Aligned_cols=109 Identities=24% Similarity=0.262 Sum_probs=58.7
Q ss_pred CCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEec
Q 010429 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDL 172 (511)
Q Consensus 93 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 172 (511)
++|+.|+|++|++++..+..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 45555555555555444444555555555555555555444444555555555555555555444444555555555555
Q ss_pred ccccccCCCCCC-CCCCcccceeccCCCCC
Q 010429 173 SNNKLTGDIPTN-GSFSLFTPISFANNQLN 201 (511)
Q Consensus 173 ~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~ 201 (511)
++|++++.++.. ..+++|+.|++++|++.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 555555544432 34555555555555553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.2e-18 Score=152.23 Aligned_cols=135 Identities=23% Similarity=0.281 Sum_probs=121.5
Q ss_pred CCCeeEEecCCCCcc-eecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 68 ENSVTRVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
..+++.|+|++|+++ +.+|..+..+++|+.|+|++|.+++. ..+..+++|++|+|++|+|++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367999999999998 77888899999999999999999965 679999999999999999998789988899999999
Q ss_pred eccCcccCCCC-CcccccCCCCceEecccccccCCCC----CCCCCCcccceeccCCCCCCCC
Q 010429 147 RLNNNSLMGEI-PRSLTNVNSLQVLDLSNNKLTGDIP----TNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 147 ~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+|++|+|++.. +..+..+++|+.|++++|++++.++ .+..+++|+.|++++|.+...+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 99999999643 3789999999999999999998887 5688999999999999875443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=5.6e-18 Score=153.03 Aligned_cols=134 Identities=23% Similarity=0.361 Sum_probs=118.1
Q ss_pred ceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCc-hhcCCccccccccccccccCCCCcccccc
Q 010429 62 HVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPE-ELGNLTNLVSLDLYLNNLNGPIPTTLGKL 140 (511)
Q Consensus 62 gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l 140 (511)
+..|.. +.|++++|+|+ .+|..+.. +|+.|+|++|+|++..+. .+..+++|++|+|++|+|++..|..|.++
T Consensus 5 ~C~C~~----~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 77 (192)
T 1w8a_A 5 MCHCEG----TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77 (192)
T ss_dssp TSEEET----TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC
T ss_pred CCEECC----CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCc
Confidence 456743 78999999997 45555543 899999999999966664 48999999999999999999889999999
Q ss_pred cccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCC
Q 010429 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 141 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~ 202 (511)
++|++|+|++|+|++..+..|.++++|++|+|++|+|++.++. +..+++|+.|++++|++.+
T Consensus 78 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 78 SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp TTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 9999999999999988888899999999999999999998764 5788999999999999854
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.9e-18 Score=162.11 Aligned_cols=135 Identities=17% Similarity=0.140 Sum_probs=122.5
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..|.++++|+.|+|++|++++..+..+.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 36999999999999888889999999999999999999777778999999999999999999888899999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCC--CCCCCCCCcccceeccCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD--IPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
++|++++..+..+..+++|+.|++++|++++. +..+..+++|+.|++++|.+...
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 99999987777899999999999999999873 34567889999999999988654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3e-18 Score=168.91 Aligned_cols=143 Identities=15% Similarity=0.120 Sum_probs=99.7
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccc-------------hhHHHHHHHHHHHHhCCCCceecccccc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-------------GGELQFQTEVEMISMAVHRNLLRLRGFC 354 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~~~h~niv~l~~~~ 354 (511)
.-|++.+.||+|++|.||+|...+|+.||||+++..... ........+..+.....|+|+++++...
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348888999999999999999999999999997643210 0011122222222223344444443322
Q ss_pred cc------CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC
Q 010429 355 MT------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 428 (511)
Q Consensus 355 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 428 (511)
.. ....++||||++++.+.... .......++.|++.+|.|||+. |||||||||.|||++++
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 21 12347999999998875432 1224567889999999999998 99999999999999887
Q ss_pred Cc----------eEEcccccccccC
Q 010429 429 FE----------AVVGDFGLAKLMD 443 (511)
Q Consensus 429 ~~----------~kl~Dfg~a~~~~ 443 (511)
+. +.|+||+-+...+
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 73 8999999876543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-17 Score=156.87 Aligned_cols=138 Identities=25% Similarity=0.285 Sum_probs=123.4
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|+++...+..|.++++|+.|+|++|++++..+..+.++++|++|+|++|+|++..+..|..+++|++|+
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 45899999999999977777889999999999999999977777889999999999999999988888899999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|++|+|++..+..|..+++|+.|+|++|++++.++. +..+++|+.|++++|.+...++
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCH
Confidence 999999977777789999999999999999988775 5778999999999999876554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-17 Score=160.70 Aligned_cols=136 Identities=28% Similarity=0.306 Sum_probs=118.3
Q ss_pred CCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
...+++.|+|++|+|++..+. ..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|
T Consensus 53 ~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L 129 (290)
T 1p9a_G 53 PYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (290)
T ss_dssp TCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence 356899999999999975443 78999999999999998 778888999999999999999998777889999999999
Q ss_pred eccCcccCCCCCcccccCCCCceEecccccccCCCCCC-CCCCcccceeccCCCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+|++|+|++..+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|.+...+.
T Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~ 189 (290)
T 1p9a_G 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK 189 (290)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred ECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccCh
Confidence 99999999877778889999999999999999887754 668999999999999875443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-17 Score=159.74 Aligned_cols=137 Identities=24% Similarity=0.233 Sum_probs=122.5
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccccc-ccCCCCcccccccccceee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN-LNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-i~~~~p~~~~~l~~L~~L~ 147 (511)
.+++.|+|++|++++..+..|..+++|+.|+|++|.+++..|..+.++++|++|+|++|. ++...|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 478999999999998888889999999999999999998878899999999999999997 8877788999999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|++|++++..|..+.++++|++|++++|++++.++. +..+++|+.|++++|.+...++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 999999988888899999999999999999988765 5778999999999998865443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-17 Score=156.66 Aligned_cols=137 Identities=23% Similarity=0.213 Sum_probs=124.7
Q ss_pred CCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
...+++.|+|++|++++..+..|.++++|+.|+|++|++++..+..+.++++|++|+|++|+|++..+..+..+++|+.|
T Consensus 83 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 162 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL 162 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE
Confidence 35689999999999998888889999999999999999998888889999999999999999998878888999999999
Q ss_pred eccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~ 203 (511)
+|++|++++..+..+..+++|+.|+|++|++++.++. +..+++|+.|++++|++.+.
T Consensus 163 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 163 DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 9999999988888889999999999999999998876 47889999999999988654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.9e-18 Score=167.68 Aligned_cols=150 Identities=25% Similarity=0.304 Sum_probs=129.0
Q ss_pred CCCccccceEeCC------------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccc
Q 010429 55 VNPCTWFHVTCNS------------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSL 122 (511)
Q Consensus 55 ~~~c~w~gv~c~~------------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 122 (511)
..+|.|.|+ |+. ..+++.|+|++|++++..+..|.++++|+.|+|++|++++..|..+.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 356888887 531 2479999999999998888899999999999999999998888889999999999
Q ss_pred ccccccccCCCCcccccccccceeeccCcccCCCCC-cccccCCCCceEecccc-cccCCCC-CCCCCCcccceeccCCC
Q 010429 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQVLDLSNN-KLTGDIP-TNGSFSLFTPISFANNQ 199 (511)
Q Consensus 123 ~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~~-~~~~~~~l~~l~l~~N~ 199 (511)
+|++|+|++..+..|.++++|++|+|++|++++..+ ..+.++++|++|++++| .+++.++ .+..+++|+.|++++|.
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 999999996655669999999999999999995444 47899999999999999 4776655 46788999999999999
Q ss_pred CCCCCC
Q 010429 200 LNNPPP 205 (511)
Q Consensus 200 ~~~~~~ 205 (511)
+.+..+
T Consensus 186 l~~~~~ 191 (353)
T 2z80_A 186 LQSYEP 191 (353)
T ss_dssp CCEECT
T ss_pred cCccCH
Confidence 866543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.1e-18 Score=173.48 Aligned_cols=150 Identities=19% Similarity=0.287 Sum_probs=132.2
Q ss_pred CCccccc--eEeCCC---------CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCC-CchhcCCccccccc
Q 010429 56 NPCTWFH--VTCNSE---------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSLD 123 (511)
Q Consensus 56 ~~c~w~g--v~c~~~---------~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 123 (511)
..|.|.+ |.|... .+++.|+|++|++++..+..|.++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 3466655 888642 47999999999999998999999999999999999998665 56799999999999
Q ss_pred cccccccCCCCcccccccccceeeccCcccCCCCCcc--cccCCCCceEecccccccCCCCC--CCCCCcccceeccCCC
Q 010429 124 LYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRS--LTNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTPISFANNQ 199 (511)
Q Consensus 124 Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~ 199 (511)
|++|++++..|..|.++++|++|+|++|++++.+|.. +.++++|++|+|++|++++..|. +..+++|+.|++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999866554 99999999999999999998775 5788999999999999
Q ss_pred CCCCCC
Q 010429 200 LNNPPP 205 (511)
Q Consensus 200 ~~~~~~ 205 (511)
+.+..+
T Consensus 166 l~~~~~ 171 (455)
T 3v47_A 166 VKSICE 171 (455)
T ss_dssp BSCCCT
T ss_pred ccccCh
Confidence 976554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.6e-18 Score=178.01 Aligned_cols=148 Identities=24% Similarity=0.295 Sum_probs=131.4
Q ss_pred CccccceEeCC------------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccc
Q 010429 57 PCTWFHVTCNS------------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDL 124 (511)
Q Consensus 57 ~c~w~gv~c~~------------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 124 (511)
.|.|.|+ |+. ..+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5999998 852 237999999999999999999999999999999999999888899999999999999
Q ss_pred ccccccCCCCcccccccccceeeccCcccCC-CCCcccccCCCCceEecccccccCCCC--CCCCCCcccceeccCCCCC
Q 010429 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 125 s~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~ 201 (511)
++|+|++..|..|.++++|++|+|++|++++ ..|..+.++++|++|++++|.+.+.++ .+..+++|+.|++++|.+.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998888889999999999999999997 357789999999999999998544443 5688999999999999987
Q ss_pred CCCC
Q 010429 202 NPPP 205 (511)
Q Consensus 202 ~~~~ 205 (511)
+..+
T Consensus 162 ~~~~ 165 (549)
T 2z81_A 162 NYQS 165 (549)
T ss_dssp EECT
T ss_pred ccCh
Confidence 6543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.9e-17 Score=149.63 Aligned_cols=126 Identities=25% Similarity=0.310 Sum_probs=108.9
Q ss_pred eEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCc
Q 010429 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (511)
Q Consensus 72 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N 151 (511)
+.+++++|+|+. +|..+ .++|+.|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 467788888884 45444 358999999999998 77888999999999999999999888888999999999999999
Q ss_pred ccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCC
Q 010429 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLN 201 (511)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~ 201 (511)
+|++..|..|.++++|+.|+|++|+|++.++. +..+++|+.|++++|++.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 99988888899999999999999999988775 567899999999999883
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=164.06 Aligned_cols=135 Identities=21% Similarity=0.320 Sum_probs=119.5
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccc--------
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK-------- 139 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~-------- 139 (511)
..+++.|+|++|+++ .+|..++++++|+.|+|++|.++ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 357899999999999 78888999999999999999999 78888999999999999999888888887765
Q ss_pred -ccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 140 -LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 140 -l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+++|++|+|++|+++ .+|..+.++++|+.|+|++|++++.++.+..+++|+.|++++|.+.+..+
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p 246 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYP 246 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCC
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhH
Confidence 899999999999998 78888999999999999999999887777888999999999988866544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-18 Score=148.17 Aligned_cols=127 Identities=21% Similarity=0.265 Sum_probs=114.8
Q ss_pred CCeeEEecCCCCcc-eecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 69 NSVTRVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
.+++.|++++|+++ +.+|..+..+++|+.|+|++|.+++. ..+.++++|++|+|++|+|++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57999999999998 78888999999999999999999966 6799999999999999999987999999999999999
Q ss_pred ccCcccCCC-CCcccccCCCCceEecccccccCCCC----CCCCCCcccceeccC
Q 010429 148 LNNNSLMGE-IPRSLTNVNSLQVLDLSNNKLTGDIP----TNGSFSLFTPISFAN 197 (511)
Q Consensus 148 L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~l~~ 197 (511)
|++|++++. .+..+..+++|+.|++++|++++.++ .+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999964 34789999999999999999998876 357788999998763
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=178.13 Aligned_cols=151 Identities=18% Similarity=0.224 Sum_probs=133.0
Q ss_pred CCCccc----cceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccc
Q 010429 55 VNPCTW----FHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLV 120 (511)
Q Consensus 55 ~~~c~w----~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 120 (511)
.+||.+ ..|.|.. ..+++.|+|++|++++..+..|.++++|+.|+|++|.+++..|..|.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 456765 3577853 25799999999999999999999999999999999999988898999999999
Q ss_pred ccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccC-C-CCCCCCCCcccceeccCC
Q 010429 121 SLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG-D-IPTNGSFSLFTPISFANN 198 (511)
Q Consensus 121 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~-~~~~~~~~~l~~l~l~~N 198 (511)
+|+|++|+|++..|+.|.++++|++|+|++|++++..+..++++++|++|+|++|.+++ . +..+..+++|+.|++++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999998889999999999999999999998777889999999999999999986 3 445788999999999999
Q ss_pred CCCCCCC
Q 010429 199 QLNNPPP 205 (511)
Q Consensus 199 ~~~~~~~ 205 (511)
.+.+.++
T Consensus 164 ~l~~~~~ 170 (606)
T 3vq2_A 164 YIQTITV 170 (606)
T ss_dssp CCCEECT
T ss_pred cceecCh
Confidence 9876544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=148.99 Aligned_cols=123 Identities=26% Similarity=0.374 Sum_probs=112.2
Q ss_pred ccccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccc
Q 010429 58 CTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127 (511)
Q Consensus 58 c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 127 (511)
|.|..+.|+. ..+++.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 6788888854 247999999999999 56789999999999999999999888889999999999999999
Q ss_pred cccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCC
Q 010429 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDI 181 (511)
Q Consensus 128 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 181 (511)
+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 999888889999999999999999999777778999999999999999998754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.1e-17 Score=157.04 Aligned_cols=138 Identities=20% Similarity=0.222 Sum_probs=123.3
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccC-CCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNN-ISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
..+++.|+|++|++++..+..|.++++|+.|+|++|. +++..|..+..+++|++|+|++|.+++..|..+.++++|++|
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 4689999999999998889999999999999999997 886668889999999999999999998888899999999999
Q ss_pred eccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+|++|++++..+..|..+++|+.|+|++|++++.++. +..+++|+.|++++|.+.+..+
T Consensus 135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 194 (285)
T 1ozn_A 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (285)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCH
Confidence 9999999977777899999999999999999987764 6778999999999998866543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=170.34 Aligned_cols=137 Identities=24% Similarity=0.269 Sum_probs=127.4
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..+..+++|+.|+|++|++++..|..+.++++|++|+|++|.|++..|..|.++++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 47999999999999999999999999999999999999888989999999999999999999888999999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCC-CCCCcccceeccCCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~ 205 (511)
++|++++..|..|.++++|++|+|++|++++.++.. ..+++|+.|++++|++.+..+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999888999999999999999999999887754 788999999999999965543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.1e-17 Score=150.55 Aligned_cols=140 Identities=26% Similarity=0.238 Sum_probs=122.6
Q ss_pred cccceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccc
Q 010429 59 TWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138 (511)
Q Consensus 59 ~w~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~ 138 (511)
.|..-.|. .+.++.++++++. +|..+ .++|+.|+|++|+|++..|..+.++++|++|+|++|+|+...+..|.
T Consensus 13 ~~~~~~Cs----~~~v~c~~~~l~~-ip~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 85 (229)
T 3e6j_A 13 CPSQCSCS----GTTVDCRSKRHAS-VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85 (229)
T ss_dssp CCTTCEEE----TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCCCCEEe----CCEeEccCCCcCc-cCCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcc
Confidence 34556785 3679999999984 44444 38899999999999998899999999999999999999976667789
Q ss_pred cccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 139 KLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 139 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
.+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+..+..+..+++|+.|++++|.+...++
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCH
Confidence 9999999999999999877778899999999999999999777777889999999999999976654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.70 E-value=5.5e-17 Score=149.83 Aligned_cols=141 Identities=22% Similarity=0.256 Sum_probs=122.6
Q ss_pred CccccceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcc
Q 010429 57 PCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTT 136 (511)
Q Consensus 57 ~c~w~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~ 136 (511)
.|. .+..|.. +.+++++++++. +|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..
T Consensus 4 ~CP-~~C~C~~----~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 75 (220)
T 2v9t_B 4 HCP-AACTCSN----NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75 (220)
T ss_dssp CSC-TTSEEET----TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTT
T ss_pred CCC-CCCEECC----CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHH
Confidence 354 3567853 579999999994 455443 68999999999999777778999999999999999999888999
Q ss_pred cccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCCC
Q 010429 137 LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +..+++|+.|++++|.+...++
T Consensus 76 ~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 99999999999999999976667789999999999999999998764 5788999999999999977655
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.70 E-value=7.7e-17 Score=155.41 Aligned_cols=134 Identities=27% Similarity=0.256 Sum_probs=120.7
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..|..+++|+.|+|++|.|++. +. ...+++|++|+|++|+|+ .+|..+..+++|++|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 5789999999999998899999999999999999999954 43 378999999999999999 78889999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCC-CCCCcccceeccCCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~ 205 (511)
++|+|++..+..|.++++|+.|+|++|+|++.++.. ..+++|+.|++++|.+...++
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 165 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCH
Confidence 999999877788999999999999999999887764 678999999999999976654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.6e-17 Score=151.07 Aligned_cols=115 Identities=18% Similarity=0.234 Sum_probs=109.4
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+|+.|+|++|+|++..+..|.++++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 46899999999999998888999999999999999999988888899999999999999999998899999999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (511)
|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999998889999999999999999999998754
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.2e-17 Score=174.49 Aligned_cols=158 Identities=16% Similarity=0.142 Sum_probs=131.2
Q ss_pred CCCCCCCCCCCCc----cccceEeCC-----------------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccC
Q 010429 46 VLQSWDATLVNPC----TWFHVTCNS-----------------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNN 104 (511)
Q Consensus 46 ~l~~w~~~~~~~c----~w~gv~c~~-----------------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~ 104 (511)
.+++|.+. .+|| .|.++.|+. ..+++.|++++|.++...+..|..+++|+.|+|++|.
T Consensus 8 ~l~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~ 86 (597)
T 3oja_B 8 NVKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86 (597)
T ss_dssp ---CCCSE-ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSC
T ss_pred cccCCCCC-CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCC
Confidence 46788654 3455 266665541 1467889999999998888888999999999999999
Q ss_pred CCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCC-
Q 010429 105 ISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT- 183 (511)
Q Consensus 105 l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~- 183 (511)
|++..|..|..+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|++|+|++|.+++.++.
T Consensus 87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 166 (597)
T 3oja_B 87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166 (597)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence 9988888899999999999999999988888899999999999999999966666679999999999999999988874
Q ss_pred CCCCCcccceeccCCCCCCCC
Q 010429 184 NGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 184 ~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+..+++|+.|++++|.+.+.+
T Consensus 167 ~~~l~~L~~L~L~~N~l~~~~ 187 (597)
T 3oja_B 167 FQATTSLQNLQLSSNRLTHVD 187 (597)
T ss_dssp TTTCTTCCEEECTTSCCSBCC
T ss_pred hhcCCcCcEEECcCCCCCCcC
Confidence 678899999999999887654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=180.93 Aligned_cols=174 Identities=18% Similarity=0.179 Sum_probs=114.6
Q ss_pred CCcHHHHHHHHHHhcCC-CCCCCCCCCCCCCCCccccceEeCCCCCeeEEe------------------cCCCCcce---
Q 010429 26 SNAEGDALNALKTNLAD-PNNVLQSWDATLVNPCTWFHVTCNSENSVTRVD------------------LGNANLSG--- 83 (511)
Q Consensus 26 ~~~~~~~l~~~k~~~~~-~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~l~------------------L~~~~l~~--- 83 (511)
...++++|.++..++.. ....-.+|.......+.|.++.++. ++++.|+ |++|.|.+
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~ 208 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDD 208 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCcchhhHhhcCccCcccccCccc
Confidence 34577889998876532 1223346755545567888877643 3344444 44444433
Q ss_pred ------ecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCC
Q 010429 84 ------QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEI 157 (511)
Q Consensus 84 ------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 157 (511)
..+..+..++.|+.|+|++|.|+ .+|..+.++++|++|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .+
T Consensus 209 ~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 209 IENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred cccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 23667888999999999999999 78888889999999999999999 89999999999999999999999 78
Q ss_pred CcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 158 PRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 158 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|..|.+|++|++|+|++|.|+..+..+..+++|+.|+|++|++.+.
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~ 331 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQ 331 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSH
T ss_pred ChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCC
Confidence 9999999999999999999997777788999999999999999764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=4e-17 Score=149.40 Aligned_cols=134 Identities=25% Similarity=0.245 Sum_probs=120.3
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..+.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 46899999999999988788899999999999999999977777789999999999999999987777899999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~~~ 207 (511)
|++|++++..+..+..+++|+.|+|++|++.+.. ++|+.|++..|.+.+..|..
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~------~~l~~L~~~~n~~~g~ip~~ 184 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC------PGIRYLSEWINKHSGVVRNS 184 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT------TTTHHHHHHHHHCTTTBBCT
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecCC------CCHHHHHHHHHhCCceeecc
Confidence 9999999777777999999999999999988654 57899999999998776543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.9e-17 Score=153.83 Aligned_cols=134 Identities=21% Similarity=0.247 Sum_probs=119.9
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccC-CCCCCCchhcCCcccccccccc-ccccCCCCccccccccccee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNN-ISGKVPEELGNLTNLVSLDLYL-NNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L 146 (511)
.+++.|+|++|++++..+..|.++++|+.|+|++|. +++..+..|.++++|++|+|++ |+|++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998888899999999999999997 8866667899999999999999 99997777889999999999
Q ss_pred eccCcccCCCCCcccccCCCCc---eEecccc-cccCCCCC-CCCCCccc-ceeccCCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQ---VLDLSNN-KLTGDIPT-NGSFSLFT-PISFANNQLNNPP 204 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~~~-~~~~~~l~-~l~l~~N~~~~~~ 204 (511)
+|++|++++ +|. +..+++|+ .|++++| .+++.++. +..+++|+ .|++++|.+...+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~ 172 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQ 172 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEEC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccC
Confidence 999999996 666 88888888 9999999 99988765 57789999 9999999886433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.9e-17 Score=158.83 Aligned_cols=145 Identities=24% Similarity=0.309 Sum_probs=112.4
Q ss_pred CccccceEeCCC----------CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCC--CCchhcCCcccccccc
Q 010429 57 PCTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK--VPEELGNLTNLVSLDL 124 (511)
Q Consensus 57 ~c~w~gv~c~~~----------~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L 124 (511)
.|.|.++.|+.. .+++.|+|++|+++...+..|.++++|+.|+|++|.++.. .|..+..+++|++|+|
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 379999999642 3799999999999976666789999999999999999832 3566777888888888
Q ss_pred ccccccCCCCcccccccccceeeccCcccCCCCC-cccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCC
Q 010429 125 YLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 125 s~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~ 202 (511)
++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|+.|++++|.+++.++. +..+++|+.|++++|.+.+
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 888887 466777788888888888888875544 4677778888888888877766654 4566777777777777654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=142.74 Aligned_cols=126 Identities=29% Similarity=0.336 Sum_probs=114.0
Q ss_pred CccccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccc
Q 010429 57 PCTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (511)
Q Consensus 57 ~c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (511)
.|.|.++.|+. ..+++.|+|++|++++..+..|..+++|+.|+|++|+|++..+..+.++++|++|+|++
T Consensus 6 ~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 37899999964 24799999999999988888899999999999999999977777789999999999999
Q ss_pred ccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCC
Q 010429 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (511)
Q Consensus 127 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (511)
|+|++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99998777789999999999999999997766678899999999999999998765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.6e-17 Score=164.02 Aligned_cols=136 Identities=18% Similarity=0.179 Sum_probs=122.2
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|++++|.++...+..|..+++|+.|+|++|.+++..+..+..+++|++|+|++|.+++..|..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 57899999999999877778899999999999999999877788999999999999999999888888999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~ 204 (511)
++|+++...+..|.++++|++|++++|++++.++. +..+++|+.|++++|.+...+
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 181 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD 181 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc
Confidence 99999965555679999999999999999988765 578899999999999986653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.2e-17 Score=167.55 Aligned_cols=146 Identities=21% Similarity=0.265 Sum_probs=125.8
Q ss_pred cccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccccc
Q 010429 59 TWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128 (511)
Q Consensus 59 ~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (511)
.|..|.|.. ..+++.|+|++|+|++..+..|.++++|+.|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 366788853 2478899999999998888999999999999999999998888899999999999999999
Q ss_pred ccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCCCCCC
Q 010429 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 129 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
|+...+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|.+++..+ .+..+++|+.|++++|.+...+
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence 997666678999999999999999998888889999999999999999987765 4577888999999998876543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=6.8e-17 Score=172.36 Aligned_cols=136 Identities=21% Similarity=0.185 Sum_probs=126.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
..++.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 47999999999999999999999999999999999999888999999999999999999999889999999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCC-CCCCCCCCcccceeccCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD-IPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
++|++++..|..+.++++|++|++++|++++. ++....+++|+.|++++|.+.+.+
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 169 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEEC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccC
Confidence 99999987788899999999999999999985 466666899999999999886543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-16 Score=163.49 Aligned_cols=144 Identities=23% Similarity=0.228 Sum_probs=125.4
Q ss_pred ccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccc
Q 010429 60 WFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129 (511)
Q Consensus 60 w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i 129 (511)
|..|.|.. ..+++.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 46677753 24799999999999999999999999999999999999988889999999999999999999
Q ss_pred cCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccc-cccCCCC-CCCCCCcccceeccCCCCCCC
Q 010429 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN-KLTGDIP-TNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~-~~~~~~~l~~l~l~~N~~~~~ 203 (511)
++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++| .+....+ .+..+++|+.|++++|.+...
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9877778999999999999999999777778899999999999984 5554444 357788999999999988654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-16 Score=162.04 Aligned_cols=144 Identities=24% Similarity=0.256 Sum_probs=120.9
Q ss_pred ccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccc
Q 010429 60 WFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129 (511)
Q Consensus 60 w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i 129 (511)
|..|.|.. ..+++.|+|++|+|++..+..|.++++|+.|+|++|.|++..+..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 56788853 24689999999999998889999999999999999999988888899999999999999999
Q ss_pred cCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccc-cccCCCC-CCCCCCcccceeccCCCCCCC
Q 010429 130 NGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN-KLTGDIP-TNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~-~~~~~~~l~~l~l~~N~~~~~ 203 (511)
+...+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++| .++...+ .+..+++|+.|++++|.+...
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 200 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence 9777778999999999999999999777778888888888888884 4444443 356778888888888887644
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.1e-17 Score=146.42 Aligned_cols=127 Identities=18% Similarity=0.288 Sum_probs=62.4
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
+++.|++++|+++ .++ .+..+++|+.|+|++|.++ .+ ..+..+++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 4455555555555 222 3455555555555555443 22 234555555555555555554444555555555555555
Q ss_pred CcccCCCCCcccccCCCCceEeccccc-ccCCCCCCCCCCcccceeccCCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNK-LTGDIPTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~~l~~l~l~~N~~~ 201 (511)
+|++++..|..+..+++|+.|++++|+ ++. ++.+..+++|+.|++++|.+.
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITD-IMPLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CGGGGGCSSCCEEECTTBCCC
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCccc-cHhhcCCCCCCEEECCCCCCc
Confidence 555554444445555555555555554 332 223444455555555555543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.9e-17 Score=178.28 Aligned_cols=145 Identities=28% Similarity=0.279 Sum_probs=128.3
Q ss_pred ccccceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCC-CchhcCCccccccccccccccCCCCcc
Q 010429 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYLNNLNGPIPTT 136 (511)
Q Consensus 58 c~w~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~i~~~~p~~ 136 (511)
|+|..|.+ -..+++.|+|++|.|++..+..|.++++|+.|+|++|.+.+.+ |..|.+|++|++|+|++|.|++..|+.
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 56777777 5678999999999999999999999999999999999766666 788999999999999999999888999
Q ss_pred cccccccceeeccCcccCCCCCcc--cccCCCCceEecccccccCCCC--CCCCCCcccceeccCCCCCCC
Q 010429 137 LGKLSKLRFLRLNNNSLMGEIPRS--LTNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|.++++|++|+|++|++++.+|.. |.++++|+.|+|++|.+++..+ .+..+++|+.|++++|.+.+.
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999877665 8999999999999999998754 367889999999999988654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=155.89 Aligned_cols=133 Identities=22% Similarity=0.311 Sum_probs=65.5
Q ss_pred CeeEEecCCCCcceecc-hhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccC-CCCcccccccccceee
Q 010429 70 SVTRVDLGNANLSGQLV-SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFLR 147 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~ 147 (511)
+++.|+|++|++++..+ ..+..+++|+.|+|++|.+++..|..+.++++|++|+|++|.+++ .+|..+..+++|++|+
T Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 181 (306)
T 2z66_A 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181 (306)
T ss_dssp TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEE
Confidence 34444444444443332 344445555555555555544444445555555555555555543 3444555555555555
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~~ 202 (511)
|++|++++..|..+..+++|+.|+|++|++++.++ .+..+++|+.|++++|.+.+
T Consensus 182 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 237 (306)
T 2z66_A 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237 (306)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCB
T ss_pred CCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcc
Confidence 55555554444555555555555555555554433 22444555555555555543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.7e-16 Score=150.49 Aligned_cols=113 Identities=24% Similarity=0.289 Sum_probs=73.8
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..|.++++|+.|+|++|.+++..+..+.++++|++|+|++|++++..+..+.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 45667777777766666666666677777777777666555566666666666666666666555555666666666666
Q ss_pred cCcccCCC-CCcccccCCCCceEecccccccCCC
Q 010429 149 NNNSLMGE-IPRSLTNVNSLQVLDLSNNKLTGDI 181 (511)
Q Consensus 149 ~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~ 181 (511)
++|++++. +|..+.++++|+.|+|++|++++.+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~ 165 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCC
Confidence 66666642 4666666666666666666666543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=144.74 Aligned_cols=130 Identities=17% Similarity=0.297 Sum_probs=114.3
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|.++. +..+..+++|+.|+|++|.+++..|..+..+++|++|+|++|++++..|..+..+++|++|+
T Consensus 65 l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 4589999999997763 35899999999999999999987888999999999999999999988899999999999999
Q ss_pred ccCcc-cCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 148 LNNNS-LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 148 L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
|++|+ ++ .+| .+..+++|+.|++++|++++.. .+..+++|+.|++++|++..
T Consensus 143 L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC----
T ss_pred ccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcccCC
Confidence 99998 66 555 6899999999999999999754 67788999999999998743
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=6.1e-17 Score=161.30 Aligned_cols=134 Identities=23% Similarity=0.210 Sum_probs=117.1
Q ss_pred CCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
...+|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 34689999999999999888999999999999999999997777789999999999999999998889999999999999
Q ss_pred eccCcccCCCCCccc---ccCCCCceEecccccccCCCCC-CCCCCc--ccceeccCCCC
Q 010429 147 RLNNNSLMGEIPRSL---TNVNSLQVLDLSNNKLTGDIPT-NGSFSL--FTPISFANNQL 200 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~~~~-~~~~~~--l~~l~l~~N~~ 200 (511)
+|++|+|++..+..| ..+++|+.|+|++|+|++.++. +..++. ++.|++++|++
T Consensus 142 ~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp ECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCE
T ss_pred ECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCc
Confidence 999999996555555 6799999999999999976642 344554 47899999998
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.7e-16 Score=170.03 Aligned_cols=136 Identities=23% Similarity=0.236 Sum_probs=118.7
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..|.++++|+.|+|++|.+++..|..+.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47899999999999888888999999999999999999888989999999999999999999655567999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~ 204 (511)
++|++++..|..|.++++|++|+|++|.+++.++. +..+++|+.|++++|.+.+.+
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 99999877778899999999999999999887664 467888999999998876543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.65 E-value=8.1e-16 Score=151.35 Aligned_cols=144 Identities=23% Similarity=0.307 Sum_probs=125.4
Q ss_pred ccccceEeCCC----------CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccc
Q 010429 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127 (511)
Q Consensus 58 c~w~gv~c~~~----------~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 127 (511)
|.|..+.|... .+++.|+|++|++++..+..|.++++|+.|+|++|++++..|..+.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 68999999632 37999999999999888889999999999999999999888999999999999999999
Q ss_pred cccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccC--CCCC-CCCCCcccceeccCCCCCCCC
Q 010429 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG--DIPT-NGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 128 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~-~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+|+ .+|..+. ++|++|+|++|++++..+..|.++++|+.|++++|+++. ..+. +..+ +|+.|++++|.+...+
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~ 188 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIP 188 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCC
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccC
Confidence 999 6776665 899999999999997777789999999999999999973 4443 3444 8999999999987654
Q ss_pred C
Q 010429 205 P 205 (511)
Q Consensus 205 ~ 205 (511)
.
T Consensus 189 ~ 189 (332)
T 2ft3_A 189 K 189 (332)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.64 E-value=6e-16 Score=137.23 Aligned_cols=116 Identities=28% Similarity=0.312 Sum_probs=100.7
Q ss_pred ceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccc
Q 010429 62 HVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS 141 (511)
Q Consensus 62 gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~ 141 (511)
+.+|.. +.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.+++
T Consensus 9 ~C~C~~----~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~ 81 (174)
T 2r9u_A 9 QCSCDQ----TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLT 81 (174)
T ss_dssp TSEECS----SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCEECC----cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcc
Confidence 456742 78999999997 4555553 8999999999999988899999999999999999999977666789999
Q ss_pred ccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCC
Q 010429 142 KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184 (511)
Q Consensus 142 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 184 (511)
+|++|+|++|+|++..+..|..+++|+.|+|++|++.+.++.+
T Consensus 82 ~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~ 124 (174)
T 2r9u_A 82 QLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDI 124 (174)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGG
T ss_pred hhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccccH
Confidence 9999999999999776667999999999999999999876543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.64 E-value=4.2e-16 Score=137.73 Aligned_cols=109 Identities=31% Similarity=0.330 Sum_probs=97.6
Q ss_pred eEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCc
Q 010429 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (511)
Q Consensus 72 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N 151 (511)
+.|++++|+|+. +|..+ .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 578888999985 55544 388999999999999888999999999999999999999877778899999999999999
Q ss_pred ccCCCCCcccccCCCCceEecccccccCCCCC
Q 010429 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183 (511)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 183 (511)
+|++..+..|..+++|+.|+|++|++++..+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 99987777899999999999999999987653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.6e-16 Score=151.84 Aligned_cols=145 Identities=23% Similarity=0.334 Sum_probs=126.3
Q ss_pred CccccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccc
Q 010429 57 PCTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (511)
Q Consensus 57 ~c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (511)
.|.|..+.|.. ...++.|+|++|++++..+..|.++++|++|+|++|++++..|..+.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 36899999963 24789999999999988888999999999999999999988899999999999999999
Q ss_pred ccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccC--CCC-CCCCCCcccceeccCCCCCCC
Q 010429 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG--DIP-TNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 127 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~-~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|+|+ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|+++. ..+ .+..+++|+.|++++|.+...
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l 186 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 186 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC
Confidence 9999 6676665 799999999999998777789999999999999999963 333 456788999999999988654
Q ss_pred C
Q 010429 204 P 204 (511)
Q Consensus 204 ~ 204 (511)
+
T Consensus 187 ~ 187 (330)
T 1xku_A 187 P 187 (330)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-16 Score=141.19 Aligned_cols=128 Identities=21% Similarity=0.183 Sum_probs=109.9
Q ss_pred CCCeeEEecCCCCcceecchhhcCC-CCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQL-TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
..+++.|+|++|+++.. +. +..+ ++|+.|+|++|.|++. ..+..+++|++|+|++|+|++..+..+..+++|++|
T Consensus 18 ~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 45799999999999954 44 5544 4999999999999964 579999999999999999997655666999999999
Q ss_pred eccCcccCCCCCc--ccccCCCCceEecccccccCCCCC----CCCCCcccceeccCCCC
Q 010429 147 RLNNNSLMGEIPR--SLTNVNSLQVLDLSNNKLTGDIPT----NGSFSLFTPISFANNQL 200 (511)
Q Consensus 147 ~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l~~N~~ 200 (511)
+|++|+|+ .+|. .+..+++|+.|++++|+++..++. +..+++|+.|++++|..
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 99999997 5665 889999999999999999976653 67789999999999865
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=168.32 Aligned_cols=137 Identities=18% Similarity=0.220 Sum_probs=114.4
Q ss_pred CCCeeEEecCCCCcceecc-hhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccC-CCCcccccccccce
Q 010429 68 ENSVTRVDLGNANLSGQLV-SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRF 145 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~ 145 (511)
..+++.|+|++|++++..+ ..+..+++|+.|+|++|.+++..|..+.++++|++|+|++|++++ .+|..+..+++|+.
T Consensus 398 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 477 (606)
T 3vq2_A 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477 (606)
T ss_dssp CTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCE
Confidence 4578888898888887776 678888888889998888888888888888888888888888887 47888888888888
Q ss_pred eeccCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCCCCCC
Q 010429 146 LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 146 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
|+|++|++++..|..+.++++|+.|+|++|++++.+| .+..+++|+.|++++|.+...|
T Consensus 478 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p 537 (606)
T 3vq2_A 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537 (606)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEE
T ss_pred EECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccC
Confidence 8888888888888888888888888888888888755 4577888888888888886443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.2e-16 Score=164.89 Aligned_cols=136 Identities=17% Similarity=0.132 Sum_probs=118.5
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..|.++++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 47899999999999888889999999999999999999877888999999999999999999877889999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCC--CCCCCCCCcccceeccCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD--IPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
++|++++..+..++++++|++|++++|.+++. +..+..+++|+.|++++|.+...+
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~ 165 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence 99999876666789999999999999999873 345677889999999999886543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=155.84 Aligned_cols=137 Identities=19% Similarity=0.238 Sum_probs=120.2
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|+...+..|.++++|+.|+
T Consensus 87 l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 166 (440)
T 3zyj_A 87 LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166 (440)
T ss_dssp CSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeC
Confidence 46899999999999999899999999999999999999977777899999999999999999977777899999999999
Q ss_pred ccCcc-cCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 148 LNNNS-LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|++|+ +....+..|.++++|+.|+|++|+++.. |.+..+++|+.|++++|.+...++
T Consensus 167 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~ 224 (440)
T 3zyj_A 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELDLSGNHLSAIRP 224 (440)
T ss_dssp CCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEECTTSCCCEECT
T ss_pred CCCCCCcceeCcchhhcccccCeecCCCCcCccc-cccCCCcccCEEECCCCccCccCh
Confidence 99955 5544455789999999999999999854 567788999999999998876544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.5e-16 Score=160.38 Aligned_cols=138 Identities=21% Similarity=0.201 Sum_probs=125.0
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 46899999999999999999999999999999999999977667789999999999999999988899999999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|++|.+++..+..|.++++|+.|+|++|++++.++. +..+++|+.|++++|.+...++
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~ 193 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECT
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeCh
Confidence 999999988888999999999999999999987653 5778899999999998865443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.62 E-value=6.5e-16 Score=144.54 Aligned_cols=136 Identities=17% Similarity=0.178 Sum_probs=116.2
Q ss_pred CCCeeEEecCCCC-cceecchhhcCCCCCcEEEeec-cCCCCCCCchhcCCccccccccccccccCCCCcccccccccc-
Q 010429 68 ENSVTRVDLGNAN-LSGQLVSQLGQLTNLQYLELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLR- 144 (511)
Q Consensus 68 ~~~l~~l~L~~~~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~- 144 (511)
..+++.|+|++|+ ++...+..|.++++|+.|+|++ |++++..+..|.++++|++|+|++|++++ +|. +..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 4579999999997 8888788999999999999998 99997777789999999999999999995 676 88888888
Q ss_pred --eeeccCc-ccCCCCCcccccCCCCc-eEecccccccCCCCCCCCCCcccceeccCCC-CCCCCC
Q 010429 145 --FLRLNNN-SLMGEIPRSLTNVNSLQ-VLDLSNNKLTGDIPTNGSFSLFTPISFANNQ-LNNPPP 205 (511)
Q Consensus 145 --~L~L~~N-~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~-~~~~~~ 205 (511)
.|+|++| ++++..+..|.++++|+ .|++++|+++..++.....++|+.|++++|+ +...++
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~ 197 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDK 197 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCH
Confidence 9999999 89877777899999999 9999999999666655445789999999995 765443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.9e-16 Score=151.85 Aligned_cols=130 Identities=27% Similarity=0.189 Sum_probs=103.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccc-cccccceee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG-KLSKLRFLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~ 147 (511)
.+++.|+|++|++++..+. .+++|+.|+|++|++++..|..+..+++|++|+|++|.|++..|..+. .+++|++|+
T Consensus 99 ~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 5677788888888766544 367788999999998877777888888899999999988877777664 688899999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|+|++. +. ...+++|+.|+|++|++++.++.+..+++|+.|++++|.+...
T Consensus 176 L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l 229 (317)
T 3o53_A 176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLI 229 (317)
T ss_dssp CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEE
T ss_pred CCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccch
Confidence 999988854 32 3358888899999998888777777788888888988888654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-16 Score=154.15 Aligned_cols=108 Identities=22% Similarity=0.265 Sum_probs=51.9
Q ss_pred CeeEEecCCCCcceecchhh--cCCCCCcEEEeeccCCCCCCCchhcCC-----ccccccccccccccCCCCcccccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQL--GQLTNLQYLELYSNNISGKVPEELGNL-----TNLVSLDLYLNNLNGPIPTTLGKLSK 142 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~i~~~~p~~~~~l~~ 142 (511)
+++.|+|++|++++..|..+ ..+++|+.|+|++|++++. |..+..+ ++|++|+|++|+|++..|..|.++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 45555555555554444443 4555555555555555533 4444444 45555555555555444445555555
Q ss_pred cceeeccCcccCCC--CCccc--ccCCCCceEeccccccc
Q 010429 143 LRFLRLNNNSLMGE--IPRSL--TNVNSLQVLDLSNNKLT 178 (511)
Q Consensus 143 L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~l~~N~l~ 178 (511)
|++|+|++|++.+. .|..+ ..+++|++|+|++|+++
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 55555555554432 12222 44445555555555444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.9e-16 Score=157.72 Aligned_cols=137 Identities=18% Similarity=0.203 Sum_probs=120.5
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+.++++|++|+|++|+|+...+..|.++++|+.|+
T Consensus 98 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 177 (452)
T 3zyi_A 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLD 177 (452)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEe
Confidence 46899999999999999999999999999999999999977777899999999999999999977777899999999999
Q ss_pred ccCc-ccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 148 LNNN-SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|++| .+....+..|.++++|+.|+|++|++++. |.+..+++|+.|++++|.+.+.++
T Consensus 178 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~ 235 (452)
T 3zyi_A 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRP 235 (452)
T ss_dssp CCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECG
T ss_pred CCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCc
Confidence 9995 45544455789999999999999999865 567788999999999998866544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-16 Score=171.40 Aligned_cols=133 Identities=23% Similarity=0.389 Sum_probs=122.2
Q ss_pred CCCeeEEecCCCCccee-----------------cchhhc--CCCCCcEEEeeccCCCCCCCchhcCCcccccccccccc
Q 010429 68 ENSVTRVDLGNANLSGQ-----------------LVSQLG--QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (511)
.++++.|+|++|++++. +|..++ ++++|++|+|++|++.+.+|..++++++|++|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 56899999999999986 899988 99999999999999999999999999999999999998
Q ss_pred -ccC-CCCcccccc------cccceeeccCcccCCCCCc--ccccCCCCceEecccccccCCCCCCCCCCcccceeccCC
Q 010429 129 -LNG-PIPTTLGKL------SKLRFLRLNNNSLMGEIPR--SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN 198 (511)
Q Consensus 129 -i~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N 198 (511)
+++ .+|..+.++ ++|++|+|++|+++ .+|. .++++++|+.|++++|+++|.+|.+..+++|+.|++++|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN 363 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence 998 899998887 99999999999999 8888 899999999999999999977777777888899999998
Q ss_pred CCC
Q 010429 199 QLN 201 (511)
Q Consensus 199 ~~~ 201 (511)
.+.
T Consensus 364 ~l~ 366 (636)
T 4eco_A 364 QIT 366 (636)
T ss_dssp EEE
T ss_pred ccc
Confidence 876
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=7e-16 Score=162.16 Aligned_cols=121 Identities=26% Similarity=0.305 Sum_probs=103.6
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
.++.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..+++|++|+.|+|++|+|++ +| .+.++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999986 455 899999999999999999 788899999999999999999996 67 88999999999999
Q ss_pred CcccCCCC-CcccccCCCCceEecccccccCCCCCCCC----CCcccceec
Q 010429 150 NNSLMGEI-PRSLTNVNSLQVLDLSNNKLTGDIPTNGS----FSLFTPISF 195 (511)
Q Consensus 150 ~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~----~~~l~~l~l 195 (511)
+|+|++.+ |..+..+++|+.|+|++|+|++.++.... +++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999776 88999999999999999999988875533 567777653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-16 Score=152.73 Aligned_cols=136 Identities=21% Similarity=0.205 Sum_probs=106.7
Q ss_pred CCCCeeEEecCCCCcceecchhhcCC-----CCCcEEEeeccCCCCCCCchhcCCccccccccccccccCC--CCccc--
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP--IPTTL-- 137 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~--~p~~~-- 137 (511)
...+++.|+|++|++++. |..+..+ ++|++|+|++|++++..|..++++++|++|+|++|++.+. .|..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 346789999999999877 7777776 8899999999999988878899999999999999987765 33444
Q ss_pred ccccccceeeccCcccCCC--CC-cccccCCCCceEecccccccCCCC--CCCCCCcccceeccCCCCCCC
Q 010429 138 GKLSKLRFLRLNNNSLMGE--IP-RSLTNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 138 ~~l~~L~~L~L~~N~l~~~--~~-~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~~~ 203 (511)
..+++|++|+|++|+|++. ++ ..+.++++|+.|+|++|++++.++ ....+++|+.|++++|.+...
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~i 268 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV 268 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSC
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChh
Confidence 7888899999999988831 22 344577888889998888888663 345578888888888888643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-15 Score=162.70 Aligned_cols=133 Identities=23% Similarity=0.159 Sum_probs=119.2
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+|+.|+|++|+|++..+..|..+++|+.|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|++|+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 35799999999999999899999999999999999999998888899999999999999999976666689999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
|++|.+++..|..|.++++|+.|+|++|.+++.. ...+++|+.|++++|.+.+
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSE
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCcccc
Confidence 9999999988989999999999999999999764 3456777777777776644
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=153.26 Aligned_cols=133 Identities=23% Similarity=0.163 Sum_probs=119.8
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..|..+++|+.|+|++|.+++..|..+.++++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 57999999999999988889999999999999999999888888999999999999999999555555799999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
++|++++..|..+..+++|+.|++++|++++.. ...+++|+.+++++|.+...
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeeccccccccc
Confidence 999999888889999999999999999999763 45678888899988877543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=7.8e-16 Score=164.72 Aligned_cols=132 Identities=24% Similarity=0.346 Sum_probs=99.6
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCC-CCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNI-SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
.+++.++++.|.+++..+..+..++.|+.|+|++|++ .+.+|..+..+++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 4567777777777777777777778888888887764 345667777788888888888888877777788888888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCC-CCC-CcccceeccCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSF-SLFTPISFANNQL 200 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~~l~~l~l~~N~~ 200 (511)
|++|+|++..|..|.++++|+.|+|++|+|++.+|.. ..+ ++|+.|++++|++
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~ 579 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence 8888887777777777888888888888887776643 444 5677888888877
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=149.05 Aligned_cols=136 Identities=22% Similarity=0.237 Sum_probs=88.9
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCC--CCCCchhcCC--------------------ccccccccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS--GKVPEELGNL--------------------TNLVSLDLYLN 127 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l--------------------~~L~~L~Ls~N 127 (511)
+++.|+|++|++++..+..|.++++|+.|+|++|.++ +..|..+..+ ++|++|+|++|
T Consensus 124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHN 203 (332)
T ss_dssp TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSS
T ss_pred cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCC
Confidence 5666666666666555566777777777777777774 2445545444 35555556666
Q ss_pred cccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 128 NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 128 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
.+++..|..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|+++..++.+..+++|+.|++++|++...++
T Consensus 204 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~~~~ 281 (332)
T 2ft3_A 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGV 281 (332)
T ss_dssp CCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCBCCT
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCccCh
Confidence 666555566667777777777777777666666777777777777777777555555666777777777777655443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-15 Score=147.86 Aligned_cols=136 Identities=21% Similarity=0.200 Sum_probs=84.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCC--CCCchhcCCcccc---------------------ccccc
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG--KVPEELGNLTNLV---------------------SLDLY 125 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~---------------------~L~Ls 125 (511)
.+++.|++++|++++..+..|.++++|+.|+|++|.++. ..+..+.++++|+ +|+|+
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~ 200 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD 200 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECT
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECC
Confidence 356677777777666666666666666666666666642 4444555555554 45555
Q ss_pred cccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 126 ~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+|++++..|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|+++..+..+..+++|+.|++++|++...+
T Consensus 201 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~ 279 (330)
T 1xku_A 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 279 (330)
T ss_dssp TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccC
Confidence 5555555555666666666666666666655555666666666666666666655555566666666666666665543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.1e-16 Score=170.00 Aligned_cols=133 Identities=23% Similarity=0.356 Sum_probs=122.4
Q ss_pred CCCeeEEecCCCCcce-----------------ecchhhc--CCCCCcEEEeeccCCCCCCCchhcCCcccccccccccc
Q 010429 68 ENSVTRVDLGNANLSG-----------------QLVSQLG--QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN 128 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (511)
..+|+.|+|++|+|++ .+|..++ ++++|+.|+|++|++.+.+|..+++|++|+.|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 5689999999999998 3888877 99999999999999999999999999999999999998
Q ss_pred -ccC-CCCccccccc-------ccceeeccCcccCCCCCc--ccccCCCCceEecccccccCCCCCCCCCCcccceeccC
Q 010429 129 -LNG-PIPTTLGKLS-------KLRFLRLNNNSLMGEIPR--SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197 (511)
Q Consensus 129 -i~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~ 197 (511)
|++ .+|..+.+++ +|+.|+|++|+++ .+|. .+.++++|+.|+|++|+++ .+|.+..+++|+.|++++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 998 8999888777 9999999999999 8888 8999999999999999999 555788899999999999
Q ss_pred CCCCC
Q 010429 198 NQLNN 202 (511)
Q Consensus 198 N~~~~ 202 (511)
|.+..
T Consensus 605 N~l~~ 609 (876)
T 4ecn_A 605 NQIEE 609 (876)
T ss_dssp SCCSC
T ss_pred Ccccc
Confidence 99873
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=7.1e-16 Score=150.24 Aligned_cols=130 Identities=18% Similarity=0.159 Sum_probs=67.4
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCC--C--CchhcCCccccccccccccccCCCCc----cccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK--V--PEELGNLTNLVSLDLYLNNLNGPIPT----TLGKLS 141 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~i~~~~p~----~~~~l~ 141 (511)
+++.|+|++|++++..+..|..+++|+.|+|++|++.+. + +..+..+++|++|+|++|+|+ .++. .+..++
T Consensus 146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGV 224 (310)
T ss_dssp CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTC
T ss_pred CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCC
Confidence 455555555555555555555555555555555555431 1 112245555555555555554 2222 134555
Q ss_pred ccceeeccCcccCCCCCcccccC---CCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 142 KLRFLRLNNNSLMGEIPRSLTNV---NSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 142 ~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
+|++|+|++|+|++..|..+..+ ++|+.|+|++|+|+..+.... ++|+.|++++|.+.+
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNR 286 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCS
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCC
Confidence 56666666666655545544444 456666666666654333221 455666666665544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=7.4e-16 Score=161.20 Aligned_cols=137 Identities=25% Similarity=0.301 Sum_probs=116.8
Q ss_pred CCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCC--CCCchhcCCccccccccccccccCCCCcc-ccccccc
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG--KVPEELGNLTNLVSLDLYLNNLNGPIPTT-LGKLSKL 143 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~-~~~l~~L 143 (511)
...+++.|+|++|++++..|..+..+++|+.|+|++|++++ .+|..+..+++|++|+|++|.+++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 45689999999999998888899999999999999999986 56677899999999999999999756654 8888999
Q ss_pred ceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 144 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+.|+|++|++++.+|..+. ++|+.|+|++|+|+..++....+++|+.|++++|.+...++
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~ 461 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPD 461 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCT
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCH
Confidence 9999999999887777664 78999999999999666666788999999999998875443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=161.65 Aligned_cols=137 Identities=25% Similarity=0.316 Sum_probs=112.9
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCC-chhcCCccccccccccccccCCCCccccccccccee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP-EELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
..+++.|+|++|.+++..+. +..+++|+.|+|++|.+++..| ..+.++++|++|+|++|.+++..|..+.++++|+.|
T Consensus 372 ~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 372 TTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp CSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred cCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 45788999999998876555 8888889999999988887665 467888888888888888888888888888888888
Q ss_pred eccCcccC-CCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCCCCCCC
Q 010429 147 RLNNNSLM-GEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 147 ~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+|++|.++ +.+|..+..+++|+.|+|++|++++.+| .+..+++|+.|++++|.+.+.++
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 511 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCH
Confidence 88888887 5688888888888888888888888755 45778888888888888876654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=151.73 Aligned_cols=134 Identities=18% Similarity=0.184 Sum_probs=118.6
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCC-ccccccccccee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP-TTLGKLSKLRFL 146 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L 146 (511)
..+++.|+|++|++++..+..|.++++|+.|+|++|++++..+..+.++++|++|+|++|++++..+ ..+.++++|++|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence 4689999999999999889999999999999999999996666669999999999999999995433 479999999999
Q ss_pred eccCcc-cCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCCC
Q 010429 147 RLNNNS-LMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 147 ~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~ 201 (511)
+|++|+ +.+..+..|.++++|+.|++++|++++..+ .+..+++|+.|++++|.+.
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 999994 776677889999999999999999998855 5678899999999999763
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.8e-15 Score=159.82 Aligned_cols=138 Identities=27% Similarity=0.323 Sum_probs=120.3
Q ss_pred CCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCC--CCchhcCCccccccccccccccCCCCc-ccccccc
Q 010429 66 NSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK--VPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSK 142 (511)
Q Consensus 66 ~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~i~~~~p~-~~~~l~~ 142 (511)
....+++.|+|++|++++..|..+.++++|+.|+|++|++++. +|..+.++++|++|+|++|++++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 3456899999999999998899999999999999999999963 356789999999999999999985655 5888999
Q ss_pred cceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 143 LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 143 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|+.|+|++|++++.+|..+. ++|+.|+|++|+|+..++....+++|+.|++++|.+...++
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~ 490 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPD 490 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCT
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCH
Confidence 99999999999987776654 79999999999999877777889999999999999976544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.9e-15 Score=144.41 Aligned_cols=127 Identities=25% Similarity=0.367 Sum_probs=102.4
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++..+ +..+++|+.|+|++|.+++ +|. +..+++|++|+|++|+|++. ..+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEE
Confidence 4578888888888886554 8888888888888888884 443 88888888888888888853 5688888888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|++++. ..+..+++|+.|+|++|++++.++ +..+++|+.|++++|.+...
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l 193 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL 193 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCC
Confidence 888888854 567888888888888888887766 67788888888888887654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.8e-15 Score=159.89 Aligned_cols=132 Identities=20% Similarity=0.174 Sum_probs=116.7
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 368999999999999988899999999999999999999888999999999999999999999 67776 899999999
Q ss_pred ccCcccCC-CCCcccccCCCCceEecccccccCCCCCCCCCCcc--cceeccCCCC--CCCC
Q 010429 148 LNNNSLMG-EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF--TPISFANNQL--NNPP 204 (511)
Q Consensus 148 L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l--~~l~l~~N~~--~~~~ 204 (511)
|++|++++ .+|..|.++++|++|+|++|++++. .+..+++| +.|++++|.+ .+..
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~L~~n~l~~~~~~ 187 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVSYHIKGGE 187 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--TTGGGTTSCEEEEEEEESSCCCCSSS
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccC--chhhhhhceeeEEEeecccccccccC
Confidence 99999997 3468999999999999999999863 34455666 9999999988 5443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.2e-15 Score=162.96 Aligned_cols=138 Identities=25% Similarity=0.240 Sum_probs=125.0
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++..|..|.++++|+.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 48 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 48 YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127 (680)
T ss_dssp GTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE
T ss_pred CCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEE
Confidence 35799999999999999999999999999999999999966666799999999999999999988788999999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCC---CCCCcccceeccCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN---GSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|++|.+++..|..+.++++|+.|++++|.+++.++.. ..+++|+.|++++|.+.+.++
T Consensus 128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 188 (680)
T 1ziw_A 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP 188 (680)
T ss_dssp CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCT
T ss_pred CCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccCh
Confidence 9999999988999999999999999999999887642 345899999999999876554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-15 Score=158.82 Aligned_cols=127 Identities=20% Similarity=0.207 Sum_probs=116.2
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 58999999999999988899999999999999999999888999999999999999999999 57776 8999999999
Q ss_pred cCcccCC-CCCcccccCCCCceEecccccccCCCCCCCCCCcc--cceeccCCCC
Q 010429 149 NNNSLMG-EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF--TPISFANNQL 200 (511)
Q Consensus 149 ~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l--~~l~l~~N~~ 200 (511)
++|++++ .+|..|+++++|++|++++|++++. .+..+++| +.|++++|.+
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--SVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG--GGGGGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchh--hccccccceeeEEEeecccc
Confidence 9999997 4789999999999999999999863 34566777 9999999998
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.1e-16 Score=164.15 Aligned_cols=139 Identities=27% Similarity=0.350 Sum_probs=102.5
Q ss_pred CCCCCCCCCCCCc-----cccce-EeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccc
Q 010429 46 VLQSWDATLVNPC-----TWFHV-TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL 119 (511)
Q Consensus 46 ~l~~w~~~~~~~c-----~w~gv-~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 119 (511)
.+.+|.. ..+|| .|.|+ .|. .++++.|+|++|+|++ +|..+ +++|+.|+|++|+|+ .+| ..+++|
T Consensus 32 ~l~~W~~-~~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEK-QALPGENRNEAVSLLKECL-INQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHT-TCCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhc-cCCccccccchhhhccccc-cCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCC
Confidence 3556754 35778 79998 674 4579999999999987 55544 377888888888888 666 457888
Q ss_pred cccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCC
Q 010429 120 VSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQ 199 (511)
Q Consensus 120 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 199 (511)
++|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++.++ .+++|+.|++++|.
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQ 171 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSC
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCC
Confidence 888888888886 666 654 78888888888875 555 56778888888888776443 45677777777777
Q ss_pred CCCCC
Q 010429 200 LNNPP 204 (511)
Q Consensus 200 ~~~~~ 204 (511)
+.+.|
T Consensus 172 L~~lp 176 (571)
T 3cvr_A 172 LTFLP 176 (571)
T ss_dssp CSCCC
T ss_pred CCCcc
Confidence 76543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.9e-15 Score=141.26 Aligned_cols=126 Identities=24% Similarity=0.269 Sum_probs=91.8
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|+|++..+ +.++++|+.|+|++|++++ +|. +.. ++|++|+|++|+|++. +.+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEE
Confidence 3567788888888776544 7778888888888888774 443 333 7788888888887753 3577788888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|+|++. + .+..+++|+.|+|++|++++. +.+..+++|+.|++++|++...
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 888888754 3 577788888888888888776 5566777888888888877554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.57 E-value=3.1e-15 Score=145.53 Aligned_cols=129 Identities=28% Similarity=0.444 Sum_probs=106.4
Q ss_pred CCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
...+++.|+|++|++++. +.+..+++|+.|+|++|++++ ++. +..+++|++|+|++|++++..+ +..+++|+.|
T Consensus 83 ~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L 156 (308)
T 1h6u_A 83 NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156 (308)
T ss_dssp TCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEE
Confidence 356899999999999864 368899999999999999985 443 8899999999999999986533 8889999999
Q ss_pred eccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+|++|++++..+ +..+++|+.|++++|++++.++ +..+++|+.|++++|.+.+.+
T Consensus 157 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG
T ss_pred EccCCcCCCChh--hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccc
Confidence 999999986443 8888999999999999987665 667788899999999886654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.57 E-value=5.1e-15 Score=143.99 Aligned_cols=128 Identities=24% Similarity=0.395 Sum_probs=106.2
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++..+ +..+++|+.|+|++|.+++ ++ .+..+++|++|+|++|+|++ ++. +..+++|++|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 4678999999999986554 8899999999999999885 44 58889999999999999985 443 88899999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|.+...+
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcCh
Confidence 99999986543 8889999999999999987665 777889999999999886544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-15 Score=158.39 Aligned_cols=125 Identities=20% Similarity=0.181 Sum_probs=63.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|.|++..+ .++|+.|+|++|.|++..+. .+++|+.|+|++|.|++..|..+.++++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 151 (487)
T 3oja_A 80 STLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151 (487)
T ss_dssp TTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEEC
T ss_pred CCCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEEC
Confidence 345555555555553322 14555555555555543332 2345555555555555555555555555555555
Q ss_pred cCcccCCCCCcccc-cCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 149 NNNSLMGEIPRSLT-NVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 149 ~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
++|.+++.+|..+. .+++|+.|+|++|.|++.++ ...+++|+.|++++|.+.+
T Consensus 152 s~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~ 205 (487)
T 3oja_A 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAF 205 (487)
T ss_dssp TTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSSCCCE
T ss_pred CCCCCCCcChHHHhhhCCcccEEecCCCccccccc-cccCCCCCEEECCCCCCCC
Confidence 55555554444443 45555555555555554422 2234555555555555544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=5.1e-15 Score=130.70 Aligned_cols=106 Identities=23% Similarity=0.262 Sum_probs=96.2
Q ss_pred CcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEeccc
Q 010429 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174 (511)
Q Consensus 95 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 174 (511)
.+.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 5776664 8999999999999988899999999999999999999987777889999999999999
Q ss_pred ccccCCCCC-CCCCCcccceeccCCCCCCC
Q 010429 175 NKLTGDIPT-NGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 175 N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~ 203 (511)
|+|++.++. +..+++|+.|++++|++...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999998885 67899999999999998543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.56 E-value=7.7e-15 Score=130.02 Aligned_cols=105 Identities=22% Similarity=0.232 Sum_probs=95.4
Q ss_pred CcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEeccc
Q 010429 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174 (511)
Q Consensus 95 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 174 (511)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999998 7787665 8999999999999998899999999999999999999977667789999999999999
Q ss_pred ccccCCCCC-CCCCCcccceeccCCCCCC
Q 010429 175 NKLTGDIPT-NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 175 N~l~~~~~~-~~~~~~l~~l~l~~N~~~~ 202 (511)
|+|++.++. +..+++|+.|++++|++..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 999998876 6789999999999999854
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5.8e-15 Score=142.30 Aligned_cols=129 Identities=27% Similarity=0.321 Sum_probs=114.0
Q ss_pred CCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
...+++.|+|++|++++. +.+..+++|+.|+|++|++++. ..+..+++|++|+|++|+|++. ..+..+++|+.|
T Consensus 88 ~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 161 (291)
T 1h6t_A 88 NLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 161 (291)
T ss_dssp TCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cCCCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE
Confidence 456899999999999863 3499999999999999999964 4699999999999999999965 689999999999
Q ss_pred eccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+|++|++++..+ +..+++|+.|+|++|++++. +.+..+++|+.|++++|++...+
T Consensus 162 ~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEECCC
T ss_pred EccCCccccchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccCCc
Confidence 999999997655 89999999999999999976 45788999999999999986543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.6e-15 Score=147.77 Aligned_cols=134 Identities=14% Similarity=0.111 Sum_probs=79.5
Q ss_pred CeeEEecCCCCcceecchhh--cCCCCCcEEEeeccCCCCCCC----chhcCCccccccccccccccCCCCccccccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQL--GQLTNLQYLELYSNNISGKVP----EELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 143 (511)
+++.|+|++|++++..|..+ ..+++|+.|+|++|.+++..+ ..+..+++|++|+|++|+|++..|..|..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 36777777777776666666 666667777777776665444 233456666666666666666666666666666
Q ss_pred ceeeccCcccCCC--C--CcccccCCCCceEecccccccCCCCC----CCCCCcccceeccCCCCCCC
Q 010429 144 RFLRLNNNSLMGE--I--PRSLTNVNSLQVLDLSNNKLTGDIPT----NGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 144 ~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~l~~l~l~~N~~~~~ 203 (511)
++|+|++|++.+. + +..+..+++|++|+|++|+++...+. +..+++|+.|++++|.+.+.
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 239 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRAT 239 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCcc
Confidence 6666666665431 1 12234556666666666666532221 13345566666666666444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.56 E-value=3e-15 Score=131.89 Aligned_cols=113 Identities=24% Similarity=0.260 Sum_probs=102.2
Q ss_pred cCCCCCcEEEeeccCCC-CCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCc
Q 010429 90 GQLTNLQYLELYSNNIS-GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQ 168 (511)
Q Consensus 90 ~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 168 (511)
...++|+.|+|++|.++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34588999999999998 78898899999999999999999965 8899999999999999999987888888899999
Q ss_pred eEecccccccCCC--CCCCCCCcccceeccCCCCCCCC
Q 010429 169 VLDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 169 ~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
.|+|++|++++.+ +.+..+++|+.|++++|++...+
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 136 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTST
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchH
Confidence 9999999999865 56788999999999999986554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.55 E-value=9.5e-16 Score=166.11 Aligned_cols=134 Identities=25% Similarity=0.353 Sum_probs=117.7
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
...|+.|+|++|.+. .++..+.++++|+.|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|.+|++|++|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 467999999999999 67777779999999999999999 89999999999999999999999 7899999999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCC--cccceeccCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS--LFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~--~l~~l~l~~N~~~~~~~ 205 (511)
|++|.|+ .+|..|.+|++|+.|+|++|+|++.+|...... .+..+++++|.+.+..|
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 9999998 788889999999999999999998877542211 22347789998877654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=3.3e-15 Score=159.25 Aligned_cols=138 Identities=18% Similarity=0.104 Sum_probs=123.5
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++..|..|.++++|+.|+|++|.+++..|..|+++++|++|+|++|+|++..|..+.++++|++|+
T Consensus 56 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~ 135 (606)
T 3t6q_A 56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135 (606)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEE
T ss_pred CccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEE
Confidence 46899999999999999999999999999999999999988899999999999999999999987788999999999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCccc--ceeccCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFT--PISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~--~l~l~~N~~~~~~~ 205 (511)
|++|++++..+..+..+++|+.|++++|++++..+. +..+++|+ .|++++|.+.+.++
T Consensus 136 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~ 196 (606)
T 3t6q_A 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP 196 (606)
T ss_dssp CCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECT
T ss_pred CCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccCh
Confidence 999999975545555699999999999999987653 46677888 78999999877554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-15 Score=131.19 Aligned_cols=112 Identities=21% Similarity=0.237 Sum_probs=101.4
Q ss_pred CCCCCcEEEeeccCCC-CCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCce
Q 010429 91 QLTNLQYLELYSNNIS-GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169 (511)
Q Consensus 91 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 169 (511)
..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 4578999999999998 78999899999999999999999966 88999999999999999999878888888999999
Q ss_pred EecccccccCCC--CCCCCCCcccceeccCCCCCCCC
Q 010429 170 LDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 170 L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
|++++|++++.+ ..+..+++|+.|++++|++.+.+
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 129 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGST
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchH
Confidence 999999999854 56788899999999999986543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=138.22 Aligned_cols=126 Identities=29% Similarity=0.368 Sum_probs=109.6
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|+++.. + .+..+++|+.|+|++|+|++..+ +.++++|++|+|++|+|++ +|.. .. ++|+.|+
T Consensus 40 l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~ 112 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLF 112 (263)
T ss_dssp HTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEE
T ss_pred cCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEE
Confidence 45799999999999854 4 78999999999999999996544 9999999999999999996 4443 33 9999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|++++. ..+..+++|+.|+|++|++++. +.+..+++|+.|++++|.+.+.
T Consensus 113 L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 113 LDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC
T ss_pred ccCCccCCC--hhhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch
Confidence 999999963 3689999999999999999986 4577889999999999999765
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=153.26 Aligned_cols=127 Identities=26% Similarity=0.365 Sum_probs=93.8
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+|+.|+|++|+|++..+ +..+++|+.|+|++|.|++ +| .+..|++|+.|+|++|+|++. ..+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEE
Confidence 4578888888888876554 7788888888888888874 34 577788888888888887753 4577777788888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|+|++. ..+..+++|+.|+|++|+|++.++ +..+++|+.|+|++|.+...
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC
Confidence 888877754 567777777777777777777666 66677777777777777553
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=7.1e-15 Score=154.78 Aligned_cols=126 Identities=20% Similarity=0.219 Sum_probs=107.2
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccC-CCCccccccccccee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG-PIPTTLGKLSKLRFL 146 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L 146 (511)
..+++.|+|++|++++..+..|.++++|+.|+|++|.+++..|..++++++|++|+|++|.+++ ..|..+.++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 4689999999999999989999999999999999999998888889999999999999999986 367889999999999
Q ss_pred eccCcccCCCCC-cccccCCCCceEecccccccCCCCC-CCCCCcccce
Q 010429 147 RLNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPI 193 (511)
Q Consensus 147 ~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l 193 (511)
+|++|++.+.+| ..|.++++|+.|++++|++++..+. +..+++|+.|
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 177 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEE
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceE
Confidence 999999554554 6899999999999999999986553 3443333333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.53 E-value=1e-14 Score=144.29 Aligned_cols=126 Identities=23% Similarity=0.348 Sum_probs=63.9
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|++++|.+++..+ +..+++|+.|+|++|.+++..+ +..+++|++|+|++|.+++. +.+..+++|+.|+|
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEc
Confidence 345555555555554332 5555555555555555553222 55555555555555555532 33555555555555
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~ 202 (511)
++|++++. ..+..+++|+.|++++|++++..+. +..+++|+.|++++|++.+
T Consensus 273 ~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 273 GSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred cCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 55555532 2345555555555555555544332 2344555555555555543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=5.2e-15 Score=144.58 Aligned_cols=127 Identities=19% Similarity=0.153 Sum_probs=79.4
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++.. ..++|+.|+|++|++++..+. .+++|++|+|++|+|++..|..+..+++|++|+
T Consensus 79 l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 150 (317)
T 3o53_A 79 LSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150 (317)
T ss_dssp CTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEE
T ss_pred cCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEE
Confidence 456667777777666433 236677777777776644333 245667777777777666566666677777777
Q ss_pred ccCcccCCCCCccc-ccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|++++..+..+ ..+++|+.|+|++|.+++.+ ....+++|+.|++++|.+.+.
T Consensus 151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~~l 206 (317)
T 3o53_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAFM 206 (317)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCCEE
T ss_pred CCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCCcc
Confidence 77777766555554 35667777777777766553 233466677777777766543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-16 Score=145.21 Aligned_cols=128 Identities=26% Similarity=0.307 Sum_probs=86.8
Q ss_pred CeeEEecCCCCcceecch------hhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccc
Q 010429 70 SVTRVDLGNANLSGQLVS------QLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL 143 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 143 (511)
+++.++|+.+.++|..|. .+..+++|+.|+|++|.+++ +| .+.++++|++|+|++|.|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 445555555555555444 67777777777777777774 55 6777777777777777777 566666667777
Q ss_pred ceeeccCcccCCCCCcccccCCCCceEecccccccCCCC--CCCCCCcccceeccCCCCCC
Q 010429 144 RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 144 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~~ 202 (511)
+.|+|++|++++ +| .+..+++|+.|++++|++++..+ .+..+++|+.|++++|++.+
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 777777777774 34 46677777777777777775432 34566777777777776643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=152.48 Aligned_cols=130 Identities=27% Similarity=0.323 Sum_probs=115.9
Q ss_pred CCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
...+|+.|+|++|.|++. +.+..+++|+.|+|++|.|++ ++ .+..|++|+.|+|++|+|++. ..+..|++|+.|
T Consensus 85 ~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp GCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred cCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 356899999999999963 379999999999999999995 44 599999999999999999965 789999999999
Q ss_pred eccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+|++|+|++..| +..+++|+.|+|++|+|++. +.+..+++|+.|++++|++.+.+.
T Consensus 159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECCCC
T ss_pred ECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCCcc
Confidence 999999997766 89999999999999999976 567889999999999999976544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.2e-14 Score=156.48 Aligned_cols=131 Identities=25% Similarity=0.266 Sum_probs=118.6
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 57999999999999999999999999999999999999888999999999999999999999888999999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
++|++.+..+..|.++++|+.|+|++|.+++... +++|+.|++++|++...
T Consensus 346 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~----~~~L~~L~l~~N~l~~l 396 (844)
T 3j0a_A 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF----IPSIPDIFLSGNKLVTL 396 (844)
T ss_dssp CSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS----CCSCSEEEEESCCCCCC
T ss_pred CCCCCCccChhhhcCCCCCCEEECCCCCCCcccC----CCCcchhccCCCCcccc
Confidence 9999998888889999999999999999986533 56777777777777543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.5e-14 Score=141.60 Aligned_cols=111 Identities=23% Similarity=0.204 Sum_probs=96.7
Q ss_pred ccccceEeCCCCCeeEEecCCC-CcceecchhhcCCCCCcEEEeec-cCCCCCCCchhcCCccccccccccccccCCCCc
Q 010429 58 CTWFHVTCNSENSVTRVDLGNA-NLSGQLVSQLGQLTNLQYLELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT 135 (511)
Q Consensus 58 c~w~gv~c~~~~~l~~l~L~~~-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~ 135 (511)
|.|..|.|+ ++ +|+. +|. +..+++|+.|+|++ |+|++..|..|.+|++|++|+|++|+|++..|.
T Consensus 8 C~~~~v~~~-----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 777666664 44 6774 666 99999999999996 999988888999999999999999999999999
Q ss_pred ccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCC
Q 010429 136 TLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (511)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (511)
.|.+|++|+.|+|++|+|++..+..|..++ |+.|+|.+|+|.+...
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 999999999999999999977666777766 9999999999987643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=3.2e-15 Score=157.14 Aligned_cols=107 Identities=26% Similarity=0.348 Sum_probs=98.8
Q ss_pred CCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecc
Q 010429 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS 173 (511)
Q Consensus 94 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 173 (511)
.|+.|+|++|.|++ +|. +++|++|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++ +| .++++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58999999999995 676 999999999999999999 889999999999999999999996 67 89999999999999
Q ss_pred cccccCC--CCCCCCCCcccceeccCCCCCCCCC
Q 010429 174 NNKLTGD--IPTNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 174 ~N~l~~~--~~~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+|+|++. +..+..+++|+.|++++|++++.++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 9999998 4567889999999999999977654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-14 Score=145.33 Aligned_cols=127 Identities=31% Similarity=0.408 Sum_probs=87.4
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|.+++..+ +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 467778888877776544 7777777777777777775433 6777777777777777775433 667777777777
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
++|++++..| +..+++|+.|++++|++++. +.+..+++|+.|++++|++.+.+
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~ 369 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLT 369 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCG
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccc
Confidence 7777776544 56677777777777777655 34556667777777777665543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.48 E-value=6.3e-14 Score=144.44 Aligned_cols=127 Identities=31% Similarity=0.433 Sum_probs=104.1
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++. +.+..+++|+.|+|++|.+++..| +..+++|++|+|++|.+++..+ +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 35788999999988864 467888899999999999886554 8888899999999999886543 88888999999
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|++++..+ +..+++|+.|+|++|++++.++ ...+++|+.|++++|.+.+.
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc
Confidence 99999886544 7888999999999999888766 56788889999999888665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=2.2e-14 Score=127.45 Aligned_cols=113 Identities=21% Similarity=0.184 Sum_probs=96.9
Q ss_pred hhhcCCCCCcEEEeeccCCCCCCCchhcCCc-cccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCC
Q 010429 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLT-NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165 (511)
Q Consensus 87 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 165 (511)
..+.++++|+.|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..+..+++|++|+|++|+|++..+..+..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 45678899999999999999 5565 55555 999999999999965 7899999999999999999966556669999
Q ss_pred CCceEecccccccCCCC--CCCCCCcccceeccCCCCCCC
Q 010429 166 SLQVLDLSNNKLTGDIP--TNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 166 ~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~~~ 203 (511)
+|+.|+|++|+|+..++ .+..+++|+.|++++|+++..
T Consensus 89 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~ 128 (176)
T 1a9n_A 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 128 (176)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred CCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCc
Confidence 99999999999986655 567889999999999998643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.47 E-value=6.5e-14 Score=138.72 Aligned_cols=147 Identities=14% Similarity=0.119 Sum_probs=118.2
Q ss_pred ccccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCC-chhcCCccccc-cccc
Q 010429 58 CTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP-EELGNLTNLVS-LDLY 125 (511)
Q Consensus 58 c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~Ls 125 (511)
|.|..|.|++ ..++++|+|++|+|+.+.+..|.++++|+.|+|++|++.+.+| ..|.++++|++ ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 6888999953 2468999999999998777889999999999999999976665 46788988775 6777
Q ss_pred cccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEeccc-ccccCCCCC-CCCC-CcccceeccCCCCCC
Q 010429 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN-NKLTGDIPT-NGSF-SLFTPISFANNQLNN 202 (511)
Q Consensus 126 ~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~-~~~~-~~l~~l~l~~N~~~~ 202 (511)
+|+|+...|+.|..+++|++|++++|+|++..+..+....++..|++.+ |++....+. +..+ ..++.|++++|.+..
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 8999988889999999999999999999977666777777888888865 567655543 2333 457888999998865
Q ss_pred CC
Q 010429 203 PP 204 (511)
Q Consensus 203 ~~ 204 (511)
.+
T Consensus 169 i~ 170 (350)
T 4ay9_X 169 IH 170 (350)
T ss_dssp EC
T ss_pred CC
Confidence 43
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=6.5e-16 Score=140.15 Aligned_cols=128 Identities=21% Similarity=0.254 Sum_probs=110.4
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++ +| .+..+++|+.|+|++|.|+ .+|..+..+++|++|+|++|+|++ +| .+..+++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 4589999999999997 55 8999999999999999999 788888889999999999999996 55 699999999999
Q ss_pred ccCcccCCCCC-cccccCCCCceEecccccccCCCCC-----------CCCCCcccceeccCCCCCC
Q 010429 148 LNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPT-----------NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 148 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~-----------~~~~~~l~~l~l~~N~~~~ 202 (511)
|++|++++..+ ..+..+++|+.|++++|++++.+|. +..+++|+.|+ +|+++.
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 99999995433 4788999999999999999987664 45677888775 666643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.1e-13 Score=144.88 Aligned_cols=116 Identities=26% Similarity=0.283 Sum_probs=75.6
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 166 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS 166 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence 4578888888888886 444 544 77788888887775 555 56777777777777774 554 456777777
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcc-------cceeccCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF-------TPISFANNQLNN 202 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l-------~~l~l~~N~~~~ 202 (511)
|++|+|++ +|. |. ++|+.|+|++|+|+..++ +.. +| +.|++++|.+..
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~ 221 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRITH 221 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCCC
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCccee
Confidence 77777764 555 44 667777777777664443 322 45 666666666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.42 E-value=2e-13 Score=134.98 Aligned_cols=127 Identities=24% Similarity=0.407 Sum_probs=92.3
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|+|++|.+++.. . +..+++|++|+
T Consensus 176 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~-~-~~~l~~L~~L~ 249 (347)
T 4fmz_A 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS-P-LANLSQLTWLE 249 (347)
T ss_dssp CTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEE
T ss_pred CCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCc-c-hhcCCCCCEEE
Confidence 3467788888888775433 7777888888888888775443 777788888888888887543 3 77778888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|.+++. ..+..+++|+.|++++|++++. +.+..+++|+.|++++|.+.+.
T Consensus 250 l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~ 302 (347)
T 4fmz_A 250 IGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNE 302 (347)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGG
T ss_pred CCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCc
Confidence 888887753 4577778888888888887765 4456677788888888877544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=2.5e-13 Score=134.35 Aligned_cols=104 Identities=20% Similarity=0.133 Sum_probs=94.1
Q ss_pred cEEEeecc-CCCCCCCchhcCCcccccccccc-ccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecc
Q 010429 96 QYLELYSN-NISGKVPEELGNLTNLVSLDLYL-NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLS 173 (511)
Q Consensus 96 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 173 (511)
..++++++ +|+ .+|. +..+++|++|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 899 6888 99999999999996 99998888999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcccceeccCCCCC
Q 010429 174 NNKLTGDIPTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 174 ~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 201 (511)
+|+|++.++.......|+.|++.+|++.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~ 116 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLH 116 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCccceeCHHHcccCCceEEEeeCCCcc
Confidence 9999998887654445999999999984
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=134.29 Aligned_cols=130 Identities=18% Similarity=0.182 Sum_probs=76.7
Q ss_pred ccceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccc
Q 010429 60 WFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139 (511)
Q Consensus 60 w~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~ 139 (511)
..++......+++.|+|++|++++. + ++.+++|+.|+|++|++++. + ++++++|++|++++|+..+.+ .+..
T Consensus 97 l~~~~~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~ 168 (457)
T 3bz5_A 97 LTNLDVTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTP 168 (457)
T ss_dssp CSCCCCTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTT
T ss_pred CceeecCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--cccc
Confidence 3333333456788888888888864 3 77888888888888888753 3 566666666666666433333 3555
Q ss_pred ccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 140 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
+++|+.|+|++|++++ +| +..+++|+.|++++|++++. .+..+++|+.|++++|.+.+
T Consensus 169 l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 169 QTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp CTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC
T ss_pred CCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc
Confidence 5566666666665554 22 44555555555555555543 23444455555555555444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-13 Score=146.45 Aligned_cols=136 Identities=23% Similarity=0.269 Sum_probs=75.1
Q ss_pred CCCCCCCCCCCCccccce--------EeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCc
Q 010429 46 VLQSWDATLVNPCTWFHV--------TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT 117 (511)
Q Consensus 46 ~l~~w~~~~~~~c~w~gv--------~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 117 (511)
+.++|... .+||.|.|. .|. .++++.|++++|+|+ .+|..+. ++|+.|+|++|.|+ .+|. .++
T Consensus 11 ~w~~W~~~-~~~~~~~~r~~~~~~~~~c~-~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 11 VWSAWRRA-APAEESRGRAAVVQKMRACL-NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp HHHHHHHT-CCGGGHHHHHHHHHHHHHHH-HHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHhc-CCcchhccccccCccccccc-CCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 34456433 467888553 221 234677777777776 4444443 56777777777766 4444 456
Q ss_pred cccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccC
Q 010429 118 NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197 (511)
Q Consensus 118 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~ 197 (511)
+|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|++.+.. +++|+.|++++
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~ 150 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSD 150 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCS
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcC
Confidence 6777777777766 3444 45666666666666663 332 344555555555555443321 24444444444
Q ss_pred CCCC
Q 010429 198 NQLN 201 (511)
Q Consensus 198 N~~~ 201 (511)
|.+.
T Consensus 151 N~l~ 154 (622)
T 3g06_A 151 NQLA 154 (622)
T ss_dssp SCCS
T ss_pred CcCC
Confidence 4443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.1e-12 Score=132.37 Aligned_cols=123 Identities=23% Similarity=0.250 Sum_probs=84.9
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|++++. + ++.+++|+.|+|++|.|++. | ++++++|++|+|++|+|++ +| +..+++|++|+
T Consensus 63 l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~ 133 (457)
T 3bz5_A 63 LTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLN 133 (457)
T ss_dssp CTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEE
Confidence 35778888888888764 2 77788888888888888753 3 7778888888888888875 34 77778888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|++|++++. + +..+++|+.|++++|+..+.+ .+..+++|+.|++++|.+.+.
T Consensus 134 l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~l 185 (457)
T 3bz5_A 134 CARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKITEL 185 (457)
T ss_dssp CTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-CCTTCTTCCEEECCSSCCCCC
T ss_pred CCCCcccee-c--cccCCcCCEEECCCCCccccc-ccccCCcCCEEECCCCcccee
Confidence 888887753 2 566666666666666444443 344556666666666665543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.37 E-value=2.7e-14 Score=143.44 Aligned_cols=134 Identities=16% Similarity=0.238 Sum_probs=75.0
Q ss_pred CCeeEEecCCCCcce----ecchhhcCC---------CCCcEEEeeccCCC-CCCC---chhcCCcccccccccccccc-
Q 010429 69 NSVTRVDLGNANLSG----QLVSQLGQL---------TNLQYLELYSNNIS-GKVP---EELGNLTNLVSLDLYLNNLN- 130 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~----~~~~~~~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~i~- 130 (511)
.+++.|+|++|++++ .++..+..+ ++|+.|+|++|+++ +.+| ..+..+++|++|+|++|+|+
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 201 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence 456666666666642 234445444 66666666666665 3333 34555666666666666665
Q ss_pred -C---CCCcccccccccceeeccCcccC----CCCCcccccCCCCceEecccccccCC----CC-CC--CCCCcccceec
Q 010429 131 -G---PIPTTLGKLSKLRFLRLNNNSLM----GEIPRSLTNVNSLQVLDLSNNKLTGD----IP-TN--GSFSLFTPISF 195 (511)
Q Consensus 131 -~---~~p~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~l~~N~l~~~----~~-~~--~~~~~l~~l~l 195 (511)
| .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++. ++ .+ ..+++|+.|++
T Consensus 202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L 281 (386)
T 2ca6_A 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281 (386)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEEC
Confidence 2 23335556666666666666664 34555566666666666666666543 11 11 22556666666
Q ss_pred cCCCCCC
Q 010429 196 ANNQLNN 202 (511)
Q Consensus 196 ~~N~~~~ 202 (511)
++|.+..
T Consensus 282 ~~n~i~~ 288 (386)
T 2ca6_A 282 QYNEIEL 288 (386)
T ss_dssp CSSCCBH
T ss_pred cCCcCCH
Confidence 6666543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.36 E-value=6.8e-14 Score=139.29 Aligned_cols=134 Identities=23% Similarity=0.247 Sum_probs=88.9
Q ss_pred CCeeEEecCCCCcceecc----hhhcCCC-CCcEEEeeccCCCCCCCchhcCC-----ccccccccccccccCCCCcccc
Q 010429 69 NSVTRVDLGNANLSGQLV----SQLGQLT-NLQYLELYSNNISGKVPEELGNL-----TNLVSLDLYLNNLNGPIPTTLG 138 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~i~~~~p~~~~ 138 (511)
.+++.|+|++|++++..+ ..|..++ +|+.|+|++|.|++..+..+..+ ++|++|+|++|.|++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 357777777777776655 6667777 77777777777776666666654 7777777777777766666544
Q ss_pred cc-----cccceeeccCcccCCCCCcccc----c-CCCCceEecccccccCCCCC-----CCCCC-cccceeccCCCCCC
Q 010429 139 KL-----SKLRFLRLNNNSLMGEIPRSLT----N-VNSLQVLDLSNNKLTGDIPT-----NGSFS-LFTPISFANNQLNN 202 (511)
Q Consensus 139 ~l-----~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~l~~N~l~~~~~~-----~~~~~-~l~~l~l~~N~~~~ 202 (511)
.. ++|++|+|++|+|++..+..+. . .++|++|+|++|++++.... +..++ +|+.|++++|.+..
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 43 6777777777777765554433 2 25777777777777743221 12233 67777777777643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.7e-12 Score=131.55 Aligned_cols=120 Identities=25% Similarity=0.320 Sum_probs=54.6
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
+++.|+|++|++++ +| .|+++++|+.|+|++|++++ +|..+ .+|++|+|++|++++ +| .+.++++|+.|+++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 34444444444443 22 24444444444444444442 33221 244444444444443 33 34445555555555
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
+|++++ +|.. .++|+.|++++|+++. +|.+..+++|+.|++++|.+.+
T Consensus 204 ~N~l~~-l~~~---~~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 204 NNSLKK-LPDL---PLSLESIVAGNNILEE-LPELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp SSCCSS-CCCC---CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSS
T ss_pred CCcCCc-CCCC---cCcccEEECcCCcCCc-ccccCCCCCCCEEECCCCcCCc
Confidence 555543 2221 1345555555555542 2334555555666666655544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.34 E-value=4.3e-14 Score=139.03 Aligned_cols=138 Identities=19% Similarity=0.211 Sum_probs=88.7
Q ss_pred ccccceEeCCCCCeeEEecCCCCcceecchhhcCC--CCCcEEEeeccCCCCCCCchhcCCccccccccccccccCC-CC
Q 010429 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQL--TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGP-IP 134 (511)
Q Consensus 58 c~w~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~-~p 134 (511)
..|.++.|+ ...++.|++++|++. +..+..+ ++|+.|++++|.+++..+. +..+++|++|+|++|.+++. +|
T Consensus 37 ~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 37 KRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp HHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHH
T ss_pred HHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHH
Confidence 367776664 345667777777665 3445555 6677777777777755554 45667777777777776654 66
Q ss_pred cccccccccceeeccCcccCCCCCcccccCCCCceEecccc-cccCC-CC-CCCCCCcccceeccCC-CC
Q 010429 135 TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN-KLTGD-IP-TNGSFSLFTPISFANN-QL 200 (511)
Q Consensus 135 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~-~~-~~~~~~~l~~l~l~~N-~~ 200 (511)
..+..+++|++|+|++|++++..+..+..+++|+.|+|++| .+++. ++ ....+++|+.|++++| .+
T Consensus 112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l 181 (336)
T 2ast_B 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 181 (336)
T ss_dssp HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTC
T ss_pred HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCc
Confidence 66667777777777777776666666666777777777777 55531 22 2345666777777766 44
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.33 E-value=9.9e-14 Score=136.46 Aligned_cols=131 Identities=22% Similarity=0.249 Sum_probs=94.9
Q ss_pred CCeeEEecCCCCccee-cchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccc-cccCC-CCcccccccccce
Q 010429 69 NSVTRVDLGNANLSGQ-LVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN-NLNGP-IPTTLGKLSKLRF 145 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~i~~~-~p~~~~~l~~L~~ 145 (511)
.+++.|+|++|.+++. ++..+..+++|+.|+|++|.+++..|..+..+++|++|+|++| .+++. ++..+.++++|++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 5688888888887755 6777788888888888888887777777888888888888888 56652 5666777888888
Q ss_pred eeccCc-ccCCC-CCcccccCC-CCceEeccccc--cc-C-CCCCCCCCCcccceeccCCC
Q 010429 146 LRLNNN-SLMGE-IPRSLTNVN-SLQVLDLSNNK--LT-G-DIPTNGSFSLFTPISFANNQ 199 (511)
Q Consensus 146 L~L~~N-~l~~~-~~~~~~~l~-~L~~L~l~~N~--l~-~-~~~~~~~~~~l~~l~l~~N~ 199 (511)
|+|++| .+++. ++..+..++ +|+.|+|++|. ++ + .+.....+++|+.|++++|.
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~ 233 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 233 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence 888888 77753 456667777 78888887773 43 1 22223456777777777776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.8e-12 Score=119.85 Aligned_cols=145 Identities=13% Similarity=0.027 Sum_probs=111.9
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~ 364 (511)
..+.|.....++.|+.+.||++... +..+++|+...... .....+.+|+++++.+. +..+.++++++...+..+++|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3356777778888999999999865 78999999865321 12234888999998885 667888898888888899999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH------------------------------------ 408 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------ 408 (511)
||++|.++.+.+. +......++.+++++++.||+.
T Consensus 90 e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999876531 1223457888999999999981
Q ss_pred --------------------CCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 409 --------------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 409 --------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
....++|+|++|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013689999999999998765667999998753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.32 E-value=4.4e-13 Score=137.42 Aligned_cols=124 Identities=22% Similarity=0.215 Sum_probs=55.0
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCc--------------------------------
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT-------------------------------- 117 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-------------------------------- 117 (511)
++++|++++|++ |.+|..++++++|++|+|++|.++|.+|..+++++
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~~ 90 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELP 90 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSCC
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCCc
Confidence 455555555555 45555555555555555555555555555555444
Q ss_pred -cccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceecc
Q 010429 118 -NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFA 196 (511)
Q Consensus 118 -~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~ 196 (511)
+|++|+|++|.+++ +|+.+ ++|+.|++++|++++ +|.. .++|++|++++|++++ +|.+..+++|+.|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVD 161 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-CcccCCCCCCCEEECC
Confidence 45555555555553 34322 344444444444442 1111 1466667777776665 3356666677777777
Q ss_pred CCCCCCC
Q 010429 197 NNQLNNP 203 (511)
Q Consensus 197 ~N~~~~~ 203 (511)
+|.+.+.
T Consensus 162 ~N~l~~l 168 (454)
T 1jl5_A 162 NNSLKKL 168 (454)
T ss_dssp SSCCSCC
T ss_pred CCcCccc
Confidence 7766543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.31 E-value=9.8e-14 Score=139.36 Aligned_cols=132 Identities=21% Similarity=0.279 Sum_probs=60.8
Q ss_pred CCeeEEecCCCCcce----ecchhhcCCCCCcEEEeeccCCCCCCCchh----cCC---------cccccccccccccc-
Q 010429 69 NSVTRVDLGNANLSG----QLVSQLGQLTNLQYLELYSNNISGKVPEEL----GNL---------TNLVSLDLYLNNLN- 130 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l---------~~L~~L~Ls~N~i~- 130 (511)
.+++.|+|++|.+++ .++..+..+++|+.|+|++|.|++..+..+ ..+ ++|++|+|++|+|+
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 345555555555544 234444555555555555555542222222 222 45555555555554
Q ss_pred CCCC---cccccccccceeeccCcccCC-----CCCcccccCCCCceEeccccccc----CCC-CCCCCCCcccceeccC
Q 010429 131 GPIP---TTLGKLSKLRFLRLNNNSLMG-----EIPRSLTNVNSLQVLDLSNNKLT----GDI-PTNGSFSLFTPISFAN 197 (511)
Q Consensus 131 ~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~-~~~~~~~~l~~l~l~~ 197 (511)
+.+| ..+..+++|++|+|++|+|+. ..|..+..+++|+.|+|++|.++ +.+ ..+..+++|+.|++++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 2223 234445555555555555541 12224455555555555555553 111 1223445555555555
Q ss_pred CCC
Q 010429 198 NQL 200 (511)
Q Consensus 198 N~~ 200 (511)
|.+
T Consensus 254 n~i 256 (386)
T 2ca6_A 254 CLL 256 (386)
T ss_dssp CCC
T ss_pred CCC
Confidence 554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.8e-13 Score=133.86 Aligned_cols=130 Identities=20% Similarity=0.196 Sum_probs=111.5
Q ss_pred EEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCC----chhcCCc-cccccccccccccCCCCcccccc-----cc
Q 010429 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP----EELGNLT-NLVSLDLYLNNLNGPIPTTLGKL-----SK 142 (511)
Q Consensus 73 ~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l-----~~ 142 (511)
.++|++|++++.+|..+...++|+.|+|++|.|++..+ ..+..++ +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999988888889999999999997776 7788999 99999999999998888888886 99
Q ss_pred cceeeccCcccCCCCCccccc----C-CCCceEecccccccCCCCCC-----CC-CCcccceeccCCCCCC
Q 010429 143 LRFLRLNNNSLMGEIPRSLTN----V-NSLQVLDLSNNKLTGDIPTN-----GS-FSLFTPISFANNQLNN 202 (511)
Q Consensus 143 L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~l~~N~l~~~~~~~-----~~-~~~l~~l~l~~N~~~~ 202 (511)
|++|+|++|++++..+..+.. + ++|+.|+|++|++++..+.. .. .++|+.|++++|.+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 999999999999877765444 4 89999999999998765421 22 2589999999998853
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.3e-12 Score=135.30 Aligned_cols=55 Identities=31% Similarity=0.266 Sum_probs=37.2
Q ss_pred cccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 141 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+..++ .+++|+.|++++|.+..
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~~ 275 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLTR 275 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCCS
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCCc
Confidence 567777777777774 44 345677777777777775444 45677777777777763
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.26 E-value=6.2e-12 Score=124.41 Aligned_cols=132 Identities=16% Similarity=0.163 Sum_probs=106.4
Q ss_pred eEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCC-ccccccc
Q 010429 63 VTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP-TTLGKLS 141 (511)
Q Consensus 63 v~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~ 141 (511)
.+|.. ++++.++++|+ .+|..+ .++|+.|+|++|+|+...+..|.+|++|++|+|++|+|.+.+| ..|.+++
T Consensus 7 C~C~~----~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 7 CHCSN----RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp SEEET----TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred cEeeC----CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence 56753 46889999999 456555 4689999999999996555679999999999999999976665 4688999
Q ss_pred ccce-eeccCcccCCCCCcccccCCCCceEecccccccCCCCCC-CCCCcccceeccCC-CCC
Q 010429 142 KLRF-LRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANN-QLN 201 (511)
Q Consensus 142 ~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N-~~~ 201 (511)
+|+. +.++.|+|++..|..|.++++|++|++++|++++.++.. ....++..+++.++ .+.
T Consensus 80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~ 142 (350)
T 4ay9_X 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 142 (350)
T ss_dssp TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC
T ss_pred hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc
Confidence 8775 677789999888899999999999999999999877643 44556777887664 443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.4e-11 Score=114.65 Aligned_cols=129 Identities=14% Similarity=0.039 Sum_probs=95.4
Q ss_pred ccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCc--eeccccccccCCceeEEeecccCCCHHH
Q 010429 297 GRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPFMVNGSVAS 374 (511)
Q Consensus 297 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 374 (511)
+.|..+.||++...+|..+++|...... ...+.+|.++++.+.+.+ +.+++++...++..+++|||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 4566699999987778889999976531 124678888888886544 455788877777889999999998873
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 010429 375 CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--------------------------------------------- 409 (511)
Q Consensus 375 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------------- 409 (511)
... . ....++.++++.++.||+..
T Consensus 104 -~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 111 1 12356777777788887641
Q ss_pred ----------CCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 410 ----------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 410 ----------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.16 E-value=6.3e-13 Score=136.62 Aligned_cols=134 Identities=22% Similarity=0.209 Sum_probs=95.1
Q ss_pred CCCeeEEecCCCCcceec-----chhhcCCCCCcEEEeeccCCCCC----CCchhcCCccccccccccccccCCCCcccc
Q 010429 68 ENSVTRVDLGNANLSGQL-----VSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNGPIPTTLG 138 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~ 138 (511)
..+++.|+|++|.+++.. +..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|.|++..+..+.
T Consensus 226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence 357888888888887543 22333678888888888888853 567777788888888888888755444454
Q ss_pred cc-----cccceeeccCcccCCC----CCcccccCCCCceEecccccccCCCCC-C----C-CCCcccceeccCCCCC
Q 010429 139 KL-----SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDIPT-N----G-SFSLFTPISFANNQLN 201 (511)
Q Consensus 139 ~l-----~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~-~----~-~~~~l~~l~l~~N~~~ 201 (511)
.. ++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++..+. + . ..++|+.|++++|.+.
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 43 6888888888888754 455666778888888888887754221 1 1 1467888888888775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=7e-11 Score=117.22 Aligned_cols=142 Identities=15% Similarity=0.181 Sum_probs=104.9
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEec--ccccchhHHHHHHHHHHHHhCCC--CceeccccccccC---CceeEEee
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTP---TERLLVYP 365 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~---~~~~lv~e 365 (511)
.+.++.|.++.||+.... +..+++|+.. ..........+.+|..+++.+.+ ..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 457899999999999876 4678888876 43322233457889999988874 4577888877665 45899999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------------ 409 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 409 (511)
|++|..+.+. ....++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9998876431 1123678888999999999999999730
Q ss_pred -------------------CCCeEecCCCCCCeeeCCCCc--eEEcccccccc
Q 010429 410 -------------------DPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 441 (511)
Q Consensus 410 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 441 (511)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999998753 68999998864
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.08 E-value=3.8e-12 Score=130.79 Aligned_cols=131 Identities=24% Similarity=0.270 Sum_probs=66.0
Q ss_pred CeeEEecCCCCcce----ecchhhcCCCCCcEEEeeccCCCCCCCchhc-----CCccccccccccccccCCC----Ccc
Q 010429 70 SVTRVDLGNANLSG----QLVSQLGQLTNLQYLELYSNNISGKVPEELG-----NLTNLVSLDLYLNNLNGPI----PTT 136 (511)
Q Consensus 70 ~l~~l~L~~~~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~i~~~~----p~~ 136 (511)
+++.|+|++|+++. .++..+..+++|+.|+|++|.+++..+..+. .+++|++|+|++|++++.. +..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 45666666666552 3355555666666666666665533222222 1345666666666555422 334
Q ss_pred cccccccceeeccCcccCCCCCcccc-----cCCCCceEecccccccCC-----CCCCCCCCcccceeccCCCC
Q 010429 137 LGKLSKLRFLRLNNNSLMGEIPRSLT-----NVNSLQVLDLSNNKLTGD-----IPTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~-----~~~~~~~~~l~~l~l~~N~~ 200 (511)
+..+++|++|+|++|.+++..+..+. .+++|+.|+|++|.+++. +..+..+++|+.|++++|.+
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l 239 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcC
Confidence 44455666666666655543333222 134566666666655542 11123345556666666554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=9e-11 Score=113.60 Aligned_cols=187 Identities=19% Similarity=0.164 Sum_probs=121.8
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCc--eeccccccccCC---ceeEEeec
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRN--LLRLRGFCMTPT---ERLLVYPF 366 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~n--iv~l~~~~~~~~---~~~lv~e~ 366 (511)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999864 45888986532 33456889999998773 333 334444433322 34789999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH-------------------------------------- 408 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------- 408 (511)
++|.++...... .++..++..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888654332 267777888888888888888861
Q ss_pred -----------------CCCCeEecCCCCCCeeeCC--CCceEEcccccccccCCCCCceee-ec---ccc-------cc
Q 010429 409 -----------------CDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDYKDTHVTT-AV---RGT-------IG 458 (511)
Q Consensus 409 -----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~-~~---~gt-------~~ 458 (511)
..+.++|+|++|.||++++ +..+.|+||+.+...++....... .. .+. ..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1236899999999999998 456889999988654321100000 00 000 01
Q ss_pred c--cc-ccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 459 H--IA-PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 459 y--~a-PE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
| .. |+.... .....+.|++|.++|++.+|..+|-
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 11 222111 1122588999999999999999884
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=5.1e-12 Score=125.78 Aligned_cols=133 Identities=18% Similarity=0.212 Sum_probs=88.4
Q ss_pred CCeeEEecCCCCcceecchhh-cCCCCCcEEEeeccCCCCCCCchh-----cCCccccccccccccccC----CCCcccc
Q 010429 69 NSVTRVDLGNANLSGQLVSQL-GQLTNLQYLELYSNNISGKVPEEL-----GNLTNLVSLDLYLNNLNG----PIPTTLG 138 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~i~~----~~p~~~~ 138 (511)
.+++.|+|++|+|+......+ ..+++|+.|+|++|.|+......+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 478888888888865433332 345678888888888874433333 245778888888888764 2344456
Q ss_pred cccccceeeccCcccCCC----CCcccccCCCCceEecccccccCCCC-----CCCCCCcccceeccCCCCC
Q 010429 139 KLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDIP-----TNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 139 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~~~~l~~l~l~~N~~~ 201 (511)
.+++|++|+|++|.|++. +...+..+++|+.|+|++|.|+.... .....++|+.|++++|.+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 677888888888888743 24556667788888888888864311 1123467888888888763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.99 E-value=7.6e-10 Score=108.34 Aligned_cols=135 Identities=19% Similarity=0.183 Sum_probs=99.8
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhc---------------------------------
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG--------------------------------- 114 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--------------------------------- 114 (511)
..+++.|+|.+ +++.+.+.+|.++++|+.|+|++|.++...+.+|.
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 35789999999 89888888999999999999999986422222221
Q ss_pred ---------------------------------------------CCccccccccccccccCCCCcccccccccceeecc
Q 010429 115 ---------------------------------------------NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 115 ---------------------------------------------~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
.+++|+.|+|++|+++...+..|.++++|+.|+|.
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 25678888888888886666678888888888888
Q ss_pred CcccCCCCCcccccCCCCc-eEecccccccCCCC-CCCCCCcccceeccCCCCCCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQ-VLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
+| ++...+..|.+|++|+ .|++.+ .++.+.+ .+.++++|+.+++.+|.+...+.
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~ 314 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGD 314 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECT
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccch
Confidence 87 6656666788888888 888877 6665543 34677888888888887755444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.2e-11 Score=115.98 Aligned_cols=67 Identities=31% Similarity=0.447 Sum_probs=41.4
Q ss_pred cCCccccccccccccccC--CCCcccccccccceeeccCcccCCCCCcccccCC--CCceEecccccccCCCC
Q 010429 114 GNLTNLVSLDLYLNNLNG--PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN--SLQVLDLSNNKLTGDIP 182 (511)
Q Consensus 114 ~~l~~L~~L~Ls~N~i~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~ 182 (511)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|++++..+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 346667777777777765 3445566677777777777777643 2233333 67777777777765443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-11 Score=122.85 Aligned_cols=133 Identities=19% Similarity=0.198 Sum_probs=101.1
Q ss_pred CCeeEEecCCCCcceecchhhcCC-----CCCcEEEeeccCCCCCCCch-hcCCccccccccccccccCCCCcccc----
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQL-----TNLQYLELYSNNISGKVPEE-LGNLTNLVSLDLYLNNLNGPIPTTLG---- 138 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~i~~~~p~~~~---- 138 (511)
..++.|+|++|.|+......+..+ ++|+.|+|++|.|+...... ...+++|+.|+|++|.|+......+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 579999999999986554444433 79999999999998543333 33567899999999999865444443
Q ss_pred -cccccceeeccCcccCCC----CCcccccCCCCceEecccccccCCC-----CCCCCCCcccceeccCCCCC
Q 010429 139 -KLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDI-----PTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 139 -~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N~~~ 201 (511)
..++|+.|+|++|.|++. ++..+..+++|++|+|++|.|+... ..+...++|+.|++++|.+.
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 457899999999999753 3445578899999999999998531 12344578999999999763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.79 E-value=2.6e-10 Score=120.87 Aligned_cols=134 Identities=14% Similarity=0.176 Sum_probs=89.0
Q ss_pred CCeeEEecCCCCcceecchhhcC-CCCCcEEEee----ccCCCCC-----CCchhcCCccccccccccc--cccCCCCcc
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQ-LTNLQYLELY----SNNISGK-----VPEELGNLTNLVSLDLYLN--NLNGPIPTT 136 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~i~~~~p~~ 136 (511)
.+++.|+|..|++++.....+.. +++|+.|+|+ .|.+++. ++..+.++++|++|+|++| .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 35677777667776655555554 7777777775 5666643 3333566777777777643 355544444
Q ss_pred ccc-ccccceeeccCcccCC-CCCcccccCCCCceEecccccccCC-CCC-CCCCCcccceeccCCCCCC
Q 010429 137 LGK-LSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVLDLSNNKLTGD-IPT-NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 137 ~~~-l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~-~~~-~~~~~~l~~l~l~~N~~~~ 202 (511)
+.. +++|++|+|++|++++ .++..+.++++|+.|+|++|++++. ++. ...+++|+.|++++|+++.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 444 7788888888888875 3444557788888888888887643 222 2456788888888888644
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.78 E-value=1.4e-09 Score=102.04 Aligned_cols=80 Identities=28% Similarity=0.294 Sum_probs=67.4
Q ss_pred cCCCCCcEEEeeccCCCC--CCCchhcCCccccccccccccccCCCCccccccc--ccceeeccCcccCCCCCc------
Q 010429 90 GQLTNLQYLELYSNNISG--KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS--KLRFLRLNNNSLMGEIPR------ 159 (511)
Q Consensus 90 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~------ 159 (511)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+.+.+|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 578999999999999997 4567788999999999999999965 4456666 999999999999976663
Q ss_pred -ccccCCCCceEe
Q 010429 160 -SLTNVNSLQVLD 171 (511)
Q Consensus 160 -~~~~l~~L~~L~ 171 (511)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 366788888876
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.74 E-value=9.6e-09 Score=100.42 Aligned_cols=125 Identities=14% Similarity=0.044 Sum_probs=85.9
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccc-eee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLR-FLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~-~L~ 147 (511)
.+++.+.+.++-...........+++|+.|+|++|+++...+.+|.++++|+.|+|++| ++...+..|.++++|+ .|+
T Consensus 202 ~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~ 280 (329)
T 3sb4_A 202 RDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLE 280 (329)
T ss_dssp GGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEE
Confidence 45566665554222111112224778888888888888555667888888888888887 6656667788888888 888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceec
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISF 195 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l 195 (511)
|.+ .++...+..|.+|++|+.|++++|.++...+ .+.++++|+.++.
T Consensus 281 l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 281 LPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp ECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred Ecc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 877 6665666788888888888888888876665 3466677776653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.72 E-value=3.6e-09 Score=112.09 Aligned_cols=104 Identities=13% Similarity=0.203 Sum_probs=65.8
Q ss_pred CeeEEecCCCC-cce-ecchhhcCCCCCcEEEeeccCCCCC----CCchhcCCccccccccccccccC----CCCccccc
Q 010429 70 SVTRVDLGNAN-LSG-QLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNG----PIPTTLGK 139 (511)
Q Consensus 70 ~l~~l~L~~~~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~i~~----~~p~~~~~ 139 (511)
+++.|+|++|. ++. .++....++++|+.|+|++|.+++. ++..+.++++|++|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 47778777776 221 1223334677788888877777655 33445567777777777777762 33444556
Q ss_pred ccccceeeccCcccCCCCCcccccCCCCceEeccc
Q 010429 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174 (511)
Q Consensus 140 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 174 (511)
+++|+.|+|++|.+.+ +|..+.++++|+.|++++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 7777777777777764 455566666666666653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.70 E-value=1.8e-09 Score=96.27 Aligned_cols=111 Identities=19% Similarity=0.213 Sum_probs=69.9
Q ss_pred CCCeeEEecCCC-Cccee----cchhhcCCCCCcEEEeeccCCCCC----CCchhcCCccccccccccccccCC----CC
Q 010429 68 ENSVTRVDLGNA-NLSGQ----LVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNGP----IP 134 (511)
Q Consensus 68 ~~~l~~l~L~~~-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~i~~~----~p 134 (511)
..+++.|+|++| +|... +...+...++|+.|+|++|.|+.. +...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 346777777777 77532 344555667777777777777632 334455556777777777777642 34
Q ss_pred cccccccccceeec--cCcccCCC----CCcccccCCCCceEeccccccc
Q 010429 135 TTLGKLSKLRFLRL--NNNSLMGE----IPRSLTNVNSLQVLDLSNNKLT 178 (511)
Q Consensus 135 ~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~ 178 (511)
..+...+.|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 45566667777777 66777643 2233444567777777777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.65 E-value=9.5e-10 Score=98.06 Aligned_cols=120 Identities=18% Similarity=0.193 Sum_probs=93.2
Q ss_pred cceecchhhcCCCCCcEEEeecc-CCCCC----CCchhcCCccccccccccccccCC----CCcccccccccceeeccCc
Q 010429 81 LSGQLVSQLGQLTNLQYLELYSN-NISGK----VPEELGNLTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNN 151 (511)
Q Consensus 81 l~~~~~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~N 151 (511)
+...+...+...+.|+.|+|++| .|+.. +...+...++|++|+|++|.|+.. +...+...++|++|+|++|
T Consensus 24 ~~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N 103 (185)
T 1io0_A 24 VEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESN 103 (185)
T ss_dssp HHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSS
T ss_pred HHHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCC
Confidence 34455677888999999999999 98742 455677789999999999999743 3445566689999999999
Q ss_pred ccCCC----CCcccccCCCCceEec--ccccccCCC-----CCCCCCCcccceeccCCCC
Q 010429 152 SLMGE----IPRSLTNVNSLQVLDL--SNNKLTGDI-----PTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 152 ~l~~~----~~~~~~~l~~L~~L~l--~~N~l~~~~-----~~~~~~~~l~~l~l~~N~~ 200 (511)
.|.+. +...+...++|+.|+| ++|.|...- ......++|+.|++++|.+
T Consensus 104 ~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 104 FISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp CCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred cCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 99864 4556778899999999 889997431 1223457899999999865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=4.2e-07 Score=85.94 Aligned_cols=135 Identities=19% Similarity=0.146 Sum_probs=96.9
Q ss_pred eecccccc-EEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCceeEEeecccCCC
Q 010429 295 ILGRGGFG-KVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 295 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
.+..|..| .||+.... ++..+++|+-... ....+.+|...++.+. +--+.++++++.+.+..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45566665 68988765 4567899986532 3345788988888764 3336677888888888999999999988
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 010429 372 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH------------------------------------------- 408 (511)
Q Consensus 372 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------- 408 (511)
+.+..... ......+..++++.|+-||..
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 87765431 123345666666677777642
Q ss_pred ------------CCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 409 ------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 409 ------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012388999999999999887778999998864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.54 E-value=5.9e-09 Score=110.40 Aligned_cols=87 Identities=11% Similarity=0.138 Sum_probs=42.5
Q ss_pred hcCCccccccccccccccCCCCccccc-ccccceeeccCcccCCCCCccc-ccCCCCceEecccccccCCCC--CCCCCC
Q 010429 113 LGNLTNLVSLDLYLNNLNGPIPTTLGK-LSKLRFLRLNNNSLMGEIPRSL-TNVNSLQVLDLSNNKLTGDIP--TNGSFS 188 (511)
Q Consensus 113 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~--~~~~~~ 188 (511)
+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|+.|+|++|++++... ....++
T Consensus 428 ~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~ 506 (594)
T 2p1m_B 428 VEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLE 506 (594)
T ss_dssp HHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGG
T ss_pred HhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCC
Confidence 34445555555544 444333333333 5556666666666554333333 445666666666666532211 123345
Q ss_pred cccceeccCCCC
Q 010429 189 LFTPISFANNQL 200 (511)
Q Consensus 189 ~l~~l~l~~N~~ 200 (511)
+|+.|++++|++
T Consensus 507 ~L~~L~l~~~~~ 518 (594)
T 2p1m_B 507 TMRSLWMSSCSV 518 (594)
T ss_dssp GSSEEEEESSCC
T ss_pred CCCEEeeeCCCC
Confidence 566666665543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=9.6e-07 Score=85.17 Aligned_cols=138 Identities=18% Similarity=0.169 Sum_probs=92.7
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCC---ceeccccccc-cCCceeEEeeccc
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR---NLLRLRGFCM-TPTERLLVYPFMV 368 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~---niv~l~~~~~-~~~~~~lv~e~~~ 368 (511)
.+.++.|....||+. |..+++|+-.. ......+.+|.++++.+.+. .+.+++.+.. ..+..+++|||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356888888999988 46688887532 23345688999999988753 2455555553 3456789999999
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH---------------------------------------- 408 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------- 408 (511)
|..+.+..-. .++......++.++++.|+.||+.
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9887653211 133444444555555555554432
Q ss_pred -----------------CCCCeEecCCCCCCeeeCC---CCc-eEEcccccccccC
Q 010429 409 -----------------CDPKIIHRDVKAANILLDE---EFE-AVVGDFGLAKLMD 443 (511)
Q Consensus 409 -----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfg~a~~~~ 443 (511)
.++.++|+|+++.||+++. ++. +.|+||+.+..-+
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2336799999999999998 455 4899999886543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.44 E-value=1e-08 Score=108.67 Aligned_cols=130 Identities=15% Similarity=0.140 Sum_probs=76.7
Q ss_pred CCeeEEecCCCCcceecchhhc-CCCCCcEEEeecc-CCCCC-CCchhcCCccccccccccccccCCCCcccc----ccc
Q 010429 69 NSVTRVDLGNANLSGQLVSQLG-QLTNLQYLELYSN-NISGK-VPEELGNLTNLVSLDLYLNNLNGPIPTTLG----KLS 141 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~----~l~ 141 (511)
.+++.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4677777777777766555554 5777777777777 44422 344445677777777777777655444443 455
Q ss_pred ccceeeccCcc--cCCC-CCcccccCCCCceEecccc-cccCCCCCCCCCCcccceeccCC
Q 010429 142 KLRFLRLNNNS--LMGE-IPRSLTNVNSLQVLDLSNN-KLTGDIPTNGSFSLFTPISFANN 198 (511)
Q Consensus 142 ~L~~L~L~~N~--l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~~~l~~l~l~~N 198 (511)
+|+.|+|++|. +... ++..+.++++|+.|+|++| .+.+.+.....+++|+.|++..+
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBC
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccc
Confidence 77777777776 2211 1112234577777777776 34332222234455666654433
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.40 E-value=4.3e-08 Score=96.68 Aligned_cols=60 Identities=22% Similarity=0.219 Sum_probs=25.0
Q ss_pred hhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccc--cccccceeecc
Q 010429 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLG--KLSKLRFLRLN 149 (511)
Q Consensus 87 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~--~l~~L~~L~L~ 149 (511)
..+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++......+. .+++|+.|+|+
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 33444555555555554211 1121 22 44555555555444422222222 34555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.29 E-value=2.2e-06 Score=85.90 Aligned_cols=127 Identities=14% Similarity=0.066 Sum_probs=72.5
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeec---------------------cCCCCCCCchhcCCcccccccccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYS---------------------NNISGKVPEELGNLTNLVSLDLYLNN 128 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~---------------------N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (511)
+++.+.|.+ +++.+...+|.++++|+.|+|.+ |+++..-+.+|.++++|+.++|.+|.
T Consensus 204 ~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~~~L~~i~lp~~i~~I~~~aF~~c~~L~~l~l~~~~ 282 (401)
T 4fdw_A 204 GIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRESGITTVKLPNGVTNIASRAFYYCPELAEVTTYGST 282 (401)
T ss_dssp CCSEEECCT-TCCEECTTTTTTCTTCCCEECCTTCCEECTTTTTTCCCSEEEEETTCCEECTTTTTTCTTCCEEEEESSC
T ss_pred ccCEEEeCC-chheehhhHhhCCCCCCEEecCCCccCccccccccCCccEEEeCCCccEEChhHhhCCCCCCEEEeCCcc
Confidence 455555553 25444455555555555555544 33443334556666677777766665
Q ss_pred cc-----CCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCCC
Q 010429 129 LN-----GPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQL 200 (511)
Q Consensus 129 i~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~ 200 (511)
+. ...+..|.++++|+.++|. |.++......|.+|++|+.+.|..| ++.... .+..+ +|+.+.+.+|..
T Consensus 283 ~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 283 FNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp CCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred ccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 54 2344566667777777776 3455445556677777777777544 443333 23445 677777777644
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.26 E-value=2e-06 Score=86.20 Aligned_cols=109 Identities=13% Similarity=0.112 Sum_probs=90.7
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCC-----CCCCchhcCCccccccccccccccCCCCcccccccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS-----GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLR 144 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 144 (511)
+++.+.| .++++.+....|.++++|+.++|.+|.+. ...+.+|.++++|+.++|. |.++..-...|.++++|+
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT 326 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence 5677777 45677677889999999999999998875 3556789999999999999 558866778899999999
Q ss_pred eeeccCcccCCCCCcccccCCCCceEecccccccCCCC
Q 010429 145 FLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182 (511)
Q Consensus 145 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 182 (511)
.|.|..| ++.....+|.++ +|+.|++++|.+....+
T Consensus 327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~ 362 (401)
T 4fdw_A 327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFE 362 (401)
T ss_dssp EEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCC
T ss_pred EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccc
Confidence 9999665 776667899999 99999999998876544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=2.5e-07 Score=91.13 Aligned_cols=131 Identities=20% Similarity=0.297 Sum_probs=92.5
Q ss_pred CCCeeEEecCCCC-cceecchhhcCCCCCcEEEeeccCCCCCCCchhc--CCcccccccccc--ccccCC-----CCccc
Q 010429 68 ENSVTRVDLGNAN-LSGQLVSQLGQLTNLQYLELYSNNISGKVPEELG--NLTNLVSLDLYL--NNLNGP-----IPTTL 137 (511)
Q Consensus 68 ~~~l~~l~L~~~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~i~~~-----~p~~~ 137 (511)
.++|+.|+|++|. ++ ++. + .+++|+.|+|..|.++......+. .+++|+.|+|+. |...+. +...+
T Consensus 171 ~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp CTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 4689999998873 32 233 3 389999999999998744334444 789999999864 332211 11223
Q ss_pred --ccccccceeeccCcccCCCCCcccc---cCCCCceEecccccccCC-----CCCCCCCCcccceeccCCCCCC
Q 010429 138 --GKLSKLRFLRLNNNSLMGEIPRSLT---NVNSLQVLDLSNNKLTGD-----IPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 138 --~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~l~~N~l~~~-----~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
..+++|+.|+|.+|.+.+..+..+. .+++|+.|+|+.|.|++. ......+++|+.|++++|.+..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 2479999999999999754443333 578999999999999863 2222457889999999997743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.4e-06 Score=86.04 Aligned_cols=80 Identities=8% Similarity=-0.010 Sum_probs=52.6
Q ss_pred Cee-ccccccEEEEEEeC-------CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCC---CceeccccccccC---
Q 010429 294 NIL-GRGGFGKVYKGRLT-------DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH---RNLLRLRGFCMTP--- 357 (511)
Q Consensus 294 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h---~niv~l~~~~~~~--- 357 (511)
+.| +.|....+|+.... ++..+++|+...... ......+.+|..+++.+.. ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998754 266789998654320 0011246778888777643 2456677766544
Q ss_pred CceeEEeecccCCCHH
Q 010429 358 TERLLVYPFMVNGSVA 373 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~ 373 (511)
+..+++|||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=3.7e-05 Score=74.97 Aligned_cols=142 Identities=15% Similarity=0.179 Sum_probs=78.6
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCC--Cceeccccc------cccCCceeEEee
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGF------CMTPTERLLVYP 365 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~------~~~~~~~~lv~e 365 (511)
+.|+.|..+.||+....+| .+++|+..... .++..|.++++.+.. -.+.+++.. ....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE-----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH-----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH-----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3466677899999987644 58999886521 223344444444331 123333321 123456789999
Q ss_pred cccCCCHH--------------HHHHhcCCCC--C--------CCCHHHH------------------------------
Q 010429 366 FMVNGSVA--------------SCLRERGQSQ--P--------PLNWSVR------------------------------ 391 (511)
Q Consensus 366 ~~~~gsL~--------------~~l~~~~~~~--~--------~l~~~~~------------------------------ 391 (511)
|++|..+. ..++...... + .-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1122211100 0 0122211
Q ss_pred -HHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 392 -KQIALGAARGLAYLHD----------HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 392 -~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
..+...+.+++++|++ ..+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666653 0234899999999999998888999999998753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.06 E-value=7.8e-07 Score=77.36 Aligned_cols=83 Identities=13% Similarity=0.241 Sum_probs=48.7
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccC-CCCCCCchhcCC----cccccccccccc-ccCCCCccccccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNN-ISGKVPEELGNL----TNLVSLDLYLNN-LNGPIPTTLGKLSKL 143 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-i~~~~p~~~~~l~~L 143 (511)
.++.|||++|.|+..--..+.++++|+.|+|++|. |+..--..+..+ ++|++|+|+++. |+..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 57777777777765555556677777777777764 553333334443 256666666653 553322345556666
Q ss_pred ceeeccCcc
Q 010429 144 RFLRLNNNS 152 (511)
Q Consensus 144 ~~L~L~~N~ 152 (511)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1.3e-05 Score=80.15 Aligned_cols=76 Identities=9% Similarity=-0.044 Sum_probs=48.3
Q ss_pred CCeeccccccEEEEEEeC-CCCEEEEEEeccccc------chhHHHHHHHHHHHHhCCC--Cc-eeccccccccCCceeE
Q 010429 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT------QGGELQFQTEVEMISMAVH--RN-LLRLRGFCMTPTERLL 362 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~~~h--~n-iv~l~~~~~~~~~~~l 362 (511)
.+.+|.|..+.||++... +++.++||....... .....++..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999764 468899998653211 0112346678888876642 33 3345443 3455789
Q ss_pred EeecccCC
Q 010429 363 VYPFMVNG 370 (511)
Q Consensus 363 v~e~~~~g 370 (511)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.2e-06 Score=76.25 Aligned_cols=87 Identities=13% Similarity=0.103 Sum_probs=70.0
Q ss_pred CCCCcEEEeeccCCCCCCCchhcCCcccccccccccc-ccCCCCcccccc----cccceeeccCcc-cCCCCCcccccCC
Q 010429 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNN-LNGPIPTTLGKL----SKLRFLRLNNNS-LMGEIPRSLTNVN 165 (511)
Q Consensus 92 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-i~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~ 165 (511)
-.+|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..++.+ ++|++|+|++|. |++.--..+..++
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 3579999999999986655668899999999999995 775433445554 479999999985 8876556788999
Q ss_pred CCceEeccccc-cc
Q 010429 166 SLQVLDLSNNK-LT 178 (511)
Q Consensus 166 ~L~~L~l~~N~-l~ 178 (511)
+|+.|+|++++ ++
T Consensus 140 ~L~~L~L~~c~~It 153 (176)
T 3e4g_A 140 NLKYLFLSDLPGVK 153 (176)
T ss_dssp TCCEEEEESCTTCC
T ss_pred CCCEEECCCCCCCC
Confidence 99999999874 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=7.3e-06 Score=82.70 Aligned_cols=79 Identities=11% Similarity=0.024 Sum_probs=48.6
Q ss_pred CCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCceeeecccccccccccccccC---CCCcccCeehhhHHHHHHH
Q 010429 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELI 487 (511)
Q Consensus 411 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~ell 487 (511)
..++|+|++|.||+++.++ ++++||+.+..-++..........-...|++|+..... ....+.++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3899999999999999876 99999998864332111000000012346666654311 1223345567888888887
Q ss_pred hCC
Q 010429 488 TGQ 490 (511)
Q Consensus 488 tg~ 490 (511)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=7.3e-05 Score=71.85 Aligned_cols=139 Identities=14% Similarity=0.127 Sum_probs=90.8
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCC---CCceeccccccccCCceeEEeecccC
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
.+.|+.|....+|+.... +..+++|+.... ....+..|.+.++.+. ...+.+++.+....+..+++|||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 457899999999999864 678899987532 2445788988887764 35577888887777889999999998
Q ss_pred CCHH--------H---HHHhcCC-CC-----------------CCCCHHHHH---HHHHH----------------HHHH
Q 010429 370 GSVA--------S---CLRERGQ-SQ-----------------PPLNWSVRK---QIALG----------------AARG 401 (511)
Q Consensus 370 gsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~~~----------------i~~~ 401 (511)
..+. . .++.... .. ..-+|.... ++..+ +...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7542 1 2333221 00 011444321 11111 1111
Q ss_pred -HHHHHh-CCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 402 -LAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 402 -L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
...|.. ..++.++|+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 2246899999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00018 Score=68.37 Aligned_cols=79 Identities=16% Similarity=0.219 Sum_probs=55.2
Q ss_pred CCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCC---ceeccccccccCCceeEEee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR---NLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~---niv~l~~~~~~~~~~~lv~e 365 (511)
.....+.+|.|..+.||+.+..+|+.|++|+-.... ......+..|.+.|+.+... -+.+++++ +..+++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 344456799999999999999999999999875433 22233478899888877422 23444443 24578999
Q ss_pred cccCCCH
Q 010429 366 FMVNGSV 372 (511)
Q Consensus 366 ~~~~gsL 372 (511)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.59 E-value=1.3e-05 Score=70.98 Aligned_cols=61 Identities=20% Similarity=0.258 Sum_probs=25.5
Q ss_pred CeeEEecCCC-Cccee----cchhhcCCCCCcEEEeeccCCCC----CCCchhcCCcccccccccccccc
Q 010429 70 SVTRVDLGNA-NLSGQ----LVSQLGQLTNLQYLELYSNNISG----KVPEELGNLTNLVSLDLYLNNLN 130 (511)
Q Consensus 70 ~l~~l~L~~~-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~i~ 130 (511)
.++.|+|++| +|... +...+..-+.|+.|+|++|+|.. .+...+..-+.|+.|+|++|.|+
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 4555555543 44321 22333334445555555555441 12222333344444444444444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.58 E-value=9.2e-05 Score=73.87 Aligned_cols=116 Identities=7% Similarity=0.126 Sum_probs=66.3
Q ss_pred CcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCc
Q 010429 80 NLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR 159 (511)
Q Consensus 80 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 159 (511)
+++.....+|.++..|+.+.+.++..+ ....+|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++.....
T Consensus 252 ~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 328 (394)
T 4gt6_A 252 GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDD 328 (394)
T ss_dssp TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence 344444556667777777776655433 444556666667766664 3444344456666667777766543 4434445
Q ss_pred ccccCCCCceEecccccccCCCC-CCCCCCcccceeccCCC
Q 010429 160 SLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQ 199 (511)
Q Consensus 160 ~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~ 199 (511)
+|.+|.+|+.+.+..+ ++.... .+.++++|+.+.+.++.
T Consensus 329 aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 329 AFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred HhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 6666777777766543 443322 23455666666666553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00037 Score=66.66 Aligned_cols=139 Identities=12% Similarity=0.072 Sum_probs=74.3
Q ss_pred CCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCce-eccccccccCCceeEEeecc-cCC
Q 010429 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFM-VNG 370 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g 370 (511)
.+.|+.|....+|+. ..+++|+....... .....+|..+++.+....+ .+++++ ..+..++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 577999999999999 45888887543211 1123467777666543333 344443 344467999999 554
Q ss_pred CHHH------------------HHHhcCCCC-CCCC-HHHHHHHHHH--------------HHHHHH----HHHh-CCCC
Q 010429 371 SVAS------------------CLRERGQSQ-PPLN-WSVRKQIALG--------------AARGLA----YLHD-HCDP 411 (511)
Q Consensus 371 sL~~------------------~l~~~~~~~-~~l~-~~~~~~i~~~--------------i~~~L~----~LH~-~~~~ 411 (511)
++.. .++...... ...+ +.....+... +.+.+. .+.. ..+.
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4321 111111100 0011 1111111110 111111 1111 1233
Q ss_pred CeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 412 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 6899999999999 5566889999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00016 Score=59.68 Aligned_cols=38 Identities=24% Similarity=0.217 Sum_probs=19.9
Q ss_pred ccceeeccCcccCCCCCcccccCCCCceEecccccccC
Q 010429 142 KLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG 179 (511)
Q Consensus 142 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 179 (511)
+|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 34555555555554444445555555555555555543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00094 Score=64.53 Aligned_cols=143 Identities=18% Similarity=0.184 Sum_probs=80.7
Q ss_pred CeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCc--eeccccc-----cccCCceeEEeec
Q 010429 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGF-----CMTPTERLLVYPF 366 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~-----~~~~~~~~lv~e~ 366 (511)
+.++ |....||+....+|+.+++|..+.... ....+..|..++..+.... +.+++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 888899998877777899999864322 2334666777776664222 3444443 1113455789999
Q ss_pred ccCCCHH-----H------H---HHhcCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 010429 367 MVNGSVA-----S------C---LRERGQ-----SQPPLNWSVR----KQI---------------ALGAARGLAYLHDH 408 (511)
Q Consensus 367 ~~~gsL~-----~------~---l~~~~~-----~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~ 408 (511)
++|..+. . . ++.... .....++... ..+ ...+.+.++.+.+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875431 1 1 121110 0111222211 001 11111223333221
Q ss_pred ----CCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 409 ----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 409 ----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
.+..++|+|+++.||+++ + .+.++||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234789999999999999 5 899999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00085 Score=65.07 Aligned_cols=143 Identities=17% Similarity=0.086 Sum_probs=71.7
Q ss_pred CeeccccccE-EEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCC--CceeccccccccCCceeEEeecccCC
Q 010429 294 NILGRGGFGK-VYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVNG 370 (511)
Q Consensus 294 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~lv~e~~~~g 370 (511)
+.|+.|.... +|+....+|..+++|....... ..+..|..++..+.. -.+.+++.+.... -+++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 3465565554 6677654467788886644321 123455665555532 2244555543322 37899999776
Q ss_pred CHHHHHHhc---------------------CCC-CCCCCHHHHHH--------H------------HHHHHHHHHHHHh-
Q 010429 371 SVASCLRER---------------------GQS-QPPLNWSVRKQ--------I------------ALGAARGLAYLHD- 407 (511)
Q Consensus 371 sL~~~l~~~---------------------~~~-~~~l~~~~~~~--------i------------~~~i~~~L~~LH~- 407 (511)
.+.+++... ... .+.++...... + ...+...++.+.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665433211 000 11122211100 0 0111122233311
Q ss_pred --CCCCCeEecCCCCCCeeeCCC----CceEEccccccccc
Q 010429 408 --HCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLM 442 (511)
Q Consensus 408 --~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~ 442 (511)
.....++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123489999999999999875 68999999988643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0045 Score=59.50 Aligned_cols=159 Identities=11% Similarity=0.077 Sum_probs=85.4
Q ss_pred cCHHHHHHHhhCCCC-----CCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCc--eecc
Q 010429 278 FSLRELQVATDNFSN-----RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRL 350 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l 350 (511)
++..++......|.. .+.|+.|....+|+....+| .+++|........ ..+..|..++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence 344455544455654 23466788899999987655 6889988653211 23456666666554222 2333
Q ss_pred cccc------ccCCceeEEeecccCCCHHH--------------HHHhcCCC-CCC----C---CHHHHHH---------
Q 010429 351 RGFC------MTPTERLLVYPFMVNGSVAS--------------CLRERGQS-QPP----L---NWSVRKQ--------- 393 (511)
Q Consensus 351 ~~~~------~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~~----l---~~~~~~~--------- 393 (511)
+... ...+..+++++|++|..+.. .++..... ..+ . .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 3221 12345689999998865311 12221111 000 1 1221000
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 394 ---IALGAARGLAYLHDH----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 394 ---i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+...+.+.++++++. .+.+++|+|+.+.||+++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 23479999999999999987656899998775
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00021 Score=58.96 Aligned_cols=56 Identities=27% Similarity=0.284 Sum_probs=28.0
Q ss_pred EEecCCCCcc-eecchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccccccc
Q 010429 73 RVDLGNANLS-GQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130 (511)
Q Consensus 73 ~l~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~ 130 (511)
.++.++++|+ ..+|..+ -++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5566666665 1222211 124555666666655444444555555555555555443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00063 Score=67.27 Aligned_cols=122 Identities=15% Similarity=0.158 Sum_probs=76.0
Q ss_pred eeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccC
Q 010429 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150 (511)
Q Consensus 71 l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 150 (511)
++.+.+.. +++......|.++..|+.+.+..+ ++..-..++.++.+|+.+.+..+ ++......|.++++|+.+.+.+
T Consensus 219 l~~i~~~~-~~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~ 295 (379)
T 4h09_A 219 LKKITITS-GVTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDN 295 (379)
T ss_dssp CSEEECCT-TCCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECC
T ss_pred cceeeecc-ceeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccc
Confidence 34444433 244344556677777777777665 44344556777777777777544 4434445677778888888877
Q ss_pred cccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceecc
Q 010429 151 NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFA 196 (511)
Q Consensus 151 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~ 196 (511)
|.++......|.+|.+|+.+.|..+ ++.+.. .+.++++|+.+.+.
T Consensus 296 ~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 296 SAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 7777555567778888888887644 443332 23555666666654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00043 Score=68.93 Aligned_cols=124 Identities=11% Similarity=0.118 Sum_probs=83.6
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
.++.+.+.++-. .+....|.++++|+.+.+. +.++.....+|.++++|+.++|..| ++..-...|.++++|+.+.|.
T Consensus 266 ~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 456666665433 3566788889999999996 4566455667889999999999765 564556789999999999996
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQ 199 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 199 (511)
.+ ++.....+|.+|++|+.+++.+|.... ..+...++|+.+.+..|.
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC---------
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCCC
Confidence 54 664556789999999999998876542 233445667776665554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00056 Score=67.64 Aligned_cols=104 Identities=13% Similarity=0.134 Sum_probs=85.8
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
..++.+.+..+ ++.+....|.++.+|+.+.+..+ ++.....+|.++++|+.+.+.+|.++..-...|.++.+|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 46788888765 77677888999999999999765 55455567999999999999999998666788999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccc
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNN 175 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N 175 (511)
..+ ++.....+|.+|.+|+.+.+..|
T Consensus 318 p~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 318 PTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred Ccc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 765 66455678999999999998654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00081 Score=67.73 Aligned_cols=71 Identities=15% Similarity=0.197 Sum_probs=47.1
Q ss_pred CeeccccccEEEEEEeCC--------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCce-eccccccccCCceeEEe
Q 010429 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 364 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~ 364 (511)
+.|+.|-...+|+....+ +..+++|+...... ...+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 568888899999998653 47899998843211 1234578888877754444 455554432 4899
Q ss_pred ecccCCC
Q 010429 365 PFMVNGS 371 (511)
Q Consensus 365 e~~~~gs 371 (511)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0012 Score=65.66 Aligned_cols=102 Identities=14% Similarity=0.076 Sum_probs=46.1
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcC---------------------Ccccccccccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN---------------------LTNLVSLDLYLNN 128 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------------------l~~L~~L~Ls~N~ 128 (511)
.++.+.+.. .++......|..+..|+.+.+..+..+ .....+.+ +.+|+.+.+..+
T Consensus 231 ~l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~- 307 (394)
T 4fs7_A 231 GVKNIIIPD-SFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS- 307 (394)
T ss_dssp CCCEEEECT-TCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-
T ss_pred CCceEEECC-CceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccc-
Confidence 455555543 233334455556666666666554332 23333444 444444444332
Q ss_pred ccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccc
Q 010429 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175 (511)
Q Consensus 129 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 175 (511)
++..-...|.++++|+.++|.++ ++.....+|.+|.+|+.+++..|
T Consensus 308 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 308 VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 33222334445555555555322 33233344555555555555443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0015 Score=64.99 Aligned_cols=124 Identities=11% Similarity=0.012 Sum_probs=63.6
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+|+.+.|.. +++.+...+|.++++|+.++|.+| ++..-..+|.++++|+.+.+..+ +...-...|.++..++....
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECC
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccC
Confidence 3567777753 366555666777777777777644 44334455666666766665543 22122333433332222222
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCC-CCCCCCcccceeccCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANN 198 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~l~~l~l~~N 198 (511)
... .......|.++++|+.+.+.++..+ ... .+..+.+|+.+.+..|
T Consensus 148 ~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~ 195 (394)
T 4fs7_A 148 EGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN 195 (394)
T ss_dssp TTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT
T ss_pred ccc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC
Confidence 111 1122345666777777777654322 222 2344556666665544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00017 Score=63.73 Aligned_cols=93 Identities=17% Similarity=0.184 Sum_probs=69.2
Q ss_pred ecchhhcCCCCCcEEEeecc-CCCC----CCCchhcCCccccccccccccccCC----CCcccccccccceeeccCcccC
Q 010429 84 QLVSQLGQLTNLQYLELYSN-NISG----KVPEELGNLTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSLM 154 (511)
Q Consensus 84 ~~~~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~ 154 (511)
.+...+.+-+.|+.|+|++| +|.. .+...+..-+.|+.|+|++|+|... +.+.+..-+.|+.|+|++|+|.
T Consensus 32 ~l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 32 CINRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 34455567788999999986 8763 2455677788999999999999843 3344556688999999999998
Q ss_pred CC----CCcccccCCCCceEeccccc
Q 010429 155 GE----IPRSLTNVNSLQVLDLSNNK 176 (511)
Q Consensus 155 ~~----~~~~~~~l~~L~~L~l~~N~ 176 (511)
+. +-..+..-+.|+.|+|++|.
T Consensus 112 ~~Ga~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 112 PELLARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred HHHHHHHHHHHhhCCceeEEECCCCc
Confidence 54 23345556789999998653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0022 Score=63.14 Aligned_cols=72 Identities=8% Similarity=0.059 Sum_probs=42.1
Q ss_pred CeeccccccEEEEEEeCC---------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCce-eccccccccCCceeEE
Q 010429 294 NILGRGGFGKVYKGRLTD---------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLV 363 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv 363 (511)
+.++.|....+|+....+ +..+++|+....... ......|.++++.+...++ .++++.. ..+++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 457888889999998753 268888887543211 1123567777776653333 3455433 24789
Q ss_pred eecccCCC
Q 010429 364 YPFMVNGS 371 (511)
Q Consensus 364 ~e~~~~gs 371 (511)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0042 Score=61.22 Aligned_cols=142 Identities=15% Similarity=0.159 Sum_probs=81.6
Q ss_pred CeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCce-eccccccccCCceeEEe
Q 010429 294 NILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 364 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~ 364 (511)
+.+..|-...+|+.... +++.+++|+.... ......+.+|..+++.+....+ .++++.+.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 46777888999999864 2478999986332 1223456688888877653333 445555443 3999
Q ss_pred ecccCCCHH--------------HH---HHhcCC--CCCCC-CHHHHHHHHHHHHH-------------------HHHHH
Q 010429 365 PFMVNGSVA--------------SC---LRERGQ--SQPPL-NWSVRKQIALGAAR-------------------GLAYL 405 (511)
Q Consensus 365 e~~~~gsL~--------------~~---l~~~~~--~~~~l-~~~~~~~i~~~i~~-------------------~L~~L 405 (511)
||++|..+. +. ++.... ...+. -+.+..++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 999875542 11 121111 11111 24455555544321 23333
Q ss_pred Hh----C-CCCCeEecCCCCCCeeeCCC----CceEEcccccccc
Q 010429 406 HD----H-CDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKL 441 (511)
Q Consensus 406 H~----~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~ 441 (511)
.+ . .+..++|+|+.+.||+++++ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 1 22378999999999999876 7899999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.017 Score=56.08 Aligned_cols=31 Identities=26% Similarity=0.354 Sum_probs=27.7
Q ss_pred CCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 411 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 411 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0058 Score=61.82 Aligned_cols=73 Identities=11% Similarity=0.104 Sum_probs=46.3
Q ss_pred CeeccccccEEEEEEeCC-CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCce-eccccccccCCceeEEeecccCCC
Q 010429 294 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
+.|+.|-...+|+....+ +..+++|+..... .. .....+|..++..+...++ .++++.+. ..+||||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence 568888899999998764 4788899874322 11 1113578888888765554 45666552 236999998754
Q ss_pred H
Q 010429 372 V 372 (511)
Q Consensus 372 L 372 (511)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.21 E-value=0.028 Score=56.13 Aligned_cols=141 Identities=9% Similarity=0.084 Sum_probs=82.5
Q ss_pred CeeccccccEEEEEEeCC--------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCce-eccccccccCCceeEEe
Q 010429 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 364 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~ 364 (511)
+.+..|-...+|+....+ +..+++|+..... .. .....+|..+++.+...++ .++++.+ ..++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 467778889999998753 5789999864422 11 1124567777776653333 3444432 247899
Q ss_pred ecccCCCHH--------------HH---HHhc-------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 010429 365 PFMVNGSVA--------------SC---LRER-------GQ--SQPPLNWSVRKQIALGA-------------------A 399 (511)
Q Consensus 365 e~~~~gsL~--------------~~---l~~~-------~~--~~~~l~~~~~~~i~~~i-------------------~ 399 (511)
||++|..+. +. ++.. .. ...+--+.+..++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 999886531 11 1111 00 11122344444443322 2
Q ss_pred HHHHHHHhC---------------------CCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 400 RGLAYLHDH---------------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 400 ~~L~~LH~~---------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
..+++|.+. .+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333211 1236889999999999 7788999999998753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.03 Score=35.55 Aligned_cols=35 Identities=26% Similarity=0.323 Sum_probs=23.5
Q ss_pred CccceeecccchhhHHHHHHhHHhhhhhhccCCCC
Q 010429 223 SATGAIAGGVAAGAALLFAAPAIALAYWRKRKPED 257 (511)
Q Consensus 223 s~~~~i~~~v~~~~~~l~~~~~~~~~~~r~~~~~~ 257 (511)
+.+.+++.++.+|++.++++....++++|||+.+.
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34456777777777777776666777777765543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.63 E-value=0.042 Score=34.99 Aligned_cols=34 Identities=21% Similarity=0.216 Sum_probs=22.7
Q ss_pred CccceeecccchhhHHHHHHhHHhhhhhhccCCC
Q 010429 223 SATGAIAGGVAAGAALLFAAPAIALAYWRKRKPE 256 (511)
Q Consensus 223 s~~~~i~~~v~~~~~~l~~~~~~~~~~~r~~~~~ 256 (511)
+.+.+++.++.+|++.++++....++++|||+.+
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3445677777777777776666667777776553
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.04 E-value=0.17 Score=44.97 Aligned_cols=102 Identities=16% Similarity=0.096 Sum_probs=65.5
Q ss_pred CCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCc
Q 010429 369 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 448 (511)
Q Consensus 369 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 448 (511)
.-+|.+.|+..+. ++++++++.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 32 ~vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc--------
Confidence 3489999988654 5999999999999998877662211 111233457889999999998764 1110
Q ss_pred eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCC
Q 010429 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 490 (511)
Q Consensus 449 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~ 490 (511)
.....+.|||... ...+.+.=|||+|+++|.-+-=.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0122456788753 34456778999999999887533
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.49 E-value=0.094 Score=51.99 Aligned_cols=30 Identities=30% Similarity=0.453 Sum_probs=25.2
Q ss_pred CeEecCCCCCCeee------CCCCceEEcccccccc
Q 010429 412 KIIHRDVKAANILL------DEEFEAVVGDFGLAKL 441 (511)
Q Consensus 412 ~ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~~ 441 (511)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.50 E-value=1.3 Score=39.25 Aligned_cols=84 Identities=13% Similarity=0.091 Sum_probs=59.1
Q ss_pred CCCceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCC
Q 010429 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA-YLHDHCDPKIIHRDVKAA 421 (511)
Q Consensus 343 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlkp~ 421 (511)
.||.+ -..+-.+.+...+.++.-+++.-...++. .+...+++++.+++.... +++. -+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 46666 23333556666666665544433334443 788999999999887666 5544 478899999
Q ss_pred CeeeCCCCceEEccccccc
Q 010429 422 NILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 422 NIll~~~~~~kl~Dfg~a~ 440 (511)
||++|.++.++|.-.|+-.
T Consensus 114 NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GEEECTTCCEEESCCEETT
T ss_pred eEEEeCCCcEEEEEcCCcc
Confidence 9999999999999877653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.56 E-value=0.9 Score=40.22 Aligned_cols=86 Identities=6% Similarity=-0.007 Sum_probs=59.8
Q ss_pred CCCCceeccccccccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 010429 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (511)
Q Consensus 342 ~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 421 (511)
..||++++. .+-.+.+...+.++.-+.+.-...++. .+...+++++.+++....+++.. +|--+.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 347777765 344455555555554432222222332 78899999999998877666544 78899999
Q ss_pred CeeeCCCCceEEccccccc
Q 010429 422 NILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 422 NIll~~~~~~kl~Dfg~a~ 440 (511)
|++++.++.+++.=-|+-.
T Consensus 109 NL~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp GEEECTTSCEEESCCEETT
T ss_pred eEEEcCCCCEEEEEccCcc
Confidence 9999999999998877643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.01 E-value=0.15 Score=51.56 Aligned_cols=61 Identities=5% Similarity=0.018 Sum_probs=17.1
Q ss_pred CCCeeccccccEEEEEEeCC-CCEEEE------EEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccc
Q 010429 292 NRNILGRGGFGKVYKGRLTD-GSLVAV------KRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (511)
Q Consensus 292 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 355 (511)
+.+.+| ||.||+|.+.. ..+||| |..+.... ......+.+|..+++..+|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345666 99999999863 357888 76654332 222345778888888899999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 511 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 5e-04 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-62
Identities = 50/213 (23%), Positives = 99/213 (46%), Gaps = 10/213 (4%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
+++ D+F + LG G G V+K G ++A K + E Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
++ G + E + M GS+ L++ G + + ++++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L YL + KI+HRDVK +NIL++ E + DFG++ + + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE L S ++D++ G+ L+E+ G+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-59
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRN 346
+ +G G FG VYKG+ VAVK L +LQ F+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+L G+ T + +V + S+ L + IA A+G+ YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYL 465
IIHRD+K+ NI L E+ +GDFGLA + + +H + G+I +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 466 STGKS---SEKTDVFGYGVMLLELITGQRAFD 494
S ++DV+ +G++L EL+TGQ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-58
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 8/207 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ LG G FG+V+ G + VAVK LK+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRL 70
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
+RL T ++ +M NGS+ L+ L + +A A G+A++ +
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
IHRD++AANIL+ + + DFGLA+L++ + + I APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAFD 494
G + K+DV+ +G++L E++T R
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY 211
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-57
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 7/213 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHR 345
+++ +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 346 NLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
N++R + T L V + G +AS + + + + L+ ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 404 YLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
H ++HRD+K AN+ LD + +GDFGLA++++ DT A GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE ++ +EK+D++ G +L EL F
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (474), Expect = 6e-56
Identities = 61/240 (25%), Positives = 104/240 (43%), Gaps = 30/240 (12%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQF 332
L L+ +N +G G FG+V++ R ++VAVK LKEE + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 333 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ--------- 383
Q E +++ + N+++L G C L++ +M G + LR
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 384 -----------PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 432
PPL+ + + IA A G+AYL + K +HRD+ N L+ E
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 433 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 491
+ DFGL++ + D I + PE + + + ++DV+ YGV+L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 9e-56
Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 14/221 (6%)
Query: 281 RELQVATDNFSNRNI-LGRGGFGKVYKGRL---TDGSLVAVKRLKEERTQGGELQFQTEV 336
++L + DN +I LG G FG V +G VA+K LK+ + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 396
+++ + ++RL G C +LV G + L + + + S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 397 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVR 454
+ G+ YL + +HRD+ A N+LL A + DFGL+K + D++ T +A +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 455 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+ APE ++ K S ++DV+ YGV + E ++ GQ+ +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 2e-55
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 278 FSLRELQVATDNFSNR---------NILGRGGFGKVYKGRLT----DGSLVAVKRLKEER 324
F+ + A F+ ++G G FG+V G L VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 325 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 384
T+ F +E ++ H N++ L G T +++ FM NGS+ S LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DG 123
Query: 385 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444
+ G A G+ YL D +HRD+ A NIL++ V DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 445 KDTHVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+ T + I APE + K + +DV+ YG+++ E+++ G+R +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-55
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 8/206 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ +G G FG V+ G + VA+K ++E E F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 62
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
++L G C+ LV+ FM +G ++ LR + + L G+AYL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE 119
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
C +IHRD+ A N L+ E V DFG+ + + +T + + +PE S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAF 493
+ S K+DV+ +GV++ E+ + +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIP 202
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-55
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 13/225 (5%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+++ LG G +G+V VAVK + +R + E+ + M H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++ G + L + G + + + ++ G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYL 465
I HRD+K N+LLDE + DFGLA + Y + + + GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 466 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509
+ +E DV+ G++L ++ G+ +D +D DW
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDW 219
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-55
Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + LG G FG V G+ VA+K +KE E +F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKL 61
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
++L G C ++ +M NG + + LRE + ++ + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
+HRD+ A N L++++ V DFGL++ + + + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFD 494
K S K+D++ +GV++ E+ + G+ ++
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-55
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQF 332
++++L ++F LG+G FG VY R ++A+K L + + G E Q
Sbjct: 1 RQWAL-------EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 333 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK 392
+ EVE+ S H N+LRL G+ T L+ + G+V L++ +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTA 109
Query: 393 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 452
A L+Y H ++IHRD+K N+LL E + DFG +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 163
Query: 453 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ GT+ ++ PE + EK D++ GV+ E + G+ F+
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-54
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 294 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 351
+GRG F VYKG T+ VA L++ + E Q F+ E EM+ H N++R
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 352 GFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
+ + +LV M +G++ + L+ + V + +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 130
Query: 408 HCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
P IIHRD+K NI + +GD GLA L AV GT +APE
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFD 494
K E DV+ +G+ +LE+ T + +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS 213
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-54
Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 338
++ + + ++G G FG+VYKG L S VA+K LK T+ + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 398
+ H N++RL G +++ +M NG++ LRE+ + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGI 119
Query: 399 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 456
A G+ YL + +HRD+ A NIL++ V DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
I APE +S K + +DV+ +G+++ E++T
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-54
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 8/206 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
++ LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 74
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 407
++L + +V +M GS+ +G++ L +A A G+AY+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 408 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 467
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 468 GKSSEKTDVFGYGVMLLELITGQRAF 493
G+ + K+DV+ +G++L EL T R
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVP 214
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (457), Expect = 3e-53
Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV 343
FS+ +G G FG VY R + + +VA+K++ Q E EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H N ++ RG + LV + + + + PL + GA +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
YLH H +IHRDVKA NILL E +GDFG A +M ++ V GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 181
Query: 464 YLST---GKSSEKTDVFGYGVMLLELITGQRAFD 494
+ G+ K DV+ G+ +EL +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-53
Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
+F+ ++GRG FG VY G L D AVK L G QF TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 345 RNLLRLRGFCM-TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
N+L L G C+ + L+V P+M +G + + +R L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGM- 143
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHI 460
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
A E L T K + K+DV+ +GV+L EL+T
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 7e-53
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62
Query: 348 LRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++L G + L +V +M GS+ LR RG+S L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 120
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
+ +HRD+ A N+L+ E+ A V DFGL K + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAF 493
K S K+DV+ +G++L E+ + R
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVP 200
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 9e-53
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 31/235 (13%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISM 341
+N +LG G FGKV S VAVK LKE+ +E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 342 AV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---------------- 384
H N++ L G C L++ + G + + LR + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 385 ---PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441
L + A A+G+ +L +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 442 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
+ +V R + +APE L G + K+DV+ YG++L E+ + G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (451), Expect = 1e-52
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 8/220 (3%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT 334
+ + ++ + + ++ LG G +G+VY+G VAVK LKE+ + E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 335 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 394
E ++ H NL++L G C ++ FM G++ LRE + ++ V +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120
Query: 395 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 454
A + + YL IHRD+ A N L+ E V DFGL++LM +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 455 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
I APE L+ K S K+DV+ +GV+L E+ T +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-52
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 287 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
D + LG G FGKVYK + + L A K + + + E + E+++++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++L ++ F G+V + + E + PL S + + L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYL 126
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
HD+ KIIHRD+KA NIL + + + DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182
Query: 466 STGKS-----SEKTDVFGYGVMLLELITGQRAFD 494
S K DV+ G+ L+E+ +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 8e-52
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMIS-MAV 343
++ ++++G G FG+V K R+ L A+KR+KE ++ F E+E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER------------GQSQPPLNWSVR 391
H N++ L G C L + +G++ LR+ + L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
A ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
R + +A E L+ + +DV+ YGV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 226
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-51
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 294 NILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLR 349
LG G FG V KG VAVK LK E + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 409
+ G C + +LV G + L++ + ++ + G+ YL +
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 410 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 467
+HRD+ A N+LL + A + DFGL+K + D T + + APE ++
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 468 GKSSEKTDVFGYGVMLLELIT-GQRAFD 494
K S K+DV+ +GV++ E + GQ+ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 212
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 6e-51
Identities = 58/246 (23%), Positives = 98/246 (39%), Gaps = 25/246 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMIS- 340
+ S LG G FGKV + VAVK LK +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS--------------QPPL 386
+ H N++ L G C L++ + G + + LR + S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 387 NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
+ + A+G+A+L IHRD+ A NILL + DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 447 TH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 505
+ V R + +APE + + ++DV+ YG+ L EL + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 506 LLDWDF 511
++ F
Sbjct: 260 MIKEGF 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-50
Identities = 45/209 (21%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
++ +G+G G VY + G VA++++ ++ E E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N++ + E +V ++ GS+ + E + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFL 132
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H + ++IHRD+K+ NILL + + DFG + + + +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ K D++ G+M +E+I G+ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-49
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
+ +G+G FG+V++G+ G VAVK + + E+ M H N+L
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIA 64
Query: 353 FCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
T T+ LV + +GS+ L + ++AL A GLA+LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 119
Query: 409 C-----DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHI 460
P I HRD+K+ NIL+ + + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 461 APEYLST------GKSSEKTDVFGYGVMLLELITGQRAFD 494
APE L +S ++ D++ G++ E+
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-48
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 13/212 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
F +LG G FG VYKG VA+K L+E + + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 402
+ ++ RL G C+T T +L+ M G + +RE + + A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGM 124
Query: 403 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIA 461
YL D +++HRD+ A N+L+ + DFGLAKL+ ++ + + I +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E + + ++DV+ YGV + EL+T
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 7e-48
Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 11/211 (5%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH 344
++F ILG G F V R L A+K L++ + E +++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
++L + + NG L + + + + + L Y
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPE 463
LH IIHRD+K NILL+E+ + DFG AK++ + + GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
L+ + + +D++ G ++ +L+ G F
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-46
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 16/225 (7%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY+G + VA+K + E + ++F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ------PPLNWS 389
++ +++RL G L++ M G + S LR + P + S
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 390 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-TH 448
Q+A A G+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 449 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ ++PE L G + +DV+ +GV+L E+ T
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (414), Expect = 1e-46
Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 12/210 (5%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D++ LG G FG V++ G+ A K + E + E++ +S+ H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L+ L E +++Y FM G + + + ++ + +GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141
Query: 407 DHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
++ +H D+K NI+ E + DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
TD++ GV+ L++G F
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-46
Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAV 343
+ +G G FG V++G VA+K K + +F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H ++++L G T ++ G + S L+ R + L+ + A + LA
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALA 122
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
YL + +HRD+ A N+L+ +GDFGL++ M+ + + + I +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQR 491
++ + + +DV+ +GV + E++
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (413), Expect = 3e-46
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAV- 343
++FS I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 344 --HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
++ + TP + + M G + L + G + + + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L ++H+ +++RD+K ANILLDE + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 462 PEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWDF 511
PE L G + D F G ML +L+ G F + + ++ +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-46
Identities = 66/216 (30%), Positives = 91/216 (42%), Gaps = 16/216 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGEL--QFQTEVEMISM 341
+ LG G FG V +G VAVK LK + E F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
HRNL+RL G +TP ++ V GS+ LR+ Q + A+ A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 123
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGH 459
+ YL IHRD+ A N+LL +GDFGL + + D H + +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 494
APE L T S +D + +GV L E+ T GQ +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (399), Expect = 3e-45
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--------EERTQGGELQFQTEVE- 337
+N+ + ILGRG V + AVK + E Q EV+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 397
+ ++ H N+++L+ T T LV+ M G + L E+ L+ ++I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 118
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
+ LH I+HRD+K NILLD++ + DFG + +D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173
Query: 458 GHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFD 494
++APE + ++ D++ GV++ L+ G F
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 159 bits (404), Expect = 4e-45
Identities = 45/210 (21%), Positives = 82/210 (39%), Gaps = 12/210 (5%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D + LG G FG V++ G + K + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 87
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
L+ L E +L+ F+ G + + ++ + A GL ++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMH 144
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
+H I+H D+K NI+ + + + V DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ TD++ GV+ L++G F
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 6e-45
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 13/217 (5%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
A + +G G +GKV+K R G VA+KR++ + +G L EV ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 343 V---HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE--RGQSQPPLNWSVRKQIALG 397
H N++RL C +V V L +P + K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
RGL +LH H +++HRD+K NIL+ + + DFGLA++ ++ + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ APE L + D++ G + E+ + F
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 7e-45
Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 13/218 (5%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMI 339
++ + D + R++LG G F +V LVA+K + ++ +G E + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 340 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
H N++ L + L+ + G + + E+G ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 456
+ YLHD I+HRD+K N+L DE+ + ++ DFGL+K+ D V + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGT 172
Query: 457 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
G++APE L+ S+ D + GV+ L+ G F
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-44
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
D LGRG FG+V + VAVK LKE T +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 342 AVHR-NLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPP------------LN 387
H N++ L G C P L ++ F G++++ LR + P L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 388 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 448 HV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+V R + +APE + + ++DV+ +GV+L E+ + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-44
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMI 339
D LG G FG+V + VAVK LK + T+ +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 340 SMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG------------QSQPPL 386
M H+N++ L G C ++ + G++ L+ R + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 387 NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
+ A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 447 THVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ T R + +APE L + ++DV+ +GV+L E+ T +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-44
Identities = 47/211 (22%), Positives = 95/211 (45%), Gaps = 8/211 (3%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
++N + +G G +G V + VA+K++ Q + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N++ + PT + ++V + + L + ++Q L+ RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPE 463
H ++HRD+K +N+LL+ + + DFGLA++ D H T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 464 YLSTG-KSSEKTDVFGYGVMLLELITGQRAF 493
+ ++ D++ G +L E+++ + F
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-44
Identities = 44/210 (20%), Positives = 84/210 (40%), Gaps = 13/210 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
+ + LGRG FG V++ + K +K + T ++ + E+ ++++A HRN
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRN 62
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+L L + E ++++ F+ + + LN L +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH 119
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
H I H D++ NI+ + + +FG A+ + D + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEV 174
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
S TD++ G ++ L++G F
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFL 204
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 3e-43
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRN 346
+ + +G G +G VYK + G A+K+++ E+ +G E+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
+++L T +LV+ + G L K L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCH 117
Query: 407 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 466
D +++HRD+K N+L++ E E + DFGLA+ T + +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 467 TGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ K S D++ G + E++ G F
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-43
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 12/211 (5%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV- 343
++F +LG+G FGKV+ A+K LK++ + E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 344 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
H L + T V ++ G + ++ + S A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 463
+LH I++RD+K NILLD++ + DFG+ K D T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
L K + D + +GV+L E++ GQ F
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 2e-42
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEE--RTQGGELQFQTEVEMISMAV 343
+D + ILG GG +V+ R L VAVK L+ + R L+F+ E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 344 HRNLLRLRGFCMTPTERL----LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 399
H ++ + T +V ++ ++ + G P+ ++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121
Query: 400 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTI 457
+ L + H + IIHRDVK ANI++ V DFG+A+ + V T AV GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+++PE ++DV+ G +L E++TG+ F
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-42
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 8/209 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 345
+NF +G G +G VYK R G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N+++L T + LV+ F+ + + + K +GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
H H ++HRD+K N+L++ E + DFGLA+ T V L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFD 494
S D++ G + E++T + F
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFP 204
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (381), Expect = 4e-42
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVH 344
+F LG G FG+V+ R +G A+K LK+E + E M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
++R+ G + ++ ++ G + S LR+ + P+ ++ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------A 116
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
L II+RD+K NILLD+ + DFG AK + + GT +IAPE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEV 172
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ST ++ D + +G+++ E++ G F
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 7e-41
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K++ +++ E++++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCN 74
Query: 347 LLRLRGFCMTPTE-RLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
++RLR F + E + VY +V +V R +++ L K R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 460
LAY+H I HRD+K N+LLD + + DFG AK + + +V+ +
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRA 190
Query: 461 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ DV+ G +L EL+ GQ F
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-40
Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 14/207 (6%)
Query: 294 NILGRGGFGKVYKGRLT-DGSLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLL 348
+ LG G F VYK R +VA+K++K E G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L + LV+ FM + L S K L +GL YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 409 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 468
I+HRD+K N+LLDE + DFGLAK + T V T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 469 KS-SEKTDVFGYGVMLLELITGQRAFD 494
+ D++ G +L EL+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLP 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 6e-40
Identities = 44/223 (19%), Positives = 78/223 (34%), Gaps = 20/223 (8%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 340
EL+V + + +G G FG +Y G + G VA+K + Q E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYK 57
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 400
M + +C + ++ ++ S+ + + +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMIS 114
Query: 401 GLAYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDTHV------TT 451
+ Y+H IHRDVK N L + + DFGLAK TH
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ GT + + + S + D+ G +L+ G +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 22/209 (10%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRG 352
+LG G GKV + A+K L++ + + EVE+ A +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72
Query: 353 FCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 408
L+V + G + S +++RG +I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130
Query: 409 CDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
I HRDVK N+L + + DFG AK ++ T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAFD 494
K + D++ GV++ L+ G F
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY 214
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-38
Identities = 49/227 (21%), Positives = 95/227 (41%), Gaps = 24/227 (10%)
Query: 295 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE-----LQFQTEVEMISM--AVHRN 346
+LG GGFG VY G ++D VA+K ++++R + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 406
++RL + P +L+ L + + L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 407 DHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
+ ++HRD+K NIL+D E + DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 466 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWDF 511
+ V+ G++L +++ G F+ +D++++ F
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQVFF 223
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-38
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 19/217 (8%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-----QFQTEVEMISM 341
D + LG G F V K R + G A K +K+ RT+ + EV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H N++ L T+ +L+ + G L + + L + G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLMDYKDTHVTTAVRGTI 457
+ YLH I H D+K NI+L + + DFGLA +D+ + + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 458 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+APE ++ + D++ GV+ L++G F
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (348), Expect = 9e-38
Identities = 32/211 (15%), Positives = 68/211 (32%), Gaps = 21/211 (9%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G FG +++G L + VA+K Q + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 355 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 414
++ ++ S+ L G + A + +H+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 415 HRDVKAANILLDEEFEAVVG-----DFGLAKLMDYKDTHV------TTAVRGTIGHIAPE 463
+RD+K N L+ DFG+ K T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 464 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+ S + D+ G + + + G +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-37
Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 11/213 (5%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISM 341
V ++F +LG+G FGKV R G A+K L++E + TE ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
H L L+ T V + G + L +I
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA---- 117
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 461
L +++RD+K N++LD++ + DFGL K GT ++A
Sbjct: 118 ---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 462 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
PE L D +G GV++ E++ G+ F
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-37
Identities = 53/239 (22%), Positives = 96/239 (40%), Gaps = 20/239 (8%)
Query: 275 LKRFSLRELQVAT-DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-- 330
LK++ A D F LG G FG+V + G+ A+K L +++ +
Sbjct: 27 LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 331 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV 390
E ++ L++L + +V ++ G + S LR G +
Sbjct: 87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPH 142
Query: 391 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 450
+ A YLH +I+RD+K N+L+D++ V DFG AK + +
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-- 197
Query: 451 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 509
+ GT +APE + + ++ D + GV++ E+ G F D + + +
Sbjct: 198 --LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYEK 249
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-37
Identities = 42/208 (20%), Positives = 78/208 (37%), Gaps = 9/208 (4%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 345
+ +G G +G V+K + +VA+KR++ ++ +G E+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 405
N++RL + + LV+ F G P + S Q+ G L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG-------L 114
Query: 406 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 465
++HRD+K N+L++ E + +FGLA+ + V
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 466 STGKSSEKTDVFGYGVMLLELITGQRAF 493
S D++ G + EL R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-37
Identities = 46/222 (20%), Positives = 88/222 (39%), Gaps = 12/222 (5%)
Query: 278 FSLRELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQ 331
F +E+ +G G +G V G+ VA+K+L + +++ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 332 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR 391
E+ ++ H N++ L F + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 392 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 451
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D+ +T
Sbjct: 124 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 452 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
V L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 9e-37
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 21/221 (9%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHR 345
+ +G+G FG+V+K R G VA+K++ E +G + E++++ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 346 NLLRLRGFCMTPTER--------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 397
N++ L C T LV+ F + + V + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 398 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVR 454
L L+ KI+HRD+KAAN+L+ + + DFGLA+ + T
Sbjct: 127 ----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 455 GTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 494
T+ + PE L + D++G G ++ E+ T
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER---TQGGELQFQTEV 336
+V +NF +LG G +GKV+ R G L A+K LK+ +TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 337 EMISMAVHR-NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 395
+++ L+ L T T+ L+ ++ G + + L +R + +I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138
Query: 396 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 455
+ L II+RD+K NILLD V+ DFGL+K +T G
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 456 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFD 494
TI ++AP+ + G S + D + GV++ EL+TG F
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (308), Expect = 6e-32
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHR 345
D++ LGRG + +V++ +T+ V VK LK + + + + E++ + ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGP 90
Query: 346 NLLRLRGFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 403
N++ L P R LV+ + N + L + + L
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143
Query: 404 YLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 462
Y H I+HRDVK N+++D E + + D+GLA+ + + P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 463 E-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 493
E + D++ G ML +I + F
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 8/210 (3%)
Query: 287 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVH 344
+ + N + +G G +G V G VAVK+L + E+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L + + L + + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
+H IIHRD+K +N+ ++E+ E + DFGLA+ D +T V
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
L+ ++ D++ G ++ EL+TG+ F
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 8e-31
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 10/209 (4%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHR 345
+ N +G G G V VA+K+L + + Q + E+ ++ H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 346 NLLRLRGFCMTP-TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
N++ L T ++V + + L + Q + + G+ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKH 134
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 464
LH IIHRD+K +NI++ + + DFGLA+ + + T T + APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEV 189
Query: 465 LSTGKSSEKTDVFGYGVMLLELITGQRAF 493
+ E D++ G ++ E++ + F
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 6e-28
Identities = 43/215 (20%), Positives = 81/215 (37%), Gaps = 21/215 (9%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 355 -------------MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 401
P +V F V G L ++ + + KQI+ G
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISKQLLLG 137
Query: 402 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGH 459
L Y+H C IIH D+K N+L++ + +A L + T +
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 460 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494
+PE L D++ ++ ELITG F+
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.1 bits (246), Expect = 1e-24
Identities = 24/162 (14%), Positives = 48/162 (29%), Gaps = 20/162 (12%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERT---------QGGELQFQTEVEMISMAVH 344
++G G V+ VK K T G+L F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 404
R L +L+G + + G+ + + ++ +A
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 405 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446
+ I+H D+ N+L+ E + DF + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.4 bits (207), Expect = 1e-18
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 12/187 (6%)
Query: 29 EGDALNALKTNLADPNNVLQSWDATLVNPC--TWFHVTCNSENSVTRV---DLGNANLSG 83
+ AL +K +L +P L SW T + C TW V C+++ RV DL NL
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 84 --QLVSQLGQLTNLQYLELYSN-NISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKL 140
+ S L L L +L + N+ G +P + LT L L + N++G IP L ++
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 141 SKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF--SLFTPISFANN 198
L L + N+L G +P S++++ +L + N+++G IP + LFT ++ + N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 199 QLNNPPP 205
+L P
Sbjct: 185 RLTGKIP 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 3e-14
Identities = 22/61 (36%), Positives = 33/61 (54%)
Query: 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSP 207
L NN + G +P+ LT + L L++S N L G+IP G+ F ++ANN+ P P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310
Query: 208 P 208
Sbjct: 311 A 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.5 bits (163), Expect = 5e-13
Identities = 24/66 (36%), Positives = 32/66 (48%), Gaps = 1/66 (1%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
NL L+L +N I G +P+ L L L SL++ NNL G IP G L + NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 153 LMGEIP 158
+ P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.5 bits (158), Expect = 2e-12
Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 123 DLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
DL N + G +P L +L L L ++ N+L GEIP N+ V +NNK P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 3e-11
Identities = 21/81 (25%), Positives = 32/81 (39%), Gaps = 3/81 (3%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN 115
N + ++ +DL N + G L L QL L L + NN+ G++P + GN
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289
Query: 116 LTNLVSLDLYLNNL--NGPIP 134
L N P+P
Sbjct: 290 LQRFDVSAYANNKCLCGSPLP 310
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.0 bits (183), Expect = 3e-15
Identities = 25/94 (26%), Positives = 42/94 (44%), Gaps = 6/94 (6%)
Query: 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT 117
++ ++T + L N+S +S + LT LQ L +N +S L NLT
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLT 351
Query: 118 NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
N+ L N ++ P L L+++ L LN+
Sbjct: 352 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.3 bits (181), Expect = 5e-15
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L NL YL LY NNIS P + +LT L L N ++ ++L L+ + +L +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGH 360
Query: 151 NSLMGEIPRSLTNVNSLQVLDLSNN 175
N + P L N+ + L L++
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 4e-13
Identities = 35/160 (21%), Positives = 54/160 (33%), Gaps = 48/160 (30%)
Query: 65 CNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVP-EELGNLTNL---- 119
++ + L L + L LTNL L+L +N IS P L LT L
Sbjct: 215 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 272
Query: 120 -------------------------------------VSLDLYLNNLNGPIPTTLGKLSK 142
L LY NN++ P + L+K
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 143 LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L+ L NN + SL N+ ++ L +N+++ P
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 9e-12
Identities = 40/168 (23%), Positives = 65/168 (38%), Gaps = 27/168 (16%)
Query: 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT 117
++ + N +S ++ LG LTNL L L N + L +LT
Sbjct: 186 KVSDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTLASLT 241
Query: 118 NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP------------------- 158
NL LDL N ++ P L L+KL L+L N + P
Sbjct: 242 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED 299
Query: 159 -RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
++N+ +L L L N ++ P S + + FANN++++
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISPV-SSLTKLQRLFFANNKVSDVSS 346
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.9 bits (123), Expect = 8e-08
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 6/81 (7%)
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ LG N++ L + L+ I K + + L NL ++ N L
Sbjct: 24 KMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT 79
Query: 131 GPIPTTLGKLSKLRFLRLNNN 151
P L L+KL + +NNN
Sbjct: 80 DITP--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.8 bits (115), Expect = 8e-07
Identities = 16/78 (20%), Positives = 31/78 (39%), Gaps = 10/78 (12%)
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNV---NSLQVLD 171
L + L N+ + + L ++ L+ + + +S+ V N+L ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI-----KSIDGVEYLNNLTQIN 72
Query: 172 LSNNKLTGDIPTNGSFSL 189
SNN+LT P L
Sbjct: 73 FSNNQLTDITPLKNLTKL 90
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.7 bits (169), Expect = 1e-13
Identities = 31/165 (18%), Positives = 47/165 (28%), Gaps = 10/165 (6%)
Query: 58 CTWFHVTCNSEN----------SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
C V C+ +DL N ++ L NL L L +N IS
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSL 167
P L L L L N L L +LR + + L + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 168 QVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
++ + + I A+ + P PP L
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT 174
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 4e-10
Identities = 43/224 (19%), Positives = 71/224 (31%), Gaps = 18/224 (8%)
Query: 3 KLERVVWAFLVSILFFDLLLRVASNAEGDALNALK--TNLADPNNVLQSWDATLVNPCTW 60
+++ + L ++ L+ S A L L N L+ +
Sbjct: 45 EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQE 104
Query: 61 FHVTCNSENSVTRVDLG-------------NANLSGQLVSQLGQLTNLQYLELYSNNISG 107
V N V + SG + L Y+ + NI+
Sbjct: 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSL 167
+P+ G +L L L N + +L L+ L L L+ NS+ SL N L
Sbjct: 164 TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
Query: 168 QVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 211
+ L L+NNKL + NN ++ + P
Sbjct: 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 24/148 (16%), Positives = 46/148 (31%), Gaps = 32/148 (21%)
Query: 60 WFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNL 119
+ ++ + + + N++ G +L L L N I+ L L NL
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 120 VSLDLYLNNLNGPI-----------------------PTTLGKLSKLRFLRLNNNSLMG- 155
L L N+++ P L ++ + L+NN++
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 156 -----EIPRSLTNVNSLQVLDLSNNKLT 178
P T S + L +N +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 58.2 bits (140), Expect = 4e-11
Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 75 DLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP 134
L + +L+ + L QL + +L+L N + P L L L L N L
Sbjct: 4 HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60
Query: 135 TTLGKLSKLRFLRLNNNSL-MGEIPRSLTNVNSLQVLDLSNNKLTGD 180
L +L+ L L NN L + L + L +L+L N L +
Sbjct: 61 VA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 4e-07
Identities = 28/115 (24%), Positives = 39/115 (33%), Gaps = 7/115 (6%)
Query: 96 QYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMG 155
+ L L +++ V L L + LDL N L P L L L L +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLE--VLQASDNAL 55
Query: 156 EIPRSLTNVNSLQVLDLSNNKLTG--DIPTNGSFSLFTPISFANNQLNNPPPSPP 208
E + N+ LQ L L NN+L I S ++ N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.5 bits (81), Expect = 0.004
Identities = 12/95 (12%), Positives = 30/95 (31%), Gaps = 7/95 (7%)
Query: 34 NALKTNLADPNNVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANL-SGQLVSQLGQL 92
N L+ + + + + + L N L + L
Sbjct: 30 NRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSC 89
Query: 93 TNLQYLELYSNNISG------KVPEELGNLTNLVS 121
L L L N++ ++ E L +++++++
Sbjct: 90 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 124
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.0 bits (143), Expect = 3e-10
Identities = 20/92 (21%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 94 NLQYLELYSNNISGK-VPEELGNLTNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRL 148
++Q L++ +S E L L + L L I + L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 149 NNNSLMGEIPRSL-----TNVNSLQVLDLSNN 175
+N L + T +Q L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (142), Expect = 4e-10
Identities = 19/80 (23%), Positives = 34/80 (42%), Gaps = 5/80 (6%)
Query: 118 NLVSLDLYLNNLN-GPIPTTLGKLSKLRFLRLNNNSL----MGEIPRSLTNVNSLQVLDL 172
++ SLD+ L+ L L + + +RL++ L +I +L +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 173 SNNKLTGDIPTNGSFSLFTP 192
+N+L L TP
Sbjct: 63 RSNELGDVGVHCVLQGLQTP 82
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (136), Expect = 2e-09
Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 13/91 (14%)
Query: 93 TNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNGPIPTTLGK-----LSKL 143
+ L+ L L ++S + L +L LDL N L L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 144 RFLRLNNNSLMGEIPRSLTNV----NSLQVL 170
L L + E+ L + SL+V+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 9e-09
Identities = 18/106 (16%), Positives = 34/106 (32%), Gaps = 15/106 (14%)
Query: 57 PCTWFHVTCNSENSVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEE 112
+ + + L + ++S L + L +L+ L+L +N + +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 113 LG-----NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
L L L LY + + L L K + SL
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK------DKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 2e-08
Identities = 16/92 (17%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 70 SVTRVDLGNANLSGQLVSQL-GQLTNLQYLELYSNNISGKVPEELG----NLTNLVSLDL 124
+ +D+ LS ++L L Q + L ++ +++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 125 YLNNLNGPIPTTLGKL-----SKLRFLRLNNN 151
N L + + K++ L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 9/77 (11%)
Query: 115 NLTNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGEIPRSL-----TNVN 165
+ L L L +++ + TL LR L L+NN L L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 166 SLQVLDLSNNKLTGDIP 182
L+ L L + + ++
Sbjct: 427 LLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 1e-04
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 10/71 (14%)
Query: 141 SKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---- 192
S LR L L + + + +L +SL+ LDLSNN L S+ P
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 193 --ISFANNQLN 201
+ + +
Sbjct: 429 EQLVLYDIYWS 439
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 12/68 (17%), Positives = 18/68 (26%), Gaps = 9/68 (13%)
Query: 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGKVPEELG-----NLTNLV 120
V L + L+ + S L L L L SN + + +
Sbjct: 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87
Query: 121 SLDLYLNN 128
L L
Sbjct: 88 KLSLQNCC 95
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (138), Expect = 7e-10
Identities = 35/166 (21%), Positives = 56/166 (33%), Gaps = 3/166 (1%)
Query: 47 LQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS 106
L + ++ + L + L L NL +L L+ N IS
Sbjct: 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 107 GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166
L +L L L+ N + P L +L L L N+L +L + +
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 167 LQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 212
LQ L L++N D + L+ + + P S P L
Sbjct: 227 LQYLRLNDNPWVCDCR---ARPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 4e-07
Identities = 27/137 (19%), Positives = 40/137 (29%), Gaps = 1/137 (0%)
Query: 47 LQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVS-QLGQLTNLQYLELYSNNI 105
L + ++DL + + L L L L +
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 106 SGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVN 165
P L L L L N L T L L L L+ N + R+ ++
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 166 SLQVLDLSNNKLTGDIP 182
SL L L N++ P
Sbjct: 178 SLDRLLLHQNRVAHVHP 194
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (113), Expect = 9e-07
Identities = 25/157 (15%), Positives = 44/157 (28%), Gaps = 28/157 (17%)
Query: 47 LQSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNIS 106
LQ T ++T + L +S L +L L L+ N ++
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 107 GKVPEELGNLT------------------------NLVSLDLYLNNLNGPIPTTLGKLSK 142
P +L L L L N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249
Query: 143 LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
L+ R +++ + +P+ L + L+ N L G
Sbjct: 250 LQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 1e-05
Identities = 33/194 (17%), Positives = 52/194 (26%), Gaps = 55/194 (28%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
C +E VT L + + Q + L+ N IS NL L
Sbjct: 7 VCYNEPKVT-TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 124 LYLNNLNGPI-------------------------PTTLGKLSKLRFLRLNN-------- 150
L+ N L P T L +L L L+
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 151 ----------------NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTP 192
N+L + ++ +L L L N+++ G SL
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 193 ISFANNQLNNPPPS 206
+ N + P +
Sbjct: 183 LLHQNRVAHVHPHA 196
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 1e-09
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 3/101 (2%)
Query: 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG 131
+DL NL + +L + + + + E + + +DL + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 132 -PIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLD 171
+ L + SKL+ L L L I +L ++L L+
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 3e-07
Identities = 18/80 (22%), Positives = 30/80 (37%), Gaps = 2/80 (2%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK-VPEELGNLTNLVSLDLYL 126
V + + L +Q+++L ++ I + L + L +L L
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 127 NNLNGPIPTTLGKLSKLRFL 146
L+ PI TL K S L L
Sbjct: 81 LRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 3e-07
Identities = 16/88 (18%), Positives = 38/88 (43%), Gaps = 3/88 (3%)
Query: 96 QYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMG 155
Q L+L N+ V L + +++ + ++ P+ +++ + L+N+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 156 E-IPRSLTNVNSLQVLDLSNNKLTGDIP 182
+ L+ + LQ L L +L+ I
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 18/60 (30%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 65 CNSENSVTRVDLGNANLSG-QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
S V +DL N+ + L L Q + LQ L L +S + L +NLV L+
Sbjct: 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 4/115 (3%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLEL-YSNNISGKVPEELG 114
+ N V + L + QL LQ+L L +I + ELG
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169
+ L +L ++ +G + L L++N + ++ N + ++
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEI 274
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 5e-09
Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 16/103 (15%)
Query: 100 LYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR 159
Y N S ++ +L L++ N L +P +L +L + N L E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHL-AEVPE 321
Query: 160 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202
N L+ L + N L P P S + ++N+
Sbjct: 322 LPQN---LKQLHVEYNPLRE-FPD-------IPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 2e-08
Identities = 19/121 (15%), Positives = 41/121 (33%), Gaps = 16/121 (13%)
Query: 56 NPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGN 115
+ + + S ++ S +L+ L + +N + ++P
Sbjct: 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR 305
Query: 116 LTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLDLS 173
L L N+L +P L+ L + N L +IP S+ + L ++
Sbjct: 306 LER---LIASFNHLAE-VPELPQ---NLKQLHVEYNPLREFPDIPESVED------LRMN 352
Query: 174 N 174
+
Sbjct: 353 S 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.002
Identities = 15/67 (22%), Positives = 30/67 (44%), Gaps = 5/67 (7%)
Query: 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127
+ ++L N LS L +L+ L N+++ ++PE +L +L+ + L
Sbjct: 37 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 128 NLNGPIP 134
L+ P
Sbjct: 92 ALSDLPP 98
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 1e-07
Identities = 22/101 (21%), Positives = 32/101 (31%), Gaps = 4/101 (3%)
Query: 50 WDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV 109
L L N ++ L L+ L L+ N IS
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-- 187
Query: 110 PEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L +L NL+ + L N ++ P L S L + L N
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.3 bits (116), Expect = 3e-07
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 4/65 (6%)
Query: 110 PEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQV 169
L NL+ L +L N ++ P L L L + L NN + P L N ++L +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 170 LDLSN 174
+ L+N
Sbjct: 222 VTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 5e-05
Identities = 11/61 (18%), Positives = 25/61 (40%), Gaps = 4/61 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ ++ G +N++ L + L + ++ E + L NL+ L+L N +
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
Query: 130 N 130
Sbjct: 76 T 76
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 6e-05
Identities = 12/63 (19%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
L N + + +N+ + T L + L + I + +N+L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 175 NKL 177
N++
Sbjct: 73 NQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 11/64 (17%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L N + +N++ V + +L + +L + + + L+ L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 151 NSLM 154
N +
Sbjct: 73 NQIT 76
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 14/46 (30%), Positives = 25/46 (54%), Gaps = 2/46 (4%)
Query: 137 LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L LSKL L+ ++N + P L ++ +L + L NN+++ P
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 1e-06
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
+ +L ++ + T +L+ + + NN+ + + + ++ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 175 NKLTG 179
NKLT
Sbjct: 78 NKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 1e-04
Identities = 9/65 (13%), Positives = 21/65 (32%), Gaps = 4/65 (6%)
Query: 91 QLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
L +++ V + L ++ + +++ + L + L LN
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 151 NSLMG 155
N L
Sbjct: 78 NKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 16/37 (43%), Positives = 19/37 (51%), Gaps = 2/37 (5%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY 125
L LT LQ L L N+IS L L NL L+L+
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 3e-04
Identities = 11/61 (18%), Positives = 26/61 (42%), Gaps = 4/61 (6%)
Query: 71 VTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLN 130
+ +L +++ V+Q +L ++ + +++I + L N+ L L N L
Sbjct: 26 TIKDNLKKKSVTD-AVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81
Query: 131 G 131
Sbjct: 82 D 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.003
Identities = 13/38 (34%), Positives = 22/38 (57%), Gaps = 2/38 (5%)
Query: 137 LGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
L L+KL+ L L+ N + R+L + +L VL+L +
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 1e-06
Identities = 14/61 (22%), Positives = 20/61 (32%), Gaps = 3/61 (4%)
Query: 64 TCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLD 123
+ S V+ NL+ L L + L L N + L T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 124 L 124
L
Sbjct: 62 L 62
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 2e-06
Identities = 22/80 (27%), Positives = 26/80 (32%), Gaps = 1/80 (1%)
Query: 101 YSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRS 160
N + P L L L L NNL L L L L L NSL IP+
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 161 LTNVNSLQVLDLSNNKLTGD 180
+ L L N +
Sbjct: 191 FFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 1e-05
Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 90 GQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149
++ + + N++ +P +L + L L N L TL ++L L L+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 150 NNSLM 154
L
Sbjct: 64 RAELT 68
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 3e-05
Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 112 ELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLD 171
E+ + + + ++ NL +P L K L L+ N L +L L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 172 LSNNK 176
L +
Sbjct: 62 LDRAE 66
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (107), Expect = 2e-06
Identities = 25/137 (18%), Positives = 46/137 (33%), Gaps = 9/137 (6%)
Query: 81 LSGQLVSQLGQLTN---LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTL 137
L+ +L+ Q Q TN + L+L I + L ++D N +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF-- 59
Query: 138 GKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197
L +L+ L +NNN + + L L L+NN L ++ +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKS--LTY 116
Query: 198 NQLNNPPPSPPPPLQPT 214
+ P + +
Sbjct: 117 LCILRNPVTNKKHYRLY 133
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 9e-06
Identities = 10/48 (20%), Positives = 17/48 (35%), Gaps = 3/48 (6%)
Query: 111 EELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP 158
+ + V LD+ ++ L L KLR N ++P
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 3e-05
Identities = 8/41 (19%), Positives = 12/41 (29%), Gaps = 2/41 (4%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ L++ I L NL L + NL
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 3e-05
Identities = 7/44 (15%), Positives = 12/44 (27%)
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNK 176
S L ++ + L N+ L+ N K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 11/76 (14%), Positives = 23/76 (30%), Gaps = 14/76 (18%)
Query: 58 CTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLT 117
C+ C E+ VT + ++L N L +
Sbjct: 8 CSNRVFLC-QESKVTEI---PSDLP----------RNAIELRFVLTKLRVIQKGAFSGFG 53
Query: 118 NLVSLDLYLNNLNGPI 133
+L +++ N++ I
Sbjct: 54 DLEKIEISQNDVLEVI 69
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (83), Expect = 0.004
Identities = 10/53 (18%), Positives = 22/53 (41%), Gaps = 2/53 (3%)
Query: 154 MGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 205
+ E+P + +LD+S ++ +P+ G +L + + L P
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLKKLPT 240
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 1e-05
Identities = 25/123 (20%), Positives = 44/123 (35%), Gaps = 4/123 (3%)
Query: 89 LGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNG--PIPTTLGKLSKLRFL 146
L L ++++ + N+ L+SL+L N L + + + K L+ L
Sbjct: 38 LVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN-NQLNNPPP 205
L+ N L E L+ L L N L+ ++ F +L+
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHEL 156
Query: 206 SPP 208
PP
Sbjct: 157 PPP 159
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 3e-05
Identities = 11/86 (12%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 73 RVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNN 128
++D + + L + +++ + L N I + + E + + +L +
Sbjct: 11 KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70
Query: 129 LNGPIPTTLGKLSKLRFLRLNNNSLM 154
L L L L
Sbjct: 71 TGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 4e-05
Identities = 16/109 (14%), Positives = 32/109 (29%), Gaps = 10/109 (9%)
Query: 48 QSWDATLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISG 107
S A + ++ ++ G A + + LQ L L N I
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLS--ARGAAAVVDAF--SKLENIGLQTLRLQYNEIEL 287
Query: 108 KVPEEL-----GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
L + +L+ L+L N + ++ ++ R
Sbjct: 288 DAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 6e-05
Identities = 16/79 (20%), Positives = 26/79 (32%), Gaps = 12/79 (15%)
Query: 100 LYSNNISGKVPEELGN------LTNLVSLDLYLNNLNGPIPTTL-----GKLSKLRFLRL 148
L +S + + + L +L L N + TL K+ L FL L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 149 NNNSLMGEIPRSLTNVNSL 167
N N E + + +
Sbjct: 310 NGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 13/68 (19%), Positives = 26/68 (38%), Gaps = 11/68 (16%)
Query: 124 LYLNNLNGPIPTTLG------KLSKLRFLRLNNNSLMGEIPRSL-----TNVNSLQVLDL 172
L L+ + + L+ LRL N + + R+L + L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 173 SNNKLTGD 180
+ N+ + +
Sbjct: 310 NGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 8/68 (11%), Positives = 28/68 (41%), Gaps = 8/68 (11%)
Query: 118 NLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGE----IPRSLTNVNSLQV 169
++ L L+ + + L + ++ + L+ N++ E + ++ + L++
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 170 LDLSNNKL 177
+ S+
Sbjct: 64 AEFSDIFT 71
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 4e-05
Identities = 20/110 (18%), Positives = 31/110 (28%), Gaps = 2/110 (1%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLNNN 151
L + L NL L + + L L +LR L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201
L P + L L+LS N L + + N L+
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 1e-04
Identities = 18/101 (17%), Positives = 34/101 (33%), Gaps = 26/101 (25%)
Query: 101 YSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL----------------- 143
N I + L L +L+LY N ++ +P + L+ L
Sbjct: 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145
Query: 144 ------RFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLT 178
R LN + P + + +Q+ DL +++
Sbjct: 146 WFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFK 183
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 3e-04
Identities = 13/65 (20%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 115 NLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSN 174
L + L N+ + + L ++ L+ + + I + +N+L ++ SN
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 175 NKLTG 179
N+LT
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 3e-04
Identities = 17/70 (24%), Positives = 25/70 (35%), Gaps = 2/70 (2%)
Query: 53 TLVNPCTWFHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEE 112
L + L ++ + L LT L+ L++ SN +S
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189
Query: 113 LGNLTNLVSL 122
L LTNL SL
Sbjct: 190 LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 6e-04
Identities = 11/62 (17%), Positives = 20/62 (32%), Gaps = 4/62 (6%)
Query: 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+ LG N++ L + L+ I + + L NL ++ N L
Sbjct: 19 EKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQL 74
Query: 130 NG 131
Sbjct: 75 TD 76
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.3 bits (90), Expect = 5e-04
Identities = 15/61 (24%), Positives = 22/61 (36%), Gaps = 8/61 (13%)
Query: 68 ENSVTRVDLGNANLSGQ------LVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVS 121
SV + L G + + L L ++L L +NNI L + NL
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE--KISSLSGMENLRI 74
Query: 122 L 122
L
Sbjct: 75 L 75
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.65 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.64 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.64 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.64 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.62 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.61 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.52 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.48 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.43 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.43 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.43 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.43 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.32 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.27 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.25 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.14 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.04 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.86 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.79 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.7 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.66 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.61 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.6 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.52 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.36 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.25 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.46 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.46 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.51 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-49 Score=371.84 Aligned_cols=202 Identities=25% Similarity=0.406 Sum_probs=175.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||+|+||+||+|++. +|+.||||+++.........++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57889999999999999999985 78999999997655444455689999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++|+|.++++... .+++.+++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999986543 489999999999999999999999 99999999999999999999999999998764332
Q ss_pred C-ceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......+||+.|||||++.+..+ +.++||||+||++|||+||++||...
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 2 22345679999999999988775 67899999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=365.60 Aligned_cols=198 Identities=21% Similarity=0.385 Sum_probs=178.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||+|+||+||+|++. +|+.||||+++.... .....+.+|++++++++|||||++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 46999999999999999999975 799999999975432 3355789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++|+|.+++.+. .+++.++..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988763 389999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......||+.|+|||++.+..++.++||||+||++|||+||++||..
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 2 23445699999999999999999999999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=362.57 Aligned_cols=199 Identities=30% Similarity=0.469 Sum_probs=178.4
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||+||+|++. +++.||+|++.+.. .......+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57889999999999999999986 68899999986533 2233556899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
|||++|+|.+++.+.. ++++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998754 389999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 2 234467999999999999999999999999999999999999999743
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=368.02 Aligned_cols=207 Identities=24% Similarity=0.397 Sum_probs=167.7
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc--CCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv 363 (511)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .+.....+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67899999999999999999975 78999999997654 33445568999999999999999999998865 4567899
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
||||++|+|.+++.+.......+++..++.++.|+++||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765444456999999999999999999999861 11499999999999999999999999999987
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+..... ......||+.|||||++.+..++.++|||||||++|||+||++||..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 654322 23456799999999999999999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=376.28 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=180.6
Q ss_pred HhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
..++|++.+.||+|+||+||+|++. +|+.||+|+++.........++.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 789999999976655555677999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||++|+|.+++.+.+ .+++..+..++.|+++||+|||+ + +|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999998754 38999999999999999999996 5 89999999999999999999999999998654
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.. .....+||+.|||||++.+..++.++||||+||++|||++|+.||....
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 1234579999999999999999999999999999999999999997543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=364.94 Aligned_cols=203 Identities=31% Similarity=0.487 Sum_probs=170.3
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
++..++|.+.+.||+|+||+||+|+++ ..||||+++... .......|.+|++++++++|||||++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 344678999999999999999999875 359999997543 34445679999999999999999999998754 56899
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
|||||++|+|.++++.... ++++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 81 v~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 9999999999999986433 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-ceeeecccccccccccccccC---CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 443 DYKDT-HVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 443 ~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
..... .......||+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 54322 233456799999999998643 478899999999999999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=364.93 Aligned_cols=202 Identities=24% Similarity=0.405 Sum_probs=177.1
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||+||+|++. +|+.||||+++... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999985 78999999996543 2333456899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988764 389999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... .......||+.|||||++.+..++.++||||+||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 332 2334567999999999999999999999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-47 Score=367.31 Aligned_cols=206 Identities=30% Similarity=0.434 Sum_probs=182.2
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
++++..++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||++++++.+++..
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 44556678999999999999999999986 58899999997543 3345799999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
+++||||++|+|.+++.+... ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999986433 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
..............|++.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 776554444444558999999999999999999999999999999999777664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=359.08 Aligned_cols=199 Identities=27% Similarity=0.461 Sum_probs=166.1
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
++|++.+.||+|+||+||+|++.+++.||||+++... ....++.+|++++++++|||||+++|++..++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 5678889999999999999999888899999997643 23457999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999987643 2489999999999999999999999 999999999999999999999999999987655444
Q ss_pred ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhC-CCccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFD 494 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg-~~pf~ 494 (511)
.......||+.|+|||++.+..++.++|||||||++|||+|+ ++||.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 444445689999999999999999999999999999999995 55554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=363.07 Aligned_cols=203 Identities=29% Similarity=0.468 Sum_probs=176.1
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
++..++|++.+.||+|+||+||+|+++++..||||+++... ....+|.+|++++++++|||||+++|++.+ +..++|
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 34457788899999999999999999888899999997543 234569999999999999999999998754 567999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
|||+++|+|.+++..... .++++..+..|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 86 ~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 999999999998765322 2489999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
...........||+.|||||++.++.++.++|||||||++|||+||..|+.
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 544444445568999999999998999999999999999999999655553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=362.49 Aligned_cols=201 Identities=27% Similarity=0.388 Sum_probs=174.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
+.|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46888899999999999999976 78999999996543 33445688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
|++|+|.+++.+... ++++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999876432 489999999999999999999999 99999999999999999999999999997543211
Q ss_pred Cceeeecccccccccccccc-----cCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 447 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.......||+.|||||++. +..++.++|||||||++|||+||++||...
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 1223456999999999984 455789999999999999999999999743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=363.58 Aligned_cols=201 Identities=27% Similarity=0.429 Sum_probs=162.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.+.|++.+.||+|+||+||+|++. +|+.||||++...........+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467899999999999999999986 6899999999766544555668899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC---CCCceEEccccccccc
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLM 442 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~ 442 (511)
||++|+|.+++.+.+ .+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997643 499999999999999999999999 999999999999994 5789999999999865
Q ss_pred CCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... .....+||+.|||||++.+..++.++||||+||++|||++|++||...
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 4332 233456999999999999999999999999999999999999999643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=363.39 Aligned_cols=202 Identities=25% Similarity=0.346 Sum_probs=180.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
.++|++++.||+|+||+||+|+.. +|+.||||++++.. .......+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999975 79999999997543 233456688999999999999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
||||++|+|.+++.+.+. +++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999987653 89999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......+||+.|+|||++.+..++.++||||+||++|||++|++||...
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 332 2334567999999999999999999999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-46 Score=360.70 Aligned_cols=203 Identities=29% Similarity=0.495 Sum_probs=167.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CC---CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
.++|++.+.||+|+||+||+|++. ++ ..||||.+.........++|.+|++++++++|||||+++|++..++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356777889999999999999875 23 25899998776666667789999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
|||||++|+|.+++..... .+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 v~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998886432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce----eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 443 DYKDTHV----TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 443 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
....... .....||+.|||||.+.++.++.++|||||||++|||+| |++||..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 5432211 122347999999999999999999999999999999998 8999964
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=349.88 Aligned_cols=201 Identities=25% Similarity=0.434 Sum_probs=180.5
Q ss_pred hhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
.++|+..+.||+|+||+||+|++++++.||||+++.... ...++.+|++++++++||||++++|++.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 367899999999999999999998888999999976543 345799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+++|++..++..... .+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999776433 389999999999999999999999 99999999999999999999999999998765544
Q ss_pred CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 444444568999999999999999999999999999999998 8999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=350.61 Aligned_cols=194 Identities=30% Similarity=0.456 Sum_probs=167.8
Q ss_pred CCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceecccccccc----CCceeEEe
Q 010429 291 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 364 (511)
Q Consensus 291 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~ 364 (511)
+..+.||+|+||+||+|++. ++..||+|++.... .......+.+|++++++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44567999999999999976 68899999987544 33445678999999999999999999999864 34578999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeeC-CCCceEEcccccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKL 441 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~ 441 (511)
||+++|+|.+++++.. .+++..++.++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999998754 389999999999999999999998 6 99999999999996 578999999999986
Q ss_pred cCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 442 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 442 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.... ......||+.|||||++.+ .++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 4332 2345679999999999865 589999999999999999999999963
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-45 Score=359.21 Aligned_cols=198 Identities=30% Similarity=0.435 Sum_probs=177.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++.+.||+|+||+||+|+++ +|+.||||+++... .......+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57889999999999999999985 68999999997543 2234567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
|||++|++..++..... +++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998887543 78899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. .....||+.|||||++.+..++.++||||+||++|||+||+.||...
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 2 23457999999999999999999999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=354.59 Aligned_cols=201 Identities=28% Similarity=0.450 Sum_probs=173.9
Q ss_pred hCCCCCCe-eccccccEEEEEEeC---CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEE
Q 010429 288 DNFSNRNI-LGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 363 (511)
++|.+.+. ||+|+||+||+|.++ ++..||||+++.........+|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45555564 999999999999764 3557999999876666667789999999999999999999999864 568999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
||||++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus 87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999986543 2489999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 444 YKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 444 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 443322 223458999999999999999999999999999999998 9999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-45 Score=356.95 Aligned_cols=196 Identities=31% Similarity=0.452 Sum_probs=172.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+.|+..+.||+|+||+||+|++. +|+.||||+++.... ......+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999975 788999999975442 233456899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
|||++|++..++.... ++++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987665543 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeeccccccccccccccc---CCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ....||+.|||||++.+ +.++.++|||||||++|||++|+.||..
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 2 23569999999999864 4578999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-45 Score=360.33 Aligned_cols=201 Identities=23% Similarity=0.360 Sum_probs=178.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999975 78999999997544 3445678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC--CCceEEcccccccccC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~ 443 (511)
||++|+|.+++.+.. .++++..+..|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 104 ~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999986532 2499999999999999999999999 9999999999999964 5789999999998765
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
.... .....||+.|||||++.+..++.++||||+||++|||+||+.||...
T Consensus 178 ~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 178 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp TTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 4332 34456999999999999999999999999999999999999999643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=361.17 Aligned_cols=210 Identities=27% Similarity=0.442 Sum_probs=176.6
Q ss_pred HHHhhCCCCCCeeccccccEEEEEEeCC-C-----CEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceecccccccc
Q 010429 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-G-----SLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 356 (511)
Q Consensus 284 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 356 (511)
++..++|++.+.||+|+||+||+|++.. + ..||||.+...........+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3456789999999999999999998642 2 369999997665555566789999999988 89999999999999
Q ss_pred CCceeEEeecccCCCHHHHHHhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 010429 357 PTERLLVYPFMVNGSVASCLRERGQ-------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 417 (511)
Q Consensus 357 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 417 (511)
.+..++|||||++|+|.++++.... ....+++..++.++.|+++||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999986532 123589999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 418 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 418 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|||+||+++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |++||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 2334558999999999999999999999999999999998 8999974
Q ss_pred c
Q 010429 496 A 496 (511)
Q Consensus 496 ~ 496 (511)
.
T Consensus 270 ~ 270 (325)
T d1rjba_ 270 I 270 (325)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=351.12 Aligned_cols=201 Identities=26% Similarity=0.383 Sum_probs=178.1
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|++.+.||+|+||+||+|++. +|+.||||++++.... ...+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999985 7899999998644321 2356799999999999999999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC----ceEEccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 436 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 436 (511)
++|||||++|+|.+++.+.+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999998754 399999999999999999999999 999999999999998876 4999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 9998765432 233456899999999999999999999999999999999999999743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.7e-45 Score=358.77 Aligned_cols=200 Identities=22% Similarity=0.333 Sum_probs=178.0
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|++.+.||+|+||+||+|++. +|+.||||+++... ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999999999999975 79999999997544 3345568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeC--CCCceEEcccccccccC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~ 443 (511)
||++|+|.+++.... .++++.++..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 107 ~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999998876533 2499999999999999999999999 999999999999998 57899999999998776
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
... ......||+.|||||++.+..++.++||||+||++|||+||++||..
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 433 23445699999999999999999999999999999999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=349.60 Aligned_cols=201 Identities=28% Similarity=0.475 Sum_probs=168.5
Q ss_pred hCCCCCCeeccccccEEEEEEeCCC-----CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDG-----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
+.|+..++||+|+||+||+|.++.. ..||||+++....+....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677789999999999999987532 36999999876666666779999999999999999999999999999999
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
+|||+.+|++.+.+..... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998876432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 443 DYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 443 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
..... .......||+.|||||++.+..++.++|||||||++|||+||..||.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 44322 22233458999999999999999999999999999999999766654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=348.14 Aligned_cols=194 Identities=27% Similarity=0.417 Sum_probs=165.9
Q ss_pred CeeccccccEEEEEEeC---CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecccC
Q 010429 294 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 369 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 369 (511)
+.||+|+||+||+|.++ .++.||||+++... ......++.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 34689999997543 23345679999999999999999999999864 567899999999
Q ss_pred CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCce
Q 010429 370 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 449 (511)
Q Consensus 370 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 449 (511)
|+|.+++++.. ++++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998754 389999999999999999999999 99999999999999999999999999998765443332
Q ss_pred e--eecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 450 T--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 450 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
. ....||+.|||||.+.+..++.++|||||||++|||+| |++||..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~ 213 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence 2 23458999999999999999999999999999999998 8999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=352.79 Aligned_cols=202 Identities=29% Similarity=0.438 Sum_probs=169.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
+..++|++.+.||+|+||+||+|++++++.||||+++.... ....|.+|+.++++++|||||+++|++. +++.++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 44578999999999999999999998888999999975543 3457999999999999999999999985 46689999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|++..++..... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 91 Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999998875422 2389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
..........||+.|+|||++..+.++.++|||||||++|||+||..||.
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 44444444568999999999999999999999999999999999766654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-45 Score=357.53 Aligned_cols=198 Identities=25% Similarity=0.352 Sum_probs=178.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEe
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 364 (511)
++|++++.||+|+||+||+|+++ +|+.||||+++... .......+.+|++++++++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999985 79999999986433 2233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+.+|+|..++.+.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999998764 389999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
. .....||+.|||||++.+..++.++|||||||++|||+||++||...
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 2 23456999999999999999999999999999999999999999743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=349.10 Aligned_cols=206 Identities=23% Similarity=0.376 Sum_probs=167.4
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeCC----CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
+..++|++.+.||+|+||+||+|++.. +..||||.++..........+.+|++++++++||||+++++++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345788999999999999999998752 34689999876665666677999999999999999999999985 4678
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++|++.+++..... ++++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999998876432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 497 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~~ 497 (511)
..............||+.|+|||++.+..++.++|||||||++|||+| |++||....
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 776554444555668999999999999999999999999999999998 899997543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=350.13 Aligned_cols=200 Identities=28% Similarity=0.408 Sum_probs=175.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc--cchhHHHHHHHHHHHH-hCCCCceeccccccccCCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~~~h~niv~l~~~~~~~~~~~lv 363 (511)
++|.+.+.||+|+||+||+|++. +|+.||||++++.. .......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999986 78999999996532 2233445666766654 68999999999999999999999
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 443 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 443 (511)
||||++|+|.++++.... +++..++.++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999987543 89999999999999999999999 99999999999999999999999999998655
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence 3322 23445699999999999999999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-44 Score=355.31 Aligned_cols=201 Identities=30% Similarity=0.445 Sum_probs=172.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHH---HHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ......+.+ |+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367899999999999999999976 699999999864331 112223344 46677778899999999999999999
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++|||||++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999998754 378999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 765432 234569999999999875 468999999999999999999999997543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-44 Score=341.94 Aligned_cols=202 Identities=27% Similarity=0.380 Sum_probs=169.6
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCceeccccccccCC----c
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----E 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~ 359 (511)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... .....++.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 789999999975443 333456899999999999999999999987654 3
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.++||||+++++|.+++...+ ++++.+++.++.||++||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999988764 389999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCC--CceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 440 KLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 440 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
....... ........||+.|||||++.+..++.++|||||||++|||+||++||..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 7654322 2233445699999999999999999999999999999999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-44 Score=347.85 Aligned_cols=213 Identities=29% Similarity=0.479 Sum_probs=182.6
Q ss_pred HHHHHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccc
Q 010429 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353 (511)
Q Consensus 280 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~ 353 (511)
+.+++...++|++.+.||+|+||+||+|++. +++.||||+++.........++.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455666788999999999999999999864 3578999999876666667789999999999999999999999
Q ss_pred cccCCceeEEeecccCCCHHHHHHhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 010429 354 CMTPTERLLVYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 413 (511)
Q Consensus 354 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 413 (511)
+......+++|||+++|+|.++++.... ....+++..+..|+.|++.||+|||++ ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999975321 123489999999999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCC-C
Q 010429 414 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-R 491 (511)
Q Consensus 414 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~-~ 491 (511)
+||||||+|||++.++.+||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986644322 2334456899999999999999999999999999999999995 5
Q ss_pred cccc
Q 010429 492 AFDL 495 (511)
Q Consensus 492 pf~~ 495 (511)
||..
T Consensus 242 p~~~ 245 (301)
T d1lufa_ 242 PYYG 245 (301)
T ss_dssp TTTT
T ss_pred CCCC
Confidence 6754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-43 Score=337.54 Aligned_cols=200 Identities=27% Similarity=0.376 Sum_probs=175.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc--------chhHHHHHHHHHHHHhCC-CCceeccccccccC
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--------QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 357 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~ 357 (511)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... +....++.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67889999999999999999975 789999999865431 112345889999999997 99999999999999
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
+..++|||||++|+|.++++..+ ++++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999998754 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccccccccccccc------CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||+||+.||...
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 998765432 2344569999999999863 34678999999999999999999999754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=344.57 Aligned_cols=200 Identities=22% Similarity=0.302 Sum_probs=176.8
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++... .....+.+|++++++++|||||++++++.+++..|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367899999999999999999986 68899999997643 334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC--CceEEcccccccccC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMD 443 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~ 443 (511)
||++|+|.++++..+ .++++.++..++.||++||+|||++ +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999997643 2489999999999999999999999 99999999999999854 489999999998764
Q ss_pred CCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 444 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 444 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
... ......+|+.|+|||.+.+..++.++||||+||++|||++|++||...
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 332 334456899999999999999999999999999999999999999753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=347.24 Aligned_cols=202 Identities=29% Similarity=0.504 Sum_probs=169.6
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCC----EEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCCceeE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 362 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 362 (511)
++|++.+.||+|+||+||+|.+. +|+ .||+|+++........+++.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46889999999999999999875 443 58999987666566677899999999999999999999998764 5678
Q ss_pred EeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 010429 363 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 442 (511)
Q Consensus 363 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 442 (511)
++||+.+|+|.+++..... .+++..+++++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998876533 489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCce-eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 443 DYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
....... .....||+.|||||++.++.++.++|||||||++|||+| |++||+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 5443332 233458999999999999999999999999999999999 89999743
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=343.87 Aligned_cols=215 Identities=27% Similarity=0.392 Sum_probs=170.8
Q ss_pred CHHHHHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccc
Q 010429 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLR 351 (511)
Q Consensus 279 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~ 351 (511)
...++++..++|++.+.||+|+||.||+|++. +++.||||+++..........+.+|.+.+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556666788999999999999999999853 34689999998766566666788888877776 689999999
Q ss_pred cccccC-CceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 010429 352 GFCMTP-TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 418 (511)
Q Consensus 352 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 418 (511)
+++..+ ...+++||||++|+|.++++.... ....+++..+..++.||++||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 987664 568999999999999999976432 123589999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhC-CCccccc
Q 010429 419 KAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLA 496 (511)
Q Consensus 419 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg-~~pf~~~ 496 (511)
||+|||+++++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+|| ++||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 23345699999999999999999999999999999999996 5677643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=340.07 Aligned_cols=195 Identities=29% Similarity=0.339 Sum_probs=164.3
Q ss_pred CCeeccccccEEEEEEeC-CCCEEEEEEecccccchh----HHHHHHHHHHHHhCCCCceeccccccccCCceeEEeecc
Q 010429 293 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 367 (511)
+++||+|+||+||+|++. +|+.||||+++....... ...+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 689999999965432221 235889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
.++++....... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 988776655432 2489999999999999999999999 999999999999999999999999999986654322
Q ss_pred ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 448 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 448 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
......||+.|+|||++... .++.++|||||||++|||+||++||..
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 22345699999999998654 579999999999999999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=337.90 Aligned_cols=198 Identities=30% Similarity=0.488 Sum_probs=165.2
Q ss_pred HhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc-CCceeEEe
Q 010429 286 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVY 364 (511)
Q Consensus 286 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv~ 364 (511)
..++|++.+.||+|+||.||+|+++ |..||||+++... ..+.+.+|++++++++||||++++|++.+ ++..++||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3467888899999999999999995 7899999997543 34568999999999999999999998865 46689999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 444 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 444 (511)
||+++|+|.+++...... .+++..+++|+.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~~~--~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHHHHH--HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhcCCC--CCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999764321 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCccccc
Q 010429 445 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 496 (511)
Q Consensus 445 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~~ 496 (511)
. .....+|..|+|||++.+..++.++|||||||++|||+| |++||...
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 2 223357899999999999999999999999999999998 78888653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=343.84 Aligned_cols=198 Identities=25% Similarity=0.324 Sum_probs=169.3
Q ss_pred hhCCCCCC-eeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHh-CCCCceecccccccc----CCc
Q 010429 287 TDNFSNRN-ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMT----PTE 359 (511)
Q Consensus 287 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~----~~~ 359 (511)
.++|.+.+ .||+|+||+||+|++. +++.||||+++.. ..+.+|++++.+ .+|||||++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35787764 6999999999999974 7899999998642 246789988655 589999999998865 456
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEEccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 436 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 436 (511)
.++|||||++|+|.+++.+.+. ..+++.+++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 8999999999999999986432 3499999999999999999999999 9999999999999986 457999999
Q ss_pred ccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 437 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 437 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
|+|+....... .....||+.|||||++.+..++.++|||||||++|||+||++||....
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 99987654332 334569999999999999999999999999999999999999997543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=336.83 Aligned_cols=201 Identities=26% Similarity=0.433 Sum_probs=168.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|++.+.||+|+||+||+|++. +|+.||||+++.... +....++.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999975 789999999965432 2234578899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
|+.++ +.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765 4444443222 2499999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. .......||+.|+|||.+.... .+.++||||+||++|||++|+.||..
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 2 2233346999999999877665 57899999999999999999999964
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-43 Score=338.37 Aligned_cols=210 Identities=27% Similarity=0.418 Sum_probs=181.4
Q ss_pred HHHHhhCCCCCCeeccccccEEEEEEe------CCCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccc
Q 010429 283 LQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (511)
Q Consensus 283 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 355 (511)
+++..++|++.+.||+|+||.||+|++ .+++.||||+++.........++.+|+.++.++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 344567888999999999999999975 246689999998776666677899999999998 6999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQ--------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 421 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 421 (511)
+++..+++||||++|+|.++++.... ....+++..+.+++.||++||+|||++ +++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 99999999999999999999986432 223589999999999999999999999 9999999999
Q ss_pred CeeeCCCCceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 422 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 422 NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
||+++.++.+|++|||.++........ ......||+.|+|||.+.++.++.++|||||||++|||+| |++||..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 999999999999999999876544332 3344568999999999999999999999999999999999 5555643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=332.62 Aligned_cols=202 Identities=32% Similarity=0.445 Sum_probs=163.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC--CC--CEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCceeccccccccCCce
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT--DG--SLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 360 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 360 (511)
.++|++.+.||+|+||.||+|++. ++ ..||||+++... .....++|.+|++++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356888999999999999999863 23 368999987543 23334579999999999999999999999965 467
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
++||||+++|++.+++..... ++++..+.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999998876432 389999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCce--eeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 441 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 441 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
......... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 775443322 223457889999999999999999999999999999998 8999963
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=336.91 Aligned_cols=208 Identities=30% Similarity=0.451 Sum_probs=175.2
Q ss_pred HHhhCCCCCCeeccccccEEEEEEeC--------CCCEEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccc
Q 010429 285 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 355 (511)
Q Consensus 285 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 355 (511)
+..++|.+.+.||+|+||.||+|+.. ++..||||+++.........++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 44578889999999999999999853 23479999998777666667788998888887 8999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 423 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 423 (511)
+++..++||||+++|+|.+++..... ....+++.++++++.|+++||+|||+. +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999986532 124589999999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccccccccCCCCC-ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHh-CCCcccc
Q 010429 424 LLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 495 (511)
Q Consensus 424 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~pf~~ 495 (511)
|++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |.+||..
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 999999999999999987654322 22344568999999999999999999999999999999998 7888864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=333.21 Aligned_cols=197 Identities=35% Similarity=0.509 Sum_probs=170.0
Q ss_pred CCeeccccccEEEEEEeCCC----CEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecccccccc-CCceeEEeecc
Q 010429 293 RNILGRGGFGKVYKGRLTDG----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPFM 367 (511)
Q Consensus 293 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv~e~~ 367 (511)
.++||+|+||+||+|++.++ ..||||+++.........+|.+|++++++++||||++++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36799999999999987532 25899999766556666789999999999999999999999875 45789999999
Q ss_pred cCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 010429 368 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 447 (511)
Q Consensus 368 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 447 (511)
++|+|.++++.... ..++..+.+++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999886433 378899999999999999999999 999999999999999999999999999987644322
Q ss_pred c---eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 448 H---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 448 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 1 22234589999999999999999999999999999999998888864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=338.29 Aligned_cols=211 Identities=28% Similarity=0.438 Sum_probs=181.1
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeC------CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccc
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 355 (511)
+|++..++|++.+.||+|+||+||+|.+. ++..||||+++..........+.+|++++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34555678899999999999999999863 357899999987665666667999999999999999999999999
Q ss_pred cCCceeEEeecccCCCHHHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC
Q 010429 356 TPTERLLVYPFMVNGSVASCLRERG------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 429 (511)
Q Consensus 356 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 429 (511)
..+..++||||+++|+|.+++.... .....+++..+.+++.|+++||+|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999887531 2223479999999999999999999999 999999999999999999
Q ss_pred ceEEcccccccccCCCCCc-eeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCC-Ccccc
Q 010429 430 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFDL 495 (511)
Q Consensus 430 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~-~pf~~ 495 (511)
++||+|||+|+........ ......||+.|+|||.+.+..++.++||||||+++|||+||. +||..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 9999999999866443222 223345899999999999999999999999999999999985 77753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=334.79 Aligned_cols=200 Identities=27% Similarity=0.371 Sum_probs=162.8
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC----ceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~lv 363 (511)
.+|.+.+.||+|+||+||+|+++ |+.||||+++.... .....+.|+..+.+++||||+++++++..++ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45667789999999999999984 89999999964321 1222334555556789999999999998654 57899
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
||||++|+|.+++++. .+++..+.+++.|++.||+|+|+.+ .++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999874 3899999999999999999999631 23999999999999999999999999999
Q ss_pred ccccCCCCCc---eeeecccccccccccccccCC------CCcccCeehhhHHHHHHHhCCCcccc
Q 010429 439 AKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 439 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9876543322 223456999999999987543 56789999999999999999998864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-43 Score=332.60 Aligned_cols=199 Identities=25% Similarity=0.415 Sum_probs=169.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccc-----hhHHHHHHHHHHHHhCC--CCceeccccccccCCc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTE 359 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~ 359 (511)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ....++.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57899999999999999999975 7899999998653311 11223678999999886 8999999999999999
Q ss_pred eeEEeecccC-CCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCC-CceEEcccc
Q 010429 360 RLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFG 437 (511)
Q Consensus 360 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 437 (511)
.++||||+.+ +++.+++.... .+++..++.++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 67888887653 389999999999999999999999 99999999999999854 799999999
Q ss_pred cccccCCCCCceeeecccccccccccccccCCC-CcccCeehhhHHHHHHHhCCCccccc
Q 010429 438 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 438 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||...
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 99865432 2344569999999999987665 67799999999999999999999753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=336.13 Aligned_cols=203 Identities=29% Similarity=0.477 Sum_probs=170.0
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCC--EEEEEEecccccchhHHHHHHHHHHHHhC-CCCceeccccccccCCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 363 (511)
++|++.+.||+|+||+||+|++. +|. .||||+++........+++.+|++++.++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888899999999999999876 344 47888886555555566799999999998 799999999999999999999
Q ss_pred eecccCCCHHHHHHhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCce
Q 010429 364 YPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 431 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 431 (511)
|||+++|+|.++++... .....+++..+.+++.||++||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997642 2344699999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCC-Ccccc
Q 010429 432 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFDL 495 (511)
Q Consensus 432 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~-~pf~~ 495 (511)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 9999999975443221 12345899999999999999999999999999999999975 56753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-42 Score=331.26 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=171.0
Q ss_pred hCCCCCCeeccccccEEEEEEeCCCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEeec
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 366 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 366 (511)
++|++.+.||+|+||+||+|++++|+.||||+++.... +....++.+|+.++++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57889999999999999999999999999999965432 33356789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 010429 367 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 446 (511)
Q Consensus 367 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 446 (511)
+.++.+..+.+.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887766665433 2499999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 447 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 447 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 2 23344589999999998764 468999999999999999999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=332.21 Aligned_cols=202 Identities=22% Similarity=0.366 Sum_probs=169.4
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccCC----cee
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERL 361 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~ 361 (511)
.++|++++.||+|+||+||+|++. +|+.||||+++.........++.+|++++++++||||+++++++..+. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357889999999999999999874 899999999976655555667899999999999999999999987643 345
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
++++|+.+|+|.++++.. .+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 566677799999999764 389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc--eeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 442 MDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 442 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 6443221 2234569999999999854 45688999999999999999999999754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=329.47 Aligned_cols=202 Identities=27% Similarity=0.445 Sum_probs=165.9
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-C-CCEEEEEEecccccc-hhHHHHHHHHHHHHhC---CCCceecccccccc----
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-D-GSLVAVKRLKEERTQ-GGELQFQTEVEMISMA---VHRNLLRLRGFCMT---- 356 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~---~h~niv~l~~~~~~---- 356 (511)
.++|++++.||+|+||+||+|++. + ++.||||+++..... .....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 567999998654322 1222356777766554 79999999998853
Q ss_pred -CCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcc
Q 010429 357 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 435 (511)
Q Consensus 357 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 435 (511)
....+++|||+.++++........ ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346789999998887665544322 2489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 436 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 436 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
||+++...... ......||+.|+|||++.+..++.++||||+||++|||+||++||...
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 99987654322 234456999999999999999999999999999999999999999743
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=328.60 Aligned_cols=203 Identities=29% Similarity=0.400 Sum_probs=176.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC----CCCEEEEEEeccccc---chhHHHHHHHHHHHHhCCC-CceeccccccccCCc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTE 359 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~ 359 (511)
++|++.+.||+|+||+||+|+.. +|+.||||.++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 578999999865431 2223457899999999987 799999999999999
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+++|||+.+|+|.+++..... +.+..+..++.|++.||+|+|++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999987653 68899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCC--CCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+.+............|++.|+|||.+.+.. ++.++||||+||++|||+||+.||....
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 877554444445567999999999997653 6789999999999999999999997553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-40 Score=318.23 Aligned_cols=201 Identities=17% Similarity=0.248 Sum_probs=172.2
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCC-CceeccccccccCCceeEEe
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 364 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~~~lv~ 364 (511)
.++|++.+.||+|+||+||+|++. +|+.||||+++..... ..+.+|++.++.+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 467899999999999999999976 6889999998654322 246788999999876 89999999999999999999
Q ss_pred ecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC-----CCceEEcccccc
Q 010429 365 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLA 439 (511)
Q Consensus 365 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a 439 (511)
||+ +++|.++++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|
T Consensus 81 e~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 7899998876543 489999999999999999999999 9999999999999974 568999999999
Q ss_pred cccCCCCC------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 440 KLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 440 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
+.+..... .......||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 87643221 12334569999999999999999999999999999999999999997543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=325.78 Aligned_cols=197 Identities=25% Similarity=0.383 Sum_probs=164.7
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCceeccccccccCC------
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 358 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 358 (511)
.++|++++.||+|+||+||+|.+. +|+.||||+++... .......+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467899999999999999999975 69999999997543 3334556889999999999999999999987654
Q ss_pred ceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 010429 359 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 438 (511)
Q Consensus 359 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 438 (511)
..++||||+ +.++....+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 66787777653 399999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 439 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 439 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
|+..+.. .....||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 9876533 2345699999999998764 5689999999999999999999999754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=323.50 Aligned_cols=201 Identities=26% Similarity=0.392 Sum_probs=165.8
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceecccccccc--------C
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------P 357 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--------~ 357 (511)
++|++.+.||+|+||+||+|++. +|+.||||++..... +....++.+|++++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67889999999999999999975 799999999864432 3344568899999999999999999998754 3
Q ss_pred CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 010429 358 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 437 (511)
Q Consensus 358 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 437 (511)
+..+++|||++++.+....... ..+++..++.++.|+++||.|||++ +|+||||||+|||+++++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 4578999999888766544332 2489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC---ceeeecccccccccccccccC-CCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 438 LAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 438 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|++||+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 9976653221 122334699999999998765 578999999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=326.68 Aligned_cols=197 Identities=27% Similarity=0.408 Sum_probs=162.7
Q ss_pred CCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceeccccccccC------Ccee
Q 010429 289 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERL 361 (511)
Q Consensus 289 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~~ 361 (511)
+|+..++||+|+||+||+|++. +|+.||||+++..... ..+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777889999999999999986 6899999999754322 34799999999999999999988543 2468
Q ss_pred EEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEccccccc
Q 010429 362 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 440 (511)
Q Consensus 362 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 440 (511)
+|||||+++.+....+ .......+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999998764444333 222334599999999999999999999999 999999999999999775 89999999998
Q ss_pred ccCCCCCceeeeccccccccccccccc-CCCCcccCeehhhHHHHHHHhCCCccccc
Q 010429 441 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 441 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|++||...
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 7654332 233569999999998865 46899999999999999999999999643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-40 Score=314.99 Aligned_cols=199 Identities=23% Similarity=0.370 Sum_probs=174.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 365 (511)
++|++++.||+|+||+||+|++. +++.||||+++.... .....++.+|+.+++.++||||+++++++......+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57899999999999999999975 788999999965443 3345678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 445 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 445 (511)
++.++++..+++..+ .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888776543 388999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccc
Q 010429 446 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFD 494 (511)
Q Consensus 446 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~ 494 (511)
... .....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 322 23344788999999987665 6899999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-39 Score=312.74 Aligned_cols=200 Identities=21% Similarity=0.239 Sum_probs=164.9
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCceecc-ccccccCCceeEEee
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL-RGFCMTPTERLLVYP 365 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l-~~~~~~~~~~~lv~e 365 (511)
++|++.+.||+|+||+||+|++. +|+.||||++...... .++..|++++++++|+|++.. .++..+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 57999999999999999999975 6889999998654322 247889999999988775555 455566778889999
Q ss_pred cccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCC---CCceEEccccccccc
Q 010429 366 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKLM 442 (511)
Q Consensus 366 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~ 442 (511)
|+ ++++...+..... .+++..+..++.|+++||+|||++ +|+||||||+|||++. +..+||+|||+|+.+
T Consensus 84 ~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 5566666654332 489999999999999999999999 9999999999999864 457999999999876
Q ss_pred CCCCC------ceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 443 DYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 443 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
..... .......||+.|||||.+.+..++.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 54322 12234569999999999999999999999999999999999999997543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-39 Score=316.22 Aligned_cols=193 Identities=22% Similarity=0.318 Sum_probs=166.3
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceecccccccc--CCceeEE
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLLV 363 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~--~~~~~lv 363 (511)
++|++++.||+|+||+||+|++. +|+.||||+++... ..++.+|+++++.+. ||||+++++++.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 67999999999999999999985 78999999997533 346889999999985 9999999999874 3568899
Q ss_pred eecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCC-ceEEccccccccc
Q 010429 364 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 442 (511)
Q Consensus 364 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 442 (511)
|||+.+++|....+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999876532 389999999999999999999999 999999999999998655 6999999999876
Q ss_pred CCCCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 443 DYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 443 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
..... .....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||...
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 54322 33456899999999987654 689999999999999999999999643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=318.30 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=166.3
Q ss_pred hhCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceeccccccccC-----Cc
Q 010429 287 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 359 (511)
Q Consensus 287 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 359 (511)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... .....++.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999975 799999999975432 33445688999999999999999999988643 34
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.+++++|+.+|+|.++++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 57778888999999998643 399999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeecccccccccccccccCC-CCcccCeehhhHHHHHHHhCCCccccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLA 496 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~pf~~~ 496 (511)
...... .....||+.|+|||.+.+.. ++.++||||+||++|||++|++||...
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 754322 23355899999999876654 688999999999999999999999643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=315.32 Aligned_cols=196 Identities=22% Similarity=0.269 Sum_probs=159.2
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCceecccccccc------CCc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 359 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~ 359 (511)
++|++.+.||+|+||+||+|++. +|+.||||+++.... .....++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999986 699999999975432 3344568899999999999999999999864 367
Q ss_pred eeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 010429 360 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 439 (511)
Q Consensus 360 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 439 (511)
.|+||||+.++.+. .+.. .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 79999999766544 4432 389999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccc
Q 010429 440 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 495 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~ 495 (511)
+..... .......+|+.|+|||++.+..++.++||||+||++|||++|++||..
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 765432 223345689999999999999999999999999999999999999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-34 Score=281.50 Aligned_cols=200 Identities=23% Similarity=0.280 Sum_probs=156.5
Q ss_pred hCCCCCCeeccccccEEEEEEeC-CCCEEEEEEecccccchhHHHHHHHHHHHHhCC-----------CCceeccccccc
Q 010429 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----------HRNLLRLRGFCM 355 (511)
Q Consensus 288 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~niv~l~~~~~ 355 (511)
.+|++++.||+|+||+||+|++. +|+.||||+++... .....+.+|+.++++++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 35889999999999999999975 79999999997643 22345778888887765 577898988876
Q ss_pred cC--CceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeeCCCC---
Q 010429 356 TP--TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEF--- 429 (511)
Q Consensus 356 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~--- 429 (511)
.. ...+++++++..+......... .....+++..++.++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 43 4455666666554433332222 223348999999999999999999998 6 899999999999998665
Q ss_pred ---ceEEcccccccccCCCCCceeeecccccccccccccccCCCCcccCeehhhHHHHHHHhCCCcccccc
Q 010429 430 ---EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 497 (511)
Q Consensus 430 ---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~pf~~~~ 497 (511)
.++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 3999999999755432 234569999999999999999999999999999999999999997543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=4.8e-28 Score=234.82 Aligned_cols=179 Identities=32% Similarity=0.598 Sum_probs=160.7
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCCCCCCCCCCc--cccceEeCCCC---CeeEEecCCCCcce--ecchhhcCCCCCcE
Q 010429 25 ASNAEGDALNALKTNLADPNNVLQSWDATLVNPC--TWFHVTCNSEN---SVTRVDLGNANLSG--QLVSQLGQLTNLQY 97 (511)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c--~w~gv~c~~~~---~l~~l~L~~~~l~~--~~~~~~~~l~~L~~ 97 (511)
|.++|++||++||+++.||. .+++|..+ .||| .|.||+|+..+ +|+.|+|++|+++| .+|..+++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 67899999999999999885 68999754 6999 49999998644 69999999999987 57899999999999
Q ss_pred EEeec-cCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEeccccc
Q 010429 98 LELYS-NNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNK 176 (511)
Q Consensus 98 L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 176 (511)
|+|++ |+++|.+|..|++|++|++|+|++|+|++..+..+..+++|+.+++++|.+.+.+|..+.+++.|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 89999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCC-CCCCCcc-cceeccCCCCCCCCC
Q 010429 177 LTGDIPT-NGSFSLF-TPISFANNQLNNPPP 205 (511)
Q Consensus 177 l~~~~~~-~~~~~~l-~~l~l~~N~~~~~~~ 205 (511)
+++.+|. ...+..+ +.+++++|.+.+..+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~ 191 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECC
T ss_pred ccccccccccccccccccccccccccccccc
Confidence 9988774 4555554 788999998866543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=7.5e-25 Score=196.04 Aligned_cols=163 Identities=12% Similarity=0.076 Sum_probs=120.4
Q ss_pred CCCCeeccccccEEEEEEeCCCCEEEEEEecccccc-----------------hhHHHHHHHHHHHHhCCCCceeccccc
Q 010429 291 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----------------GGELQFQTEVEMISMAVHRNLLRLRGF 353 (511)
Q Consensus 291 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~h~niv~l~~~ 353 (511)
.+.+.||+|+||+||+|++.+|+.||||+++..... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346789999999999999888999999987532210 112235568888999999998887755
Q ss_pred cccCCceeEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeeCCCCceEE
Q 010429 354 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 433 (511)
Q Consensus 354 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 433 (511)
. ..+++|||++++.+.. ++...+..++.|++++++|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 2 3479999998865432 45566788999999999999999 99999999999999976 5899
Q ss_pred cccccccccCCCCCceeeecccccccccc------cccccCCCCcccCeehhhHH
Q 010429 434 GDFGLAKLMDYKDTHVTTAVRGTIGHIAP------EYLSTGKSSEKTDVFGYGVM 482 (511)
Q Consensus 434 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~s~Gvi 482 (511)
+|||.|......... .|... |.+ .+.++.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 999999765432211 11111 111 3557788999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=9e-20 Score=162.69 Aligned_cols=143 Identities=22% Similarity=0.290 Sum_probs=106.8
Q ss_pred ccccceEeCCC----------CCeeEEecCCCCccee-cchhhcCCCCCcEEEeeccCCCCCCCchhcCCcccccccccc
Q 010429 58 CTWFHVTCNSE----------NSVTRVDLGNANLSGQ-LVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYL 126 (511)
Q Consensus 58 c~w~gv~c~~~----------~~l~~l~L~~~~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (511)
|.|..|.|++. .+++.|+|++|+|++. .+..|.++++|+.|+|++|.+++..+..+..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 56888888532 3678888888888753 456778888888888888888877778888888888888888
Q ss_pred ccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCC
Q 010429 127 NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 127 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 200 (511)
|+|++..|+.|.++++|++|+|++|+|++..++.|..+++|++|+|++|++.+..+...-...++.+.+..|.+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~ 161 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAA 161 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCe
Confidence 88887777778888888888888888887777778888888888888888876544222123345555555555
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=4.1e-18 Score=151.73 Aligned_cols=135 Identities=23% Similarity=0.342 Sum_probs=118.9
Q ss_pred cceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCC-CCchhcCCccccccccccccccCCCCccccc
Q 010429 61 FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGK-VPEELGNLTNLVSLDLYLNNLNGPIPTTLGK 139 (511)
Q Consensus 61 ~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~ 139 (511)
.|.+|.. +.++.++++|+ .+|..+. ++++.|+|++|+|++. .+..|.++++|++|+|++|+++...+..|..
T Consensus 4 ~~C~C~~----~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~ 76 (192)
T d1w8aa_ 4 AMCHCEG----TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG 76 (192)
T ss_dssp TTSEEET----TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred CCCEEcC----CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccc
Confidence 4677853 57999999999 4565542 6899999999999864 4667899999999999999999999999999
Q ss_pred ccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCC
Q 010429 140 LSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 140 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~ 202 (511)
+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..+++|+++++++|++..
T Consensus 77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred ccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 99999999999999988888999999999999999999998876 4778999999999998843
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=2.3e-16 Score=147.82 Aligned_cols=135 Identities=27% Similarity=0.287 Sum_probs=108.9
Q ss_pred CCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCccccccccccee
Q 010429 67 SENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFL 146 (511)
Q Consensus 67 ~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 146 (511)
..++|+.|+|++|+|+.. + .++.+++|+.|+|++|+++ ..+..+.++++|++|++++|.+....+..+..+.+|+.|
T Consensus 53 ~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L 129 (266)
T d1p9ag_ 53 PYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (266)
T ss_dssp TCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred cccccccccccccccccc-c-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccc
Confidence 356799999999999854 3 3578899999999999998 456678888999999999998887777778888888888
Q ss_pred eccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCC
Q 010429 147 RLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 147 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~ 204 (511)
++++|.+++..+..+..+++|+.|++++|+|++.++. +..+++|+.|++++|.+...|
T Consensus 130 ~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp 188 (266)
T d1p9ag_ 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIP 188 (266)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred cccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccC
Confidence 8888888876677777888888888888888877765 466788888888888886543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.64 E-value=2.6e-16 Score=128.95 Aligned_cols=105 Identities=28% Similarity=0.345 Sum_probs=88.0
Q ss_pred eEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCc
Q 010429 72 TRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151 (511)
Q Consensus 72 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N 151 (511)
+.|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+|..++.+++|+.|++++|.|+. +| .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 368999999984 33 4889999999999999998 677789999999999999999994 44 5889999999999999
Q ss_pred ccCCCC-CcccccCCCCceEecccccccCCC
Q 010429 152 SLMGEI-PRSLTNVNSLQVLDLSNNKLTGDI 181 (511)
Q Consensus 152 ~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~ 181 (511)
+|++.. ...+..+++|+.|++++|++++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 998543 256888999999999999998653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=7.1e-16 Score=144.48 Aligned_cols=135 Identities=27% Similarity=0.275 Sum_probs=121.3
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|. ++.+++|++|+|++|+|+ .++..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-ccccccccccccccccc
Confidence 47999999999999888889999999999999999998 5553 688999999999999999 56888999999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCC-CCCCcccceeccCCCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 206 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~~~~~~ 206 (511)
++|.+.+..+..+..+.+|+.|++++|.++..++.. ..+++++.+++++|.+...++.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~ 166 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence 999999888888999999999999999999887754 6688999999999999776553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.64 E-value=8.4e-16 Score=146.98 Aligned_cols=73 Identities=29% Similarity=0.372 Sum_probs=65.1
Q ss_pred ccccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccc
Q 010429 58 CTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN 127 (511)
Q Consensus 58 c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 127 (511)
|.|.+|.|+. ...++.|+|++|+|+...+..|.++++|+.|++++|.++...|..|.++++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 6899999964 256899999999999777778999999999999999999777888999999999999998
Q ss_pred ccc
Q 010429 128 NLN 130 (511)
Q Consensus 128 ~i~ 130 (511)
+|+
T Consensus 90 ~l~ 92 (305)
T d1xkua_ 90 QLK 92 (305)
T ss_dssp CCS
T ss_pred ccC
Confidence 876
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.62 E-value=1.7e-16 Score=152.43 Aligned_cols=134 Identities=27% Similarity=0.457 Sum_probs=106.0
Q ss_pred CeeEEecCCCCcceecchhhcCCCCC-cE-----------------------EEeeccCCCCCCCchhcCCccccccccc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNL-QY-----------------------LELYSNNISGKVPEELGNLTNLVSLDLY 125 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L-~~-----------------------L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 125 (511)
.++.+++++|.+++.+|..+..+..+ +. +++++|.+.+.+|..+..+++|+.|+++
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~ 229 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred ccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45555555555555555555554443 44 4455555555566666778889999999
Q ss_pred cccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCC-CCCC
Q 010429 126 LNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL-NNPP 204 (511)
Q Consensus 126 ~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~-~~~~ 204 (511)
+|.+++.+| .+..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|..+++++|+.+++++|+. |+.|
T Consensus 230 ~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 999987654 68889999999999999999999999999999999999999999999888899999999999985 7754
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=4.6e-16 Score=147.30 Aligned_cols=132 Identities=20% Similarity=0.224 Sum_probs=86.0
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
++++.|+|++|++....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 45666666666666555566666666666666666666555556666666666666666666656666666666666666
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQL 200 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~ 200 (511)
++|++++..|..|.++++|++|++++|++++.++. +..+++|+.|++++|++
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l 237 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCC
Confidence 66666666666666666666666666666665543 34566666666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=3.8e-16 Score=134.35 Aligned_cols=124 Identities=19% Similarity=0.113 Sum_probs=99.5
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..++++|+|++|+|+.. +..+..+++|+.|+|++|.|+ .++ .+..+++|++|+|++|+|+...+..+..+++|+.|+
T Consensus 17 ~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 17 AVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence 44789999999999854 666788999999999999998 554 488999999999999999966566677899999999
Q ss_pred ccCcccCCCCC-cccccCCCCceEecccccccCCCC----CCCCCCccccee
Q 010429 148 LNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIP----TNGSFSLFTPIS 194 (511)
Q Consensus 148 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~~l~~l~ 194 (511)
|++|+|+.... ..+..+++|+.|++++|+++..+. .+..+++|+.|+
T Consensus 94 L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 94 LTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 99999985322 468889999999999999986543 134567777765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=9.3e-16 Score=125.55 Aligned_cols=104 Identities=26% Similarity=0.341 Sum_probs=91.6
Q ss_pred cEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccc
Q 010429 96 QYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNN 175 (511)
Q Consensus 96 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 175 (511)
+.|+|++|+|+ .++. +..+++|++|+|++|+|+ .+|+.+..+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57999999999 6664 899999999999999999 678889999999999999999995 44 5899999999999999
Q ss_pred cccCCCC--CCCCCCcccceeccCCCCCCCC
Q 010429 176 KLTGDIP--TNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 176 ~l~~~~~--~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
+|+.... ....+++|+.+++++|+++..+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 9997653 4577889999999999996543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=1.9e-15 Score=129.88 Aligned_cols=114 Identities=20% Similarity=0.169 Sum_probs=97.9
Q ss_pred hhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCC
Q 010429 87 SQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166 (511)
Q Consensus 87 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 166 (511)
..|.++.+|+.|+|++|+|+ .+|+.+..+++|+.|||++|+|+. + +.|..+++|++|+|++|++++..+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccc
Confidence 34678889999999999999 567777889999999999999994 4 45899999999999999999666666778999
Q ss_pred CceEecccccccCCC--CCCCCCCcccceeccCCCCCCC
Q 010429 167 LQVLDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 167 L~~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
|+.|++++|+|+... ..+..+++|+.+++++|+++..
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred cccceeccccccccccccccccccccchhhcCCCccccc
Confidence 999999999998653 3456789999999999988543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=4e-14 Score=133.68 Aligned_cols=137 Identities=23% Similarity=0.228 Sum_probs=110.7
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccc-cccccCCCCcccccccccceee
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLY-LNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..++.|+|++|+|+...+..|.++++|+.|++++|++.+..+..+.+++.++.++.+ .|.++...|..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 357999999999998888899999999999999999997777777778888887654 5667766677888888888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCC-CCCCCcccceeccCCCCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 205 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~~~~~ 205 (511)
|++|.+....+..+..+++|+.+++++|+|++.++. +..+++|+.|++++|.+...++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 888888766667777888888888888888877654 3566778888888888765444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.48 E-value=6.1e-14 Score=124.97 Aligned_cols=126 Identities=28% Similarity=0.440 Sum_probs=92.5
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
.++++.|+|++|++++..+ +.++++|+.|++++|.+. .++ .+.++++|+.|++++|.+... +.+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhh
Confidence 4577888888888875432 777888888888888777 444 377788888888888877743 3477788888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
+++|++.. + +.+..+++|+.|++++|++++.. .+.++++|+.|++++|++..
T Consensus 135 l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 135 LSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC
T ss_pred hhhhhhcc-c-ccccccccccccccccccccCCc-cccCCCCCCEEECCCCCCCC
Confidence 88888763 3 35777888888888888887653 35677888888888887754
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.43 E-value=1.9e-13 Score=121.67 Aligned_cols=127 Identities=25% Similarity=0.387 Sum_probs=109.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|++++|+++.. ..+..+++|++|+|++|+|++..| ++++++|++|++++|.+.. ++ .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccc
Confidence 5789999999999853 458899999999999999996443 9999999999999999984 44 4899999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
++|.+... ..+..+++|+.|++++|++... +.+..+++++.|++.+|.+...+
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~l~ 166 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTDLK 166 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCCCG
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccccCCc
Confidence 99999853 3578899999999999999854 45678899999999999886643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=1.5e-13 Score=117.07 Aligned_cols=104 Identities=22% Similarity=0.163 Sum_probs=84.4
Q ss_pred ecCCCCcceecchhhcCCCCCcEEEeecc-CCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCccc
Q 010429 75 DLGNANLSGQLVSQLGQLTNLQYLELYSN-NISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153 (511)
Q Consensus 75 ~L~~~~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l 153 (511)
+++++++. ..|..+..+++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|
T Consensus 14 ~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 92 (156)
T d2ifga3 14 RCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92 (156)
T ss_dssp ECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred EecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCC
Confidence 33445555 34667888999999999876 58866667899999999999999999988888999999999999999999
Q ss_pred CCCCCcccccCCCCceEecccccccCC
Q 010429 154 MGEIPRSLTNVNSLQVLDLSNNKLTGD 180 (511)
Q Consensus 154 ~~~~~~~~~~l~~L~~L~l~~N~l~~~ 180 (511)
+...+..|.. .+|+.|+|++|++.+.
T Consensus 93 ~~l~~~~~~~-~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 93 ESLSWKTVQG-LSLQELVLSGNPLHCS 118 (156)
T ss_dssp SCCCSTTTCS-CCCCEEECCSSCCCCC
T ss_pred cccChhhhcc-ccccccccCCCcccCC
Confidence 9544445544 4799999999999754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.43 E-value=1.7e-13 Score=130.61 Aligned_cols=127 Identities=25% Similarity=0.360 Sum_probs=77.6
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
+++.+++++|+++. ++.. .+++|+.|++++|.+++..+..+.+++.+++|++++|.+++..+..+.++++|++|+|+
T Consensus 151 ~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~ 227 (305)
T d1xkua_ 151 KLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227 (305)
T ss_dssp TCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred ccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence 45666666666653 2222 24566666666666666666666666666666666666666666666666666666666
Q ss_pred CcccCCCCCcccccCCCCceEecccccccCCCCC-------CCCCCcccceeccCCCC
Q 010429 150 NNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT-------NGSFSLFTPISFANNQL 200 (511)
Q Consensus 150 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-------~~~~~~l~~l~l~~N~~ 200 (511)
+|+|+ .+|..|.++++|+.|+|++|+|+..... .....+|+.|++++|++
T Consensus 228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~ 284 (305)
T d1xkua_ 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284 (305)
T ss_dssp SSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred ccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence 66666 4556666666666666666666644321 12334566666666665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.43 E-value=2.4e-13 Score=122.06 Aligned_cols=126 Identities=25% Similarity=0.379 Sum_probs=97.8
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..++++|+|++|++++.. .++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|.+.. + ..+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-cccccccccccccccccccc-c-ccccccccccccc
Confidence 457888888888888643 3678888888888888888 455 47888888888888888773 2 4577888888888
Q ss_pred ccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCC
Q 010429 148 LNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 148 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~ 202 (511)
+++|.+++ +..+..+++|+.+++++|++++.. .+..+++|+.|++++|.+..
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~-~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCB
T ss_pred cccccccc--cccccccccccccccccccccccc-cccCCCCCCEEECCCCCCCC
Confidence 88888874 345677888999999999888654 36678888999999888754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.5e-13 Score=116.98 Aligned_cols=108 Identities=19% Similarity=0.085 Sum_probs=95.8
Q ss_pred CCCCcEEEeeccCCCCCCCchhcCCccccccccccc-cccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceE
Q 010429 92 LTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN-NLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVL 170 (511)
Q Consensus 92 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 170 (511)
....+.+++++++++ ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...+..|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344567899999998 67888999999999999876 5997777889999999999999999998888899999999999
Q ss_pred ecccccccCCCCCCCCCCcccceeccCCCC
Q 010429 171 DLSNNKLTGDIPTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 171 ~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 200 (511)
+|++|+|+..++......+|+.|++++|++
T Consensus 86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp ECCSSCCSCCCSTTTCSCCCCEEECCSSCC
T ss_pred eccCCCCcccChhhhccccccccccCCCcc
Confidence 999999998888776666899999999988
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.37 E-value=5.3e-13 Score=131.14 Aligned_cols=129 Identities=26% Similarity=0.361 Sum_probs=92.8
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCC---------------
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI--------------- 133 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~--------------- 133 (511)
.+++.|++++|.++.. +.+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 4577777777777642 356677777777777777774432 666677777777776665422
Q ss_pred -----CcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 134 -----PTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 134 -----p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
...+..+++++.|+|++|++++.. .+..+++|+.|++++|+|++. +.+..+++|+.|++++|++.+.+
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCCBCG
T ss_pred cccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-hhHcCCCCCCEEECCCCcCCCCh
Confidence 134667788899999999998643 378889999999999998864 45677888999999999887653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=8.8e-15 Score=130.16 Aligned_cols=114 Identities=26% Similarity=0.309 Sum_probs=86.5
Q ss_pred ecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCccccc
Q 010429 84 QLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTN 163 (511)
Q Consensus 84 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 163 (511)
.++..+..+++|+.|+|++|+|+ .++ .+.+|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 35567888888888888888888 454 4788888888888888887 566666667788888888888874 3 34777
Q ss_pred CCCCceEecccccccCCC--CCCCCCCcccceeccCCCCCC
Q 010429 164 VNSLQVLDLSNNKLTGDI--PTNGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 164 l~~L~~L~l~~N~l~~~~--~~~~~~~~l~~l~l~~N~~~~ 202 (511)
+++|+.|++++|+|+... ..+..+++|+.|++++|+++.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 888888888888887543 245677888888888887643
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.35 E-value=1e-12 Score=117.93 Aligned_cols=126 Identities=28% Similarity=0.381 Sum_probs=108.1
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
.+++.|++++|+++... .+..+++|+.|+|++|+|++ ++ .+++|++|++|++++|+|++ +| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 47899999999998543 48899999999999999996 44 37899999999999999995 55 5899999999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
++|.+.. + ..+..+++|+.+++++|.+++.. ....+++|+.+++++|.+...
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDI 171 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCC
T ss_pred ccccccc-c-ccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 9999873 3 46889999999999999998643 456788999999999998654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=1.3e-14 Score=128.95 Aligned_cols=122 Identities=23% Similarity=0.273 Sum_probs=100.9
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceee
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLR 147 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 147 (511)
..+++.|+|++|+|+.. + .+..+++|+.|+|++|.|+ .+|.....+++|++|++++|+|+. + +.+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEE
T ss_pred ccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccccccc
Confidence 46899999999999954 3 5899999999999999998 677767777899999999999995 3 4588999999999
Q ss_pred ccCcccCCCCC-cccccCCCCceEecccccccCCCCCC-----------CCCCccccee
Q 010429 148 LNNNSLMGEIP-RSLTNVNSLQVLDLSNNKLTGDIPTN-----------GSFSLFTPIS 194 (511)
Q Consensus 148 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~-----------~~~~~l~~l~ 194 (511)
|++|+|++... ..+..+++|+.|+|++|++....+.. ..+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999985322 46899999999999999998665543 2356666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.32 E-value=2e-12 Score=117.51 Aligned_cols=129 Identities=23% Similarity=0.398 Sum_probs=92.8
Q ss_pred CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCC-------------
Q 010429 68 ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIP------------- 134 (511)
Q Consensus 68 ~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p------------- 134 (511)
.++|+.|+|++|++++.. .+..+++|+.|++++|.++ .++ .+..+++|+.|++++|.+.+..+
T Consensus 62 l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeeccc--ccccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 567888888888887543 3778888888888888877 444 47778888888888777663221
Q ss_pred -------cccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCCCC
Q 010429 135 -------TTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 203 (511)
Q Consensus 135 -------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~ 203 (511)
..+.++++|+.|++++|.+.+. ..+.++++|+.|+|++|++++. +.+..+++|++|++++|++...
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCCBC
T ss_pred hhhhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCCCC
Confidence 2355667788888888877643 2377788888888888888764 3466778888888888877654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.27 E-value=4.8e-12 Score=124.09 Aligned_cols=125 Identities=31% Similarity=0.421 Sum_probs=60.1
Q ss_pred CeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeecc
Q 010429 70 SVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLN 149 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 149 (511)
++..+++++|.+++..+ +...++|+.|++++|+++. ++ .+..+++|+.|++++|.+++.. .+..+++|+.|+++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~ 271 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLG 271 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCC--cccccccCCEeecc
Confidence 34555555555554322 3344555555555555552 22 3455555555555555555332 24445555555555
Q ss_pred CcccCCCCC--------------------cccccCCCCceEecccccccCCCCCCCCCCcccceeccCCCCC
Q 010429 150 NNSLMGEIP--------------------RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 150 ~N~l~~~~~--------------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 201 (511)
+|++++..+ ..+..+++++.|++++|++++..+ +..+++|+.|++++|.+.
T Consensus 272 ~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~ 342 (384)
T d2omza2 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVS 342 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCC
T ss_pred CcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCC
Confidence 555443211 123334455555555555554332 344555555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=1.4e-11 Score=112.78 Aligned_cols=99 Identities=17% Similarity=0.273 Sum_probs=81.1
Q ss_pred ccccceEeCC----------CCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCC-CchhcCCcccccccccc
Q 010429 58 CTWFHVTCNS----------ENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYL 126 (511)
Q Consensus 58 c~w~gv~c~~----------~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~ 126 (511)
|....|.|.. ..++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 5677788852 237999999999999877788999999999999999988654 44688889999888764
Q ss_pred -ccccCCCCcccccccccceeeccCcccCCC
Q 010429 127 -NNLNGPIPTTLGKLSKLRFLRLNNNSLMGE 156 (511)
Q Consensus 127 -N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~ 156 (511)
|++....+..|.++++|+.|++++|.+...
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~ 118 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSC
T ss_pred cccccccccccccccccccccccchhhhccc
Confidence 678777778888899999999999887643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.14 E-value=4.8e-11 Score=108.10 Aligned_cols=122 Identities=26% Similarity=0.363 Sum_probs=89.3
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCC--------------------CchhcCCcccccccccccc
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKV--------------------PEELGNLTNLVSLDLYLNN 128 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------------------p~~~~~l~~L~~L~Ls~N~ 128 (511)
.+++.+++++|.++.. ..+.++++|+.|++++|.+.+.. ...+.++++|+.|++++|.
T Consensus 85 ~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 85 TKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp CSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccc--ccccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccc
Confidence 3556666666665532 23555555555555555544321 1235678899999999999
Q ss_pred ccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCCCCCCCCCCcccceeccC
Q 010429 129 LNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAN 197 (511)
Q Consensus 129 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~ 197 (511)
++.. ..+.++++|+.|+|++|++++ ++ .+.++++|++|+|++|+|++..+ +..+++|+.|++++
T Consensus 163 ~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 163 VSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred cccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEeeC
Confidence 9854 348999999999999999985 33 38899999999999999997654 67889999999863
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=3e-10 Score=103.73 Aligned_cols=135 Identities=17% Similarity=0.179 Sum_probs=103.2
Q ss_pred cceEeCCCCCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCC-Cccccc
Q 010429 61 FHVTCNSENSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPI-PTTLGK 139 (511)
Q Consensus 61 ~gv~c~~~~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~-p~~~~~ 139 (511)
.-.+|.. +.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+
T Consensus 4 ~~C~C~~----~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~ 76 (242)
T d1xwdc1 4 RICHCSN----RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 76 (242)
T ss_dssp SSEEECS----SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEES
T ss_pred CcCCCcC----CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccc
Confidence 3456643 57888899998 5555442 58999999999999655667999999999999999987654 557899
Q ss_pred ccccceeeccC-cccCCCCCcccccCCCCceEecccccccCCCCC--CCCCCcccceeccCCCCCC
Q 010429 140 LSKLRFLRLNN-NSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTPISFANNQLNN 202 (511)
Q Consensus 140 l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~~~~ 202 (511)
+++++.|.+.. |++....+..|.++++|+.|++++|.+....+. ...++.+..+...++.+..
T Consensus 77 l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~ 142 (242)
T d1xwdc1 77 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 142 (242)
T ss_dssp CTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence 99999999864 778878888899999999999999999865442 2334555555555555533
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.86 E-value=3.8e-09 Score=101.41 Aligned_cols=101 Identities=29% Similarity=0.379 Sum_probs=80.0
Q ss_pred CCeeEEecCCCCcceecchhhcCCCCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeec
Q 010429 69 NSVTRVDLGNANLSGQLVSQLGQLTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRL 148 (511)
Q Consensus 69 ~~l~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 148 (511)
+++++|||++|+|+. +|+ .+++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++ .+++.. +.|++|+|
T Consensus 38 ~~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEEC
T ss_pred cCCCEEEeCCCCCCC-CCC---CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---cccccccc
Confidence 367899999999984 554 3578999999999999 778654 57888899999988 444321 46999999
Q ss_pred cCcccCCCCCcccccCCCCceEecccccccCCCCC
Q 010429 149 NNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183 (511)
Q Consensus 149 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 183 (511)
++|.++ .+|. ++.+++|+.|++++|.++..+..
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~ 138 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL 138 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC
T ss_pred cccccc-cccc-hhhhccceeeccccccccccccc
Confidence 999998 5564 67899999999999998866554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=1.3e-10 Score=99.16 Aligned_cols=67 Identities=28% Similarity=0.317 Sum_probs=29.4
Q ss_pred cCCccccccccccccccCC--CCcccccccccceeeccCcccCCCCCcccccCCCCceEecccccccCC
Q 010429 114 GNLTNLVSLDLYLNNLNGP--IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGD 180 (511)
Q Consensus 114 ~~l~~L~~L~Ls~N~i~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 180 (511)
..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|++++.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence 3444555555555555432 123344445555555555555432221222233455555555555433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.70 E-value=1.9e-08 Score=96.32 Aligned_cols=99 Identities=29% Similarity=0.313 Sum_probs=81.1
Q ss_pred CCCcEEEeeccCCCCCCCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCcccccCCCCceEec
Q 010429 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDL 172 (511)
Q Consensus 93 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 172 (511)
.+|+.|+|++|.++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 36899999999999 67864 578999999999999 778764 57899999999998 44431 257999999
Q ss_pred ccccccCCCCCCCCCCcccceeccCCCCCCCC
Q 010429 173 SNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 204 (511)
Q Consensus 173 ~~N~l~~~~~~~~~~~~l~~l~l~~N~~~~~~ 204 (511)
++|.++..+ ....+++|+.|++++|.+...+
T Consensus 106 ~~n~l~~lp-~~~~l~~L~~L~l~~~~~~~~~ 136 (353)
T d1jl5a_ 106 SNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLP 136 (353)
T ss_dssp CSSCCSSCC-CCTTCTTCCEEECCSSCCSCCC
T ss_pred ccccccccc-chhhhccceeeccccccccccc
Confidence 999998654 5678899999999999886544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=2.5e-09 Score=100.03 Aligned_cols=37 Identities=22% Similarity=0.266 Sum_probs=26.7
Q ss_pred ccCCCCceEecccc-cccCC-CCCCCCCCcccceeccCC
Q 010429 162 TNVNSLQVLDLSNN-KLTGD-IPTNGSFSLFTPISFANN 198 (511)
Q Consensus 162 ~~l~~L~~L~l~~N-~l~~~-~~~~~~~~~l~~l~l~~N 198 (511)
.++++|+.|++++| .+++. +..+..+++|++|+++++
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence 45788999999886 46643 334567788888888884
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=2.2e-09 Score=91.28 Aligned_cols=92 Identities=25% Similarity=0.167 Sum_probs=70.4
Q ss_pred ecchhhcCCCCCcEEEeeccCCCCC--CCchhcCCccccccccccccccCCCCcccccccccceeeccCcccCCCCCc--
Q 010429 84 QLVSQLGQLTNLQYLELYSNNISGK--VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPR-- 159 (511)
Q Consensus 84 ~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-- 159 (511)
.++..+..+++|+.|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|.+......
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~ 135 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQS 135 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccch
Confidence 4455567899999999999999954 345678899999999999999954443455567899999999999865543
Q ss_pred -----ccccCCCCceEecccccc
Q 010429 160 -----SLTNVNSLQVLDLSNNKL 177 (511)
Q Consensus 160 -----~~~~l~~L~~L~l~~N~l 177 (511)
.+..+|+|+.|| ++.+
T Consensus 136 ~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 136 TYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHHTTSTTCCEET--TEEC
T ss_pred hHHHHHHHHCCCCCEEC--cCCC
Confidence 256688888775 4444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=1.9e-09 Score=107.33 Aligned_cols=110 Identities=25% Similarity=0.314 Sum_probs=87.7
Q ss_pred CeeEEecCCCCcceec-chhhcCCCCCcEEEeeccCCCC----CCCchhcCCccccccccccccccCC----CCcccc-c
Q 010429 70 SVTRVDLGNANLSGQL-VSQLGQLTNLQYLELYSNNISG----KVPEELGNLTNLVSLDLYLNNLNGP----IPTTLG-K 139 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~~-~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~-~ 139 (511)
+|+.||++.|++++.. ...+..+++|+.|+|++|.|+. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998643 4557788999999999999983 3456678899999999999998732 122222 2
Q ss_pred ccccceeeccCcccCCC----CCcccccCCCCceEecccccccC
Q 010429 140 LSKLRFLRLNNNSLMGE----IPRSLTNVNSLQVLDLSNNKLTG 179 (511)
Q Consensus 140 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~ 179 (511)
.++|+.|+|++|++++. ++..+..+++|+.|+|++|+++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999754 45567889999999999999874
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.52 E-value=2.9e-09 Score=102.42 Aligned_cols=131 Identities=20% Similarity=0.211 Sum_probs=69.7
Q ss_pred CeeEEecCCCCccee----cchhhcCCCCCcEEEeeccCCCCC-----CCchhcCCccccccccccccccCC----CCcc
Q 010429 70 SVTRVDLGNANLSGQ----LVSQLGQLTNLQYLELYSNNISGK-----VPEELGNLTNLVSLDLYLNNLNGP----IPTT 136 (511)
Q Consensus 70 ~l~~l~L~~~~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~i~~~----~p~~ 136 (511)
.++.+++++|.++.. +...+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 455555555555421 223344556667777777666521 223355566677777777766532 2334
Q ss_pred cccccccceeeccCcccCCCCCc----ccc--cCCCCceEecccccccCCC-----CCC-CCCCcccceeccCCCC
Q 010429 137 LGKLSKLRFLRLNNNSLMGEIPR----SLT--NVNSLQVLDLSNNKLTGDI-----PTN-GSFSLFTPISFANNQL 200 (511)
Q Consensus 137 ~~~l~~L~~L~L~~N~l~~~~~~----~~~--~l~~L~~L~l~~N~l~~~~-----~~~-~~~~~l~~l~l~~N~~ 200 (511)
+..+++|++|+|++|.|++.... .+. ..+.|+.|++++|+|+..- ... ..+++|+.|++++|.+
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 55666677777777766543222 222 1245667777777665310 011 1245566677777666
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=2.7e-07 Score=84.53 Aligned_cols=149 Identities=14% Similarity=0.053 Sum_probs=96.3
Q ss_pred HHHHHhhCCCCCCeeccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCC-CCceeccccccccCCce
Q 010429 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 360 (511)
Q Consensus 282 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~ 360 (511)
++....+.|+..+..+.++.+.||+... ++..+++|+..... ......+.+|...+..+. +--+.+++.+...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 3444445666555444445578999875 46677888875432 122224667887776653 33356677777777888
Q ss_pred eEEeecccCCCHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------
Q 010429 361 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH-------------------------------- 408 (511)
Q Consensus 361 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------- 408 (511)
++||+++++..+.+.... ......++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999877554321 112233455555556666542
Q ss_pred ------------------------CCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 409 ------------------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 409 ------------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
....++|+|+.|.||++++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012378999999999999876677999998753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.36 E-value=1.4e-08 Score=97.61 Aligned_cols=85 Identities=21% Similarity=0.208 Sum_probs=39.9
Q ss_pred CccccccccccccccCC----CCcccccccccceeeccCcccCCC-----CCcccccCCCCceEecccccccCC-----C
Q 010429 116 LTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSLMGE-----IPRSLTNVNSLQVLDLSNNKLTGD-----I 181 (511)
Q Consensus 116 l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~-----~ 181 (511)
.+.|+.|++++|+++.. +...+..++.|+.|+|++|+|... +...+..+++|+.|+|++|.++.. .
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 34455555555554421 122233445566666666655421 222344555566666666655421 1
Q ss_pred CCCCCCCcccceeccCCCC
Q 010429 182 PTNGSFSLFTPISFANNQL 200 (511)
Q Consensus 182 ~~~~~~~~l~~l~l~~N~~ 200 (511)
..+..+++|+.|++++|.+
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i 255 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLL 255 (344)
T ss_dssp HHGGGCTTCCEEECTTCCC
T ss_pred ccccccccchhhhhhcCcc
Confidence 1123345555666655544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.25 E-value=1.7e-08 Score=100.38 Aligned_cols=109 Identities=24% Similarity=0.233 Sum_probs=83.7
Q ss_pred CCCcEEEeeccCCCCCC-CchhcCCccccccccccccccC----CCCcccccccccceeeccCcccCCC----CCcccc-
Q 010429 93 TNLQYLELYSNNISGKV-PEELGNLTNLVSLDLYLNNLNG----PIPTTLGKLSKLRFLRLNNNSLMGE----IPRSLT- 162 (511)
Q Consensus 93 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~- 162 (511)
++|+.|||++|++++.. ...+..+++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999999532 3446778999999999999883 3455678899999999999999642 222232
Q ss_pred cCCCCceEecccccccCCC-----CCCCCCCcccceeccCCCCC
Q 010429 163 NVNSLQVLDLSNNKLTGDI-----PTNGSFSLFTPISFANNQLN 201 (511)
Q Consensus 163 ~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~l~l~~N~~~ 201 (511)
...+|+.|+|++|++++.. ..+..+++|+.|++++|.+.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 2358999999999997542 23456789999999999873
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=2.8e-07 Score=85.63 Aligned_cols=131 Identities=20% Similarity=0.258 Sum_probs=86.8
Q ss_pred CCCeeEEecCCC-Cccee-cchhhcCCCCCcEEEeecc-CCCCC-CCchhcC-Cccccccccccc--cccCC-CCccccc
Q 010429 68 ENSVTRVDLGNA-NLSGQ-LVSQLGQLTNLQYLELYSN-NISGK-VPEELGN-LTNLVSLDLYLN--NLNGP-IPTTLGK 139 (511)
Q Consensus 68 ~~~l~~l~L~~~-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~i~~~-~p~~~~~ 139 (511)
.++++.|+|++| +++.. +...+..+++|+.|+|+++ .++.. +...+.. .++|+.|+++++ .++.. +.....+
T Consensus 94 ~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~ 173 (284)
T d2astb2 94 NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR 173 (284)
T ss_dssp CTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHH
T ss_pred CCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccc
Confidence 357899999885 56532 2233457888999999885 45421 2222333 467888888864 34422 2333456
Q ss_pred ccccceeeccCc-ccCCCCCcccccCCCCceEeccc-ccccCCC-CCCCCCCcccceeccCC
Q 010429 140 LSKLRFLRLNNN-SLMGEIPRSLTNVNSLQVLDLSN-NKLTGDI-PTNGSFSLFTPISFANN 198 (511)
Q Consensus 140 l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~-~~~~~~~~l~~l~l~~N 198 (511)
+++|++|+|++| .+++.....+..+++|++|+|++ +.+++.. .....+++|+.|++.++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 788888888886 47767777788888888888888 4566432 23456778888888776
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=1.6e-06 Score=78.67 Aligned_cols=74 Identities=11% Similarity=0.028 Sum_probs=52.0
Q ss_pred eeccccc-cEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCC--ceeccccccccCCceeEEeecccCCC
Q 010429 295 ILGRGGF-GKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR--NLLRLRGFCMTPTERLLVYPFMVNGS 371 (511)
Q Consensus 295 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~l~~~~~~~~~~~lv~e~~~~gs 371 (511)
.+..|.. +.||+...+++..+++|........ .+..|...++.+... .+.+++.+..+++..+++|+|++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3455554 6799999888888999987654322 356777777665432 35667777777788899999998765
Q ss_pred H
Q 010429 372 V 372 (511)
Q Consensus 372 L 372 (511)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.03 E-value=6.9e-07 Score=75.76 Aligned_cols=107 Identities=15% Similarity=0.140 Sum_probs=58.7
Q ss_pred CCeeEEecCCC-Cccee----cchhhcCCCCCcEEEeeccCCCC----CCCchhcCCccccccccccccccCC----CCc
Q 010429 69 NSVTRVDLGNA-NLSGQ----LVSQLGQLTNLQYLELYSNNISG----KVPEELGNLTNLVSLDLYLNNLNGP----IPT 135 (511)
Q Consensus 69 ~~l~~l~L~~~-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~i~~~----~p~ 135 (511)
+++++|+|+++ .++.. +...+...+.|+.|+|++|.++. .+...+...+.|++|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 46777777764 35422 23445566677777777777662 2333445556677777777766632 122
Q ss_pred ccccccccceeeccCcccCCC-------CCcccccCCCCceEecccc
Q 010429 136 TLGKLSKLRFLRLNNNSLMGE-------IPRSLTNVNSLQVLDLSNN 175 (511)
Q Consensus 136 ~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~l~~N 175 (511)
.+...+.|++|+|++|.+... +...+...++|+.|+++.+
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 344455666666666654421 1223333455666655444
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.85 E-value=2.7e-05 Score=75.22 Aligned_cols=76 Identities=11% Similarity=-0.027 Sum_probs=46.9
Q ss_pred CeeccccccEEEEEEeCC-CCEEEEEEecccc------cchhHHHHHHHHHHHHhCC-C--CceeccccccccCCceeEE
Q 010429 294 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEER------TQGGELQFQTEVEMISMAV-H--RNLLRLRGFCMTPTERLLV 363 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~~~-h--~niv~l~~~~~~~~~~~lv 363 (511)
+.||.|....||++...+ ++.++||.-.... ......+...|.+.++.+. + ..+.+++.+ +++..+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998764 6789999754211 1112223456777776542 2 334555543 45567899
Q ss_pred eecccCCC
Q 010429 364 YPFMVNGS 371 (511)
Q Consensus 364 ~e~~~~gs 371 (511)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.56 E-value=8.5e-06 Score=68.74 Aligned_cols=91 Identities=18% Similarity=0.193 Sum_probs=67.2
Q ss_pred hcCCCCCcEEEeecc-CCCCC----CCchhcCCccccccccccccccCC----CCcccccccccceeeccCcccCCC---
Q 010429 89 LGQLTNLQYLELYSN-NISGK----VPEELGNLTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNSLMGE--- 156 (511)
Q Consensus 89 ~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~~~--- 156 (511)
..+.+.|+.|+|+++ .++.. +-..+...++|+.|+|++|.++.. +.+.+...+.|+.|+|++|.|++.
T Consensus 11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 346789999999974 56632 334567788999999999998742 334455678899999999998853
Q ss_pred -CCcccccCCCCceEecccccccC
Q 010429 157 -IPRSLTNVNSLQVLDLSNNKLTG 179 (511)
Q Consensus 157 -~~~~~~~l~~L~~L~l~~N~l~~ 179 (511)
+-..+...+.|+.|+|++|.+..
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~~ 114 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQSV 114 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCC
T ss_pred HHHHHHHhCCcCCEEECCCCcCCC
Confidence 22356667889999999887653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.46 E-value=0.00021 Score=66.86 Aligned_cols=137 Identities=16% Similarity=0.134 Sum_probs=77.6
Q ss_pred ccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCce--ecccc-----ccccCCceeEEeecccCCCHH
Q 010429 301 FGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL--LRLRG-----FCMTPTERLLVYPFMVNGSVA 373 (511)
Q Consensus 301 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~ 373 (511)
--.||++..++|..+++|+.+..... ..++..|...+..+....+ +..+. .....+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 35899999999999999998765432 3457778887776653322 22221 112345567889998764221
Q ss_pred -----H---------HHHh----cC-CCCCCCC-------------------HHHHHHHHHHHHHHHHHHHh----CCCC
Q 010429 374 -----S---------CLRE----RG-QSQPPLN-------------------WSVRKQIALGAARGLAYLHD----HCDP 411 (511)
Q Consensus 374 -----~---------~l~~----~~-~~~~~l~-------------------~~~~~~i~~~i~~~L~~LH~----~~~~ 411 (511)
. .++. .. ......+ ......+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 0 1111 00 0011111 11122222223333333332 2244
Q ss_pred CeEecCCCCCCeeeCCCCceEEcccccccc
Q 010429 412 KIIHRDVKAANILLDEEFEAVVGDFGLAKL 441 (511)
Q Consensus 412 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 441 (511)
+++|+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 89999999999999754 46899998763
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.46 E-value=8.5e-06 Score=68.65 Aligned_cols=109 Identities=19% Similarity=0.212 Sum_probs=62.7
Q ss_pred CCeeEEecCC-CCccee----cchhhcCCCCCcEEEeeccCCCCC----CCchhcCCccccccccccccccCC----CCc
Q 010429 69 NSVTRVDLGN-ANLSGQ----LVSQLGQLTNLQYLELYSNNISGK----VPEELGNLTNLVSLDLYLNNLNGP----IPT 135 (511)
Q Consensus 69 ~~l~~l~L~~-~~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~i~~~----~p~ 135 (511)
++++.|+|++ +.++.. +...+...++|+.|+|++|.++.. +...+...++|+.|++++|.++.. +..
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4677777776 445422 234455677777777777777632 223445566777777777776532 223
Q ss_pred ccccccccceeec--cCcccCCC----CCcccccCCCCceEecccccc
Q 010429 136 TLGKLSKLRFLRL--NNNSLMGE----IPRSLTNVNSLQVLDLSNNKL 177 (511)
Q Consensus 136 ~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l 177 (511)
.+...++|+.++| ++|.+... +...+...+.|+.|+++.|..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 4555666665433 45555431 233444566677776665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.16 E-value=7.8e-06 Score=68.90 Aligned_cols=117 Identities=17% Similarity=0.191 Sum_probs=81.8
Q ss_pred ceecchhhcCCCCCcEEEeec-cCCCCC----CCchhcCCccccccccccccccCC----CCcccccccccceeeccCcc
Q 010429 82 SGQLVSQLGQLTNLQYLELYS-NNISGK----VPEELGNLTNLVSLDLYLNNLNGP----IPTTLGKLSKLRFLRLNNNS 152 (511)
Q Consensus 82 ~~~~~~~~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~N~ 152 (511)
...+.....+.+.|+.|+|++ |.++.. +-..+...++|++|+|++|.++.. +-+.+...+.|+.|++++|.
T Consensus 6 ~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~ 85 (166)
T d1io0a_ 6 EETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF 85 (166)
T ss_dssp HHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred HHHHHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccc
Confidence 334445566789999999998 567622 344567889999999999998743 22345667899999999999
Q ss_pred cCCC----CCcccccCCCCceEec--ccccccCCC-----CCCCCCCcccceeccCC
Q 010429 153 LMGE----IPRSLTNVNSLQVLDL--SNNKLTGDI-----PTNGSFSLFTPISFANN 198 (511)
Q Consensus 153 l~~~----~~~~~~~l~~L~~L~l--~~N~l~~~~-----~~~~~~~~l~~l~l~~N 198 (511)
+... +...+...++|+.++| ++|.+.... ......++|+.|+++.+
T Consensus 86 ~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 86 ISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp CCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred ccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 8753 3356677889998666 466775311 11234577888887655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.85 E-value=0.006 Score=56.16 Aligned_cols=159 Identities=10% Similarity=0.027 Sum_probs=80.3
Q ss_pred cCHHHHHHHhhCCCCCCe-----eccccccEEEEEEeCCCCEEEEEEecccccchhHHHHHHHHHHHHhCCCCce--ecc
Q 010429 278 FSLRELQVATDNFSNRNI-----LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL--LRL 350 (511)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni--v~l 350 (511)
.+.++++....+|.+.+. |..|---+.|+.+..+| .+++|++....... ++..|++++..+...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCHH---HHHHHHHHHHhhhhcccccccc
Confidence 355677777778877554 34566677899987655 48999886543222 34456666665543321 111
Q ss_pred ccc------cccCCceeEEeecccCCCHH--------------HHHHhcCCC-C----CCC------------------C
Q 010429 351 RGF------CMTPTERLLVYPFMVNGSVA--------------SCLRERGQS-Q----PPL------------------N 387 (511)
Q Consensus 351 ~~~------~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~~-~----~~l------------------~ 387 (511)
+.. .........++.+..+.... ..++..... . ... .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 111 11123445666666553221 011110000 0 000 0
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 010429 388 WSVRKQIALGAARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 440 (511)
Q Consensus 388 ~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 440 (511)
.......+......+.-.+ ...+.+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111111222222222222 1234489999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.51 E-value=0.003 Score=60.41 Aligned_cols=72 Identities=14% Similarity=0.185 Sum_probs=47.3
Q ss_pred CeeccccccEEEEEEeCC--------CCEEEEEEecccccchhHHHHHHHHHHHHhCCCCcee-ccccccccCCceeEEe
Q 010429 294 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVY 364 (511)
Q Consensus 294 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv-~l~~~~~~~~~~~lv~ 364 (511)
+.|+.|-.-.+|++...+ .+.|.+++.-. .. ......+|..+++.+.-.+++ ++++++. -.+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PE-TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 568888899999998653 24566666542 12 223466788888877544443 5666653 37899
Q ss_pred ecccCCCH
Q 010429 365 PFMVNGSV 372 (511)
Q Consensus 365 e~~~~gsL 372 (511)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|